<!DOCTYPE html>
<!-- saved from url=(0062)http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039 -->
<html lang="en" class="pb-page gr__pubs_acs_org" data-request-id="5766e1c2-946f-4992-8d67-8732f6d2008d"><head data-pb-dropzone="head"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script type="text/javascript" src="./test1_files/300lo.json"></script><script type="text/javascript" src="./test1_files/_ate.track.config_resp"></script><script src="./test1_files/4ffda2bef05d1da6300032e0.js" async=""></script><script id="google-api" src="./test1_files/platform.js" gapi_processed="true"></script><script id="facebook-jssdk" src="./test1_files/sdk.js"></script><script id="twitter-wjs" src="./test1_files/widgets.js"></script><script src="./test1_files/osd.js"></script><script type="text/javascript" async="" src="./test1_files/elqCfg.min.js"></script><script src="./test1_files/ads"></script><meta name="pbContext" content=";issue:issue:10.1021/mpohbp.2017.14.issue-7;page:string:Article/Chapter View;journal:journal:mpohbp;wgroup:string:ACHS website Group;article:article:10.1021/acs.molpharmaceut.7b00039;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"><meta data-pb-head="head-widgets-start">
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="dc.Title" content="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><meta name="dc.Creator" content="Hanah Mesallati"><meta name="dc.Creator" content="Anita Umerska"><meta name="dc.Creator" content="Krzysztof J. Paluch"><meta name="dc.Creator" content="Lidia Tajber"><meta name="dc.Subject" content="ciprofloxacin; amorphous solid dispersion; polymer; polymeric drug salts; solubility; PAMPA"><meta name="dc.Description" content="Ciprofloxacin (CIP) is a poorly soluble drug that also displays poor permeability. Attempts to improve the solubility of this drug to date have largely focused on the formation of crystalline salts and metal complexes. The aim of this study was to prepare amorphous solid dispersions (ASDs) by ball milling CIP with various polymers. Following examination of their solid state characteristics and physical stability, the solubility advantage of these ASDs was studied, and their permeability was investigated via parallel artificial membrane permeability assay (PAMPA). Finally, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the ASDs were compared to those of CIP. It was discovered that acidic polymers, such as Eudragit L100, Eudragit L100-55, Carbopol, and HPMCAS, were necessary for the amorphization of CIP. In each case, the positively charged secondary amine of CIP was found to interact with carboxylate groups in the polymers, forming amorphous polymeric drug salts...."><meta name="dc.Description" content=""><meta name="dc.Publisher" content="American Chemical Society"><meta name="dc.Date" scheme="WTN8601" content="June 9, 2017"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.molpharmaceut.7b00039"><meta name="dc.Language" content="EN"><meta name="dc.Coverage" content="world"><meta name="keywords" content="ciprofloxacin, amorphous solid dispersion, polymer, polymeric drug salts, solubility, PAMPA">
        
        

        
            <link rel="meta" type="application/atom+xml" href="http://dx.doi.org/10.1021%2Facs.molpharmaceut.7b00039">
            <link rel="meta" type="application/rdf+json" href="http://dx.doi.org/10.1021%2Facs.molpharmaceut.7b00039">
            <link rel="meta" type="application/unixref+xml" href="http://dx.doi.org/10.1021%2Facs.molpharmaceut.7b00039">
        
    <title>Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin - Molecular Pharmaceutics (ACS Publications)</title>



































<meta data-pb-head="head-widgets-end">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<link rel="stylesheet" type="text/css" href="./test1_files/product.css"><link rel="stylesheet" type="text/css" href="./test1_files/head_1_46_183_298.css" id="pb-css" data-pb-css-id="t1500992084671-v1497472240000/head_1_46_183_298.css">


<script async="" src="./test1_files/analytics.js"></script><script async="" type="text/javascript" src="./test1_files/gpt.js"></script><script type="text/javascript" src="./test1_files/product.js"></script>
<script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script>
<meta http-equiv="X-UA-Compatible" content="IE=edge">









    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                                (i[r].q = i[r].q || []).push(arguments)
                            }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                        
                        
                                , 'auto'
                            
                        );
                
                ga('send', 'pageview');
            </script>
            
        
    







    
<script src="./test1_files/pubads_impl_140.js" async=""></script><script type="text/javascript" src="./test1_files/addthis_widget.js" async=""></script><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MathJax_Preview .MJXf-math {color: inherit!important}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><script id="altmetric-embed-js" src="./test1_files/altmetric_badges-371ee1d310707290b26c075361d4d83e.js"></script><meta property="og:image" content="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627/images/medium/mp-2017-00039m_0009.gif&quot;/"><meta property="og:title" content="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><meta property="og:description" content="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><meta property="og:url" content="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039"><meta property="”og:type”" content="”article&quot;/"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content="@ACHS"><meta name="twitter:image" content="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627/images/medium/mp-2017-00039m_0009.gif"><meta name="twitter:title" content="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><meta name="twitter:description" content="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><script src="./test1_files/snapengage-faq.js" class="lazyload" charset="utf-8"></script><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="./test1_files/embed-2c47105b6381604898bbf8ae8a680350.css"><style type="text/css">.at-icon{fill:#fff;border:0}.at-icon-wrapper{display:inline-block;overflow:hidden}a .at-icon-wrapper{cursor:pointer}.at-rounded,.at-rounded-element .at-icon-wrapper{border-radius:12%}.at-circular,.at-circular-element .at-icon-wrapper{border-radius:50%}.addthis_32x32_style .at-icon{width:2pc;height:2pc}.addthis_24x24_style .at-icon{width:24px;height:24px}.addthis_20x20_style .at-icon{width:20px;height:20px}.addthis_16x16_style .at-icon{width:1pc;height:1pc}#at16lb{display:none;position:absolute;top:0;left:0;width:100%;height:100%;z-index:1001;background-color:#000;opacity:.001}#at_complete,#at_error,#at_share,#at_success{position:static!important}.at15dn{display:none}#at15s,#at16p,#at16p form input,#at16p label,#at16p textarea,#at_share .at_item{font-family:arial,helvetica,tahoma,verdana,sans-serif!important;font-size:9pt!important;outline-style:none;outline-width:0;line-height:1em}* html #at15s.mmborder{position:absolute!important}#at15s.mmborder{position:fixed!important;width:250px!important}#at15s{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);float:none;line-height:1em;margin:0;overflow:visible;padding:5px;text-align:left;position:absolute}#at15s a,#at15s span{outline:0;direction:ltr;text-transform:none}#at15s .at-label{margin-left:5px}#at15s .at-icon-wrapper{width:1pc;height:1pc;vertical-align:middle}#at15s .at-icon{width:1pc;height:1pc}.at4-icon{display:inline-block;background-repeat:no-repeat;background-position:top left;margin:0;overflow:hidden;cursor:pointer}.addthis_16x16_style .at4-icon,.addthis_default_style .at4-icon,.at4-icon,.at-16x16{width:1pc;height:1pc;line-height:1pc;background-size:1pc!important}.addthis_32x32_style .at4-icon,.at-32x32{width:2pc;height:2pc;line-height:2pc;background-size:2pc!important}.addthis_24x24_style .at4-icon,.at-24x24{width:24px;height:24px;line-height:24px;background-size:24px!important}.addthis_20x20_style .at4-icon,.at-20x20{width:20px;height:20px;line-height:20px;background-size:20px!important}.at4-icon.circular,.circular .at4-icon,.circular.aticon{border-radius:50%}.at4-icon.rounded,.rounded .at4-icon{border-radius:4px}.at4-icon-left{float:left}#at15s .at4-icon{text-indent:20px;padding:0;overflow:visible;white-space:nowrap;background-size:1pc;width:1pc;height:1pc;background-position:top left;display:inline-block;line-height:1pc}.addthis_vertical_style .at4-icon,.at4-follow-container .at4-icon{margin-right:5px}html>body #at15s{width:250px!important}#at15s.atm{background:none!important;padding:0!important;width:10pc!important}#at15s_inner{background:#fff;border:1px solid #fff;margin:0}#at15s_head{position:relative;background:#f2f2f2;padding:4px;cursor:default;border-bottom:1px solid #e5e5e5}.at15s_head_success{background:#cafd99!important;border-bottom:1px solid #a9d582!important}.at15s_head_success a,.at15s_head_success span{color:#000!important;text-decoration:none}#at15s_brand,#at15sptx,#at16_brand{position:absolute}#at15s_brand{top:4px;right:4px}.at15s_brandx{right:20px!important}a#at15sptx{top:4px;right:4px;text-decoration:none;color:#4c4c4c;font-weight:700}#at15sptx:hover{text-decoration:underline}#at16_brand{top:5px;right:30px;cursor:default}#at_hover{padding:4px}#at_hover .at_item,#at_share .at_item{background:#fff!important;float:left!important;color:#4c4c4c!important}#at_share .at_item .at-icon-wrapper{margin-right:5px}#at_hover .at_bold{font-weight:700;color:#000!important}#at_hover .at_item{width:7pc!important;padding:2px 3px!important;margin:1px;text-decoration:none!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover{margin:0!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover,#at_share .at_item.athov,#at_share .at_item:hover{background:#f2f2f2!important;border:1px solid #e5e5e5;color:#000!important;text-decoration:none}.ipad #at_hover .at_item:focus{background:#fff!important;border:1px solid #fff}.at15t{display:block!important;height:1pc!important;line-height:1pc!important;padding-left:20px!important;background-position:0 0;text-align:left}.addthis_button,.at15t{cursor:pointer}.addthis_toolbox a.at300b,.addthis_toolbox a.at300m{width:auto}.addthis_toolbox a{margin-bottom:5px;line-height:initial}.addthis_toolbox.addthis_vertical_style{width:200px}.addthis_button_facebook_like .fb_iframe_widget{line-height:100%}.addthis_button_facebook_like iframe.fb_iframe_widget_lift{max-width:none}.addthis_toolbox a.addthis_button_counter,.addthis_toolbox a.addthis_button_facebook_like,.addthis_toolbox a.addthis_button_facebook_send,.addthis_toolbox a.addthis_button_facebook_share,.addthis_toolbox a.addthis_button_foursquare,.addthis_toolbox a.addthis_button_google_plusone,.addthis_toolbox a.addthis_button_linkedin_counter,.addthis_toolbox a.addthis_button_pinterest_pinit,.addthis_toolbox a.addthis_button_stumbleupon_badge,.addthis_toolbox a.addthis_button_tweet{display:inline-block}.at-share-tbx-element .google_plusone_iframe_widget>span>div{vertical-align:top!important}.addthis_toolbox span.addthis_follow_label{display:none}.addthis_toolbox.addthis_vertical_style span.addthis_follow_label{display:block;white-space:nowrap}.addthis_toolbox.addthis_vertical_style a{display:block}.addthis_toolbox.addthis_vertical_style.addthis_32x32_style a{line-height:2pc;height:2pc}.addthis_toolbox.addthis_vertical_style .at300bs{margin-right:4px;float:left}.addthis_toolbox.addthis_20x20_style span{line-height:20px}.addthis_toolbox.addthis_32x32_style span{line-height:2pc}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact,.addthis_toolbox.addthis_pill_combo_style a{float:left}.addthis_toolbox.addthis_pill_combo_style a.addthis_button_tweet{margin-top:-2px}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact{margin-right:4px}.addthis_default_style .addthis_separator{margin:0 5px;display:inline}div.atclear{clear:both}.addthis_default_style .addthis_separator,.addthis_default_style .at4-icon,.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300bs,.addthis_default_style .at300m{float:left}.at300b img,.at300bo img{border:0}a.at300b .at4-icon,a.at300m .at4-icon{display:block}.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300m{padding:0 2px}.at300b,.at300bo,.at300bs,.at300m{cursor:pointer}.addthis_button_facebook_like.at300b:hover,.addthis_button_facebook_like.at300bs:hover,.addthis_button_facebook_send.at300b:hover,.addthis_button_facebook_send.at300bs:hover{opacity:1}.addthis_20x20_style .at15t,.addthis_20x20_style .at300bs{overflow:hidden;display:block;height:20px!important;width:20px!important;line-height:20px!important}.addthis_32x32_style .at15t,.addthis_32x32_style .at300bs{overflow:hidden;display:block;height:2pc!important;width:2pc!important;line-height:2pc!important}.at300bs{overflow:hidden;display:block;background-position:0 0;height:1pc;width:1pc;line-height:1pc!important}.addthis_default_style .at15t_compact,.addthis_default_style .at15t_expanded{margin-right:4px}#at_share .at_item{width:123px!important;padding:4px;margin-right:2px;border:1px solid #fff}#at16p{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);z-index:10000001;position:absolute;top:50%;left:50%;width:300px;padding:10px;margin:0 auto;margin-top:-185px;margin-left:-155px;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#5e5e5e}#at_share{margin:0;padding:0}#at16pt{position:relative;background:#f2f2f2;height:13px;padding:5px 10px}#at16pt a,#at16pt h4{font-weight:700}#at16pt h4{display:inline;margin:0;padding:0;font-size:9pt;color:#4c4c4c;cursor:default}#at16pt a{position:absolute;top:5px;right:10px;color:#4c4c4c;text-decoration:none;padding:2px}#at15sptx:focus,#at16pt a:focus{outline:thin dotted}#at15s #at16pf a{top:1px}#_atssh{width:1px!important;height:1px!important;border:0!important}.atm{width:10pc!important;padding:0;margin:0;line-height:9pt;letter-spacing:normal;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#444;background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);padding:4px}.atm-f{text-align:right;border-top:1px solid #ddd;padding:5px 8px}.atm-i{background:#fff;border:1px solid #d5d6d6;padding:0;margin:0;box-shadow:1px 1px 5px rgba(0,0,0,.15)}.atm-s{margin:0!important;padding:0!important}.atm-s a:focus{border:transparent;outline:0;-webkit-transition:none;transition:none}#at_hover.atm-s a,.atm-s a{display:block;text-decoration:none;padding:4px 10px;color:#235dab!important;font-weight:400;font-style:normal;-webkit-transition:none;transition:none}#at_hover.atm-s .at_bold{color:#235dab!important}#at_hover.atm-s a:hover,.atm-s a:hover{background:#2095f0;text-decoration:none;color:#fff!important}#at_hover.atm-s .at_bold{font-weight:700}#at_hover.atm-s a:hover .at_bold{color:#fff!important}.atm-s a .at-label{vertical-align:middle;margin-left:5px;direction:ltr}.at_PinItButton{display:block;width:40px;height:20px;padding:0;margin:0;background-image:url(//s7.addthis.com/static/t00/pinit00.png);background-repeat:no-repeat}.at_PinItButton:hover{background-position:0 -20px}.addthis_toolbox .addthis_button_pinterest_pinit{position:relative}.at-share-tbx-element .fb_iframe_widget span{vertical-align:baseline!important}#at16pf{height:auto;text-align:right;padding:4px 8px}.at-privacy-info{position:absolute;left:7px;bottom:7px;cursor:pointer;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:10px;line-height:9pt;letter-spacing:.2px;color:#666}.at-privacy-info:hover{color:#000}.body .wsb-social-share .wsb-social-share-button-vert{padding-top:0;padding-bottom:0}.body .wsb-social-share.addthis_counter_style .addthis_button_tweet.wsb-social-share-button{padding-top:40px}.body .wsb-social-share.addthis_counter_style .addthis_button_google_plusone.wsb-social-share-button{padding-top:0}.body .wsb-social-share.addthis_counter_style .addthis_button_facebook_like.wsb-social-share-button{padding-top:21px}@media print{#at4-follow,#at4-share,#at4-thankyou,#at4-whatsnext,#at4m-mobile,#at15s,.at4,.at4-recommended{display:none!important}}@media screen and (max-width:400px){.at4win{width:100%}}@media screen and (max-height:700px) and (max-width:400px){.at4-thankyou-inner .at4-recommended-container{height:122px;overflow:hidden}.at4-thankyou-inner .at4-recommended .at4-recommended-item:first-child{border-bottom:1px solid #c5c5c5}}</style><style type="text/css">.at-branding-logo{font-family:helvetica,arial,sans-serif;text-decoration:none;font-size:10px;display:inline-block;margin:2px 0;letter-spacing:.2px}.at-branding-logo .at-branding-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAMAAAC67D+PAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAAZQTFRF////+GlNUkcc1QAAAB1JREFUeNpiYIQDBjQmAwMmkwEM0JnY1WIxFyDAABGeAFEudiZsAAAAAElFTkSuQmCC")}.at-branding-logo .at-branding-icon,.at-branding-logo .at-privacy-icon{display:inline-block;height:10px;width:10px;margin-left:4px;margin-right:3px;margin-bottom:-1px;background-repeat:no-repeat}.at-branding-logo .at-privacy-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAkAAAAKCAMAAABR24SMAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABhQTFRF8fr9ot/xXcfn2/P5AKva////////AKTWodjhjAAAAAd0Uk5T////////ABpLA0YAAAA6SURBVHjaJMzBDQAwCAJAQaj7b9xifV0kUKJ9ciWxlzWEWI5gMF65KUTv0VKkjVeTerqE/x7+9BVgAEXbAWI8QDcfAAAAAElFTkSuQmCC")}.at-branding-logo span{text-decoration:none}.at-branding-logo .at-branding-addthis,.at-branding-logo .at-branding-powered-by{color:#666}.at-branding-logo .at-branding-addthis:hover{color:#333}.at-cv-with-image .at-branding-addthis,.at-cv-with-image .at-branding-addthis:hover{color:#fff}a.at-branding-logo:visited{color:initial}.at-branding-info{display:inline-block;padding:0 5px;color:#666;border:1px solid #666;border-radius:50%;font-size:10px;line-height:9pt;opacity:.7;transition:all .3s ease;text-decoration:none}.at-branding-info span{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}.at-branding-info:before{content:'i';font-family:Times New Roman}.at-branding-info:hover{color:#0780df;border-color:#0780df}</style><script type="text/javascript" charset="utf-8" async="" src="./test1_files/commons.8a198992fcc7f532786f.js"></script><script type="text/javascript" charset="utf-8" async="" src="./test1_files/old_files_viewer.7a56e8125c5d0d580b73.js"></script><style type="text/css">.leaflet-image-layer,.leaflet-layer,.leaflet-map-pane,.leaflet-marker-icon,.leaflet-marker-pane,.leaflet-marker-shadow,.leaflet-overlay-pane,.leaflet-overlay-pane svg,.leaflet-popup-pane,.leaflet-shadow-pane,.leaflet-tile,.leaflet-tile-container,.leaflet-tile-pane,.leaflet-zoom-box{position:absolute;left:0;top:0}.leaflet-container{overflow:hidden;-ms-touch-action:none;touch-action:none}.leaflet-marker-icon,.leaflet-marker-shadow,.leaflet-tile{-webkit-user-select:none;-moz-user-select:none;user-select:none;-webkit-user-drag:none}.leaflet-marker-icon,.leaflet-marker-shadow{display:block}.leaflet-container img{max-width:none!important}.leaflet-container img.leaflet-image-layer{max-width:15000px!important}.leaflet-tile{filter:inherit;visibility:hidden}.leaflet-tile-loaded{visibility:inherit}.leaflet-zoom-box{width:0;height:0}.leaflet-overlay-pane svg{-moz-user-select:none}.leaflet-tile-pane{z-index:2}.leaflet-objects-pane{z-index:3}.leaflet-overlay-pane{z-index:4}.leaflet-shadow-pane{z-index:5}.leaflet-marker-pane{z-index:6}.leaflet-popup-pane{z-index:7}.leaflet-vml-shape{width:1px;height:1px}.lvml{behavior:url(#default#VML);display:inline-block;position:absolute}.leaflet-control{position:relative;z-index:7;pointer-events:auto}.leaflet-bottom,.leaflet-top{position:absolute;z-index:1000;pointer-events:none}.leaflet-top{top:0}.leaflet-right{right:0}.leaflet-bottom{bottom:0}.leaflet-left{left:0}.leaflet-control{float:left;clear:both}.leaflet-right .leaflet-control{float:right}.leaflet-top .leaflet-control{margin-top:10px}.leaflet-bottom .leaflet-control{margin-bottom:10px}.leaflet-left .leaflet-control{margin-left:10px}.leaflet-right .leaflet-control{margin-right:10px}.leaflet-fade-anim .leaflet-popup,.leaflet-fade-anim .leaflet-tile{opacity:0;-webkit-transition:opacity .2s linear;-moz-transition:opacity .2s linear;-o-transition:opacity .2s linear;transition:opacity .2s linear}.leaflet-fade-anim .leaflet-map-pane .leaflet-popup,.leaflet-fade-anim .leaflet-tile-loaded{opacity:1}.leaflet-zoom-anim .leaflet-zoom-animated{-webkit-transition:-webkit-transform .25s cubic-bezier(0,0,.25,1);-moz-transition:-moz-transform .25s cubic-bezier(0,0,.25,1);-o-transition:-o-transform .25s cubic-bezier(0,0,.25,1);transition:transform .25s cubic-bezier(0,0,.25,1)}.leaflet-pan-anim .leaflet-tile,.leaflet-touching .leaflet-zoom-animated,.leaflet-zoom-anim .leaflet-tile{-webkit-transition:none;-moz-transition:none;-o-transition:none;transition:none}.leaflet-zoom-anim .leaflet-zoom-hide{visibility:hidden}.leaflet-clickable{cursor:pointer}.leaflet-container{cursor:-webkit-grab;cursor:-moz-grab}.leaflet-control,.leaflet-popup-pane{cursor:auto}.leaflet-dragging .leaflet-clickable,.leaflet-dragging .leaflet-container{cursor:move;cursor:-webkit-grabbing;cursor:-moz-grabbing}.leaflet-container{background:#ddd;outline:0}.leaflet-container a{color:#0078a8}.leaflet-container a.leaflet-active{outline:2px solid orange}.leaflet-zoom-box{border:2px dotted #38f;background:hsla(0,0%,100%,.5)}.leaflet-container{font:12px/1.5 Helvetica Neue,Arial,Helvetica,sans-serif}.leaflet-bar{box-shadow:0 1px 5px rgba(0,0,0,.65);border-radius:4px}.leaflet-bar a,.leaflet-bar a:hover{background-color:#fff;border-bottom:1px solid #ccc;width:26px;height:26px;line-height:26px;display:block;text-align:center;text-decoration:none;color:#000}.leaflet-bar a,.leaflet-control-layers-toggle{background-position:50% 50%;background-repeat:no-repeat;display:block}.leaflet-bar a:hover{background-color:#f4f4f4}.leaflet-bar a:first-child{border-top-left-radius:4px;border-top-right-radius:4px}.leaflet-bar a:last-child{border-bottom-left-radius:4px;border-bottom-right-radius:4px;border-bottom:none}.leaflet-bar a.leaflet-disabled{cursor:default;background-color:#f4f4f4;color:#bbb}.leaflet-touch .leaflet-bar a{width:30px;height:30px;line-height:30px}.leaflet-control-zoom-in,.leaflet-control-zoom-out{font:700 18px Lucida Console,Monaco,monospace;text-indent:1px}.leaflet-control-zoom-out{font-size:20px}.leaflet-touch .leaflet-control-zoom-in{font-size:22px}.leaflet-touch .leaflet-control-zoom-out{font-size:24px}.leaflet-control-layers{box-shadow:0 1px 5px rgba(0,0,0,.4);background:#fff;border-radius:5px}.leaflet-control-layers-toggle{background-image:url(data:image/png;base64,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);width:36px;height:36px}.leaflet-retina .leaflet-control-layers-toggle{background-image:url(data:image/png;base64,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);background-size:26px 26px}.leaflet-touch .leaflet-control-layers-toggle{width:44px;height:44px}.leaflet-control-layers-expanded .leaflet-control-layers-toggle,.leaflet-control-layers .leaflet-control-layers-list{display:none}.leaflet-control-layers-expanded .leaflet-control-layers-list{display:block;position:relative}.leaflet-control-layers-expanded{padding:6px 10px 6px 6px;color:#333;background:#fff}.leaflet-control-layers-selector{margin-top:2px;position:relative;top:1px}.leaflet-control-layers label{display:block}.leaflet-control-layers-separator{height:0;border-top:1px solid #ddd;margin:5px -10px 5px -6px}.leaflet-container .leaflet-control-attribution{background:#fff;background:hsla(0,0%,100%,.7);margin:0}.leaflet-control-attribution,.leaflet-control-scale-line{padding:0 5px;color:#333}.leaflet-control-attribution a{text-decoration:none}.leaflet-control-attribution a:hover{text-decoration:underline}.leaflet-container .leaflet-control-attribution,.leaflet-container .leaflet-control-scale{font-size:11px}.leaflet-left .leaflet-control-scale{margin-left:5px}.leaflet-bottom .leaflet-control-scale{margin-bottom:5px}.leaflet-control-scale-line{border:2px solid #777;border-top:none;line-height:1.1;padding:2px 5px 1px;font-size:11px;white-space:nowrap;overflow:hidden;-moz-box-sizing:content-box;box-sizing:content-box;background:#fff;background:hsla(0,0%,100%,.5)}.leaflet-control-scale-line:not(:first-child){border-top:2px solid #777;border-bottom:none;margin-top:-2px}.leaflet-control-scale-line:not(:first-child):not(:last-child){border-bottom:2px solid #777}.leaflet-touch .leaflet-bar,.leaflet-touch .leaflet-control-attribution,.leaflet-touch .leaflet-control-layers{box-shadow:none}.leaflet-touch .leaflet-bar,.leaflet-touch .leaflet-control-layers{border:2px solid rgba(0,0,0,.2);background-clip:padding-box}.leaflet-popup{position:absolute;text-align:center}.leaflet-popup-content-wrapper{padding:1px;text-align:left;border-radius:12px}.leaflet-popup-content{margin:13px 19px;line-height:1.4}.leaflet-popup-content p{margin:18px 0}.leaflet-popup-tip-container{margin:0 auto;width:40px;height:20px;position:relative;overflow:hidden}.leaflet-popup-tip{width:17px;height:17px;padding:1px;margin:-10px auto 0;-webkit-transform:rotate(45deg);-moz-transform:rotate(45deg);-ms-transform:rotate(45deg);-o-transform:rotate(45deg);transform:rotate(45deg)}.leaflet-popup-content-wrapper,.leaflet-popup-tip{background:#fff;box-shadow:0 3px 14px rgba(0,0,0,.4)}.leaflet-container a.leaflet-popup-close-button{position:absolute;top:0;right:0;padding:4px 4px 0 0;text-align:center;width:18px;height:14px;font:16px/14px Tahoma,Verdana,sans-serif;color:#c3c3c3;text-decoration:none;font-weight:700;background:transparent}.leaflet-container a.leaflet-popup-close-button:hover{color:#999}.leaflet-popup-scrolled{overflow:auto;border-bottom:1px solid #ddd;border-top:1px solid #ddd}.leaflet-oldie .leaflet-popup-content-wrapper{zoom:1}.leaflet-oldie .leaflet-popup-tip{width:24px;margin:0 auto;-ms-filter:"progid:DXImageTransform.Microsoft.Matrix(M11=0.70710678, M12=0.70710678, M21=-0.70710678, M22=0.70710678)";filter:progid:DXImageTransform.Microsoft.Matrix(M11=0.70710678,M12=0.70710678,M21=-0.70710678,M22=0.70710678)}.leaflet-oldie .leaflet-popup-tip-container{margin-top:-1px}.leaflet-oldie .leaflet-control-layers,.leaflet-oldie .leaflet-control-zoom,.leaflet-oldie .leaflet-popup-content-wrapper,.leaflet-oldie .leaflet-popup-tip{border:1px solid #999}.leaflet-div-icon{background:#fff;border:1px solid #666}</style><style type="text/css">.fs-figshare-viewer .fs-archive-display .fs-archive-row>.fs-archive-dir.fs-expanded:before,.fs-figshare-viewer .fs-archive-display .fs-archive-row>.fs-archive-dir:before,.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-next-page:before,.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-prev-page:before,.fs-figshare-viewer .fs-controls-wrapper .fs-trigger:after,.fs-figshare-viewer .fs-controls-wrapper .fs-trigger:before,.fs-figshare-viewer .fs-dataset-display .fs-carousel-left-control:before,.fs-figshare-viewer .fs-dataset-display .fs-carousel-right-control:before,.fs-figshare-viewer .fs-molecule-display .fs-decrease-speed:before,.fs-figshare-viewer .fs-molecule-display .fs-increase-speed:before,.fs-figshare-viewer .fs-molecule-display .fs-pause:before,.fs-figshare-viewer .fs-molecule-display .fs-play:before,.fs-icon-base,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-archive:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-audio:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-dataset:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document_canvas:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document_failsafe:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-graph:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-jupyter:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-kml:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-molecule:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-txt:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-viewer3d:before,figshare-overlay .fs-large-viewer .fs-close-button:after,figshare-overlay .fs-large-viewer .fs-download-button:before,figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination .fs-next-page:before,figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination .fs-prev-page:before,figshare-overlay .fs-large-viewer .fs-hide-full-description:before,figshare-overlay .fs-large-viewer .fs-show-more:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-cite:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-enlarge:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:after,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls .fs-next-page:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls .fs-prev-page:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-share:before,figshare-widget.fs-collection-viewer .fs-file-viewer button.fs-details:before,figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-next-page:before,figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-prev-page:before{font-family:figIcon;speak:none;font-style:normal;font-weight:400;font-variant:normal;text-transform:none;line-height:1;letter-spacing:0;-webkit-font-feature-settings:"liga";-moz-font-feature-settings:"liga=1";-moz-font-feature-settings:"liga";-ms-font-feature-settings:"liga" 1;-o-font-feature-settings:"liga";font-feature-settings:"liga";-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.fs-figshare-viewer{text-align:left}.fs-figshare-viewer .fs-not-previewable{height:100%;position:relative;z-index:1}.fs-figshare-viewer .fs-not-previewable:before{content:'';position:absolute;width:106%;height:1px;background-color:#eee;top:50%;left:-3%;-webkit-transform:rotate(23deg);transform:rotate(23deg)}.fs-figshare-viewer .fs-not-previewable:after{content:'';position:absolute;width:106%;height:1px;background-color:#eee;top:50%;left:-3%;-webkit-transform:rotate(-23deg);transform:rotate(-23deg)}.fs-figshare-viewer .fs-not-previewable .fs-not-previewable-content{display:inline-block;height:100%;width:100%;vertical-align:middle;text-align:center;position:relative;z-index:10;white-space:nowrap}.fs-figshare-viewer .fs-not-previewable .fs-not-previewable-content:before{content:' ';display:inline-block;vertical-align:middle;height:100%}.fs-figshare-viewer .fs-not-previewable .fs-not-previewable-message{background:#fff;box-shadow:0 0 50px 30px #fff;white-space:normal}.fs-figshare-viewer .image-display{overflow:hidden;position:absolute;width:100%;height:100%}.fs-figshare-viewer .fs-image-display img{box-shadow:0 0 7px #c4c4c4;position:absolute;top:50%;left:50%;-webkit-transform:translateY(-50%) translateX(-50%);transform:translateY(-50%) translateX(-50%)}.fs-figshare-viewer .fs-archive-display{height:100%;overflow:auto;font-size:13px}.fs-figshare-viewer .fs-archive-display .fs-archive-table{display:table;width:100%;height:100%;text-align:left}.fs-figshare-viewer .fs-archive-display .fs-archive-row{margin:0 7px;height:28px;line-height:28px;white-space:nowrap}.fs-figshare-viewer .fs-archive-display .fs-archive-row:first-child{border-top:7px solid #fff}.fs-figshare-viewer .fs-archive-display .fs-archive-row:nth-child(even){background:#fff}.fs-figshare-viewer .fs-archive-display .fs-archive-row:nth-child(odd){background:#f5f5f5}.fs-figshare-viewer .fs-archive-display .fs-archive-row>.fs-archive-dir{font-weight:700;cursor:pointer}.fs-figshare-viewer .fs-archive-display .fs-archive-row>.fs-archive-dir:before{content:"\F12F";color:#bbb;font-size:11px;margin-right:7px}.fs-figshare-viewer .fs-archive-display .fs-archive-row>.fs-archive-dir.fs-expanded:before{content:"\F130";color:#bbb;font-size:11px;margin-right:7px}.fs-figshare-viewer .fs-audio-wrapper,.fs-figshare-viewer .fs-media-wrapper{width:100%;height:100%;max-width:100%;max-height:100%}.fs-figshare-viewer .fs-molecule-display{position:relative}.fs-figshare-viewer .fs-molecule-display canvas{background:linear-gradient(0deg,#202020 0,#000 29%,#131313 0,#000 55%)}.fs-figshare-viewer .fs-molecule-display .fs-speed-controls{position:absolute;left:0;bottom:28px;width:100%;height:48px;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-ms-flex-align:center;align-items:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin:0 auto;transition:opacity .3s ease-out;opacity:0}.fs-figshare-viewer .fs-molecule-display.fs-mode-mobile .fs-speed-controls{opacity:1;bottom:21px}.fs-figshare-viewer .fs-molecule-display:hover .fs-speed-controls{transition:opacity .3s ease-in;opacity:1}.fs-figshare-viewer .fs-molecule-display .fs-play{height:48px;background-color:rgba(70,70,70,.55);font-size:21px;color:#fff;cursor:pointer;text-align:center;width:76px;border-radius:3px}.fs-figshare-viewer .fs-molecule-display .fs-play:before{display:inline-block;vertical-align:middle}.fs-figshare-viewer .fs-molecule-display .fs-play[disabled]{cursor:auto;color:#464646}.fs-figshare-viewer .fs-molecule-display .fs-play:focus{outline:none;box-shadow:none}.fs-figshare-viewer .fs-molecule-display .fs-play:before{content:"\F14A"}.fs-figshare-viewer .fs-molecule-display .fs-decrease-speed{height:48px;background-color:rgba(70,70,70,.55);font-size:21px;color:#fff;cursor:pointer;text-align:center;width:56px;border-top-left-radius:3px;border-bottom-left-radius:3px}.fs-figshare-viewer .fs-molecule-display .fs-decrease-speed:before{display:inline-block;vertical-align:middle}.fs-figshare-viewer .fs-molecule-display .fs-decrease-speed[disabled]{cursor:auto;color:#464646}.fs-figshare-viewer .fs-molecule-display .fs-decrease-speed:focus{outline:none;box-shadow:none}.fs-figshare-viewer .fs-molecule-display .fs-decrease-speed:before{line-height:48px;content:"\F163"}.fs-figshare-viewer .fs-molecule-display .fs-increase-speed{height:48px;background-color:rgba(70,70,70,.55);font-size:21px;color:#fff;cursor:pointer;text-align:center;width:56px;border-top-right-radius:3px;border-bottom-right-radius:3px}.fs-figshare-viewer .fs-molecule-display .fs-increase-speed:before{display:inline-block;vertical-align:middle}.fs-figshare-viewer .fs-molecule-display .fs-increase-speed[disabled]{cursor:auto;color:#464646}.fs-figshare-viewer .fs-molecule-display .fs-increase-speed:focus{outline:none;box-shadow:none}.fs-figshare-viewer .fs-molecule-display .fs-increase-speed:before{line-height:48px;content:"\F165"}.fs-figshare-viewer .fs-molecule-display .fs-pause{height:48px;background-color:rgba(70,70,70,.55);font-size:21px;color:#fff;cursor:pointer;text-align:center;width:76px;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:column;-ms-flex-flow:column;flex-flow:column;-webkit-align-items:center;-ms-flex-align:center;align-items:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center}.fs-figshare-viewer .fs-molecule-display .fs-pause:before{display:inline-block;vertical-align:middle}.fs-figshare-viewer .fs-molecule-display .fs-pause[disabled]{cursor:auto;color:#464646}.fs-figshare-viewer .fs-molecule-display .fs-pause:focus{outline:none;box-shadow:none}.fs-figshare-viewer .fs-molecule-display .fs-pause:before{font-size:10px;margin-bottom:4px;content:"\F14D"}.fs-figshare-viewer .fs-molecule-display .fs-pause .fs-speed-indicator{line-height:14px;font-size:13px}.fs-figshare-viewer .fs-molecule-display .fs-pause .fs-speed-indicator.default-speed{font-size:11px}.fs-figshare-viewer .fs-document-display{overflow:auto!important;position:relative}.fs-figshare-viewer .fs-document-display .figshare-loader{overflow:hidden!important}.fs-figshare-viewer .fs-document-display .fs-image-display{position:relative;margin:30px auto;border:1px solid #ddd;box-shadow:0 0 7px #c4c4c4;opacity:.9;transition:opacity 1s,-webkit-transform 1s,-webkit-transform-origin 1s;transition:opacity 1s,transform 1s,transform-origin 1s;transition:opacity 1s,transform 1s,transform-origin 1s,-webkit-transform 1s,-webkit-transform-origin 1s}.fs-figshare-viewer .fs-document-display .fs-image-display.fs-prev-page{-webkit-transform-origin:center bottom;transform-origin:center bottom;-webkit-transform:perspective(600px) rotateX(1deg) translateZ(-2px);transform:perspective(600px) rotateX(1deg) translateZ(-2px)}.fs-figshare-viewer .fs-document-display .fs-image-display.fs-next-page{-webkit-transform-origin:center top;transform-origin:center top;-webkit-transform:perspective(600px) rotateX(-1deg) translateZ(-2px);transform:perspective(600px) rotateX(-1deg) translateZ(-2px)}.fs-figshare-viewer .fs-document-display .fs-image-display.fs-current-page{opacity:1;-webkit-transform:perspective(600px) rotateX(0deg) translateZ(0);transform:perspective(600px) rotateX(0deg) translateZ(0)}.fs-figshare-viewer .fs-document-display .fs-canvas-document-container{overflow:auto;position:absolute}.fs-figshare-viewer .fs-document-display .fs-canvas-document-container .fs-page-wrapper{margin:30px auto;border:1px solid #ddd;box-shadow:0 0 7px #c4c4c4;position:relative}.fs-figshare-viewer .fs-document-display .fs-canvas-document-container .fs-page-wrapper .fs-canvas-clone{position:absolute;top:0;left:0;width:100%;height:100%}.fs-figshare-viewer .fs-text-layer{position:absolute;left:0;top:0;right:0;bottom:0;overflow:hidden;opacity:.2;line-height:1}.fs-figshare-viewer .fs-text-layer>div{color:transparent;position:absolute;white-space:pre;cursor:text;-webkit-transform-origin:0 0;transform-origin:0 0}.fs-figshare-viewer .fs-text-layer .highlight{margin:-1px;padding:1px;border-radius:4px}.fs-figshare-viewer .fs-text-layer .highlight.begin{border-radius:4px 0 0 4px}.fs-figshare-viewer .fs-text-layer .highlight.end{border-radius:0 4px 4px 0}.fs-figshare-viewer .fs-text-layer .highlight.middle{border-radius:0}.fs-figshare-viewer .fs-text-layer ::selection{background:#3496fb}.fs-figshare-viewer .fs-text-layer ::-moz-selection{background:#3496fb}.fs-figshare-viewer .fs-text-layer .endOfContent{display:block;position:absolute;left:0;top:100%;right:0;bottom:0;z-index:-1;cursor:default;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.fs-figshare-viewer .fs-text-layer .endOfContent.active{top:0}.fs-figshare-viewer .fs-dataset-display{overflow:hidden;width:100%;height:100%}.fs-figshare-viewer .fs-dataset-display .fs-sheet-display{position:relative;overflow:auto;height:100%}.fs-figshare-viewer .fs-dataset-display .fs-sheet-wrapper{width:100%}.fs-figshare-viewer .fs-dataset-display .fs-sheet-wrapper table{white-space:normal;text-align:left;min-width:100%;border-collapse:collapse;border-spacing:0;vertical-align:middle;line-height:28px}.fs-figshare-viewer .fs-dataset-display .fs-sheet-wrapper td,.fs-figshare-viewer .fs-dataset-display .fs-sheet-wrapper th{border:1px solid #ccc;padding:.4em .8em;vertical-align:middle;white-space:nowrap}.fs-figshare-viewer .fs-dataset-display .fs-sheet-wrapper th{background:#ddd;font-weight:400;text-align:center;vertical-align:middle}.fs-figshare-viewer .fs-dataset-display .fs-sheet-wrapper tbody th{width:60px}.fs-figshare-viewer .fs-dataset-display .fs-carousel{position:relative;width:100%;height:34px;overflow:hidden}.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper{position:relative;width:100%;height:34px;overflow:hidden;z-index:0}.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active{width:calc(100% - 80px)}.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active:after,.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active:before{z-index:1;content:" ";opacity:0;transition:opacity .5s}.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active:before{position:absolute;top:0;left:0;right:auto;display:block;width:20px;height:34px;background:linear-gradient(90deg,#fff,hsla(0,0%,100%,0))}.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active:after{position:absolute;top:0;left:auto;right:0;display:block;width:20px;height:34px;background:linear-gradient(270deg,#fff,hsla(0,0%,100%,0))}.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active.fs-fade-left:before,.fs-figshare-viewer .fs-dataset-display .fs-carousel-wrapper.fs-controls-active.fs-fade-right:after{opacity:1}.fs-figshare-viewer .fs-dataset-display .fs-carousel-container{position:relative;top:0;display:inline-block;height:34px;text-align:left;white-space:nowrap;z-index:0;transition:left .5s}.fs-figshare-viewer .fs-dataset-display .fs-carousel-controls{position:absolute;top:0;left:auto;right:0;width:80px;height:34px;text-align:center;background:#fff}.fs-figshare-viewer .fs-dataset-display .fs-carousel-left-control,.fs-figshare-viewer .fs-dataset-display .fs-carousel-right-control{width:21px;height:34px;color:#ddd;line-height:34px}.fs-figshare-viewer .fs-dataset-display .fs-carousel-left-control.fs-active,.fs-figshare-viewer .fs-dataset-display .fs-carousel-right-control.fs-active{color:#c74d56;cursor:pointer}.fs-figshare-viewer .fs-dataset-display .fs-carousel-left-control:before{content:"\F107"}.fs-figshare-viewer .fs-dataset-display .fs-carousel-right-control:before{content:"\F108"}.fs-figshare-viewer .fs-dataset-display .fs-carousel{border-top:1px solid #ddd}.fs-figshare-viewer .fs-dataset-display .fs-selector{position:relative;display:inline-block;margin-right:-13px;padding:0 20px;color:#fff;text-align:center;vertical-align:middle;height:24px;width:auto;z-index:0;cursor:pointer}.fs-figshare-viewer .fs-dataset-display .fs-selector:before{left:0;right:0;bottom:0;border-top:24px solid #c74d56;z-index:-1}.fs-figshare-viewer .fs-dataset-display .fs-selector:after,.fs-figshare-viewer .fs-dataset-display .fs-selector:before{position:absolute;top:0;border-left:13px solid transparent;border-right:13px solid transparent;border-radius:0 0 18px 18px;content:""}.fs-figshare-viewer .fs-dataset-display .fs-selector:after{left:-1px;right:-1px;bottom:-1px;border-top:25px solid #ddd;z-index:-2}.fs-figshare-viewer .fs-dataset-display .fs-selector.fs-active{color:#464646;font-weight:700}.fs-figshare-viewer .fs-dataset-display .fs-selector.fs-active:before{border-top:24px solid #fff}.fs-figshare-viewer .leaflet-bar{background-color:#eee;background-color:hsla(0,0%,100%,.4);border-radius:4px;padding:2px;box-shadow:none}.fs-figshare-viewer .leaflet-bar a,.fs-figshare-viewer .leaflet-bar a:hover{color:#fff;font-size:1.14em;font-weight:700;text-decoration:none;text-align:center;height:1.375em;width:1.375em;line-height:1.4em;background-color:#7b98bc;background-color:rgba(0,60,136,.5);margin:1px;border:none}.fs-figshare-viewer a.leaflet-disabled,.fs-figshare-viewer a.leaflet-disabled:hover{color:#bbb;background-color:hsla(0,0%,100%,.4)!important}.fs-figshare-viewer .leaflet-bar a:hover{background-color:#4c6079;background-color:rgba(0,60,136,.7)}.fs-figshare-viewer .leaflet-control-zoom-in{border-radius:2px 2px 0 0!important}.fs-figshare-viewer .leaflet-control-zoom-out{border-radius:0 0 2px 2px!important}.fs-figshare-viewer .fs-info{cursor:pointer}.fs-figshare-viewer .fs-info:before{content:"i"}.fs-figshare-viewer .fs-info.fs-open:before{content:">"}.fs-figshare-viewer .leaflet-control-attribution{left:-10px;top:-10px;padding:7px 30px 7px 7px;border-radius:4px}.fs-figshare-viewer .fs-text-display{position:relative}.fs-figshare-viewer .fs-text-display .fs-text-container{height:100%;overflow:auto;text-align:left}.fs-figshare-viewer .fs-text-display pre{white-space:pre;font-size:12px;line-height:14px}.fs-figshare-viewer .fs-text-display .hljs,.fs-figshare-viewer .fs-text-display [class^=hljs-]{font-family:Lucida Console,Monaco,monospace}.fs-figshare-viewer .fs-text-display .hljs{display:block;padding:14px;color:#464646}.fs-figshare-viewer .fs-text-display .hljs-comment,.fs-figshare-viewer .fs-text-display .hljs-quote{color:#999;font-style:italic}.fs-figshare-viewer .fs-text-display .hljs-keyword,.fs-figshare-viewer .fs-text-display .hljs-selector-tag,.fs-figshare-viewer .fs-text-display .hljs-subst{color:#157009;font-weight:700}.fs-figshare-viewer .fs-text-display .hljs-literal,.fs-figshare-viewer .fs-text-display .hljs-number,.fs-figshare-viewer .fs-text-display .hljs-tag .hljs-attr,.fs-figshare-viewer .fs-text-display .hljs-template-variable,.fs-figshare-viewer .fs-text-display .hljs-variable{color:teal;font-weight:700}.fs-figshare-viewer .fs-text-display .hljs-doctag,.fs-figshare-viewer .fs-text-display .hljs-string{color:#c7404d}.fs-figshare-viewer .fs-text-display .hljs-section,.fs-figshare-viewer .fs-text-display .hljs-selector-id,.fs-figshare-viewer .fs-text-display .hljs-title{color:#c81a2b;font-weight:700}.fs-figshare-viewer .fs-text-display .hljs-subst{font-weight:400}.fs-figshare-viewer .fs-text-display .hljs-class .hljs-title,.fs-figshare-viewer .fs-text-display .hljs-type{color:#458;font-weight:700}.fs-figshare-viewer .fs-text-display .hljs-attribute,.fs-figshare-viewer .fs-text-display .hljs-name,.fs-figshare-viewer .fs-text-display .hljs-tag{color:navy;font-weight:400}.fs-figshare-viewer .fs-text-display .hljs-link,.fs-figshare-viewer .fs-text-display .hljs-regexp{color:#a3cd3d}.fs-figshare-viewer .fs-text-display .hljs-bullet,.fs-figshare-viewer .fs-text-display .hljs-symbol{color:#990073}.fs-figshare-viewer .fs-text-display .hljs-built_in,.fs-figshare-viewer .fs-text-display .hljs-builtin-name{color:#0086b3;font-weight:700}.fs-figshare-viewer .fs-text-display .hljs-meta{color:#556471;font-weight:700}.fs-figshare-viewer .fs-text-display .hljs-deletion{background:#f3dbde}.fs-figshare-viewer .fs-text-display .hljs-addition{background:#edf3d7}.fs-figshare-viewer .fs-text-display .hljs-emphasis{font-style:italic}.fs-figshare-viewer .fs-text-display .hljs-strong{font-weight:700}.fs-figshare-viewer .fs-jupyter-display{position:relative}.fs-figshare-viewer .fs-jupyter-display .figshare-loader{overflow:hidden!important}.fs-figshare-viewer .fs-viewer3d-display{position:relative}.fs-figshare-viewer .fs-viewer3d-display canvas{background:linear-gradient(0deg,#202020 0,#000 29%,#131313 0,#000 55%)}.fs-figshare-viewer .fs-graph-display{position:relative}.fs-figshare-viewer .fs-graph-display canvas{background:radial-gradient(circle,#fff 50%,#ddd)}.fs-figshare-viewer .fs-figshare-viewer{position:relative;text-align:left}.fs-figshare-viewer .fs-controls-wrapper{position:absolute;top:0;left:0;height:auto;width:100%}.fs-figshare-viewer .fs-controls-wrapper .fs-molecule-controls-wrap{width:100%;height:38px;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:row;-ms-flex-flow:row;flex-flow:row;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;-webkit-align-items:center;-ms-flex-align:center;align-items:center;background:#f5f5f5}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal{margin:0 14px 0 7px}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-pagination-info{display:inline-block;width:42px;text-align:right;font-size:11px;font-weight:400;margin-right:7px}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-next-page,.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-prev-page{margin:0 7px;cursor:pointer}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-next-page[disabled],.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-prev-page[disabled]{cursor:default}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-next-page:before,.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-prev-page:before{vertical-align:middle}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-prev-page:before{content:"\F163"}.fs-figshare-viewer .fs-controls-wrapper .fs-pagination.fs-horizontal .fs-next-page:before{content:"\F165"}.fs-figshare-viewer .fs-controls-wrapper .fs-comment-list{max-width:270px;height:100%;display:inline-block;vertical-align:middle;position:relative}.fs-figshare-viewer .fs-controls-wrapper .fs-trigger{position:relative;margin-right:10px;padding-right:5px;cursor:pointer}.fs-figshare-viewer .fs-controls-wrapper .fs-trigger:after,.fs-figshare-viewer .fs-controls-wrapper .fs-trigger:before{position:absolute;right:-9px;font-size:5px}.fs-figshare-viewer .fs-controls-wrapper .fs-trigger:after{top:12px;content:"\F109"}.fs-figshare-viewer .fs-controls-wrapper .fs-trigger:before{top:20px;content:"\F106"}.fs-figshare-viewer .fs-controls-wrapper .fs-current-comment{font-size:13px;line-height:38px;white-space:nowrap;max-width:100%;overflow:hidden;text-overflow:ellipsis}.fs-figshare-viewer .fs-controls-wrapper .fs-menu-wrapper{position:absolute;right:-105px;bottom:0;width:0;height:0;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu{position:absolute;top:0;left:auto;right:0;max-width:385px;border:1px solid #ddd}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu:after,.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu:before{top:0;right:110px;border:solid transparent;content:" ";height:0;width:0;position:absolute}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu:after{border-bottom-color:#fff;border-width:7px;margin-right:-7px;margin-top:-14px}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu:before{border-bottom-color:#ddd;border-width:8px;margin-right:-8px;margin-top:-16px}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu .fs-drop-item{white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:13px;line-height:20px;border-bottom:1px solid #ddd;padding:7px 14px;cursor:pointer;color:#464646}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu .fs-drop-item:last-child{border-bottom:0}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu .fs-drop-item.fs-active{font-weight:700}.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu .fs-drop-item.fs-active,.fs-figshare-viewer .fs-controls-wrapper .fs-comments-menu .fs-drop-item:hover{background-color:#f8f8f8}.fs-figshare-viewer .fs-controls-wrapper .fs-items-wrap{max-height:244px;min-width:182px;background-color:#fff;overflow-y:auto}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile.fs-molecule-controls-wrap{border-top:1px solid #464646;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;background:#000}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-pagination{display:none}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-trigger{color:#f8f8f8}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-menu-wrapper{right:0}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-comments-menu{position:fixed;top:83px;left:0;right:0;bottom:0;width:auto;height:auto;max-width:none}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-comments-menu:after,.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-comments-menu:before{right:50%}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-current-comment{font-weight:700}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-drop-item{padding:21px 14px}.fs-figshare-viewer .fs-controls-wrapper .fs-mode-mobile .fs-items-wrap{max-height:60%;width:100%}figshare-overlay{display:none;z-index:200}figshare-overlay.fs-active{display:block;position:fixed;top:0;left:0;bottom:0;right:0;width:100%;min-height:100%;overflow-y:auto}figshare-overlay .fs-curtains{position:absolute;width:100%;height:100%;display:block;overflow:auto;background:hsla(0,0%,100%,.7)}figshare-overlay .fs-curtains>.fs-container{position:relative;display:block;margin:0 auto;background:#f4f4f4}figshare-overlay,figshare-widget{display:block;font-size:13px}figshare-overlay a,figshare-overlay abbr,figshare-overlay acronym,figshare-overlay address,figshare-overlay applet,figshare-overlay article,figshare-overlay aside,figshare-overlay audio,figshare-overlay b,figshare-overlay big,figshare-overlay blockquote,figshare-overlay body,figshare-overlay canvas,figshare-overlay caption,figshare-overlay center,figshare-overlay cite,figshare-overlay code,figshare-overlay dd,figshare-overlay del,figshare-overlay details,figshare-overlay dfn,figshare-overlay div,figshare-overlay dl,figshare-overlay dt,figshare-overlay em,figshare-overlay embed,figshare-overlay fieldset,figshare-overlay figcaption,figshare-overlay figure,figshare-overlay footer,figshare-overlay form,figshare-overlay h1,figshare-overlay h2,figshare-overlay h3,figshare-overlay h4,figshare-overlay h5,figshare-overlay h6,figshare-overlay header,figshare-overlay hgroup,figshare-overlay html,figshare-overlay i,figshare-overlay iframe,figshare-overlay img,figshare-overlay ins,figshare-overlay kbd,figshare-overlay label,figshare-overlay legend,figshare-overlay li,figshare-overlay mark,figshare-overlay menu,figshare-overlay nav,figshare-overlay object,figshare-overlay ol,figshare-overlay output,figshare-overlay p,figshare-overlay pre,figshare-overlay q,figshare-overlay ruby,figshare-overlay s,figshare-overlay samp,figshare-overlay section,figshare-overlay small,figshare-overlay span,figshare-overlay strike,figshare-overlay strong,figshare-overlay summary,figshare-overlay table,figshare-overlay tbody,figshare-overlay td,figshare-overlay tfoot,figshare-overlay th,figshare-overlay thead,figshare-overlay time,figshare-overlay tr,figshare-overlay tt,figshare-overlay u,figshare-overlay ul,figshare-overlay var,figshare-overlay video,figshare-widget a,figshare-widget abbr,figshare-widget acronym,figshare-widget address,figshare-widget applet,figshare-widget article,figshare-widget aside,figshare-widget audio,figshare-widget b,figshare-widget big,figshare-widget blockquote,figshare-widget body,figshare-widget canvas,figshare-widget caption,figshare-widget center,figshare-widget cite,figshare-widget code,figshare-widget dd,figshare-widget del,figshare-widget details,figshare-widget dfn,figshare-widget div,figshare-widget dl,figshare-widget dt,figshare-widget em,figshare-widget embed,figshare-widget fieldset,figshare-widget figcaption,figshare-widget figure,figshare-widget footer,figshare-widget form,figshare-widget h1,figshare-widget h2,figshare-widget h3,figshare-widget h4,figshare-widget h5,figshare-widget h6,figshare-widget header,figshare-widget hgroup,figshare-widget html,figshare-widget i,figshare-widget iframe,figshare-widget img,figshare-widget ins,figshare-widget kbd,figshare-widget label,figshare-widget legend,figshare-widget li,figshare-widget mark,figshare-widget menu,figshare-widget nav,figshare-widget object,figshare-widget ol,figshare-widget output,figshare-widget p,figshare-widget pre,figshare-widget q,figshare-widget ruby,figshare-widget s,figshare-widget samp,figshare-widget section,figshare-widget small,figshare-widget span,figshare-widget strike,figshare-widget strong,figshare-widget summary,figshare-widget table,figshare-widget tbody,figshare-widget td,figshare-widget tfoot,figshare-widget th,figshare-widget thead,figshare-widget time,figshare-widget tr,figshare-widget tt,figshare-widget u,figshare-widget ul,figshare-widget var,figshare-widget video{margin:0;padding:0;border:0;font-size:100%;font-family:Arial,Helvetica,sans-serif;vertical-align:baseline}figshare-overlay sub,figshare-overlay sup,figshare-widget sub,figshare-widget sup{margin:0;padding:0;border:0;font-family:Arial,Helvetica,sans-serif}figshare-overlay article,figshare-overlay aside,figshare-overlay details,figshare-overlay figcaption,figshare-overlay figure,figshare-overlay footer,figshare-overlay header,figshare-overlay hgroup,figshare-overlay menu,figshare-overlay nav,figshare-overlay section,figshare-widget article,figshare-widget aside,figshare-widget details,figshare-widget figcaption,figshare-widget figure,figshare-widget footer,figshare-widget header,figshare-widget hgroup,figshare-widget menu,figshare-widget nav,figshare-widget section{display:block}figshare-overlay body,figshare-widget body{line-height:1}figshare-overlay ol,figshare-overlay ul,figshare-widget ol,figshare-widget ul{list-style:none}figshare-overlay blockquote,figshare-overlay q,figshare-widget blockquote,figshare-widget q{quotes:none}figshare-overlay blockquote:after,figshare-overlay blockquote:before,figshare-overlay q:after,figshare-overlay q:before,figshare-widget blockquote:after,figshare-widget blockquote:before,figshare-widget q:after,figshare-widget q:before{content:'';content:none}figshare-overlay table,figshare-widget table{border-collapse:collapse;border-spacing:0}figshare-overlay input,figshare-overlay select,figshare-overlay textarea,figshare-widget input,figshare-widget select,figshare-widget textarea{outline:none}figshare-overlay body,figshare-overlay button,figshare-overlay h1,figshare-overlay h2,figshare-overlay h3,figshare-overlay h4,figshare-overlay h5,figshare-overlay h6,figshare-overlay input,figshare-overlay pre,figshare-overlay select,figshare-overlay textarea,figshare-widget body,figshare-widget button,figshare-widget h1,figshare-widget h2,figshare-widget h3,figshare-widget h4,figshare-widget h5,figshare-widget h6,figshare-widget input,figshare-widget pre,figshare-widget select,figshare-widget textarea{font-family:Arial,Helvetica,sans-serif}figshare-overlay strong,figshare-widget strong{font-weight:700}figshare-overlay input,figshare-overlay textarea,figshare-widget input,figshare-widget textarea{border:0 none;padding:0;font-size:13px;background-color:transparent}figshare-overlay button,figshare-widget button{margin:0;background:transparent;border:0;padding:0}figshare-overlay button:focus,figshare-widget button:focus{outline:none}figshare-overlay .figshare-loader,figshare-widget .figshare-loader{width:100%;position:relative}figshare-overlay .figshare-loader .fs-figshare-loader-holder,figshare-widget .figshare-loader .fs-figshare-loader-holder{display:inline-block;vertical-align:middle;text-align:center;position:absolute;width:100%;height:100%;top:0;bottom:0;left:0;right:0}figshare-overlay .figshare-loader .fs-figshare-loader-holder:before,figshare-widget .figshare-loader .fs-figshare-loader-holder:before{content:'';height:100%;vertical-align:middle;display:inline-block}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message{padding:14px 28px;display:inline-block;vertical-align:middle;position:relative;z-index:200;border:1px solid #ddd;background:#fff}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message:before,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message:before{content:'';height:100%;vertical-align:middle}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .figshare-logo,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .figshare-logo{width:21px;height:21px}@-webkit-keyframes opacityPulse{0%{opacity:0}10%{opacity:1}to{opacity:0}}@keyframes opacityPulse{0%{opacity:0}10%{opacity:1}to{opacity:0}}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message g[class^=group],figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message g[class^=group]{opacity:1;-webkit-animation:.8s opacityPulse infinite linear;animation:.8s opacityPulse infinite linear}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-20,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-20{-webkit-animation-delay:.76s!important;animation-delay:.76s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-19,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-19{-webkit-animation-delay:.72s!important;animation-delay:.72s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-18,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-18{-webkit-animation-delay:.6799999999999999s!important;animation-delay:.6799999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-17,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-17{-webkit-animation-delay:.6399999999999999s!important;animation-delay:.6399999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-16,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-16{-webkit-animation-delay:.5999999999999999s!important;animation-delay:.5999999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-15,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-15{-webkit-animation-delay:.5599999999999998s!important;animation-delay:.5599999999999998s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-14,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-14{-webkit-animation-delay:.5199999999999998s!important;animation-delay:.5199999999999998s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-13,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-13{-webkit-animation-delay:.4799999999999998s!important;animation-delay:.4799999999999998s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-12,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-12{-webkit-animation-delay:.43999999999999984s!important;animation-delay:.43999999999999984s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-11,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-11{-webkit-animation-delay:.39999999999999986s!important;animation-delay:.39999999999999986s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-10,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-10{-webkit-animation-delay:.3599999999999999s!important;animation-delay:.3599999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-9,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-9{-webkit-animation-delay:.3199999999999999s!important;animation-delay:.3199999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-8,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-8{-webkit-animation-delay:.2799999999999999s!important;animation-delay:.2799999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-7,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-7{-webkit-animation-delay:.2399999999999999s!important;animation-delay:.2399999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-6,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-6{-webkit-animation-delay:.1999999999999999s!important;animation-delay:.1999999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-5,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-5{-webkit-animation-delay:.1599999999999999s!important;animation-delay:.1599999999999999s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-4,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-4{-webkit-animation-delay:.11999999999999988s!important;animation-delay:.11999999999999988s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-3,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-3{-webkit-animation-delay:.07999999999999988s!important;animation-delay:.07999999999999988s!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-2,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-2{-webkit-animation-delay:39.99999999999988ms!important;animation-delay:39.99999999999988ms!important}figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-1,figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-1{-webkit-animation-delay:-1.249e-16s!important;animation-delay:-1.249e-16s!important}figshare-overlay .figshare-loader.fs-loading,figshare-widget .figshare-loader.fs-loading{position:relative}figshare-overlay .figshare-loader.fs-loading:before,figshare-widget .figshare-loader.fs-loading:before{content:'';opacity:.7;background:#fff;position:absolute;width:100%;height:100%;top:0;bottom:0;left:0;right:0;z-index:100}figshare-overlay .figshare-loader .fs-logo,figshare-overlay .figshare-loader .fs-message-wrap,figshare-overlay .figshare-loader .fs-retry-action,figshare-widget .figshare-loader .fs-logo,figshare-widget .figshare-loader .fs-message-wrap,figshare-widget .figshare-loader .fs-retry-action{display:inline-block;vertical-align:middle}figshare-overlay .figshare-loader .fs-message-wrap,figshare-overlay .figshare-loader .fs-retry-action,figshare-widget .figshare-loader .fs-message-wrap,figshare-widget .figshare-loader .fs-retry-action{margin-left:7px}figshare-overlay .figshare-loader .fs-retry-action,figshare-widget .figshare-loader .fs-retry-action{color:#c74d5a;margin-left:7px}figshare-overlay .figshare-loader .fs-retry-action:hover,figshare-widget .figshare-loader .fs-retry-action:hover{text-decoration:underline}figshare-overlay .figshare-loader.fs-error .fs-figshare-loader-message,figshare-widget .figshare-loader.fs-error .fs-figshare-loader-message{background-color:#f3dbde;border:none;border-radius:3px}figshare-overlay section,figshare-widget section{border:0 none transparent;background:transparent;margin:0;overflow:visible}@font-face{font-family:figIcon;src:url(data:application/vnd.ms-fontobject;base64,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);src:url(data:application/vnd.ms-fontobject;base64,WGMAALRiAAABAAIAAAAAAAIABQMAAAAAAAABAJABAAAAAExQAAAAAAAAAAAAAAAAAAAAAAEAAAAAAAAAhqVDXQAAAAAAAAAAAAAAAAAAAAAAAA4AZgBpAGcASQBjAG8AbgAAAA4AUgBlAGcAdQBsAGEAcgAAABYAVgBlAHIAcwBpAG8AbgAgADEALgAwAAAADgBmAGkAZwBJAGMAbwBuAAAAAAAAAQAAAAsAgAADADBHU1VCIIwleQAAATgAAABUT1MvMkCRYOQAAAGMAAAAVmNtYXAGUTtqAAAEFAAACPxnbHlmc555qgAADiwAAEr4aGVhZA5vIN0AAADgAAAANmhoZWEGRAUzAAAAvAAAACRobXR4P3H+9QAAAeQAAAIwbG9jYc6Gu5QAAA0QAAABGm1heHABrwDeAAABGAAAACBuYW1lAUkhIQAAWSQAAAIKcG9zdP/OfKoAAFswAAAHgQABAAAB9AAAAAAEsP+e//YEsAABAAAAAAAAAAAAAAAAAAAAjAABAAAAAQAAXUOlhl8PPPUACwH0AAAAANWA7/wAAAAA1YDv/P+e//sEsAH5AAAACAACAAAAAAAAAAEAAACMANIAGQAAAAAAAgAAAAoACgAAAP8AAAAAAAAAAQAAAAoAMAA+AAJsYXRuAA5ERkxUABoABAAAAAAAAAABAAAABAAAAAAAAAABAAAAAWxpZ2EACAAAAAEAAAABAAQABAAAAAEACAABAAYAAAABAAAAAQJIAZAABQAACqkBXgAAAEYKqQFeAAAA8AAYAIEAAAIABQMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUGZFZABA8QHxiwH0AAAALQH5AAUAAAABAAAAAAAAAAAAAAHzAAAC7v//AW3//wKaAAACKwAAA4D//wEW//0BFv//A4D//wIwAAAC7f+eAeIAAAH0AAAB9AAAAfQAAAKa//wA6QAAAxEAAALKAAACWAAAAvgAAAI8//8CggAAAwb//gI5AAABwgAAAfQAAAMR//8B9AAAAfMAAAIGAAACMgAAAnEAAAKpAAABkAAAAXcAAAF3AAABjwAAAh0AAASwAAAA8AAAAwb//gKCAAACOgAAAxEAAAJYAAACmgAAArH//wKa/54C7QAAAWT//wIA//8CMv//AfQAAAKpAAAB4P//AlcAAAGZ//8CwP//AdP//wLf//8B8wAAAcT//wJ///sCmgAAAfMAAAKCAAAB4P//ARn/+QGF//8BtQAAAfMAAAG4//8BQgAAAgMAAAMR//8BVQAAAfQAAAMR//8B8wAAAmMAAAMR//8DEf//BET//gMR//8BQv//AnEAAAH0AAACjAAAAZAAAAH0AAAB7QAAAe3/+AHu//wB0P//AocAAALuAAABggAAAU0AAAGCAAABTQAAAocAAALuAAAB9AAAAxH//wE4AAABOAAAAwoAAAMKAAADCf//AwkAAAMJAAADCQAAAwkAAAMR//8DCQAAAwkAAAMJAAADCQAAAwkAAAFk//8DCQAAAwkAAAMJAAADCQAAAwkAAAJ8AAABtv//AdQAAAH0AAABjwAAAjsAAAMR//8DCwAAAfQAAAGb//8B8wAAAfMAAAHzAAAAAAAFAAAAAwAAACwAAAAEAAACaAABAAAAAAFiAAMAAQAAACwAAwAKAAACaAAEATYAAAAEAAQAAQAA8Yv//wAA8QH//wAAAAEABAAAAAEAAgADAAQABQAGAAcACAAJAAoACwAMAA0ADgAPABAAEQASABMAFAAVABYAFwAYABkAGgAbABwAHQAeAB8AIAAhACIAIwAkACUAJgAnACgAKQAqACsALAAtAC4ALwAwADEAMgAzADQANQA2ADcAOAA5ADoAOwA8AD0APgA/AEAAQQBCAEMARABFAEYARwBIAEkASgBLAEwATQBOAE8AUABRAFIAUwBUAFUAVgBXAFgAWQBaAFsAXABdAF4AXwBgAGEAYgBjAGQAZQBmAGcAaABpAGoAawBsAG0AbgBvAHAAcQByAHMAdAB1AHYAdwB4AHkAegB7AHwAfQB+AH8AgACBAIIAgwCEAIUAhgCHAIgAiQCKAIsAAAEGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAABpQAAAAAAAAAiwAA8QEAAPEBAAAAAQAA8QIAAPECAAAAAgAA8QMAAPEDAAAAAwAA8QQAAPEEAAAABAAA8QUAAPEFAAAABQAA8QYAAPEGAAAABgAA8QcAAPEHAAAABwAA8QgAAPEIAAAACAAA8QkAAPEJAAAACQAA8QoAAPEKAAAACgAA8QsAAPELAAAACwAA8QwAAPEMAAAADAAA8Q0AAPENAAAADQAA8Q4AAPEOAAAADgAA8Q8AAPEPAAAADwAA8RAAAPEQAAAAEAAA8REAAPERAAAAEQAA8RIAAPESAAAAEgAA8RMAAPETAAAAEwAA8RQAAPEUAAAAFAAA8RUAAPEVAAAAFQAA8RYAAPEWAAAAFgAA8RcAAPEXAAAAFwAA8RgAAPEYAAAAGAAA8RkAAPEZAAAAGQAA8RoAAPEaAAAAGgAA8RsAAPEbAAAAGwAA8RwAAPEcAAAAHAAA8R0AAPEdAAAAHQAA8R4AAPEeAAAAHgAA8R8AAPEfAAAAHwAA8SAAAPEgAAAAIAAA8SEAAPEhAAAAIQAA8SIAAPEiAAAAIgAA8SMAAPEjAAAAIwAA8SQAAPEkAAAAJAAA8SUAAPElAAAAJQAA8SYAAPEmAAAAJgAA8ScAAPEnAAAAJwAA8SgAAPEoAAAAKAAA8SkAAPEpAAAAKQAA8SoAAPEqAAAAKgAA8SsAAPErAAAAKwAA8SwAAPEsAAAALAAA8S0AAPEtAAAALQAA8S4AAPEuAAAALgAA8S8AAPEvAAAALwAA8TAAAPEwAAAAMAAA8TEAAPExAAAAMQAA8TIAAPEyAAAAMgAA8TMAAPEzAAAAMwAA8TQAAPE0AAAANAAA8TUAAPE1AAAANQAA8TYAAPE2AAAANgAA8TcAAPE3AAAANwAA8TgAAPE4AAAAOAAA8TkAAPE5AAAAOQAA8ToAAPE6AAAAOgAA8TsAAPE7AAAAOwAA8TwAAPE8AAAAPAAA8T0AAPE9AAAAPQAA8T4AAPE+AAAAPgAA8T8AAPE/AAAAPwAA8UAAAPFAAAAAQAAA8UEAAPFBAAAAQQAA8UIAAPFCAAAAQgAA8UMAAPFDAAAAQwAA8UQAAPFEAAAARAAA8UUAAPFFAAAARQAA8UYAAPFGAAAARgAA8UcAAPFHAAAARwAA8UgAAPFIAAAASAAA8UkAAPFJAAAASQAA8UoAAPFKAAAASgAA8UsAAPFLAAAASwAA8UwAAPFMAAAATAAA8U0AAPFNAAAATQAA8U4AAPFOAAAATgAA8U8AAPFPAAAATwAA8VAAAPFQAAAAUAAA8VEAAPFRAAAAUQAA8VIAAPFSAAAAUgAA8VMAAPFTAAAAUwAA8VQAAPFUAAAAVAAA8VUAAPFVAAAAVQAA8VYAAPFWAAAAVgAA8VcAAPFXAAAAVwAA8VgAAPFYAAAAWAAA8VkAAPFZAAAAWQAA8VoAAPFaAAAAWgAA8VsAAPFbAAAAWwAA8VwAAPFcAAAAXAAA8V0AAPFdAAAAXQAA8V4AAPFeAAAAXgAA8V8AAPFfAAAAXwAA8WAAAPFgAAAAYAAA8WEAAPFhAAAAYQAA8WIAAPFiAAAAYgAA8WMAAPFjAAAAYwAA8WQAAPFkAAAAZAAA8WUAAPFlAAAAZQAA8WYAAPFmAAAAZgAA8WcAAPFnAAAAZwAA8WgAAPFoAAAAaAAA8WkAAPFpAAAAaQAA8WoAAPFqAAAAagAA8WsAAPFrAAAAawAA8WwAAPFsAAAAbAAA8W0AAPFtAAAAbQAA8W4AAPFuAAAAbgAA8W8AAPFvAAAAbwAA8XAAAPFwAAAAcAAA8XEAAPFxAAAAcQAA8XIAAPFyAAAAcgAA8XMAAPFzAAAAcwAA8XQAAPF0AAAAdAAA8XUAAPF1AAAAdQAA8XYAAPF2AAAAdgAA8XcAAPF3AAAAdwAA8XgAAPF4AAAAeAAA8XkAAPF5AAAAeQAA8XoAAPF6AAAAegAA8XsAAPF7AAAAewAA8XwAAPF8AAAAfAAA8X0AAPF9AAAAfQAA8X4AAPF+AAAAfgAA8X8AAPF/AAAAfwAA8YAAAPGAAAAAgAAA8YEAAPGBAAAAgQAA8YIAAPGCAAAAggAA8YMAAPGDAAAAgwAA8YQAAPGEAAAAhAAA8YUAAPGFAAAAhQAA8YYAAPGGAAAAhgAA8YcAAPGHAAAAhwAA8YgAAPGIAAAAiAAA8YkAAPGJAAAAiQAA8YoAAPGKAAAAigAA8YsAAPGLAAAAiwAAAAAAIABSAQIBLAF0AaIByAHuAhwCYgJ2AygDQgN2A8gD8gQEBFQEpATaBPoFHAU8BWAF2AYqBloGzAcYB0YHYAeQB8AH6AgUCC4ISAhYCGwIgAi8COIJAgkWCjAKegq2CwQLbguCC5oMFgxMDG4MkAzWDOwNXg2MDcoN+A4uD0QPjg/uEDQQThCUEMQRCBFKEWARyhHqEjISlBKoEwQTNBNIE4gT/BSYFSQWGhY8FmYWnhb0Fx4XUheSF9AYUhiQGKQYuBjIGNoY6hj6GQ4ZIhlSGY4Zohm2Gi4ajhtGG6Yb7hx+HPYdfh2sHcQewB+gIAQgVCCYIMQhPCGeIkAiWCKcIwojQCNQI64j5CRKJJIkwCT0JTwlfAAAAAEAAAAAAfQB9AARAAAlBzUhBxcHNxc3ESM3FyMRMzUB9EH++nwQQQwWgRYhIBX6riEWhRAOQRWLAQc2Nv77FQAC/////wLuAfUAFgAcAAABLgIjIgYHDgIVFB4BMyEyPgE0LgEFJzcXNxcCXQtCYThDbx4uTSwyVzMBlipIKidC/rRuLEKhLAE3NlYxRTkFNFIwMlcyKkhTRSvXbSxBoiwAAAAABf//AAABbgH3AAgAEgBYAGUAcgAAJScHJzc+AT8BByInLgEvAQc3FxMnJj0BNCYvASYvAS4BDwEGLwEmBg8BBg8BDgEdARQPAQYUHwEWHQEUFh8BFh8BHgE/ATYfARY2PwE2PwE+AT0BND8BPgEHNi4CDgIeAj4BJyYOAh4CPgE0LgEBRDgnIhIVFxIPcwkIFBcSESM1KtkJCBEODw4ICQkcDg4ODg8OHAgKCA4PDhEJCQkICQkRDg4OCQkIHA4PDg4ODhwJCQkODg4SCQkIATIBIz1JPiUBIz1JPiWEHjMeAR0yPDIfHDIZDSaAAgIGCAcZAQIGCQiADScBXQ0LDw8PGAUFBAwMDAoFBAUFBAUJDAwMBAUEGA8PDwwMDB0MDAwPDw8YBQQFDAwMCgUFBAUEBQkMDAwEBQQYDw8PDAwMHREkPiUBIz1JPiQCJDyUAR0yOzMeARwyPDMeAAAAAAYAAAAAApsB9AADAAcACwAPABMAFwAANyE1ISczNSMRMzUjNTM1IzcVITUBITUhpwH0/gynU1NTU1NTpwH0/gwB9P4M0FR9U/4MU31U0FNT/gxTAAYAAP//AiwB9QAbAB8AIwAnACsALwAAATUjNTQmIyEiBhURFBYzITI2PQEzNSM1MzUjNQMhESEFMxUjEzMVIyczFSM3MxUjAiw4IRf+fBchIRcBhBchODg4ODj+fAGE/rOLi6dvb6eLi6dvbwFNODcXISEX/nwXISEXNzg3ODf+6wGE3m8BFlNTixynAAAAAAH////7A4EB9QAXAAARFBcBFhcWNjcBNjQmIgcBDgEmJwEmDgEQAWcgExUoHwFqECAtEP64Dg4MDv63EC0fAb0XD/6YIAkLEh8BahAuIBD+uA4IBg4BSRABHwAAAf/9//8BFwH1ABUAACU2NC8BJjQ/ATY0JiIPAQ4BFh8BFjIBDQkJtwoLtwkSGQnKEgoLEskJGAkJGAm4CgkLtwkZEgnKEhYWEsgJAAH//wAAARoB9QAVAAAzMj8BPgEmLwEmIgYUHwEWFA8BBhQWHwwJyRILChLKCRkSCbcLCrcJEQnIEhYWEsoJEhkJtwsJCrgJGREAAAAB/////wOBAfkAFwAANx4BNwE+ARYXARYyNjQnAS4BBwYHAQYUEA8tEAFJDgwODgFIEC0gEP6WHygVEyD+mRARDwEQAUkOBggO/rgQIC4QAWofEgsJIP6YDy0AAAMAAAAAAjoB9AALABoAKQAAETQ2OwE3EScjBiY1JTY3HgEHBgcnLgE3Njc2NzY3NjcWFxYGByc+AScmGhRTtLdTERoBeRAQHhoKDCIRCgcCHwICHwUFDhA0EREmMyUoIQ4OATITGpX+DJUBGxCHDxAWUCgrGg4IBwIhJitqBgUPDjFGQogwJiNtNTkAAv+eAAAC7gH1AAAABwAAAwUhFSc3FSFhA0/9/uzsAgIBMm7E+vrEAAoAAAAAAeMB9QALABcAIwAvAE8AUwBfAGsAeACFAAA3MzI2NCYrASIGFBY7ATI2NCYrASIGFBYXMzI2NCYrASIGFBYjMzI2NCYrASIGFBYBIxUUBiImPQEjFRQGIiY9ASMiBhURFBYzITI2NRE0JgMhNSEHMzI2NCYrASIGFBYXMzI2NCYrASIGFBYDMjY9ATQmIgYdARQWMzI2PQE0JiIGHQEUFnkeDBISDB4NERHgHg0REQ0eDRERDR4NERENHg0REcYeDBISDB4NEREBPyMaJhp5GyUaIxkfEgwBpwwSIhv+lgFqxx8MEhIMHwwSEgwfDBISDB8MEhJLDBISGRER4AwSEhkREc8UHRQUHRQUHRQUHRRoFRwUFBwVFRwUFBwVAVkRFR8fFRERFR8fFREmH/6oDxQUDwFYHSj+hfFnFB0UFB0UaBUcFBQcFQEmFA4jDhQUDiMOFBQOIw4UFA4jDhQAAQAAAAAB9AH0AAsAAAEnBycHFwcXNxc3JwH0GOLiGOLiGOLiGOIB3Bji4hji4hji4hjiAAIAAAAAAfUB9QAPACAAAAEyFhURFAYjISImNRE0NjMlISIGFREUFjMhMjY1ETQmIwGRDBISDP7TDBISDAEt/tMpOzspAS0pOzspAa8SDP7TDBISDAEtDBJGOyn+0yk7OykBLSk7AAAAAwAAAAAB9QH1AA8AIAA0AAABMhYVERQGIyEiJjURNDYzJSEiBhURFBYzITI2NRE0JiMXNh8BHgEUDwEOAScmJyY/ATYfAQGRDBISDP7TDBISDAEt/tMpOzspAS0pOzspFgUGDDIFA+oEBQUPlAUEQAYFYAGvEgz+0wwSEgwBLQwSRjsp/tMpOzspAS0pO0QGBQ0xBgQC6AQBBA6PBQVABgVaAAAB//z//wKbAfYAFgAAAT4BHwEeARQPAQ4CJyUmPwE2HwEGNwIeAwoEF04HBJrXDQgH/vsJB2cJCJoFiQHvBAIEF0wJBwSY1A0BBvsJB2cJCJEFiAABAAAAAADqAfQABgAAEyMRBycRM+oiZGTIAb3+vnt7AXkAAAADAAAAAAMSAfUADwAgADMAAAEhIgYVERQWMyEyNjURNCYBFhQGIi8BJjQ/ATYyFhQPAQUwMQcGIiY0PwEnJjQ2Mh8BFhQC4v1NExwcEwKzFBwc/koNGyUOaw0Naw4lGw1LAYlsDSYaDUtLDRomDWwNAfQcE/5qExwbEwGVFRz+uw0mGw5rDSYNaw4bJg1LIGsOGyYNS0sNJhsOaw0mAAAABAAAAAACywH1AAgAFQAkADMAACUyNjQmIgYUFicyPgE0LgEiDgEUHgEFIgcGBwYdASE1NCcmJyYlIgcGBwYdATM1NDc2NyYCBiU0NEo0NOcdMR0dMToxHR0xASkkLDIeJQGJJB8xLP7QLjg/Jy76DxUxMfo0SjU1SjQkHDI6MR0dMToyHGsLDRQYH1BQHxgUDQsjDg8aHydZUB8cJhsKAAMAAAAAAlkB9AAIABoAHwAAEyMRFBYzITUhASMnIyIGFREUFjMhMjY9ATQmATcXNxcyMh0VAcL+PgH0yDKWFR0dFQGQFR0d/nRxVz9XAZD+ohUdMgGQMh0V/tQVHR0V+hUd/u2WcUxxAAAAAAMAAAAAAvkB9AADAAkADwAAESERIQUhNSERMxMhNSERMwJd/aMCrv2NAkcsSv2NAkgrAfT+plArAUT+RysBRAAB//8AAAI9AfUAEgAAASEiBhURFBY7AQc3ITI2NRE0JgIZ/gsPFRUPcg9yASAOFhYB9BUP/pwPFUhIFQ8BZA8VAAAAAAMAAAAAAoMB9AADAAcADgAAEyERIQEhESElFzUXBzUj0gGx/k8BkP6RAW/9nlx2dlwB9P4MAdP+TvsBVXZ2VQAB//7//wMKAfUAEgAANzY3Njc2MhcWABcWDgEjISIuAQYOnJYYEicSGwExCwkGGBD9UBEXBUEZvLQYEhIb/o4TEB8TFB8AAAAFAAAAAAI7AfUABwAPABwAMgBJAAABDgIfATcmBxY3PgIvATcmIgcBBhQWMjcBNjQBNyY1ND4BFzIXNyYGBwYPAQYUHwEWJTQvASYnBxYVFA4BIyInBxY2NzY/ATYBFSA0HAIBgwwRDAsgNBwCAYsLHgv+VQsVHwoBrAr+KkIGJ0InERQhQYQ4OyYDAgIDHQIZCwMbKEIEJkInEBMiQIE2OicFBgFiAiQ4IAaDAesCAQIkOCAG7wsL/lULHhULAasLHv6mQhUQJ0InAQUiDxooKkMCBAgFBDQ/BA8FKyNDExAnQicFIQ8ZJig/CQoAAAAEAAAAAAHDAfQAFQAeACcANQAAASMuASIGByMiBhURFBYzITI2NRE0JiMyFhQGIiY0NhcyFhQGIiY0NhMhNTQ3Njc2MhcWFxYVAZBoCSYwJgloFR0dFQFeFR0dxAoPDxQPDwofLCw+LCy1/tQcFyYiNiImFxwBwhYcHBYdFf6iFR0dFQFeFR0PFA8PFA9kLD4sLD4s/tQjFxMQCwkJCxATFwAAAAMAAAAAAfUB9QAIABgAHQAANyEVISImNREzJTIWFREUBiMhIiY1ETQ2MwUjFTcXMgFe/qIVHTIBkBUdHRX+1BUdHRUBLH0/PjIyHRUBXmQdFf7UFR0dFQEsFR0yyCYmABD/////AxIB9QAPABYAGgAeACIAJgAqAC4AMgA2ADoAQQBFAEkATQBRAAABISIGFREUFjMhMjY1ETQmASIjIj0BMzUjNTM1IzUzNSM1MzUjNTMTIzUzNSM1MzUjNTM1IzUzNSM1MxMUBisBNTM1IzUzNSM1MzUjNTM1IzUzAt39WBYfHxYCqBYfH/4OaGgO3t7e3t7e3t7e99zc3Nzc3Nzc3Nz3BgjO3Nzc3Nzc3NzcAfQeFf5yFR4eFQGOFR7+Lw4WGSQaJBojGiT+5iQZJBokGiMaJP70CAYkGSQaJBojGiQAAAQAAP//AfUB9AAPABgAKAAxAAAlISIGHQEUFjMhMjY9ATQmBSImNDYyFhQGASEiBh0BFBYzITI2PQE0JgUiJjQ2MhYUBgHY/kQMEBAMAbwMEBD+ixcgIC4hIQFS/kQMEBAMAbwMEBD+ixcgIC4hId4QDKYMEBAMpgwQpiAuISEuIAG8EAymDBAQDKYMEKchLiAgLiEAAAAAAQAAAAAB9AH0ABsAACU3NjQmIg8BJyYiBhQfAQcGFBYyPwEXFjI2NCcBa3EYL0IYcXEYQi8XcnIXL0IYcXEXQy8Y+nEXQy8YcXEYL0IYcXEYQi8XcnIXL0IYAAABAAAAAAIHAfQACwAAAQcXBycHJzcnNxc3AgasrFatrVatrVesrQGhp6dTp6dTp6ZUp6cAAgAAAAACMwH1ABcAHgAAASEiBhURFBY7ATUjESERIxUzMjY1ETQmDwEzFTM1MwH0/ksaJSUafX0BtX19GiUl9X1eP10B9CUZ/okaJT8BOP7IPyUaAXcZJbt9vLwAAAAABAAAAAACcQH0AA8AEwAXABsAAAEhIgYVERQWMyEyNjURNCYDITUhNSE1IRMjETMCM/4MGiUlGgH0GSUltv6pAVf+qQFXnX19AfQlGf6JGiUlGgF3GSX+S30fff7nARkABQAAAAACqgH0AAMABwALAA8AEwAANSE1IQEhNSEFITUhARUhNSkBFSECqv1WAWwBPv7C/pQBPv7CAWwBPv6U/sIBPuMu/u+2trYBPra2tgADAAAAAAGRAfUADQAZABwAABMjIgYVERQWMyEyNjURByMVIzUjNTM1MxUzJzUX+sgVHR0VASwVHWRLMktLMktLigH0HRX+cBUdHRUBLMhLSzJLS32KigAAAgAAAAABeAH0AAUACwAAJQcnNRc3NQcnNRc3AXe7vLy7u7y8u7i4uGy4uGS4uGy4uAAAAAIAAAAAAXgB9AAFAAsAACUnBzU3FxEnBzU3FwF3u7y8u7u8vLvQuLhsuLj+xLi4bLi4AAABAAAAAAGQAfQABgAANzUzFTMHJ2TIZMjI+vr6+voAAAEAAAAAAh4B9AAGAAAlBSUzESERAh7+8f7xbwFA0NDQAST+3AAAAAACAAAAAASwAfQAAwAHAAA1IRUhESEVIQSw+1AEsPtQZGQB9GQAAAAAAwAA//8A9QH5AAkAFgAhAAA3JicmIw8BNycmEwYPATIXHgInNy4BNyYGDwEeARc3NiY4DA4KCggCYQsPLwUMVgISFhghAmYYKz4VKAkGHSwXBwgPgAUBAgGHYgsMASYMHMsCBAoaAfMWElIJEhUQARIWEBUpAAAAAf/+//8DCgH0ABMAABMgITIeAQcGAAcGIicmJyYnJj4BKwFYAVgQGAYJC/7PGxInEhiWnA4IBRcB9BQeEBP+jhsSEhi0vBkOHxQAAAMAAAAAAoMB9AADAAcADgAAEyERIQEhESElJxUnNxUz0gGx/k8BkP6RAW/+cFx2dlwB9P4MAdP+TrcBVXZ2VQABAAAAAAI7AfQABgAALQEVJRElFQI7/sv++gEG+vrMzP4MzMwAAAAAGQAAAAADEgH1AAIAEgAcACwAOQBJAFAAVABYAFwAYABkAGgAbABwAHQAewB/AIMAhwCLAJsArQC2ANEAACUXBzcVFAYjISImPQE0NjMhMhYHNCYiBhQWMjY1ASEiBh0BFBYzITI2PQE0JgcUBiMhIiY9ATcXNxcHISIGHQEUFjMhMjY9ATQmByIjIj0BMzUjNTM1IzUzNSM1MzUjNTMXIzUzNSM1MzUjNTM1IzUzNSM1MxcUBisBNTM1IzUzNSM1MzUjNTM1IzUzASEiBh0BFBYzITI2PQE0JgcUKwEiPQE0PwEWNxcWFzEWFSc0NjIWFAYiJhcUBisBJz4BJy4BDgEXByMiJj0BNDY7ATIWFQJPODjDDgr+zgoODgoBMgoObyc2Jyc2J/6n/s4KDg4KATIKDg4CCQr+5AoJY1E9UQj+zgoODgoBMgoODuEuLwZjY2NjY2NjY2NwY2NjY2NjY2NjY28DA11jY2NjY2NjY2MBqP7OCg4OCgEyCg4OsAFDAgESEBECDgEBOw4UDw8UDsYOC2wTBgQDBBsaBAsUDQoODgrLCw6WJiaAswoNDQqzCg0NYxsmJjcmJhsBhA0KswoNDQqzCg2+CgkJCgtPL144pg0KswoNDQqzCg3RBgoLEAwQDBAMEH8QCxAMEAwQDBB5BAIQCxAMEAwQDBABZQ0KswkODQqzCg3AAgIhAgERCwwDDQICAS4KDg4VDg4GCw4UBhAIDgwQHgsTDgtKCg8PCgAABAAAAAACWQH1ABMAIwAqADEAACkBIi4BNRE0PgEzITIeARURFA4BASIGFREUFjMhMjY1ETQmIwcVMwcnMz0CIzcXIxUB6P6JHzQeHjQfAXceNB4eNP5rJTMzJQF2JTMzJKJBW1tBQVtbQR40HwETHjQeHjQf/u4fNB4B2zMk/uwkMzMkARQkM/xVXFxVNlVcXFUAAAEAAAAAApsB9QApAAABISIGHQEjIiY9ATQ2MyE1NCYjITQmKwEiBhU1DgEVERQWMyEyNj0BNCYCcf5dITAVCA06KQGRGBH+3BgSfREYExc9KwHfIzEZAU0vIqkNCKwpOioRGBIYGBIBCycW/uUrPTEi0REYAAAAAAH/////ArMB9AAxAAAlISIHBgcVBgcGBwYnJj8BNjc2NzYzITc0JiMhJy4BKwEiBhURFBYzBDcyPwE+ASYnJgKC/mISDAgMJA8LDwwLHhI2Cw8NFAweAXwCHBT+zhsGFQuKExsXEQEu2hAcKCgHBQYPxgwHEwI6FxACAgYRHl0SCQcDAYARGkQJCxoT/mURGwEBITAyExUJEgAAAAL/nv//ApsB9QBOAE8AABMyFhUUFjMhMhYdATM1NCYjITQmKwEiBhU1DgEVERQWMyEyNj0BNCYjISIGHQEUFjY9ATQ2MyEyFh0BFAYjISIuAjURNDY3Njc2NTQ2MwfQBggQDAEkBQgcGBH+3BgSfREYExc9KwHfIzEZEf5dITAODh8WAaMGCCEX/iEPHBUMDgwEAwkIBbQB2AgGCxEIBTg4ERgSGBgSAQwmFv7lKz0xIuwSGDAhtwgHBwi3Fh8IBuwXIAwVHA8BGw8YBwIECAsGCKYAAgAAAAAC7gH0AAAABwAALQEhNRcHNSEBd/6JAgLs7P3++jbE+vrEAAL//wAAAWUB9AAFAAoAABMjESERIxMhETMX1r4BNXeP/pvigwHc/jwBTf6bAfSFAAH////+AgEB9QBTAAABIg4BFRQeARcWNjUnBicmJzEmJyYvASY2PwEWFxYfARYXFjc2NyYnJjU0NyYnJjczMhcWFzYyFzY3NjsBFgcUBxYVFAcGBxYdARQWNz4CNTQuAQEARXZFLVAyCQkBLBkNBAUHBgYECwEGBQwKBwYFDxkREQMONRslGgQBAQkHCg0SFh9DHxUTDQoHCQIFGyUcNBEJCTJQLUV2AfRFdkU4Y0gRAQgGKwkVCg0NCgcEAwcHAQEBBwUHBxkCAggXCwYXH0MoHQoNFhcFBw8JCQ8HBRcWDQodKEMfFwUPIUYGCAERSGM4RXZFAAAAAv////8CMwH0ABsAJAAAKQEiJjURNDY7ARUjIgYVERQWMyEWNj0BMxUUBgMzBxc3FTM1IwHV/oknNzcnu7sNEhINAXcNEj43hE9nMmM+uzcnATgnNz8SDf7IDRIBEw19fSc3AbV1K3dTuwAAAgAAAAAB9QH1AAkAEgAAJSERMzUjESE1IwMHMwcXNxU3NQFb/t1vpwGTOClGn9gx2Tc4ASM4/m2nAU032THYkTjCAAAEAAAAAAKqAfQAAwAHAAsADwAAKQE1ISUhNSERITUhARUhNQFsAT7+wv6UAT7+wgE+/sIBbAE+4y7j/gzjARHj4wAAAAL/////AeIB9wAVACsAADcWMj8BNjIfARYyNjQvAS4BBg8BBhQXFjI/ATYyHwEWMjY0LwEuAQYPAQYUCQgYCLIJCQqxCBkRCcMQFhURwQkICBgJsQoIC7AIGREJwhEWFRHBCfAICLEKC7EIERkIwxEJCxHBCBjwCAixCguwCREZCMMRCQoSwQgYAAAAAQAAAAACWAH0AAoAADUJASMVIzUjFSM1ASwBLGSFhoXpAQv+9emnp+kAAAAF/////wGaAfUAMwA3ADsARABHAAApASImNRMmNzUmJwcGLgE2PwEmNycuAT4BHwE2NycmPgEWHwE2Fzc+AR4BDwEWFzMXERQGJzM1IzUzNSMnBh4BPgEuAQYXFTMBa/7oExwBAQEHAwsFCAQEBAsCAgsEBAQIBAwGCQUCBAkIAgQLCwQCCQgEAgUEBJ6LG/q2tra2TwMHEBEGBhEQwHwbFAE8AgMRBQYFAQMJCAIECwsEAgkIBAIFCQcLBAgEBAQLAgILBAQECAQLAgSM/ucUG18sMyzJCBAHBxARBgYNfAAAAAAC//8AAALBAfUAFwAeAAAlIREhFTM1NCYjISIGFREUFjMhMjY9ASM3JxUjFTMVAcb+cgGONyMb/n8ZJSUZAYEbIzf6gvr6NwFOOHAZHiUa/ooaJR4ZOHh5ZjhcAAH/////AdQB9QAoAAAlIgYHJzY1NCc3HgEzMjY0JiIGFRQXByYOARQWMzI2NxcGFRQWMjY0JgF6FCQMhgQJjQwjEyU1NUo1CI0aTDU1JRYnDIQHNUo1NbMRDzkODhUSTw0QNUo0NCUUEVAcATRKNBQROBATJTQ0SjUAAAAB//8AAALgAfUAHQAAAS4CIyIGBw4CFRQeATsBNSM3FyMVMzI+ATQuAQJRCkFgNkJtHS5LKy9SMaNkgntjvSlGKCZBATg1VjFFOAU0Ui8zVzOZg4OZK0lSRSsAAAMAAAAAAfQB9AAMABgAIQAAEyIOARQeATI+ATQuAQMUBiImPQE0NjIWFSciJjQ2MhYUBvpEc0NDc4hzQ0NzJRIaEhIaEh4OEhIbEhIB9ENziHNDQ3OIc0P+iQ0SEg2cDRISDT4TGhMTGhMAABT//wAAAcUB9QAaACMALAA1AD4ARwBQAFkAYgBrAHQAfQCGAI8AmAChAKoAtgC/AMgAACU1NCYrATU0JiM0JisBIgYVIgYdASMiBhURIQEyFhQGIiY0NjMyFhQGIiY0NjMyFhQGIiY0NhcyFhQGIiY0NiMyFhQGIiY0NiMyFhQGIiY0NhcyFhQGIiY0NjMyFhQGIiY0NjMyFhQGIiY0NicyFhQGIiY0NhcyFhQGIiY0NiUyFhQGIiY0NhcyFhQGIiY0NgcyFhQGIiY0NiMyFhQGIiY0NiMyFhQGIiY0NhczMhYUBisBIiY0NicyFhQGIiY0NiEyFhQGIiY0NgHEGBEpMCIYESkRGCMwKREYAcT+zAgNDREMDFsJDAwRDAxaCQwMEQwMCAkMDBEMDEoJDAwRDAxKCA0NEQwMCQgNDREMDFsJDAwRDAxaCQwMEQwM7ggMDBEMDAkIDAwRDAwBUggMDBEMDAkIDAwRDAxKCQwMEQwMSgkMDBEMDEoIDQ0RDAwJpAkMDAmkCQwMSQgMDBEMDAFSCAwMEQwMp30RGCojMBIYGBIwIyoYEf7cAaENEQwMEQ0NEQwMEQ0NEQwMEQ1UDBEMDBEMDBEMDBEMDBEMDBEMUwwRDQ0RDAwRDQ0RDAwRDQ0RDCoNEQwMEQ1UDBEMDBEMVA0RDAwRDVQMEQwMEQwpDREMDBENDREMDBENDREMDBENVAwRDAwRDCoMEQ0NEQwMEQ0NEQwAAAAC//v/+wKEAfkAFgAsAAABLgEGDwEOARc3NjIWFA8BFjY/AT4BJg8BBiImND8BJgYPAQ4BHgI2PwE+AQJXG0dHG3AaEgjFFDkpFMckSRtwGhMT8cUUOSkUxyRJG28bExM1R0gacBoSAcsbExMbcRpGI8MUKToUxQsSHHAbSEiTwxQpOhTFCxIccBtISDYTExtxGkYABgAAAAACmwH1AAgAEQAaACYAMgA+AAATIgYUFjI2NCYHIgYUFjI2NCYHIgYUFjI2NCYTITI2NCYjISIGFBYFISIGFBYzITI2NCYHISIGFBYzITI2NCYqEhgYIxgYERIYGCMYGBESGBgjGBiVAaERGRkR/l8RGBgBsv5fERgYEQGhERkZEf5fERgYEQGhERkZAfQYIxgYIxjQGSIZGSIZ0RgjGBgjGAFOGCMYGCMYfRkiGRkiGdEYIxgYIxgAAAAAAwAA//8B9AH1AA8AHwAvAAABISIGHQEUFjMhMjY9ATQmAyEiBh0BFBYzITI2PQE0JichIgYdARQWMyEyNj0BNCYB0v5QDhQUDgGwDhQUDv5QDhQUDgGwDhQUDv5QDhQUDgGwDhQUAfQUDSINFBQNIg0U/nAUDSINFBQNIg0UyBQNIg0UFA0iDRQAAAADAAAAAAKDAfQAAwAHAAsAABEhNSEBNSEVNSE1IQKD/X0Cg/19AoP9fQFzgf4MgYG6gAAAAv////0B4gH0ABUAKwAANRQfAR4BNj8BNjQmIg8BBiIvASYiBicUHwEeATY/ATY0JiIPAQYiLwEmIgYJwREVFhDDCREZCLEKCQmyCBgRAQnBERUWEcIJERkIsAsICrEJGBHvDAnBEQsKEcIJGBIJsAsJsQkR2wwJwRELChHCCRgSCbALCbEJEQAAAAAC//kAAAEhAfQAEQAaAAATIgcOARcWFxYfATc2NzYmJyYHIiY0NjIWFAaNMSUiHA0OIxkhHDc6FA4cIiUwKTo6Ujo6AfQdG1UqK1M6STx6hj0qVRsd7zpSOjpSOgAAAAAD//8AAAGGAfUAGQAiAC4AAAEjNTQuASIOAR0BIyIGHQEUFjMhMjY9ATQmByImNDYyFhQGNxQHIyY9ATQ2MhYVAVURIztHOyMQFB0dFAEkFBwcpxsmJjYmJiYDewMmNSYBG2QgNh8fNiBkHRW3FR0dFbcVHbYnNycnNyfHCQgICVMVHR0VAAAABQAAAAABtgH0ABUAGQAdACEAKgAAKQEiJjURNDY7AT4BMhYXMzIWFREUBiUzNSM3IxUzFSMVMwMyFhQGIiY0NgGc/n0KDw8KfwMmNCYCfwsODv69oqL6+vr6+oMOExMcFBQPCgGDCw4bJCQbDgv+fQoPZDKvMiYyARcVHBUVHBUAAAAAAgAAAAAB9gEtAAQACAAAJSIjNSEFIRUhAfT6+gH0/g0B9P4MyGQBYgAAAAAB/////wG6AfQASQAAASYGBycVMTQmJxc3MjY0JiIGFRQWFwc3DgEdATUHLgEjIgYUFjI2PQE3NR4BMzcHFw4BFRQWMjY0JisBJwc+ATcVFxUGHgE+ASYBixAZBU0WEgILFh8gLCAXEQkCFRtHBhsRFx8fLR9GBBoRBAMQFh0nNiYmGwIQAg4TAksBGycdARoBEgERDg0BEhsEAVkfLR8fFxIcBVoBAR0UBAIPDxQgLCAgFgUQAhAVAQFNBSQXGyYmNidOAQQWDgIOAxQdARooHAAAAAEAAP/7AUMB+AAQAAATFhcWFxYUBw4BBwYmNRE0NioQeXUPDAwS7gwQGxwB8AlkYRALGgsSxQcJERABvBEPAAAEAAAAAAIEAfUAAgAGACIALAAAPwEnJScHHwEUBiMhIiY1ETQ2OwE3ISIGFREUFjMhMjY1EQc3JyYiDwEXNz4BuG1OAQNOqk2UHBT+zhQdHRTRMP7vIi8vIgFSITAxOzEGEQcXThcGAasfTWdNqk1zFB0dFAEiFB0wLyL+viIvLyIBAjGcMAYHF00XBxEAAAAL/////wMSAfQADwAWABoAHgAiACkALQAxADcAPQBBAAABISIGFREUFjMhMjY1ETQmBTIzMh0BIRU1IR0CIT0CIRUFIiMiPQEhNRUhPQIhFTUhNTQzIQEUIyE1IREhNSEC4v1NExwcEwKzFBwc/qmhoQ7+sAFQ/rABUP6FoaIOAVH+rwFR/q8OAUMBew7+vgFQ/rEBTwH0HBP+ahMcGxMBlRUcJA4V7CMjLCQkeCQk6Q4VTSMjLSMjTbUO/mEOIwEVJAAAAgAAAAABVgH0AAMABwAAETMRIxMzESOEhNODgwH0/gwB9P4MAAAAAAcAAAAAAfUB9QAPABsAJQAvADMAPABAAAABISIGFREUFjMhMjY1ETQmBxQGKwEVIzUzMhYVFxQGKwE1MzIWFTMjFTMVIxUjNTMFMzUjJyMRFBYzITUhNzM1IwHC/tQVHR0VASwVHR3pFhAZJT4QFn0WED4+EBZkJiYmJUv+4BkZfTIdFQFe/qL6GRkB9B0V/tQVHR0VASwVHbsQFjKWFg9LEBaWFg8ZJjKWPhk+/qIVHTLVSwAAAAAC/////wMSAfUADwAcAAABISIGFREUFjMhMjY1ETQmAxQGIyEiJj0BNxc3FwLd/VgWHx8WAqgWHx8EExf9iBYU3bOItAH0HhX+chUeHhUBjhUe/loXExQWGa9p0n0AAAABAAAAAAH0AfQACwAAJSMVIzUjNTM1MxUzAfTIZMjIZMjIyMhkyMgABgAAAAACZAH1ABMAFwAbAB8AIwAnAAABISIGFREUFjsBFTM1MzI2NRE0JgMhESEHIRUhFSEVISUjFTMVIxUzAiz+DBchIReK34sWISEW/gwB9Dj+zgEy/s4BMv6zODg4OAH0IRf+sxcgODggFwFNFyH+ewFNUzc4OKc3ODgAAAAE/////wMSAfUADwAkAC0ATgAAASEiBhURFBYzITI2NRE0JgEUKwEiPQE0PwE2NxY2NxcWHwEWFSc0NjIWFAYiJgUUBisBJz4BJy4CDgMWFwYPASMiJj0BNDYzITIWFQLd/VgWHx8WAqgWHx/+eQOVAwIKFgcSJhIHHAIBAoQgLSAgLSABuSAX8CsNCQUFFB0hGxEDCwsMFQ0bFiEhFgHDFyAB9B4V/nIUHx4VAY4VHv5UAwNMAwMJFAcLAQwHHAMBAwJkFiAgLR8fDxYhLQ0kEg4XDAIRGh8eCwwUDCEWphYhIRYAAAAABv////8DEgH0AA8AKAA5AFUAWQBjAAABISIGFREUFjMhMjY1ETQmBTcyHwE3Nh8BHgEOASMvAQcGLwEHBi4BNhc3Nh8BHgEOASsBJwcGLgE2BSIjJwciIycHBi4BNj8BNh8BNzYfARYXNxcHBjcnNxc3Byc3NjIfARYUAuL9TRMcHBMCsxQcHP1eVwQDSFQEA00FBgMHBQNKVAMESFQFCgMGBlcEA0wFBgMHBQRIVAUKAwYBUAIBSlQDBEhUBQoDBgZXBANIVAQDTQcCGENbA2dDk0IeFEIUBQ8FKgUB9BwT/moTHBsTAZUVHJkVARMTAQEUAgoKBgEUFAEBFBQCBwsKZBUBARUBCgsFFBQBBgsKfxQUFBQBBgsKAhQBARQUAQEVAQhTQhoJLEKRQh4UQhQGBSkFDwAABf/+//4ERQH1ABkAKwBIAEwAVgAAEzc2HwE3Nh8BHgEOASMiLwEHBi8BBwYuATYXNzYfAR4BDgEjIi8BBwYuATYFIi8BBwYvAQcGLgE2PwE2HwE3Nh8BFhc3FwcOATcnNxc3Byc3NjIfARYGEpYGBnyRBQaECgoFDQgDA36RBQZ9jwoRBQsJlgYGggoKBQ0IAwN9kAkRBQsCQQMDfpEFBn2QCREFCwmWBgZ8kQUGhA0EKHObAwy6c/xyNCNyIgoaCUcJAQGKIwEBIiIBASQCERIKASIiAQEiIgIKExGrJAEBJAISEQoBIiICChMR2gEiIgICIiIDCxMRAiQBASIiAQEkAwyNcSwHCUxx+nI0InEiCghHCRoAABH/////AxIB9QAPABgAJQAyAEIASwBUAF0AZgBwAHYAfACCAIgAjgCWAJ4AAAEhIgYVERQWMyEyNjURNCYDBgcmJz4BMhYXDgEHJic+ATMyFxUWJTYzMhYXBgcuAScmNxM0NjMhMhYdARQGIyEiJjUFBgcmJz4BMhYHBgcmJz4BMhYHBgcmJz4BMhYHBgcmJz4BMhYnMhYXBgcmJz4BFz4BMhYXMz4BMhYXMz4BMhYXMz4BMhYXMz4BMhYXMz4BMhYXBgchJic+ATIWFwLd/VgWHx8WAqgWHx9MFwwNFgUTFhNQAQcBDRcGEwsHCAH9IQcICxMFFwwCBwEGAVYgFwHDFyAgF/49FyAB0hcMDRYFExYTYBcMDRYFExYTYBcMDRcGExYTYBcMDRcGExYSggsSBhcMDRcGExYFFBoVBBkFFBoVBBoFFBoVBBgEFRoUBBkFFBoVBBsFFBkTBQcI/XkJBwUUGRQFAfQeFf5yFR4eFQGOFR7+TwYUFAYJCwsYAQgCFAYJCwICExUCCwkGFAIIAQwTARwXICAXfhcgIBeuBhQUBgkLCwkGFBQGCQsLCQYUFAYJCwsJBhQUBgkLCwsLCQYUFAYJCz0LDg0MCw4NDAsODQwLDg0MCw4NDAsOCwoDAQEDCgsOCwAAAAH////7AUMB+AARAAABFBUUBicuAScmNDc2NzY3NhYBQxsQDO8SCwsQdHkRDhwB2N7eEBEJB8USCxoLEGFkCQgPAAAABgAAAAACcQH0AAMABwALAA8AEwAXAAA3MxUjByE1ITczFSMHITUhNzMVIwchNSE/Pj4/AnH9jz8+Pj8Ccf2PPz4+PwJx/Y9ePx99nD4ffZw/H30AAwAAAAAB9QH0AAgAGAAkAAATIxEUFjMhNSEBISIGFREUFjMhMjY1ETQmByMVIzUjNTM1MxUzMjIdFQFe/qIBkP7UFR0dFQEsFR0dLmQyZGQyZAGQ/qIVHTIBwh0V/tQVHR0VASwVHeFkZDJkZAAAAAIAAP//Ao0B9QAdADsAAAEOAxUUFhc+ATMyFhUUDgIjIi4CNTQ+AjcFDgMVFBYXPgEzMhYVFA4CIyIuAjU0PgI3ARojPCwYBAMGIRQrLRIgKRgoPCcTJkJVMAGgIzwsGQQDBiIUKy0SICkYKTsnEyVCVjABuRcrMDgkCxUMBQw6KBcoHhEgMTscRWZOORo7FiwwOCQLFQwFDDooFygeESAxOxxFZk45GgAAAAAEAAAAAAGRAfUADQARABUAGAAAEyMiBhURFBYzITI2NREHIzUzNSM1Myc1F/rIFR0dFQEsFR1kyMjIyEuKAfQdFf5wFR0dFQEs+jIyMkuKigAAAAABAAAAAAH1AfQAIQAAEz4BMzIeARQOASMiJic3HgEzMj4BNC4BIyIGBxcjIiY9AUojWzJEc0NDc0Q4ZCMsG0wsM1YzM1YzJUQaZr4NEgGqIiZDc4dyQy8pLSEmMlZmVTMdGmUSDb0AAAMAAAAAAfYB+AAMABgAJQAAJSIuAT4CHgEHDgIDIg4BHgI+AScuAQMWFA8BBiImND8BNjIBMDtjKSBdeWYxDAg3TywxUSIaTGVUKAoKWLMKCnoKHBQKegoceEVwdkwJPm46LEYoAVs5XGBABzNaMDdI/uEKHAl7ChQcCnoKAAAAA//4AAAB7gH4AAwAGAAkAAATJj4BHgIOASMiLgE3Bh4BPgIuASMiBgUXFhQGIi8BJjQ2MgMLMWZ5XSApYzssUDYYCShUZUwaIlExN1gBOnsKFBwKegoUHAESOm4+CUx2cEUoRm4wWjMHQGBcOUjXegocFAp6ChwUAAAAAAL//P/8AfIB+ABHAFAAACUnNic3PgEuAQ8BJic3Ni4BBg8BJgcnLgEOAR8BBgcnJg4BFh8BBhcHDgEeAT8BFhcHBh4BNj8BFjcXHgE+AS8BNjcXFj4BJicOAS4BPgEeAQHXJQcHJQ8MDB0OJhUeDwYMHR0GDyQlDwYdHQwGDx8UJg4dDAwOJgcHJQ8MDB0PJRUeEAYMHR0GECQlDwYdHQwGDx4VJQ4dDAyqDDc4Fxc4NxfFECUlEAYdHQwGDx8VJQ4eDAwPJQcHJQ8MDB0PJhUfEAYMHh0GECQlDwYdHgwGEB8VJg8dDAwPJggIJg8MDB4OJhUeDwYMHR0fHBcXODgYGDgAAf////8B0QH1ACgAACUiBgcnNjU0JzceATMyNjQmIgYVFBcHJiIGFBYzMjY3FwYVFBYyNjQmAXcUIw2FBQmLDSITJTQ0SjQIjBpMNDQlFiYNgwc0SjQ0sxEOOA4OFRJQDg80SjQ0JRQRUBw1SjQUETgQEyU0NEo1AAAAAAEAAAAAAogB9AAFAAAJAjUJAQKI/rz+vAFEAUQBPP7EATy4/sQBPAABAAAAAALvAfQABQAAJQEXCQE3AXcBAXb+if6Jd/ABBHj+hAF7eQAAAQAAAAABgwH0AAUAADMnNzMHF/T09I709Pr6+voAAAABAAAAAAFOAfUABQAAJQcnNxcHAU1Q/f5PrU9P+vpPqwAAAAABAAAAAAGDAfQABQAAMTcnMxcH9PSO9PT6+vr6AAAAAAEAAAAAAU4B9QAFAAA3JzcXByetrVD9/VD6q0/6+k8AAQAAAAACiAH0AAUAACEJATUJAQKI/rz+vAFEAUQBPP7EuAE8/sQAAAEAAAAAAu8B9AAFAAAzJwkBBwF3dwF3AXd2/v95AXv+hHgBBAAAAAAEAAD//wH1AfUADwATABcAGwAAASEiBhURFBYzITI2NRE0JgEjNTMXIxEzEyM1MwG8/nwXISEXAYQXISH+1Dg4bzg4bzg4AfQhF/58FyEhFwGEFyH+e8PDARb+6m8AAAAD/////wMSAfQADwAeACIAAAEhIgYVERQWMyEyNjURNCYDBgcGJyY1ND8BFzcWFxYnLQEFAuL9TRMcHBMCsxQcHMhjPU9rBAICtKYBAQGp/qgBWAFYAfQcE/5qExwbEwGVFRz+YQ8BAREcGhIPDFVVARghAp+PjwABAAAAAAE5AfUACAAAExEnFRc3NQcRiYmcnIkB9P5ORjFXVzFFAbEAAQAAAAABOQH1AAgAADMRFzUnBxU3Ea+JnJyJAbJGMVdXMUb+TgAAAAUAAP//AwoB9QAPACEAQABKAFQAAAEhIgYVERQWMyEyNjURNCYDNSMHFwc3Fzc1IzcXIxUzNRcnFjI2NCYrATUzMjY1NCMiByc2MhYVFAcxHgEUBiInNzYzMhYUBiMiJzcWMzI2NCYjIgcC1f1gFh8fFgKgFh8f2sxaDjYJE10SGxwSwjbUBhEHCgcGBgUKDAcHAgcUCgwGCQ0XB1AKChMTFBUKBwkDBg8QDw4HBAH0HhX+chUeHhUBjhUe/qsTYg0LNhJmzS4uyxIbSAQIDAcHBgULBQcFCQcMBAIJEAwFQwESIhQBBwEQGw8BAAAAAAQAAAAAAkgBvQARADAAOgBEAAAlNSMHFwc3Fzc1IzcXIxUzNRcnFjI2NCYrATUzMjY1NCMiByc2MhYVFAcxHgEUBiInNzYzMhYUBiMiJzcWMzI2NCYjIgcCEcxaDjYJE10SGxwSwjbUBhEHCgcGBgUKDAcHAgcUCgwGCQ0XB1AKChMTFBUKBwkDBg8QDw4GBZ8TYg0LNhJmzS4uyxIbSAQIDAcHBgULBQcFCQcMBAIJEAwFQwESIhQBBwEQGw8BAA//////AwoB9QAPABkAIwAtADcAQQBLAFMAXQBnAHEAewCFAI8AmQAAASEiBhURFBYzITI2NRE0JgU9ATMVMxUjFSMVPQEzFTMVIxUjFT0BMxUzFSMVIxU9ATMVMxUjFSMVPQEzFTMVIxUjFT0BMxUzFSMVIxcjFSM1MxUzNx0BIzUjNTM1MzUdASM1IzUzNTM1HQEjNSM1MzUzNR0BIzUjNTM1MzUdASM1IzUzNTM1HQEjNSM1MzUzNR0BIzUjNTM1MwLV/WAWHx8WAqAWHx/+cDEQEDExEBAxMRAQMTEQEDExEBAxMRAQMUEQMTEQEzEQEDExEBAxMRAQMTEQEDExEBAxMRAQMTEQEDEB9B4V/nIVHh4VAY4VHlkNBAQNAzoNBAQNAzoNBAQNAzoNBAQNAzoNBAQNAzoNBAQNAzoDFAQfDQQEDQM6DQQEDQM6DQQEDQM6DQQEDQM6DQQEDQM6DQMDDQM6DQMDDQMAAAAABAAA//8DCgH0AA8AHQAsADsAAAEhIgYVERQWMyEyNjURNCYBJxQjJyImPQE0NjsBNxcmLwEmNzY3Nic3HgEHBhcmLwE+AScmJzc2Nx4BBgLV/WAWHx8WAqAWHx/+vX04Dg0PDw1GfTMEBwgDARQCARcVFREHCBkFCgobFgkKHgcJCyIYGgH0HhX+chUeHhUBjhUe/l9iAQEQDkwOEmLsAwYHAwEWGhwYFA42Gh1FBAoLF0kjJhkICQohW1oAAAAAAwAAAAACRwGhAA0AHAArAAAlJxQjJyImPQE0NjsBNxcmLwEmNzY3Nic3HgEHBhcmLwE+AScmJzc2Nx4BBgGofTgODQ8PDUZ9MwQHCAMBFAIBFxUVEQcIGQUKChsWCQoeBwkLIhgaU2IBARAOTA4SYuwDBgcDARYaHBgUDjYaHUUECgsXSSMmGQgJCiFbWgAABgAA//8DCgH1AA8AJAA5AEkAWQBpAAABISIGFREUFjMhMjY1ETQmARYUBzEGIi8BJjQ/ATYyFzEWFA8BBQcGIicxJjQ/AScmNDcxNjIfARYUFxQGKwEiJjUxNDY7ATIWFTUUBisBIiY1MTQ2OwEyFhU1FAYrASImPQE0NjsBMhYVAtX9YBYfHxYCoBYfH/4OBQUFDgRUBQVUBA4FBQVJAQFTBQ4FBQVKSgUFBQ4FUwW/Cgd5BwkJB3kHCgoHWgcKCgdaBwoKB3kHCQkHeQcKAfQeFf5yFR4eFQGOFR7+wAUOBQQFVAUOBVUFBQUOBUkMVAUEBQ4FSUkFDgUFBVUFDk0HCgoHBwoKB1QHCgoHBwoKB1UHCgoHAQYKCgYAAAAABQAAAAACdQFkABQAKQA5AEkAWQAANxYUBzEGIi8BJjQ/ATYyFzEWFA8BBQcGIicxJjQ/AScmNDcxNjIfARYUFxQGKwEiJjUxNDY7ATIWFTUUBisBIiY9ATQ2OwEyFhU1FAYrASImPQE0NjsBMhYV+QUFBQ4EVAUFVAQOBQUFSQEBUwUOBQUFSkoFBQUOBVMFvwoHeQcJCQd5BwoKB1oHCgoHWgcKCgd5BwkJB3kHCrQFDgUEBVQFDgVVBQUFDgVJDFQFBAUOBUlJBQ4FBQVVBQ5NBwoKBwcKCgdUBwoKBwEGCgoGVAcKCgcBBwkJBwAAEf////8DEgH1AAMABwALABEAFQAZAB0AIQAlACkALQAxADUAOQBBAFEAYQAAJTMVIzUzNSMnMzUjERQ7ATUjNTM1IzczNSMnMzUjFTM1IyUzNSM1MzUjFTM1IyczNSM1MzUjFzM1IxUyMzI2PQEjExEUBiMhIiY1ETQ2MyEyFgc0JiMhIgYVERQWMyEyNjUBHNzc3Nz53t4O0N7e3vnc3Pne3t7eAfDc3Nzc3Nz33Nzc3Pfc3GdnCAbc/x8W/VgWHx8WAqgWHw4XEP1YEBcXEAKoEBdHJD0klST+9A4kGSQaJBojYSQaIxoknyQaIxok3SRhBggWAXr+chUeHhUBjhUeHhUPFhYP/nIPFhYPAAADAAD//wMKAfUABQAVABoAAAEzFSMRMyUhIgYVERQWMyEyNjURNCYBETMXEQGgWeiPATX9YBYfHxYCoBYfH/4UqmIBSvkBUlEeFf5yFR4eFQGOFR7+SwF2Y/7tAAIAAAAAAgsBtQAEAAoAAAEjESERAyMRMxUzAamqAQwS6I9ZAbX+igET/v8BUlkAAAUAAP//AwoB9QARACcAPABMAKsAACUmJwcGDwEGDwEWFxYXPgE3JicGIicGFRQXNzE3MDE2NzMWHwE2NTQHIjEnJi8BJi8BBgcGBx4BFzY3NjcBISIGFREUFjMhMjY1ETQmAw4BJyYnJicmJyYnDwEwMQYrASIvAQYHBgcGBwYHBi4BNjc2FzY3Njc2NzQ/ATY/ATY/ATY3JjU0NzY3JjU0NjIWFRQHFhUUBwYHHwEWHwEWFzEfARYXFhcWFzYXHgEB7hUcAgICAgMECBEWGyQBCQgVcwgSCBAKBAcFBQQFBQsJRgEDBAICAgEDHBUbFQcKASQbFhEBcf1gFh8fFgKgFh8fkQkiDxEDJx4RDwUFBQgFBAQFBgsTFxIVDhADEQ8iEgkPERMWHhEVBwkBAQICAgMDBAMDCwYEBxAZIhkQEQYDAgYDBAMCAgECAR8XEg8KCRMRDwmxDQUKBQQDBQQIFg0QBAkPBh7RBAQhIBkaAQIBAQEBAxoZILADBAUDBAQLBQ0QHwUPCQQQDRYBWB4V/nIVHh4VAY4VHv5XDwgICxQEEgoQBgYCAgEBBBgOCwYDAhQLCQkdIgkLCCESCgYCAQUFBQQFAwQEBAMCHRsVFQ4ODRQSGBgSFA0jIxQVCAcFBAQEAwQEBwgGDgoQCw0HCwkhAAAAAAQAAAAAAmMBwwBdAG8AgwCXAAAlJgcmJyYnJic0JzEnMSYvASYvASYnNjc2NTQnNjU0JiIGFRQXBgcGFRQXBg8BBg8BBg8BBhUGBwYHBgcmBw4BHgE3Njc2NzY3NjcXFjsBMj8BFhcWFxYXFhcWPgEmJxYyNxYVFAcnJicjBiMHJjU0BwYHLgEnNjc2NxcwMRYfARYfAQY3Nj8BNj8BNj8BFhcWFw4BByYnJgJLERMJCg8SFx8BAgECAgMEAwMDAgMGERAZIhkQBwQGCwMDBAMDAgICAQEICBURHhYTEQ8JEiIPEQMQDhUSFxMLBgUEBAUNBQUPER4nAxEPIhIJ5ggSCA8JCwUFBAUFCwonGyQBCgcVGxUcAwECAgIECRFTAwIDBAMCAgICHBUbFQgJASQbFoQLCA4KEQoOBQQFBwQDAwUEBAMCBwgVFCIkDRQSGBgSFA0ODhUVGx0DAgQEBQMEBAUFBQECBgoSIQcKCSIdCQkLFAEEBgoOGQQBAQQGBhAKEgQUCwkJHiH3BAQhIBkaAwEBAQQaGSDYEAQJDwUfEA0FCwQEAwUECBYWAgMDBAUDBAUKBQ0QHgUQCQQQDQAGAAD//wMKAfQADAAcACEAJwAzAEUAACU1PgEyFh0BFAYjIiYBERQGIyEiJjURNDYzITIWBycjESEDMxUjETMHIxUxJyMVMzUxFzM3FTM3HgEzMjY9ATQmIyIGBzUBoAIKEwoKCwcLAWgfFv1gFh8fFgKgFh//YqoBDGtZ6I8fCDcICDcIFwYBBAsIDQ4ODQgLA68gBggRDQIMDwcBGP5yFR4eFQGOFR4ehGP+igEL+QFSqFFRX1FRZmYLBgYTDwIRFAYGKgAAAAX//wAAAWUB9AAFAAoAFgAoADYAABMjESERIxMhETMXByMnMRUjNTMXMTUzFxQGIyImJwcjNTMVPgEzMhYVIzQmIyIGBxUeATMyNjXWvgE1d4/+m+KDtwtMDAxMC3AUEgsQBQIICwUPCxIUCw8ODA4DBA4LDg8B3P48AU3+mwH0hfpycoZzc1cXGgkID487CAkdFxMXCwguCQoWEgAAAAADAAD//wMKAfUADwAgACkAAAERFAYjISImNRE0NjMhMhYFIgcOARcWFxYXMTc2NzYuAQciJjQ2MhYUBgMKHxb9YBYfHxYCoBYf/nQkGxoUCQ4tFhMpKw8KFDUkHisrPSsrAcH+chUeHhUBjhUeHicWFEAfLmUyKVtlLh9AKrMrPisrPisAAAAAAgAAAAAB7AGvAA4AFwAAASIHDgEXFh8BNzY3Ni4BByImNDYyFhQGAX4kGxoUCQ4tKSkrDwoUNSQeKys9KysBrxYUQB8uZVtbZS4fQCqzKz4rKz4rAAAAAAIAAP//AwoB9QAPAFYAAAEhIgYVERQWMyEyNjURNCYDFAYuATc1JzUOAQczFzMyFhQGIiY1NDY3JyMiJicxBxUUBiImNDYzMhYXNzE1NDYzMTcuATU0NjIWFAYjBx4BFRc+ARcyFgLV/WAWHx8WAqAWHx+5FyAVATwBEAsBDgEWHh4sHhcRDQENFAQ4GSMZGREOFgQ5Fg8HDhEZIxkZEQgNET0EFA0PFgH0HhX+chUeHhUBjhUe/vIPFgEXEAMLAQsRAz4fKx4eFhIdBD0QDA0EEhkZJBkQDAwCEBdIAxcPERkZIxlGAxUOCwsOARcAAAEAAAAAAjMBwgBGAAAlFAYuATc1JzUOAQczFzMyFhQGIiY1NDY3JyMiJicxBxUUBiImNDYzMhYXNzE1NDYzMTcuATU0NjIWFAYjBx4BFRc+ARcyFgIyFyAVATwBEAsBDgEWHh4sHhcRDQENFAQ4GSMZGREOFgQ5Fg8HDhEZIxkZEQgNET0EFA0PFuYPFgEXEAMLAQsRAz4fKx4eFhIdBD0QDA0EEhkZJBkQDAwCEBdIAxcPERkZIxlGAxUOCwsOARcAAAAOAAAAAAGvAcsACQATAB0AJwAxADsAQwBNAFcAYQBrAHUAfwCJAAABPQEzFTMVIxUjFT0BMxUzFSMVIxU9ATMVMxUjFSMVPQEzFTMVIxUjFT0BMxUzFSMVIxU9ATMVMxUjFSMXIxUjNTMVMzcdASM1IzUzNTM1HQEjNSM1MzUzNR0BIzUjNTM1MzUdASM1IzUzNTM1HQEjNSM1MzUzNR0BIzUjNTM1MzUdASM1IzUzNTMBWzEQEDExEBAxMRAQMTEQEDExEBAxMRAQMUEQMTEQEzEQEDExEBAxMRAQMTEQEDExEBAxMRAQMTEQEDEBmw0EBA0DOg0EBA0DOg0EBA0DOg0EBA0DOg0EBA0DOg0EBA0DOgMUBB8NBAQNAzoNBAQNAzoNBAQNAzoNBAQNAzoNBAQNAzoNAwMNAzoNAwMNAwAAAAADAAAAAAJ9AfQAAwAHAAsAADEzESMTITUhERUhNVtbiAH0/gwB9AH0/gzjARHj4wAD/////wG2AfUAAgAgAC0AAD8BBzc1MzI2NCYrASIGFBY7ARUOAhUUHgEyPgE1NC4BAyIuATQ+ATIeARQOAfFFczcfDRMTDX0NEhINIDVWMTtkd2U7MlVUK0cqKkdVSCoqSMVyRcEDEhoSEhoSAwg9XTY8ZDs7ZDw2XT3+kytHVUgqKkhVRysABgAAAAAB1QH0ABYAGgAqADcARABRAAABISIGFBY7ARUUFjMhMjY9ATMyNjQmIwMjNTMnMzIWFTM0JisBIgYVMzQ2AzI2PQE0JiIGHQEUFjMyNj0BNCYiBh0BFBYzMjY9ATQmIgYdARQWAbb+aQwTEwwHJRkBChkmCQwTEw1Q+vqpXQ0THyUaXRolHxMOBwsLDwoKTwgKCg8LC08HCgoPCgoBiRUbFvwaLS0a/BYbFf6+/I4WDRosLBoNFv6ZBwaaBQgIBZoGBwcGmgUICAWaBgcHBpoFCAgFmgYHAAEAAAAAAfUB9AAiAAABHQEUBisBNy4BIyIOARQeATMyNjcXDgEjIi4BND4BMzIWFwH0Eg29ZRpDJjNWMjJWMyxNGiwjYzlEc0NDc0QzWiMB9J4fDRJlGh0zVWZWMiYhLSkvQ3KHc0MmIgAAAAEAAAAAAZAB9AAGAAA1NxcjFSM1yMhkyPr6+vr6AAAAAQAAAAACPAH0AD4AACUmJyYnLgErATc+ATc1NjU0JyYrASIHBgcGFRQXFh8BIyIGBwYPAQYHDgEHFRceAR8BITI3Nj8BNTQ1LgEnJgHyDw8mKwEOCxYDGRoFChIfSgMvHRgLBwoLLQMWCw4BKSsjExgOCAEBAQcHBgIPCQYEAgECCQwbZQUFDQ8KEjALJRoBNSMsHjAYEiAYGCA5Ow8wEwoQDgoHBQMGCysGBAoCAQcDBwYpAgMHBQMHAAAD/////wMSAfUAAgASAB8AAAEXBwERFAYjISImNRE0NjMhMhYHNC4BIg4BFB4BMj4BAWF9fQGxHxb9WBYfHxYCqBYf9ydET0MnJ0NPRCcBTlVUARz+chUeHhUBjhUeHtwoQycnQ1BDJydDAAAEAAAAAAMMAfQAJQAmADMAQAAAJRQHBgcGBwYHBiMiJyYnJicmNTQ3Njc2NzY3NjMyFxYXFhcWFxYBNzQuASIOARQeATI+ASciDgEUHgEyPgE0LgEDDBASHCMrMzpDSlNOQjkvHxwRFB8lKzQ4QERIQjo0KyQeEhH+esc2XG1cNjZcbVw2yC1KLCxKWUssLEv7DRwgICceIxQWIhwyKCwnEAscHyAnHiMUFhYUIx4nIB8b/vn5N1w1NVxtXDY2XNksS1hLLCxLWEssAAAGAAD//wH1AfUACAANABYAHwAoADEAABMzNSMiBh0BMxcHIScHNzQmIgYUFjI2NyMVMxUzNTQmAyMVMzI2PQEjISMVFBY7ATUjMq+vFR0ylmQBLEszZRYfFhYfFkuvrzIdFa+vFR0y/nAyHRWvrwHCMh0VrzJ9ZETODxYWHxYWsjKvrxUd/j4yHRWvrxUdMgAE/////wGcAfUADwATABcAGwAAASEiBhURFBYzITI2NRE0JgMjNTM1IzUzNSM1MwFh/toZIiIZASYYIyM17Ozs7OzsAfQiGf6CGSIiGQF+GSL+nx46HjsdAAAAAAMAAAAAAfQB9AAMABYAHwAAMzI+ATQuASIOARQeARMmNjIWDwEGIicXMhYUBiImNDb6RHNDQ3OIc0NDcxcCIRwhAhMELAQZDhISGxISQ3OIc0NDc4hzQwFyDBgYDJcgID4TGhMTGhMAAwAA//8B9AH0ABYAIwAvAAAlJzY1NC4BIg4BFB4BMzI3FxYyPwE2NCUiLgE0PgEyHgEUDgEnMxUjFSM1IzUzNTMB71kfOmV2ZTs7ZDxJMFkFDQQsBf7nKkgqKkhUSCoqSAs/Pz8+Pj9HWTBJO2U7PGZ2ZDkfWQUFLAQNOitIVUgqKkhVSCu8Pj8/Pj8AAAAAAwAA//8B9AH0ABYAIwAnAAAlJzY1NC4BIg4BFB4BMzI3FxYyPwE2NCUiLgE0PgEyHgEUDgEnMzUjAe9ZHzpldmU7O2Q8STBZBQ0ELAX+5ypIKipIVEgqKkiIvLxHWTBJO2U7PGZ2ZDkfWQUFLAQNOitIVUgqKkhVSCt+PgAAAAAAABAAxgABAAAAAAABAAcAAAABAAAAAAACAAcABwABAAAAAAADAAcADgABAAAAAAAEAAcAFQABAAAAAAAFAAsAHAABAAAAAAAGAAcAJwABAAAAAAAKACsALgABAAAAAAALABMAWQADAAEECQABAA4AbAADAAEECQACAA4AegADAAEECQADAA4AiAADAAEECQAEAA4AlgADAAEECQAFABYApAADAAEECQAGAA4AugADAAEECQAKAFYAyAADAAEECQALACYBHmZpZ0ljb25SZWd1bGFyZmlnSWNvbmZpZ0ljb25WZXJzaW9uIDEuMGZpZ0ljb25HZW5lcmF0ZWQgYnkgc3ZnMnR0ZiBmcm9tIEZvbnRlbGxvIHByb2plY3QuaHR0cDovL2ZvbnRlbGxvLmNvbQBmAGkAZwBJAGMAbwBuAFIAZQBnAHUAbABhAHIAZgBpAGcASQBjAG8AbgBmAGkAZwBJAGMAbwBuAFYAZQByAHMAaQBvAG4AIAAxAC4AMABmAGkAZwBJAGMAbwBuAEcAZQBuAGUAcgBhAHQAZQBkACAAYgB5ACAAcwB2AGcAMgB0AHQAZgAgAGYAcgBvAG0AIABGAG8AbgB0AGUAbABsAG8AIABwAHIAbwBqAGUAYwB0AC4AaAB0AHQAcAA6AC8ALwBmAG8AbgB0AGUAbABsAG8ALgBjAG8AbQAAAAIAAAAAAAAABQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAjAECAQMBBAEFAQYBBwEIAQkBCgELAQwBDQEOAQ8BEAERARIBEwEUARUBFgEXARgBGQEaARsBHAEdAR4BHwEgASEBIgEjASQBJQEmAScBKAEpASoBKwEsAS0BLgEvATABMQEyATMBNAE1ATYBNwE4ATkBOgE7ATwBPQE+AT8BQAFBAUIBQwFEAUUBRgFHAUgBSQFKAUsBTAFNAU4BTwFQAVEBUgFTAVQBVQFWAVcBWAFZAVoBWwFcAV0BXgFfAWABYQFiAWMBZAFlAWYBZwFoAWkBagFrAWwBbQFuAW8BcAFxAXIBcwF0AXUBdgF3AXgBeQF6AXsBfAF9AX4BfwGAAYEBggGDAYQBhQGGAYcBiAGJAYoBiwGMAY0AAjNECmFjY2Vzc2libGUMYWNoaWV2ZW1lbnRzCGFjdGl2aXR5A2FwaQphcnJvd19kb3duCmFycm93X2xlZnQLYXJyb3dfcmlnaHQIYXJyb3dfdXAFYXVkaW8KYmFja19hcnJvdwhjYWxlbmRhcgZjYW5jZWwIY2hlY2tib3gPY2hlY2tib3hfbWFya2VkCWNoZWNrbWFyawRjaXRlBGNvZGUUY29sbGFib3JhdGl2ZS1zcGFjZXMSY29sbGVjdGlvbnMtZm9sZGVyC2NvbGxlY3Rpb25zB2NvbW1lbnQQY29tcGFjdF9jb250cm9scwhjb21wcmVzcwxjb25maWRlbnRpYWwIY3VyYXRpb24PZGF0YS1tYW5hZ2VtZW50B2RhdGFzZXQJZGF0YXN0b3JlBmRlbGV0ZQxkZWxldGVfc2hhcnAQZGVza3RvcC11cGxvYWRlcg1kaXNzZW1pbmF0aW9uDGRpdmlkZXJfdmlldwNkb2kXZG91YmxlX3NoYXJwX2Fycm93X2Rvd24VZG91YmxlX3NoYXJwX2Fycm93X3VwCGRvd25sb2FkDWRvd25sb2FkX2JvbGQLZHJhZ19oYW5kbGUEZWRpdAZleHBhbmQPZXhwYW5kX2NvbnRyb2xzFWZhc3RfZm9yd2FyZF9iYWNrd2FyZAdmaWxlc2V0C2ZpdF90b192aWV3C2ZvbGRlcl9maWxsC2ZvbGRlcl9vcGVuDmZvbGRlcl9vdXRsaW5lDWZvcndhcmRfYXJyb3cMZ2VuZXJpY19maWxlC2dpdGh1Yl9sb2dvFmdvLXRvLWxpbmstYWx0ZXJuYXRpdmUKZ29fdG9fbGluawlncmlkX3ZpZXcMaGlkZV9kZXRhaWxzBGhvbWULaG9tZV9tYW5hZ2UMaG9tZV9wdWJsaXNoCmhvbWVfc2hhcmULaG9tZV91cGxvYWQEaW5mbxVpbnN0aXR1dGlvbmFsX2FjY291bnQGbGlua2VkBGxpc3QVbGlzdF92aWV3LWFsdGVybmF0aXZlCWxpc3Rfdmlldwlsb2FkX21vcmUMbG9jYXRpb25fcGluBmxvY2tlZAhtZXRhZGF0YQptaW51c19pY29uCG1vbGVjdWxlBG5leHQEbm90ZQVwYXBlcgtwYXVzZV92aWRlbwhwZGYtZmlsZQhwaWN0dXJlcwlwbHVzX2ljb24GcG9ydGFsBnBvc3RlcghwcmVwcmludApwcmVwcmludF9pDHByZXNlbnRhdGlvbghwcmV2aW91cw1wcml2YXRlLXNwYWNlDHB1YmxpYy1zcGFjZQVxdW90ZQtyZXNlcnZlLWRvaQVyZXRyeQZzZWFyY2gLc2VhcmNoX2xlZnQIc2V0dGluZ3MFc2hhcmUQc2hhcnBfYXJyb3dfZG93bhFzaGFycF9hcnJvd19kb3duMhBzaGFycF9hcnJvd19sZWZ0EXNoYXJwX2Fycm93X2xlZnQyEXNoYXJwX2Fycm93X3JpZ2h0EnNoYXJwX2Fycm93X3JpZ2h0Mg5zaGFycF9hcnJvd191cA9zaGFycF9hcnJvd191cDIFc3RhdHMGdGhlc2lzD3RoaW5fYXJyb3dfZG93bg10aGluX2Fycm93X3VwDnRodW1iXzNkdmlld2VyEHRodW1iXzNkdmlld2VyX2kNdGh1bWJfYXJjaGl2ZQt0aHVtYl9hdWRpbw10aHVtYl9hdWRpb19pD3RodW1iX2NvZGVfdGV4dBF0aHVtYl9jb2RlX3RleHRfaQ90aHVtYl9kYXRhc2V0X2kNdGh1bWJfZ2VuZXJpYw90aHVtYl9nZW5lcmljX2kLdGh1bWJfZ3JhcGgNdGh1bWJfZ3JhcGhfaQt0aHVtYl9pcHluYg10aHVtYl9pcHluYl9pCXRodW1iX21hcAt0aHVtYl9tYXBfaQ50aHVtYl9tb2xlY3VsZRB0aHVtYl9tb2xlY3VsZV9pC3RodW1iX3ppcF9pDXRpbWVsaW5lX3ZpZXcFdGltZXIFdHJhc2gGdXBkYXRlBnVwbG9hZAR1c2VyDHZpZGVvX3BsYXllcgt2aWV3X3B1YmxpYwZ2aWV3ZXINdmlld2VyX2ZvbGRlcgd3YXJuaW5nB3pvb21faW4Iem9vbV9vdXQAAAAAAA==?#iefix) format("embedded-opentype"),url(data:application/font-woff;base64,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) format('woff'),url(data:application/x-font-ttf;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?> 
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<defs>
  <font id="figIcon" horiz-adv-x="4300.8">
    <font-face font-family="figIcon"
      units-per-em="500" ascent="500"
      descent="0" />
    <missing-glyph horiz-adv-x="0" />
    <glyph glyph-name="3D"
      unicode="&#xF101;"
      horiz-adv-x="499.9720982142858" d=" M499.9720982142858 173.828125L434.654017857143 141.2388392857143V163.0301339285715H184.7377232142858H173.1863839285715L48.7444196428572 29.8828125L65.0669642857143 14.2299107142858L0 0L11.8582589285714 65.2622767857143L33.7332589285714 44.2801339285714L163.0022321428572 182.5892857142857V184.7935267857143V445.5915178571429H141.1830357142857L173.7723214285714 500L206.3616071428571 445.5915178571429H184.7098214285715V184.7935267857143H434.6261160714286V206.4453125L499.9720982142858 173.828125z" />
    <glyph glyph-name="accessible"
      unicode="&#xF102;"
      horiz-adv-x="750" d=" M604.8549107142858 311.4118303571429C583.59375 418.9174107142857 488.7555803571428 500 375 500C284.6819196428571 500 206.4174107142857 448.7444196428572 167.1875 373.9118303571429C73.2700892857143 363.7555803571429 0 284.2075892857143 0 187.5C0 83.9006696428572 83.9006696428572 0 187.5 0H593.75C679.9944196428571 0 750 70.0055803571429 750 156.25C750 238.7555803571429 685.7700892857143 305.6361607142857 604.8549107142858 311.4118303571429M312.5 93.75L203.125 203.125L247.3493303571429 247.3493303571429L312.5 182.1986607142857L474.21875 343.9174107142857L518.4430803571429 299.6930803571429L312.5 93.75z" />
    <glyph glyph-name="achievements"
      unicode="&#xF103;"
      horiz-adv-x="365.4854910714286" d=" M323.5770089285715 25.2232142857143L268.0524553571429 37.6395089285714L228.6830357142857 0.390625L195.2287946428572 128.3482142857143C195.2287946428572 128.3482142857143 227.0926339285715 129.9944196428572 244.4196428571429 134.4587053571429C264.2020089285715 139.5647321428572 290.1506696428572 153.1808035714286 290.1506696428572 153.1808035714286L323.5770089285715 25.2232142857143zM174.8325892857143 127.5390625C174.8325892857143 127.5390625 145.5636160714286 128.7388392857142 125.8649553571429 134.2075892857143C108.6495535714286 139.0066964285715 80.2176339285714 153.515625 80.2176339285714 153.515625L45.2287946428571 25.9486607142857L97.9631696428572 38.5044642857143L139.84375 0L174.8325892857143 127.5390625zM356.9754464285715 349.1908482142857L348.0747767857143 361.5792410714286C342.4944196428572 369.3359375 339.5368303571429 378.6830357142857 339.5647321428572 388.2254464285715L339.6484375 403.4877232142857C339.7600446428572 423.1026785714286 327.2321428571429 440.5412946428571 308.6216517857143 446.7075892857143L294.140625 451.5066964285714C285.0725446428571 454.5200892857143 277.1763392857143 460.3236607142857 271.5959821428571 468.0803571428571L262.7232142857143 480.46875C251.2834821428572 496.4006696428572 230.8872767857143 503.1529017857143 212.1930803571429 497.1819196428572L197.65625 492.5502232142857C188.5602678571429 489.6484375 178.7667410714286 489.7042410714286 169.6707589285715 492.7176339285714L155.2176339285714 497.4888392857143C136.6071428571429 503.6551339285714 116.1272321428571 497.1261160714286 104.5200892857143 481.3337053571428L95.4799107142857 469.0569196428571C89.8158482142857 461.3560267857143 81.8638392857143 455.6361607142857 72.7678571428571 452.734375L58.2310267857143 448.1026785714286C39.5368303571429 442.1595982142857 26.8136160714286 424.8325892857143 26.7020089285714 405.2176339285715L26.6183035714286 389.9553571428572C26.5625 380.3850446428571 23.4933035714286 371.09375 17.8292410714286 363.3928571428571L8.7890625 351.1160714285715C-2.8180803571429 335.3236607142857 -2.9575892857143 313.8392857142857 8.4821428571429 297.9073660714286L17.3828125 285.5189732142857C22.9631696428571 277.7622767857144 25.9207589285714 268.4151785714286 25.8928571428571 258.8727678571429L25.8091517857143 243.6104910714286C25.6975446428571 223.9955357142857 38.2254464285714 206.5569196428571 56.8359375 200.390625L71.3169642857143 195.5915178571428C80.3850446428572 192.578125 88.28125 186.7745535714286 93.8616071428571 179.0178571428571L102.7622767857143 166.6294642857142C114.2020089285714 150.6975446428571 134.5982142857143 143.9453125 153.2924107142857 149.9162946428571L167.8292410714286 154.5479910714285C176.9252232142857 157.4497767857142 186.71875 157.3939732142856 195.8147321428572 154.3805803571428L210.2957589285714 149.5814732142856C228.90625 143.4151785714285 249.3861607142857 149.9441964285713 260.9933035714286 165.7366071428571L270.0334821428571 178.0133928571428C275.6975446428571 185.7142857142856 283.6495535714285 191.4341517857142 292.7455357142857 194.3359375L307.2823660714285 198.9676339285713C325.9765625 204.9107142857142 338.6997767857142 222.2377232142856 338.8113839285714 241.8526785714285L338.8950892857142 257.1149553571428C338.9508928571428 266.6852678571428 342.0200892857142 275.9765625 347.6841517857142 283.6774553571428L356.7243303571428 295.9542410714286C368.3035714285715 311.7745535714286 368.4151785714286 333.2589285714286 356.9754464285715 349.1908482142857zM316.0714285714286 319.7265625C317.1595982142857 393.5546875 258.203125 454.296875 184.375 455.3850446428571C110.546875 456.4732142857143 49.8046875 397.5167410714286 48.7165178571429 323.6886160714286S106.5848214285714 189.1183035714286 180.4129464285714 188.0301339285714C254.2410714285715 186.9140625 314.9832589285715 245.8984375 316.0714285714286 319.7265625zM184.0122767857143 431.3058035714286C123.4933035714286 432.1986607142857 73.6886160714286 383.8448660714286 72.7957589285714 323.3258928571429S120.2566964285714 213.0022321428572 180.7756696428572 212.109375C241.2946428571429 211.2165178571428 291.0993303571429 259.5703125 291.9921875 320.0892857142857S244.5591517857143 430.4129464285715 184.0122767857143 431.3058035714286z" />
    <glyph glyph-name="activity"
      unicode="&#xF104;"
      horiz-adv-x="666.6294642857142" d=" M166.6573660714286 208.3426339285715H666.6573660714287V291.6573660714286H166.6573660714287V208.3426339285715zM0 416.6573660714286H83.3426339285714V500H0V416.6573660714286zM0 0H83.3426339285714V83.3426339285715H0V0zM0 208.3426339285715H83.3426339285714V291.6573660714286H0V208.3426339285715zM166.6573660714286 500V416.6573660714286H666.6573660714287V500H166.6573660714286zM166.6573660714286 0H666.6573660714287V83.3426339285715H166.6573660714287V0z" />
    <glyph glyph-name="api"
      unicode="&#xF105;"
      horiz-adv-x="555.5524553571429" d=" M555.5524553571429 333.3426339285715V388.8950892857143H500V444.4475446428571C500 475 475.0000000000001 500 444.4475446428572 500H55.5524553571429C25 500 0 475 0 444.4475446428571V55.5524553571428C0 24.9999999999999 25 0 55.5524553571429 0H444.4475446428572C475.0000000000001 0 500 24.9999999999999 500 55.5524553571428V111.1049107142857H555.5524553571429V166.6573660714286H500V222.2098214285714H555.5524553571429V277.7901785714286H500V333.3426339285715H555.5524553571429zM444.4475446428572 55.5524553571428H55.5524553571429V444.4475446428571H444.4475446428572V55.5524553571428zM111.1049107142857 222.2098214285714H250V111.1049107142857H111.1049107142857V222.2098214285714zM277.7901785714286 388.8950892857143H388.8950892857143V305.5524553571429H277.7901785714286V388.8950892857143zM111.1049107142857 388.8950892857143H250V250H111.1049107142857V388.8950892857143zM277.7901785714286 277.7901785714286H388.8950892857143V111.1328125000001H277.7901785714286V277.7901785714286z" />
    <glyph glyph-name="arrow_down"
      unicode="&#xF106;"
      horiz-adv-x="896.2890625000001" d=" M0 444.7544642857143C0 430.9430803571429 5.3013392857143 417.1316964285715 15.9040178571429 406.640625L375.3627232142857 47.0703125C436.0212053571429 -13.5881696428572 457.1707589285714 -16.6573660714286 517.8013392857143 43.9732142857143L880.1339285714287 406.3337053571429C901.5625000000002 427.6506696428571 901.7020089285716 462.3604910714286 880.4129464285714 483.8169642857143C859.1238839285714 505.3013392857143 824.4977678571429 505.4129464285714 803.0412946428571 484.0959821428572C803.0412946428571 484.0959821428572 566.5457589285714 247.3772321428572 475.3627232142857 156.1941964285714C447.8515625 128.6830357142857 445.3404017857143 129.6875 421.484375 153.5435267857143C333.0915178571429 241.9363839285715 91.796875 482.8683035714286 91.796875 482.8683035714286C70.703125 503.7667410714286 36.6071428571429 503.6551339285714 15.6529017857143 482.6171875C5.2176339285714 472.1261160714286 0 458.4263392857143 0 444.7544642857143z" />
    <glyph glyph-name="arrow_left"
      unicode="&#xF107;"
      horiz-adv-x="278.93415178571433" d=" M269.2243303571429 8.7332589285714C280.9709821428572 20.4241071428572 281.0267857142857 39.4531249999999 269.3638392857144 51.2276785714286C269.3638392857144 51.2276785714286 134.9609375 185.8258928571428 85.6584821428572 235.15625C72.3493303571429 248.4654017857143 71.7912946428572 249.8604910714286 87.1372767857143 265.2064732142857C138.0022321428572 316.0714285714286 270.0613839285715 447.9910714285715 270.0613839285715 447.9910714285715C281.9475446428572 459.9609375 281.8917410714286 479.2689732142857 269.9218750000001 491.1551339285714C257.9520089285715 503.0412946428571 238.5881696428572 502.9575892857143 226.7020089285715 491.015625L24.5256696428571 288.8671875C-9.2912946428571 255.0502232142857 -7.5892857142857 243.2477678571429 26.2555803571428 209.4029017857143L226.8415178571429 8.8727678571428C232.7008928571429 2.9575892857142 240.4017857142857 0 248.1026785714286 0C255.7477678571429 0 263.3928571428572 2.9017857142857 269.2243303571429 8.7332589285714z" />
    <glyph glyph-name="arrow_right"
      unicode="&#xF108;"
      horiz-adv-x="278.93415178571433" d=" M30.8314732142857 0C38.5323660714286 0 46.2332589285714 2.9575892857142 52.0926339285714 8.8727678571428L252.6785714285714 209.4029017857143C286.5234375 243.2477678571429 288.2254464285715 255.0502232142857 254.4084821428572 288.8671875L52.2600446428571 490.9877232142857C40.3738839285714 502.9575892857143 21.0100446428571 503.0133928571428 9.0401785714286 491.1272321428571C-2.9296875 479.2410714285714 -3.0133928571429 459.9330357142857 8.9006696428571 447.9631696428571C8.9006696428571 447.9631696428571 140.9598214285715 316.015625 191.8247767857143 265.1785714285715C207.1707589285715 249.8325892857143 206.6127232142857 248.4375 193.3035714285714 235.1283482142857C143.9732142857143 185.8258928571428 9.5703125 51.1997767857143 9.5703125 51.1997767857143C-2.0926339285714 39.4252232142857 -2.0368303571429 20.3962053571428 9.7098214285714 8.7053571428572C15.5691964285714 2.9017857142857 23.1863839285714 0 30.8314732142857 0z" />
    <glyph glyph-name="arrow_up"
      unicode="&#xF109;"
      horiz-adv-x="896.2890625000001" d=" M15.6529017857143 17.4107142857143C36.6071428571429 -3.6272321428572 70.703125 -3.7667410714286 91.796875 17.1595982142857C91.796875 17.1595982142857 333.0915178571429 258.0915178571429 421.484375 346.484375C445.3404017857143 370.3404017857143 447.8515625 371.3448660714286 475.3627232142857 343.8337053571429C566.5457589285714 252.6506696428572 803.0412946428571 15.9040178571428 803.0412946428571 15.9040178571428C824.4698660714287 -5.4129464285714 859.1238839285714 -5.3013392857143 880.4129464285714 16.1830357142857C901.7020089285716 37.6674107142857 901.5904017857144 72.3493303571428 880.1339285714287 93.6662946428572L517.8013392857143 456.0546875C457.1986607142858 516.6573660714286 436.021205357143 513.6160714285714 375.3627232142858 452.9575892857143L15.9040178571429 93.3593749999999C5.3013392857143 82.8683035714286 0 69.0569196428571 0 55.2455357142857C0 41.5736607142857 5.2176339285714 27.8738839285714 15.6529017857143 17.4107142857143z" />
    <glyph glyph-name="audio"
      unicode="&#xF10A;"
      horiz-adv-x="560.2678571428571" d=" M0 305.7477678571429C0 331.4732142857143 19.7265625 351.4787946428571 45.7310267857143 351.4787946428571C70.0892857142857 351.4787946428571 128.6272321428572 351.4787946428571 128.6272321428572 351.4787946428571L308.59375 500V0L125.78125 148.5212053571428C125.78125 148.5212053571428 61.3839285714286 148.6607142857143 42.8850446428571 148.5212053571428C20.0055803571429 148.3816964285714 0 170.4241071428571 0 191.40625S0 294.3080357142857 0 305.7477678571429zM377.2042410714286 325.7533482142857C377.2042410714286 325.7533482142857 392.3270089285715 341.1272321428571 408.6495535714286 357.1986607142857C470.7310267857144 313.2254464285715 481.3337053571429 199.9720982142857 408.6495535714286 145.7868303571428C388.2254464285715 164.0345982142857 373.6607142857144 173.2979910714286 377.2042410714286 177.2321428571428C414.9274553571429 217.6618303571428 426.3671875 276.6183035714286 377.2042410714286 325.7533482142857zM442.8292410714286 397.0982142857143C442.8292410714286 397.0982142857143 457.3939732142857 413.8392857142857 482.8404017857143 437.109375C588.4765625 336.2444196428571 584.5145089285714 165.6808035714286 479.9944196428572 68.4709821428572C466.0993303571429 82.0870535714286 448.4095982142859 100.4743303571429 442.8292410714287 105.6361607142857C524.1071428571429 176.8415178571428 535.5189732142858 319.2243303571429 442.8292410714286 397.0982142857143z" />
    <glyph glyph-name="back_arrow"
      unicode="&#xF10B;"
      horiz-adv-x="749.9720982142858" d=" M-97.3772321428571 305.8035714285715 M749.9720982142858 195.5636160714286H235.9933035714286V0L0 250L235.9933035714286 500.0279017857143V304.4921875H749.9720982142857V195.5636160714286z" />
    <glyph glyph-name="calendar"
      unicode="&#xF10C;"
      horiz-adv-x="482.75669642857144" d=" M120.703125 206.8917410714286H150.8928571428572C167.578125 206.8917410714286 181.0546875 222.3214285714286 181.0546875 241.3783482142857S167.5502232142857 275.8649553571429 150.8928571428572 275.8649553571429H120.703125C104.0178571428572 275.8649553571429 90.5412946428571 260.4352678571429 90.5412946428571 241.3783482142857C90.5133928571429 222.3214285714286 104.0178571428572 206.8917410714286 120.703125 206.8917410714286zM331.8917410714286 206.8917410714286H362.0814732142857C378.7667410714286 206.8917410714286 392.2433035714286 222.3214285714286 392.2433035714286 241.3783482142857S378.7388392857144 275.8649553571429 362.0814732142857 275.8649553571429H331.8917410714286C315.2064732142857 275.8649553571429 301.7299107142857 260.4352678571429 301.7299107142857 241.3783482142857S315.2064732142857 206.8917410714286 331.8917410714286 206.8917410714286zM331.8917410714286 103.4598214285714H362.0814732142857C378.7667410714286 103.4598214285714 392.2433035714286 118.8895089285714 392.2433035714286 137.9464285714286C392.2433035714286 157.0033482142857 378.7388392857144 172.4330357142857 362.0814732142857 172.4330357142857H331.8917410714286C315.2064732142857 172.4330357142857 301.7299107142857 157.0033482142857 301.7299107142857 137.9464285714286C301.7299107142857 118.8616071428571 315.2064732142857 103.4598214285714 331.8917410714286 103.4598214285714zM120.703125 103.4598214285714H150.8928571428572C167.578125 103.4598214285714 181.0546875 118.8895089285714 181.0546875 137.9464285714286C181.0546875 157.0033482142857 167.5502232142857 172.4330357142857 150.8928571428572 172.4330357142857H120.703125C104.0178571428572 172.4330357142857 90.5412946428571 157.0033482142857 90.5412946428571 137.9464285714286C90.5133928571429 118.8616071428571 104.0178571428572 103.4598214285714 120.703125 103.4598214285714zM427.0089285714286 448.2700892857143H392.2433035714286V431.0267857142857C392.2433035714286 402.4832589285715 371.9587053571429 379.296875 346.9866071428571 379.296875C321.9866071428572 379.296875 301.7299107142857 402.4832589285715 301.7299107142857 431.0267857142857V448.2700892857143H181.0267857142857V431.0267857142857C181.0267857142857 402.4832589285715 160.7421875 379.296875 135.7700892857143 379.296875C110.7700892857143 379.296875 90.5133928571429 402.4832589285715 90.5133928571429 431.0267857142857V448.2700892857143H55.7477678571429C23.1863839285714 448.2700892857143 0 419.921875 0 379.3247767857143V34.5145089285714C0 15.4575892857143 13.5044642857143 0.0279017857143 30.1618303571429 0.0279017857143H452.5669642857143C469.2522321428572 0.0279017857143 482.7287946428571 15.4575892857143 482.7287946428571 34.5145089285714V379.3247767857143C482.7566964285714 417.7734375 455.8035714285714 448.2700892857143 427.0089285714286 448.2700892857143zM422.4051339285715 68.9732142857143H60.3515625V310.3515625H422.4330357142857L422.4051339285715 68.9732142857143L422.4051339285715 68.9732142857143zM223.4654017857143 206.8917410714286H253.6272321428572C270.3125 206.8917410714286 283.7890625 222.3214285714286 283.7890625 241.3783482142857S270.3125 275.8649553571429 253.6272321428572 275.8649553571429H223.4654017857143C206.7801339285714 275.8649553571429 193.2756696428572 260.4352678571429 193.2756696428572 241.3783482142857C193.3035714285714 222.3214285714286 206.7801339285715 206.8917410714286 223.4654017857143 206.8917410714286zM223.4654017857143 103.4598214285714H253.6272321428572C270.3125 103.4598214285714 283.7890625 118.8895089285714 283.7890625 137.9464285714286C283.7890625 157.0033482142857 270.3125 172.4330357142857 253.6272321428572 172.4330357142857H223.4654017857143C206.7801339285714 172.4330357142857 193.2756696428572 157.0033482142857 193.2756696428572 137.9464285714286C193.3035714285714 118.8616071428571 206.7801339285715 103.4598214285714 223.4654017857143 103.4598214285714zM135.7700892857143 396.5401785714286C152.4553571428572 396.5401785714286 165.9319196428572 411.9698660714286 165.9319196428572 431.0267857142857V465.5133928571428C165.9598214285714 484.5703125 152.4553571428572 500 135.7700892857143 500S105.6082589285714 484.5703125 105.6082589285714 465.5133928571428V431.0267857142857C105.6082589285714 411.9698660714286 119.1127232142857 396.5401785714286 135.7700892857143 396.5401785714286zM346.9866071428571 396.5401785714286C363.6718750000001 396.5401785714286 377.1484375 411.9698660714286 377.1484375 431.0267857142857V465.5133928571428C377.1484375 484.5703125 363.6439732142858 500 346.9866071428571 500C330.3013392857144 500 316.8247767857143 484.5703125 316.8247767857143 465.5133928571428V431.0267857142857C316.8247767857143 411.9698660714286 330.3013392857143 396.5401785714286 346.9866071428571 396.5401785714286z" />
    <glyph glyph-name="cancel"
      unicode="&#xF10D;"
      horiz-adv-x="500" d=" M500 476.0881696428571L476.0881696428572 500L250 273.9397321428571L23.9397321428571 500L0 476.0881696428571L226.0602678571429 250L0 23.9397321428572L23.9397321428571 0L250 226.0881696428571L476.0881696428572 0L500 23.9397321428572L273.9397321428572 250z" />
    <glyph glyph-name="checkbox"
      unicode="&#xF10E;"
      horiz-adv-x="500.7533482142857" d=" M400.5859375 430.9988839285715C411.5513392857143 430.9988839285715 418.75 425.4185267857143 422.0703125 422.0982142857143C425.3906250000001 418.7779017857143 430.9709821428572 411.5513392857143 430.9709821428572 400.6138392857143V100.1674107142857C430.9709821428572 89.2020089285715 425.3906250000001 82.0033482142857 422.0703125 78.6830357142857C418.75 75.3627232142857 411.5234375000001 69.7823660714286 400.5859375 69.7823660714286H100.1395089285714C89.1741071428572 69.7823660714286 81.9754464285714 75.3627232142857 78.6551339285714 78.6830357142857C75.3348214285714 82.0033482142857 69.7544642857143 89.2299107142858 69.7544642857143 100.1674107142857V400.6138392857143C69.7544642857143 411.5513392857143 75.3348214285714 418.7779017857143 78.6551339285714 422.0982142857143C81.9754464285714 425.4185267857143 89.2020089285714 430.9988839285715 100.1395089285714 430.9988839285715H400.5859375M400.5859375 500.7533482142857H100.1395089285714C44.8381696428572 500.7533482142857 0 455.9151785714286 0 400.6138392857143V100.1674107142857C0 44.8660714285714 44.8381696428572 0.0279017857142 100.1395089285714 0.0279017857142H400.5859375C455.8872767857142 0.0279017857142 500.7254464285714 44.8660714285714 500.7254464285714 100.1674107142857V400.6138392857143C500.7533482142857 455.9151785714286 455.9151785714286 500.7533482142857 400.5859375 500.7533482142857L400.5859375 500.7533482142857z" />
    <glyph glyph-name="checkbox_marked"
      unicode="&#xF10F;"
      horiz-adv-x="500.7533482142857" d=" M400.5859375 430.9988839285715C411.5513392857143 430.9988839285715 418.75 425.4185267857143 422.0703125 422.0982142857143S430.9709821428572 411.5513392857143 430.9709821428572 400.6138392857143V100.1674107142857C430.9709821428572 89.2020089285715 425.3906250000001 82.0033482142857 422.0703125 78.6830357142857S411.5234375000001 69.7823660714286 400.5859375 69.7823660714286H100.1395089285714C89.1741071428572 69.7823660714286 81.9754464285714 75.3627232142857 78.6551339285714 78.6830357142857S69.7544642857143 89.2299107142858 69.7544642857143 100.1674107142857V400.6138392857143C69.7544642857143 411.5513392857143 75.3348214285714 418.7779017857143 78.6551339285714 422.0982142857143S89.2020089285714 430.9988839285715 100.1395089285714 430.9988839285715H400.5859375M400.5859375 500.7533482142857H100.1395089285714C44.8381696428572 500.7533482142857 0 455.9151785714286 0 400.6138392857143V100.1674107142857C0 44.8660714285714 44.8381696428572 0.0279017857142 100.1395089285714 0.0279017857142H400.5859375C455.8872767857142 0.0279017857142 500.7254464285714 44.8660714285714 500.7254464285714 100.1674107142857V400.6138392857143C500.7533482142857 455.9151785714286 455.9151785714286 500.7533482142857 400.5859375 500.7533482142857L400.5859375 500.7533482142857z M422.7120535714286 432.7566964285715C424.9720982142857 435.3794642857143 429.4642857142857 437.8348214285715 433.5100446428572 433.7332589285715C438.1696428571429 429.0457589285715 495.4520089285714 373.0747767857143 498.3537946428571 369.3917410714286C501.6183035714285 365.234375 501.4787946428571 362.9743303571429 498.4933035714286 359.7098214285715C495.2566964285714 356.1941964285715 270.2566964285714 134.9609375 264.0345982142857 128.2645089285714C258.5100446428572 122.3214285714286 256.0267857142857 121.9866071428571 250.2790178571429 127.2879464285714C243.6104910714286 133.4263392857142 90.5691964285714 280.9709821428571 87.2209821428572 284.2075892857142C83.8727678571429 287.4441964285715 82.7566964285714 290.4854910714286 86.2444196428572 293.9453125C89.7321428571429 297.4330357142857 147.7957589285715 356.0267857142857 150.0837053571429 358.2868303571429C152.8459821428572 361.0212053571428 157.0033482142857 363.0301339285714 160.8816964285715 359.1796875C168.1361607142858 352.0089285714286 257.1428571428572 268.6104910714286 257.1428571428572 268.6104910714286C257.1428571428571 268.6383928571429 421.2611607142857 431.0825892857143 422.7120535714286 432.7566964285715z" />
    <glyph glyph-name="checkmark"
      unicode="&#xF110;"
      horiz-adv-x="666.9084821428571" d=" M541.9642857142857 495.0055803571429C545.5636160714286 499.1908482142857 552.7622767857142 503.125 559.2633928571429 496.5680803571429C566.7131696428571 489.0345982142857 658.3984375000001 399.4977678571429 663.0301339285714 393.6104910714286C668.2477678571429 386.9419642857144 668.0245535714287 383.3147321428572 663.2533482142858 378.125C658.091517857143 372.4888392857143 297.9352678571429 18.3872767857143 287.9743303571429 7.7008928571428C279.1573660714287 -1.7857142857143 275.1674107142857 -2.3437500000001 265.9598214285715 6.1383928571428C255.2734375000001 15.9877232142858 10.3515625 252.1205357142858 4.9665178571429 257.3102678571429C-0.390625 262.5000000000001 -2.1763392857142 267.3270089285715 3.4040178571429 272.9073660714286C8.9564732142858 278.4877232142858 101.9252232142858 372.2377232142858 105.6082589285715 375.8649553571429C110.0446428571429 380.2176339285715 116.6573660714286 383.4821428571429 122.9073660714286 377.2879464285715C134.5145089285715 365.7924107142858 276.9810267857144 232.3381696428572 276.9810267857144 232.3381696428572C276.953125 232.3102678571429 539.6484375 492.2991071428572 541.9642857142857 495.0055803571429z" />
    <glyph glyph-name="cite"
      unicode="&#xF111;"
      horiz-adv-x="233.53794642857144" d=" M233.5379464285715 444.7544642857143L200.0558035714286 444.7544642857143V123.046875L100.0279017857143 0L0 123.046875V500H200.3348214285715L233.5379464285715 444.7544642857143z" />
    <glyph glyph-name="code"
      unicode="&#xF112;"
      horiz-adv-x="785.7142857142858" d=" M738.3091517857143 500.0279017857143H47.4330357142857C21.3448660714286 500.0279017857143 0 478.6830357142857 0 452.5948660714286V47.4330357142857C0 21.3448660714286 21.3448660714286 0 47.4330357142857 0H738.3091517857143C764.3973214285714 0 785.7421875 21.3448660714286 785.7421875 46.0379464285714V451.1997767857143C785.7421875 478.6830357142857 764.3973214285714 500.0279017857143 738.3091517857143 500.0279017857143zM319.6428571428571 175.0279017857143C337.4162946428572 157.2544642857143 337.4162946428572 128.4598214285715 319.6428571428571 110.7142857142857C301.8694196428571 92.9408482142857 273.046875 92.9408482142857 255.2734375 110.7142857142857L148.3537946428572 217.5502232142857C148.2421875 217.6618303571428 148.0747767857143 217.6897321428572 147.9910714285715 217.7734375C139.0625 226.7020089285715 134.6540178571429 238.3370535714286 134.6540178571429 250C134.6540178571429 261.6629464285715 139.0625 273.2979910714286 147.9910714285715 282.2265625C148.0747767857143 282.3102678571429 148.2142857142857 282.3381696428571 148.3537946428572 282.4776785714286L255.2734375 389.3136160714286C273.046875 407.0870535714286 301.8694196428572 407.0870535714286 319.6428571428571 389.3136160714286C337.4162946428572 371.5401785714286 337.4162946428572 342.7734375 319.6428571428571 325L244.6149553571429 250L319.6428571428571 175.0279017857143zM637.6953125 217.7734375C637.6116071428571 217.6897321428572 637.4720982142857 217.6618303571428 637.3325892857142 217.5502232142857L530.4129464285713 110.7142857142858C512.6395089285713 92.9408482142857 483.8169642857142 92.9408482142857 466.0435267857142 110.7142857142858C448.2700892857142 128.4877232142857 448.2700892857142 157.2544642857143 466.0435267857142 175.0279017857143L541.0993303571429 250L466.0714285714286 324.9720982142857C448.2979910714286 342.7455357142857 448.2979910714286 371.5122767857143 466.0714285714286 389.2857142857143C483.8448660714286 407.0591517857143 512.6674107142858 407.0591517857143 530.4408482142858 389.2857142857143L637.3604910714287 282.4497767857143C637.4720982142858 282.3381696428572 637.6116071428572 282.3102678571429 637.7232142857144 282.1986607142857C646.6517857142858 273.2979910714286 651.060267857143 261.6350446428571 651.060267857143 249.9720982142857C651.0323660714287 238.3370535714286 646.6238839285714 226.7020089285715 637.6953125 217.7734375z" />
    <glyph glyph-name="collaborative-spaces"
      unicode="&#xF113;"
      horiz-adv-x="714.2857142857143" d=" M517.8571428571429 250C567.1316964285714 250 606.7801339285714 290.0111607142857 606.7801339285714 339.2857142857143S567.1316964285714 428.5714285714286 517.8571428571429 428.5714285714286S428.5714285714286 388.5602678571429 428.5714285714286 339.2857142857143S468.5825892857143 250 517.8571428571429 250M250 285.7142857142857C309.2912946428572 285.7142857142857 356.7801339285715 333.5658482142857 356.7801339285715 392.8571428571429S309.2912946428572 500 250 500S142.8571428571429 452.1484375 142.8571428571429 392.8571428571429S190.7087053571429 285.7142857142857 250 285.7142857142857M517.8571428571429 178.5714285714286C452.5111607142858 178.5714285714286 321.4285714285715 145.703125 321.4285714285715 80.3571428571428V0H714.2857142857143V80.3571428571428C714.2857142857143 145.703125 583.203125 178.5714285714286 517.8571428571429 178.5714285714286M250 214.2857142857143C166.796875 214.2857142857143 0 172.4888392857143 0 89.2857142857143V0H250V80.3571428571428C250 110.7142857142857 261.7745535714286 163.9229910714286 334.6540178571429 204.296875C303.5714285714286 210.7142857142857 273.5770089285715 214.2857142857143 250 214.2857142857143" />
    <glyph glyph-name="collections-folder"
      unicode="&#xF114;"
      horiz-adv-x="600" d=" M50 400H0V275H0.2511160714286L0 50C0 22.4888392857143 22.4888392857143 0 50 0H500V50H50V400zM550 450H350L300 500H150C122.4888392857143 500 100.2511160714286 477.5111607142857 100.2511160714286 450L100 150C100 122.4888392857143 122.4888392857143 99.9999999999999 150 99.9999999999999H550C577.5111607142857 99.9999999999999 599.9999999999999 122.4888392857143 599.9999999999999 150V400C600 427.5111607142857 577.5111607142858 450 550 450M175 175L287.5000000000001 325L375 212.2488839285715L437.5 287.5L525 175H175z" />
    <glyph glyph-name="collections"
      unicode="&#xF115;"
      horiz-adv-x="760.0167410714287" d=" M0 500H604.9944196428572V154.296875H0V500zM685.7142857142857 74.0234375H59.0959821428572V117.2433035714286H642.4944196428572V441.3504464285715H685.7142857142858V74.0234375zM760.0167410714287 0H133.4263392857143V43.2198660714286H716.796875V367.3270089285715H760.0167410714287V0z" />
    <glyph glyph-name="comment"
      unicode="&#xF116;"
      horiz-adv-x="572.5725446428571" d=" M536.5513392857143 500.0558035714286H36.0212053571429C16.1272321428571 500.0558035714286 0 483.9285714285714 0 464.0345982142857V108.0357142857143C0 88.1417410714286 16.1272321428571 72.0145089285715 36.0212053571429 72.0145089285715H150.1674107142857L135.2678571428572 0L248.5770089285715 72.0424107142857H536.5513392857143C556.4453125 72.0424107142857 572.5725446428571 88.1696428571428 572.5725446428571 108.0636160714286V464.0345982142857C572.5725446428571 483.9285714285714 556.4453125 500.0558035714286 536.5513392857143 500.0558035714286z" />
    <glyph glyph-name="compact_controls"
      unicode="&#xF117;"
      horiz-adv-x="642.9966517857143" d=" M209.6540178571429 500H642.9966517857143V0H209.6540178571429V500zM609.6540178571429 466.6573660714286H242.9966517857143V33.3426339285714H609.6540178571429V466.6573660714286zM0 283.8448660714286L92.0758928571429 283.3147321428571V367.8292410714286L209.9330357142858 250L92.0758928571429 132.1428571428571V216.6852678571428L0 217.1875V283.8448660714286z" />
    <glyph glyph-name="compress"
      unicode="&#xF118;"
      horiz-adv-x="774.6930803571429" d=" M5.7477678571429 64.5368303571428C26.8694196428571 102.6506696428572 323.4933035714286 455.8314732142857 350.0279017857143 482.1986607142857C373.7723214285714 505.8035714285714 400.7533482142857 506.0267857142857 424.609375 482.1986607142857C461.2165178571429 445.5915178571429 753.0970982142857 92.1037946428571 768.1082589285714 65.8761160714286C786.8303571428571 33.1473214285714 763.0301339285716 0 731.0267857142858 0C706.3616071428571 0 78.4040178571429 0 42.6339285714286 0C7.3660714285714 0 -9.765625 36.6071428571428 5.7477678571429 64.5368303571428z" />
    <glyph glyph-name="confidential"
      unicode="&#xF119;"
      horiz-adv-x="569.2522321428572" d=" M276.953125 353.7667410714286C211.8582589285714 349.3861607142857 162.5837053571428 293.2477678571429 166.9921875 227.9854910714286C167.1316964285714 225.8370535714286 167.8013392857143 223.8560267857143 168.0524553571428 221.7075892857143L299.3582589285714 353.0133928571429C292.0479910714286 353.90625 284.5703125000001 354.2689732142857 276.953125 353.7667410714286zM270.3962053571429 118.7779017857142C277.7064732142857 117.8850446428571 285.1841517857143 117.5502232142856 292.8013392857143 118.0245535714286C357.8683035714286 122.3772321428571 407.0870535714286 178.7388392857143 402.734375 243.8337053571429C402.5948660714286 245.9542410714286 401.953125 247.9352678571429 401.6741071428571 250.0279017857143L270.3962053571429 118.7779017857142zM540.5412946428572 489.3694196428572C526.3950892857144 503.5435267857143 503.4040178571429 503.5435267857143 489.2299107142858 489.3694196428572L61.8303571428572 61.9698660714286C47.65625 47.7957589285714 47.65625 24.8046875 61.8303571428572 10.6305803571428C76.0044642857143 -3.515625 98.9676339285715 -3.515625 113.1417410714286 10.6305803571428L540.5412946428572 438.0580357142857C554.7154017857142 452.2321428571429 554.7154017857142 475.1953125 540.5412946428572 489.3694196428572zM80.5245535714286 133.203125L146.6238839285715 199.3024553571428C143.4709821428572 211.1886160714286 141.2667410714286 223.3537946428571 141.2946428571429 236.2444196428571C141.4620535714286 315.5970982142857 205.8314732142857 379.6595982142857 285.1841517857143 379.4921875C297.7957589285715 379.4363839285714 309.8214285714286 377.2879464285714 321.5122767857143 374.21875L355.2734375 407.9799107142857C226.4508928571429 438.3649553571429 83.5658482142857 385.15625 4.5479910714286 247.9631696428571C4.5479910714286 247.9631696428571 0 244.9776785714286 0 238.1696428571429C0 231.3616071428571 4.5479910714286 225.4185267857142 4.5479910714286 225.4185267857142C25.6138392857143 188.4486607142857 51.6741071428571 158.1194196428572 80.5245535714286 133.203125zM570.8426339285714 235.9095982142857C570.8426339285714 241.6015625 560.2678571428571 254.8549107142857 557.3660714285714 259.5145089285715C538.1138392857142 290.3180803571429 515.2622767857142 315.9877232142857 490.3180803571428 337.7232142857144L423.5770089285714 270.9821428571429C426.4508928571428 259.5703125 428.4319196428571 247.8794642857143 428.4040178571428 235.5747767857143C428.2366071428571 156.3337053571429 363.7834821428571 92.1595982142858 284.5145089285714 92.3270089285715C272.4330357142856 92.3549107142857 260.9095982142856 94.3080357142857 249.7488839285714 97.154017857143L216.4341517857142 63.8392857142858C341.9642857142856 35.1283482142857 480.3850446428571 85.0725446428572 559.9330357142856 215.0948660714286C559.2912946428571 214.0345982142857 570.8426339285714 232.5613839285715 570.8426339285714 235.9095982142857z" />
    <glyph glyph-name="curation"
      unicode="&#xF11A;"
      horiz-adv-x="450" d=" M400 450H295.5078125C284.9888392857144 478.9899553571429 257.5055803571429 500 225 500C192.4944196428572 500 165.0111607142858 478.9899553571429 154.4921875 450H50C22.4888392857143 450 0 427.5111607142857 0 400V50C0 22.4888392857143 22.4888392857143 0 50 0H400.0000000000001C427.5111607142857 0 450.0000000000001 22.4888392857142 450.0000000000001 50V400C450.0000000000001 427.5111607142857 427.5111607142857 450 400 450M225 450C238.7555803571429 450 250 438.7555803571429 250 425C250 411.2444196428572 238.7555803571429 400 225 400S200.0000000000001 411.2444196428572 200.0000000000001 425C200 438.7555803571429 211.2444196428571 450 225 450M225 350C266.4899553571429 350 300 316.4899553571429 300 275S266.4899553571429 200 225 200S150 233.5100446428571 150 275S183.5100446428572 350 225 350M375 50H75V84.9888392857142C75 134.9888392857143 175 162.5 225 162.5S375 134.9888392857143 375 84.9888392857142V50z" />
    <glyph glyph-name="data-management"
      unicode="&#xF11B;"
      horiz-adv-x="500" d=" M50 50H400.0000000000001V0H50C22.4888392857143 0 0 22.4888392857142 0 50V400H50V50zM450.0000000000001 500C477.5111607142858 500 500 477.5111607142857 500 450V150C500 122.4888392857143 477.5111607142858 100 450.0000000000001 100H150C122.4888392857143 100 100 122.4888392857143 100 150V450C100 477.5111607142857 122.4888392857143 500 150 500H450.0000000000001M450.0000000000001 450H325.0000000000001V250L387.5000000000001 287.5L450.0000000000001 250V450z" />
    <glyph glyph-name="dataset"
      unicode="&#xF11C;"
      horiz-adv-x="785.7142857142858" d=" M732.5892857142857 500.0279017857143H53.0691964285714C23.7444196428571 500.0279017857143 -0.0279017857143 477.1763392857143 -0.0279017857143 448.9955357142857V51.0323660714286C-0.0279017857143 22.8515625 23.7444196428571 0 53.0691964285714 0H732.6171875C761.9419642857142 0 785.7142857142858 22.8515625 785.7142857142858 51.0323660714286V448.9955357142857C785.6863839285714 477.1763392857143 761.9419642857143 500.0279017857143 732.5892857142857 500.0279017857143zM256.6127232142857 34.8772321428571C256.6127232142857 34.8772321428571 63.4207589285715 34.8772321428571 48.9955357142857 34.8772321428571C38.5881696428571 34.8772321428571 35.0446428571429 41.6015624999999 35.0446428571429 48.828125C35.0446428571429 50 35.0446428571429 70.5915178571428 35.0446428571429 70.5915178571428H256.6127232142857V34.8772321428571zM256.6127232142857 96.484375H35.0446428571429V132.1986607142857H256.6127232142857V96.484375zM256.6127232142857 158.0636160714286H35.0446428571429V193.7779017857143H256.6127232142857V158.0636160714286zM256.6127232142857 219.6428571428572H35.0446428571429V255.3571428571429H256.6127232142857V219.6428571428572zM256.6127232142857 281.25H35.0446428571429V316.9642857142857H256.6127232142857V281.25zM504.3805803571429 34.8772321428571H283.6495535714286V70.5915178571428H504.3805803571428V34.8772321428571zM504.3805803571429 96.484375H283.6495535714286V132.1986607142857H504.3805803571428V96.484375zM504.3805803571429 158.0636160714286H283.6495535714286V193.7779017857143H504.3805803571428V158.0636160714286zM504.3805803571429 219.6428571428572H283.6495535714286V255.3571428571429H504.3805803571428V219.6428571428572zM504.3805803571429 281.25H283.6495535714286V316.9642857142857H504.3805803571428V281.25zM750.7254464285714 48.828125C750.7254464285714 37.9464285714286 747.3493303571429 34.8772321428571 736.7745535714286 34.8772321428571C726.4229910714286 34.8772321428571 530.5524553571429 34.8772321428571 530.5524553571429 34.8772321428571V70.5915178571428H750.7254464285714C750.7254464285714 70.5915178571428 750.7254464285714 53.6551339285714 750.7254464285714 48.828125zM750.7254464285714 96.484375H530.5524553571429V132.1986607142857H750.7254464285714V96.484375zM750.7254464285714 158.0636160714286H530.5524553571429V193.7779017857143H750.7254464285714V158.0636160714286zM750.7254464285714 219.6428571428572H530.5524553571429V255.3571428571429H750.7254464285714V219.6428571428572zM750.7254464285714 281.25H530.5524553571429V316.9642857142857H750.7254464285714V281.25z" />
    <glyph glyph-name="datastore"
      unicode="&#xF11D;"
      horiz-adv-x="500" d=" M472.2098214285714 222.2098214285714H27.7901785714286C12.5 222.2098214285714 0 209.7098214285714 0 194.4196428571428V27.7622767857143C0 12.4720982142857 12.5 -0.0279017857143 27.7901785714286 -0.0279017857143H472.2377232142857C487.5279017857143 -0.0279017857143 500.0279017857143 12.4720982142857 500.0279017857143 27.7622767857143V194.4475446428572C500 209.7098214285714 487.4999999999999 222.2098214285714 472.2098214285714 222.2098214285714M111.1049107142857 55.5524553571428C80.5524553571429 55.5524553571428 55.5524553571429 80.5524553571428 55.5524553571429 111.1049107142857S80.5524553571429 166.6573660714286 111.1049107142857 166.6573660714286S166.6573660714286 141.6573660714286 166.6573660714286 111.1049107142857S141.6573660714286 55.5524553571428 111.1049107142857 55.5524553571428M472.2098214285714 500H27.7901785714286C12.5 500 0 487.5 0 472.2098214285714V305.5524553571429C0 290.2622767857143 12.5 277.7622767857143 27.7901785714286 277.7622767857143H472.2377232142857C487.5279017857143 277.7622767857143 500.0279017857143 290.2622767857143 500.0279017857143 305.5524553571429V472.2098214285714C500 487.5 487.4999999999999 500 472.2098214285714 500M111.1049107142857 333.3426339285715C80.5524553571429 333.3426339285715 55.5524553571429 358.3426339285715 55.5524553571429 388.8950892857143S80.5524553571429 444.4475446428571 111.1049107142857 444.4475446428571S166.6573660714286 419.4475446428571 166.6573660714286 388.8950892857143S141.6573660714286 333.3426339285715 111.1049107142857 333.3426339285715" />
    <glyph glyph-name="delete"
      unicode="&#xF11E;"
      horiz-adv-x="499.72098214285717" d=" M363.0859375 249.8604910714286L476.2834821428572 363.0580357142857C507.5334821428572 394.3080357142857 507.5334821428572 445.0055803571429 476.2834821428572 476.2555803571428C445.0334821428572 507.5334821428572 394.3359375 507.5334821428572 363.0859375 476.2555803571428L249.8604910714286 363.0580357142857L136.6629464285714 476.2834821428572C105.3850446428571 507.5334821428572 54.7154017857143 507.5334821428572 23.4375 476.2834821428572C-7.8125 445.0055803571429 -7.8125 394.3359375 23.4375 363.0580357142857L136.6350446428572 249.8604910714286L23.4375 136.6629464285714C-7.8125 105.3850446428572 -7.8125 54.7154017857142 23.4375 23.4375C54.6875 -7.8125 105.3850446428571 -7.8125 136.6350446428572 23.4375L249.8325892857143 136.6350446428572L363.0301339285715 23.4375C394.2801339285715 -7.8125 444.9776785714286 -7.8125 476.2276785714286 23.4375C507.4776785714286 54.6875 507.4776785714286 105.3850446428572 476.2276785714286 136.6350446428572L363.0859375 249.8604910714286z" />
    <glyph glyph-name="delete_sharp"
      unicode="&#xF11F;"
      horiz-adv-x="518.4151785714286" d=" M518.4151785714286 416.5736607142857L345.5636160714286 249.9162946428572L518.1919642857142 83.4542410714286L431.8638392857142 0.1953125L259.2354910714285 166.6573660714286L86.4118303571429 0L0 83.3147321428571L172.8515625 250L0.2232142857143 416.4341517857143L86.5513392857143 499.6930803571428L259.1796875000001 333.2310267857143L432.0312500000001 499.9162946428571L518.4151785714286 416.5736607142857z" />
    <glyph glyph-name="desktop-uploader"
      unicode="&#xF120;"
      horiz-adv-x="562.5" d=" M500 500H62.5C27.9575892857143 500 0 472.0424107142857 0 437.5V62.5C0 27.9575892857143 27.9575892857143 0 62.5 0H187.5V62.5H62.5V375H500V62.5H375V0H500C534.5424107142858 0 562.5 27.9575892857143 562.5 62.5V437.5C562.5 472.0424107142857 534.5424107142858 500 500 500M281.25 312.5L156.25 187.5H250V0H312.5V187.5H406.25L281.25 312.5z" />
    <glyph glyph-name="dissemination"
      unicode="&#xF121;"
      horiz-adv-x="625" d=" M562.5 500H62.5C28.125 500 0.3069196428571 471.875 0.3069196428571 437.5L0 62.5C0 28.125 28.125 0 62.5 0H562.5C596.875 0 625 28.125 625 62.5V437.5C625 471.875 596.875 500 562.5 500M406.25 62.5H62.5V187.5H406.25V62.5zM406.25 218.75H62.5V343.75H406.25V218.75zM562.5 62.5H437.5V343.75H562.5V62.5z" />
    <glyph glyph-name="divider_view"
      unicode="&#xF122;"
      horiz-adv-x="681.9475446428571" d=" M0 227.2321428571429H681.9475446428571V272.6283482142857H0V227.2321428571429zM363.7555803571429 0H681.9475446428572V181.8080357142857H363.7555803571429V0zM0 0H318.1919642857144V181.8080357142857H0V0zM363.7555803571429 500V318.1919642857143H681.9475446428572V500H363.7555803571429zM318.1919642857144 500H0V318.1919642857143H318.1919642857144V500z" />
    <glyph glyph-name="doi"
      unicode="&#xF123;"
      horiz-adv-x="400" d=" M250 500H50C22.4888392857143 500 0.2511160714286 477.5111607142857 0.2511160714286 450L0 50C0 22.4888392857143 22.2377232142857 0 49.7488839285714 0H350C377.5111607142857 0 400 22.4888392857142 400 50V350L250 500zM300 150H225V75H175V150H100V200H175V275H225V200H300V150zM225 325V462.5L362.5 325H225z" />
    <glyph glyph-name="double_sharp_arrow_down"
      unicode="&#xF124;"
      horiz-adv-x="375.2511160714286" d=" M375.2511160714286 184.0122767857143L187.6395089285715 0L0 184.0122767857143V291.5457589285715L187.6395089285715 107.5334821428571L375.2511160714286 291.5457589285714V184.0122767857143zM375.2511160714286 392.3270089285715L187.6395089285715 208.3147321428571L0 392.3270089285715V499.8604910714286L187.6395089285715 315.8482142857143L375.2511160714286 499.8604910714286V392.3270089285715z" />
    <glyph glyph-name="double_sharp_arrow_up"
      unicode="&#xF125;"
      horiz-adv-x="375.2511160714286" d=" M375.2511160714286 208.3147321428571L187.6395089285715 392.3270089285715L0 208.3147321428571V315.8203125L187.6395089285715 499.8325892857143L375.2511160714286 315.8203125V208.3147321428571zM375.2511160714286 0L187.6395089285715 184.0122767857143L0 0V107.5334821428571L187.6395089285715 291.5457589285714L375.2511160714286 107.5334821428571V0z" />
    <glyph glyph-name="download"
      unicode="&#xF126;"
      horiz-adv-x="399.8883928571429" d=" M99.9720982142857 249.9441964285715V499.8604910714286H299.9162946428572V249.9441964285715H399.8883928571429L199.9441964285715 0.0279017857142L0 249.9441964285715H99.9720982142857z" />
    <glyph glyph-name="download_bold"
      unicode="&#xF127;"
      horiz-adv-x="541.6573660714286" d=" M541.6573660714286 208.3147321428571L270.6473214285715 0L0 208.3426339285715H111.1049107142857V500H430.5524553571429V208.3147321428571H541.6573660714286z" />
    <glyph glyph-name="drag_handle"
      unicode="&#xF128;"
      horiz-adv-x="1200" d=" M0 100H1200V0H0V100zM0 500H1200V400H0V500z" />
    <glyph glyph-name="edit"
      unicode="&#xF129;"
      horiz-adv-x="240.15066964285717" d=" M55.5245535714286 127.7901785714286C30.2455357142857 138.5044642857143 1.953125 135.0446428571428 1.953125 135.0446428571428L0 -0.0279017857143L97.3493303571429 98.2142857142857C97.3493303571429 98.2142857142857 79.7991071428571 117.5223214285715 55.5245535714286 127.7901785714286zM117.6897321428572 414.7879464285715C84.2354910714286 335.2399553571429 22.6004464285714 188.671875 15.4575892857143 171.7354910714286C15.9877232142857 172.0982142857143 49.609375 169.140625 69.3917410714286 160.7700892857143C88.4486607142857 152.7064732142858 111.9977678571429 130.859375 111.8582589285715 130.9151785714286C118.6383928571429 147.0703125 180.4408482142857 293.9732142857143 214.0066964285715 373.8002232142857C201.5904017857143 385.1841517857143 185.4910714285714 397.6283482142857 167.5223214285714 405.2455357142857C150.8928571428572 412.2767857142857 132.8125 414.4252232142857 117.6897321428572 414.7879464285715zM208.5100446428572 495.7868303571428C180.8035714285715 507.5334821428572 150.8649553571428 493.6383928571428 139.1462053571428 465.8203125C139.1462053571428 465.8203125 136.6071428571428 459.7377232142857 132.5334821428571 450.0837053571429C148.0189732142857 449.5535714285715 166.4620535714286 447.2098214285715 183.3147321428571 440.0669642857143C201.0044642857143 432.5892857142857 216.7131696428572 420.4241071428571 228.8783482142857 409.2075892857143C232.9520089285714 418.8895089285715 235.5189732142857 425 235.5189732142857 425C247.2098214285715 452.8459821428571 236.2444196428572 484.0401785714286 208.5100446428572 495.7868303571428z" />
    <glyph glyph-name="expand"
      unicode="&#xF12A;"
      horiz-adv-x="774.6930803571429" d=" M42.6060267857143 499.9720982142857C78.3761160714286 499.9720982142857 706.3058035714284 499.9720982142857 730.9988839285713 499.9720982142857C763.002232142857 499.9720982142857 786.830357142857 466.8526785714286 768.0803571428571 434.0959821428571C753.0970982142857 407.8404017857143 461.2165178571428 54.3805803571428 424.5814732142857 17.7734375C400.7254464285714 -6.0546875 373.7444196428571 -5.8314732142857 350 17.7734375C323.4933035714286 44.140625 26.8694196428571 397.3214285714286 5.7477678571429 435.4631696428571C-9.765625 463.3649553571428 7.3660714285714 499.9720982142857 42.6060267857143 499.9720982142857z" />
    <glyph glyph-name="expand_controls"
      unicode="&#xF12B;"
      horiz-adv-x="642.9966517857143" d=" M209.6540178571429 500H642.9966517857143V0H209.6540178571429V500zM609.6540178571429 466.6573660714286H242.9966517857143V33.3426339285714H609.6540178571429V466.6573660714286zM209.9330357142858 216.1272321428572L117.8571428571429 216.6573660714286L117.8571428571429 132.1428571428571L0 249.9720982142857L117.8571428571429 367.8292410714286V283.2868303571429L209.9330357142858 282.7845982142857V216.1272321428572z" />
    <glyph glyph-name="fast_forward_backward"
      unicode="&#xF12C;"
      horiz-adv-x="570.8426339285714" d=" M570.8426339285714 249.8883928571429L261.6071428571429 499.8046875L261.6071428571429 296.2053571428571L0 499.8046875L0 0L261.6071428571429 203.5714285714286L261.6350446428572 0.0279017857142z" />
    <glyph glyph-name="fileset"
      unicode="&#xF12D;"
      horiz-adv-x="785.7142857142858" d=" M591.1830357142858 150.4743303571428L647.4330357142858 112.2488839285714L591.1830357142858 74.0234375L591.1830357142858 150.4743303571428L591.1830357142858 150.4743303571428zM785.7142857142858 202.0368303571428V22.9631696428572C785.7142857142858 10.2678571428572 775.0279017857142 1e-13 761.8303571428572 1e-13H456.0267857142858C442.8292410714286 1e-13 432.1428571428572 10.2957589285715 432.1428571428572 22.9631696428572V202.0368303571428C432.1428571428572 214.7321428571428 442.8292410714286 225 456.0267857142858 225H761.8024553571429C775 225 785.7142857142858 214.7321428571428 785.7142857142858 202.0368303571428zM674.5814732142857 112.5C674.5814732142857 148.7723214285715 645.1729910714286 178.1808035714286 608.9006696428571 178.1808035714286S543.2477678571429 148.7723214285715 543.2477678571429 112.5S572.65625 46.8191964285714 608.9285714285714 46.8191964285714S674.5814732142857 76.2276785714286 674.5814732142857 112.5z M329.6875 500H23.8839285714286C10.6863839285714 500 0 489.7042410714286 0 477.0368303571428V297.9631696428572C0 285.2678571428572 10.6863839285714 275 23.8839285714286 275H329.6875C342.8850446428571 275 353.5714285714286 285.2957589285715 353.5714285714286 297.9631696428572V477.0368303571428C353.5714285714286 489.7042410714286 342.8850446428572 500 329.6875 500zM337.7790178571429 310.1004464285715C337.7790178571429 296.1774553571429 332.7287946428572 291.1830357142857 318.8616071428572 291.1830357142857C299.9162946428571 291.2109375 98.6049107142857 291.2946428571429 34.7098214285714 291.2946428571429C21.2332589285714 291.2946428571429 15.7924107142857 296.8470982142857 15.7924107142857 310.2120535714286C15.7645089285714 314.5368303571429 15.7645089285714 314.5368303571429 15.7645089285714 321.1774553571429C56.3616071428572 353.3761160714286 115.2064732142857 400.0558035714286 115.2064732142857 400.0558035714286L195.5915178571429 352.7622767857143L257.0591517857143 447.3214285714286C257.0591517857143 447.3214285714286 296.8191964285715 419.7265625 337.890625 391.2109375C337.8627232142857 348.5770089285715 337.7790178571429 315.0669642857144 337.7790178571429 310.1004464285715z M329.6875 225H23.8839285714286C10.6863839285714 225 0 214.7042410714286 0 202.0368303571428V22.9631696428572C0 10.2678571428572 10.6863839285714 1e-13 23.8839285714286 1e-13H329.6875C342.8850446428571 1e-13 353.5714285714286 10.2957589285715 353.5714285714286 22.9631696428572V202.0368303571428C353.5714285714286 214.7321428571428 342.8850446428572 225 329.6875 225zM115.4854910714286 15.6808035714286C115.4854910714286 15.6808035714286 28.5435267857143 15.6808035714286 22.0703125 15.6808035714286C17.3828125 15.6808035714286 15.7924107142857 18.6941964285714 15.7924107142857 21.9587053571428C15.7924107142857 22.4888392857143 15.7924107142857 31.7522321428571 15.7924107142857 31.7522321428571H115.4854910714286V15.6808035714286zM115.4854910714286 43.4151785714286H15.7924107142857V59.4866071428571H115.4854910714286L115.4854910714286 43.4151785714286L115.4854910714286 43.4151785714286zM115.4854910714286 71.1216517857143H15.7924107142857V87.1930803571428H115.4854910714286L115.4854910714286 71.1216517857143L115.4854910714286 71.1216517857143zM115.4854910714286 98.828125H15.7924107142857V114.8995535714286H115.4854910714286L115.4854910714286 98.828125L115.4854910714286 98.828125zM115.4854910714286 126.5625H15.7924107142857V142.6339285714286H115.4854910714286L115.4854910714286 126.5625L115.4854910714286 126.5625zM226.9810267857143 15.6808035714286H127.6506696428572V31.7522321428571H226.9810267857143V15.6808035714286zM226.9810267857143 43.4151785714286H127.6506696428572V59.4866071428571H226.9810267857143V43.4151785714286zM226.9810267857143 71.1216517857143H127.6506696428572V87.1930803571428H226.9810267857143V71.1216517857143zM226.9810267857143 98.828125H127.6506696428572V114.8995535714286H226.9810267857143V98.828125zM226.9810267857143 126.5625H127.6506696428572V142.6339285714286H226.9810267857143V126.5625zM337.8348214285715 21.9866071428571C337.8348214285715 17.1037946428571 336.328125 15.7087053571428 331.5569196428572 15.7087053571428C326.8973214285714 15.7087053571428 238.7555803571429 15.7087053571428 238.7555803571429 15.7087053571428V31.7801339285714H337.8348214285715C337.8348214285715 31.7801339285714 337.8348214285715 24.1350446428571 337.8348214285715 21.9866071428571zM337.8348214285715 43.4151785714286H238.7555803571429V59.4866071428571H337.8348214285715V43.4151785714286zM337.8348214285715 71.1216517857143H238.7555803571429V87.1930803571428H337.8348214285715V71.1216517857143zM337.8348214285715 98.828125H238.7555803571429V114.8995535714286H337.8348214285715V98.828125zM337.8348214285715 126.5625H238.7555803571429V142.6339285714286H337.8348214285715V126.5625z M761.8303571428572 500H456.0267857142858C442.8571428571429 500 432.1428571428572 489.7042410714286 432.1428571428572 477.0368303571428V297.9631696428572C432.1428571428572 285.9375 442.8292410714286 275 456.0267857142858 275H761.8303571428572C775.0279017857143 275 785.7142857142858 285.2957589285715 785.7142857142858 297.9631696428572V477.0368303571428C785.7142857142858 489.7042410714286 775.0279017857142 500 761.8303571428572 500zM596.0379464285714 307.6171875C596.0379464285714 306.8638392857143 595.4241071428571 306.25 594.6707589285713 306.25H527.5111607142857C526.7578124999999 306.25 526.1439732142857 306.8638392857143 526.1439732142857 307.6171875V341.4341517857144C526.1439732142857 342.7455357142857 527.1484374999999 344.1685267857143 527.260044642857 344.3080357142857C527.9854910714284 345.1450892857143 539.6205357142856 355.4408482142857 544.838169642857 360.6863839285715C555.4129464285713 353.7667410714286 567.4665178571428 354.1852678571429 577.7343749999999 361.5792410714286C583.0078124999999 356.3058035714286 593.666294642857 345.7589285714286 594.6986607142857 344.1685267857143C594.9497767857142 343.7779017857143 595.9542410714284 342.6618303571429 596.010044642857 341.4341517857144V307.6171875L596.0379464285714 307.6171875zM536.5513392857143 386.5513392857143C536.5513392857143 400.0837053571429 547.5167410714286 411.0491071428571 561.0491071428572 411.0491071428571C574.5814732142858 411.0491071428571 585.5468750000001 400.0837053571429 585.5468750000001 386.5513392857143S574.5814732142858 362.0535714285715 561.0491071428572 362.0535714285715C547.5167410714286 362.0814732142857 536.5513392857143 373.046875 536.5513392857143 386.5513392857143zM735.2120535714286 369.6986607142857C735.2120535714286 356.0267857142857 724.1350446428572 344.9497767857143 710.4631696428572 344.9497767857143C710.4631696428572 344.9497767857143 605.8872767857143 344.8939732142857 602.3158482142858 344.8939732142857C597.544642857143 349.6651785714286 586.5234375000001 361.2444196428571 582.7566964285716 365.0669642857143C590.4854910714287 372.8236607142857 593.443080357143 384.4308035714286 590.4296875000001 394.9776785714286C587.9185267857144 403.7109375 581.3895089285716 411.0212053571429 573.0468750000001 414.5647321428571C564.0625000000001 418.359375 553.5714285714286 417.5502232142857 545.2566964285716 412.4441964285715C537.3604910714287 407.5892857142857 531.9754464285716 399.1350446428571 530.943080357143 389.8995535714286C529.9107142857143 380.46875 533.3705357142858 370.9542410714286 540.2343750000001 364.4252232142857C532.0033482142858 356.3337053571429 524.4140625000001 349.5535714285715 519.5312500000001 344.921875L507.4497767857144 344.921875C493.7779017857144 344.921875 482.7008928571429 355.9988839285715 482.7008928571429 369.6707589285715V443.9453125C482.7008928571429 457.6171875 493.7779017857144 468.6941964285714 507.4497767857144 468.6941964285714H710.435267857143C724.107142857143 468.6941964285714 735.1841517857143 457.6171875 735.2120535714287 443.9453125L735.2120535714286 369.6986607142857L735.2120535714286 369.6986607142857z" />
    <glyph glyph-name="fit_to_view"
      unicode="&#xF12E;"
      horiz-adv-x="600.0279017857143" d=" M487.5279017857143 0H112.5279017857143C50.5022321428572 0 0.0279017857143 50.4743303571429 0.0279017857143 112.5V387.5C0.0279017857143 449.5256696428572 50.5022321428572 500 112.5279017857143 500H487.5279017857143C549.5535714285716 500 600.0279017857143 449.5256696428572 600.0279017857143 387.5V112.5C600.0279017857143 50.4743303571429 549.5535714285714 0 487.5279017857143 0zM112.5 475C64.2578125 475 25 435.7421875 25 387.5V112.4999999999999C25 64.2578125 64.2578125 24.9999999999999 112.5 24.9999999999999H487.4999999999999C535.7421875 24.9999999999999 574.9999999999999 64.2578125 574.9999999999999 112.4999999999999V387.5C574.9999999999999 435.7421875 535.7421875 475 487.4999999999999 475H112.5z M325.7254464285715 222.6841517857143V137.890625H391.0156250000001L300.0000000000001 45.6752232142857L208.9843750000001 137.890625L274.2466517857144 137.890625V222.6841517857143L325.7254464285715 222.6841517857143z M274.2745535714286 277.34375V362.1372767857143L209.0122767857143 362.1372767857143L300.0279017857142 454.3526785714286L391.0435267857142 362.1372767857143H325.7533482142856V277.34375L274.2745535714286 277.34375z" />
    <glyph glyph-name="folder_fill"
      unicode="&#xF12F;"
      horiz-adv-x="666.7968750000001" d=" M625.1116071428572 333.3984375H206.4174107142857C161.4397321428571 333.3984375 125.0279017857143 296.9866071428571 125.0279017857143 252.0089285714286V83.3705357142858H104.1852678571429C92.7176339285714 83.3705357142858 83.3426339285714 92.6897321428572 83.3426339285714 104.2131696428572V275.9207589285715C83.3426339285714 330.6919642857144 127.734375 375.0558035714286 182.4776785714286 375.0558035714286H583.4542410714286V416.7410714285715C583.4542410714286 439.7600446428571 564.8158482142857 458.4263392857143 541.7689732142857 458.4263392857143H250.0558035714286C250.0558035714286 481.4732142857143 231.4174107142858 500.1116071428571 208.3705357142858 500.1116071428571H83.3426339285714C60.3236607142857 500.0837053571428 41.6852678571429 481.4453125 41.6852678571429 458.4263392857143V458.59375C16.8526785714286 444.140625 0 417.578125 0 386.8024553571429V104.1852678571429C0 46.6517857142857 46.6517857142857 0 104.1852678571429 0H583.4542410714286C629.4921875 0 666.7968749999999 37.3325892857143 666.7968749999999 83.3426339285715V291.7131696428571C666.7968750000001 314.7600446428571 648.1584821428571 333.3984375 625.1116071428572 333.3984375z" />
    <glyph glyph-name="folder_open"
      unicode="&#xF130;"
      horiz-adv-x="689.2857142857143" d=" M641.8247767857143 197.9631696428571H227.8180803571429C200.8649553571429 197.9631696428571 189.2020089285714 177.5111607142857 177.5669642857143 158.3147321428572C164.5089285714286 136.7466517857143 131.1104910714286 83.4263392857143 126.6741071428572 76.8415178571429C110.7421875 53.1808035714286 90.1506696428572 56.3058035714286 77.5111607142858 63.4207589285715C63.8671875000001 71.0937500000001 51.5066964285715 85.5189732142858 66.2946428571429 109.9330357142858C77.7901785714286 128.9062500000001 107.0591517857143 182.2823660714286 119.7265625000001 203.2087053571429C144.0569196428572 243.3872767857144 178.0412946428572 240.9877232142858 228.8783482142858 240.9877232142858H601.4787946428572L602.6506696428572 368.6383928571429C602.6506696428572 392.4107142857144 581.4174107142858 411.6908482142858 555.2176339285714 411.6908482142858H248.6049107142857L221.9866071428571 479.9944196428572C213.4765625 492.4386160714286 199.1350446428571 499.9162946428572 183.7611607142857 499.9162946428572H45.9263392857143C20.5636160714286 499.9162946428572 -0.0279017857143 479.8828125000001 -0.0279017857143 455.1897321428572V44.2522321428572C-0.0279017857143 21.7075892857143 16.5457589285714 0.1395089285715 40.1227678571429 0.1674107142857C138.5881696428572 -0.0837053571428 551.8694196428571 0.1116071428572 560.1004464285713 0.1395089285715C575.8091517857142 0.1395089285715 593.4430803571428 20.2008928571429 604.0736607142856 32.6729910714286C604.0736607142856 32.6729910714286 682.7845982142856 126.3113839285715 687.2767857142856 139.8158482142857C691.6573660714283 152.9575892857143 688.5044642857141 168.4151785714286 679.5479910714284 179.8549107142857C670.6473214285714 191.2388392857143 656.640625 197.9631696428571 641.8247767857143 197.9631696428571z" />
    <glyph glyph-name="folder_outline"
      unicode="&#xF131;"
      horiz-adv-x="666.7968750000001" d=" M208.3705357142857 472.1540178571428C213.3370535714286 472.1540178571428 216.6015625 469.6428571428571 218.1082589285714 468.1361607142857C219.6149553571428 466.6294642857143 222.1261160714286 463.3649553571428 222.1261160714286 458.3984375C222.1261160714286 451.0044642857143 225.0558035714286 443.8895089285715 230.3013392857143 438.671875C235.546875 433.4263392857143 242.6339285714286 430.4966517857143 250.0279017857143 430.4966517857143H541.7410714285714C546.7075892857142 430.4966517857143 549.9720982142857 427.9575892857144 551.4787946428571 426.4787946428571C552.9854910714287 424.9720982142857 555.4966517857143 421.7075892857143 555.4966517857143 416.7410714285715V360.7979910714286H583.3984375V416.7131696428571C583.3984375 439.7321428571429 564.7600446428572 458.3984375 541.7131696428571 458.3984375H250.0558035714286C250.0558035714286 481.4453125 231.4174107142858 500.0837053571428 208.3705357142858 500.0837053571428L208.3705357142858 500.0837053571428H83.3426339285714C60.2957589285714 500.0837053571428 41.6573660714286 481.4453125 41.6573660714286 458.3984375V458.5658482142857C16.8247767857143 444.1127232142857 -0.0279017857143 417.5502232142857 -0.0279017857143 386.7745535714286V104.1294642857143C-0.0279017857143 46.5959821428571 46.6238839285714 -0.0558035714286 104.1573660714286 -0.0558035714286H583.4263392857143C629.4642857142858 -0.0558035714286 666.7689732142857 37.2767857142857 666.7689732142857 83.2868303571429V319.2801339285715C666.7689732142857 342.3270089285715 648.1305803571428 360.9654017857144 625.1116071428571 360.9654017857144H206.4174107142857C161.4397321428571 360.9654017857144 125.0279017857143 324.5535714285715 125.0279017857143 279.5758928571429C125.0279017857143 279.5758928571429 125.0279017857143 104.0178571428571 125.0279017857143 97.2656249999999C125.0279017857143 78.8783482142857 152.9296875 78.8783482142857 152.9296875 97.2656249999999C152.9296875 103.6830357142857 152.9296875 279.5758928571429 152.9296875 279.5758928571429C152.9296875 293.8895089285715 158.4821428571429 307.3102678571429 168.5825892857143 317.4107142857143C178.6830357142857 327.5111607142857 192.1037946428572 333.0636160714286 206.4174107142857 333.0636160714286H625.1116071428571C630.078125 333.0636160714286 633.3426339285713 330.5524553571429 634.8493303571428 329.0457589285715C636.3560267857142 327.5390625 638.8671875 324.2745535714286 638.8671875 319.2801339285715V83.2868303571428C638.8671875 68.4709821428572 633.0915178571429 54.5479910714286 622.6283482142858 44.0848214285714C612.1651785714286 33.6216517857143 598.2421875 27.8459821428571 583.4263392857143 27.8459821428571H104.1852678571429C93.8895089285714 27.8459821428571 83.9006696428571 29.8549107142857 74.4977678571429 33.8169642857143C65.4296875 37.6674107142857 57.2544642857143 43.1640625 50.2511160714286 50.1674107142857C43.2477678571429 57.1707589285714 37.7232142857143 65.3459821428572 33.9006696428571 74.4140625C29.9386160714286 83.7890625 27.9296875 93.7779017857142 27.9296875 104.1015624999999V386.7466517857143C27.9296875 396.5401785714286 30.5524553571429 406.1383928571429 35.546875 414.5089285714286C40.0111607142857 422.0145089285715 46.2890625 428.4598214285715 53.7388392857143 433.203125C56.5569196428571 434.5424107142857 59.1796875 436.3839285714286 61.4397321428571 438.6439732142857C66.6852678571429 443.8895089285715 69.6149553571429 450.9765625 69.6149553571429 458.3705357142857C69.6149553571429 463.3370535714286 72.1261160714286 466.6015625 73.6328125 468.1082589285714C75.1395089285714 469.6149553571428 78.4040178571429 472.1261160714286 83.3705357142857 472.1261160714286H208.3705357142857 M-97.3772321428571 305.8035714285715" />
    <glyph glyph-name="forward_arrow"
      unicode="&#xF132;"
      horiz-adv-x="749.9720982142858" d=" M374.9720982142857 250 M0 304.4642857142857H513.9787946428571V500L749.9720982142858 250L513.9787946428572 0V195.5636160714286H0L0 304.4642857142857z" />
    <glyph glyph-name="generic_file"
      unicode="&#xF133;"
      horiz-adv-x="356.6964285714286" d=" M214.0066964285715 475.9207589285714H23.7444196428572V24.0792410714286H332.8962053571429V357.0033482142857H214.0066964285715V475.9207589285714zM356.7243303571429 0.3069196428571H-0.0279017857143V499.6930803571428H225.8928571428572L356.6685267857143 367.4944196428571V0.3069196428571H356.7243303571429z" />
    <glyph glyph-name="github_logo"
      unicode="&#xF134;"
      horiz-adv-x="512.6395089285714" d=" M256.3058035714286 500C114.7879464285714 500 0 385.2399553571429 0 243.6383928571429C0 130.4129464285715 73.4375 34.3191964285714 175.3069196428572 0.4185267857143C188.1138392857143 -1.9252232142858 192.8013392857143 5.9709821428572 192.8013392857143 12.7790178571428C192.8013392857143 18.8616071428571 192.578125 34.9888392857142 192.4665178571429 56.3616071428571C121.1774553571429 40.8761160714286 106.1104910714286 90.7087053571428 106.1104910714286 90.7087053571428C94.4475446428571 120.3125 77.6506696428571 128.2087053571428 77.6506696428571 128.2087053571428C54.3805803571429 144.1127232142857 79.4084821428571 143.7779017857143 79.4084821428571 143.7779017857143C105.1339285714286 141.9642857142857 118.6662946428572 117.3549107142857 118.6662946428572 117.3549107142857C141.5178571428572 78.1808035714285 178.6551339285714 89.5089285714286 193.2756696428572 96.0658482142857C195.5915178571428 112.6395089285715 202.2321428571429 123.9397321428572 209.5424107142857 130.3292410714286C152.6227678571428 136.8024553571428 92.7734375 158.7890625 92.7734375 257.0033482142857C92.7734375 284.9888392857142 102.7622767857143 307.8683035714286 119.1685267857143 325.78125C116.5457589285714 332.2544642857143 107.7287946428571 358.3147321428571 121.6796875 393.6104910714286C121.6796875 393.6104910714286 143.1919642857143 400.5022321428571 192.1595982142857 367.3270089285715C212.6116071428571 373.0189732142857 234.5424107142857 375.8649553571429 256.3337053571429 375.9486607142857C278.0970982142857 375.8370535714286 300.0279017857143 373.0189732142857 320.5078125 367.3270089285715C369.4475446428571 400.5022321428571 390.9319196428571 393.6104910714286 390.9319196428571 393.6104910714286C404.9107142857142 358.3147321428571 396.1216517857142 332.2544642857143 393.4709821428571 325.78125C409.9051339285714 307.8683035714286 419.8102678571429 284.9888392857142 419.8102678571429 257.0033482142857C419.8102678571429 158.5379464285714 359.8772321428572 136.8582589285715 302.7901785714286 130.5245535714286C311.9977678571429 122.6004464285714 320.2008928571429 106.9754464285714 320.2008928571429 83.0636160714286C320.2008928571429 48.8002232142857 319.8939732142857 21.1495535714286 319.8939732142857 12.7511160714286C319.8939732142857 5.8872767857143 324.4977678571429 -2.0647321428571 337.5279017857144 0.4185267857143C439.2857142857144 34.375 512.6674107142858 130.3850446428571 512.6674107142858 243.6104910714286C512.6395089285714 385.2399553571429 397.8794642857143 500 256.3058035714286 500z" />
    <glyph glyph-name="go-to-link-alternative"
      unicode="&#xF135;"
      horiz-adv-x="562.4720982142858" d=" M468.7220982142858 0H93.75C42.0479910714286 0 0 42.0479910714286 0 93.75V406.2220982142857C0 457.9241071428572 42.0479910714286 499.9720982142857 93.75 499.9720982142857H281.25V437.4720982142857H93.75C76.5345982142857 437.4720982142857 62.5 423.4375 62.5 406.2220982142857V93.75C62.5 76.5345982142857 76.5345982142857 62.5 93.75 62.5H468.7220982142858C485.9654017857144 62.5 499.9720982142858 76.5345982142857 499.9720982142858 93.75V218.75H562.4720982142858V93.75C562.4720982142858 42.0479910714286 520.4241071428571 0 468.7220982142858 0zM374.8046875 437.4720982142857H454.0736607142858L350.6975446428572 319.6428571428571L401.2555803571429 276.8415178571429L499.8046875000001 395.9821428571429V312.5H562.3046875000001V500H374.8046875000001V437.4720982142857z" />
    <glyph glyph-name="go_to_link"
      unicode="&#xF136;"
      horiz-adv-x="500.1674107142857" d=" M347.3493303571429 55.5803571428572H55.5803571428572V347.3493303571429H166.7410714285715V402.9296875C86.4118303571429 402.9296875 0.0279017857143 402.9296875 0.0279017857143 402.9296875V0H402.9575892857142V166.7131696428571H347.3772321428571V55.5803571428572zM305.6640625 500.1674107142857L236.1886160714286 444.5870535714286H395.4799107142858L179.1852678571429 228.2924107142857L228.3203125 179.1573660714286L444.6149553571429 395.4520089285715V250.0558035714286L500.1953124999999 305.6361607142857V500.1395089285714H305.6640625z" />
    <glyph glyph-name="grid_view"
      unicode="&#xF137;"
      horiz-adv-x="681.9475446428571" d=" M363.7555803571429 0H681.9475446428572V227.2321428571429H363.7555803571429V0zM0 272.7678571428571H318.1919642857144V500H0V272.7678571428571zM0 0H318.1919642857144V227.2321428571429H0V0zM363.7555803571429 500V272.6283482142857H681.9475446428572V500H363.7555803571429z" />
    <glyph glyph-name="hide_details"
      unicode="&#xF138;"
      horiz-adv-x="480.97098214285717" d=" M8.5379464285714 240.2901785714286C19.7823660714286 228.9899553571429 38.1138392857143 228.90625 49.4419642857143 240.1506696428572C49.4419642857143 240.1506696428572 179.0736607142858 369.5870535714286 226.5625 417.0758928571429C239.3694196428572 429.8828125 240.7366071428572 430.4408482142857 255.4966517857143 415.6529017857143C304.4921875 366.6573660714286 431.5569196428572 239.4810267857143 431.5569196428572 239.4810267857143C443.0803571428572 228.0133928571429 461.6908482142857 228.0970982142857 473.1305803571429 239.6205357142857C484.5703125 251.1439732142857 484.5145089285714 269.8102678571429 472.9910714285714 281.25L278.3203125 475.9486607142857C245.7589285714286 508.5100446428572 234.4029017857143 506.8638392857143 201.7857142857143 474.2745535714286L8.6495535714286 281.0825892857144C2.9575892857143 275.4464285714286 0.1116071428571 268.0245535714286 0.1116071428571 260.6026785714286C0.1116071428571 253.2645089285715 2.9296875 245.9263392857143 8.5379464285714 240.2901785714286z M7.8404017857143 9.3470982142857C19.0848214285714 -1.953125 37.4162946428572 -2.0368303571428 48.7444196428572 9.2075892857143C48.7444196428572 9.2075892857143 178.3761160714286 138.6439732142857 225.8649553571429 186.1328125C238.671875 198.9397321428571 240.0390625 199.4977678571428 254.7991071428572 184.7098214285715C303.7946428571429 135.7142857142857 430.8314732142857 8.5379464285714 430.8314732142857 8.5379464285714C442.3549107142857 -2.9296875 460.9654017857143 -2.8459821428572 472.4051339285714 8.6774553571428C483.8448660714286 20.2008928571428 483.7890625 38.8671875 472.265625 50.3069196428571L277.6227678571429 245.0055803571429C245.0613839285714 277.5669642857143 233.7053571428572 275.9207589285715 201.0881696428572 243.3314732142857L7.9520089285714 50.1395089285714C2.2600446428571 44.5033482142857 -0.5859375 37.0814732142857 -0.5859375 29.6595982142857C-0.5580357142857 22.3214285714286 2.2321428571429 14.9832589285714 7.8404017857143 9.3470982142857z" />
    <glyph glyph-name="home"
      unicode="&#xF139;"
      horiz-adv-x="599.8046875" d=" M0 233.3426339285714L299.8883928571429 500L599.7767857142857 233.3426339285714L499.8604910714286 233.3147321428571V0H366.5457589285715V166.6573660714286H233.2310267857143V0H99.9162946428572V233.3147321428572L0 233.3426339285714z" />
    <glyph glyph-name="home_manage"
      unicode="&#xF13A;"
      horiz-adv-x="409.4308035714286" d=" M362.8069196428572 0H82.8404017857143C57.0870535714286 0 36.4397321428571 20.9263392857143 36.4397321428571 46.7912946428572L36.6350446428571 363.0580357142857C36.328125 364.5368303571429 36.328125 366.015625 36.6350446428571 367.5502232142857L36.6350446428571 384.8772321428572C32.8125 388.1696428571429 29.296875 391.7689732142857 26.5345982142857 395.8705357142857L15.5691964285714 391.3225446428571C9.8772321428571 388.9787946428572 3.3482142857143 391.6852678571429 0.9765625 397.3493303571429C-1.3671875 403.0412946428571 1.3392857142857 409.5703125 7.03125 411.8861607142857L18.0524553571429 416.4341517857143C16.6852678571429 423.3537946428571 16.6015625 430.5803571428571 17.9966517857143 437.6953125L6.9196428571428 442.2712053571429C1.2276785714286 444.6428571428571 -1.4787946428572 451.1439732142857 0.8649553571428 456.8080357142857C3.2366071428571 462.5 9.765625 465.2064732142857 15.4575892857142 462.8348214285714L26.5066964285714 458.2868303571428C30.6361607142857 464.453125 35.8816964285714 469.5870535714286 41.8247767857143 473.5770089285714L37.2209821428571 484.6540178571428C34.8493303571429 490.3459821428571 37.5558035714286 496.8470982142857 43.2477678571429 499.1908482142857C48.9397321428571 501.5345982142857 55.46875 498.828125 57.8404017857143 493.1640625L62.4162946428571 482.1707589285714C69.3917410714286 483.5379464285714 76.6462053571429 483.6216517857143 83.8448660714285 482.2265625L88.3370535714286 493.0524553571429C90.7087053571428 498.7444196428572 97.2377232142857 501.4508928571429 102.9296875 499.0792410714286C108.6216517857143 496.7075892857143 111.328125 490.2064732142857 108.984375 484.5424107142857L104.4921875 473.7165178571429C107.0591517857143 471.9866071428572 109.3470982142857 469.9776785714286 111.5513392857143 467.9129464285714H269.5591517857143L409.4308035714286 327.5390625V46.7912946428571C409.4308035714286 20.9263392857143 388.5602678571429 0 362.8069196428572 0zM131.5848214285714 95.0334821428571H314.3694196428571V138.8950892857143H131.5848214285714V95.0334821428571zM131.5848214285714 190.0669642857143H314.3694196428571V233.9285714285714H131.5848214285714V190.0669642857143zM53.3482142857143 435.3515625C48.828125 424.4140625 54.0457589285714 411.8861607142857 64.9832589285714 407.3660714285715C75.9486607142857 402.8459821428571 88.5044642857143 408.0357142857143 93.0245535714286 418.9732142857143C97.5446428571429 429.9107142857143 92.3549107142857 442.4386160714286 81.3895089285714 446.9587053571429C70.4520089285714 451.4508928571428 57.8962053571429 446.2611607142857 53.3482142857143 435.3515625zM248.5491071428572 431.3337053571429V307.03125H372.8515625L248.5491071428572 431.3337053571429z" />
    <glyph glyph-name="home_publish"
      unicode="&#xF13B;"
      horiz-adv-x="704.0178571428571" d=" M453.9062500000001 55.46875H55.5803571428572V388.9508928571429H453.9062500000001V333.3705357142857H509.4866071428572V444.53125C509.4866071428572 479.0736607142857 481.5848214285714 500 447.1261160714286 500H62.3604910714286C27.9017857142857 500 0 472.0145089285714 0 437.5V62.5C0 27.9575892857143 27.9017857142857 0 62.3604910714286 0H447.0982142857144C481.5569196428572 0 509.4587053571429 20.9263392857143 509.4587053571429 55.46875V111.0491071428571H453.8783482142858V55.46875zM704.0178571428571 231.3337053571429L574.3303571428571 351.8973214285715V250H324.21875V194.4196428571428H574.3303571428572V101.7857142857143L704.0178571428571 231.3337053571429z" />
    <glyph glyph-name="home_share"
      unicode="&#xF13C;"
      horiz-adv-x="467.9966517857143" d=" M377.9854910714286 178.5714285714286C350.7254464285715 178.5714285714286 326.2555803571429 166.5178571428571 309.7377232142858 147.4888392857143L175.5022321428572 204.296875C178.4040178571429 213.0580357142857 179.9665178571429 222.4330357142857 179.9665178571429 232.1707589285715C179.9665178571429 245.9821428571429 176.8136160714286 259.0680803571429 171.1774553571429 270.7589285714286L311.6350446428572 350.4464285714286C328.0970982142857 332.6450892857144 351.7299107142858 321.484375 377.9854910714286 321.484375C427.7064732142858 321.484375 467.9966517857143 361.4676339285715 467.9966517857143 410.7700892857143C467.9966517857143 460.0725446428572 427.7064732142858 500.0558035714286 377.9854910714287 500.0558035714286C328.2645089285715 500.0558035714286 287.974330357143 460.0725446428572 287.974330357143 410.7700892857143C287.974330357143 397.5167410714286 290.904017857143 384.9330357142857 296.1216517857144 373.6049107142857L155.2455357142859 293.6941964285715C138.8392857142859 310.8258928571429 115.6808035714288 321.5122767857144 89.9832589285716 321.5122767857144C40.2901785714286 321.4006696428571 0 281.4453125 0 232.1428571428571C0 182.8404017857143 40.2901785714286 142.8571428571428 90.0111607142857 142.8571428571428C120.1450892857143 142.8571428571428 146.8191964285715 157.5613839285715 163.1417410714286 180.1060267857143L295.1450892857144 124.2745535714286C290.5412946428572 113.5323660714286 287.9743303571429 101.7020089285715 287.9743303571429 89.2857142857143C287.9743303571429 39.9832589285714 328.2645089285715 0 377.9854910714287 0S467.9966517857143 39.9832589285714 467.9966517857143 89.2857142857143C467.9966517857143 138.5881696428572 427.7064732142858 178.5714285714286 377.9854910714286 178.5714285714286z" />
    <glyph glyph-name="home_upload"
      unicode="&#xF13D;"
      horiz-adv-x="735.1283482142857" d=" M592.8571428571429 312.4162946428571C572.0145089285714 419.3359375 479.0736607142857 500 367.5781250000001 500C279.0457589285715 500 202.3158482142858 449.0234375 163.8950892857143 374.5814732142857C71.8191964285714 364.4810267857143 0 285.3794642857143 0 189.2020089285714C0 86.1607142857143 76.8415178571429 0 178.3761160714286 0H340.5412946428572V153.1529017857143H241.4341517857143L371.1774553571429 283.7890625L493.6941964285714 153.1529017857143H394.5870535714286V0H583.7890625000001C668.3314732142858 0 735.1283482142858 72.3214285714286 735.1283482142858 158.1194196428572C735.1283482142857 240.1506696428572 672.1819196428571 306.6685267857143 592.8571428571429 312.4162946428571z" />
    <glyph glyph-name="info"
      unicode="&#xF13E;"
      horiz-adv-x="499.94419642857144" d=" M249.9720982142858 499.9441964285714C111.9140625 499.9441964285714 0 388.0301339285715 0 249.9720982142857S111.9140625 0 249.9720982142858 0C388.0301339285715 0 499.9441964285715 111.9140624999999 499.9441964285715 249.9720982142857S388.0301339285715 499.9441964285714 249.9720982142858 499.9441964285714zM281.2220982142857 125C281.2220982142857 107.7287946428571 267.2433035714286 93.75 249.9720982142858 93.75C232.7008928571429 93.75 218.7220982142858 107.7287946428571 218.7220982142858 125V281.2220982142857C218.7220982142858 298.4933035714286 232.7008928571429 312.4720982142857 249.9720982142858 312.4720982142857C267.2154017857143 312.4720982142857 281.2220982142857 298.4933035714286 281.2220982142857 281.2220982142857V125zM250.5301339285715 343.1640625C232.9520089285715 343.1640625 218.7220982142858 357.3939732142857 218.7220982142858 374.9720982142857C218.7220982142858 392.5502232142857 232.9520089285715 406.7801339285715 250.5301339285715 406.7801339285715C268.0803571428572 406.7801339285715 282.3381696428572 392.5502232142857 282.3381696428572 374.9720982142857C282.3381696428572 357.3939732142857 268.1082589285715 343.1640625 250.5301339285715 343.1640625z" />
    <glyph glyph-name="institutional_account"
      unicode="&#xF13F;"
      horiz-adv-x="452.3716517857143" d=" M452.3716517857143 166.6573660714286V291.6573660714286C452.3716517857143 314.7042410714286 433.9843750000001 333.3147321428571 411.2444196428572 333.3147321428571H370.1171875V375C370.1171875 421.0379464285715 333.2868303571429 458.3426339285714 287.8627232142857 458.3426339285714C287.8627232142857 481.3616071428571 269.4754464285715 500 246.7354910714286 500H205.6361607142857C182.8962053571429 500 164.5089285714286 481.3616071428571 164.5089285714286 458.3426339285714C119.0848214285714 458.3426339285714 82.2544642857143 421.0379464285715 82.2544642857143 375V333.3426339285715H41.1272321428571C18.3872767857143 333.3426339285715 0 314.7042410714286 0 291.6852678571429V166.6852678571429V0H41.1272321428571H164.5089285714286H287.890625H411.2723214285715H452.3995535714286M143.9453125 416.6573660714286C155.2734375 416.6573660714286 164.5089285714286 407.3102678571429 164.5089285714286 395.8147321428572S155.2734375 375 143.9453125 375C132.6171875000001 375 123.3816964285715 384.3470982142857 123.3816964285715 395.8426339285715S132.6171875 416.6573660714286 143.9453125 416.6573660714286zM226.1997767857143 416.6573660714286C237.5558035714286 416.6573660714286 246.7633928571429 407.3102678571429 246.7633928571429 395.8147321428572S237.5558035714286 374.9720982142857 226.1997767857143 374.9720982142857C214.8716517857143 374.9720982142857 205.6361607142857 384.3191964285715 205.6361607142857 395.8147321428572S214.8716517857143 416.6573660714286 226.1997767857143 416.6573660714286zM308.4263392857144 416.6573660714286C319.8102678571429 416.6573660714286 328.9899553571429 407.3102678571429 328.9899553571429 395.8147321428572S319.7823660714286 374.9720982142857 308.4263392857144 374.9720982142857C297.0703125 374.9720982142857 287.8627232142857 384.3191964285715 287.8627232142857 395.8147321428572S297.0703125 416.6573660714286 308.4263392857144 416.6573660714286zM308.4263392857144 333.3426339285715C319.8102678571429 333.3426339285715 328.9899553571429 323.9955357142857 328.9899553571429 312.5C328.9899553571429 300.9765625 319.7823660714286 291.6573660714286 308.4263392857144 291.6573660714286C297.0703125 291.6573660714286 287.8627232142857 300.9765625 287.8627232142857 312.5C287.8627232142857 323.9676339285715 297.0703125 333.3426339285715 308.4263392857144 333.3426339285715zM226.1997767857143 333.3426339285715C237.5558035714286 333.3426339285715 246.7633928571429 323.9955357142857 246.7633928571429 312.5C246.7633928571429 300.9765625 237.5558035714286 291.6573660714286 226.1997767857143 291.6573660714286C214.8716517857143 291.6573660714286 205.6361607142857 300.9765625 205.6361607142857 312.5C205.6361607142857 323.9676339285715 214.8716517857143 333.3426339285715 226.1997767857143 333.3426339285715zM143.9453125 333.3426339285715C155.2734375 333.3426339285715 164.5089285714286 323.9955357142857 164.5089285714286 312.5C164.5089285714286 300.9765625 155.2734375000001 291.6573660714286 143.9453125 291.6573660714286C132.6171875000001 291.6573660714286 123.3816964285715 300.9765625 123.3816964285715 312.5C123.3816964285715 323.9676339285715 132.6171875 333.3426339285715 143.9453125 333.3426339285715zM143.9453125 250C155.2734375 250 164.5089285714286 240.6808035714286 164.5089285714286 229.1573660714286C164.5089285714286 217.6339285714286 155.2734375000001 208.3426339285714 143.9453125 208.3426339285714C132.6171875000001 208.3426339285714 123.3816964285715 217.6618303571428 123.3816964285715 229.1573660714286C123.3816964285715 240.6808035714286 132.6171875 250 143.9453125 250zM226.1997767857143 250C237.5558035714286 250 246.7633928571429 240.6808035714286 246.7633928571429 229.1573660714286C246.7633928571429 217.6339285714286 237.5558035714286 208.3426339285714 226.1997767857143 208.3426339285714C214.8716517857143 208.3426339285714 205.6361607142857 217.6618303571428 205.6361607142857 229.1573660714286C205.6361607142857 240.6808035714286 214.8716517857143 250 226.1997767857143 250zM308.4263392857144 250C319.8102678571429 250 328.9899553571429 240.6808035714286 328.9899553571429 229.1573660714286C328.9899553571429 217.6339285714286 319.7823660714286 208.3426339285714 308.4263392857144 208.3426339285714C297.0703125 208.3426339285714 287.8627232142857 217.6618303571428 287.8627232142857 229.1573660714286C287.8627232142857 240.6808035714286 297.0703125 250 308.4263392857144 250zM61.6908482142857 291.6573660714286C73.0189732142857 291.6573660714286 82.2544642857143 282.3381696428572 82.2544642857143 270.8147321428571C82.2544642857143 259.2912946428571 73.0189732142857 249.9720982142857 61.6908482142857 249.9720982142857C50.3627232142857 249.9720982142857 41.1272321428571 259.2912946428571 41.1272321428571 270.8147321428571C41.1272321428571 282.3381696428571 50.3627232142857 291.6573660714286 61.6908482142857 291.6573660714286zM61.6908482142857 208.3426339285715C73.0189732142857 208.3426339285715 82.2544642857143 199.0234375000001 82.2544642857143 187.5C82.2544642857143 175.9765625 73.0189732142857 166.6573660714286 61.6908482142857 166.6573660714286C50.3627232142857 166.6573660714286 41.1272321428571 175.9765625 41.1272321428571 187.5C41.1272321428571 199.0234375 50.3627232142857 208.3426339285715 61.6908482142857 208.3426339285715zM390.6808035714286 291.6573660714286C402.0368303571429 291.6573660714286 411.2444196428572 282.3381696428572 411.2444196428572 270.8147321428571C411.2444196428572 259.2912946428571 402.0368303571429 249.9720982142857 390.6808035714286 249.9720982142857C379.3247767857143 249.9720982142857 370.1171875 259.2912946428571 370.1171875 270.8147321428571C370.1171875 282.3381696428571 379.3247767857143 291.6573660714286 390.6808035714286 291.6573660714286zM390.6808035714286 208.3426339285715C402.0368303571429 208.3426339285715 411.2444196428572 199.0234375000001 411.2444196428572 187.5C411.2444196428572 175.9765625 402.0368303571429 166.6573660714286 390.6808035714286 166.6573660714286C379.3247767857143 166.6573660714286 370.1171875 175.9765625 370.1171875 187.5C370.1171875 199.0234375 379.3247767857143 208.3426339285715 390.6808035714286 208.3426339285715zM308.4263392857144 166.6573660714286C319.8102678571429 166.6573660714286 328.9899553571429 157.3381696428572 328.9899553571429 145.8147321428571C328.9899553571429 134.2912946428571 319.7823660714286 124.9720982142857 308.4263392857144 124.9720982142857C297.0703125 124.9720982142857 287.8627232142857 134.2912946428571 287.8627232142857 145.8147321428571C287.8627232142857 157.3381696428572 297.0703125 166.6573660714286 308.4263392857144 166.6573660714286zM226.1997767857143 166.6573660714286C237.5558035714286 166.6573660714286 246.7633928571429 157.3381696428572 246.7633928571429 145.8147321428571C246.7633928571429 134.2912946428571 237.5558035714286 124.9720982142857 226.1997767857143 124.9720982142857C214.8716517857143 124.9720982142857 205.6361607142857 134.2912946428571 205.6361607142857 145.8147321428571C205.6361607142857 157.3381696428572 214.8716517857143 166.6573660714286 226.1997767857143 166.6573660714286zM143.9453125 166.6573660714286C155.2734375 166.6573660714286 164.5089285714286 157.3381696428572 164.5089285714286 145.8147321428571C164.5089285714286 134.2912946428571 155.2734375000001 124.9720982142857 143.9453125 124.9720982142857C132.6171875000001 124.9720982142857 123.3816964285715 134.2912946428571 123.3816964285715 145.8147321428571C123.3816964285715 157.3381696428572 132.6171875 166.6573660714286 143.9453125 166.6573660714286zM143.9453125 83.3147321428571H308.4542410714286C319.8381696428572 83.3147321428571 329.0178571428572 73.9955357142857 329.0178571428572 62.5C329.0178571428572 50.9765625 319.8102678571429 41.6573660714286 308.4542410714286 41.6573660714286H143.9453125C132.6171875000001 41.6573660714286 123.3816964285715 50.9765625 123.3816964285715 62.5C123.3816964285715 74.0234375 132.6171875 83.3147321428571 143.9453125 83.3147321428571zM61.6908482142857 125C73.0189732142857 125 82.2544642857143 115.6808035714286 82.2544642857143 104.1573660714286C82.2544642857143 92.6339285714286 73.0189732142857 83.3147321428571 61.6908482142857 83.3147321428571C50.3627232142857 83.3147321428571 41.1272321428571 92.6339285714286 41.1272321428571 104.1573660714286C41.1272321428571 115.6808035714286 50.3627232142857 125 61.6908482142857 125zM390.6808035714286 125C402.0368303571429 125 411.2444196428572 115.6808035714286 411.2444196428572 104.1573660714286C411.2444196428572 92.6339285714286 402.0368303571429 83.3147321428571 390.6808035714286 83.3147321428571C379.3247767857143 83.3147321428571 370.1171875 92.6339285714286 370.1171875 104.1573660714286C370.1171875 115.6808035714286 379.3247767857143 125 390.6808035714286 125z" />
    <glyph glyph-name="linked"
      unicode="&#xF140;"
      horiz-adv-x="639.2020089285714" d=" M598.6607142857142 459.0122767857143C544.6149553571429 513.6439732142858 456.9754464285714 513.6160714285714 402.9017857142857 459.0401785714286L291.4620535714286 346.3448660714286C256.0825892857144 310.6305803571429 244.3359375000001 260.4352678571429 255.2455357142857 214.6205357142857L451.8415178571429 409.5703125C478.8783482142858 436.8582589285715 522.6841517857143 436.8861607142857 549.7488839285714 409.5424107142857C576.7578125000001 382.2265625 576.7578125000001 337.9464285714286 549.7488839285714 310.6305803571429L351.0881696428572 113.671875C397.9073660714286 100.0558035714286 450.3069196428572 111.2444196428571 487.1930803571429 148.5491071428572L598.6886160714287 261.2165178571429C652.7064732142858 315.7924107142857 652.734375 404.3805803571429 598.6607142857142 459.0122767857143zM383.9564732142857 285.3236607142857L187.3604910714286 90.4017857142857C160.3515625 63.1138392857143 116.5178571428572 63.1138392857143 89.4810267857143 90.4296874999999C62.4720982142857 117.7455357142857 62.4720982142857 162.0256696428572 89.4810267857143 189.3694196428572L288.1417410714286 386.3002232142857C241.3225446428572 399.8883928571429 188.9229910714286 388.7276785714286 152.0368303571429 351.4229910714286L40.5412946428571 238.7555803571429C-13.5044642857143 184.1517857142857 -13.5323660714286 95.5915178571428 40.5412946428571 40.9598214285714C94.5870535714286 -13.671875 182.2544642857143 -13.6439732142858 236.3002232142857 40.9319196428572L347.7678571428572 153.5993303571428C383.1194196428571 189.3415178571428 394.8939732142857 239.5368303571429 383.9564732142857 285.3236607142857z" />
    <glyph glyph-name="list"
      unicode="&#xF141;"
      horiz-adv-x="666.6294642857142" d=" M41.6573660714286 500C18.6383928571429 500 0 481.3337053571429 0 458.3426339285714C0 435.3236607142857 18.6662946428572 416.6852678571429 41.6573660714286 416.6852678571429C64.6763392857143 416.6852678571429 83.3147321428572 435.3515625 83.3147321428572 458.3426339285714C83.3426339285715 481.3337053571429 64.6763392857143 500 41.6573660714286 500zM41.6573660714286 291.6852678571429C18.6383928571429 291.6852678571429 0 273.046875 0 250.0279017857143S18.6662946428572 208.3705357142857 41.6573660714286 208.3705357142857C64.6763392857143 208.3705357142857 83.3147321428572 227.0368303571429 83.3147321428572 250.0279017857143S64.6763392857143 291.6852678571429 41.6573660714286 291.6852678571429zM41.6573660714286 83.3426339285715C18.6383928571429 83.3426339285715 0 64.6763392857143 0 41.6852678571429C0 18.6941964285714 18.6662946428572 0.0279017857143 41.6573660714286 0.0279017857143C64.6763392857143 0.0279017857143 83.3147321428572 18.6941964285715 83.3147321428572 41.6852678571429C83.3426339285715 64.7042410714286 64.6763392857143 83.3426339285715 41.6573660714286 83.3426339285715zM208.3147321428572 416.6573660714286H624.9720982142858C647.9910714285714 416.6573660714286 666.6294642857142 435.3236607142857 666.6294642857142 458.3147321428572C666.6294642857142 481.3337053571429 647.9631696428571 499.9720982142857 624.9720982142858 499.9720982142857H208.3147321428572C185.2957589285715 499.9720982142857 166.6573660714286 481.3058035714286 166.6573660714286 458.3147321428572C166.6573660714286 435.3236607142857 185.3236607142857 416.6573660714286 208.3147321428572 416.6573660714286zM624.9720982142858 291.6852678571429H208.3147321428572C185.2957589285715 291.6852678571429 166.6573660714286 273.046875 166.6573660714286 250.0279017857143S185.3236607142857 208.3705357142857 208.3147321428572 208.3705357142857H624.9720982142858C647.9910714285714 208.3705357142857 666.6294642857142 227.0368303571429 666.6294642857142 250.0279017857143S647.9910714285714 291.6852678571429 624.9720982142858 291.6852678571429zM624.9720982142858 83.3426339285715H208.3147321428572C185.2957589285715 83.3426339285715 166.6573660714286 64.6763392857143 166.6573660714286 41.6852678571429C166.6573660714286 18.6941964285714 185.3236607142857 0.0279017857143 208.3147321428572 0.0279017857143H624.9720982142858C647.9910714285714 0.0279017857143 666.6294642857142 18.6941964285715 666.6294642857142 41.6852678571429C666.6294642857142 64.7042410714286 647.9910714285714 83.3426339285715 624.9720982142858 83.3426339285715z" />
    <glyph glyph-name="list_view-alternative"
      unicode="&#xF142;"
      horiz-adv-x="499.91629464285717" d=" M466.1272321428571 500H33.7890625C15.1227678571429 500 0 485.0725446428572 0 466.6573660714286V433.3147321428571C0 414.8995535714286 15.1227678571429 399.9720982142857 33.7890625 399.9720982142857H466.1272321428571C484.7935267857143 399.9720982142857 499.9162946428571 414.8995535714286 499.9162946428571 433.3147321428571V466.6573660714286C499.9162946428571 485.0725446428572 484.7935267857143 500 466.1272321428571 500zM466.1272321428571 100H33.7890625C15.1227678571429 100 0 85.0725446428572 0 66.6573660714286V33.3147321428572C0 14.8995535714286 15.1227678571429 -0.0279017857143 33.7890625 -0.0279017857143H466.1272321428571C484.7935267857143 -0.0279017857143 499.9162946428571 14.8995535714286 499.9162946428571 33.3147321428572V66.6573660714286C499.9162946428571 85.0725446428572 484.7935267857143 100 466.1272321428571 100zM466.1272321428571 300H33.7890625C15.1227678571429 300 0 285.0725446428571 0 266.6573660714286V233.3147321428572C0 214.8995535714286 15.1227678571429 199.9720982142857 33.7890625 199.9720982142857H466.1272321428571C484.7935267857143 199.9720982142857 499.9162946428571 214.8995535714286 499.9162946428571 233.3147321428572V266.6573660714286C499.9162946428571 285.0725446428571 484.7935267857143 300 466.1272321428571 300z" />
    <glyph glyph-name="list_view"
      unicode="&#xF143;"
      horiz-adv-x="642.8571428571429" d=" M0 371.4285714285715H642.8571428571429V500H0V371.4285714285715zM642.8571428571429 0V128.5714285714286H0V0H642.8571428571429zM0 185.7142857142857H642.8571428571429V314.2857142857143H0V185.7142857142857z" />
    <glyph glyph-name="load_more"
      unicode="&#xF144;"
      horiz-adv-x="480.97098214285717" d=" M0.1116071428571 238.9508928571429C0.1116071428571 231.5290178571429 2.9575892857143 224.1071428571428 8.6495535714286 218.4709821428571L201.7857142857143 25.2790178571428C234.375 -7.3102678571429 245.7310267857143 -8.9564732142858 278.3203125 23.6049107142857L472.9631696428572 218.3035714285714C484.4866071428572 229.7712053571429 484.5424107142858 248.4095982142857 473.1026785714286 259.9330357142857C461.6629464285715 271.4564732142857 443.0524553571429 271.5401785714286 431.5290178571429 260.0725446428571C431.5290178571429 260.0725446428571 304.4642857142858 132.8962053571428 255.4966517857144 83.9006696428571C240.7087053571429 69.1127232142857 239.3694196428572 69.6428571428571 226.5625000000001 82.4776785714286C179.0736607142857 129.9665178571428 49.4419642857143 259.4029017857143 49.4419642857143 259.4029017857143C38.1138392857143 270.6473214285715 19.7823660714286 270.5636160714286 8.5379464285714 259.2633928571429C2.9296875 253.6551339285714 0.1116071428571 246.2890625 0.1116071428571 238.9508928571429z M-0.5580357142857 469.8660714285714C-0.5580357142857 462.4441964285714 2.2879464285714 455.0223214285714 7.9799107142857 449.3861607142857L201.1160714285714 256.2220982142857C233.7053571428572 223.6328125 245.0613839285714 221.9866071428572 277.6506696428572 254.5479910714286L472.2935267857143 449.2466517857143C483.8169642857143 460.7142857142857 483.8727678571429 479.3526785714286 472.4330357142857 490.8761160714286C460.9933035714286 502.3995535714286 442.3828125 502.4832589285714 430.859375 491.015625C430.859375 491.015625 303.7946428571429 363.8392857142857 254.8270089285715 314.84375C240.0390625000001 300.0558035714286 238.6997767857143 300.5859375 225.8928571428572 313.4207589285715C178.4040178571429 360.9095982142857 48.7444196428571 490.3459821428571 48.7444196428571 490.3459821428571C37.4162946428571 501.5904017857143 19.0848214285714 501.5066964285714 7.8404017857143 490.2064732142857C2.2321428571429 484.5982142857143 -0.5580357142857 477.2321428571428 -0.5580357142857 469.8660714285714z" />
    <glyph glyph-name="location_pin"
      unicode="&#xF145;"
      horiz-adv-x="281.0825892857143" d=" M141.0714285714286 499.8046875C39.1741071428571 499.8046875 -19.8102678571429 400.3627232142857 6.0825892857143 317.3549107142857C36.71875 219.1964285714286 141.0714285714286 0 141.0714285714286 0S242.3549107142857 219.6707589285714 274.4977678571428 317.3549107142857C302.2042410714286 401.5345982142857 239.4531250000001 499.8046875 141.0714285714286 499.8046875zM141.0714285714286 261.2165178571429C86.4955357142857 261.2165178571429 42.1875 305.4966517857143 42.1875 360.1004464285715S86.4676339285714 458.984375 141.0714285714286 458.984375C195.6473214285714 458.984375 239.9553571428572 414.7042410714286 239.9553571428572 360.1004464285715S195.6473214285715 261.2165178571429 141.0714285714286 261.2165178571429z" />
    <glyph glyph-name="locked"
      unicode="&#xF146;"
      horiz-adv-x="389.2299107142857" d=" M340.5691964285714 283.3705357142857H324.3582589285715V383.3705357142857C324.3582589285715 447.8236607142857 266.2667410714286 500.0558035714286 194.6149553571429 500.0558035714286C122.9631696428572 500.0558035714286 64.8716517857143 447.8236607142857 64.8716517857143 383.3705357142857V283.3705357142857H48.6607142857143C21.7912946428571 283.3705357142857 0 260.9933035714286 0 233.3705357142857V50C0 22.3772321428572 21.7912946428572 0 48.6607142857143 0H340.5691964285714C367.4386160714286 0 389.2299107142857 22.3772321428572 389.2299107142857 50V233.3705357142857C389.2299107142857 260.9933035714286 367.4386160714286 283.3705357142857 340.5691964285714 283.3705357142857zM193.6941964285715 100.5022321428572C157.8683035714286 100.5301339285714 128.8504464285715 130.3850446428572 128.8504464285715 167.2154017857143C128.8783482142858 204.0457589285715 157.9241071428572 233.8727678571429 193.75 233.8448660714286C229.5758928571429 233.8169642857144 258.5937500000001 203.9620535714286 258.5937500000001 167.1316964285715C258.5658482142857 130.3292410714286 229.5200892857143 100.5022321428572 193.6941964285715 100.5022321428572zM259.4866071428572 300.0279017857143C259.4866071428572 294.1964285714286 258.1752232142857 288.5881696428571 255.8035714285714 283.3705357142857H133.4263392857143C131.0267857142857 288.5881696428571 129.7433035714286 294.1964285714286 129.7433035714286 300.0279017857143V383.3705357142857C129.7433035714286 410.9933035714286 158.7890625 433.3705357142857 194.6149553571429 433.3705357142857C230.4408482142858 433.3984375 259.4866071428572 410.9933035714286 259.4866071428572 383.3705357142857V300.0279017857143z" />
    <glyph glyph-name="metadata"
      unicode="&#xF147;"
      horiz-adv-x="437.44419642857144" d=" M412.4441964285715 0H25C11.1886160714286 0 0 11.1886160714286 0 24.9999999999999V412.4441964285715C0 426.2555803571429 11.1886160714286 437.4441964285715 25 437.4441964285715H152.1763392857143C155.3850446428572 472.4330357142857 183.7611607142858 499.9441964285714 218.7220982142858 499.9441964285714S282.0591517857144 472.4609375 285.2678571428572 437.4441964285715H412.4441964285715C426.2555803571429 437.4441964285715 437.4441964285715 426.2555803571429 437.4441964285715 412.4441964285714V24.9999999999999C437.4441964285715 11.1886160714286 426.2555803571429 0 412.4441964285715 0zM99.9720982142857 99.9720982142857H262.4441964285714V149.9720982142857H99.9720982142857V99.9720982142857zM349.9441964285715 324.9441964285715H99.9720982142857V274.9441964285715H349.9441964285714V324.9441964285715zM349.9441964285715 237.4720982142857H99.9720982142857V187.4720982142857H349.9441964285714V237.4720982142857zM218.7220982142858 465.5412946428571C237.2767857142858 465.5412946428571 252.3158482142858 450.0558035714286 252.3158482142858 430.9709821428572S237.2767857142858 396.4006696428572 218.7220982142858 396.4006696428572C200.1674107142858 396.4006696428572 185.1283482142857 411.8861607142857 185.1283482142857 430.9709821428572S200.1674107142858 465.5412946428571 218.7220982142858 465.5412946428571z" />
    <glyph glyph-name="minus_icon"
      unicode="&#xF148;"
      horiz-adv-x="499.94419642857144" d=" M499.9441964285714 200.2232142857143C333.2961216517857 200.2232142857143 166.64806640625 200.2232142857143 0 200.2232142857143L0 300.1116071428571C166.6573660714286 300.1116071428571 333.3147321428571 300.1116071428571 499.9720982142858 300.1116071428571L499.9720982142858 200.2232142857143z M0.5040318080357 299.3951702008929H501.0080496651786V200.6048493303571H0.5040318080357V299.3951702008929z" />
    <glyph glyph-name="molecule"
      unicode="&#xF149;"
      horiz-adv-x="440.56919642857144" d=" M394.9497767857143 274.1629464285715C374.0513392857143 274.9441964285715 355.8035714285714 262.0814732142857 348.828125 243.5267857142857C347.8794642857143 243.8058035714286 346.9029017857143 244.0569196428572 345.8984375 244.3080357142857L272.2935267857144 257.3660714285715L272.2935267857144 255.5803571428572C272.2935267857144 255.7198660714286 272.3214285714286 255.859375 272.3214285714286 255.9988839285714C272.3214285714286 280.6361607142857 255.8314732142858 300.390625 232.3660714285714 304.7712053571429L234.1796875 304.4084821428571L244.5870535714286 392.8013392857143C273.9118303571429 393.1082589285715 297.6004464285714 416.9363839285715 297.6004464285714 446.3169642857143C297.6004464285714 475.9207589285714 273.6049107142857 499.8883928571429 244.0290178571429 499.8883928571429C214.4252232142857 499.8883928571429 190.4575892857143 475.8928571428572 190.4575892857143 446.3169642857143C190.4575892857143 421.6238839285715 207.2544642857143 401.0602678571429 229.9665178571428 394.8381696428572L221.0658482142856 305.4966517857144L222.5725446428571 305.5524553571429C195.7310267857142 304.9665178571429 174.8604910714285 283.0357142857143 174.8604910714285 255.9709821428572C174.8604910714285 254.4921875 175.1674107142856 253.0970982142857 175.2790178571428 251.6741071428572L175 254.0178571428572L103.6272321428571 238.6439732142857C96.0379464285714 259.0401785714286 76.5904017857142 273.6328125 53.5435267857143 273.6328125C23.9397321428571 273.6328125 -0.0279017857143 249.6372767857143 -0.0279017857143 220.0613839285715S23.9676339285714 166.4899553571428 53.5435267857143 166.4899553571428C83.1473214285714 166.4899553571428 107.1149553571428 190.4854910714286 107.1149553571428 220.0613839285715C107.1149553571428 221.8470982142857 106.7522321428571 223.4933035714286 106.5848214285714 225.2232142857143L177.2600446428571 241.2667410714286L176.8694196428571 242.6060267857143C182.6171874999999 221.7075892857143 201.2555803571428 206.2779017857143 223.6049107142856 206.2779017857143C224.9441964285713 206.2779017857143 226.2276785714285 206.5290178571429 227.5390624999999 206.6406250000001L225.1395089285713 206.3616071428572L241.1830357142856 128.9341517857143C212.1651785714285 122.2098214285715 190.4575892857142 96.3448660714286 190.4575892857142 65.2622767857143C190.4575892857142 29.1015625000001 219.7823660714285 -0.2232142857143 255.9430803571428 -0.2232142857143S321.4285714285715 29.1573660714286 321.4285714285715 65.3180803571428S292.1037946428572 130.8035714285714 255.9430803571429 130.8035714285714C255.3571428571429 130.8035714285714 254.8270089285714 130.6361607142857 254.2410714285715 130.6361607142857L237.6674107142857 208.6774553571429L236.1607142857143 208.2310267857143C254.296875 213.28125 268.4988839285715 229.6875 271.484375 247.65625L271.1774553571429 246.0379464285714L345.8147321428571 232.03125C345.8984375 232.0033482142857 345.9542410714286 231.9754464285714 346.0379464285714 231.9754464285714C345.9263392857142 230.8872767857143 345.8426339285714 229.7712053571429 345.7868303571428 228.6272321428571C344.8102678571428 202.4832589285715 365.1785714285714 180.4966517857143 391.3225446428571 179.5200892857143S439.4531249999999 198.9118303571429 440.4296874999999 225.0558035714286S421.0658482142857 273.1584821428571 394.9497767857143 274.1629464285715z" />
    <glyph glyph-name="next"
      unicode="&#xF14A;"
      horiz-adv-x="322.69682345314413" d=" M41.6516603039689 496.2904271411078C66.2500900381762 482.658647266441 294.1907368724339 291.2194770582728 311.2079521717208 274.0942159475618C326.442411582511 258.7697183605849 326.5864726644097 241.3563350860765 311.2079521717208 225.9598069581503C287.58193474033 202.3337895267594 59.4432039184614 13.955917308939 42.5160267953612 4.2678095512498C21.3930706619607 -7.8153136930059 0 7.5451991644458 0 28.1999567816754C0 44.1187063314845 0 449.3985449830729 0 472.4843333573435C0 495.2459842973421 23.6260174313909 506.3026723330692 41.6516603039689 496.2904271411078z" />
    <glyph glyph-name="note"
      unicode="&#xF14B;"
      horiz-adv-x="515.4575892857143" d=" M184.2912946428572 170.9263392857143L292.6618303571429 201.6741071428572L215.234375 278.5993303571429L184.2912946428572 170.9263392857143zM473.7444196428572 381.6127232142857L396.3169642857144 458.5100446428572L226.0044642857143 289.3136160714286L303.4319196428572 212.4162946428571L473.7444196428572 381.6127232142857zM451.171875 96.8191964285715C451.171875 70.0892857142857 429.4921875 48.4095982142857 402.7343750000001 48.4095982142857H96.8470982142857C70.1171875 48.4095982142857 48.4375 70.0892857142857 48.4375 96.8191964285715V387.2209821428571C48.4375 413.9508928571429 70.1171875 435.6305803571429 96.8470982142857 435.6305803571429H305.9151785714286L354.3247767857144 484.0401785714286H80.6919642857143C36.1328125 484.0401785714286 0 447.9073660714286 0 403.3761160714286V80.6919642857143C0 36.1328125 36.1328125 0.0279017857142 80.6919642857143 0.0279017857142H418.8895089285715C463.4486607142857 0.0279017857142 499.5814732142857 36.1328125 499.5814732142857 80.6919642857142V338.8113839285715L451.171875 290.4296875V96.8191964285715zM509.7098214285714 446.2053571428571L461.328125 494.2801339285714C453.3203124999999 502.2321428571428 439.8716517857142 501.8136160714286 431.3337053571429 493.3314732142857L408.1194196428571 470.2566964285714L485.5468749999999 393.359375L508.7611607142857 416.4341517857143C517.2991071428571 424.8883928571429 517.7455357142857 438.2254464285715 509.7098214285714 446.2053571428571z" />
    <glyph glyph-name="paper"
      unicode="&#xF14C;"
      horiz-adv-x="785.7142857142858" d=" M738.3091517857143 500H47.4051339285714C21.3169642857143 500 -0.0279017857143 478.6551339285714 -0.0279017857143 452.5669642857143V47.4051339285714C-0.0279017857143 21.3169642857143 21.3169642857143 -0.0279017857143 47.4051339285714 -0.0279017857143H738.28125C764.3694196428571 -0.0279017857143 785.7142857142858 21.3169642857143 785.7142857142858 46.0100446428572V451.171875C785.7421875 478.6551339285714 764.3973214285714 500 738.3091517857143 500zM415.4296875000001 464.2857142857143C415.4296875000001 464.2857142857143 722.2098214285714 464.2857142857143 736.6350446428572 464.2857142857143C747.0424107142859 464.2857142857143 750.5859375000001 457.5613839285714 750.5859375000001 450.3348214285715C750.5859375000001 449.1629464285715 750.5859375000001 428.5714285714286 750.5859375000001 428.5714285714286H415.4296875000001V464.2857142857143zM415.4854910714286 192.5223214285715V228.2366071428571H750.5580357142858V192.5223214285715H415.4854910714286zM750.5301339285714 148.6607142857143V112.9464285714286H415.4854910714286V148.6607142857143H750.5301339285714zM415.4854910714286 268.9732142857143V304.6875H750.5580357142858V268.9732142857143H415.4854910714286zM372.1819196428572 35.6863839285714C372.1819196428572 35.6863839285714 63.4486607142857 35.6863839285714 49.0234375 35.6863839285714C38.6160714285714 35.6863839285714 35.0725446428572 42.4107142857143 35.0725446428572 49.6372767857143C35.0725446428572 50.8091517857143 35.0725446428572 71.4006696428572 35.0725446428572 71.4006696428572H372.1819196428572V35.6863839285714zM372.1819196428572 148.4375V112.7232142857143H35.1283482142857V148.4375H372.1819196428572zM35.1283482142857 192.5223214285715V228.2366071428571H372.154017857143V192.5223214285715H35.1283482142857zM372.1819196428572 269.53125H35.0725446428571C35.0725446428571 269.53125 35.0725446428571 449.7209821428571 35.0725446428571 450.8928571428571C35.0725446428571 458.1194196428571 38.6160714285714 464.84375 49.0234375 464.84375C63.4486607142857 464.84375 372.1819196428572 464.84375 372.1819196428572 464.84375L372.1819196428572 269.53125L372.1819196428572 269.53125zM750.5859375 49.6372767857143C750.5859375 42.4107142857143 747.0424107142858 35.6863839285714 736.6350446428571 35.6863839285714C722.2098214285714 35.6863839285714 415.4296875 35.6863839285714 415.4296875 35.6863839285714V71.4006696428572H750.5859375C750.5859375 71.4006696428572 750.5859375 50.8091517857142 750.5859375 49.6372767857143zM750.8091517857143 348.4654017857143H415.7645089285714V384.1796875H750.8370535714286V348.4654017857143z" />
    <glyph glyph-name="pause_video"
      unicode="&#xF14D;"
      horiz-adv-x="341.93638392857144" d=" M0 500H131.5848214285715L131.5848214285715 0L0 0V500zM210.546875 500H341.9363839285715V0L210.546875 0L210.546875 500z" />
    <glyph glyph-name="pdf-file"
      unicode="&#xF14E;"
      horiz-adv-x="500" d=" M450.0000000000001 500H150C122.4888392857143 500 100 477.5111607142857 100 450V150C100 122.4888392857143 122.4888392857142 100 150 100H450.0000000000001C477.5111607142858 100 500 122.4888392857143 500 150V450C500 477.5111607142857 477.5111607142858 500 450.0000000000001 500M237.5000000000001 312.5C237.5000000000001 291.7410714285715 220.7589285714286 275 200 275H175V225H137.5V375H200C220.7589285714286 375 237.5000000000001 358.2589285714286 237.5000000000001 337.5V312.5zM362.5 262.5C362.5 241.7410714285714 345.7589285714286 225 325 225H262.5V375H325C345.7589285714286 375 362.5 358.2589285714286 362.5 337.5V262.5zM462.5 337.5H425V312.5H462.5V275H425V225H387.5V375H462.5V337.5zM175 312.5H200V337.5H175V312.5zM50 400H0V50C0 22.4888392857143 22.4888392857143 0 50 0H400.0000000000001V50H50V400zM300 262.5H325V337.5H300V262.5z" />
    <glyph glyph-name="pictures"
      unicode="&#xF14F;"
      horiz-adv-x="785.7142857142858" d=" M732.5892857142857 500.0279017857143H53.0691964285714C23.7444196428571 500.0279017857143 -0.0279017857143 477.1763392857143 -0.0279017857143 448.9955357142857V51.0323660714286C-0.0279017857143 22.8515625 23.7444196428571 0 53.0691964285714 0H732.6171875C761.9419642857142 0 785.7142857142858 22.8515625 785.7142857142858 51.0323660714286V448.9955357142857C785.6863839285714 477.1763392857143 761.9419642857143 500.0279017857143 732.5892857142857 500.0279017857143zM750.5859375 78.0133928571428C750.5859375 47.0703124999999 739.3694196428572 35.9933035714286 708.5658482142858 35.9933035714286C666.4899553571428 36.0770089285714 219.1127232142857 36.2723214285714 77.1205357142857 36.2723214285714C47.1540178571429 36.2723214285714 35.1004464285715 48.6328125 35.1004464285715 78.2924107142857C35.0167410714286 87.890625 35.0167410714286 87.890625 35.0167410714286 102.6506696428571C125.2232142857143 174.1908482142857 255.9988839285715 277.9017857142857 255.9988839285715 277.9017857142857L434.5982142857143 172.8515625L571.1774553571429 382.9520089285715C571.1774553571429 382.9520089285715 659.5145089285714 321.6238839285715 750.7812500000001 258.2310267857143C750.8091517857143 163.5044642857143 750.5859375 89.0625 750.5859375 78.0133928571428z" />
    <glyph glyph-name="plus_icon"
      unicode="&#xF150;"
      horiz-adv-x="499.94419642857144" d=" M499.9441964285714 200.2232142857143H299.7209821428571V0H199.8325892857143V200.2232142857143H0V300.1116071428571H199.8325892857143V499.9441964285714H299.7488839285715V300.1116071428571H499.9720982142858V200.2232142857143z" />
    <glyph glyph-name="portal"
      unicode="&#xF151;"
      horiz-adv-x="611.1049107142857" d=" M555.5524553571429 500H55.5524553571428C25 500 0 475 0 444.4475446428571V111.1049107142857C0 80.5524553571428 25 55.5524553571428 55.5524553571429 55.5524553571428H194.4475446428572V0H416.6573660714286V55.5524553571428H555.552455357143C586.1049107142858 55.5524553571428 610.825892857143 80.5524553571428 610.825892857143 111.1049107142857L611.1049107142858 444.4475446428572C611.1049107142857 475 586.1049107142857 500 555.5524553571429 500M555.5524553571429 111.1049107142857H55.5524553571428V444.4475446428571H555.5524553571429V111.1049107142857zM500 361.1049107142857H194.4475446428572V305.5524553571429H500V361.1049107142857zM500 250H194.4475446428572V194.4475446428572H500V250zM166.6573660714286 361.1049107142857H111.1049107142857V305.5524553571429H166.6573660714286V361.1049107142857zM166.6573660714286 250H111.1049107142857V194.4475446428572H166.6573660714286V250z" />
    <glyph glyph-name="poster"
      unicode="&#xF152;"
      horiz-adv-x="785.7142857142858" d=" M732.6171875 500.0279017857143H53.0412946428571C23.7444196428571 500.0279017857143 -0.0279017857143 477.1763392857143 -0.0279017857143 448.9955357142857V51.0323660714286C-0.0279017857143 24.3303571428572 23.7444196428572 0 53.0691964285714 0H732.6171875C761.9419642857142 0 785.7142857142858 22.8515625 785.7142857142858 51.0323660714286V448.9955357142857C785.6863839285714 477.1763392857143 761.9698660714287 500.0279017857143 732.6171875 500.0279017857143zM364.2299107142857 72.4888392857143C364.2299107142857 70.8147321428571 362.8627232142857 69.4475446428571 361.1886160714286 69.4475446428571H211.9419642857143C210.2678571428572 69.4475446428571 208.9006696428572 70.8147321428571 208.9006696428572 72.4888392857143V147.6841517857143C208.9006696428572 150.6138392857143 211.1328125 153.7667410714286 211.3839285714286 154.0457589285714C213.0022321428572 155.9151785714286 238.8671875 178.7667410714285 250.4743303571429 190.4575892857143C273.9676339285715 175.0837053571428 300.78125 176.0044642857143 323.5770089285715 192.4665178571428C335.2678571428572 180.7198660714285 359.0122767857144 157.2823660714285 361.3002232142857 153.7667410714286C361.8861607142857 152.8738839285714 364.0625000000001 150.4185267857143 364.2299107142857 147.6841517857143V72.4888392857143zM232.03125 247.9352678571429C232.03125 277.9854910714286 256.3895089285715 302.34375 286.4397321428571 302.34375C316.4899553571429 302.34375 340.8482142857143 277.9854910714286 340.8482142857143 247.9352678571429S316.4899553571429 193.5267857142857 286.4397321428571 193.5267857142857S232.03125 217.8850446428571 232.03125 247.9352678571429zM673.4654017857142 210.4631696428571C673.4654017857142 180.078125 648.8281249999999 155.4408482142857 618.4430803571429 155.4408482142857C618.4430803571429 155.4408482142857 386.0770089285715 155.3292410714285 378.125 155.3292410714285C367.4944196428572 165.9040178571428 343.0524553571429 191.6573660714285 334.6540178571429 200.1674107142857C351.8136160714286 217.4107142857142 358.4263392857144 243.2198660714285 351.7020089285715 266.6294642857142C346.0937500000001 286.0491071428571 331.640625 302.2879464285714 313.0580357142857 310.15625C293.0803571428572 318.6104910714286 269.7544642857143 316.796875 251.2834821428572 305.46875C233.7053571428572 294.6707589285714 221.7633928571429 275.8928571428571 219.5033482142857 255.3571428571428C217.1875 234.4308035714285 224.9162946428572 213.2533482142856 240.1785714285715 198.7444196428571C221.875 180.7477678571428 205.0502232142857 165.6808035714286 194.1964285714286 155.3850446428572L167.3270089285715 155.4129464285715C136.9419642857143 155.4129464285715 112.3046875 180.0502232142857 112.3046875 210.4352678571429V375.5022321428571C112.3046875 405.8872767857143 136.9419642857143 430.5245535714286 167.3270089285715 430.5245535714286H618.3872767857143C648.7723214285716 430.5245535714286 673.4095982142858 405.8872767857143 673.4375000000001 375.5022321428571L673.4654017857142 210.4631696428571L673.4654017857142 210.4631696428571z" />
    <glyph glyph-name="preprint"
      unicode="&#xF153;"
      horiz-adv-x="785.7142857142858" d=" M738.3370535714286 500H47.4051339285714C21.3169642857143 500 -0.0279017857143 478.6551339285714 -0.0279017857143 452.5669642857143V47.4051339285714C-0.0279017857143 21.3169642857143 21.3169642857143 -0.0279017857143 47.4051339285714 -0.0279017857143H738.28125C764.3694196428571 -0.0279017857143 785.7142857142858 21.3169642857143 785.7142857142858 46.0100446428572V451.171875C785.7700892857142 478.6551339285714 764.4252232142857 500 738.3370535714286 500zM84.0401785714286 346.9308035714286L171.1216517857143 367.5223214285715C173.3816964285714 368.0524553571429 175.7533482142857 368.0245535714286 177.9854910714286 367.4107142857143L250.3348214285715 347.7399553571429L334.2633928571429 367.4944196428571C336.4955357142857 368.0245535714286 338.8392857142857 367.9966517857143 341.0714285714286 367.3828125L417.8292410714286 346.8191964285715C425.2790178571429 344.8381696428571 429.6875 337.1651785714286 427.7064732142858 329.7433035714286C426.0323660714286 323.5212053571429 420.3962053571429 319.3917410714286 414.2299107142858 319.3917410714286C413.0301339285715 319.3917410714286 411.8303571428572 319.5591517857143 410.6026785714286 319.8660714285715L337.2488839285715 339.5089285714286L253.2924107142858 319.7544642857143C251.0323660714287 319.2243303571429 248.6886160714287 319.2522321428571 246.4285714285715 319.8660714285715L174.1071428571429 339.5647321428571L90.4854910714286 319.7823660714286C82.9799107142857 317.9966517857144 75.4743303571429 322.65625 73.6886160714286 330.1618303571429S76.5625 345.1729910714286 84.0401785714286 346.9308035714286zM84.0401785714286 246.2332589285714L171.1216517857143 266.8247767857143C173.3816964285714 267.3549107142857 175.7533482142857 267.3270089285714 177.9854910714286 266.7131696428571L253.7388392857143 246.1216517857143C261.1607142857143 244.1127232142857 265.5691964285715 236.4397321428571 263.5323660714286 228.9899553571429C261.8582589285715 222.7678571428572 256.2220982142857 218.6941964285715 250.0837053571429 218.6941964285715C248.8839285714286 218.6941964285715 247.6283482142857 218.8616071428572 246.4285714285714 219.1964285714286L174.1071428571429 238.8671875L90.4854910714286 219.0848214285715C82.9799107142857 217.2991071428572 75.4743303571429 221.9587053571428 73.6886160714286 229.4642857142857S76.5625 244.4754464285715 84.0401785714286 246.2332589285714zM414.2020089285715 117.9966517857143C413.0022321428572 117.9966517857143 411.8024553571429 118.1640625 410.5747767857143 118.4709821428572L337.2209821428571 138.1138392857143L253.2645089285714 118.3593750000001C251.0044642857143 117.8292410714286 248.6607142857143 117.857142857143 246.4006696428571 118.4709821428572L174.1071428571429 138.1696428571428L90.4854910714286 118.3872767857143C82.9799107142857 116.6294642857143 75.4743303571429 121.2611607142857 73.6886160714286 128.7667410714286C71.9029017857143 136.2723214285715 76.5625 143.7779017857143 84.0680803571429 145.5636160714286L171.1495535714286 166.1551339285715C173.4095982142858 166.6852678571429 175.78125 166.6573660714286 178.0133928571429 166.0435267857143L250.3627232142858 146.3727678571428L334.2912946428572 166.1272321428571C336.5234375000001 166.6573660714286 338.8671875000001 166.6294642857142 341.099330357143 166.015625L417.857142857143 145.4520089285713C422.5167410714288 144.1964285714285 426.0044642857144 140.7366071428571 427.4553571428573 136.4676339285713L451.1160714285716 218.8058035714285L517.5781250000001 152.7622767857142L427.3437500000001 127.1484375C425.2790178571429 121.5959821428571 419.9776785714286 118.0245535714286 414.2020089285715 117.9966517857143zM526.7857142857143 161.9698660714286L460.3236607142857 227.9854910714286L606.5290178571429 373.2142857142857L672.9910714285714 307.1986607142857L526.7857142857143 161.9698660714286zM703.0412946428571 337.109375L683.1194196428571 317.2991071428571L616.6573660714286 383.3147321428572L636.5792410714286 403.125C643.9174107142858 410.4073660714286 655.4408482142857 410.7700892857143 662.3325892857143 403.9341517857143L703.8504464285716 362.6674107142857C710.7421875000001 355.8035714285715 710.3515625 344.3638392857144 703.0412946428571 337.109375z" />
    <glyph glyph-name="preprint_i"
      unicode="&#xF154;"
      horiz-adv-x="1092.6060267857144" d=" M18.4709821428571 393.6104910714286L168.1640625 429.0178571428571C172.0424107142857 429.9386160714286 176.1160714285715 429.8828125 179.9665178571429 428.8225446428571L304.3526785714286 395.0055803571429L448.6607142857143 428.9620535714286C452.5111607142857 429.8828125 456.5290178571429 429.7991071428571 460.3515625000001 428.7946428571429L592.2991071428572 393.4430803571429C605.1060267857143 390.0111607142857 612.6953125 376.8694196428572 609.263392857143 364.0625C606.3895089285714 353.3482142857143 596.7075892857144 346.2890625 586.1049107142858 346.2890625C584.0401785714287 346.2890625 581.9754464285714 346.5680803571429 579.8828125000001 347.1261160714286L453.7667410714286 380.9151785714286L309.4308035714286 346.9308035714286C305.5524553571429 346.0100446428571 301.5066964285714 346.09375 297.65625 347.1261160714286L173.2700892857143 380.9151785714286L29.5200892857143 346.9308035714286C16.6294642857143 343.8895089285715 3.7109375 351.8694196428571 0.6696428571429 364.7600446428571S5.5803571428571 390.5691964285715 18.4709821428571 393.6104910714286zM18.4709821428571 220.4799107142857L168.1640625 255.859375C172.0424107142857 256.7801339285715 176.1160714285715 256.7243303571429 179.9665178571429 255.6640625L310.2120535714286 220.2566964285714C322.9910714285714 216.7689732142857 330.5524553571429 203.5993303571429 327.0647321428572 190.8203125C324.1629464285715 180.1339285714286 314.4810267857144 173.1305803571428 303.9341517857143 173.1305803571428C301.8415178571429 173.1305803571428 299.7488839285715 173.4095982142857 297.6283482142857 173.9676339285715L173.2700892857143 207.7845982142857L29.4921875 173.8002232142857C16.6015625 170.7589285714286 3.6830357142857 178.7388392857143 0.6417410714286 191.6294642857143C-2.3995535714286 204.4921875 5.5803571428571 217.4107142857143 18.4709821428571 220.4799107142857zM586.1328125 0C584.0680803571428 0 582.0033482142857 0.2790178571428 579.9107142857142 0.8091517857143L453.7946428571428 34.5982142857143L309.4308035714286 0.6417410714286C305.5524553571429 -0.2790178571429 301.5066964285714 -0.1953125 297.65625 0.8370535714286L173.2700892857143 34.6540178571428L29.4921875 0.6696428571429C16.6015625 -2.3716517857143 3.6830357142857 5.6082589285714 0.6417410714286 18.4988839285714C-2.3995535714286 31.3895089285715 5.5803571428572 44.3080357142858 18.4709821428572 47.3493303571429L168.1640625 82.7566964285715C172.0424107142857 83.677455357143 176.1160714285715 83.6216517857143 179.9665178571429 82.5613839285715L304.3526785714286 48.7444196428572L448.6328125000001 82.700892857143C452.4832589285714 83.6216517857143 456.5011160714286 83.5379464285715 460.3236607142858 82.5334821428572L592.271205357143 47.1819196428572C600.3069196428573 45.0334821428572 606.2779017857143 39.0625000000001 608.7611607142858 31.7522321428572L649.4419642857144 173.2979910714287L763.6997767857144 59.7656250000001L608.5658482142858 15.7366071428572C605.1339285714287 6.1662946428571 596.0100446428571 0 586.1328125 0zM779.6595982142858 75.5859375L665.3738839285716 189.0625000000001L916.7410714285716 438.7834821428572L1031.0267857142858 325.3069196428572L779.6595982142858 75.5859375zM1082.700892857143 376.7020089285715L1048.4375 342.6339285714286L934.1796875 456.1104910714286L968.4430803571428 490.1785714285714C981.0546875 502.7064732142857 1000.8928571428572 503.3203125 1012.7232142857144 491.5736607142857L1084.1238839285716 420.6194196428571C1095.9542410714287 408.8727678571429 1095.3125 389.1741071428571 1082.700892857143 376.7020089285715z" />
    <glyph glyph-name="presentation"
      unicode="&#xF155;"
      horiz-adv-x="785.7142857142858" d=" M732.5892857142857 500.0279017857143H53.0412946428571C23.7444196428571 500.0279017857143 -0.0279017857143 477.1763392857143 -0.0279017857143 448.9955357142857V51.0323660714286C-0.0279017857143 22.8515625 23.7444196428572 0 53.0691964285714 0H732.6171875C761.9419642857142 0 785.7142857142858 22.8515625 785.7142857142858 51.0323660714286V448.9676339285715C785.6584821428572 477.1484375 761.9419642857143 500.0279017857143 732.5892857142857 500.0279017857143zM678.90625 67.0758928571429C664.4531249999999 63.0580357142857 651.8136160714286 53.5993303571429 643.9453124999999 40.7645089285714C635.9933035714284 53.6551339285714 623.2421875 63.2533482142857 608.5379464285713 67.2154017857143C615.6249999999999 79.2689732142857 628.7109374999999 87.3604910714286 643.6941964285713 87.3604910714286C658.7053571428572 87.3325892857143 671.8470982142858 79.1852678571428 678.90625 67.0758928571429zM754.1294642857143 52.2879464285714C752.2321428571429 48.8839285714286 747.4888392857143 44.9776785714286 744.8660714285716 40.7645089285714C736.9140625000001 53.6551339285714 724.1629464285716 63.2533482142857 709.458705357143 67.2154017857143C716.5457589285716 79.2689732142857 729.6316964285716 87.3604910714286 744.614955357143 87.3604910714286C749.8604910714287 87.3604910714286 754.9107142857144 86.3560267857143 759.5145089285716 84.5424107142858C759.5982142857143 80.5245535714286 761.4118303571429 65.6529017857143 754.1294642857143 52.2879464285714zM26.0881696428571 84.5145089285715C30.6919642857143 86.328125 35.7142857142857 87.3325892857143 40.9877232142857 87.3325892857143C55.9709821428572 87.3325892857143 69.0569196428571 79.2410714285715 76.1439732142857 67.1875C61.4397321428571 63.2254464285714 48.6886160714286 53.6272321428572 40.7366071428571 40.7366071428571C38.1417410714286 44.9776785714286 33.3984375 48.8002232142857 31.4732142857143 52.2600446428571C24.1629464285714 65.6529017857143 25.9765625 80.5245535714286 26.0881696428571 84.5145089285715zM112.1372767857143 367.1316964285715C112.1372767857143 397.5167410714286 136.7466517857143 422.1540178571429 167.1595982142857 422.1540178571429H618.2198660714286C648.6049107142857 422.1540178571429 673.2421874999999 397.5167410714286 673.2700892857143 367.1316964285715V241.1551339285714C673.2700892857143 210.7700892857143 648.6328125 186.1328125 618.2477678571429 186.1328125H167.1595982142857C136.7745535714286 186.1328125 112.1372767857143 210.7700892857143 112.1372767857143 241.1551339285714V367.1316964285715zM577.9017857142857 67.0758928571429C563.4486607142857 63.0580357142857 550.8091517857142 53.5993303571429 542.9129464285713 40.7645089285714C534.9609374999999 53.6551339285714 522.2098214285713 63.2533482142857 507.5055803571428 67.2154017857143C514.5926339285713 79.2689732142857 527.6785714285713 87.3604910714286 542.6618303571428 87.3604910714286C557.7008928571429 87.3325892857143 570.8426339285714 79.1852678571428 577.9017857142857 67.0758928571429zM476.8973214285714 67.0758928571429C462.4441964285714 63.0580357142857 449.8046875000001 53.5993303571429 441.9084821428572 40.7645089285714C433.9564732142857 53.6551339285714 421.2053571428571 63.2533482142857 406.5011160714286 67.2154017857143C413.5881696428572 79.2689732142857 426.6741071428571 87.3604910714286 441.6573660714286 87.3604910714286C456.6964285714286 87.3325892857143 469.8381696428572 79.1852678571428 476.8973214285714 67.0758928571429zM375.8928571428572 67.0758928571429C361.4397321428572 63.0580357142857 348.8002232142858 53.5993303571429 340.9040178571429 40.7645089285714C332.9520089285715 53.6551339285714 320.2008928571429 63.2533482142857 305.4966517857143 67.2154017857143C312.5837053571429 79.2689732142857 325.6696428571429 87.3604910714286 340.6529017857143 87.3604910714286C355.6919642857143 87.3325892857143 368.8337053571429 79.1852678571428 375.8928571428572 67.0758928571429zM274.8604910714286 67.0758928571429C260.4073660714286 63.0580357142857 247.7678571428571 53.5993303571429 239.8995535714286 40.7645089285714C231.9475446428572 53.6551339285714 219.1964285714286 63.2533482142857 204.4921875 67.2154017857143C211.5792410714286 79.2689732142857 224.6651785714286 87.3604910714286 239.6484375 87.3604910714286C254.6875 87.3325892857143 267.8013392857143 79.1852678571428 274.8604910714286 67.0758928571429zM138.6439732142857 87.3325892857143C153.6830357142857 87.3325892857143 166.796875 79.1852678571428 173.8560267857143 67.0758928571429C159.4029017857143 63.0580357142857 146.7633928571429 53.5993303571429 138.8950892857143 40.7645089285714C130.9430803571429 53.6551339285714 118.1919642857143 63.2533482142857 103.4877232142857 67.2154017857143C110.5747767857143 79.2410714285715 123.6607142857143 87.3325892857143 138.6439732142857 87.3325892857143zM149.7767857142857 26.0881696428571C155.9988839285714 40.5970982142857 170.4241071428572 50.78125 187.2209821428572 50.78125C204.9665178571429 50.78125 220.0334821428572 41.9642857142857 225.6417410714286 26.1439732142857M251.3950892857143 26.0881696428571C257.6171875 40.5970982142857 272.0424107142857 50.78125 288.8392857142857 50.78125C306.5848214285715 50.78125 321.6517857142857 41.9642857142857 327.2600446428572 26.1439732142857M353.0133928571429 26.0881696428571C359.2354910714286 40.5970982142857 373.6607142857144 50.78125 390.4575892857144 50.78125C408.203125 50.78125 423.2700892857143 41.9642857142857 428.8783482142858 26.1439732142857M452.5669642857143 26.0881696428571C458.7890625 40.5970982142857 473.2142857142857 50.78125 490.0111607142857 50.78125C507.7566964285714 50.78125 522.8236607142857 41.9642857142857 528.4319196428572 26.1439732142857M552.9575892857143 26.0881696428571C559.1796875 40.5970982142857 573.6049107142858 50.78125 590.4017857142858 50.78125C608.1473214285714 50.78125 623.2142857142857 41.9642857142857 628.8225446428571 26.1439732142857M655.8035714285714 26.0881696428571C662.0256696428572 40.5970982142857 676.4508928571429 50.78125 693.2477678571429 50.78125C709.4308035714286 50.78125 723.3816964285714 43.4430803571428 729.9665178571428 30.1618303571428C729.0178571428571 29.6874999999999 720.2566964285713 26.5904017857143 714.5089285714286 26.1439732142857C711.3839285714286 25.9486607142857 655.8035714285714 26.0881696428571 655.8035714285714 26.0881696428571zM67.8850446428572 26.1439732142857C61.71875 26.7020089285714 53.3761160714286 29.6875 52.4274553571429 30.1618303571429C59.0122767857143 43.4430803571428 72.9631696428571 50.7812500000001 89.1462053571429 50.7812500000001C105.9430803571429 50.7812500000001 120.3683035714286 40.625 126.5904017857143 26.0881696428572C126.5904017857143 26.0881696428571 71.0379464285714 25.9486607142857 67.8850446428572 26.1439732142857z" />
    <glyph glyph-name="previous"
      unicode="&#xF156;"
      horiz-adv-x="322.69682345314413" d=" M322.6968234531442 472.4843333573435C322.6968234531442 449.3985449830729 322.6968234531442 44.1187063314845 322.6968234531442 28.1999567816754C322.6968234531442 7.5451991644458 301.3037527911835 -7.8153136930059 280.180796657783 4.2678095512498C263.2536195346828 13.955917308939 35.1148887128142 202.3337895267594 11.4888712814234 225.9598069581503C-3.8896492112656 241.3563350860765 -3.7455881293668 258.7697183605849 11.4888712814234 274.0942159475618C28.5060865807103 291.2194770582727 256.4467334149681 482.658647266441 281.0451631491753 496.2904271411078C299.0708060217533 506.3026723330692 322.6968234531442 495.2459842973421 322.6968234531442 472.4843333573435z" />
    <glyph glyph-name="private-space"
      unicode="&#xF157;"
      horiz-adv-x="625" d=" M62.5 93.75H125.0279017857143V31.2220982142857H62.5V93.75zM0 0H625V125H0V0zM62.5 281.25H125.0279017857143V218.75H62.5V281.25zM0 187.5H625V312.5H0V187.5zM62.5 468.75H125.0279017857143V406.25H62.5V468.75zM0 375H625V500H0V375z" />
    <glyph glyph-name="public-space"
      unicode="&#xF158;"
      horiz-adv-x="500" d=" M50 400H0V50C0 22.3772321428572 22.3772321428572 0 50 0H400.0000000000001V50H50V400zM450.0000000000001 500H150C122.3772321428571 500 100 477.6227678571428 100 450V150C100 122.3772321428571 122.3772321428571 100 150 100H450.0000000000001C477.6227678571429 100 500 122.3772321428572 500 150V450C500 477.6227678571428 477.6227678571429 500 450.0000000000001 500M425 275H325V175H275V275H175V325H275V425H325V325H425V275z" />
    <glyph glyph-name="quote"
      unicode="&#xF159;"
      horiz-adv-x="652.6227678571429" d=" M281.9754464285715 441.3783482142857C258.7053571428572 426.0881696428572 237.1372767857143 411.1607142857143 217.2154017857143 396.5401785714286C197.265625 381.9196428571429 179.9944196428572 366.6573660714286 165.4017857142857 350.7254464285715C150.78125 334.7935267857143 139.3136160714286 317.4944196428571 131.0267857142857 298.9118303571429C122.7120535714286 280.3013392857143 118.5825892857143 259.0680803571429 118.5825892857143 235.15625C118.5825892857143 227.8459821428571 119.2243303571429 220.703125 120.5636160714286 213.7276785714286C121.875 206.7522321428571 123.5491071428572 199.2745535714286 125.5580357142857 191.3225446428572C129.5479910714286 194.6428571428571 137.1651785714286 198.2979910714286 148.4654017857143 202.2879464285715C159.765625 206.2779017857143 172.0424107142857 208.2589285714286 185.3236607142857 208.2589285714286C213.8671875 208.2589285714286 235.6305803571429 198.6328125 250.5859375 179.3526785714286C265.5412946428571 160.0725446428571 272.9910714285714 136.8303571428572 272.9910714285714 109.5982142857143C272.9910714285714 94.3080357142857 270.0055803571429 80.0223214285714 264.0345982142857 66.7410714285715C258.0636160714286 53.4319196428571 249.7488839285714 41.8247767857143 239.1183035714286 31.8638392857143C228.4877232142857 21.9029017857143 216.3504464285714 14.0904017857143 202.7622767857143 8.4542410714286C189.1462053571428 2.7901785714286 174.3582589285714 0 158.4263392857143 0C131.1941964285714 0 107.6171875 5.3013392857143 87.6953125 15.9319196428571C67.7734375 26.5345982142857 51.3392857142857 40.0111607142857 38.3649553571428 56.2779017857142C25.4185267857142 72.5446428571428 15.7645089285714 90.6529017857142 9.4587053571428 110.5747767857142C3.1529017857143 130.5245535714286 0 149.7767857142857 0 168.3872767857143C0 214.2299107142857 6.3058035714286 254.0736607142857 18.9174107142857 287.9464285714286C31.5290178571429 321.8191964285715 48.828125 351.7020089285715 70.7310267857143 377.6227678571429C92.6618303571429 403.515625 117.8850446428572 426.1160714285715 146.4564732142857 445.3683035714286C175 464.6205357142857 205.2455357142857 482.8962053571429 237.1372767857143 500.1674107142857L281.9754464285715 441.3783482142857zM652.6227678571429 441.3783482142857C629.3526785714286 426.0881696428572 607.7845982142858 411.1328125 587.8627232142858 396.5401785714286C567.9408482142858 381.9196428571429 550.6696428571429 366.6573660714286 536.0491071428572 350.6975446428571C521.4285714285714 334.765625 509.9609375 317.4665178571429 501.6741071428572 298.8839285714286C493.359375 280.2734375 489.2299107142858 259.0401785714286 489.2299107142858 235.1283482142857C489.2299107142858 227.8180803571429 489.8716517857143 220.6752232142857 491.2109375 213.6997767857143C492.5223214285714 206.7243303571429 494.1964285714286 199.2466517857143 496.2053571428572 191.2946428571429C500.1953125 194.6149553571428 507.8125 198.2700892857143 519.1127232142858 202.2600446428572C530.4129464285714 206.25 542.6897321428571 208.2310267857143 555.9709821428571 208.2310267857143C584.5145089285714 208.2310267857143 606.2779017857143 198.6049107142858 621.2332589285714 179.3247767857143C636.1886160714286 160.0446428571428 643.6383928571429 136.8024553571429 643.6383928571429 109.5703125C643.6383928571429 94.2801339285715 640.6529017857144 79.9944196428572 634.6819196428572 66.7131696428572C628.7109375000001 53.4040178571429 620.396205357143 41.7968750000001 609.765625 31.8359375C599.1350446428572 21.875 586.9977678571429 14.0625 573.4095982142857 8.4263392857143C559.7935267857143 2.7622767857143 545.0055803571429 -0.0279017857143 529.0736607142857 -0.0279017857143C501.8415178571428 -0.0279017857143 478.2645089285714 5.2734375 458.3426339285714 15.9040178571428C438.4207589285714 26.5066964285714 421.9866071428571 39.9832589285714 409.0122767857143 56.2499999999999C396.0658482142857 72.5167410714285 386.4118303571429 90.625 380.1060267857143 110.5468749999999C373.7723214285714 130.46875 370.6473214285714 149.7209821428571 370.6473214285714 168.3314732142857C370.6473214285714 214.1741071428571 376.953125 254.0178571428572 389.5647321428571 287.890625C402.1763392857143 321.7633928571429 419.4475446428571 351.6462053571429 441.3783482142857 377.5669642857143C463.3091517857142 403.4598214285715 488.5323660714286 426.0602678571429 517.1037946428571 445.3125C545.6473214285713 464.5647321428571 575.892857142857 482.8404017857143 607.7845982142857 500.1116071428571L652.6227678571429 441.3783482142857z" />
    <glyph glyph-name="reserve-doi"
      unicode="&#xF15A;"
      horiz-adv-x="400" d=" M250 500H50C22.3772321428572 500 0.2511160714286 477.6227678571428 0.2511160714286 450L0 50C0 22.3772321428572 22.1261160714286 0 49.7488839285714 0H350C377.6227678571429 0 400 22.3772321428572 400 50V350L250 500zM300 100H100V150H300V100zM300 200H100V250H300V200zM225 325V462.5L362.5 325H225z" />
    <glyph glyph-name="retry"
      unicode="&#xF15B;"
      horiz-adv-x="500.4185267857143" d=" M74.4977678571429 425.5859375C119.6428571428572 470.1171875 181.5848214285714 497.7957589285714 250.1953125000001 497.7957589285714C388.3649553571429 497.7957589285714 500.4185267857143 386.3560267857143 500.4185267857143 248.8839285714286C500.4185267857143 111.4397321428572 388.3928571428572 0 250.1953125000001 0C173.5212053571429 0 104.9665178571429 34.4029017857142 59.0680803571429 88.4486607142857L103.3761160714286 132.8404017857143C137.7790178571429 89.8716517857142 190.7087053571429 62.2209821428571 250.1953125000001 62.2209821428571C353.8225446428571 62.2209821428571 437.8627232142858 145.8147321428571 437.8627232142858 248.8839285714286C437.8627232142858 351.9810267857142 353.8504464285715 435.546875 250.1953125000001 435.546875C198.8560267857144 435.546875 152.8459821428572 414.5368303571429 119.0011160714287 381.25L220.7868303571429 279.9665178571428H65.3738839285714H62.5558035714286V280.1339285714286H31.2779017857143C14.0066964285714 280.1339285714286 0 294.0569196428571 0 311.2444196428571V341.2388392857143V342.4107142857142V499.6930803571428L74.4977678571429 425.5859375z" />
    <glyph glyph-name="search"
      unicode="&#xF15C;"
      horiz-adv-x="493.7220982142857" d=" M303.7667410714286 120.2566964285715C224.8325892857143 120.2566964285715 152.3716517857143 170.8705357142857 125.2790178571428 245.0055803571429C97.7678571428571 320.2566964285715 121.6796875 406.6964285714286 183.5658482142857 457.421875C244.9776785714286 507.7287946428572 334.1517857142857 513.9787946428571 402.0647321428572 472.8794642857143C469.5591517857143 432.03125 505.3850446428572 351.2555803571429 490.2622767857143 273.8002232142857C473.0468750000001 185.6305803571428 393.5825892857143 120.2566964285715 303.7667410714286 120.2566964285715zM303.7667410714286 466.6573660714286C238.9508928571429 466.6573660714286 179.4084821428571 425.2232142857143 157.0033482142857 364.3973214285715C134.3191964285714 302.8459821428571 153.4040178571428 232.0870535714286 203.6272321428571 190.0948660714286C254.2410714285714 147.7678571428571 328.5156249999999 142.2154017857142 384.9330357142857 176.4787946428571C440.4017857142858 210.1841517857143 469.6986607142858 276.5625 457.3102678571429 340.2622767857143C443.1919642857144 412.8348214285715 377.6506696428572 466.6573660714286 303.7667410714286 466.6573660714286zM179.9665178571429 180.1618303571428C193.1082589285715 167.0200892857143 193.1082589285715 145.6752232142857 179.9665178571429 132.5334821428571L57.5055803571429 10.0725446428571C44.3638392857143 -3.0691964285714 23.0189732142857 -3.0691964285714 9.8772321428572 10.0725446428571C-3.2645089285714 23.2142857142857 -3.2645089285714 44.5591517857142 9.8772321428572 57.7008928571428L132.3381696428572 180.1618303571428C145.4799107142857 193.3035714285714 166.796875 193.3035714285714 179.9665178571429 180.1618303571428z" />
    <glyph glyph-name="search_left"
      unicode="&#xF15D;"
      horiz-adv-x="493.7220982142857" d=" M3.4598214285714 273.7444196428571C-11.6629464285714 351.1997767857144 24.1629464285714 431.9754464285715 91.6573660714286 472.8236607142857C159.5703125 513.9229910714286 248.7444196428572 507.6729910714286 310.15625 457.3660714285714C372.0424107142857 406.640625 395.9542410714286 320.2008928571429 368.4430803571429 244.9497767857143C341.3504464285715 170.8147321428572 268.8895089285715 120.2008928571429 189.9553571428572 120.2008928571429C100.1395089285714 120.2008928571428 20.6752232142857 185.5747767857143 3.4598214285714 273.7444196428571zM36.4118303571429 340.2064732142857C24.0234375 276.5066964285715 53.3203125 210.1283482142857 108.7890625 176.4229910714286C165.2064732142857 142.1595982142857 239.4810267857143 147.7120535714286 290.0948660714286 190.0390625C340.3180803571429 232.03125 359.4029017857143 302.7901785714286 336.71875 364.3415178571429C314.3136160714286 425.1674107142857 254.7712053571429 466.6015625 189.9553571428572 466.6015625C116.0714285714286 466.6015625 50.5301339285714 412.7790178571429 36.4118303571429 340.2064732142857zM361.3839285714286 180.1060267857143L483.8448660714286 57.6450892857142C496.9866071428571 44.5033482142857 496.9866071428571 23.1584821428571 483.8448660714286 10.0167410714285S449.3582589285715 -3.125 436.2165178571429 10.0167410714285L313.7555803571429 132.4776785714286C300.6138392857144 145.6194196428572 300.6138392857144 166.9642857142857 313.7555803571429 180.1060267857143C326.9252232142857 193.2477678571428 348.2421875 193.2477678571428 361.3839285714286 180.1060267857143z" />
    <glyph glyph-name="settings"
      unicode="&#xF15E;"
      horiz-adv-x="494.1964285714286" d=" M470.8984375 197.4609375L433.9285714285715 212.9464285714286C438.8113839285715 237.8348214285715 438.6160714285715 262.890625 434.0401785714286 286.9698660714286L471.4006696428572 302.6506696428571C490.6808035714286 310.7421875 499.7767857142858 333.0357142857143 491.8805803571429 352.5111607142857C483.8727678571429 372.0145089285715 461.8024553571428 381.2220982142857 442.5223214285715 373.2142857142857L405.1339285714286 357.6450892857143C391.6573660714286 377.8180803571429 374.3582589285715 395.703125 353.5714285714286 409.7935267857143L368.7500000000001 446.875C376.7299107142857 466.3504464285714 367.5502232142858 488.6439732142857 348.2700892857144 496.7354910714286S306.8917410714286 495.5357142857143 298.9118303571429 476.0602678571429L283.7332589285715 438.9787946428572C259.3470982142858 443.7779017857143 234.7656250000001 443.4709821428572 211.1886160714286 438.7834821428572L195.703125 476.4508928571429C187.7232142857143 495.9263392857143 165.6250000000001 505.1339285714286 146.3448660714286 497.1261160714286C127.0647321428572 489.0345982142857 117.9687500000001 466.7410714285714 125.9486607142857 447.265625L141.4620535714286 409.4866071428572C121.2890625 395.7868303571429 103.5993303571429 378.125 89.5926339285714 357.03125L52.2321428571429 372.6283482142857C32.9520089285714 380.7198660714286 10.8537946428571 371.4285714285715 2.8738839285714 351.953125S4.0736607142857 310.1841517857144 23.3537946428571 302.0926339285715L60.8258928571429 286.3839285714286C56.1383928571429 261.9140625 56.4453125 237.1372767857143 61.0491071428572 213.4486607142857L23.7723214285714 197.8515625C4.4921875 189.8716517857143 -4.6037946428571 167.4665178571428 3.2924107142857 147.9910714285715C11.2723214285714 128.515625 33.3705357142857 119.3080357142857 52.6506696428571 127.3158482142858L89.9274553571429 142.9129464285715C103.3203125 122.8236607142857 120.5078125 105.0502232142857 141.0714285714286 90.9598214285715L125.390625 52.7901785714286C117.4107142857143 33.3147321428572 126.5904017857143 11.0212053571428 145.8705357142858 2.9296875S187.2488839285715 4.1294642857143 195.2287946428572 23.6049107142857L210.8258928571429 61.6629464285714C235.4073660714286 56.7801339285714 260.0725446428572 57.0591517857143 283.7611607142857 61.6629464285714L299.2466517857143 23.8839285714286C307.2265625 4.4084821428571 329.3247767857143 -4.7991071428572 348.6049107142857 3.2924107142857C367.8850446428572 11.2723214285714 377.0926339285715 33.6774553571428 369.0848214285715 53.1529017857143L353.5993303571429 90.9319196428572C373.4933035714286 104.4084821428571 390.9598214285715 121.5959821428571 404.7433035714286 142.2991071428571L441.9084821428572 126.7020089285714C461.1049107142858 118.7220982142857 483.2868303571429 127.9017857142857 491.2667410714287 147.3772321428572C499.2745535714286 167.1037946428572 490.1785714285714 189.4810267857143 470.8984375 197.4609375zM314.8158482142857 222.0424107142857C299.4419642857142 184.5703125 256.9754464285715 166.796875 219.8939732142857 182.2823660714286S165.234375 240.7366071428571 180.5245535714286 278.2087053571429C195.8984375 315.6808035714286 238.3649553571429 333.4542410714286 275.4464285714286 317.96875S330.1060267857143 259.5145089285715 314.8158482142857 222.0424107142857z" />
    <glyph glyph-name="share"
      unicode="&#xF15F;"
      horiz-adv-x="464.39732142857144" d=" M375.0837053571429 178.5993303571428C348.0189732142857 178.5993303571428 323.7444196428572 166.5457589285715 307.3660714285714 147.5167410714286L174.1629464285714 204.3247767857143C177.0368303571429 213.0859375 178.5993303571428 222.4609375 178.5993303571428 232.1986607142857C178.5993303571428 246.0100446428572 175.4743303571428 259.0959821428571 169.8660714285714 270.7868303571429L309.2354910714286 350.5022321428571C325.5580357142857 332.7008928571429 349.0234375 321.5401785714286 375.0837053571429 321.5401785714286C424.4140625 321.5401785714286 464.3973214285714 361.5234375 464.3973214285714 410.8537946428572C464.3973214285714 460.1841517857143 424.4140625000001 500.1674107142857 375.083705357143 500.1674107142857C325.7533482142858 500.1674107142857 285.7700892857144 460.1841517857143 285.7700892857144 410.8537946428572C285.7700892857144 397.6004464285715 288.6718750000001 385.0167410714286 293.8616071428572 373.6886160714286L154.0736607142858 293.75C137.8069196428572 310.8816964285715 114.8158482142858 321.5680803571429 89.3136160714286 321.5680803571429C39.9832589285714 321.484375 0 281.5011160714286 0 232.1986607142857C0 182.8683035714286 39.9832589285714 142.8850446428571 89.3136160714286 142.8850446428571C119.2243303571429 142.8850446428571 145.6752232142857 157.5892857142858 161.8861607142857 180.1339285714286L292.8850446428572 124.2745535714286C288.3091517857143 113.5323660714286 285.7700892857144 101.7020089285715 285.7700892857144 89.2857142857143C285.7700892857144 39.9553571428572 325.7533482142857 -0.0279017857143 375.083705357143 -0.0279017857143C424.4140625000001 -0.0279017857143 464.3973214285714 39.9553571428572 464.3973214285714 89.2857142857143C464.3973214285714 138.6160714285714 424.4140625 178.5993303571428 375.0837053571429 178.5993303571428z" />
    <glyph glyph-name="sharp_arrow_down"
      unicode="&#xF160;"
      horiz-adv-x="647.5498699045968" d=" M647.5498699045968 315.5897658282741L323.7930037583117 1e-13L0 315.5897658282741L0 500L323.7930037583117 184.4463717837525L647.5498699045968 500V315.5897658282741z" />
    <glyph glyph-name="sharp_arrow_down2"
      unicode="&#xF161;"
      horiz-adv-x="750.3627232142858" d=" M375.0837053571429 240.1227678571429L632.2544642857143 500L750.3627232142858 380.4408482142857L374.609375 0L0 379.2410714285715L118.8337053571429 499.5535714285714L375.0837053571429 240.1227678571429z" />
    <glyph glyph-name="sharp_arrow_left"
      unicode="&#xF162;"
      horiz-adv-x="386.0491071428571" d=" M243.6662946428572 0L0 249.9720982142857L243.6662946428572 499.9720982142857H386.0491071428571L142.4107142857143 249.9720982142857L386.0491071428571 0H243.6662946428572z" />
    <glyph glyph-name="sharp_arrow_left2"
      unicode="&#xF163;"
      horiz-adv-x="333.2868303571429" d=" M332.9799107142857 79.2131696428571L252.7901785714286 0L0 249.6930803571429L253.5714285714286 500.1674107142857L333.2868303571429 421.4564732142857L160.0725446428572 250.0279017857143L332.9799107142857 79.2131696428571z" />
    <glyph glyph-name="sharp_arrow_right"
      unicode="&#xF164;"
      horiz-adv-x="386.0491071428571" d=" M0 0L243.6383928571429 249.9720982142857L0 500H142.3828125L386.0491071428571 250L142.3828125 0H0z" />
    <glyph glyph-name="sharp_arrow_right2"
      unicode="&#xF165;"
      horiz-adv-x="333.2868303571429" d=" M173.2142857142857 250.0279017857143L0 421.4564732142857L79.7154017857143 500.1953125L333.2868303571429 249.7209821428572L80.4966517857143 0.0279017857142L0.3069196428571 79.2410714285713L173.2142857142857 250.0279017857143z" />
    <glyph glyph-name="sharp_arrow_up"
      unicode="&#xF166;"
      horiz-adv-x="647.5498699045968" d=" M647.5498699045968 1e-13L323.7930037583117 315.5536282162475L0 1e-13L0 184.410234171726L323.7930037583117 500L647.5498699045968 184.410234171726V1e-13z" />
    <glyph glyph-name="sharp_arrow_up2"
      unicode="&#xF167;"
      horiz-adv-x="750.3627232142858" d=" M118.8337053571429 0.4464285714286L0 120.7589285714286L374.609375 500L750.390625 119.5591517857143L632.2544642857143 0L375.0837053571429 259.8772321428572L118.8337053571429 0.4464285714286z" />
    <glyph glyph-name="stats"
      unicode="&#xF168;"
      horiz-adv-x="500" d=" M444.4475446428572 500H55.5524553571429C25 500 0 475 0 444.4475446428571V55.5524553571428C0 24.9999999999999 25 0 55.5524553571429 0H444.4475446428572C475.0000000000001 0 500 24.9999999999999 500 55.5524553571428V444.4475446428571C500 475 475.0000000000001 500 444.4475446428572 500M166.6573660714286 111.1049107142857H111.1049107142857V305.5524553571429H166.6573660714286V111.1049107142857zM277.7901785714286 111.1049107142857H222.2377232142857V388.8950892857144H277.7901785714286V111.1049107142857zM388.8950892857143 111.1049107142857H333.3426339285715V222.2098214285714H388.8950892857143V111.1049107142857z" />
    <glyph glyph-name="thesis"
      unicode="&#xF169;"
      horiz-adv-x="785.7142857142858" d=" M738.3370535714286 500H47.4051339285714C21.3169642857143 500 -0.0279017857143 478.6551339285714 -0.0279017857143 452.5669642857143V47.4051339285714C-0.0279017857143 21.3169642857143 21.3169642857143 -0.0279017857143 47.4051339285714 -0.0279017857143H738.28125C764.3694196428571 -0.0279017857143 785.7142857142858 21.3169642857143 785.7142857142858 46.0100446428572V451.171875C785.7700892857142 478.6551339285714 764.4252232142857 500 738.3370535714286 500zM558.2868303571429 85.4073660714286C440.4575892857144 67.2991071428571 365.318080357143 60.0725446428571 212.1930803571429 85.4073660714286C203.3203125 147.9073660714286 212.1930803571429 184.0959821428571 212.1930803571429 184.0959821428571L392.1316964285715 99.4977678571428L558.2589285714287 184.0680803571428C558.2868303571429 184.0401785714286 562.8069196428571 150.2232142857143 558.2868303571429 85.4073660714286zM392.1875 127.6785714285714L48.0189732142857 286.9419642857143L392.1595982142857 430.3013392857143L736.328125 286.9419642857143L392.1875 127.6785714285714z" />
    <glyph glyph-name="thin_arrow_down"
      unicode="&#xF16A;"
      horiz-adv-x="312.36049107142856" d=" M137.4441964285714 500.0558035714286V66.4899553571428L0 135.9654017857143V86.8582589285715L156.1662946428572 0.0279017857142L312.3604910714286 86.8582589285715V135.9654017857143L174.9162946428572 66.5178571428572V500.0558035714286H137.4441964285714z" />
    <glyph glyph-name="thin_arrow_up"
      unicode="&#xF16B;"
      horiz-adv-x="312.36049107142856" d=" M174.9162946428572 0.0558035714285V433.59375L312.3604910714286 364.1462053571429V413.2533482142857L156.1662946428572 500.0837053571428L0 413.2533482142857V364.1462053571429L137.4441964285714 433.59375V0.0279017857142H174.9162946428572z" />
    <glyph glyph-name="thumb_3dviewer"
      unicode="&#xF16C;"
      horiz-adv-x="778.0133928571429" d=" M725.3627232142857 500.0279017857143H52.5669642857143C23.5212053571428 500.0279017857143 0 477.1763392857143 0 448.9955357142857V51.0323660714286C0 22.8515625 23.5491071428571 0 52.5669642857143 0H725.4185267857143C754.4642857142858 0 777.9854910714287 22.8515625 777.9854910714287 51.0323660714286V448.9955357142857C777.9575892857142 477.1763392857143 754.4363839285714 500.0279017857143 725.3627232142857 500.0279017857143zM528.9899553571429 159.4029017857143V177.5669642857143H334.5982142857144H324.9720982142857L235.1562500000001 80.46875L248.7723214285715 67.4107142857142L194.53125 55.5803571428572L204.4084821428572 109.9609374999999L222.6283482142858 92.4665178571429L316.4620535714286 193.8337053571428V195.6752232142857V399.1629464285714H298.2979910714286L325.474330357143 444.53125L352.6506696428572 399.1629464285714H334.5982142857144V195.6752232142857H528.989955357143V213.7276785714286L583.4263392857144 186.5513392857143L528.9899553571429 159.4029017857143zM370.6194196428572 259.2075892857143C373.2421875 257.5055803571429 379.3526785714286 254.8828125 385.7979910714286 254.8828125C397.6841517857143 254.8828125 401.3950892857144 262.4720982142857 401.2834821428572 268.1640625C401.1997767857144 277.734375 392.5502232142857 281.8638392857144 383.59375 281.8638392857144H378.4319196428572V288.8113839285715H383.59375C390.3459821428572 288.8113839285715 398.8560267857143 292.2712053571429 398.8560267857143 300.390625C398.8560267857143 305.859375 395.3683035714286 310.7142857142857 386.8303571428572 310.7142857142857C381.3616071428572 310.7142857142857 376.0881696428572 308.2868303571429 373.130580357143 306.1941964285715L370.7031250000001 312.9464285714286C374.2745535714286 315.5691964285715 381.2500000000001 318.2198660714286 388.6160714285715 318.2198660714286C402.0926339285715 318.2198660714286 408.2310267857144 310.2120535714286 408.2310267857144 301.8973214285715C408.2310267857144 294.8381696428571 404.0178571428572 288.8392857142857 395.591517857143 285.7700892857144V285.546875C404.0178571428572 283.8727678571429 410.8537946428572 277.5390625 410.8537946428572 267.96875C410.8537946428572 257.0033482142857 402.3158482142859 247.4330357142857 385.8816964285715 247.4330357142857C378.1808035714287 247.4330357142857 371.4564732142858 249.8604910714286 368.0803571428572 252.0647321428572L370.6194196428572 259.2075892857143zM448.0189732142857 318.6104910714286C453.5993303571428 319.4475446428571 460.2399553571429 320.0892857142857 467.5223214285714 320.0892857142857C480.6919642857142 320.0892857142857 490.0669642857143 317.0200892857144 496.2890624999999 311.2444196428571C502.6227678571428 305.4408482142857 506.3058035714286 297.2377232142857 506.3058035714286 285.7421875C506.3058035714286 274.1629464285715 502.7343749999999 264.6763392857143 496.0658482142858 258.1473214285715C489.4252232142857 251.5066964285714 478.4598214285715 247.9352678571429 464.6763392857143 247.9352678571429C458.1473214285714 247.9352678571429 452.6785714285714 248.2421875 448.0189732142858 248.7723214285714V318.6104910714286zM457.1986607142857 255.8314732142857C459.5145089285714 255.4129464285714 462.890625 255.3013392857143 466.4620535714285 255.3013392857143C486.0770089285714 255.3013392857143 496.7075892857142 266.2667410714286 496.7075892857142 285.4352678571429C496.8191964285714 302.1763392857143 487.3325892857143 312.8348214285715 467.9408482142857 312.8348214285715C463.1975446428571 312.8348214285715 459.5982142857142 312.4162946428571 457.1986607142857 311.8861607142857V255.8314732142857z" />
    <glyph glyph-name="thumb_3dviewer_i"
      unicode="&#xF16D;"
      horiz-adv-x="778.0133928571429" d=" M528.9899553571429 159.375V177.5390625000001H334.5982142857144H324.9720982142857L235.1562500000001 80.4408482142858L248.7723214285715 67.3828125000001L194.53125 55.5524553571429L204.4084821428572 109.9330357142858L222.6283482142858 92.4386160714286L316.4620535714286 193.8058035714286V195.6473214285715V399.1350446428571H298.2979910714286L325.474330357143 444.5033482142857L352.6785714285715 399.1350446428571H334.6261160714286V195.6473214285715H529.0178571428571V213.7276785714286L583.4542410714286 186.5513392857143L528.9899553571429 159.375zM370.6473214285715 259.2075892857143C373.2700892857144 257.5055803571429 379.3805803571429 254.8828125 385.825892857143 254.8828125C397.7120535714286 254.8828125 401.4229910714287 262.4720982142857 401.3113839285715 268.1640625C401.2276785714287 277.734375 392.5781250000001 281.8638392857144 383.6216517857144 281.8638392857144H378.4598214285715V288.7834821428571H383.6216517857144C390.3738839285715 288.7834821428571 398.8839285714286 292.2433035714286 398.8839285714286 300.3627232142857C398.8839285714286 305.8314732142857 395.3962053571429 310.6863839285715 386.8582589285715 310.6863839285715C381.3895089285715 310.6863839285715 376.1160714285715 308.2589285714286 373.1584821428572 306.1662946428571L370.7310267857144 312.9185267857143C374.302455357143 315.5412946428571 381.2779017857144 318.1919642857143 388.6439732142859 318.1919642857143C402.1205357142858 318.1919642857143 408.2589285714287 310.1841517857144 408.2589285714287 301.8694196428571C408.2589285714287 294.8102678571429 404.0457589285716 288.8113839285714 395.6194196428572 285.7421875V285.5189732142857C404.0457589285716 283.8448660714286 410.8816964285716 277.5111607142857 410.8816964285716 267.9408482142857C410.8816964285716 256.9754464285715 402.3437500000001 247.4051339285714 385.9095982142859 247.4051339285714C378.208705357143 247.4051339285714 371.4843750000001 249.8325892857143 368.1082589285716 252.0368303571429L370.6473214285715 259.2075892857143zM448.046875 318.6104910714286C453.6272321428572 319.4475446428571 460.2678571428571 320.0892857142857 467.5502232142857 320.0892857142857C480.7198660714285 320.0892857142857 490.0948660714286 317.0200892857144 496.3169642857142 311.2444196428571C502.6506696428571 305.4408482142857 506.3337053571428 297.2377232142857 506.3337053571428 285.7421875C506.3337053571428 274.1629464285715 502.7622767857142 264.6763392857143 496.09375 258.1473214285715C489.4531249999999 251.5066964285715 478.4877232142858 247.9352678571429 464.7042410714286 247.9352678571429C458.1752232142857 247.9352678571429 452.7064732142857 248.2421875 448.046875 248.7723214285714V318.6104910714286zM457.2265624999999 255.8314732142857C459.5424107142857 255.4129464285714 462.9185267857143 255.3013392857143 466.4899553571428 255.3013392857143C486.1049107142857 255.3013392857143 496.7354910714285 266.2667410714286 496.7354910714285 285.4352678571429C496.8470982142857 302.1763392857143 487.3604910714286 312.8348214285715 467.9687499999999 312.8348214285715C463.2254464285714 312.8348214285715 459.6261160714285 312.4162946428571 457.2265624999999 311.8861607142857L457.2265624999999 255.8314732142857L457.2265624999999 255.8314732142857z" />
    <glyph glyph-name="thumb_archive"
      unicode="&#xF16E;"
      horiz-adv-x="777.9296875" d=" M725.3069196428571 500H52.5669642857143C23.5491071428572 500 0 477.1484375 0 448.9676339285715V51.0323660714286C0 22.8515625 23.5212053571428 0 52.5669642857143 0H725.3906250000001C754.4084821428572 0 777.9575892857142 22.8515625 777.9575892857142 51.0323660714286V448.9397321428571C777.9017857142858 477.1484375 754.3805803571428 500 725.3069196428571 500zM347.265625 411.328125V424.4977678571429V427.7901785714286H395.703125V424.4977678571429H411.8582589285714V411.328125H395.703125V408.0357142857144H347.265625V411.328125zM347.265625 350.1953125V363.3649553571429V366.6294642857143C347.265625 366.6294642857143 395.703125 366.6294642857143 395.703125 366.6015625V363.3091517857143H411.8582589285714V350.1395089285715H395.703125V346.875H347.265625V350.1953125zM347.265625 289.1741071428571V302.34375V305.6361607142857H395.703125V302.34375H411.8582589285714V289.1741071428572H395.703125V285.8816964285715H347.265625V289.1741071428571zM347.265625 228.1808035714286V241.3504464285715V244.6149553571429H395.703125V241.3225446428571H411.8582589285714V228.1529017857143H395.703125V224.8604910714286H347.265625V228.1808035714286zM347.265625 167.1037946428572V180.2455357142857V183.5379464285714H395.703125V180.2455357142857H411.8582589285714V167.0758928571428H395.703125V163.7834821428571H347.265625V167.1037946428572zM347.265625 106.0825892857143V119.2522321428572V122.5446428571428H395.703125V119.2522321428572H411.8582589285714V106.0825892857143H395.703125V102.7901785714286H347.265625V106.0825892857143zM411.8024553571429 45.0613839285714H395.6473214285715V41.7689732142857H347.2098214285715V45.0613839285714V58.2310267857143V61.5234375H395.6473214285715V58.2310267857143H411.8024553571429V45.0613839285714zM430.6082589285715 88.7276785714286V75.5580357142857V72.265625H382.1707589285715V75.5580357142857H366.0156250000001V88.7276785714286H382.1707589285715V92.0200892857143H430.6082589285715V88.7276785714286zM430.6082589285715 149.7209821428571V136.5513392857143V133.2589285714286H382.1707589285715V136.5513392857143H366.0156250000001V149.7209821428571H382.1707589285715V153.0133928571429H430.6082589285715V149.7209821428571zM430.6082589285715 210.8537946428572V197.6841517857143V194.4196428571428H382.1707589285715V197.6841517857143H366.0156250000001V210.8537946428572H382.1707589285715V214.1462053571428H430.6082589285715V210.8537946428572zM430.6082589285715 271.8470982142857V258.6774553571429V255.3850446428571H382.1707589285715V258.6774553571429H366.0156250000001V271.8470982142857H382.1707589285715V275.1395089285715H430.6082589285715V271.8470982142857zM430.6082589285715 332.8404017857143V319.6707589285715V316.3783482142857H382.1707589285715V319.6707589285715H366.0156250000001V332.8404017857143H382.1707589285715V336.1328125H430.6082589285715V332.8404017857143zM430.6082589285715 393.9732142857143V380.8035714285715V377.5111607142857H382.1707589285715V380.8035714285715H366.0156250000001V393.9732142857143H382.1707589285715V397.265625H430.6082589285715V393.9732142857143zM430.6082589285715 454.9665178571429V441.796875V438.5044642857143H382.1707589285715V441.796875H366.0156250000001V454.9665178571429H382.1707589285715V458.2589285714286H430.6082589285715V454.9665178571429z" />
    <glyph glyph-name="thumb_audio"
      unicode="&#xF16F;"
      horiz-adv-x="777.9296875" d=" M725.3069196428571 499.9720982142857H52.5669642857143C23.5212053571429 499.9720982142857 0 477.1205357142857 0 448.9397321428571V51.0323660714286C0 22.8515625 23.5212053571428 0 52.5669642857143 0H725.3627232142858C754.4084821428572 0 777.9296875000001 22.8515625 777.9296875000001 51.0323660714286V448.9676339285715C777.8738839285713 477.1205357142857 754.3805803571428 499.9720982142857 725.3069196428571 499.9720982142857zM423.6607142857144 83.3147321428571L298.6607142857144 180.5524553571428C298.6328125000001 180.1618303571428 246.6796875 180.4966517857143 229.2131696428572 180.5524553571428S201.4229910714286 192.2154017857143 201.4229910714286 210.9375C201.4229910714286 224.9162946428572 201.4229910714286 279.5479910714286 201.4229910714286 287.1651785714286C201.4229910714286 304.6875 211.6908482142858 318.9453125 229.2131696428572 319.4475446428572C248.8281250000001 320.0055803571429 298.6607142857144 319.4475446428572 298.6607142857144 319.4475446428572L423.6607142857144 416.6852678571429V83.3147321428571zM475.0279017857143 180.5245535714286C461.3560267857143 192.6897321428571 451.6183035714286 198.8560267857143 453.9620535714286 201.4787946428571C479.2131696428572 228.4319196428572 486.8582589285714 267.7455357142857 453.9620535714286 300.5022321428571C453.9620535714286 300.5022321428571 464.0904017857143 310.7700892857143 475.0279017857143 321.4564732142857C516.5736607142858 292.1595982142857 523.6886160714286 216.6573660714286 475.0279017857143 180.5245535714286zM522.7678571428571 128.9620535714286C513.4765624999999 138.0301339285715 501.6183035714285 150.2790178571428 497.8794642857143 153.7388392857143C552.2879464285714 201.1997767857143 559.9330357142858 296.1495535714286 497.8794642857143 348.046875C497.8794642857143 348.046875 507.6450892857143 359.2075892857143 524.6651785714286 374.7209821428571C595.4241071428571 307.5055803571429 592.7734375 193.7779017857143 522.7678571428571 128.9620535714286z" />
    <glyph glyph-name="thumb_audio_i"
      unicode="&#xF170;"
      horiz-adv-x="777.9296875" d=" M423.6607142857144 83.3147321428571L298.6607142857144 180.5524553571428C298.6328125000001 180.1618303571428 246.6796875000001 180.4966517857142 229.2131696428572 180.5524553571428S201.4229910714286 192.2154017857142 201.4229910714286 210.9375C201.4229910714286 224.9162946428571 201.4229910714286 279.5479910714286 201.4229910714286 287.1651785714286C201.4229910714286 304.6875 211.6908482142857 318.9453125 229.2131696428572 319.4475446428571C248.828125 320.0055803571428 298.6607142857144 319.4475446428571 298.6607142857144 319.4475446428571L423.6607142857144 416.6852678571429V83.3147321428571zM475.0279017857143 180.5245535714286C461.3560267857143 192.6897321428571 451.6183035714286 198.8560267857143 453.9620535714286 201.4787946428571C479.2131696428572 228.4319196428572 486.8582589285714 267.7455357142857 453.9620535714286 300.5022321428571C453.9620535714286 300.5022321428571 464.0904017857143 310.7700892857143 475.0279017857143 321.4564732142857C516.5736607142858 292.1595982142857 523.6886160714286 216.6573660714286 475.0279017857143 180.5245535714286zM522.7678571428571 128.9620535714286C513.4765624999999 138.0301339285715 501.6183035714285 150.2790178571428 497.8794642857143 153.7388392857143C552.2879464285714 201.1997767857143 559.9330357142858 296.1495535714286 497.8794642857143 348.046875C497.8794642857143 348.046875 507.6450892857143 359.2075892857143 524.6651785714286 374.7209821428571C595.4241071428571 307.5055803571429 592.7734375 193.7779017857143 522.7678571428571 128.9620535714286z" />
    <glyph glyph-name="thumb_code_text"
      unicode="&#xF171;"
      horiz-adv-x="777.9854910714287" d=" M725.3627232142857 500H52.5669642857143C23.5212053571428 500 0 477.1484375 0 448.9676339285714V51.0044642857143C0 22.8236607142857 23.5491071428571 -0.0279017857143 52.5669642857143 -0.0279017857143H725.4185267857143C754.4642857142858 -0.0279017857143 777.9854910714287 22.8236607142857 777.9854910714287 51.0044642857143V448.9676339285714C777.9575892857142 477.1484375 754.4363839285714 500 725.3627232142857 500zM249.2466517857143 180.1618303571428C255.859375 173.6328125 255.8314732142857 162.9464285714286 249.2187500000001 156.4174107142857L249.2187500000001 156.4174107142857C242.6618303571429 149.9441964285715 232.0870535714286 150.0279017857143 225.6138392857144 156.5848214285715L141.9363839285715 241.4620535714286C135.5189732142858 247.9631696428572 135.5189732142858 258.3984375 141.9363839285715 264.8995535714286L225.6138392857144 349.7767857142858C232.0870535714287 356.3337053571429 242.661830357143 356.4174107142857 249.2187500000001 349.9441964285715L249.2466517857144 349.9162946428572C255.8593750000001 343.3872767857144 255.8872767857144 332.7287946428572 249.3024553571429 326.1997767857144L175.6975446428572 252.9854910714286L249.2466517857143 180.1618303571428zM433.4821428571429 241.4620535714286L349.8046875 156.5848214285715C343.3314732142857 150.0279017857143 332.7566964285714 149.9441964285715 326.1997767857143 156.4174107142857H326.1997767857143C319.5870535714286 162.9464285714286 319.5591517857143 173.6328125 326.171875 180.1618303571428L399.7209821428571 252.9854910714286L326.1160714285715 326.1997767857142C319.53125 332.7566964285714 319.5591517857143 343.4151785714286 326.171875 349.9162946428571L326.1997767857143 349.9441964285714C332.7566964285714 356.4174107142857 343.3314732142857 356.3337053571429 349.8046875 349.7767857142857L433.4821428571429 264.8995535714286C439.8995535714286 258.3984375 439.8995535714286 247.9631696428572 433.4821428571429 241.4620535714286zM628.5993303571429 168.6104910714286C628.5993303571429 159.4029017857143 621.1216517857143 151.9252232142857 611.9140625 151.9252232142857H491.3783482142857C482.1707589285714 151.9252232142857 474.6930803571428 159.4029017857143 474.6930803571428 168.6104910714286V169.1964285714286C474.6930803571428 178.4040178571429 482.1707589285714 185.8816964285715 491.3783482142857 185.8816964285715H611.9140625C621.1216517857143 185.8816964285715 628.5993303571429 178.4040178571429 628.5993303571429 169.1964285714286V168.6104910714286zM628.5993303571429 252.9017857142857C628.5993303571429 243.6941964285714 621.1216517857143 236.2165178571429 611.9140625 236.2165178571429H521.8191964285714C512.6116071428571 236.2165178571429 505.1339285714285 243.6941964285714 505.1339285714285 252.9017857142857V253.4877232142857C505.1339285714285 262.6953125 512.6116071428571 270.1729910714286 521.8191964285714 270.1729910714286H611.8861607142858C621.09375 270.1729910714286 628.5714285714287 262.6953125 628.5714285714287 253.4877232142857V252.9017857142857zM628.5993303571429 338.0022321428572C628.5993303571429 328.7946428571429 621.1216517857143 321.3169642857144 611.9140625 321.3169642857144H491.3783482142857C482.1707589285714 321.3169642857144 474.6930803571428 328.7946428571429 474.6930803571428 338.0022321428572V338.5881696428571C474.6930803571428 347.7957589285715 482.1707589285714 355.2734375 491.3783482142857 355.2734375H611.9140625C621.1216517857143 355.2734375 628.5993303571429 347.7957589285715 628.5993303571429 338.5881696428571V338.0022321428572z" />
    <glyph glyph-name="thumb_code_text_i"
      unicode="&#xF172;"
      horiz-adv-x="777.9854910714287" d=" M249.2466517857143 180.1897321428571C255.859375 173.6607142857143 255.8314732142857 162.9743303571428 249.2187500000001 156.4453125L249.2187500000001 156.4453125C242.6618303571429 149.9720982142857 232.0870535714286 150.0558035714286 225.6138392857144 156.6127232142857L141.9363839285715 241.4899553571429C135.5189732142857 247.9910714285714 135.5189732142857 258.4263392857143 141.9363839285715 264.9274553571429L225.6138392857143 349.8046875C232.0870535714286 356.3616071428571 242.6618303571428 356.4453125 249.21875 349.9720982142857L249.2466517857142 349.9441964285715C255.859375 343.4151785714286 255.8872767857142 332.7566964285715 249.3024553571428 326.2276785714286L175.6975446428571 253.0133928571429L249.2466517857143 180.1897321428571zM433.4821428571429 241.4899553571429L349.8046875 156.6127232142857C343.3314732142857 150.0558035714286 332.7566964285714 149.9720982142857 326.1997767857143 156.4453125L326.1997767857143 156.4453125C319.5870535714286 162.9743303571428 319.5591517857143 173.6607142857143 326.171875 180.1897321428571L399.7209821428571 253.0133928571429L326.1160714285715 326.2276785714286C319.53125 332.7845982142857 319.5591517857143 343.4430803571428 326.171875 349.9441964285715L326.1997767857143 349.9720982142857C332.7566964285714 356.4453125 343.3314732142857 356.3616071428571 349.8046875 349.8046875L433.4821428571429 264.9274553571429C439.8995535714286 258.3984375 439.8995535714286 247.9910714285714 433.4821428571429 241.4899553571429zM628.5993303571429 168.6104910714286C628.5993303571429 159.4029017857143 621.1216517857143 151.9252232142857 611.9140625 151.9252232142857H491.3783482142857C482.1707589285714 151.9252232142857 474.6930803571428 159.4029017857143 474.6930803571428 168.6104910714286V169.1964285714286C474.6930803571428 178.4040178571429 482.1707589285714 185.8816964285714 491.3783482142857 185.8816964285714H611.9140625C621.1216517857143 185.8816964285714 628.5993303571429 178.4040178571429 628.5993303571429 169.1964285714286V168.6104910714286zM628.5993303571429 252.9296875C628.5993303571429 243.7220982142857 621.1216517857143 236.2444196428572 611.9140625 236.2444196428572H521.8191964285714C512.6116071428571 236.2444196428572 505.1339285714285 243.7220982142857 505.1339285714285 252.9296875V253.515625C505.1339285714285 262.7232142857143 512.6116071428571 270.2008928571429 521.8191964285714 270.2008928571429H611.8861607142858C621.09375 270.2008928571429 628.5714285714287 262.7232142857143 628.5714285714287 253.515625L628.5993303571429 252.9296875L628.5993303571429 252.9296875zM628.5993303571429 338.0301339285715C628.5993303571429 328.8225446428571 621.1216517857143 321.3448660714286 611.9140625 321.3448660714286H491.3783482142857C482.1707589285714 321.3448660714286 474.6930803571428 328.8225446428571 474.6930803571428 338.0301339285715V338.6160714285715C474.6930803571428 347.8236607142857 482.1707589285714 355.3013392857143 491.3783482142857 355.3013392857143H611.9140625C621.1216517857143 355.3013392857143 628.5993303571429 347.8236607142857 628.5993303571429 338.6160714285714V338.0301339285715z" />
    <glyph glyph-name="thumb_dataset_i"
      unicode="&#xF173;"
      horiz-adv-x="785.7142857142858" d=" M283.7053571428571 70.5915178571428H504.4363839285714V34.8772321428571H283.7053571428572V70.5915178571428zM283.7053571428571 96.484375H504.4363839285714V132.1986607142857H283.7053571428572V96.484375zM35.1004464285714 281.25H256.6685267857144V316.9642857142857H35.1004464285714V281.25zM35.1004464285714 48.828125C35.1004464285714 41.6015624999999 38.6439732142857 34.8772321428571 49.0513392857143 34.8772321428571C63.4765625 34.8772321428571 256.6685267857144 34.8772321428571 256.6685267857144 34.8772321428571V70.5915178571428H35.1004464285714C35.1004464285714 70.5915178571428 35.1004464285714 50 35.1004464285714 48.828125zM35.1004464285714 96.484375H256.6685267857144V132.1986607142857H35.1004464285714V96.484375zM283.7053571428571 158.0636160714286H504.4363839285714V193.7779017857143H283.7053571428572V158.0636160714286zM35.1004464285714 219.6428571428572H256.6685267857144V255.3571428571429H35.1004464285714V219.6428571428572zM35.1004464285714 158.0636160714286H256.6685267857144V193.7779017857143H35.1004464285714V158.0636160714286zM530.6082589285714 219.6428571428572H750.78125H750.78125V255.3571428571429H530.6082589285714V219.6428571428572zM530.6082589285714 281.25H750.78125H750.78125V316.9642857142857H530.6082589285714V281.25zM530.6082589285714 158.0636160714286H750.78125H750.78125V193.7779017857143H530.6082589285714V158.0636160714286zM283.7053571428571 219.6428571428572H504.4363839285714V255.3571428571429H283.7053571428572V219.6428571428572zM283.7053571428571 281.25H504.4363839285714V316.9642857142857H283.7053571428572V281.25zM530.6082589285714 96.484375H750.78125H750.78125V132.1986607142857H530.6082589285714V96.484375zM530.6082589285714 34.8772321428571C530.6082589285714 34.8772321428571 726.4787946428571 34.8772321428571 736.8303571428571 34.8772321428571C747.4051339285714 34.8772321428571 750.78125 37.9464285714286 750.78125 48.828125C750.78125 53.6551339285714 750.78125 70.5915178571428 750.78125 70.5915178571428H530.6082589285714V34.8772321428571zM785.7421875 448.9955357142857V51.0323660714286C785.7421875 22.8515625 761.9698660714287 0 732.6450892857142 0H53.0691964285714C23.7444196428572 0 -0.0279017857143 22.8515625 -0.0279017857143 51.0323660714286V448.9955357142857C-0.0279017857143 477.1763392857143 23.7444196428572 500.0279017857143 53.0691964285714 500.0279017857143H732.5892857142859C761.9698660714287 500.0279017857143 785.6863839285714 477.1763392857143 785.7421875 448.9955357142857zM771.7912946428571 448.9955357142857C771.7912946428571 458.7890625 767.7734375 468.0524553571428 760.5189732142857 475.0279017857143C753.0970982142857 482.1428571428572 743.1919642857143 486.0770089285714 732.6171875 486.0770089285714H53.0691964285714C31.4732142857143 486.0770089285714 13.9229910714286 469.4475446428572 13.9229910714286 448.9955357142857V51.0323660714286C13.9229910714286 30.5803571428572 31.4732142857143 13.9508928571428 53.0691964285714 13.9508928571428H732.6171875C754.2131696428571 13.9508928571428 771.7633928571429 30.5803571428571 771.7633928571429 51.0323660714286V448.9955357142857z" />
    <glyph glyph-name="thumb_generic"
      unicode="&#xF174;"
      horiz-adv-x="777.9296875" d=" M415.6808035714286 330.1339285714286H504.7154017857143V80.8035714285714H273.1863839285715V419.1964285714286H415.6808035714286V330.1339285714286zM725.3069196428571 500H52.5669642857143C23.5212053571428 500 0 477.1484375 0 448.9676339285715V51.0323660714285C0 22.8515624999999 23.5212053571428 -1e-13 52.5669642857143 -1e-13H725.3627232142858C754.4084821428572 -1e-13 777.9296875000001 22.8515624999999 777.9296875000001 51.0323660714285V448.9676339285715C777.8738839285714 477.1484375 754.3805803571428 500 725.3069196428571 500zM255.3850446428572 63.0022321428571V436.9977678571429H424.5814732142857L522.5167410714286 338.0022321428571V63.0022321428571H255.3850446428572z" />
    <glyph glyph-name="thumb_generic_i"
      unicode="&#xF175;"
      horiz-adv-x="777.9296875" d=" M424.5814732142857 436.9977678571429H255.3850446428572V63.0022321428571H522.5167410714287V338.0022321428571L424.5814732142857 436.9977678571429zM504.7154017857143 80.8035714285714H273.1863839285715V419.1964285714286H415.6808035714286V330.1339285714286H504.7154017857143V80.8035714285714z" />
    <glyph glyph-name="thumb_graph"
      unicode="&#xF176;"
      horiz-adv-x="777.9296875" d=" M494.0569196428572 177.2600446428571C477.9854910714286 186.8861607142857 460.6584821428572 192.2433035714286 444.8381696428572 195.1450892857142C444.6149553571429 193.3035714285714 444.2801339285715 191.4341517857143 443.8616071428572 189.5926339285713C443.8337053571429 189.5089285714285 443.8337053571429 189.453125 443.8058035714286 189.3694196428571C443.7220982142857 189.0345982142857 443.6383928571429 188.6997767857142 443.5546875 188.3649553571428C443.5267857142857 188.1975446428571 443.4709821428571 188.0580357142857 443.4430803571428 187.890625C443.3872767857142 187.6395089285713 443.3035714285714 187.4162946428571 443.2477678571428 187.1651785714286C443.1919642857142 186.9140625 443.1082589285714 186.6908482142857 443.0524553571428 186.4397321428572C442.9966517857142 186.2723214285715 442.96875 186.1328125000001 442.9129464285714 185.9654017857143C442.8292410714285 185.6305803571428 442.7176339285714 185.3236607142857 442.6060267857142 184.9888392857143C442.578125 184.9051339285715 442.5502232142857 184.8493303571428 442.5223214285714 184.765625C441.5178571428571 181.6964285714286 440.2901785714285 178.7667410714286 438.8113839285714 175.9486607142857C438.7834821428571 175.8928571428572 438.7555803571429 175.8370535714286 438.7276785714286 175.7812500000001C438.5602678571429 175.474330357143 438.4207589285715 175.1953125000001 438.2533482142857 174.8883928571429C438.1696428571429 174.7209821428572 438.0580357142857 174.5535714285715 437.9743303571429 174.3861607142858C437.890625 174.2187500000001 437.7790178571429 174.0513392857143 437.6674107142857 173.8839285714286C437.5 173.6049107142858 437.3325892857143 173.2979910714287 437.1651785714286 173.0189732142858C437.1372767857144 172.9631696428572 437.109375 172.9073660714286 437.0814732142857 172.8794642857144C435.1841517857144 169.7823660714287 433.0078125000001 166.8247767857144 430.4966517857144 164.0904017857144C430.4687500000001 164.0625000000001 430.4408482142857 164.0345982142858 430.4408482142857 164.0066964285716C430.1897321428572 163.7276785714287 429.9386160714286 163.4486607142858 429.6595982142858 163.1975446428572C429.5479910714286 163.0859375000001 429.4642857142857 162.974330357143 429.3526785714286 162.8906250000001C429.1573660714286 162.6953125000001 428.989955357143 162.5279017857144 428.794642857143 162.3325892857144C428.5993303571429 162.1372767857144 428.4319196428572 161.9698660714287 428.2366071428572 161.7745535714287C428.1250000000001 161.6629464285715 428.0412946428572 161.5792410714287 427.9296875000001 161.4676339285716C427.6506696428572 161.216517857143 427.3716517857144 160.9375000000001 427.1205357142858 160.6863839285716C427.0926339285715 160.6584821428574 427.0647321428572 160.630580357143 427.036830357143 160.6026785714287C425.3069196428572 159.0122767857145 423.4654017857144 157.5334821428573 421.568080357143 156.1662946428573C431.3058035714288 144.0011160714287 444.2801339285716 131.0267857142859 460.6026785714287 121.2611607142859C481.7522321428573 108.6216517857145 504.9944196428572 103.3203125000002 524.1908482142859 101.3113839285716C524.8604910714288 106.9754464285716 526.7299107142859 112.5837053571431 529.8549107142859 117.8013392857144C532.9799107142859 123.0189732142858 537.0535714285716 127.3158482142858 541.7410714285716 130.6082589285716C531.5569196428571 145.6194196428572 515.7645089285714 164.2857142857143 494.0569196428572 177.2600446428571z M405.9430803571429 370.1171875C400.7254464285715 367.8013392857143 394.9497767857143 366.4899553571429 388.8950892857144 366.4899553571429C382.8125000000001 366.4899553571429 377.036830357143 367.8013392857143 371.8191964285715 370.1171875C364.2299107142857 353.7388392857143 356.3058035714287 330.6082589285715 356.3058035714287 305.3013392857144C356.3058035714287 286.5513392857143 360.5747767857144 268.9453125 366.2109375000001 253.8783482142857C367.5223214285715 254.4363839285715 368.833705357143 254.9665178571429 370.1729910714287 255.4408482142858C370.1729910714287 255.4408482142858 370.1729910714287 255.4408482142858 370.1729910714287 255.4408482142858C370.5636160714287 255.5803571428572 370.982142857143 255.7198660714286 371.372767857143 255.8593750000001C371.4564732142858 255.8872767857143 371.5401785714286 255.9151785714286 371.6238839285715 255.9430803571429C371.958705357143 256.0546875 372.2656250000001 256.1383928571429 372.6004464285715 256.25C372.7678571428572 256.3058035714286 372.935267857143 256.3337053571429 373.0747767857144 256.3895089285715C373.325892857143 256.4732142857143 373.5491071428573 256.5290178571429 373.8002232142858 256.5848214285715C374.0513392857144 256.6406250000001 374.302455357143 256.7243303571429 374.5256696428572 256.7801339285715C374.6930803571429 256.8359375000001 374.8604910714287 256.8638392857144 375.0000000000001 256.8917410714286C375.3348214285715 256.9754464285715 375.669642857143 257.0591517857144 375.9765625000001 257.1428571428572C376.060267857143 257.1707589285715 376.1439732142858 257.1707589285715 376.2276785714287 257.1986607142858C376.646205357143 257.2823660714286 377.0647321428572 257.3939732142858 377.4832589285715 257.4776785714286C377.4832589285715 257.4776785714286 377.4832589285715 257.4776785714286 377.4832589285715 257.4776785714286C380.6640625000001 258.1194196428572 383.872767857143 258.5100446428572 387.0814732142859 258.5937500000001C387.1372767857145 258.5937500000001 387.193080357143 258.5937500000001 387.2209821428573 258.5937500000001C387.5558035714288 258.5937500000001 387.8906250000002 258.6216517857144 388.2254464285715 258.6216517857144C388.4207589285716 258.6216517857144 388.6160714285716 258.6216517857144 388.8113839285715 258.6216517857144C389.0066964285715 258.6216517857144 389.2020089285715 258.6216517857144 389.3973214285715 258.6216517857144C389.732142857143 258.6216517857144 390.0669642857144 258.6216517857144 390.4017857142857 258.5937500000001C390.4575892857144 258.5937500000001 390.5133928571429 258.5937500000001 390.5412946428572 258.5937500000001C394.1964285714286 258.4821428571429 397.8515625000001 258.0357142857144 401.4787946428572 257.1986607142858C401.5625 257.1707589285715 401.6183035714286 257.1707589285715 401.7020089285715 257.1428571428572C402.0368303571429 257.0591517857144 402.3716517857144 256.9754464285715 402.7064732142857 256.8917410714286C402.8738839285714 256.8638392857144 403.0133928571429 256.8080357142858 403.1808035714286 256.7801339285715C403.4319196428572 256.7243303571429 403.6551339285715 256.6406250000001 403.90625 256.5848214285715C404.1573660714286 256.5290178571429 404.3805803571429 256.4453125 404.6316964285714 256.3895089285715C404.7991071428571 256.3337053571429 404.9386160714285 256.3058035714286 405.1060267857143 256.25C405.4408482142857 256.1662946428572 405.7477678571429 256.0546875 406.0825892857143 255.9430803571429C406.1662946428571 255.9151785714286 406.2220982142857 255.8872767857143 406.3058035714286 255.8593750000001C408.0915178571429 255.2734375000001 409.8493303571429 254.6037946428572 411.5792410714286 253.8504464285715C417.0200892857143 268.4709821428571 421.484375 286.2444196428572 421.484375 305.2734375C421.4564732142857 329.9386160714286 414.0625 352.5948660714286 405.9430803571429 370.1171875z M350.7254464285715 160.6863839285715C350.4464285714286 160.9375000000001 350.1674107142857 161.1886160714286 349.9162946428571 161.4676339285715C349.8046875 161.5792410714286 349.6930803571429 161.6629464285715 349.609375 161.7745535714286C349.4140625 161.9698660714286 349.2466517857144 162.1372767857143 349.0513392857143 162.3325892857143C348.8560267857143 162.5279017857143 348.6886160714286 162.6953125 348.4933035714286 162.890625C348.3816964285714 163.0022321428572 348.2979910714286 163.0859375 348.1863839285715 163.1975446428571C347.9352678571429 163.4765625 347.65625 163.7555803571428 347.4051339285715 164.0066964285714C347.3772321428572 164.0345982142857 347.3493303571429 164.0625 347.3214285714286 164.0904017857143C344.8102678571429 166.8247767857142 342.5781250000001 169.7823660714286 340.6808035714287 172.9352678571428C340.6529017857144 172.9910714285715 340.6250000000001 173.0189732142857 340.5970982142858 173.0747767857143C340.4296875000001 173.3537946428571 340.2622767857144 173.6328125 340.0948660714287 173.9118303571428C340.0111607142859 174.0792410714285 339.8995535714287 174.2466517857143 339.8158482142859 174.4140625C339.732142857143 174.5814732142857 339.6205357142858 174.7488839285714 339.536830357143 174.9162946428571C339.3694196428573 175.1953125 339.2299107142859 175.5022321428571 339.0625000000001 175.78125C339.0345982142859 175.8370535714285 339.0066964285715 175.8928571428571 338.9787946428572 175.9207589285713C337.6953125000001 178.3482142857142 336.5792410714287 180.8872767857142 335.6584821428572 183.5100446428571C335.6584821428572 183.5100446428571 335.6584821428572 183.5100446428571 335.6584821428572 183.5100446428571C335.5189732142858 183.9006696428571 335.3794642857144 184.3191964285714 335.239955357143 184.7098214285713C335.2120535714287 184.7935267857142 335.1841517857144 184.8772321428571 335.1562500000001 184.9609375C335.0446428571429 185.2957589285714 334.9609375000001 185.6026785714285 334.849330357143 185.9375C334.7935267857144 186.1049107142857 334.7656250000001 186.2723214285714 334.7098214285716 186.4118303571428C334.6261160714287 186.6629464285715 334.5703125000001 186.8861607142857 334.5145089285715 187.1372767857142C334.458705357143 187.3883928571428 334.3750000000001 187.6395089285713 334.3191964285715 187.8627232142856C334.263392857143 188.0301339285713 334.2354910714287 188.1975446428571 334.2075892857144 188.3370535714285C334.1238839285715 188.671875 334.0401785714287 189.0066964285714 333.9564732142857 189.3136160714285C333.9285714285715 189.3973214285713 333.9285714285715 189.4810267857142 333.9006696428572 189.5647321428571C333.8169642857144 189.9832589285714 333.7053571428572 190.4017857142857 333.6216517857144 190.8203125C333.6216517857144 190.8203125 333.6216517857144 190.8203125 333.6216517857144 190.8203125C333.3426339285715 192.2154017857142 333.0915178571429 193.6383928571428 332.9241071428572 195.0334821428571C317.578125 192.1595982142857 300.0558035714286 186.8582589285714 283.7611607142857 177.0647321428571C262.6395089285715 164.3973214285713 247.0145089285714 146.3727678571428 236.1886160714286 130.3850446428571C240.8761160714286 127.1205357142856 244.9497767857143 122.8236607142857 248.0747767857143 117.6339285714285C251.1997767857143 112.4162946428571 253.0691964285715 106.7801339285713 253.7667410714286 101.1160714285713C271.7354910714286 103.0412946428571 295.6194196428572 108.1752232142856 317.3270089285715 121.2053571428571C333.3984375 130.8593749999999 346.2890625 143.5825892857142 356.3058035714286 156.166294642857C354.4084821428572 157.5055803571427 352.5669642857143 158.9843749999998 350.8370535714286 160.5747767857142C350.7533482142857 160.6305803571428 350.7254464285715 160.6584821428571 350.7254464285715 160.6863839285715z M725.3348214285714 500H52.5669642857143C23.5212053571429 500 0 477.1484375 0 448.9676339285715V51.0323660714285C0 22.8515624999999 23.5491071428571 -1e-13 52.5669642857143 -1e-13H725.3906250000001C754.4363839285714 -1e-13 777.9575892857143 22.8515624999999 777.9575892857143 51.0323660714285V448.9676339285715C777.9017857142858 477.1484375 754.4084821428572 500 725.3348214285714 500zM601.7299107142857 74.8883928571429C589.84375 55.0502232142858 564.1183035714286 48.5770089285714 544.2801339285714 60.4631696428572C532.8125 67.3270089285714 525.8091517857142 78.8225446428571 524.2187499999999 91.1551339285715C504.9944196428571 93.0803571428572 479.0736607142857 98.4654017857143 455.3571428571428 112.6395089285715C443.8058035714285 119.5591517857143 432.8683035714286 128.4877232142857 422.8515625 139.1741071428571C419.3359375 142.9408482142857 415.9319196428571 146.9029017857143 412.6395089285714 151.0881696428571C410.9933035714285 150.3348214285714 409.3191964285714 149.6372767857143 407.5892857142857 149.0234375C407.5892857142857 149.0234375 407.5892857142857 149.0234375 407.5892857142857 149.0234375C407.1986607142857 148.8839285714286 406.7801339285714 148.7444196428571 406.3895089285715 148.6049107142857C406.3058035714286 148.5770089285715 406.2220982142858 148.5491071428571 406.1383928571429 148.5212053571428C405.8035714285714 148.4095982142857 405.4966517857143 148.3258928571428 405.1618303571429 148.2142857142857C404.9944196428572 148.1584821428571 404.8270089285714 148.1305803571429 404.6875 148.0747767857143C404.4363839285714 147.9910714285715 404.2131696428571 147.9352678571428 403.9620535714286 147.8794642857143C403.7109375 147.8236607142857 403.4598214285715 147.7399553571428 403.2366071428572 147.6841517857143C403.0691964285715 147.6283482142857 402.9017857142857 147.6004464285715 402.7622767857143 147.5725446428571C402.4274553571429 147.4888392857143 402.0926339285714 147.4051339285714 401.7857142857143 147.3214285714285C401.7020089285715 147.2935267857142 401.6183035714286 147.2935267857142 401.5345982142857 147.2656249999999C401.1160714285714 147.1819196428571 400.6975446428571 147.0703124999999 400.2790178571429 146.9866071428571C400.2790178571429 146.9866071428571 400.2790178571429 146.9866071428571 400.2790178571429 146.9866071428571C397.0982142857142 146.3448660714285 393.8895089285714 145.9542410714285 390.6808035714286 145.8705357142856C390.625 145.8705357142856 390.5691964285714 145.8705357142856 390.5412946428571 145.8705357142856C390.2064732142857 145.8705357142856 389.8716517857142 145.8426339285714 389.5368303571429 145.8426339285714C389.3415178571429 145.8426339285714 389.1462053571429 145.8426339285714 388.9508928571429 145.8426339285714C388.7555803571429 145.8426339285714 388.5602678571429 145.8426339285714 388.3649553571429 145.8426339285714C388.0301339285715 145.8426339285714 387.6953125 145.8426339285714 387.3604910714286 145.8705357142856C387.3046875000001 145.8705357142856 387.2488839285715 145.8705357142856 387.2209821428572 145.8705357142856C383.5658482142858 145.9821428571428 379.9107142857144 146.4285714285713 376.2834821428572 147.2656249999999C376.1997767857144 147.2935267857142 376.1439732142858 147.2935267857142 376.060267857143 147.3214285714285C375.7254464285715 147.4051339285713 375.3906250000001 147.4888392857142 375.0558035714287 147.5725446428571C374.888392857143 147.6004464285713 374.7488839285716 147.65625 374.5814732142858 147.6841517857143C374.3303571428572 147.7399553571428 374.107142857143 147.8236607142857 373.8560267857144 147.8794642857143C373.6049107142858 147.9352678571428 373.3816964285715 148.0189732142857 373.130580357143 148.0747767857143C372.9631696428573 148.1305803571429 372.8236607142859 148.1584821428571 372.6562500000001 148.2142857142857C372.3214285714287 148.2979910714286 372.0145089285716 148.4095982142857 371.6796875000001 148.5212053571428C371.5959821428573 148.5491071428571 371.5401785714287 148.5770089285715 371.4564732142859 148.6049107142857C369.3080357142859 149.3024553571428 367.2154017857144 150.1395089285714 365.1785714285716 151.0602678571428C354.7154017857144 137.7232142857143 340.5691964285716 123.3537946428571 322.544642857143 112.5279017857143C310.9933035714287 105.6082589285715 297.9631696428573 100.1674107142857 283.8169642857145 96.3727678571428C274.2466517857145 93.8058035714285 264.146205357143 91.9921874999999 253.7388392857145 90.9319196428571C252.2042410714288 78.6272321428571 245.200892857143 67.1037946428571 233.7332589285716 60.2120535714286C213.8950892857144 48.2979910714286 188.169642857143 54.7154017857142 176.255580357143 74.5535714285715C164.341517857143 94.3917410714286 170.7589285714287 120.1171875 190.5970982142859 132.03125C202.0647321428573 138.9229910714286 215.513392857143 139.6763392857143 227.1205357142859 135.2678571428571C237.8627232142859 151.3113839285714 254.8549107142859 171.6517857142857 278.5156250000002 185.8537946428571C290.0669642857145 192.7734375 303.0970982142859 198.2142857142857 317.2433035714288 202.0089285714286C322.2098214285716 203.3482142857143 327.3437500000002 204.4642857142857 332.5613839285716 205.4129464285715C332.7287946428573 208.5658482142857 333.1752232142859 211.7466517857143 333.9006696428573 214.8716517857143C333.9285714285716 214.9553571428571 333.9285714285716 215.0111607142857 333.9564732142859 215.0948660714286C334.0401785714288 215.4296875 334.1238839285716 215.7645089285714 334.2075892857145 216.0993303571428C334.2354910714288 216.2667410714286 334.2912946428574 216.40625 334.3191964285716 216.5736607142857C334.3750000000003 216.8247767857143 334.4587053571431 217.0479910714286 334.5145089285717 217.2991071428572C334.5703125000003 217.5502232142857 334.6540178571431 217.7734375 334.7098214285717 218.0245535714286C334.7656250000003 218.1919642857143 334.7935267857145 218.3314732142857 334.8493303571431 218.4988839285715C334.933035714286 218.8337053571429 335.0446428571431 219.140625 335.1562500000003 219.4754464285715C335.1841517857145 219.5591517857143 335.2120535714288 219.6149553571429 335.2399553571431 219.6986607142857C336.2444196428574 222.7678571428572 337.4720982142859 225.6975446428572 338.9508928571431 228.515625C338.9787946428573 228.5714285714286 339.0066964285716 228.6272321428572 339.0345982142859 228.6830357142857C339.2020089285716 228.9899553571429 339.341517857143 229.2689732142858 339.5089285714288 229.5758928571429C339.5926339285716 229.7433035714286 339.7042410714288 229.9107142857144 339.7879464285716 230.0781250000001C339.8716517857145 230.2455357142858 339.9832589285716 230.4129464285715 340.0948660714288 230.5803571428572C340.2622767857145 230.859375 340.4296875000002 231.1662946428572 340.5970982142859 231.4453125C340.6250000000001 231.5011160714286 340.6529017857145 231.5569196428572 340.6808035714288 231.5848214285715C342.5781250000001 234.6819196428572 344.7544642857144 237.6395089285715 347.2656250000001 240.3738839285715C347.2935267857144 240.4017857142857 347.3214285714287 240.4296875000001 347.3214285714287 240.4575892857143C347.5725446428573 240.7366071428572 347.8236607142859 241.015625 348.1026785714287 241.2667410714286C348.2142857142859 241.3783482142857 348.2979910714287 241.4899553571429 348.4095982142858 241.5736607142857C348.6049107142859 241.7689732142857 348.7723214285715 241.9363839285715 348.9676339285715 242.1316964285715C349.1629464285715 242.3270089285715 349.3303571428572 242.4944196428572 349.5256696428572 242.6897321428572C349.6372767857144 242.8013392857143 349.7209821428572 242.8850446428572 349.8325892857144 242.9966517857143C350.1116071428572 243.2477678571429 350.3906250000001 243.5267857142857 350.6417410714287 243.7779017857143C350.6696428571429 243.8058035714286 350.6975446428572 243.8337053571429 350.7254464285715 243.8616071428571C352.7622767857144 245.7310267857143 354.9386160714286 247.4330357142857 357.1986607142858 248.9676339285714C351.1718750000001 264.8158482142857 346.1216517857144 284.3191964285715 346.1216517857144 305.3571428571429C346.1216517857144 318.8058035714286 348.1584821428572 332.7845982142857 352.2042410714286 346.875C354.9386160714286 356.3895089285715 358.5658482142858 365.9877232142857 363.0301339285715 375.4743303571429C353.2645089285715 383.1473214285715 346.9866071428572 395.0613839285715 346.9866071428572 408.4263392857144C346.9866071428572 431.5569196428572 365.7366071428572 450.3069196428572 388.8671875 450.3069196428572C411.9977678571429 450.3069196428572 430.7477678571429 431.5569196428572 430.7477678571429 408.4263392857144C430.7477678571429 395.0613839285715 424.4698660714286 383.1473214285715 414.7042410714286 375.4743303571429C422.9352678571429 358.0078125 431.6127232142857 332.9799107142857 431.6127232142857 305.3571428571429C431.6127232142857 291.9084821428571 429.5758928571429 277.9296875 425.5301339285714 263.8392857142858C424.1071428571429 258.9006696428572 422.4609375 253.9062500000001 420.5357142857142 248.9676339285715C422.7678571428571 247.4609375000001 424.8883928571428 245.7589285714286 426.9252232142857 243.9174107142858C426.953125 243.8895089285715 426.9810267857143 243.8616071428572 427.0089285714286 243.8616071428572C427.2879464285714 243.6104910714286 427.5669642857143 243.3593750000001 427.8180803571429 243.0803571428572C427.9296875 242.9687500000001 428.0412946428571 242.8850446428572 428.125 242.7734375000001C428.3203125 242.578125 428.4877232142857 242.4107142857144 428.6830357142857 242.2154017857144C428.8783482142857 242.0200892857143 429.0457589285714 241.8526785714286 429.2410714285714 241.6573660714286C429.3526785714286 241.5457589285715 429.4363839285714 241.4620535714286 429.5479910714285 241.3504464285715C429.7991071428571 241.0714285714286 430.078125 240.7924107142857 430.3292410714285 240.5412946428572C430.3571428571428 240.5133928571429 430.3850446428571 240.4854910714286 430.4129464285714 240.4575892857144C432.9241071428571 237.7232142857144 435.15625 234.7656250000001 437.0535714285714 231.6127232142857C437.0814732142856 231.5569196428572 437.109375 231.5290178571429 437.1372767857142 231.4732142857144C437.3046874999999 231.1941964285715 437.4720982142856 230.9151785714286 437.6395089285714 230.6361607142857C437.7232142857142 230.46875 437.8348214285714 230.3013392857143 437.9185267857142 230.1339285714286C438.002232142857 229.9665178571429 438.1138392857142 229.7991071428572 438.1975446428571 229.6316964285715C438.3649553571427 229.3526785714286 438.5044642857142 229.0457589285715 438.6718749999999 228.7667410714286C438.6997767857142 228.7109375000001 438.7276785714285 228.6551339285715 438.7555803571427 228.6272321428572C440.0390624999999 226.1997767857144 441.1551339285713 223.6607142857143 442.0758928571428 221.0379464285715C442.0758928571428 221.0379464285715 442.0758928571428 221.0379464285715 442.0758928571428 221.0379464285715C442.2154017857142 220.6473214285715 442.3549107142856 220.2287946428572 442.4944196428571 219.8381696428572C442.5223214285714 219.7544642857143 442.5502232142857 219.6707589285715 442.5781249999999 219.5870535714286C442.6897321428571 219.2522321428572 442.7734374999999 218.9453125000001 442.885044642857 218.6104910714286C442.9408482142856 218.4430803571429 442.9687499999999 218.2756696428572 443.0245535714285 218.1361607142858C443.1082589285713 217.8850446428572 443.1640624999999 217.6618303571429 443.2198660714285 217.4107142857143C443.2756696428571 217.1595982142858 443.3593749999999 216.9084821428572 443.4151785714285 216.6852678571429C443.4709821428571 216.5178571428572 443.4988839285714 216.3504464285715 443.5267857142857 216.2109375C443.6104910714285 215.8761160714286 443.6941964285714 215.5412946428572 443.7779017857142 215.234375C443.8058035714285 215.1506696428572 443.8058035714285 215.0669642857143 443.8337053571429 214.9832589285715C443.9174107142857 214.5647321428572 444.0290178571429 214.1462053571428 444.1127232142857 213.7276785714286C444.1127232142857 213.7276785714286 444.1127232142857 213.7276785714286 444.1127232142857 213.7276785714286C444.6707589285714 211.0212053571428 445.0055803571429 208.3147321428571 445.1729910714285 205.5803571428571C461.8582589285714 202.6227678571429 481.2220982142857 196.9308035714286 499.2466517857142 186.1328125C510.7979910714286 179.2131696428571 521.7354910714284 170.2845982142857 531.7522321428571 159.5982142857143C538.5323660714284 152.3716517857143 544.8939732142857 144.3359375 550.7254464285713 135.6305803571428C562.3325892857142 140.0669642857143 575.7533482142856 139.3415178571428 587.2488839285714 132.4776785714286C607.1428571428571 120.4520089285715 613.5881696428571 94.7265625 601.7299107142857 74.8883928571429z" />
    <glyph glyph-name="thumb_graph_i"
      unicode="&#xF177;"
      horiz-adv-x="777.9296875" d=" M587.2767857142858 132.3381696428571C575.8091517857143 139.2020089285714 562.3604910714287 139.9553571428571 550.7533482142858 135.4910714285714C544.921875 144.1964285714286 538.5602678571429 152.2321428571428 531.7801339285714 159.4587053571428C521.7633928571429 170.1729910714286 510.8258928571429 179.1015625 499.2745535714286 185.9933035714286C481.2220982142857 196.7912946428571 461.8861607142858 202.4832589285714 445.2008928571429 205.4408482142857C445.0613839285715 208.1473214285715 444.6986607142858 210.8816964285714 444.1406250000001 213.5881696428571C444.1406250000001 213.5881696428571 444.1406250000001 213.5881696428571 444.1406250000001 213.5881696428571C444.0569196428572 214.0066964285715 443.9732142857144 214.4252232142857 443.8616071428572 214.84375C443.833705357143 214.9274553571428 443.833705357143 215.0111607142857 443.8058035714286 215.0948660714286C443.7220982142858 215.4296875 443.638392857143 215.7645089285714 443.5546875 216.0714285714286C443.5267857142858 216.2388392857143 443.4709821428572 216.40625 443.4430803571429 216.5457589285715C443.3872767857143 216.796875 443.3035714285715 217.0479910714286 443.2477678571429 217.2712053571429C443.1919642857143 217.5223214285715 443.1082589285714 217.7455357142857 443.0524553571429 217.9966517857143C442.9966517857142 218.1640625 442.96875 218.3314732142857 442.9129464285714 218.4709821428572C442.8013392857142 218.8058035714286 442.7176339285714 219.1127232142857 442.6060267857143 219.4475446428572C442.578125 219.53125 442.5502232142857 219.6149553571429 442.5223214285715 219.6986607142857C442.3828125 220.0892857142857 442.2433035714286 220.5078125 442.1037946428572 220.8984375C442.1037946428572 220.8984375 442.1037946428572 220.8984375 442.1037946428572 220.8984375C441.1830357142857 223.5212053571428 440.0669642857144 226.0602678571429 438.7834821428571 228.4877232142857C438.7555803571429 228.5435267857144 438.7276785714286 228.5993303571429 438.6997767857143 228.6272321428572C438.5323660714286 228.90625 438.3928571428572 229.2131696428572 438.2254464285714 229.4921875C438.1417410714286 229.6595982142857 438.0301339285714 229.8270089285715 437.9464285714286 229.9944196428572C437.8627232142857 230.1618303571429 437.7511160714286 230.3292410714286 437.6674107142857 230.4966517857143C437.5 230.7756696428572 437.3325892857143 231.0546875 437.1651785714286 231.3337053571429C437.1372767857144 231.3895089285715 437.109375 231.4174107142857 437.0814732142857 231.4732142857143C435.1841517857144 234.5982142857143 432.9520089285715 237.5558035714286 430.4408482142857 240.3180803571429C430.4129464285715 240.3459821428572 430.3850446428572 240.3738839285715 430.3571428571429 240.4017857142857C430.1060267857143 240.6808035714286 429.8549107142858 240.9598214285715 429.5758928571429 241.2109375C429.4642857142857 241.3225446428571 429.3805803571429 241.4341517857143 429.2689732142858 241.5178571428572C429.0736607142858 241.7131696428572 428.9062500000001 241.8805803571429 428.7109375000001 242.0758928571429C428.5156250000001 242.2712053571429 428.3482142857144 242.4386160714286 428.1529017857144 242.6339285714286C428.0412946428572 242.7455357142857 427.9296875000001 242.8292410714286 427.8459821428572 242.9408482142857C427.5669642857144 243.1919642857143 427.2879464285715 243.4709821428572 427.036830357143 243.7220982142857C427.0089285714287 243.75 426.9810267857144 243.7779017857143 426.9531250000001 243.7779017857143C424.9441964285715 245.6194196428572 422.7957589285715 247.3214285714286 420.5636160714286 248.828125C422.4609375000001 253.7946428571429 424.1350446428572 258.7611607142857 425.5580357142858 263.6997767857143C429.6037946428572 277.7901785714286 431.6406250000001 291.7689732142857 431.6406250000001 305.2176339285715C431.6406250000001 332.8404017857144 422.935267857143 357.8404017857144 414.732142857143 375.3348214285715C424.497767857143 383.0078125 430.7756696428572 394.921875 430.7756696428572 408.2868303571429C430.7756696428572 431.4174107142857 412.0256696428572 450.1674107142857 388.8950892857144 450.1674107142857C365.7645089285715 450.1674107142857 347.0145089285716 431.4174107142857 347.0145089285716 408.2868303571429C347.0145089285716 394.921875 353.2924107142859 383.0078125 363.0580357142859 375.3348214285715C358.5937500000002 365.8482142857144 354.9386160714288 356.25 352.232142857143 346.7354910714286C348.1863839285716 332.6450892857144 346.1495535714288 318.6662946428571 346.1495535714288 305.2176339285715C346.1495535714288 284.1796875 351.1997767857145 264.6484375 357.2265625000002 248.828125C354.9665178571431 247.2935267857143 352.7901785714288 245.5915178571429 350.7533482142859 243.7220982142857C350.7254464285716 243.6941964285715 350.6975446428573 243.6662946428572 350.6696428571431 243.6383928571429C350.3906250000002 243.3872767857144 350.1116071428574 243.1361607142858 349.8604910714288 242.8571428571429C349.7488839285716 242.7455357142858 349.6372767857145 242.6618303571429 349.5535714285716 242.5502232142858C349.3582589285716 242.3549107142857 349.1908482142859 242.1875000000001 348.9955357142859 241.9921875000001C348.8002232142859 241.7968750000001 348.6328125000003 241.6294642857144 348.4375000000002 241.4341517857144C348.325892857143 241.3225446428572 348.2421875000002 241.2109375000001 348.1305803571431 241.1272321428572C347.8794642857145 240.8482142857144 347.6004464285716 240.5691964285715 347.3493303571431 240.3180803571429C347.3214285714289 240.2901785714286 347.2935267857145 240.2622767857144 347.2935267857145 240.2343750000001C344.7823660714288 237.5000000000001 342.6060267857145 234.5703125000001 340.7087053571431 231.4453125000001C340.6808035714289 231.3895089285715 340.6529017857145 231.333705357143 340.6250000000003 231.3058035714286C340.4575892857146 231.0267857142858 340.2901785714288 230.7198660714286 340.1227678571431 230.4408482142858C340.011160714286 230.2734375000001 339.9274553571431 230.1060267857144 339.815848214286 229.9386160714286C339.7321428571432 229.7712053571429 339.620535714286 229.6037946428572 339.5368303571432 229.4363839285715C339.3694196428575 229.1294642857144 339.2020089285718 228.8504464285715 339.0625000000003 228.5435267857144C339.034598214286 228.4877232142858 339.0066964285717 228.4319196428572 338.9787946428575 228.3761160714286C337.5000000000003 225.5580357142858 336.2444196428575 222.6283482142858 335.2678571428575 219.5591517857143C335.2399553571432 219.4754464285715 335.2120535714289 219.4196428571429 335.1841517857146 219.3359375000001C335.0725446428575 219.0011160714286 334.9888392857146 218.6941964285715 334.8772321428575 218.3593750000001C334.8214285714289 218.1919642857143 334.7935267857146 218.0524553571429 334.7377232142861 217.8850446428572C334.6819196428575 217.6339285714286 334.5982142857146 217.4107142857143 334.5424107142861 217.1595982142858C334.4866071428575 216.9084821428572 334.4029017857146 216.6852678571429 334.347098214286 216.4341517857143C334.3191964285718 216.2667410714286 334.2633928571432 216.1272321428572 334.2354910714289 215.9598214285715C334.151785714286 215.625 334.0680803571432 215.2901785714286 333.9843750000003 214.9553571428572C333.956473214286 214.8716517857143 333.956473214286 214.8158482142857 333.9285714285717 214.7321428571429C333.2031250000003 211.6071428571429 332.7566964285717 208.4263392857143 332.589285714286 205.2734375C327.3437500000003 204.3526785714286 322.237723214286 203.2087053571428 317.2712053571431 201.8694196428571C303.097098214286 198.0747767857143 290.0669642857145 192.6339285714286 278.5435267857146 185.7142857142857C254.854910714286 171.484375 237.8906250000003 151.171875 227.1484375000003 135.1283482142857C215.5412946428574 139.5368303571428 202.120535714286 138.7834821428571 190.6250000000002 131.8917410714286C170.7868303571431 119.9776785714286 164.3694196428574 94.2522321428571 176.2834821428574 74.4140625C188.1975446428574 54.5758928571429 213.9229910714288 48.1584821428572 233.761160714286 60.0725446428571C245.2287946428574 66.9642857142857 252.2042410714289 78.4598214285715 253.7667410714289 90.7924107142857C264.2020089285717 91.8526785714285 274.3024553571431 93.6662946428571 283.8448660714289 96.2332589285714C298.018973214286 100.0279017857142 311.0491071428574 105.4687499999999 322.5725446428574 112.3883928571428C340.597098214286 123.2142857142857 354.7433035714288 137.5837053571428 365.206473214286 150.9207589285714C367.2433035714288 149.9720982142857 369.3359375000003 149.1629464285714 371.4843750000003 148.4654017857143C371.5680803571431 148.4375 371.6238839285717 148.4095982142857 371.7075892857145 148.3816964285714C372.042410714286 148.2700892857142 372.3493303571431 148.1863839285714 372.6841517857145 148.0747767857143C372.8515625000002 148.0189732142857 372.9910714285716 147.9910714285715 373.1584821428574 147.9352678571428C373.409598214286 147.8794642857143 373.6328125000003 147.7957589285715 373.8839285714288 147.7399553571428C374.1350446428574 147.6841517857143 374.3582589285716 147.6004464285715 374.6093750000002 147.5446428571428C374.7767857142859 147.5167410714286 374.9162946428573 147.4609375 375.0837053571431 147.4330357142857C375.4185267857145 147.3493303571428 375.753348214286 147.265625 376.0881696428573 147.1819196428571C376.1718750000002 147.1540178571428 376.2276785714288 147.1540178571428 376.3113839285716 147.1261160714285C379.9386160714288 146.2890624999999 383.5937500000001 145.8426339285714 387.2488839285716 145.7310267857142C387.3046875000002 145.7310267857142 387.3604910714288 145.7310267857142 387.388392857143 145.7310267857142C387.7232142857145 145.7310267857142 388.0580357142859 145.703125 388.3928571428573 145.703125C388.5881696428573 145.703125 388.7834821428573 145.703125 388.9787946428573 145.703125C389.1741071428573 145.703125 389.3694196428573 145.703125 389.5647321428572 145.703125C389.8995535714287 145.703125 390.2343750000001 145.703125 390.5691964285715 145.7310267857142C390.6250000000001 145.7310267857142 390.6808035714287 145.7310267857142 390.708705357143 145.7310267857142C393.9174107142858 145.8147321428571 397.1261160714286 146.2053571428571 400.3069196428572 146.8470982142856C400.3069196428572 146.8470982142856 400.3069196428572 146.8470982142856 400.3069196428572 146.8470982142856C400.7254464285715 146.9308035714285 401.1439732142858 147.0145089285713 401.5625000000001 147.1261160714285C401.646205357143 147.1540178571427 401.7299107142858 147.1540178571427 401.8136160714287 147.1819196428571C402.1484375000001 147.2656249999999 402.4832589285716 147.3493303571428 402.7901785714287 147.4330357142857C402.9575892857144 147.4609375 403.1250000000001 147.5167410714285 403.2645089285716 147.5446428571428C403.5156250000002 147.6004464285715 403.7667410714287 147.6841517857143 403.989955357143 147.7399553571428C404.2410714285716 147.7957589285715 404.4642857142859 147.8794642857143 404.7154017857144 147.9352678571428C404.8828125000001 147.9910714285715 405.0502232142858 148.0189732142857 405.1897321428572 148.0747767857143C405.5245535714287 148.1863839285715 405.8314732142858 148.2700892857143 406.1662946428572 148.3816964285714C406.2500000000001 148.4095982142857 406.333705357143 148.4375 406.4174107142859 148.4654017857143C406.8080357142859 148.6049107142857 407.2265625000001 148.7444196428571 407.6171875000001 148.8839285714286C407.6171875000001 148.8839285714286 407.6171875000001 148.8839285714286 407.6171875000001 148.8839285714286C409.3470982142859 149.4977678571428 411.021205357143 150.1674107142857 412.6674107142858 150.9486607142857C415.9598214285715 146.7633928571428 419.3638392857144 142.8013392857143 422.8794642857144 139.0345982142857C432.896205357143 128.3203125 443.8337053571429 119.3917410714285 455.3850446428572 112.5C479.0736607142858 98.3258928571429 505.0223214285715 92.9408482142857 524.2466517857143 91.015625C525.8091517857143 78.7109375 532.8125 67.2154017857143 544.3080357142858 60.3236607142857C564.1462053571429 48.4375 589.8716517857144 54.9107142857143 601.7578125000001 74.7488839285715C613.5881696428571 94.7265625 607.1428571428571 120.4520089285715 587.2767857142858 132.3381696428571zM371.7912946428572 370.1171875C377.0089285714286 367.7734375 382.7845982142857 366.4899553571429 388.8671875 366.4899553571429C394.9497767857143 366.4899553571429 400.7254464285715 367.7734375 405.9151785714286 370.1171875C414.0625 352.6227678571429 421.4564732142857 329.9386160714286 421.4564732142857 305.3013392857144C421.4564732142857 286.2723214285715 416.9921875 268.4988839285715 411.5513392857143 253.8783482142857C409.8493303571429 254.6316964285715 408.0915178571429 255.3013392857143 406.2779017857143 255.8872767857143C406.1941964285715 255.9151785714286 406.1383928571429 255.9430803571429 406.0546875 255.9709821428572C405.7198660714286 256.0825892857144 405.4129464285715 256.1662946428572 405.078125 256.2779017857144C404.9107142857144 256.3337053571429 404.7712053571429 256.3616071428572 404.6037946428571 256.4174107142858C404.3526785714286 256.4732142857144 404.1294642857143 256.5569196428572 403.8783482142857 256.6127232142858C403.6272321428571 256.6685267857144 403.4040178571429 256.7522321428572 403.1529017857144 256.8080357142858C402.9854910714286 256.8359375000001 402.8459821428572 256.8917410714286 402.6785714285715 256.9196428571429C402.34375 257.0033482142858 402.0089285714286 257.0870535714286 401.6741071428572 257.1707589285715C401.5904017857144 257.1986607142858 401.5345982142858 257.1986607142858 401.450892857143 257.2265625000001C397.8236607142858 258.0636160714286 394.1685267857144 258.5100446428572 390.5133928571429 258.6216517857144C390.4575892857144 258.6216517857144 390.4017857142857 258.6216517857144 390.3738839285715 258.6216517857144C390.0390625000001 258.6216517857144 389.7042410714286 258.6495535714287 389.3694196428572 258.6495535714287C389.1741071428572 258.6495535714287 388.9787946428572 258.6495535714287 388.7834821428572 258.6495535714287C388.5881696428572 258.6495535714287 388.3928571428572 258.6495535714287 388.1975446428573 258.6495535714287C387.8627232142859 258.6495535714287 387.5279017857144 258.6495535714287 387.193080357143 258.6216517857144C387.1372767857145 258.6216517857144 387.0814732142859 258.6216517857144 387.0535714285716 258.6216517857144C383.8448660714288 258.5379464285715 380.6361607142859 258.1473214285715 377.4553571428573 257.5055803571429C377.4553571428573 257.5055803571429 377.4553571428573 257.5055803571429 377.4553571428573 257.5055803571429C377.036830357143 257.4218750000001 376.6183035714287 257.3381696428572 376.1997767857144 257.2265625000001C376.1160714285716 257.1986607142858 376.0323660714288 257.1986607142858 375.9486607142859 257.1707589285715C375.6138392857144 257.0870535714286 375.279017857143 257.0033482142858 374.9720982142859 256.9196428571429C374.8046875000001 256.8917410714286 374.6372767857144 256.8359375000001 374.497767857143 256.8080357142858C374.2466517857144 256.7522321428572 373.9955357142859 256.6685267857144 373.7723214285716 256.6127232142858C373.521205357143 256.5569196428572 373.2979910714287 256.4732142857144 373.0468750000001 256.4174107142858C372.8794642857145 256.3616071428572 372.7120535714287 256.3337053571429 372.5725446428573 256.2779017857144C372.2377232142859 256.1662946428572 371.9308035714288 256.0825892857144 371.5959821428573 255.9709821428572C371.5122767857145 255.9430803571429 371.4285714285716 255.9151785714286 371.3448660714287 255.8872767857143C370.9542410714287 255.7477678571429 370.5357142857144 255.6082589285715 370.1450892857144 255.4687500000001C370.1450892857144 255.4687500000001 370.1450892857144 255.4687500000001 370.1450892857144 255.4687500000001C368.8058035714287 254.9944196428572 367.466517857143 254.4642857142858 366.1830357142859 253.9062500000001C360.5468750000001 268.9732142857144 356.2779017857144 286.5792410714286 356.2779017857144 305.3292410714286C356.2779017857144 330.6082589285715 364.2020089285715 353.7388392857143 371.7912946428572 370.1171875zM317.2991071428572 121.2332589285715C295.5915178571429 108.203125 271.7075892857144 103.0691964285715 253.7388392857143 101.1439732142857C253.0412946428572 106.8080357142857 251.1997767857143 112.4441964285715 248.0468750000001 117.6618303571428C244.9218750000001 122.8794642857143 240.8482142857144 127.1484375 236.1607142857143 130.4129464285715C246.9866071428572 146.4006696428572 262.6116071428572 164.3973214285715 283.7332589285715 177.0926339285715C300.0279017857144 186.8861607142857 317.578125 192.2154017857143 332.8962053571429 195.0613839285715C333.0636160714286 193.6662946428572 333.3147321428572 192.2433035714286 333.5937500000001 190.8482142857143C333.5937500000001 190.8482142857143 333.5937500000001 190.8482142857143 333.5937500000001 190.8482142857143C333.6774553571429 190.4296875000001 333.7611607142857 190.0111607142858 333.8727678571429 189.5926339285715C333.9006696428572 189.5089285714286 333.9006696428572 189.4252232142858 333.9285714285715 189.3415178571429C334.0122767857144 189.0066964285715 334.0959821428572 188.671875 334.1796875000001 188.3649553571429C334.2075892857144 188.1975446428572 334.263392857143 188.0301339285715 334.2912946428573 187.890625C334.3470982142859 187.6395089285715 334.4308035714287 187.3883928571429 334.4866071428573 187.1651785714286C334.5424107142859 186.9140625 334.6261160714287 186.6908482142857 334.6819196428573 186.4397321428572C334.7377232142859 186.2723214285715 334.7656250000001 186.1049107142858 334.8214285714288 185.9654017857143C334.9330357142859 185.6305803571429 335.0167410714288 185.3236607142858 335.1283482142859 184.9888392857143C335.1562500000001 184.9051339285715 335.1841517857144 184.8214285714287 335.2120535714287 184.7377232142857C335.3515625000001 184.3470982142857 335.4910714285715 183.9285714285715 335.630580357143 183.5379464285715C335.630580357143 183.5379464285715 335.630580357143 183.5379464285715 335.630580357143 183.5379464285715C336.5513392857144 180.9151785714286 337.6674107142858 178.3761160714286 338.950892857143 175.9486607142857C338.9787946428572 175.8928571428572 339.0066964285716 175.8370535714286 339.0345982142859 175.8091517857143C339.2020089285715 175.5301339285715 339.341517857143 175.2232142857143 339.5089285714287 174.9441964285715C339.5926339285716 174.7767857142858 339.7042410714288 174.6093750000001 339.7879464285716 174.4419642857143C339.8716517857144 174.2745535714287 339.9832589285716 174.1071428571429 340.0669642857144 173.9397321428572C340.2343750000001 173.6607142857144 340.4017857142859 173.3816964285715 340.5691964285716 173.1026785714287C340.5970982142858 173.0468750000001 340.6250000000001 173.0189732142858 340.6529017857144 172.9631696428572C342.5502232142858 169.8381696428572 344.7823660714287 166.880580357143 347.2935267857144 164.1183035714286C347.3214285714286 164.0904017857144 347.349330357143 164.0625000000001 347.3772321428572 164.0345982142858C347.6283482142859 163.755580357143 347.8794642857144 163.4765625000001 348.1584821428572 163.2254464285715C348.2700892857144 163.1138392857143 348.3537946428572 163.0022321428572 348.4654017857144 162.9185267857144C348.6607142857144 162.7232142857143 348.828125 162.5558035714287 349.0234375000001 162.3604910714287C349.2187500000001 162.1651785714286 349.3861607142857 161.997767857143 349.5814732142857 161.802455357143C349.6930803571429 161.6908482142858 349.8046875 161.607142857143 349.8883928571429 161.4955357142858C350.1674107142857 161.2444196428572 350.4464285714286 160.9654017857144 350.6975446428572 160.7142857142858C350.7254464285715 160.6863839285716 350.7533482142858 160.6584821428572 350.78125 160.6584821428572C352.5111607142857 159.068080357143 354.3526785714286 157.5892857142858 356.25 156.2500000000001C346.2611607142857 143.6104910714286 333.3705357142857 130.8872767857143 317.2991071428572 121.2332589285715zM421.5680803571429 156.25C423.4654017857144 157.5892857142857 425.3069196428572 159.0680803571428 427.0368303571429 160.6863839285715C427.0647321428571 160.7142857142857 427.0926339285715 160.7421875000001 427.1205357142857 160.7700892857143C427.3995535714286 161.0212053571429 427.6785714285715 161.2723214285715 427.9296875 161.5513392857143C428.0412946428572 161.6629464285715 428.1529017857143 161.7466517857143 428.2366071428572 161.8582589285714C428.4319196428572 162.0535714285714 428.5993303571429 162.2209821428571 428.7946428571429 162.4162946428571C428.9899553571429 162.6116071428571 429.1573660714286 162.7790178571428 429.3526785714286 162.9743303571428C429.4642857142857 163.0859375 429.5479910714286 163.1975446428571 429.6595982142857 163.28125C429.9107142857143 163.5602678571428 430.1897321428572 163.8392857142857 430.4408482142857 164.0904017857143C430.46875 164.1183035714285 430.4966517857143 164.1462053571428 430.4966517857143 164.1741071428571C433.0078125 166.9084821428571 435.1841517857142 169.8381696428571 437.0814732142857 172.9631696428571C437.109375 173.0189732142857 437.1372767857142 173.0747767857143 437.1651785714285 173.1026785714285C437.3325892857142 173.3816964285714 437.5 173.6886160714285 437.6674107142857 173.9676339285713C437.7790178571429 174.1350446428571 437.8627232142857 174.3024553571428 437.9743303571428 174.4698660714285C438.0580357142856 174.6372767857142 438.1696428571428 174.8046875 438.2533482142856 174.9720982142856C438.4207589285713 175.2790178571427 438.5881696428571 175.5580357142856 438.7276785714285 175.8649553571428C438.7555803571427 175.9207589285713 438.7834821428571 175.9765625 438.8113839285714 176.0323660714285C440.2901785714285 178.8504464285713 441.5457589285714 181.7801339285713 442.5223214285714 184.8493303571427C442.5502232142856 184.9330357142856 442.5781249999999 184.9888392857142 442.6060267857142 185.072544642857C442.7176339285714 185.4073660714285 442.8013392857142 185.7142857142856 442.9129464285713 186.049107142857C442.9687499999999 186.2165178571427 442.9966517857141 186.3560267857141 443.0524553571427 186.5234374999999C443.1082589285713 186.7745535714285 443.1919642857141 186.9977678571427 443.2477678571427 187.2488839285713C443.3035714285713 187.4999999999999 443.3872767857142 187.7232142857142 443.4430803571427 187.9743303571427C443.470982142857 188.1417410714284 443.5267857142856 188.2812499999998 443.5546874999999 188.4486607142856C443.6383928571427 188.783482142857 443.7220982142856 189.1183035714285 443.8058035714285 189.4531249999998C443.8337053571428 189.5368303571427 443.8337053571428 189.5926339285712 443.8616071428571 189.6763392857141C444.2801339285714 191.5178571428569 444.6149553571429 193.3593749999998 444.8381696428571 195.228794642857C460.6584821428571 192.3270089285712 477.9575892857142 186.9698660714284 494.0569196428571 177.3437499999998C515.7645089285713 164.3415178571427 531.5569196428571 145.7031249999998 541.7131696428571 130.775669642857C537.0256696428571 127.4832589285713 532.9520089285713 123.2142857142856 529.8270089285714 117.9687499999998C526.7020089285714 112.7511160714283 524.8604910714286 107.1428571428569 524.1629464285714 101.4787946428569C504.9665178571428 103.4877232142856 481.7243303571429 108.7890624999998 460.5747767857142 121.4285714285712C444.2801339285715 131.1104910714286 431.3058035714286 144.0569196428571 421.5680803571429 156.25z" />
    <glyph glyph-name="thumb_ipynb"
      unicode="&#xF178;"
      horiz-adv-x="777.9296875" d=" M415.625 174.8604910714286V206.9754464285714C417.2991071428571 211.1328125 419.8102678571429 214.5089285714286 423.1584821428571 217.1316964285714C426.5066964285714 219.7544642857143 430.9151785714286 221.0658482142857 436.3560267857143 221.0658482142857C443.2756696428571 221.0658482142857 448.4654017857143 218.2756696428571 452.0089285714285 212.6674107142857C455.5245535714285 207.0591517857143 457.2823660714286 199.7767857142857 457.2823660714286 190.8203125V189.453125C457.2823660714286 180.9709821428571 455.5524553571428 174.21875 452.0647321428571 169.1964285714286C448.5770089285714 164.1741071428572 443.3872767857143 161.6629464285715 436.4955357142857 161.6629464285715C431.25 161.6629464285715 426.9252232142857 162.8348214285715 423.4654017857142 165.2064732142857S417.3828125000001 170.7868303571428 415.625 174.8604910714286zM777.9296875 448.6886160714286V50.7533482142857C777.9296875 22.5725446428571 754.4084821428571 -0.2790178571429 725.3627232142857 -0.2790178571429H52.5669642857143C23.5212053571429 -0.2790178571429 0 22.5725446428572 0 50.7533482142857V448.6886160714286C0 476.8694196428572 23.5212053571429 499.7209821428572 52.5669642857143 499.7209821428572H725.3069196428571C754.3805803571428 499.7209821428572 777.8738839285714 476.8694196428572 777.9296875 448.6886160714286zM522.5167410714286 337.7232142857143L424.5814732142857 436.71875H255.3850446428572V62.7232142857143H522.5167410714286V337.7232142857143zM415.6808035714286 329.8549107142857H504.7154017857143V80.5245535714286H273.1863839285715V418.9174107142857H415.6808035714286V329.8549107142857zM384.9888392857143 250.8091517857143H377.0647321428571V170.2008928571428L376.6741071428571 170.1450892857143L322.0982142857143 250.8091517857143H314.1741071428572V156.3058035714286H322.0982142857144V237.109375L322.4888392857144 237.1651785714286L377.0647321428572 156.3058035714286H384.9888392857144V250.8091517857143zM407.7008928571429 257.5334821428571V156.2779017857143H413.8950892857144L415.2064732142858 166.796875C417.5781250000001 163.0022321428572 420.6752232142857 160.0446428571428 424.4698660714286 158.0078125C428.2645089285715 155.9430803571428 432.7845982142858 154.9386160714286 437.974330357143 154.9386160714286C446.4564732142859 154.9386160714286 453.1250000000001 158.0636160714286 457.9799107142858 164.3136160714285C462.8069196428572 170.5636160714286 465.2343750000001 178.9620535714285 465.2343750000001 189.453125V190.8203125C465.2343750000001 202.0368303571428 462.8069196428572 210.9933035714285 457.9799107142858 217.7176339285714C453.1529017857144 224.4419642857142 446.4285714285715 227.8180803571429 437.8627232142859 227.8180803571429C432.8125000000002 227.8180803571429 428.4319196428573 226.7578125 424.7209821428573 224.6651785714286C421.0379464285716 222.5725446428571 417.9966517857145 219.5870535714286 415.6250000000002 215.7366071428571V257.5334821428571H407.7008928571429z" />
    <glyph glyph-name="thumb_ipynb_i"
      unicode="&#xF179;"
      horiz-adv-x="356.6964285714286" d=" M214.0066964285715 475.9207589285714H23.7444196428571V24.0792410714286H332.8962053571429V357.0033482142857H214.0066964285715V475.9207589285714zM356.7243303571429 0.3069196428571H-0.0279017857143V499.6930803571428H225.8928571428572L356.6685267857143 367.4944196428571V0.3069196428571H356.7243303571429zM174.1350446428572 116.796875H163.0859375L87.0814732142857 231.2220982142857L86.5234375 231.1104910714286V116.7689732142857H75.4743303571429V250.5022321428571H86.5234375L162.5558035714286 136.328125L163.1138392857143 136.4397321428571V250.5022321428571H174.1629464285715L174.1350446428572 116.796875L174.1350446428572 116.796875zM285.9375 163.6997767857143C285.9375 148.828125 282.5613839285715 136.9698660714286 275.8370535714286 128.125C269.1127232142857 119.2801339285715 259.7935267857143 114.8716517857143 247.9910714285714 114.8716517857143C240.7645089285714 114.8716517857143 234.4866071428572 116.3225446428572 229.1852678571429 119.2243303571428C223.8839285714286 122.1261160714286 219.5591517857143 126.2834821428571 216.2946428571428 131.6685267857142L214.453125 116.796875H205.8035714285714V260.0446428571429H216.8526785714286V200.8928571428571C220.1729910714286 206.3337053571428 224.3861607142857 210.546875 229.5479910714286 213.5044642857143C234.7098214285714 216.4899553571429 240.7924107142857 217.96875 247.8515625 217.96875C259.7935267857143 217.96875 269.140625 213.1975446428572 275.8928571428571 203.6830357142857C282.6171875 194.1685267857143 285.9933035714286 181.4732142857143 285.9933035714286 165.625V163.6997767857143zM274.8046875 165.625C274.8046875 178.2924107142857 272.3493303571429 188.6160714285715 267.4386160714286 196.5401785714285S255.2734375 208.4263392857142 245.6473214285714 208.4263392857142C238.0580357142857 208.4263392857142 231.9196428571429 206.5848214285714 227.2600446428572 202.8738839285713S219.0848214285715 194.3638392857142 216.796875 188.5044642857142V143.0245535714285C219.2522321428572 137.2767857142857 222.8794642857143 132.7008928571428 227.6785714285715 129.4084821428571C232.5055803571429 126.0602678571428 238.5323660714286 124.4140624999999 245.8426339285715 124.4140624999999C255.46875 124.4140624999999 262.6953125 127.9575892857142 267.5223214285715 135.0725446428571C272.3772321428572 142.1595982142857 274.7767857142857 151.7299107142856 274.7767857142857 163.7276785714285L274.8046875 165.625L274.8046875 165.625z" />
    <glyph glyph-name="thumb_map"
      unicode="&#xF17A;"
      horiz-adv-x="777.9296875" d=" M777.9296875000001 448.9676339285715V51.0323660714286C777.9296875000001 22.8515625 754.4084821428572 0 725.3627232142858 0H52.5669642857143C23.5212053571429 0 0 22.8515625 0 51.0323660714286V448.9676339285715C0 477.1484375 23.5212053571428 500 52.5669642857143 500H725.3069196428571C754.3805803571428 500 777.8738839285713 477.1484375 777.9296875000001 448.9676339285715zM382.3102678571429 430.6919642857143C306.8080357142857 430.6919642857143 263.1138392857143 356.0546875 282.3102678571428 293.75C304.9944196428571 220.0892857142857 382.3102678571429 55.5524553571428 382.3102678571429 55.5524553571428S457.3381696428571 220.4241071428571 481.1662946428572 293.75C501.7020089285714 356.9196428571429 455.1897321428572 430.6919642857143 382.3102678571429 430.6919642857143zM382.3102678571429 251.6183035714286C341.8805803571428 251.6183035714286 309.0401785714286 284.8493303571429 309.0401785714286 325.8370535714286S341.8526785714286 400.0558035714286 382.3102678571429 400.0558035714286C422.7399553571429 400.0558035714286 455.5803571428571 366.8247767857142 455.5803571428571 325.8370535714286S422.7399553571429 251.6183035714286 382.3102678571429 251.6183035714286z" />
    <glyph glyph-name="thumb_map_i"
      unicode="&#xF17B;"
      horiz-adv-x="777.9296875" d=" M382.3102678571429 430.6919642857143C306.8080357142857 430.6919642857143 263.1138392857143 356.0546875 282.3102678571429 293.75C304.9944196428572 220.0892857142857 382.310267857143 55.5524553571428 382.310267857143 55.5524553571428S457.3381696428573 220.4241071428571 481.1662946428573 293.75C501.7020089285714 356.9196428571429 455.1897321428572 430.6919642857143 382.3102678571429 430.6919642857143zM382.3102678571429 251.6183035714286C341.8805803571429 251.6183035714286 309.0401785714286 284.8493303571429 309.0401785714286 325.8370535714286S341.8526785714286 400.0558035714286 382.3102678571429 400.0558035714286C422.7399553571429 400.0558035714286 455.5803571428571 366.8247767857142 455.5803571428571 325.8370535714286S422.7399553571429 251.6183035714286 382.3102678571429 251.6183035714286z" />
    <glyph glyph-name="thumb_molecule"
      unicode="&#xF17C;"
      horiz-adv-x="777.9296875" d=" M725.3348214285714 500H52.5669642857143C23.5212053571429 500 0 477.1484375 0 448.9676339285715V51.0323660714286C0 22.8515625 23.5491071428572 0 52.5669642857143 0H725.3906250000001C754.4363839285714 0 777.9575892857142 22.8515625 777.9575892857142 51.0323660714286V448.9676339285715C777.9017857142858 477.1484375 754.4084821428572 500 725.3348214285714 500zM562.109375 230.1897321428571C561.3281249999999 209.3470982142857 543.8058035714286 193.0803571428571 522.9352678571428 193.8616071428571C502.0926339285714 194.6428571428571 485.8258928571428 212.1651785714286 486.6071428571429 233.0357142857143C486.6629464285714 233.9564732142857 486.7187500000001 234.8493303571429 486.8024553571428 235.7142857142857C486.7466517857143 235.7142857142857 486.6908482142857 235.7421875 486.6350446428571 235.7700892857143L427.0926339285714 246.9308035714286L427.34375 248.2142857142857C424.9720982142857 233.8727678571429 413.6439732142857 220.7868303571429 399.1629464285714 216.7689732142857L400.3627232142858 217.1316964285715L413.5881696428572 154.8828125C414.0625 154.8828125 414.4810267857143 155.0223214285714 414.9553571428572 155.0223214285714C443.8058035714287 155.0223214285714 467.1875000000001 131.640625 467.1875000000001 102.7901785714286S443.8058035714286 50.5580357142857 414.9553571428572 50.5580357142857S362.7232142857145 73.9397321428571 362.7232142857145 102.7901785714286C362.7232142857145 127.5948660714286 380.0502232142859 148.2142857142857 403.1808035714288 153.5714285714286L390.3738839285716 215.3459821428572C389.9553571428573 215.2901785714286 389.5647321428572 215.2622767857143 389.146205357143 215.2622767857143C371.6796875000001 215.2622767857143 357.0591517857144 227.0647321428572 352.1484375000001 243.2198660714286L352.1763392857144 243.1361607142857L295.8147321428572 230.3292410714286C295.9542410714287 228.9620535714286 296.2332589285715 227.6227678571429 296.2332589285715 226.1997767857143C296.2332589285715 202.5948660714286 277.1205357142858 183.4542410714286 253.4877232142859 183.4542410714286C229.8828125000002 183.4542410714286 210.7421875000002 202.5948660714286 210.7421875000002 226.1997767857143S229.8828125000001 268.9732142857143 253.4877232142857 268.9732142857143C271.8750000000001 268.9732142857143 287.3883928571429 257.3381696428571 293.4430803571429 241.0714285714286L350.390625 253.3482142857143L350.390625 253.3203125C350.3348214285714 253.8504464285714 350.2790178571428 254.3805803571429 350.2790178571428 254.9107142857143C350.2790178571428 276.1160714285715 366.3504464285714 293.359375 387.1930803571429 294.4196428571429L387.1651785714286 294.4196428571429L394.2522321428572 365.6808035714286C376.1439732142857 370.6473214285715 362.7232142857143 387.0535714285715 362.7232142857143 406.7522321428571C362.7232142857143 430.3571428571429 381.8359375 449.4977678571429 405.46875 449.4977678571429C429.0736607142857 449.4977678571429 448.2142857142856 430.3850446428571 448.2142857142856 406.7522321428571C448.2142857142856 383.3147321428571 429.3247767857142 364.3136160714286 405.9151785714285 364.0625L397.6004464285715 293.5267857142857L397.5725446428572 293.5267857142857C415.1785714285715 289.5926339285715 427.5390625000001 274.6372767857143 427.9854910714286 255.9709821428572L486.6629464285715 245.5636160714286C487.4720982142858 245.3683035714286 488.2533482142858 245.1729910714286 489.0066964285716 244.9497767857143C494.5591517857144 259.7377232142857 509.1238839285715 270.0055803571429 525.8091517857144 269.3917410714286C546.6517857142857 268.5825892857143 562.890625 251.0602678571429 562.109375 230.1897321428571z" />
    <glyph glyph-name="thumb_molecule_i"
      unicode="&#xF17D;"
      horiz-adv-x="777.9296875" d=" M562.109375 230.1897321428571C561.3281249999999 209.3470982142857 543.8058035714286 193.0803571428571 522.9352678571428 193.8616071428571C502.0926339285714 194.6428571428571 485.8258928571428 212.1651785714286 486.6071428571429 233.0357142857143C486.6629464285714 233.9564732142857 486.7187500000001 234.8493303571429 486.8024553571428 235.7142857142857C486.7466517857143 235.7142857142857 486.6908482142857 235.7421875 486.6350446428571 235.7700892857143L427.0926339285714 246.9308035714286L427.34375 248.2142857142857C424.9720982142857 233.8727678571429 413.6439732142857 220.7868303571429 399.1629464285714 216.7689732142857L400.3627232142857 217.1316964285714L413.5881696428572 154.8828125C414.0625 154.8828125 414.4810267857143 155.0223214285714 414.9553571428572 155.0223214285714C443.8058035714286 155.0223214285714 467.1875000000001 131.640625 467.1875000000001 102.7901785714285C467.1875000000001 73.9397321428571 443.8058035714286 50.5580357142857 414.9553571428572 50.5580357142857S362.7232142857143 73.9397321428571 362.7232142857143 102.7901785714286C362.7232142857143 127.5948660714286 380.0502232142857 148.2142857142857 403.1808035714286 153.5714285714286L390.3738839285714 215.3459821428572C389.9553571428571 215.2901785714286 389.5647321428571 215.2622767857143 389.1462053571429 215.2622767857143C371.6796875 215.2622767857143 357.0591517857142 227.0647321428572 352.1484375 243.2198660714286L352.1763392857142 243.1361607142858L295.8147321428571 230.3292410714286C295.9542410714286 228.9620535714286 296.2332589285714 227.6227678571429 296.2332589285714 226.1997767857144C296.2332589285714 202.5948660714287 277.1205357142857 183.4542410714286 253.4877232142857 183.4542410714286C229.8828125 183.4542410714286 210.7421875 202.5948660714287 210.7421875 226.1997767857144S229.8828125000001 268.9732142857143 253.4877232142857 268.9732142857143C271.8750000000001 268.9732142857143 287.3883928571429 257.3381696428571 293.4430803571429 241.0714285714286L350.390625 253.3482142857143V253.3203125C350.3348214285714 253.8504464285714 350.2790178571429 254.3805803571429 350.2790178571429 254.9107142857143C350.2790178571429 276.1160714285715 366.3504464285714 293.359375 387.1930803571429 294.4196428571429H387.1651785714286L394.2522321428572 365.6808035714286C376.1439732142857 370.6473214285715 362.7232142857143 387.0535714285715 362.7232142857143 406.7522321428572C362.7232142857143 430.3571428571429 381.8359375 449.4977678571429 405.46875 449.4977678571429C429.0736607142857 449.4977678571429 448.2142857142858 430.3850446428572 448.2142857142858 406.7522321428572C448.2142857142858 383.3147321428572 429.3247767857144 364.3136160714286 405.9151785714286 364.0625L397.6004464285715 293.5267857142857H397.5725446428572C415.1785714285715 289.5926339285715 427.5390625000001 274.6372767857143 427.9854910714286 255.9709821428572L486.6629464285715 245.5636160714286C487.4720982142858 245.3683035714286 488.2533482142858 245.1729910714286 489.0066964285716 244.9497767857143C494.5591517857144 259.7377232142857 509.1238839285715 270.0055803571429 525.8091517857144 269.3917410714286C546.6517857142857 268.5825892857143 562.890625 251.0602678571429 562.109375 230.1897321428571z" />
    <glyph glyph-name="thumb_zip_i"
      unicode="&#xF17E;"
      horiz-adv-x="777.9296875" d=" M347.265625 411.328125V424.4977678571429V427.7901785714286H395.703125V424.4977678571429H411.8582589285714V411.328125H395.703125V408.0357142857143H347.265625V411.328125zM347.265625 350.1953125V363.3649553571429V366.6294642857143C347.265625 366.6294642857143 395.703125 366.6294642857143 395.703125 366.6015625V363.3091517857143H411.8582589285714V350.1395089285715H395.703125V346.875H347.265625V350.1953125zM347.265625 289.1741071428571V302.34375V305.6361607142857H395.703125V302.34375H411.8582589285714V289.1741071428571H395.703125V285.8816964285714H347.265625V289.1741071428571zM347.265625 228.1808035714286V241.3504464285715V244.6149553571429H395.703125V241.3225446428572H411.8582589285714V228.1529017857143H395.703125V224.8604910714286H347.265625V228.1808035714286zM347.265625 167.1037946428572V180.2455357142857V183.5379464285714H395.703125V180.2455357142857H411.8582589285714V167.0758928571428H395.703125V163.7834821428571H347.265625V167.1037946428572zM347.265625 106.0825892857143V119.2522321428572V122.5446428571428H395.703125V119.2522321428572H411.8582589285714V106.0825892857143H395.703125V102.7901785714286H347.265625V106.0825892857143zM411.8024553571429 45.0613839285714H395.6473214285715V41.7689732142857H347.2098214285715V45.0613839285714V58.2310267857143V61.5234375H395.6473214285715V58.2310267857143H411.8024553571429V45.0613839285714zM430.6082589285715 88.7276785714286V75.5580357142857V72.265625H382.1707589285715V75.5580357142857H366.015625V88.7276785714286H382.1707589285715V92.0200892857143H430.6082589285715V88.7276785714286zM430.6082589285715 149.7209821428571V136.5513392857143V133.2589285714286H382.1707589285715V136.5513392857143H366.015625V149.7209821428571H382.1707589285715V153.0133928571429H430.6082589285715V149.7209821428571zM430.6082589285715 210.8537946428572V197.6841517857143V194.4196428571428H382.1707589285715V197.6841517857143H366.015625V210.8537946428572H382.1707589285715V214.1462053571428H430.6082589285715V210.8537946428572zM430.6082589285715 271.8470982142857V258.6774553571429V255.3850446428572H382.1707589285715V258.6774553571429H366.015625V271.8470982142857H382.1707589285715V275.1395089285715H430.6082589285715V271.8470982142857zM430.6082589285715 332.8404017857143V319.6707589285715V316.3783482142857H382.1707589285715V319.6707589285715H366.015625V332.8404017857143H382.1707589285715V336.1328125H430.6082589285715V332.8404017857143zM430.6082589285715 393.9732142857143V380.8035714285715V377.5111607142857H382.1707589285715V380.8035714285715H366.015625V393.9732142857143H382.1707589285715V397.265625H430.6082589285715V393.9732142857143zM430.6082589285715 454.9665178571428V441.796875V438.5044642857143H382.1707589285715V441.796875H366.015625V454.9665178571428H382.1707589285715V458.2589285714286H430.6082589285715V454.9665178571428z" />
    <glyph glyph-name="timeline_view"
      unicode="&#xF17F;"
      horiz-adv-x="636.2723214285714" d=" M0 0.0558035714286H90.9040178571429V500H0V0.0558035714286zM136.3560267857143 0.0558035714286H636.2723214285714V227.3158482142857H136.3560267857143V0.0558035714286zM136.3560267857143 500V272.7678571428571H636.2723214285714V500H136.3560267857143z" />
    <glyph glyph-name="timer"
      unicode="&#xF180;"
      horiz-adv-x="438.2533482142857" d=" M240.5691964285715 196.9308035714286L309.5982142857143 311.4955357142857L195.0334821428572 242.4665178571429L240.5691964285715 196.9308035714286zM250.0558035714286 434.9888392857143V437.5H281.3058035714286C298.5770089285714 437.5 312.5837053571429 451.4787946428572 312.5837053571429 468.75C312.5837053571429 485.9933035714286 298.6049107142857 500 281.3058035714286 500H156.2779017857143C139.0066964285714 500 125.0279017857143 485.9933035714286 125.0279017857143 468.75C125.0279017857143 451.4787946428572 139.0066964285714 437.5 156.2779017857143 437.5H187.5279017857143V435.0167410714286C81.5569196428572 419.8102678571429 0 328.90625 0 218.7220982142857C0 97.9073660714286 97.9352678571429 -0.0279017857143 218.7779017857143 -0.0279017857143S437.5558035714286 97.9073660714286 437.5558035714286 218.7220982142857C437.5837053571429 328.90625 356.0267857142857 419.8102678571429 250.0558035714286 434.9888392857143zM218.7779017857143 62.4720982142857C132.4497767857143 62.4720982142857 62.5 132.421875 62.5 218.7220982142857S132.4497767857143 374.9720982142857 218.7779017857143 374.9720982142857S375.0558035714286 305.0223214285715 375.0558035714286 218.7220982142857S305.1060267857143 62.4720982142857 218.7779017857143 62.4720982142857z" />
    <glyph glyph-name="trash"
      unicode="&#xF181;"
      horiz-adv-x="468.75" d=" M437.5 392.8571428571429H31.25C13.9787946428572 392.8571428571429 0 375.5301339285715 0 358.2589285714286C0 340.9877232142857 14.0066964285714 322.5446428571429 31.25 322.5446428571429H37.9464285714286V71.4285714285715C37.9464285714286 36.9140625 65.9319196428572 0 100.4464285714286 0H366.0714285714286C400.5859375 0 428.5714285714286 36.9140625 428.5714285714286 71.4285714285715V322.5446428571429H437.5C454.7712053571429 322.5446428571429 468.75 340.9877232142858 468.75 358.2589285714286C468.75 375.5301339285715 454.7712053571429 392.8571428571429 437.5 392.8571428571429zM357.1428571428572 71.4285714285715H107.1428571428571V322.5446428571429H357.1428571428572V71.4285714285715zM187.5 465.4017857142857H281.25C298.5212053571429 465.4017857142857 312.5 446.9587053571429 312.5 429.6875H343.75C343.75 464.2020089285714 315.7645089285715 500 281.25 500H187.5C152.9854910714286 500 125 464.2020089285714 125 429.6875H156.25C156.25 446.9587053571429 170.2287946428572 465.4017857142857 187.5 465.4017857142857zM160.7142857142857 105.8872767857143C170.5357142857143 105.8872767857143 178.5714285714286 111.6350446428571 178.5714285714286 118.7220982142857V272.8794642857143C178.5714285714286 279.9665178571429 170.5357142857143 285.7142857142857 160.7142857142857 285.7142857142857C150.8649553571429 285.7142857142857 142.8571428571429 279.9386160714286 142.8571428571429 272.8794642857143V118.75C142.8571428571429 111.6350446428571 150.8649553571429 105.8872767857143 160.7142857142857 105.8872767857143zM232.1428571428572 105.8872767857143C241.9921875 105.8872767857143 250 111.6350446428571 250 118.7220982142857V272.8794642857143C250 279.9665178571429 241.9642857142857 285.7142857142857 232.1428571428572 285.7142857142857S214.2857142857143 279.9386160714286 214.2857142857143 272.8794642857143V118.75C214.2857142857143 111.6350446428571 222.2935267857143 105.8872767857143 232.1428571428572 105.8872767857143zM303.5714285714286 105.8872767857143C313.4486607142857 105.8872767857143 321.4285714285715 111.6350446428571 321.4285714285715 118.7220982142857V272.8794642857143C321.4285714285715 279.9665178571429 313.4486607142857 285.7142857142857 303.5714285714286 285.7142857142857C293.6941964285714 285.7142857142857 285.7142857142857 279.9386160714286 285.7142857142857 272.8794642857143V118.75C285.7142857142857 111.6350446428571 293.6941964285714 105.8872767857143 303.5714285714286 105.8872767857143z" />
    <glyph glyph-name="update"
      unicode="&#xF182;"
      horiz-adv-x="500.4185267857143" d=" M500.4185267857143 499.6930803571428V342.4107142857142V341.2388392857142V311.2444196428571C500.4185267857143 294.0569196428571 486.4118303571429 280.1339285714286 469.1406250000001 280.1339285714286H437.8627232142858V279.9665178571429H435.044642857143H279.6316964285715L381.4174107142858 381.25C347.5725446428572 414.5368303571429 301.5625 435.546875 250.2232142857143 435.546875C146.5680803571429 435.546875 62.5558035714286 351.9810267857143 62.5558035714286 248.8839285714286C62.5558035714286 145.8147321428571 146.5959821428571 62.2209821428571 250.2232142857143 62.2209821428571C309.7098214285715 62.2209821428571 362.6395089285714 89.8716517857142 397.0424107142857 132.8404017857143L441.3504464285715 88.4486607142857C395.4520089285715 34.4029017857143 326.8973214285714 0 250.2232142857143 0C112.0256696428572 0 0 111.4397321428572 0 248.8839285714286C0 386.3560267857143 112.0535714285715 497.7957589285714 250.2232142857143 497.7957589285714C318.8337053571429 497.7957589285714 380.7756696428571 470.1171875 425.9207589285715 425.5859375L500.4185267857143 499.6930803571428z" />
    <glyph glyph-name="upload"
      unicode="&#xF183;"
      horiz-adv-x="399.8883928571429" d=" M0 249.9441964285715L199.9441964285715 499.8604910714286L399.8883928571429 249.9441964285715H299.9162946428572V0.0279017857142H99.9720982142857V249.9441964285715H0z" />
    <glyph glyph-name="user"
      unicode="&#xF184;"
      horiz-adv-x="571.4564732142857" d=" M497.7678571428572 101.3671875C497.7678571428572 101.3671875 455.3571428571429 114.453125 386.5513392857144 138.671875C385.9095982142858 150.6417410714286 376.9252232142857 166.7410714285714 361.0770089285715 166.7410714285714H359.375H338.7555803571429L342.0479910714286 214.5647321428571C376.2555803571429 230.6361607142857 391.5178571428572 255.8314732142857 398.0189732142857 289.3973214285715C402.9017857142857 314.5926339285715 408.4263392857143 342.9966517857143 408.4263392857143 377.7622767857143C408.4263392857143 412.0535714285715 399.2466517857143 499.9720982142857 284.8214285714286 499.9720982142857C284.4587053571429 499.9720982142857 283.984375 499.9720982142857 283.5658482142857 499.9720982142857C282.9520089285714 499.9720982142857 282.4497767857143 499.9720982142857 281.9475446428572 499.9720982142857C179.5200892857143 500 163.5602678571429 414.1462053571429 163.5602678571429 377.7901785714286C163.5602678571429 355.9151785714286 169.4754464285714 313.6439732142857 173.9397321428572 289.4252232142857C179.4363839285714 259.765625 193.4151785714286 227.2600446428571 229.8828125 214.5926339285715L233.1473214285715 166.7689732142857H212.5H210.8258928571429C194.9497767857143 166.7689732142857 186.2165178571429 149.5535714285715 185.3236607142857 137.5837053571428C118.75 112.2488839285714 66.3225446428571 98.046875 66.3225446428571 98.046875C16.5178571428571 78.7109374999999 1.4229910714286 91.3783482142857 0 66.1830357142857V46.5959821428571V23.1584821428571L0.8649553571429 17.0200892857143C1.7299107142857 13.6997767857142 3.3761160714286 10.8816964285714 5.3571428571429 8.3147321428571C8.203125 4.5758928571428 11.9977678571429 2.2042410714285 16.4899553571429 0.9765625C18.1640625 0.5580357142857 19.8381696428572 0.0279017857142 21.6796875 0.0279017857142L21.6796875 0.0279017857142H549.1071428571429C555.2455357142858 0.0279017857142 560.5189732142858 2.7064732142857 564.3694196428572 7.1149553571428C570.1729910714286 12.4720982142857 571.4564732142858 23.1584821428571 571.4564732142858 23.1584821428571V46.5959821428571C571.4564732142858 46.5959821428571 571.4564732142858 59.4308035714286 571.4564732142858 64.3136160714286C571.4564732142858 65.0111607142857 571.1216517857143 67.3828125 570.6752232142858 68.8616071428571C565.234375 86.4118303571428 550.3627232142858 77.7343749999999 497.7678571428572 101.3671875z" />
    <glyph glyph-name="video_player"
      unicode="&#xF185;"
      horiz-adv-x="785.7142857142858" d=" M353.4598214285715 334.3470982142857L478.4877232142858 249.4419642857143L353.4598214285715 164.5089285714286L353.4598214285715 334.3470982142857L353.4598214285715 334.3470982142857zM785.7421875 448.9955357142857V51.0323660714286C785.7421875 22.8515625 761.9698660714287 0 732.6450892857142 0H53.0691964285714C23.7444196428571 0 -0.0279017857143 22.8515625 -0.0279017857143 51.0323660714286V448.9955357142857C-0.0279017857143 477.1763392857143 23.7444196428571 500.0279017857143 53.0691964285714 500.0279017857143H732.5892857142857C761.9419642857143 500.0279017857143 785.6863839285714 477.1763392857143 785.7421875 448.9955357142857zM538.7834821428571 250C538.7834821428571 330.5803571428571 473.4375 395.9263392857143 392.8292410714286 395.9263392857143S246.9029017857143 330.5803571428571 246.9029017857143 250S312.2488839285715 104.0736607142857 392.8292410714286 104.0736607142857S538.7834821428571 169.3917410714286 538.7834821428571 250z" />
    <glyph glyph-name="view_public"
      unicode="&#xF186;"
      horiz-adv-x="779.5200892857143" d=" M779.6037946428571 251.1997767857143C779.6037946428571 212.7511160714286 651.4787946428572 0 389.8158482142857 0C152.2321428571428 0 0.0279017857142 213.6997767857143 0.0279017857142 251.1997767857143C0.0279017857142 284.6540178571429 148.8839285714285 499.4977678571428 387.5837053571429 499.4977678571428C643.1082589285714 499.4977678571428 779.6037946428571 284.6540178571429 779.6037946428571 251.1997767857143zM389.6484375 0M589.1183035714287 249.1350446428572C589.1183035714287 359.7935267857143 499.4140625000001 449.4977678571429 388.755580357143 449.4977678571429S188.3928571428572 359.7935267857143 188.3928571428572 249.1350446428572S278.0970982142857 48.7723214285714 388.755580357143 48.7723214285714S589.1183035714287 138.4765625 589.1183035714287 249.1350446428572zM388.755580357143 412.1372767857143C298.7165178571429 412.1372767857143 225.7254464285715 339.1462053571429 225.7254464285715 249.1071428571429S298.716517857143 86.0770089285715 388.755580357143 86.0770089285715S551.7857142857143 159.0680803571428 551.7857142857143 249.1071428571429S478.7667410714286 412.1372767857143 388.755580357143 412.1372767857143z" />
    <glyph glyph-name="viewer"
      unicode="&#xF187;"
      horiz-adv-x="500" d=" M50 450H225V500H50C22.4888392857143 500 0 477.5111607142857 0 450V275H50V450zM200 225L100 100H400L325 200L274.2466517857144 132.2544642857143L200 225zM375 337.5C375 358.2589285714286 358.2589285714286 375 337.5 375C316.7410714285714 375 300 358.2589285714286 300 337.5S316.7410714285714 300 337.5 300C358.2589285714286 300 375 316.7410714285715 375 337.5M450.0000000000001 500H275.0000000000001V450H450.0000000000001V275H500V450C500 477.5111607142857 477.5111607142858 500 450.0000000000001 500M450.0000000000001 50H275.0000000000001V0H450.0000000000001C477.5111607142858 0 500 22.4888392857142 500 50V225H450.0000000000001V50zM50 225H0V49.9999999999999C0 22.4888392857142 22.4888392857143 0 50 0H225V50H50V225z" />
    <glyph glyph-name="viewer_folder"
      unicode="&#xF188;"
      horiz-adv-x="411.8582589285714" d=" M353.0133928571429 500.1116071428571H58.8448660714286C26.3392857142857 500.1116071428571 0 473.7723214285714 0 441.2667410714286V58.8448660714286C0 26.3392857142857 26.3392857142857 0 58.8448660714286 0H353.0133928571429C385.5189732142857 0 411.8582589285714 26.3392857142857 411.8582589285714 58.8448660714286V441.2667410714286C411.8582589285714 473.7444196428571 385.4910714285714 500.1116071428571 353.0133928571429 500.1116071428571zM323.6049107142857 147.0982142857143H88.2533482142857V176.5066964285714H323.6049107142857V147.0982142857143zM323.6049107142857 235.3515625H88.2533482142857V264.7600446428571H323.6049107142857V235.3515625zM323.6049107142857 323.6049107142857H88.2533482142857V353.0133928571429H323.6049107142857V323.6049107142857z" />
    <glyph glyph-name="warning"
      unicode="&#xF189;"
      horiz-adv-x="499.94419642857144" d=" M249.9720982142858 0C388.0301339285715 0 499.9441964285715 111.9140624999999 499.9441964285715 249.9720982142857C499.9441964285715 388.0301339285714 388.0301339285715 499.9441964285714 249.9720982142858 499.9441964285714C111.9140625 499.9441964285714 0 388.0301339285714 0 249.9720982142857C0 111.9140624999999 111.9140625 0 249.9720982142858 0zM204.7712053571429 369.921875C202.5585658482143 387.0507645089286 232.7008928571429 406.1941964285715 249.9720982142858 406.1941964285715C267.2433035714286 406.1941964285715 297.3856305803572 387.0507645089286 295.1729910714286 369.921875L275.6417410714286 218.7220982142857C273.4291294642857 201.5932170758928 267.2433035714286 187.4720982142857 249.9720982142858 187.4720982142857C232.7287946428572 187.4720982142857 226.5150669642858 201.5932170758928 224.3024553571429 218.7220982142857zM249.4140625000001 156.7801339285715C266.9921875000001 156.7801339285715 281.2220982142857 142.5502232142857 281.2220982142857 124.9720982142857C281.2220982142857 107.3939732142857 266.9921875000001 93.1640625 249.4140625000001 93.1640625C231.8638392857143 93.1640625 217.6060267857143 107.3939732142857 217.6060267857143 124.9720982142857C217.6060267857143 142.5502232142857 231.8359375000001 156.7801339285715 249.4140625000001 156.7801339285715z" />
    <glyph glyph-name="zoom_in"
      unicode="&#xF18A;"
      horiz-adv-x="499.8604910714286" d=" M495.2845982142857 70.9263392857143L406.1662946428571 160.0167410714286C428.0133928571429 194.0848214285714 436.9419642857143 237.3883928571429 436.9419642857143 280.8872767857144C436.9419642857143 401.7857142857143 339.9274553571429 499.8325892857143 218.9732142857143 499.8325892857143C98.046875 499.8604910714286 0 399.8604910714286 0 278.9341517857144C0 157.9799107142857 98.046875 62.9185267857143 218.9732142857143 62.9185267857143C262.4720982142857 62.9185267857143 305.7756696428572 71.8470982142857 339.84375 93.6662946428572L428.9620535714286 4.5200892857143C435.0167410714286 -1.5345982142857 445.0055803571429 -1.5345982142857 451.0602678571429 4.5200892857143L495.3125000000001 48.7723214285714C501.3950892857143 54.8828125 501.3950892857143 64.84375 495.2845982142857 70.9263392857143zM218.9732142857143 124.4698660714286C132.7566964285714 124.4698660714286 62.5837053571429 195.6473214285715 62.5837053571429 281.8638392857144C62.5837053571429 368.0524553571429 132.7845982142857 438.2533482142857 218.9732142857143 438.2533482142857C305.2455357142857 438.2533482142857 375.3906250000001 368.0524553571429 375.3906250000001 281.8638392857144C375.3906250000001 195.6473214285715 305.2176339285715 124.4698660714286 218.9732142857143 124.4698660714286zM249.9441964285714 312.4720982142857H312.5V249.9162946428572H249.9441964285714V187.3604910714286L187.3883928571428 187.3604910714286L187.3883928571428 249.9162946428572H124.8046875V312.4720982142857H187.3604910714286V375.0279017857143H249.9162946428572V312.4720982142857z" />
    <glyph glyph-name="zoom_out"
      unicode="&#xF18B;"
      horiz-adv-x="499.8604910714286" d=" M495.2845982142857 70.9263392857143L406.1662946428571 160.0167410714286C428.0133928571429 194.0848214285714 436.9419642857143 237.3883928571429 436.9419642857143 280.8872767857144C436.9419642857143 401.7857142857143 339.9274553571429 499.8325892857143 218.9732142857143 499.8325892857143C98.046875 499.8604910714286 0 399.8604910714286 0 278.9341517857144C0 157.9799107142857 98.046875 62.9185267857143 218.9732142857143 62.9185267857143C262.4720982142857 62.9185267857143 305.7756696428572 71.8470982142857 339.84375 93.6662946428572L428.9620535714286 4.5200892857143C435.0167410714286 -1.5345982142857 445.0055803571429 -1.5345982142857 451.0602678571429 4.5200892857143L495.3125000000001 48.7723214285714C501.3950892857143 54.8828125 501.3950892857143 64.84375 495.2845982142857 70.9263392857143zM218.9732142857143 124.4698660714286C132.7566964285714 124.4698660714286 62.5837053571429 195.6473214285715 62.5837053571429 281.8638392857144C62.5837053571429 368.0524553571429 132.7845982142857 438.2533482142857 218.9732142857143 438.2533482142857C305.2455357142857 438.2533482142857 375.3906250000001 368.0524553571429 375.3906250000001 281.8638392857144C375.3906250000001 195.6473214285715 305.2176339285715 124.4698660714286 218.9732142857143 124.4698660714286zM124.8046875 249.9162946428572H312.5V312.4720982142857H124.8046875V249.9162946428572z" />
  </font>
</defs>
</svg>
#figIcon) format('svg')}figshare-overlay .fs-dataset-display .fs-selector,figshare-widget .fs-dataset-display .fs-selector{color:#ffc72c!important}figshare-overlay .fs-dataset-display .fs-selector:before,figshare-widget .fs-dataset-display .fs-selector:before{border-top-color:#003a70!important}figshare-overlay .fs-dataset-display .fs-selector.fs-active,figshare-widget .fs-dataset-display .fs-selector.fs-active{color:#003a70!important}figshare-overlay .fs-dataset-display .fs-selector.fs-active:before,figshare-widget .fs-dataset-display .fs-selector.fs-active:before{border-top-color:#fff!important}figshare-overlay .fs-dataset-display .fs-carousel-left-control.fs-active,figshare-overlay .fs-dataset-display .fs-carousel-right-control.fs-active,figshare-widget .fs-dataset-display .fs-carousel-left-control.fs-active,figshare-widget .fs-dataset-display .fs-carousel-right-control.fs-active{color:#003a70!important}figshare-widget.fs-collection-viewer{z-index:1;width:100%;height:100%;min-height:400px;position:relative}figshare-widget.fs-collection-viewer .fs-widget-description{background-color:#f5f5f5;border-top:1px solid #ddd;padding:14px}figshare-widget.fs-collection-viewer .fs-widget-description .fs-file-title{margin-bottom:7px;font-weight:700}figshare-widget.fs-collection-viewer .fs-vertical-align-wrap:after{content:"";display:inline-block;vertical-align:middle;height:100%}figshare-widget.fs-collection-viewer .fs-vertical-align-wrap .fs-vertical-align-content{display:inline-block;vertical-align:middle}figshare-widget.fs-collection-viewer.fs-responsive-hide-text .fs-button-text{display:none!important}figshare-widget.fs-collection-viewer.fs-responsive-hide-text .fs-cite{width:28px}figshare-widget.fs-collection-viewer.fs-responsive-hide-text .fs-cite:before{left:8px}figshare-widget.fs-collection-viewer.fs-responsive-hide-text .fs-details-container .fs-button-text{display:inline!important}figshare-widget.fs-collection-viewer .fs-file-viewer{width:100%}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button{height:32px;color:#999;text-decoration:none;vertical-align:middle;display:inline-block}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:after{display:inline-block;margin-left:3px;content:"\F136";font-size:10px;line-height:32px;height:32px;color:transparent}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .fs-button-text,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .fs-logo{display:inline-block;height:32px;line-height:32px;font-size:13px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .figshare-logo{width:32px;height:32px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .style0{fill:#58585a}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .style1{fill:#d1d2d4}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .style2{fill:#818286}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .style3{fill:#a8a9ad}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:hover{color:#556471}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:hover .style0{fill:#566471}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:hover .style1{fill:#a2cd3c}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:hover .style2{fill:#c54c59}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:hover .style3{fill:#5bc4bd}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button:hover:after{color:#556471}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header{background-color:#f5f5f5;padding:14px;border-bottom:1px solid #ddd}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header.fs-with-stats{position:relative;overflow:hidden}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header.fs-with-stats .fs-title-section{margin-right:200px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header .fs-stats-wrap{position:absolute;top:0;right:0;width:200px;font-size:11px;line-height:16px;height:100%}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header .fs-stats-count{font-size:14px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header .fs-stats-part{width:33%;display:inline-block;text-align:center;height:100%;border-left:1px solid #ddd;-moz-box-sizing:border-box;box-sizing:border-box}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-header h1{font-size:18px;line-height:26px;margin:0;font-weight:700}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-title{line-height:21px;white-space:nowrap;max-width:100%;overflow:hidden;text-overflow:ellipsis}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-title em{color:#999;font-style:normal}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download-wrap{display:inline-block;position:relative}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls{background-color:#f5f5f5;padding:10px 14px 8px;text-align:justify;-ms-text-justify:distribute-all-lines;text-justify:distribute-all-lines;height:40px;border-top:1px solid #ddd;-moz-box-sizing:content-box;box-sizing:content-box;color:#464646}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls .fs-download,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls button{background-color:#fff;line-height:0;padding:0 7px;cursor:pointer;border:1px solid #ddd;height:24px;min-width:22px;text-align:center;border-radius:3px;margin-left:7px;vertical-align:middle;-moz-box-sizing:border-box;box-sizing:border-box;font-size:13px;position:relative}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls .fs-download:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls button:before{display:inline-block;vertical-align:middle}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls .fs-download .fs-button-text,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls button .fs-button-text{display:inline-block;margin-left:7px;vertical-align:middle}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-viewer-controls:after{display:inline-block;width:100%;line-height:0;font-size:0;content:""}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download-menu{position:absolute;display:block;background:#fff;border-radius:3px;border:1px solid #ddd;white-space:nowrap;left:auto;right:0;top:40px;text-align:left;padding:12px 20px 9px 16px;line-height:24px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download-menu:after{width:0;height:0;border-color:transparent;border-left:10px solid transparent;border-right:10px solid transparent;border-bottom:10px solid #fff;content:" ";position:absolute;top:-10px;right:36px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download-menu:before{width:0;height:0;border-color:transparent;border-left:11px solid transparent;border-right:11px solid transparent;border-bottom:11px solid #ddd;content:" ";position:absolute;top:-12px;right:36px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download-menu a{display:block;color:#000;font-weight:700;text-decoration:none}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-viewer-container{position:relative;background-color:#fff}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-viewer{position:relative;height:100%;overflow:hidden;z-index:0;border-left:1px solid #f5f5f5;border-right:1px solid #f5f5f5}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-viewer .figshare-loader{height:100%}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-listing{overflow:hidden;top:0;left:0;right:0;bottom:0;position:absolute;background-color:hsla(0,0%,100%,.8)}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-listing-wrap{position:absolute;top:0;left:0;right:0;bottom:-1px;border-bottom:1px solid #ddd;z-index:1}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-listing-wrap .fs-arrow{position:absolute;bottom:1px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-listing-wrap .fs-arrow:after{width:0;height:0;border-color:transparent;border-left:10px solid transparent;border-right:10px solid transparent;border-top:10px solid #fff;content:" ";position:absolute;left:2px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-listing-wrap .fs-arrow:before{width:0;height:0;border-color:transparent;border-left:11px solid transparent;border-right:11px solid transparent;border-top:11px solid #ddd;content:" ";position:absolute;left:1px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-container{max-height:80%;overflow-y:auto;position:absolute;bottom:0;width:100%;box-shadow:0 -3px 22px rgba(0,0,0,.12);border:1px solid #f5f5f5;-moz-box-sizing:border-box;box-sizing:border-box}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file{padding:14px 200px 14px 14px;border-bottom:1px solid #ddd;background-color:#fff;position:relative}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file:hover{background-color:#f5f5f5}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file .fs-details-buttons{position:absolute;top:14px;right:0}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file .fs-details-item{margin-right:14px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file a{color:#000;text-decoration:none;cursor:pointer}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file:last-child{border-bottom:0}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-buttons,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-title{display:inline;max-width:100%;white-space:nowrap;cursor:pointer}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-name{overflow:hidden;text-overflow:ellipsis}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-details-item{display:inline-block}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download{display:inline-block;text-decoration:none;color:#000}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-download:before{content:"\F126";line-height:22px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls button.fs-next-page,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls button.fs-prev-page{padding:0;width:24px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls button.fs-next-page:before,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls button.fs-prev-page:before{display:inline-block;font-size:10px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls .fs-prev-page:before{content:"\F107";line-height:21px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls .fs-next-page{width:24px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls .fs-next-page:before{content:"\F108";line-height:21px}figshare-widget.fs-collection-viewer .fs-file-viewer button.fs-details{padding:0;width:24px}figshare-widget.fs-collection-viewer .fs-file-viewer button.fs-details:before{content:"\F142";font-size:10px;line-height:21px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-share:before{content:"\F15F"}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-enlarge:before{content:"\F15C"}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-cite span.fs-button-text{margin-left:14px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-cite:before{content:"\F111";position:absolute;top:-2px;font-size:22px}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button{display:inline-block;vertical-align:middle}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .fs-logo{display:inline-block}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-figshare-button .fs-button-text{margin-left:7px;display:inline-block;color:#999}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-controls-group,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-file-controls,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-misc-controls{display:inline-block;vertical-align:middle}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade{transition:opacity .25s ease-in}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade-appear,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade-enter{transition:none;opacity:.01}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade-appear.fs-fade-appear-active,figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade-enter.fs-fade-enter-active{opacity:1;transition:opacity .25s ease-in}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade-leave{opacity:1}figshare-widget.fs-collection-viewer .fs-file-viewer .fs-fade-leave.fs-fade-leave-active{opacity:.01}figshare-widget.fs-collection-viewer>.figshare-loader{width:100%;height:100%}figshare-widget.fs-collection-viewer>.figshare-loader.fs-loading{position:static}figshare-widget.fs-collection-viewer button.fs-cite{display:none}figshare-widget.fs-collection-viewer button.fs-download{overflow:visible}figshare-overlay{color:#464646}figshare-overlay .fs-icon-base{font-family:figIcon;speak:none;font-style:normal;font-weight:400;font-variant:normal;text-transform:none;line-height:1;letter-spacing:0;-webkit-font-feature-settings:"liga";-moz-font-feature-settings:"liga=1";-moz-font-feature-settings:"liga";-ms-font-feature-settings:"liga" 1;-o-font-feature-settings:"liga";font-feature-settings:"liga";-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}figshare-overlay .fs-file-listing{overflow-x:hidden;height:100%}figshare-overlay .fs-file-listing .fs-file{position:relative;width:100%;height:80px;border-bottom:1px solid #464646;transition:background .2s ease-in;cursor:pointer}figshare-overlay .fs-file-listing .fs-file.fs-active,figshare-overlay .fs-file-listing .fs-file:hover{background:#333}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container{border-bottom:1px solid #464646;width:80px;height:80px;overflow:hidden;display:inline-block;position:absolute;vertical-align:top}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container{overflow:hidden;width:68px;height:68px;margin:6px;display:block;background:#fff}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container>div,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container>img{width:100%;height:100%}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview{background-image:url('data:image/jpg;base64,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')}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-audio{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-audio:before{content:"\F170";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-archive{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-archive:before{content:"\F17E";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-molecule{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-molecule:before{content:"\F17D";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-dataset{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-dataset:before{content:"\F173";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document_canvas,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document_failsafe{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document_canvas:before,figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-document_failsafe:before{content:"\F14C";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-txt{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-txt:before{content:"\F172";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-kml{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-kml:before{content:"\F17B";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-viewer3d{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-viewer3d:before{content:"\F16D";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-jupyter{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-jupyter:before{content:"\F179";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-graph{text-align:center;content:"";background:#464646;color:#f0f0f0}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container .fs-icon-container .fs-generic-preview.fs-graph:before{content:"\F177";text-align:center;font-size:35px;vertical-align:middle;display:inline-block;line-height:68px}figshare-overlay .fs-file-listing .fs-file .fs-file-details-container{display:inline-block;font-weight:700;font-size:11px;width:100%;padding-left:80px;-moz-box-sizing:border-box;box-sizing:border-box}figshare-overlay .fs-file-listing .fs-file .fs-file-details-container .fs-file-title{margin:7px 7px 7px 3px;line-height:13px;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;max-width:100%;color:#fff}figshare-overlay .fs-file-listing .fs-file .fs-file-details-container .fs-file-size{margin:0 0 0 3px;display:block;color:#999}figshare-overlay .fs-file-listing .fs-file .fs-not-previewable{zoom:initial!important}figshare-overlay .fs-file-listing .fs-file .fs-not-previewable:after,figshare-overlay .fs-file-listing .fs-file .fs-not-previewable:before{height:1px}figshare-overlay .fs-file-listing .fs-file .fs-not-previewable:before{-webkit-transform:rotate(45deg);transform:rotate(45deg)}figshare-overlay .fs-file-listing .fs-file .fs-not-previewable:after{-webkit-transform:rotate(-45deg);transform:rotate(-45deg)}figshare-overlay .fs-file-listing .fs-file .fs-not-previewable-message{font-size:9px;line-height:9px;display:inline-block;vertical-align:middle;background:none;box-shadow:none}figshare-overlay .fs-large-viewer{width:100%;height:100%;margin:0;padding:0;white-space:nowrap;text-align:left}figshare-overlay .fs-large-viewer .fs-hide-full-description{position:absolute;top:-23px;left:50%;margin-left:-87px;padding:14px 32px 0;background-color:#efefef;border-radius:3px;box-shadow:0 -3px 5px rgba(0,0,0,.11);cursor:pointer}figshare-overlay .fs-large-viewer .fs-hide-full-description:before{content:"\F12A";font-size:7px;margin-right:7px}figshare-overlay .fs-large-viewer .fs-file-description-wrap{text-align:left;background-color:#efefef;margin-top:1px;white-space:normal;padding:14px;position:relative;line-height:21px}figshare-overlay .fs-large-viewer .fs-file-description-wrap .fs-file-title{margin-bottom:7px;font-weight:700}figshare-overlay .fs-large-viewer .fs-file-description-wrap a{text-decoration:none}figshare-overlay .fs-large-viewer .fs-file-description-wrap.fs-expanded .fs-file-description-full{position:absolute;visibility:visible;top:auto;bottom:0;left:0;right:0;padding:14px;min-height:111px;background:#ddd;background:linear-gradient(180deg,#ddd 0,#efefef 7px);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='@startColor',endColorstr='@endColor',GradientType=0);z-index:300}figshare-overlay .fs-large-viewer .fs-audio-wrapper,figshare-overlay .fs-large-viewer .fs-media-wrapper{position:relative}figshare-overlay .fs-large-viewer .fs-audio-wrapper{background-color:#fff}figshare-overlay .fs-large-viewer .fs-file-description-excerpt{overflow:hidden;max-height:63px}figshare-overlay .fs-large-viewer .fs-file-description-show-more{text-align:center;position:absolute;bottom:0;line-height:34px;width:100%;left:0;cursor:pointer;background:transparent;background:linear-gradient(180deg,transparent 0,#efefef 14px);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='@startColor',endColorstr='@endColor',GradientType=0)}figshare-overlay .fs-large-viewer .fs-show-more:before{content:"\F118";font-size:7px;margin-right:7px}figshare-overlay .fs-large-viewer .fs-file-description-full{position:absolute;top:14px;left:14px;right:14px;visibility:hidden}figshare-overlay .fs-large-viewer .fs-file-description-full .fs-description{max-height:420px;overflow-y:auto}figshare-overlay .fs-large-viewer .fs-not-previewable-message{box-shadow:0 0 50px 30px #eee;background:#eee;font-size:18px}figshare-overlay .fs-large-viewer .fs-files-list{width:20%;background:#000;max-width:280px;min-width:180px;position:relative;display:inline-block;height:100%;vertical-align:top}figshare-overlay .fs-large-viewer .fs-file-viewer{overflow:hidden}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container{width:80%;height:80%;position:relative;display:inline-block;vertical-align:middle;box-shadow:0 0 150px 10px hsla(0,0%,59%,.3)}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-figshare-viewer{overflow:hidden;width:100%;background-color:#fff;display:inline}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-figshare-viewer .fs-display{position:relative;overflow:hidden;background:#fff}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-figshare-viewer .fs-not-previewable{background-color:#efefef}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-figshare-viewer .fs-not-previewable:after,figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-figshare-viewer .fs-not-previewable:before{background-color:#ddd;height:2px}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-figshare-viewer .figshare-loader{position:absolute;height:100%;top:0;left:0;overflow:auto}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-file-details{line-height:40px;height:40px;display:inline-block;text-align:center;width:100%;white-space:nowrap;font-size:14px;margin-top:1px;background-color:#efefef}figshare-overlay .fs-large-viewer .fs-file-viewer .fs-viewer-container .fs-file-name{display:inline-block;vertical-align:middle;max-width:70%;overflow:hidden;text-overflow:ellipsis}figshare-overlay .fs-large-viewer .fs-download-button{display:inline-block;width:auto;background:#000;color:#fff;font-weight:700;border-radius:3px;margin-left:14px;padding:1px 7px;cursor:pointer;line-height:24px;vertical-align:middle;text-decoration:none}figshare-overlay .fs-large-viewer .fs-download-button:before{content:"\F126";vertical-align:middle;padding:0 4px 2px 0;font-size:11px;display:inline-block}figshare-overlay .fs-large-viewer .fs-file-viewer{width:80%;height:100%;vertical-align:middle;text-align:center;position:relative;display:inline-block;vertical-align:top}figshare-overlay .fs-large-viewer .fs-file-viewer.fs-single-file{width:100%}figshare-overlay .fs-large-viewer .fs-file-viewer.fs-single-file .fs-pagination{display:none}figshare-overlay .fs-large-viewer .fs-file-viewer:before{content:"";display:inline-block;vertical-align:middle;height:100%}figshare-overlay .fs-large-viewer .fs-close-button{position:absolute;width:24px;height:24px;top:24px;left:auto;right:24px;border-radius:3px;background:#000;color:#fff;cursor:pointer}figshare-overlay .fs-large-viewer .fs-close-button:before{font-size:13px;font-weight:700;content:"or press ESC";color:#999;position:absolute;left:-90px}figshare-overlay .fs-large-viewer .fs-close-button:after{content:"\F11E";font-size:10px;display:inline-block}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination{width:100%;height:100%;position:absolute;top:0;left:0}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination .fs-prev-page:before{content:"\F107"}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination .fs-next-page:before{content:"\F108"}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination strong{display:none}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination button{position:absolute;background:transparent;border:0 none transparent;color:#999;font-size:42px;height:70%;width:4%;top:15%;cursor:pointer}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination button:focus{outline:none}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination button[disabled]{color:#606060}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination button[disabled]:hover{color:#606060;cursor:default}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination button:hover{color:#fff}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination .fs-prev-page{left:3%}figshare-overlay .fs-large-viewer .fs-file-viewer>.fs-pagination .fs-next-page{right:3%}figshare-overlay .fs-large-viewer .fs-iframe-loader,figshare-overlay .fs-large-viewer .fs-molecule-display>.figshare-loader,figshare-overlay .fs-large-viewer .fs-viewer3d-display>.figshare-loader{overflow:hidden!important}@media all and (min-width:1400px){figshare-overlay .fs-large-viewer .fs-file-viewer{width:calc(100% - 280px)}}@media (max-width:900px){figshare-overlay .fs-large-viewer .fs-file-viewer{width:calc(100% - 180px)}figshare-overlay .fs-file-listing .fs-file .fs-viewer-container{display:none}figshare-overlay .fs-file-listing .fs-file .fs-file-details-container{padding-left:14px}}figshare-overlay .fs-share-container{position:absolute;width:560px;min-height:300px;top:50%;left:50%;-webkit-transform:translateX(-50%) translateY(-50%);transform:translateX(-50%) translateY(-50%);background:#f5f5f5;padding:40px 40px 60px;border-radius:3px;box-shadow:0 0 13px 1px rgba(0,0,0,.6)}figshare-overlay .fs-share-container h1{text-align:center;font-size:18px;line-height:28px;font-weight:700;color:#464646;margin-bottom:18px}figshare-overlay .fs-share-container .fs-exit{background:#444;width:28px;height:28px;position:absolute;right:-14px;top:-14px;border:1px solid #fff;border-radius:15px;box-shadow:0 0 13px 1px rgba(0,0,0,.6);cursor:pointer}figshare-overlay .fs-share-container .fs-exit:before{content:"\D7";color:#f5f5f5;font-size:20px}figshare-overlay .fs-share-container .fs-social-buttons{width:300px;margin:0 auto}figshare-overlay .fs-share-container .fs-social-buttons>div{border-bottom:1px solid #ddd;padding:28px 0 21px;width:100%;height:30px;text-align:left}figshare-overlay .fs-share-container .fs-social-buttons>div>h3{font-size:18px;font-weight:700;color:#474747;display:inline-block;width:190px}figshare-overlay .fs-share-container .fs-social-buttons>div .fs-share-button{display:inline-block;vertical-align:middle;width:110px}figshare-overlay .fs-share-container .fs-social-buttons>div:last-child{border:0 none transparent}figshare-overlay .fs-iframe-loader{display:inline-block;position:relative!important;background:#fff}figshare-overlay .fs-acs-dialog,figshare-overlay .fs-acs-share{background:rgba(0,0,0,.85)}figshare-overlay .fs-acs-dialog>.fs-container,figshare-overlay .fs-acs-share>.fs-container{background:transparent;width:100%;height:100%}figshare-widget .fs-dataset-display .fs-carousel .fs-selector.fs-active:before{border-top-color:#fff}figshare-widget .fs-dataset-display .fs-carousel .fs-selector:before{border-top-color:#464646}figshare-widget .fs-dataset-display .fs-carousel .fs-carousel-controls .fs-active{color:#464646}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls button{color:#104083;font-weight:700}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls button:hover{border:1px solid #999;background-color:#fff;background:#fff;background:linear-gradient(180deg,#fff 0,#eee);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='@startColor',endColorstr='@endColor',GradientType=0)}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls button:disabled{color:#ddd}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls button:disabled:hover{border:1px solid #ddd;background:#fff}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-download,figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-enlarge{background-color:#104083;border:1px solid #104083;color:#fff;color:#ffc72c}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-download:hover,figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-enlarge:hover{background-color:#104083;background:#104083;background:linear-gradient(180deg,#104083 0,#0c2e5f);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='@startColor',endColorstr='@endColor',GradientType=0);border-color:#082143}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-download{font-weight:700}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-next-page:before{content:"\F14A";line-height:21px}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-file-viewer-controls .fs-prev-page:before{content:"\F156";line-height:21px}figshare-widget .fs-file-viewer.fs-inline-viewer .fs-details-listing .fs-details-buttons a,figshare-widget .fs-file-viewer.fs-inline-viewer .fs-download-menu a{color:#104083}figshare-overlay .fs-large-viewer .fs-dataset-display .fs-carousel .fs-selector.fs-active:before{border-top-color:#fff}figshare-overlay .fs-large-viewer .fs-dataset-display .fs-carousel .fs-selector:before{border-top-color:#464646}figshare-overlay .fs-large-viewer .fs-dataset-display .fs-carousel .fs-carousel-controls .fs-active{color:#464646}figshare-overlay .fs-large-viewer .fs-close-button,figshare-overlay .fs-large-viewer .fs-download-button{background-color:#104083!important;color:#ffc72c!important}figshare-overlay .fs-large-viewer .fs-file-description-show-more,figshare-overlay .fs-large-viewer .fs-hide-full-description{color:#104083}</style><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}
</style><style type="text/css">.fb_hidden{position:absolute;top:-10000px;z-index:10001}.fb_reposition{overflow:hidden;position:relative}.fb_invisible{display:none}.fb_reset{background:none;border:0;border-spacing:0;color:#000;cursor:auto;direction:ltr;font-family:"lucida grande", tahoma, verdana, arial, sans-serif;font-size:11px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:1;margin:0;overflow:visible;padding:0;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;visibility:visible;white-space:normal;word-spacing:normal}.fb_reset>div{overflow:hidden}.fb_link img{border:none}@keyframes fb_transform{from{opacity:0;transform:scale(.95)}to{opacity:1;transform:scale(1)}}.fb_animate{animation:fb_transform .3s forwards}
.fb_dialog{background:rgba(82, 82, 82, .7);position:absolute;top:-10000px;z-index:10001}.fb_reset .fb_dialog_legacy{overflow:visible}.fb_dialog_advanced{padding:10px;-moz-border-radius:8px;-webkit-border-radius:8px;border-radius:8px}.fb_dialog_content{background:#fff;color:#333}.fb_dialog_close_icon{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 0 transparent;cursor:pointer;display:block;height:15px;position:absolute;right:18px;top:17px;width:15px}.fb_dialog_mobile .fb_dialog_close_icon{top:5px;left:5px;right:auto}.fb_dialog_padding{background-color:transparent;position:absolute;width:1px;z-index:-1}.fb_dialog_close_icon:hover{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -15px transparent}.fb_dialog_close_icon:active{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -30px transparent}.fb_dialog_loader{background-color:#f6f7f9;border:1px solid #606060;font-size:24px;padding:20px}.fb_dialog_top_left,.fb_dialog_top_right,.fb_dialog_bottom_left,.fb_dialog_bottom_right{height:10px;width:10px;overflow:hidden;position:absolute}.fb_dialog_top_left{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ye/r/8YeTNIlTZjm.png) no-repeat 0 0;left:-10px;top:-10px}.fb_dialog_top_right{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ye/r/8YeTNIlTZjm.png) no-repeat 0 -10px;right:-10px;top:-10px}.fb_dialog_bottom_left{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ye/r/8YeTNIlTZjm.png) no-repeat 0 -20px;bottom:-10px;left:-10px}.fb_dialog_bottom_right{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ye/r/8YeTNIlTZjm.png) no-repeat 0 -30px;right:-10px;bottom:-10px}.fb_dialog_vert_left,.fb_dialog_vert_right,.fb_dialog_horiz_top,.fb_dialog_horiz_bottom{position:absolute;background:#525252;filter:alpha(opacity=70);opacity:.7}.fb_dialog_vert_left,.fb_dialog_vert_right{width:10px;height:100%}.fb_dialog_vert_left{margin-left:-10px}.fb_dialog_vert_right{right:0;margin-right:-10px}.fb_dialog_horiz_top,.fb_dialog_horiz_bottom{width:100%;height:10px}.fb_dialog_horiz_top{margin-top:-10px}.fb_dialog_horiz_bottom{bottom:0;margin-bottom:-10px}.fb_dialog_iframe{line-height:0}.fb_dialog_content .dialog_title{background:#6d84b4;border:1px solid #365899;color:#fff;font-size:14px;font-weight:bold;margin:0}.fb_dialog_content .dialog_title>span{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yd/r/Cou7n-nqK52.gif) no-repeat 5px 50%;float:left;padding:5px 0 7px 26px}body.fb_hidden{-webkit-transform:none;height:100%;margin:0;overflow:visible;position:absolute;top:-10000px;left:0;width:100%}.fb_dialog.fb_dialog_mobile.loading{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ya/r/3rhSv5V8j3o.gif) white no-repeat 50% 50%;min-height:100%;min-width:100%;overflow:hidden;position:absolute;top:0;z-index:10001}.fb_dialog.fb_dialog_mobile.loading.centered{width:auto;height:auto;min-height:initial;min-width:initial;background:none}.fb_dialog.fb_dialog_mobile.loading.centered #fb_dialog_loader_spinner{width:100%}.fb_dialog.fb_dialog_mobile.loading.centered .fb_dialog_content{background:none}.loading.centered #fb_dialog_loader_close{color:#fff;display:block;padding-top:20px;clear:both;font-size:18px}#fb-root #fb_dialog_ipad_overlay{background:rgba(0, 0, 0, .45);position:absolute;bottom:0;left:0;right:0;top:0;width:100%;min-height:100%;z-index:10000}#fb-root #fb_dialog_ipad_overlay.hidden{display:none}.fb_dialog.fb_dialog_mobile.loading iframe{visibility:hidden}.fb_dialog_content .dialog_header{-webkit-box-shadow:white 0 1px 1px -1px inset;background:-webkit-gradient(linear, 0% 0%, 0% 100%, from(#738ABA), to(#2C4987));border-bottom:1px solid;border-color:#1d4088;color:#fff;font:14px Helvetica, sans-serif;font-weight:bold;text-overflow:ellipsis;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0;vertical-align:middle;white-space:nowrap}.fb_dialog_content .dialog_header table{-webkit-font-smoothing:subpixel-antialiased;height:43px;width:100%}.fb_dialog_content .dialog_header td.header_left{font-size:12px;padding-left:5px;vertical-align:middle;width:60px}.fb_dialog_content .dialog_header td.header_right{font-size:12px;padding-right:5px;vertical-align:middle;width:60px}.fb_dialog_content .touchable_button{background:-webkit-gradient(linear, 0% 0%, 0% 100%, from(#4966A6), color-stop(.5, #355492), to(#2A4887));border:1px solid #29487d;-webkit-background-clip:padding-box;-webkit-border-radius:3px;-webkit-box-shadow:rgba(0, 0, 0, .117188) 0 1px 1px inset, rgba(255, 255, 255, .167969) 0 1px 0;display:inline-block;margin-top:3px;max-width:85px;line-height:18px;padding:4px 12px;position:relative}.fb_dialog_content .dialog_header .touchable_button input{border:none;background:none;color:#fff;font:12px Helvetica, sans-serif;font-weight:bold;margin:2px -12px;padding:2px 6px 3px 6px;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog_content .dialog_header .header_center{color:#fff;font-size:16px;font-weight:bold;line-height:18px;text-align:center;vertical-align:middle}.fb_dialog_content .dialog_content{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/y9/r/jKEcVPZFk-2.gif) no-repeat 50% 50%;border:1px solid #555;border-bottom:0;border-top:0;height:150px}.fb_dialog_content .dialog_footer{background:#f6f7f9;border:1px solid #555;border-top-color:#ccc;height:40px}#fb_dialog_loader_close{float:left}.fb_dialog.fb_dialog_mobile .fb_dialog_close_button{text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog.fb_dialog_mobile .fb_dialog_close_icon{visibility:hidden}#fb_dialog_loader_spinner{animation:rotateSpinner 1.2s linear infinite;background-color:transparent;background-image:url(https://static.xx.fbcdn.net/rsrc.php/v3/yD/r/t-wz8gw1xG1.png);background-repeat:no-repeat;background-position:50% 50%;height:24px;width:24px}@keyframes rotateSpinner{0%{transform:rotate(0deg)}100%{transform:rotate(360deg)}}
.fb_iframe_widget{display:inline-block;position:relative}.fb_iframe_widget span{display:inline-block;position:relative;text-align:justify}.fb_iframe_widget iframe{position:absolute}.fb_iframe_widget_fluid_desktop,.fb_iframe_widget_fluid_desktop span,.fb_iframe_widget_fluid_desktop iframe{max-width:100%}.fb_iframe_widget_fluid_desktop iframe{min-width:220px;position:relative}.fb_iframe_widget_lift{z-index:1}.fb_hide_iframes iframe{position:relative;left:-10000px}.fb_iframe_widget_loader{position:relative;display:inline-block}.fb_iframe_widget_fluid{display:inline}.fb_iframe_widget_fluid span{width:100%}.fb_iframe_widget_loader iframe{min-height:32px;z-index:2;zoom:1}.fb_iframe_widget_loader .FB_Loader{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/y9/r/jKEcVPZFk-2.gif) no-repeat;height:32px;width:32px;margin-left:-16px;position:absolute;left:50%;z-index:4}</style><script type="text/javascript" charset="utf-8" async="" src="./test1_files/136.6af2d0105b0c788761be.js"></script><script type="text/javascript" charset="utf-8" async="" src="./test1_files/pdfjs.6416690e4951db49353f.js"></script><script id="yui__dyn_0" type="text/javascript" src="./test1_files/ServiceGetConfig"></script></head>
<body class="pb-ui" data-gr-c-s-loaded="true"><div id="MathJax_Message" style="display: none;"></div>






    

    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumAd none hide widget-none" id="8ffa8e02-92de-4357-aad5-3f0dbaea42df">
        
        
            
        

        <div class="wrapped " id="dfp-global-variables">
            
            <div class="widget-body body body-none "><div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumAd none  widget-none  widget-compact-all" id="d0e35a08-dcc3-4d89-8d7e-762d0f4034df">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
	dartInstitutionType = 'education';
</script>
        </div></div>
        </div>
    </div>
    





    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none hide widget-none" id="7353141c-1e04-41fe-acd2-4be633212fe9">
        
        
            
        

        <div class="wrapped " id="dfp-defineSlot-ad-settings">
            
            <div class="widget-body body body-none "><script type="text/javascript">
$(function() { 
	var journalTitle = 'molecular_pharmaceutics';
	var articleKeyword = $('.keywords');
	var articleTitle = $('meta[name="dc.Title"]');
	var articleDescription = $('meta[name="dc.Description"]');
	var searchTerms = [];

	if (journalTitle != '$' + '{journal.dartId}') {
		if (articleKeyword.length > 0) { 
			$('.keywords').children('.keyword').each(function() {
				searchTerms.push($(this).text().toString());
			});
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}
	}

	googletag.cmd.push(function() {
		if (journalTitle == '$' + '{journal.dartId}') {
			googletag.defineSlot('/8868/journal/default/article', [[970, 90], [728, 90]], 'dfp-journal-article-leaderboard').addService(googletag.pubads()).setTargeting('location', 'leaderboard1');
		}
		else if (searchTerms.length > 0) {
			googletag.defineSlot('/8868/journal/molecular_pharmaceutics/article', [[970, 90], [728, 90]], 'dfp-journal-article-leaderboard').addService(googletag.pubads()).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms);
		}
		else {
			googletag.defineSlot('/8868/journal/molecular_pharmaceutics/article', [[970, 90], [728, 90]], 'dfp-journal-article-leaderboard').addService(googletag.pubads()).setTargeting('location', 'leaderboard1');
		}
		//googletag.pubads().enableSingleRequest();
		googletag.pubads().collapseEmptyDivs();
		googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
		googletag.enableServices();
	});
	displayAd = $('<script>', {'type': 'text/javascript'});
	$(displayAd).append("googletag.cmd.push(function() { googletag.display('dfp-journal-article-leaderboard'); });");
	$('#dfp-journal-article-leaderboard').append(displayAd);
});
</script></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html alignCenter  widget-none  widget-compact-all" id="04bfcfa3-b2c6-4308-ba8f-d2b4563303e5">
        
        
            
        

        <div class="wrapped " id="dfp-large-leaderboard">
            
            <div class="widget-body body body-none  body-compact-all"><div class="adInfoLargeLeaderboard">
	<div class="advertisement">
		<a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=AdTop&amp;utm_medium=Pubs&amp;utm_campaign=CEN">ADVERTISEMENT</a>
	</div>
	<div class="dfp">
		<div id="dfp-journal-article-leaderboard" data-google-query-id="CJD03K64xNUCFQYfKgodFFkD3w">
			<script type="text/javascript">
				googletag.cmd.push(function() { googletag.display('dfp-journal-article-leaderboard'); });
			</script>
		<script type="text/javascript">googletag.cmd.push(function() { googletag.display('dfp-journal-article-leaderboard'); });</script><div id="google_ads_iframe_/8868/journal/molecular_pharmaceutics/article_0__container__" style="border: 0pt none;"><iframe id="google_ads_iframe_/8868/journal/molecular_pharmaceutics/article_0" title="3rd party ad content" name="google_ads_iframe_/8868/journal/molecular_pharmaceutics/article_0" width="970" height="90" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" style="border: 0px; vertical-align: bottom;" src="./test1_files/saved_resource.html"></iframe></div></div>
	</div>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget pageHeader none  widget-none  widget-compact-all" id="a044fa95-d38d-478f-b3f7-a600a053203d">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><header class="page-header">
    <div data-pb-dropzone="main">
    


    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-two-columns none ACSTop widget-none  widget-compact-all" id="6694f0f6-790b-4772-884b-03e51ea2d9f2">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="pb-columns row-fluid ">
    <div class="width_2_3">
        <div data-pb-dropzone="left" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-inline-content none  widget-none  widget-compact-all" id="9a4402ad-cf74-4122-8431-1152edd75a15">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="inline-dropzone" data-pb-dropzone="content">
    


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumNavigationLoginBar none  widget-none  widget-compact-all" id="adc37bbe-80d7-4bab-96ae-c0aef5c52c3b">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="loginBar">

    
    

    
    
    
    
            
            
            <span class="loginLink">
                <a href="https://pubs.acs.org/action/showLogin?uri=%2Fdoi%2Ffull%2F10.1021%2Facs.molpharmaceut.7b00039" id="loginButton">
                    Log In
                </a>
            </span>
            <span class="registerLink">
                
                <a id="registerButton" class="registerButton" title="Register for a free ACS ID" href="https://account.acs.org/ssoamweb/account/signUp?url_success=http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039&amp;url_cancel=http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039">Register</a>
            </span>
        
    <input type="hidden" id="forgotPasswordEndpoint" value="https://account.acs.org/ssoamweb/forgot/password">
    
    <input type="hidden" id="homeInstitutionUrl" value="https://pubs.acs.org/action/ssostart?redirectUri=%2Fdoi%2Ffull%2F10.1021%2Facs.molpharmaceut.7b00039">
    <input type="hidden" id="statusEndpoint" value="https://sso.acs.org/idp/status">
    <input type="hidden" id="clientID" value="Literatum">
    <input type="hidden" id="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3DLiteratum%26returnURL%3Dhttp%3A%2F%2Fpubs.acs.org">
    <input type="hidden" id="compiledCssId" value="/pb/css/t1500992084671-v1497472240000/head_1_46_183_298.css">
    <input type="hidden" class="confirmRegisterMsg" value="To register on this site, you must create an ACS ID on the ACS Society website (www.acs.org). After completing your registration, you will be returned back to the page you were viewing on the ACS Publications website (pubs.acs.org).">

</div></div>
        </div>
    </div>
    


</div></div>
        </div>
    </div>
    
        </div>
    </div>
    <div class="width_1_3">
        <div data-pb-dropzone="right" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none nav-society widget-none  widget-compact-all" id="50fb196a-f0ca-4c00-a4d5-a6291ca4bcde">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><ul class="inline-list">
   <li><a href="http://www.acs.org/" title="American Chemical Society"><span>ACS</span></a></li>
   <li class="activeLink"><a href="http://pubs.acs.org/" title="ACS Publications"><span>ACS Publications</span></a></li>
   <li><a href="http://pubs.acs.org/journal/cgeabj" title="C&amp;EN Global Enterprise"><span>C&amp;EN</span></a></li>
   <li><a href="http://www.cas.org/" title="Chemical Abstracts Service" target="cas"><span>CAS</span></a></li><!--t-->
</ul></div>
        </div>
    </div>
    
        </div>
    </div>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none nav-pubs-wrap widget-none  widget-compact-all" id="928bdca7-c3cc-462a-aea7-502152e0ceec">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><script type="text/javascript">
$(function(){
	$('#nav-pubs-clicklayer').hover(
		function() {
			hideAZ = setTimeout(function() {
				$('#nav-pubs').removeClass('showAzList showEbooksList');
				$('#nav-pubs-clicklayer').toggle();
			}, 1000);
		}, function() {
			clearTimeout(hideAZ);
		}
	).click(function(){
		$('#nav-pubs').removeClass('showAzList showEbooksList');
		$('#nav-pubs-clicklayer').toggle();
	});
});
function showAZList() {
	$('#nav-pubs').toggleClass('showAzList');
	$('#nav-pubs-clicklayer').toggle();
}
$(function(){
	$(".ebooks-link").click(function(e) {
		e.preventDefault();
		$('#nav-pubs').toggleClass('showEbooksList');
		$('#nav-pubs-clicklayer').toggle();
	});
});
</script>


<div id="nav-pubs" class="menuXml">

	<a href="http://pubs.acs.org/" title="ACS Publications Home" class="pubslogo-small"><img src="./test1_files/pubslogo-small.png" alt="ACS Publications"></a>

	<ul class="primaryNav">
		<li class="journal-az-link">
			<div class="overlay"></div>
			<a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" onclick="showAZList();return false;">ACS Journals <span class="arrow"></span></a>
		</li>

		<li class="ebooks-link">
			<div class="overlay"></div>
			<a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#">ACS eBooks <span class="arrow"></span></a>
		</li>

		<li class="last">
			<a href="http://pubs.acs.org/journal/cgeabj">C&amp;EN Global Enterprise</a>
		</li>
	</ul>

	<div id="nav-pubs-clicklayer" style="display:none;"></div>
	<div id="journal-az-layer">
		<ul>
			<li class="letter">A</li>
			<li>
				<a href="http://pubs.acs.org/journal/achre4">Accounts of Chemical Research</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/aamick">ACS Applied Materials &amp; Interfaces</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/abseba">ACS Biomaterials Science &amp; Engineering</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/accacs">ACS Catalysis</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/acscii">ACS Central Science</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/acbcct">ACS Chemical Biology</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/acncdm">ACS Chemical Neuroscience</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/acsccc">ACS Combinatorial Science</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/journal/jcchff">- Journal of Combinatorial Chemistry</a>
					</li>
				</ul>



			</li>
			
			<li><a href="http://pubs.acs.org/journal/aesccq">ACS Earth and Space Chemistry - New in 2017</a></li>

<li>
				<a href="http://pubs.acs.org/journal/aelccp">ACS Energy Letters</a>
			</li>

			<li>
				<a href="http://pubs.acs.org/journal/aidcbc">ACS Infectious Diseases</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/amlccd">ACS Macro Letters</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/amclct">ACS Medicinal Chemistry Letters</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/ancac3">ACS Nano</a>
			</li>
            <li>
				<a href="http://pubs.acs.org/journal/acsodf">ACS Omega</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/apchd5">ACS Photonics</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/ascefj">ACS Sensors</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/ascecg">ACS Sustainable Chemistry &amp; Engineering</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/asbcd6">ACS Synthetic Biology</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/ancham">Analytical Chemistry</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/loi/ancham">- I&amp;EC Analytical Edition</a>
					</li>
				</ul>
			</li>

			<li class="letter">B</li>
			<li>
				<a href="http://pubs.acs.org/journal/bichaw">Biochemistry</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/bcches">Bioconjugate Chemistry</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/bomaf6">Biomacromolecules</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/bipret">Biotechnology Progress</a>
			</li>

			<li class="letter">C</li>
			<li>
				<a href="http://pubs.acs.org/journal/crtoec">Chemical Research in Toxicology</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/chreay">Chemical Reviews</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/cmatex">Chemistry of Materials</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/cgdefu">Crystal Growth &amp; Design</a>
			</li>
		</ul>

		<ul>
			<li class="letter">E</li>
			<li>
				<a href="http://pubs.acs.org/journal/enfuem">Energy &amp; Fuels</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/esthag">Environmental Science &amp; Technology</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/estlcu">Environmental Science &amp; Technology Letters</a>
			</li>

			<li class="letter">I</li>
			<li>
				<a href="http://pubs.acs.org/journal/iechad">Industrial &amp; Engineering Chemistry</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/journal/iechad.1">- Journal of Industrial &amp; Engineering Chemistry</a>
					</li>
				</ul>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/iecred">Industrial &amp; Engineering Chemistry Research</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/loi/iepdaw">- I&amp;EC Process Design and Development</a>
					</li>
					<li>
						<a href="http://pubs.acs.org/loi/iecfa7">- I&amp;EC Fundamentals</a>
					</li>
					<li>
						<a href="http://pubs.acs.org/loi/iepra6">- Product Research &amp; Development</a>
					</li>
					<li>
						<a href="http://pubs.acs.org/loi/iepra6">- Product R&amp;D</a>
					</li>
					<li>
						<a href="http://pubs.acs.org/loi/iepra6">- I&amp;EC Product Research and Development</a>
					</li>
				</ul>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/inocaj">Inorganic Chemistry</a>
			</li>

			<li class="letter">J</li>
			<li>
				<a href="http://pubs.acs.org/journal/jacsat">Journal of the American Chemical Society</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jafcau">Journal of Agricultural and Food Chemistry</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jceaax">Journal of Chemical &amp; Engineering Data</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/loi/jceaax">- I&amp;EC Chemical &amp; Engineering Data Series</a>
					</li>
				</ul>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jceda8">Journal of Chemical Education</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jcisd8">Journal of Chemical Information and Modeling</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/loi/jcisd8">- Journal of Chemical Documentation</a>
					</li>
					<li>
						<a href="http://pubs.acs.org/loi/jcisd8">- Journal of Chemical Information and Computer Sciences</a>
					</li>
				</ul>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jctcce">Journal of Chemical Theory and Computation</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jmcmar">Journal of Medicinal Chemistry</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jnprdf">Journal of Natural Products</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/joceah">The Journal of Organic Chemistry</a>
			</li>
		</ul>

		<ul>
			<li class="letter">J (continued)</li>
			<li>
				<a href="http://pubs.acs.org/journal/jpcafh">The Journal of Physical Chemistry A</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jpcbfk">The Journal of Physical Chemistry B</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jpccck">The Journal of Physical Chemistry C</a>
				<ul>
					<li>
						<a href="http://pubs.acs.org/loi/jpchax">- The Journal of Physical Chemistry</a>
					</li>
					<li>
						<a href="http://pubs.acs.org/loi/jpchax">- The Journal of Physical and Colloid Chemistry</a>
					</li>
				</ul>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jpclcd">The Journal of Physical Chemistry Letters</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/jprobs">Journal of Proteome Research</a>
			</li>

			<li class="letter">L</li>
			<li>
				<a href="http://pubs.acs.org/journal/langd5">Langmuir</a>
			</li>

			<li class="letter">M</li>
			<li>
				<a href="http://pubs.acs.org/journal/mamobx">Macromolecules</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/mpohbp">Molecular Pharmaceutics</a>
			</li>

			<li class="letter">N</li>
			<li>
				<a href="http://pubs.acs.org/journal/nalefd">Nano Letters</a>
			</li>

			<li class="letter">O</li>
			<li>
				<a href="http://pubs.acs.org/journal/orlef7">Organic Letters</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/oprdfk">Organic Process Research &amp; Development</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/journal/orgnd7">Organometallics</a>
			</li>
		</ul>
	</div>
	<div id="ebooks-layer">
		<ul>
			<li>
				<a href="http://pubs.acs.org/page/books/index.html">About ACS eBooks</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/isbn/9780841230460">ACS Reagent Chemicals</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/isbn/9780841239999">ACS Style Guide</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/series/advances">Advances in Chemistry</a>
			</li>
			<li>
				<a href="http://pubs.acs.org/series/symposium">ACS Symposium Series</a>
			</li>
		</ul>
	</div>

</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-two-columns none pubsTop widget-none  widget-compact-all" id="a489a1a3-ebc5-4c6a-ba98-5e4aafb7c45e">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="pb-columns row-fluid gutterless">
    <div class="width_13_24">
        <div data-pb-dropzone="left" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none pagelogo widget-none  widget-compact-all" id="9c46435f-303e-45e1-bfa8-7ceb2b87a0ea">
        
        
            
        

        <div class="wrapped " id="series-logo">
            
            <div class="widget-body body body-none  body-compact-all"><a href="http://pubs.acs.org/journal/mpohbp"><img src="./test1_files/title.gif" alt="Molecular Pharmaceutics"></a></div>
        </div>
    </div>
    
        </div>
    </div>
    <div class="width_11_24">
        <div data-pb-dropzone="right" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-frame none qs-tabs widget-none  widget-compact-all" id="6f8be75c-ee63-44de-ad5f-0ed027c19d78">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div data-pb-dropzone="contents">
    


    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none  widget-compact-all" id="757e478d-6239-4d7a-ac1c-9323ea098af3">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><a href="http://pubs.acs.org/search/advanced" class="advSearchLink">Advanced Search</a></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-tabs none  widget-none  widget-compact-all" id="3ab7fde8-8423-410a-89d0-b202c470a197">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="tabs tabs-widget " aria-live="polite" aria-atomic="true" aria-relevant="additions">
    <ul class="tab-nav">
        
            <li class="active" aria-selected="true">
                
                        <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#3ab7fde8-8423-410a-89d0-b202c470a197-58132d06-cf2f-4e31-a696-f4f2aa0cdd9a" title="show Search" data-ga="[{&quot;eventName&quot;:&quot;_trackEvent&quot;}, {&quot;firstParam&quot;:&quot;Quick Search&quot;}, {&quot;secondParam&quot;:&quot;Search Tab&quot;}]">Search</a>
                    
            </li>
        
            <li class="">
                
                        <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#3ab7fde8-8423-410a-89d0-b202c470a197-b6de7b7c-de82-45a5-9538-313dd15c6659" title="show Citation" data-ga="[{&quot;eventName&quot;:&quot;_trackEvent&quot;}, {&quot;firstParam&quot;:&quot;Quick Search&quot;}, {&quot;secondParam&quot;:&quot;Citation Tab&quot;}]" aria-selected="false" aria-expanded="false">Citation</a>
                    
            </li>
        
            <li class="">
                
                        <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#3ab7fde8-8423-410a-89d0-b202c470a197-c99a966e-255a-48ca-bc42-73e1dc1e0708" title="show Subject" data-ga="[{&quot;eventName&quot;:&quot;_trackEvent&quot;}, {&quot;firstParam&quot;:&quot;Quick Search&quot;}, {&quot;secondParam&quot;:&quot;Subject Tab&quot;}]" aria-selected="false" aria-expanded="false">Subject</a>
                    
            </li>
        
    </ul>
    <div class="tab-content">
        
            
            
                <div class="tab-pane active" id="3ab7fde8-8423-410a-89d0-b202c470a197-58132d06-cf2f-4e31-a696-f4f2aa0cdd9a">
                    
                    <div class="tab-pane-content" data-pb-dropzone="tab-58132d06-cf2f-4e31-a696-f4f2aa0cdd9a" data-pb-dropzone-name="Search">
                        
                            
                                


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget quickSearchWidget none  widget-none  widget-compact-all" id="418cb9c3-dbc8-4fc8-bf37-ee58a4195363">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="quickSearchFormContainer">
    

    


    <form action="http://pubs.acs.org/action/doSearch" name="quickSearch" class="quickSearchForm " title="Quick Search" method="get"><span class="simpleSearchBoxContainer">
                        <input name="AllField" class="searchText magicsuggest main-search-field autocomplete ui-autocomplete-input" value="" type="search" id="searchText" title="Type search term here" placeholder="Enter search text / DOI" autocomplete="off" data-history-items-conf="3" data-publication-titles-conf="3" data-topics-conf="3" data-contributors-conf="3" data-auto-complete-target="auto-complete" data-auto-complete-max-words="7" data-auto-complete-max-chars="32"><span role="status" aria-live="polite" class="ui-helper-hidden-accessible"></span>
                </span>
                





<span class="citationSearchBoxContainer hidden">
    <input name="quickLinkJournal" class="journalName mediumTextInput  autocomplete ui-autocomplete-input" value="Molecular Pharmaceutics" type="search" title="Journal or Book Series" placeholder="Journal or Book Series" data-auto-complete-target="Title" autocomplete="off" autopopulate="true" disabled="disabled"><span role="status" aria-live="polite" class="ui-helper-hidden-accessible"></span>

    <input type="hidden" name="quickLink" value="true" disabled="disabled">
    <input class="year smallTextInput" title="Year" type="search" name="quickLinkYear" value="" autocomplete="false" placeholder="Year" disabled="disabled">
    <input class="volume smallTextInput" title="Volume" type="search" name="quickLinkVolume" value="" autocomplete="false" placeholder="Volume" disabled="disabled">
    <input class="issue smallTextInput enable" title="Issue" type="search" name="quickLinkIssue" value="" autocomplete="false" placeholder="Issue" disabled="disabled">
    <input class="page smallTextInput" title="Page" type="search" name="quickLinkPage" value="" autocomplete="false" placeholder="Page" disabled="disabled">
</span>

            

        
            
                











<span class="searchDropDownDivRight">

    <label for="searchInSelector" class="visuallyhidden">Search in:</label>
    
    <select id="searchInSelector" class="custom-dropdown js__searchInSelector">


        <option value="" data-search-in="default">Anywhere</option>


        
            <option value="Title">
                Title
            </option>
        

        
            <option value="Contrib">
                Author
            </option>
        

        
            <option value="Abstract">
                Abstract
            </option>
        


    </select>


</span>
            
        

        
            




<input class="mainSearchButton searchButtons pointer" title="search" type="submit" value="Search">
        

        
        
        






    <input type="hidden" name="type" value="within">
    <div id="qsScope">
        <label for="qsTitleButton" id="qsProduct">
            <input id="qsTitleButton" type="radio" name="publication" value="40026041" checked="checked">
            <span>Mol. Pharmaceutics</span>
        </label>
        <label for="qsAllButton" id="qsAll">
            <input id="qsAllButton" type="radio" name="publication" value="">
            <span>All Publications/Website</span>
        </label>
    </div></form>
</div>




<div class="advancedSearchLinkDropZone" data-pb-dropzone="advancedSearchLinkDropZone">
    
</div></div>
        </div>
    </div>
    

                            
                        
                    </div>
                </div>
            
        
            
            
                <div class="tab-pane" id="3ab7fde8-8423-410a-89d0-b202c470a197-b6de7b7c-de82-45a5-9538-313dd15c6659">
                    
                    <div class="tab-pane-content" data-pb-dropzone="tab-b6de7b7c-de82-45a5-9538-313dd15c6659" data-pb-dropzone-name="Citation">
                        
                            
                                


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget citationSearch none  widget-none  widget-compact-all" id="0cab95de-7577-441d-a5fe-3c4175aa325c">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="citationSearchContainer clear searchBox">

    <form action="http://pubs.acs.org/action/quickLink" id="citationSearchForm" name="citationSearch" class="citationSearchForm" method="get"><fieldset>
            <select name="quickLinkJournal" id="publicationSpan" class=" citationJournalName citation citation-search-title" data-placeholder="Journal or Book Series">

                
                    <option value="">Select a Journal or Book</option>
                
                            <option value="achre4">Acc. Chem. Res.</option>
                        
                            <option value="aamick">ACS Appl. Mater. Interfaces</option>
                        
                            <option value="abseba">ACS Biomater. Sci. Eng.</option>
                        
                            <option value="accacs">ACS Catal.</option>
                        
                            <option value="acscii">ACS Cent. Sci.</option>
                        
                            <option value="acbcct">ACS Chem. Biol.</option>
                        
                            <option value="acncdm">ACS Chem. Neurosci.</option>
                        
                            <option value="acsccc">ACS Comb. Sci.</option>
                        
                            <option value="aesccq">ACS Earth Space Chem.</option>
                        
                            <option value="aelccp">ACS Energy Lett.</option>
                        
                            <option value="aidcbc">ACS Infect. Dis.</option>
                        
                            <option value="amlccd">ACS Macro Lett.</option>
                        
                            <option value="amclct">ACS Med. Chem. Lett.</option>
                        
                            <option value="ancac3">ACS Nano</option>
                        
                            <option value="acsodf">ACS Omega</option>
                        
                            <option value="apchd5">ACS Photonics</option>
                        
                            <option value="reagents">ACS Reagent Chemicals</option>
                        
                            <option value="ascefj">ACS Sens.</option>
                        
                            <option value="ascecg">ACS Sustainable Chem. Eng.</option>
                        
                            <option value="symposium">ACS Symposium Series</option>
                        
                            <option value="asbcd6">ACS Synth. Biol.</option>
                        
                            <option value="advances">Advances in Chemistry</option>
                        
                            <option value="ancham">Anal. Chem.</option>
                        
                            <option value="bichaw">Biochemistry</option>
                        
                            <option value="bcches">Bioconjugate Chem.</option>
                        
                            <option value="bomaf6">Biomacromolecules</option>
                        
                            <option value="bipret">Biotechnol. Prog.</option>
                        
                            <option value="cgeabj">C&amp;EN Global Enterp</option>
                        
                            <option value="crtoec">Chem. Res. Toxicol.</option>
                        
                            <option value="chreay">Chem. Rev.</option>
                        
                            <option value="cmatex">Chem. Mater.</option>
                        
                            <option value="cgdefu">Crystal Growth &amp; Design</option>
                        
                            <option value="enfuem">Energy Fuels</option>
                        
                            <option value="esthag">Environ. Sci. Technol.</option>
                        
                            <option value="estlcu">Environ. Sci. Technol. Lett.</option>
                        
                            <option value="iechad">Ind. Eng. Chem.</option>
                        
                            <option value="iecred">Ind. Eng. Chem. Res.</option>
                        
                            <option value="iecnav">Ind. Eng. Chem., News Ed.</option>
                        
                            <option value="inocaj">Inorg. Chem.</option>
                        
                            <option value="jacsat">J. Am. Chem. Soc.</option>
                        
                            <option value="jafcau">J. Agric. Food Chem.</option>
                        
                            <option value="jceaax">J. Chem. Eng. Data</option>
                        
                            <option value="jceda8">J. Chem. Educ.</option>
                        
                            <option value="jcisd8">J. Chem. Inf. Model.</option>
                        
                            <option value="jctcce">J. Chem. Theory Comput.</option>
                        
                            <option value="jcchff">J. Comb. Chem.</option>
                        
                            <option value="jmcmar">J. Med. Chem.</option>
                        
                            <option value="jnprdf">J. Nat. Prod.</option>
                        
                            <option value="joceah">J. Org. Chem.</option>
                        
                            <option value="jpchax">J. Phys. Chem.</option>
                        
                            <option value="jpcafh">J. Phys. Chem. A</option>
                        
                            <option value="jpcbfk">J. Phys. Chem. B</option>
                        
                            <option value="jpccck">J. Phys. Chem. C</option>
                        
                            <option value="jpclcd">J. Phys. Chem. Lett.</option>
                        
                            <option value="jprobs">J. Proteome Res.</option>
                        
                            <option value="langd5">Langmuir</option>
                        
                            <option value="mamobx">Macromolecules</option>
                        
                            <option value="mpohbp" selected="">Mol. Pharmaceutics</option>
                        
                            <option value="nalefd">Nano Lett.</option>
                        
                            <option value="neaca9">News Ed., Am. Chem. Soc</option>
                        
                            <option value="orlef7">Org. Lett.</option>
                        
                            <option value="oprdfk">Org. Process Res. Dev.</option>
                        
                            <option value="orgnd7">Organometallics</option>
                        
            </select>

            <div class="citation-details float-right">
                <input type="hidden" name="quickLink" value="true"><input class="search-term smallTextInput" type="text" name="quickLinkVolume" value="" size="15" autocomplete="false" placeholder="vol"><input class="search-term fist-page-input smallTextInput" type="text" name="quickLinkPage" value="" size="15" autocomplete="false" placeholder="page">
            </div>

            <div class=" submitRow float-right clear">
                <input id="citationSearchSubmitButton" class="searchButtons pointer" title="Citation Search" type="submit" value="Citation Search">
            </div>
        </fieldset></form>
</div></div>
        </div>
    </div>
    

                            
                        
                    </div>
                </div>
            
        
            
            
                <div class="tab-pane" id="3ab7fde8-8423-410a-89d0-b202c470a197-c99a966e-255a-48ca-bc42-73e1dc1e0708">
                    
                    <div class="tab-pane-content" data-pb-dropzone="tab-c99a966e-255a-48ca-bc42-73e1dc1e0708" data-pb-dropzone-name="Subject">
                        
                            
                                


    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none cas-subjects widget-none  widget-compact-all" id="a2c67375-3889-40bd-9d92-6ae9bbd61c7d">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><script type="text/javascript">
function toggleSubjects(li) {
	if ($(li).hasClass("open")) {
		$(li).removeClass("open");
	}
	else {
		$(li).parent().find('.category').removeClass("open");
		$(li).addClass("open");
	}
	return false;
}
$(function(){
	$('#qs-subjects .close-tab').click(function() {
		$('.qs-tabs .tab-nav a').first().click();
	});
});
</script>

<div class="container collection" id="qs-subjects" style="display: block;">

	<a class="close-tab">x</a>
    
    <div><strong>Select a <a href="http://cas.org/" target="_blank">CAS</a> section from the 5 main topical divisions below:</strong></div>
    <ul class="collectionList">
        
        <li class="category open">
            <a title="View this subject category" onclick="toggleSubjects($(this).parent());" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#"><span class="plusMinus">&nbsp;</span>
                <span class="categoryTitle">Applied</span>
            </a>
            <div class="wrapper">
                <ul>
                    
                    <li>
                        <a href="http://pubs.acs.org/topic/industrial_hygiene">Air Pollution and Industrial Hygiene</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/plant_equipment">Apparatus and Plant Equipment</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/building_materials">Cement, Concrete, and Related Building Materials</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/ceramics">Ceramics</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/thermal_energy">Electrochemical, Radiational, and Thermal Energy Technology</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/cosmetics">Essential Oils and Cosmetics</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/metallurgy">Extractive Metallurgy</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/ferrous">Ferrous Metals and Alloys</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/fossil_fuels">Fossil Fuels, Derivatives, and Related Products</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/industrial_inorg_chem">Industrial Inorganic Chemicals</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/mineralogical_geological">Mineralogical and Geological Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/nonferrous">Nonferrous Metals and Alloys</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/pharm_analysis">Pharmaceutical Analysis</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/pharmaceuticals">Pharmaceuticals</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/propellants">Propellants and Explosives</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/unit_operations">Unit Operations and Processes</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/waste">Waste Treatment and Disposal</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/water">Water</a>
                    </li>
                </ul>
            </div>
        </li>

        
        <li class="category">
            <a title="View this subject category" onclick="toggleSubjects($(this).parent());" href="JavaScript:void(0);"><span class="plusMinus">&nbsp;</span>
                <span class="categoryTitle">Biochemistry</span>
            </a>
            <div class="wrapper">
                <ul>
                    
                    <li>
                        <a href="http://pubs.acs.org/topic/agrochem_bioregulators">Agrochemical Bioregulators</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/animal_nutrition">Animal Nutrition</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/biochem_genetics">Biochemical Genetics</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/biochem_methods">Biochemical Methods</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/enzymes">Enzymes</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/fermentation">Fermentation and Bioindustrial Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/fertilizers">Fertilizers, Soils, and Plant Nutrition</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/food_chemistry">Food and Feed Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/general_biochem">General Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/history_education">History, Education, and Documentation</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/immunochem">Immunochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/mammalian_biochem">Mammalian Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/mammalian_hormones">Mammalian Hormones</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/mammalian_path_biochem">Mammalian Pathological Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/microbial_biochem">Microbial, Algal, and Fungal Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/nonmammalian_biochem">Nonmammalian Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/pharmacology">Pharmacology</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/plant_biochem">Plant Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/radiation_biochem">Radiation Biochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/toxicology">Toxicology</a>
                    </li>
                </ul>
            </div>
        </li>

        
        <li class="category">
            <a title="View this subject category" onclick="toggleSubjects($(this).parent());" href="JavaScript:void(0);"><span class="plusMinus">&nbsp;</span>
                <span class="categoryTitle">Macromolecular</span>
            </a>
            <div class="wrapper">
                <ul>
                    
                    <li>
                        <a href="http://pubs.acs.org/topic/wood_products">Cellulose, Lignin, Paper, and Other Wood Products</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/polymer_chem">Chemistry of Synthetic High Polymers</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/coatings_inks">Coatings, Inks, and Related Products</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/dyes">Dyes, Organic Pigments, Fluorescent Brighteners, and Photographic Sensitizers</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/industrial_carb">Industrial Carbohydrates</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/industrial_org_chem">Industrial Organic Chemicals, Leather, Fats, and Waxes</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/polymer_phys">Physical Properties of Synthetic High Polymers</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/plastics_uses">Plastics Fabrication and Uses</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/plastics_manufacture">Plastics Manufacture and Processing</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/deterfents">Surface Active Agents and Detergents</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/elastomers_rubber">Synthetic Elastomers and Natural Rubber</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/textiles_fibers">Textiles and Fibers</a>
                    </li>
                </ul>
            </div>
        </li>

        
        <li class="category">
            <a title="View this subject category" onclick="toggleSubjects($(this).parent());" href="JavaScript:void(0);"><span class="plusMinus">&nbsp;</span>
                <span class="categoryTitle">Organic</span>
            </a>
            <div class="wrapper">
                <ul>
                    
                    <li>
                        <a href="http://pubs.acs.org/topic/alicyclic_compounds">Alicyclic Compounds</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/aliphatic_compounds">Aliphatic Compounds</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/alkaloids">Alkaloids</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/amino_acids">Amino Acids, Peptides, and Proteins</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/benzene">Benzene, Its Derivatives, and Condensed Benzenoid Compounds</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/biomolecules">Biomolecules and Their Synthetic Analogs</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/carbohydrates">Carbohydrates</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/general_organic">General Organic Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/heterocyclic_one">Heterocyclic Compounds (More than One Hetero Atom)</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/heterocyclic">Heterocyclic Compounds (One Hetero Atom)</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/organometallic">Organometallic and Organometalloidal Compounds</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/physical_organic">Physical Organic Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/steroids">Steroids</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/terpenes">Terpenes and Terpenoids</a>
                    </li>
                </ul>
            </div>
        </li>

        
        <li class="category">
            <a title="View this subject category" onclick="toggleSubjects($(this).parent());" href="JavaScript:void(0);"><span class="plusMinus">&nbsp;</span>
                <span class="categoryTitle">Physical, Inorganic, and Analytical</span>
            </a>
            <div class="wrapper">
                <ul>
                    
                    <li>
                        <a href="http://pubs.acs.org/topic/catalysis">Catalysis, Reaction Kinetics, and Inorganic Reaction Mechanisms</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/crystallography">Crystallography and Liquid Crystals</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/electric_phenomena">Electric Phenomena</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/electrochemistry">Electrochemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/gen_phys_chem">General Physical Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/inorganic_analytical">Inorganic Analytical Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/inorganic_chem">Inorganic Chemicals and Reactions</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/magnetic_phenomena">Magnetic Phenomena</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/nuclear_phenomena">Nuclear Phenomena</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/nuclear_technology">Nuclear Technology</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/spectroscopy">Optical, Electron, and Mass Spectroscopy and Other Related Properties</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/organic_analytical">Organic Analytical Chemistry</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/solutions">Phase Equilibriums, Chemical Equilibriums, and Solutions</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/reprographic">Radiation Chemistry, Photochemistry, and Photographic and Other Reprographic Processes</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/surface_chem">Surface Chemistry and Colloids</a>
                    </li>
                    <li>
                        <a href="http://pubs.acs.org/topic/thermodynamics">Thermodynamics, Thermochemistry, and Thermal Properties</a>
                    </li>
                </ul>
            </div>
        </li>

        
    </ul>
</div></div>
        </div>
    </div>
    

                            
                        
                    </div>
                </div>
            
        
    </div>

    

</div></div>
        </div>
    </div>
    
</div></div>
        </div>
    </div>
    
        </div>
    </div>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumInstitutionBanner none cobrandText widget-none  widget-compact-all" id="50ab07c6-00b5-4eac-9a23-cb64cfd91f9f">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="welcome">
    
    
        <span>
            
                    Subscriber access provided by SHANGHAI INST MATERIA MEDICA
                
        </span>
    
    
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none  widget-compact-all" id="b2fe694b-bba5-4e20-a4db-ff6197429fe4">
        
        
            
        

        <div class="wrapped " id="series-navigation">
            
            <div class="widget-body body body-none  body-compact-all"><div class="menuXml seriesNav">
	<ul class="primaryNav">
		<li class="home">
			<a href="http://pubs.acs.org/journal/mpohbp">
				<span>Home</span>
			</a>
		</li>

		<li>
			<a class="expander" href="http://pubs.acs.org/loi/mpohbp">Browse the Journal</a>
			<ul>
				<li><a href="http://pubs.acs.org/loi/mpohbp">List of Issues</a></li>
				<li><a href="http://pubs.acs.org/toc/mpohbp/0/ja">Just Accepted Manuscripts</a></li>
				<li><a href="http://pubs.acs.org/action/showMostReadArticles?journalCode=mpohbp">Most Read Articles</a></li>
				<li><a href="http://pubs.acs.org/action/showAuthorIndex?journalCode=mpohbp">Author Index</a></li>
				<li><a href="http://pubs.acs.org/action/showCoverGallery?journalCode=mpohbp">Cover Art Gallery</a></li>
			</ul>
		</li>

		<li>
			<a href="http://pubs.acs.org/toc/mpohbp/0/0">Articles ASAP</a>
		</li>

		<li>
			<a href="http://pubs.acs.org/toc/mpohbp/current">Current Issue</a>
		</li>

		<li>
			<a class="expander" href="http://pubs.acs.org/page/mpohbp/submission/index.html">Submission &amp; Review</a>
			<ul>
				<li><a href="http://pubs.acs.org/page/mpohbp/submission/index.html">Information for Authors and Reviewers</a></li>
				<li><a href="http://pubs.acs.org/paragonplus/submission/mpohbp/mpohbp_authguide.pdf">Author Guidelines [PDF]</a></li>
				<li><a href="http://paragonplus.acs.org/login">Submit a Manuscript or Review</a></li>
				<li><a href="http://pubs.acs.org/page/policy/ethics/index.html">Ethical Guidelines</a></li>
				<li><a href="http://pubs.acs.org/page/copyright/index.html">Copyright &amp; Permissions/RightsLink</a></li>
				<li><a href="http://pubs.acs.org/page/4authors/index.html">ACS Author &amp; Reviewer Resource Center</a></li>
			</ul>
		</li>

		<li>
			<a class="expander openaccess">Open Access</a>
			<ul>
			    <li><a href="http://pubs.acs.org/page/4authors/openaccess/index.html#mpohbp"><cite>Molecular Pharmaceutics</cite> OA Policy</a></li>
				<li><a href="http://acsopenaccess.org/">ACS Open Access Programs</a></li>
			</ul>
		</li>

		<li>
			<a class="expander" href="http://pubs.acs.org/page/mpohbp/about.html">About the Journal</a>
			<ul>
				<li><a href="http://pubs.acs.org/page/mpohbp/about.html">About the Journal</a></li>
				<li><a href="http://pubs.acs.org/page/mpohbp/profile.html">Editor Profile</a></li>
				<li><a href="http://pubs.acs.org/page/mpohbp/editors.html">Editorial Board</a></li>
				<li><a href="http://pubs.acs.org/pb-assets/documents/masthead/mpohbp-masthead.pdf">Masthead [PDF]</a></li>
				<li><a href="http://pubs.acs.org/pb-assets/documents/eab/mpohbp-eab.pdf">Editorial Advisory Board [PDF]</a></li>
				<li><a href="http://acsmediakit.org/">Advertising Media Kit</a></li>
			</ul>
		</li>
    
	</ul>      
</div></div>
        </div>
    </div>
    
    </div>
</header></div>
        </div>
    </div>
    





    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget pageBody none article-page widget-none  widget-compact-all" id="623dc177-ba39-4f83-83c5-cf9808be195f">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><!--begin pagefulltext-->
<div class="page-body pagefulltext">
    <div data-pb-dropzone="main">
    


    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
            
            
            
                
                
                
            
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-frame none  widget-regular  widget-border-toggle widget-compact-all" id="32798733-6699-4743-9ba0-bcb2ddfd5351">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-regular  body-border-toggle body-compact-all"><div data-pb-dropzone="contents">
    


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-two-columns none article-type-and-nav widget-none  widget-compact-all" id="c19b0f7c-22ac-42b9-8bcf-dad150505eb2">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="pb-columns row-fluid gutterless">
    <div class="width_1_2">
        <div data-pb-dropzone="left" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget manuscriptType none  widget-none  widget-compact-all" id="2afbd5b7-f14d-4c2a-b392-685dcc5e9d69">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><h3 class="manuscriptType">Article</h3></div>
        </div>
    </div>
    
        </div>
    </div>
    <div class="width_1_2">
        <div data-pb-dropzone="right" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumBookIssueNavigation none  widget-none  widget-compact-all" id="6d0914e1-8b40-4071-9399-235e49d836e1">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="pager issueNavPageContainer">
    
        <div class="issueNavigator">
            <div class="journalNavLeftTd">
                
                    
                            
                            <span class="prev placedLeft">
                                 <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00005" title="Previous Article">
                                     Previous Article
                                 </a>
                            </span>
                        

                    
                
            </div>

            

            <div class="journalNavRightTd">
                
                    
                            
                            <div class="next">
                                <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00053" title="Next Article">
                                    Next Article
                                </a>
                            </div>
                        

                    
                
            </div>
        </div>
    

    
        
            <div class="journalNavCenterTd">
                <span class="journalNavTitle">
                    

                    
                            
                                    <a href="http://pubs.acs.org/toc/mpohbp/14/7">Table of Contents</a>
                                
                        
                </span>

                

                
                

                

                

            </div>
        
    

</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none  widget-compact-all" id="7efd1d6e-21a6-48c5-8b37-77cf7a915c9a">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><script type="text/javascript">
$(function(){
	$('.literatumBookIssueNavigation .BookNavCenterTd b').text('Table of Contents');
});
</script></div>
        </div>
    </div>
    
        </div>
    </div>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-two-columns none article-main-cols widget-none  widget-compact-all" id="6901cc5c-a7f6-4109-bf08-278038ba53a6">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="pb-columns row-fluid gutterless">
    <div class="width_17_24">
        <div data-pb-dropzone="left" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumPublicationContentWidget none  widget-none  widget-compact-all" id="d2a196f9-55e7-492a-9643-735a41b61a8c">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><script type="text/javascript">
<!-- // hide it from old browsers

var anyDbId = -1;
var sideParts = {
    citation: "<tr><td class=\"black9pt\" width=\"15\" valign=\"top\">&nbsp;&bull;&nbsp;<\/td><td class=\"black9pt\" valign=\"top\"><a href=\"javascript:newWindow('{$linkoutUrl}')\">{$display}<\/a><\/td><\/tr>",
    citingIsi: "<tr><td class=\"black9pt\" width=\"15\" valign=\"top\">&nbsp;&bull;&nbsp;<\/td><td class=\"black9pt\" valign=\"top\">Search for citing articles in:<br/>&nbsp;<a href=\"javascript:newWindow('/servlet/linkout?suffix=s0&dbid=128&doi={$doi}&url={$urlEnc}')\">ISI Web of Science<\/a> ({$citNum} or more)<\/a><\/td><\/tr>",
    citingCrossref: "<tr><td class=\"black9pt\" width=\"15\" valign=\"top\">&nbsp;&bull;&nbsp;<\/td><td class=\"black9pt\" valign=\"top\"><a href=\"{$url}\">Citing articles in CrossRef<\/a><\/td><\/tr>",
    quicksearch: "<option value=\"{$value}\">{$display}<\/option>",
    related: ", <a href=\"javascript:newWindow('{$linkoutUrl}')\">{$display}<\/a>"
};

function genSide(part, dbid, linkoutUrl, display, doi, url, citNum, value) {
    if (dbid != anyDbId && (140737488355327 & dbid) == 0) return;
    var content = sideParts[part];
    if (linkoutUrl) { content = content.replace(/{\$linkoutUrl}/g, linkoutUrl); }
    if (display) { content = content.replace(/{\$display}/g, display); }
    if (doi) { content = content.replace(/{\$doi}/g, doi); }
    if (url) {
        content = content.replace(/{\$url}/g, url);
        content = content.replace(/{\$urlEnc}/g, encodeURIComponent(encodeURIComponent(url)));
    }
    if (citNum) { content = content.replace(/{\$citNum}/g, citNum); }
    if (value) { content = content.replace(/{\$value}/g, value); }
    document.write(content);
}

function hasSfxLinks() {
	return false;
}


function genSfxLinks(id, url, doi) {
    if (! doi) { doi = ""; }

}
function popSfxLink(prefix, id, url, doi) {
    if (doi) {
        url += "&id=doi:"+doi;
    } else {
        doi = "10.1021%2Facs.molpharmaceut.7b00039";
    }
    var redirect = prefix + encodeURIComponent("?sid=achs&genre=article"+url);
    var href = "/servlet/linkout?suffix="+id+"&dbid=16384&doi="+doi+"&url=" + encodeURIComponent(redirect);
    return newWindow(href);
}

var sfxRefDisplay = {
64:"ADS",
32:"CAS",
8192:"CIS",
256:"CSA",
16:"CrossRef",
128:"ISI",
4096:"JSTOR",
8:"PubMed",
1099511627776: "Ichushi",
17592186044416: "Medical Online",
8796093022208: "J-Stage",
2199023255552: "Medical Finder",
4398046511104: "Pier Online"
};

window.onload=disableRefLinkWrite ;

function genRefLink(dbid, id, key, textOfLink) {
    if (140737488355327 & dbid != 0) {
        if (typeof textOfLink === "undefined") {
            if (sfxRefDisplay[dbid].substring(0,1) == "[") {
                textOfLink = sfxRefDisplay[dbid];
            } else {
                textOfLink = "["+sfxRefDisplay[dbid]+"]";
            }
            // ToDo: move '[' and ']' to sfxRefDisplay (UPDATE: finish changing sfxRefDisplays and remove this branch)
        }
        else{ textOfLink = unescape(textOfLink)};

        if(document.disableRefLinkWrite == null){
            document.write("<a class='ref' href=\"javascript:popRefLink("+dbid+",'"+id+"','"+key+"')\">"+textOfLink+"<\/a>");
        }
    }
}

function disableRefLinkWrite () {
    document.disableRefLinkWrite = true;
}

function popRefLink(dbid, id, key) {
    var redirect = "/servlet/linkout?suffix=" + id + "&dbid=" + dbid + "&doi=10.1021%2Facs.molpharmaceut.7b00039&key=" + key;
    return newWindow(redirect);
}
function popRefFull(rid, citart, ptype, area) {
    return popRefImplFull(rid, citart, ptype, area, 600, 500);
}
function popRefImplFull(rid, citart, ptype, area, width, height) {
    var doi = "10.1021%2Facs.molpharmaceut.7b00039";
    if (! ptype) { ptype = ""; }
    var pt = rid.charAt(0) + "acsmolpharmaceut7b00039" + ptype;
    return popupFull(rid, doi, pt, area, width, height);
}
function popRef(rid, citart, ptype, area) {
    return popRefImpl(rid, citart, ptype, area, 600, 500);
}
function popRef2(rid, citart, ptype, area) {
    return popRefImpl(rid, citart, ptype, area, 400, 100);
}
function popRefImpl(rid, citart, ptype, area, width, height) {
    var doi = "10.1021%2Facs.molpharmaceut.7b00039";
    if (! citart) { citart = "citart1"; }
    if (! ptype) { ptype = ""; }
    var pt = rid.charAt(0) + "acsmolpharmaceut7b00039" + ptype;
    return popupRef(citart, rid, doi, pt, area, width, height);
}



function genCitingCrossref() {
}

var tollFreeLinking = new Object();

var citLinkDisplay = {
    
    0:"SYSTEM",
4:"SYSTEM",
20:"SYSTEM",
64:"ADS",
32:"CAS",
8192:"CIS",
256:"CSA",
16:"CrossRef",
128:"ISI",
4096:"JSTOR",
8:"MEDLINE"
};
var feeBasedMask = 4480;

function genCitLink(dbid, suffix, key) {
    if (dbid != anyDbId && (feeBasedMask & dbid) != 0 && (140737488355327 & dbid) == 0) return;

    var param = "/servlet/linkout?suffix=" + suffix + "&dbid=" + dbid + "&doi=10.1021%2Facs.molpharmaceut.7b00039&key=" + key;
    var display = citLinkDisplay[dbid];
    var img = "/templates/jsp/_style2/_achs/images/" + display + "_btn.gif";


    if((typeof tollFreeLinking) != "undefined" && tollFreeLinking[key])
    {
        param = param + "&tollfreelink=" + tollFreeLinking[key];
    }


    document.write("<a class='ref' href='javascript:newWindow(\"" + param + "\")'>");
    document.write("<" + "img src='"+img+"' width='85' height='20' align='BOTTOM' alt='"+display+" Abstract' border='0'/>");
    document.write("<\/a>");
}
// stop hiding -->
</script>
<script type="text/javascript" src="./test1_files/swfobject.js"></script>
<script type="text/javascript">
function addFlashMovie(id, flv) {
    var flashvars = {file: flv ,type: 'flv'};
    var params = {allowfullscreen :true};
    var attributes = {};
    swfobject.embedSWF('/flvplayer.swf', id, "352", "288", "7.0.0", false, flashvars, params, attributes);
}

function addFlashMovie(id, flv, image) {
    var flashvars = {file: flv ,type: 'flv', image: image};
    var params = {allowfullscreen :true};
    var attributes = {};
    swfobject.embedSWF('/flvplayer.swf', id, "352", "288", "7.0.0", false, flashvars, params, attributes);
}
</script>




<script type="text/javascript">
    window.MathJax = {

        AuthorInit: function () {
            $.getScript( '/templates/jsp/_style2/_achs/pb2/js/mathJaxConfig.js' );
        }
    };
</script>

<script type="text/javascript" async="" src="./test1_files/MathJax.js"></script>
    <div class="publication-tabs ja publication-content-container">
        <input type="hidden" class="taxonomiesList" value="" id="taxonomiesList">

        








    
        
    


<div class="tabs tabs-widget">
    
        
        
            
    <script type="text/javascript">
        initFigshare('https://widgets.figshare.com/static/figshare.js', '10.1021/acs.molpharmaceut.7b00039');
    </script>

        
        <div class="tab-content ">
            <div class="tab tab-pane active">
                
                        <article class="article">
                                <h1 class="articleTitle"><span class="hlFld-Title">Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin</span></h1><div id="articleMeta"><div id="authors"><span class="hlFld-ContribAuthor"><span class="hlFld-ContribAuthor"><a id="authors" href="http://pubs.acs.org/author/Mesallati%2C+Hanah">Hanah Mesallati</a></span><span><span class="NLM_xref-aff"><sup>†</sup></span></span><span>, </span></span><span class="hlFld-ContribAuthor"><span class="hlFld-ContribAuthor"><a id="authors" href="http://pubs.acs.org/author/Umerska%2C+Anita">Anita Umerska</a></span><span><span class="NLM_xref-aff"><sup>‡</sup></span></span><span>, </span></span><span class="hlFld-ContribAuthor"><span class="hlFld-ContribAuthor"><a id="authors" href="http://pubs.acs.org/author/Paluch%2C+Krzysztof+J">Krzysztof J. Paluch</a></span><span><span class="NLM_xref-aff"><sup>§</sup></span></span><span>, and </span></span><span class="hlFld-ContribAuthor"><span class="hlFld-ContribAuthor"><a id="authors" href="http://pubs.acs.org/author/Tajber%2C+Lidia">Lidia Tajber</a></span><span><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#cor1"><sup>*</sup></a></span><span><span class="NLM_xref-aff"><sup>†</sup></span></span><span> </span><span class="orcid-link-icon"> <a href="http://orcid.org/0000-0003-1544-6796" target="_blank"><img src="./test1_files/orcid.png"></a></span></span></div><div class="affiliations"><div id="aff1"><sup>†</sup> Synthesis
and Solid State Pharmaceutical Centre, School of Pharmacy and Pharmaceutical
Sciences, <span class="institution">Trinity College Dublin</span>, College Green, Dublin 2, <span class="country">Ireland</span></div><div id="aff2"><sup>‡</sup> MINT,
UNIV Angers, INSERM 1066, CNRS 6021, <span class="institution">Universite
Bretagne Loire</span>, 4 rue
Larrey, Angers 49933 Cedex, <span class="country">France</span></div><div id="aff3"><sup>§</sup> School
of Pharmacy and Medical Sciences, Faculty of Life Sciences, <span class="institution">University of Bradford</span>, Bradford, West Yorkshire, BD7 1DP, <span class="country">United Kingdom</span></div></div><div id="citation"><cite>Mol. Pharmaceutics</cite>, <span class="citation_year">2017</span>, <span class="citation_volume">14</span> (7), pp 2209–2223</div><div id="doi"><strong>DOI: </strong>10.1021/acs.molpharmaceut.7b00039</div><div id="pubDate">Publication Date (Web): June 1, 2017</div><div id="artCopyright">Copyright © 2017 American Chemical Society</div><div id="correspondence">*School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, College Green, Dublin 2, Ireland. Tel: <span class="phone">+35318962787</span>. E-mail: <a href="mailto:ltajber@tcd.ie">ltajber@tcd.ie</a>.</div></div><div id="articleBody"><div class="hlFld-Abstract"><ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="Abstract">Abstract</h2><div id="abstractBox"><div class="figure" id="f_tgr1"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="showFiguresEvent" id="absImg"><img alt="Abstract Image" src="./test1_files/mp-2017-00039m_0009.gif"><span class="overlay"></span></a></div><p class="articleBody_abstractText">Ciprofloxacin (CIP) is a poorly soluble drug that also displays poor permeability. Attempts to improve the solubility of this drug to date have largely focused on the formation of crystalline salts and metal complexes. The aim of this study was to prepare amorphous solid dispersions (ASDs) by ball milling CIP with various polymers. Following examination of their solid state characteristics and physical stability, the solubility advantage of these ASDs was studied, and their permeability was investigated via parallel artificial membrane permeability assay (PAMPA). Finally, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the ASDs were compared to those of CIP. It was discovered that acidic polymers, such as Eudragit L100, Eudragit L100-55, Carbopol, and HPMCAS, were necessary for the amorphization of CIP. In each case, the positively charged secondary amine of CIP was found to interact with carboxylate groups in the polymers, forming amorphous polymeric drug salts. Although the ASDs began to crystallize within days under accelerated stability conditions, they remained fully X-ray amorphous following exposure to 90% RH at 25 °C, and demonstrated higher than predicted glass transition temperatures. The solubility of CIP in water and simulated intestinal fluid was also increased by all of the ASDs studied. Unlike a number of other solubility enhancing formulations, the ASDs did not decrease the permeability of the drug. Similarly, no decrease in antibiotic efficacy was observed, and significant improvements in the MIC and MBC of CIP were obtained with ASDs containing HPMCAS-LG and HPMCAS-MG. Therefore, ASDs may be a viable alternative for formulating CIP with improved solubility, bioavailability, and antimicrobial activity.</p><div class="keywords"><h4>Keywords: </h4><a class="keyword" href="http://pubs.acs.org/action/doSearch?action=search&amp;AllField=Amorphous+Solid+Dispersion&amp;qsSearchArea=AllField">amorphous solid dispersion</a><span class="separator">; </span><a class="keyword" href="http://pubs.acs.org/action/doSearch?action=search&amp;AllField=Ciprofloxacin&amp;qsSearchArea=AllField">ciprofloxacin</a><span class="separator">; </span><a class="keyword" href="http://pubs.acs.org/action/doSearch?action=search&amp;AllField=PAMPA&amp;qsSearchArea=AllField">PAMPA</a><span class="separator">; </span><a class="keyword" href="http://pubs.acs.org/action/doSearch?action=search&amp;AllField=Polymer&amp;qsSearchArea=AllField">polymer</a><span class="separator">; </span><a class="keyword" href="http://pubs.acs.org/action/doSearch?action=search&amp;AllField=Polymeric+Drug+Salts&amp;qsSearchArea=AllField">polymeric drug salts</a><span class="separator">; </span><a class="keyword" href="http://pubs.acs.org/action/doSearch?action=search&amp;AllField=Solubility&amp;qsSearchArea=AllField">solubility</a><span class="separator"></span></div></div></div><div class="hlFld-Fulltext"><div id="sec1" class="NLM_sec NLM_sec_level_1"><ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i1">Introduction</h2><hr><div class="NLM_p">Ciprofloxacin (CIP) is a second generation fluoroquinolone antibiotic with a wide spectrum of activity. Anhydrous CIP usually exists as a zwitterion, as shown in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig1">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig1">1</a>; however, it can convert to the un-ionized form when heated to approximately 270 °C or spray dried in a mixture of ethanol and water.<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a> In solution, the carboxylic acid and piperazine of CIP can ionize, depending on the pH of the surrounding media. In the neutral pH range CIP is largely zwitterionic and has an overall neutral charge, making it practically insoluble in aqueous media. The solubility of CIP in water has been reported as 0.06 and 0.08 mg/mL at 25 and 37 °C respectively.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> CIP is also poorly soluble in other common solvents such as ethanol, methanol, propanol, acetone, and chloroform.<a onclick="showRef(event, &#39;ref3&#39;); return false;" href="JavaScript:void(0);" class="ref">(3)</a> CIP is also known to display poor permeability, and therefore may be considered as a class IV Biopharmaceutics Classification System (BCS) drug.<a onclick="showRef(event, &#39;ref4&#39;); return false;" href="JavaScript:void(0);" class="ref">(4)</a></div><div class="figure" id="fig1"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0001.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 1. Structure of zwitterionic ciprofloxacin.</p></div></div><div class="NLM_p">Due to the strength of its intermolecular interactions, the dissociation of CIP’s crystal lattice upon addition to water is hindered. The solubility of the drug can therefore be improved by disrupting its crystal lattice via salt formation or amorphization.<a onclick="showRef(event, &#39;ref5&#39;); return false;" href="JavaScript:void(0);" class="ref">(5)</a> Salt formation is the most frequently used process for improving the solubility of acidic and basic drugs, and is also claimed to be the most effective.<a onclick="showRef(event, &#39;ref6&#39;); return false;" href="JavaScript:void(0);" class="ref">(6)</a> For this reason it has been the main focus of research aimed at improving the solubility of CIP. The hydrochloride salt of CIP is available on the market as a tablet for oral administration. This form of the drug has been reported to have a solubility of approximately 42 mg/mL in water at 37 °C.<a onclick="showRef(event, &#39;ref7&#39;); return false;" href="JavaScript:void(0);" class="ref">(7)</a> However, due to the common ion effect, the solubility of HCl salts is decreased in the stomach.<a onclick="showRef(event, &#39;ref8&#39;); return false;" href="JavaScript:void(0);" class="ref">(8)</a> The lactate salt of CIP is available commercially as a solution for infusion, and has an aqueous solubility of just over 100 mg/mL.<a onclick="showRef(event, &#39;ref9&#39;); return false;" href="JavaScript:void(0);" class="ref">(9)</a> Novel CIP salts have also been produced using malonic, tartaric, and oxalic acid,<a onclick="showRef(event, &#39;ref10&#39;); return false;" href="JavaScript:void(0);" class="ref">(10)</a> mesylic, gluconic, and glycolic acid,<a onclick="showRef(event, &#39;ref11&#39;); return false;" href="JavaScript:void(0);" class="ref">(11)</a> and saccharin.<a onclick="showRef(event, &#39;ref12&#39;); return false;" href="JavaScript:void(0);" class="ref">(12)</a> All of these salts showed an improvement in solubility compared to the pure drug. As an alternative to small molecules, polymers may be used as counterions in pharmaceutical salts. Willis et al. found that the extent and rate of methapyrilene release in simulated gastric and intestinal fluid was improved by the formation of drug–polymer salts, in which the amine group of the drug and carboxyl groups of the polymer interacted.<a onclick="showRef(event, &#39;ref13&#39;); return false;" href="JavaScript:void(0);" class="ref">(13)</a></div><div class="NLM_p">Another method for improving the aqueous solubility of drugs is amorphization. The amorphous form does not possess long-range order and is the most energetic solid state.<a onclick="showRef(event, &#39;ref14&#39;); return false;" href="JavaScript:void(0);" class="ref">(14)</a> It is therefore more soluble than the crystalline form, as less energy is required to enter solution.<a onclick="showRef(event, &#39;ref15&#39;); return false;" href="JavaScript:void(0);" class="ref">(15)</a> The production of amorphous and partially amorphous pure CIP by various techniques was recently described by our group. This was a challenging task, as the poor solubility and thermal degradation of CIP limit the techniques that can be used to amorphize it.<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a></div><div class="NLM_p">A major disadvantage of amorphous formulations is that they are intrinsically unstable and prone to crystallization.<a onclick="showRef(event, &#39;ref14&#39;); return false;" href="JavaScript:void(0);" class="ref">(14)</a> The most common approach taken to overcome the poor stability of amorphous drugs is to formulate them as amorphous solid dispersions (ASDs). ASDs consist of an amorphous dispersion of a drug in a solid carrier, where the carrier is either a small molecule or polymer. The drug should ideally be molecularly dispersed.<a onclick="showRef(event, &#39;ref16&#39;); return false;" href="JavaScript:void(0);" class="ref">(16)</a> The carrier used to form an ASD must be chosen carefully in order to maximize the stability and solubility of the product. The physical stability of an ASD is improved if there are interactions between the components, e.g., hydrogen bonding and acid–base interactions. This reduces the molecular mobility of the drug and increases the energy required for crystallization.<a onclick="showRef(event, &#39;ref17&#39;); return false;" href="JavaScript:void(0);" class="ref">(17)</a> ASDs also enable faster drug dissolution, often resulting in supersaturation. The polymers present in an ASD help to prevent crystallization and precipitation of the drug in solution, and thus prolong this supersaturated state.<a onclick="showRef(event, &#39;ref18&#39;); return false;" href="JavaScript:void(0);" class="ref">(18)</a></div><div class="NLM_p">Despite the benefits of amorphous formulations, there is very little information in the literature regarding the formation of CIP ASDs. However, the production of amorphous salts of CIP and succinic acid with a 1:1 and 2:1 stoichiometry has previously been described by Paluch et al. These salts increased the solubility of CIP in water at 37 °C by over 300 and 600 times, respectively.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> Other amorphous formulations of CIP which have been produced include nanoplexes formed using dextran sulfate<a onclick="showRef(event, &#39;ref19&#39;); return false;" href="JavaScript:void(0);" class="ref">(19)</a> and microparticles containing chitosan and dextran.<a onclick="showRef(event, &#39;ref20&#39;); return false;" href="JavaScript:void(0);" class="ref">(20)</a></div><div class="NLM_p">Due to the lack of research in this area, the primary aim of this study was to prepare a number of solid dispersions of CIP with various polymers by ball milling, and to perform a comprehensive analysis of the successful ASDs. The solid state properties of the samples were first investigated, in particular the nature of their drug–polymer interactions and thermal stability. As previously mentioned, a major issue associated with amorphous formulations is their poor physical stability, however this can be counteracted to some degree by the use of polymers with high <i>T</i><sub>g</sub>’s that interact specifically with the drug. The stability of the ASDs during dynamic vapor sorption (DVS) analysis and under accelerated conditions was therefore examined in order to determine their resistance to crystallization.</div><div class="NLM_p last">Another major goal of this study was to determine the effect of ASD formation on the biopharmaceutical properties of CIP, specifically its solubility, permeability, and antimicrobial activity, and how these characteristics are connected. ASDs have been found to increase the solubility of drugs via supersaturation, while maintaining a constant permeability. In contrast, the solubility advantage obtained with formulations containing cyclodextrins, surfactants, and cosolvents is negatively correlated with permeability.<a onclick="showRef(event, &#39;ref21&#39;); return false;" href="JavaScript:void(0);" class="ref">(21)</a> The solubility of crystalline CIP and the ASDs was therefore investigated in water and biorelevant media, and their permeability was compared using parallel artificial membrane permeability assay (PAMPA), to discover whether a similar relationship exists between the solubility and permeability of these preparations. Finally, it was of interest to determine whether the formulation of CIP as an ASD affected its antimicrobial activity, which should also be related to permeability. Therefore, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of CIP and the ASDs were measured in a number of bacterial species.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i2">Materials and Methods</h2><hr><div id="sec2.1" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e338">Materials</span><div class="NLM_p">Anhydrous ciprofloxacin (CIP) was obtained from Carbosynth Limited, Berkshire, U.K. Ciprofloxacin hydrochloride (CIP HCl) salt was kindly donated by Hemofarm, Serbia. The following polymers were used to form solid dispersions with CIP: polyvinylpyrrolidone K17 (PVP, Plasdone C-15, ISP Technologies, New Jersey, USA); poly(vinyl alcohol) (PVA, 98% hydrolyzed, <i>M</i><sub>w</sub> 13000–23000, Sigma-Aldrich, St. Louis, MO); methacrylic acid methyl methacrylate copolymer (Eudragit L100, Evonik Röhm GmbH, Darmstadt, Germany); methacrylic acid ethyl acrylate copolymer (Eudragit L100-55, Evonik Röhm GmbH, Darmstadt, Germany); poly(acrylic acid) (Carbopol 981, BF Goodrich, OH, USA); hydroxypropyl methylcellulose acetate succinate grades LG and MG (HPMCAS-LG and HPMCAS-MG, Shin-Etsu Chemical Co., Ltd., Tokyo, Japan); polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol graft copolymer (Soluplus, BASF SE, Ludwigshafen, Germany); and polyethylene glycol 4000 (PEG 4000, BDH Ltd., Poole, England).</div><div class="NLM_p last">Fasted state simulated gastric fluid (FaSSGF) was produced by adding 60 mg of SIF Powder Original (biorelevant.com, Surrey, U.K.) to 1 L of FaSSGF HCl solution, consisting of 34 mM NaCl adjusted to pH 1.6 with HCl. Fasted state simulated intestinal fluid (FaSSIF) was produced by adding 2.24 g of SIF Powder Original to 1 L of FaSSIF phosphate buffer, consisting of 19.5 mM NaOH, 25 mM NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, and 106 mM NaCl, adjusted to pH 6.5 with NaOH. NaOH pellets were obtained from Riedel-de Haën, Seelze, Germany, NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O from Merck, Darmstadt, Germany, and NaCl from Sigma-Aldrich Ireland Ltd., Arklow, Ireland. Dodecane, triethylamine, lecithin (<span class="smallcaps">l</span>-α-phosphatidylcholine, type XVI-E), and phosphate buffered saline (PBS) tablets were obtained from Sigma-Aldrich Ireland Ltd., Arklow, Ireland. Brain-heart infusion (BHI) broth was purchased from bioMérieux (Marcy l’Étoile, France). Plates with Columbia agar supplemented with sheep blood were obtained from Oxoïd (Dardilly, France). All other chemicals and solvents were of analytical grade.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i4">Methods</h2><hr><div id="sec3.1" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e375">Ball Milling</span><div class="NLM_p last">CIP was first milled with PVP at a concentration of 10–95% (w/w). Solid dispersions of CIP with Eudragit L100, Eudragit L100-55, Carbopol 981, HPMCAS-LG, HPMCAS-MG, PVA, Soluplus, and PEG 4000 were also formed using 20–60% (w/w) polymer. For each sample, milling was performed at room temperature using a Retsch planetary ball mill PM 100 (Haan, Germany). The only exception to this was the CIP/HPMCAS-LG and HPMCAS-MG ASDs, which were milled at 2–5 °C. 2 g of powder was added to 50 mL stainless steel grinding bowls. The three stainless steel milling balls were 20 mm in diameter and weighed 32 g each. The powder mixtures were each milled for 4–6 h in total, in intervals of 15 min with 10 min breaks in between. At 1, 2, 4, and 6 h, small samples of powder were taken for analysis by powder X-ray diffraction.</div></div><div id="sec3.2" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e380">Powder X-ray Diffraction (PXRD)</span><div class="NLM_p last">PXRD was performed at room temperature using a benchtop Rigaku MiniflexII X-ray diffractometer (Tokyo, Japan) and a Haskris cooler (Illinois, USA). The measurements were carried out in reflectance mode. The samples were scanned from 5 to 40 2θ degrees in steps of 0.05. A scan rate of 0.05° per second and signal collection time per step of 1 s were used. The tube (Cu, 1 kW normal focus) output voltage and current were 30 kV and 15 mA, respectively.</div></div><div id="sec3.3" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e385">Solid State Fourier Transform Infrared Spectroscopy (FTIR)</span><div class="NLM_p last">FTIR was performed using a Spectrum One FT-IR spectrometer (PerkinElmer, Connecticut, USA) equipped with Spectrum Software version 6.1. A spectral range of 450–4000 cm<sup>–1</sup>, resolution of 4 cm<sup>–1</sup>, scan number of 10, and scan speed of 0.2 cm/s were used. KBr disks were produced by direct compression, using a pressure of approximately 10 bar for 1 min. A sample loading of 1% (w/w) was used. Physical mixtures (PMs), which were prepared by blending together the drug and polymers in the same ratio as in the ASDs with a mortar and pestle, were also analyzed for comparison.</div></div><div id="sec3.4" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e396">Differential Scanning Calorimetry (DSC)</span><div class="NLM_p last">DSC was carried out using a Mettler Toledo DSC (Schwerzenbach, Switzerland). The purge gas was nitrogen. Approximately 5–10 mg samples were analyzed in sealed 40 μL aluminum pans with pierced lids. The ASDs were first heated from 25 to 70–100 °C to remove any water present in the powder. When cool, the samples were reheated from 25 to 300 °C at a rate of 10 °C/min. Mettler Toledo STARe software (version 6.10) was used to analyze the thermograms.</div></div><div id="sec3.5" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e401">Temperature-Modulated Differential Scanning Calorimetry (StepScan)</span><div class="NLM_p last">A PerkinElmer Diamond DSC (Waltham, MA, USA) and ULSP B.V. 130 cooling system (Ede, Netherlands) were used to detect the <i>T</i><sub>g</sub>’s of the ASDs. A nitrogen gas flow of 40 mL/min was controlled with a PerkinElmer Thermal Analysis Gas Station. The instrument was calibrated for temperature and heat flow using indium standards. Approximately 5 mg samples were analyzed in 18 μL aluminum pans with sealed lids. Samples were heated at 5 °C/min in steps of 2 °C. Between each step the temperature was held constant for 1 min. The specific heat of the glass transition was calculated from the enthalpy flow using the area algorithm.</div></div><div id="sec3.6" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e411">Calculation of Theoretical Glass Transition (<i>T</i><sub>g</sub>) Values with Gordon–Taylor Equation</span><div class="NLM_p last">The theoretical <i>T</i><sub>g</sub>’s of the ASDs were calculated using the Gordon–Taylor equation:<a onclick="showRef(event, &#39;ref22 ref23&#39;); return false;" href="JavaScript:void(0);" class="ref">(22, 23)</a><span class="NLM_disp-formula" id="eq1"><img src="./test1_files/mp-2017-00039m_m001.gif" alt=""><span class="labelSpan">(1)</span></span>where <i>K</i> is approximately equal to<span class="NLM_disp-formula" id="eq2"><img src="./test1_files/mp-2017-00039m_m002.gif" alt=""><span class="labelSpan">(2)</span></span><i>w</i><sub>1</sub> and <i>w</i><sub>2</sub> are the weight fractions, <i>T</i><sub>g1</sub> and <i>T</i><sub>g2</sub> are the glass transition temperatures, and ρ<sub>1</sub> and ρ<sub>2</sub> are the densities of the two components. The <i>T</i><sub>g</sub> of pure amorphous CIP was previously determined as 86.7 °C,<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a> while the <i>T</i><sub>g</sub>’s of the polymers were obtained from the literature: Eudragit L100, 130 °C;<a onclick="showRef(event, &#39;ref24&#39;); return false;" href="JavaScript:void(0);" class="ref">(24)</a> Eudragit L100-55, 96 °C;<a onclick="showRef(event, &#39;ref25&#39;); return false;" href="JavaScript:void(0);" class="ref">(25)</a> HPMCAS-LG, 119 °C;<a onclick="showRef(event, &#39;ref26&#39;); return false;" href="JavaScript:void(0);" class="ref">(26)</a> and HPMCAS-MG, 120 °C.<a onclick="showRef(event, &#39;ref26&#39;); return false;" href="JavaScript:void(0);" class="ref">(26)</a> The average density values for the various components were also obtained from the literature: CIP, 1.5 g/cm<sup>3</sup>;<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a> Eudragit L100, 0.84 g/cm<sup>3</sup>;<a onclick="showRef(event, &#39;ref27&#39;); return false;" href="JavaScript:void(0);" class="ref">(27)</a> Eudragit L100-55, 0.83 g/cm<sup>3</sup>;<a onclick="showRef(event, &#39;ref28&#39;); return false;" href="JavaScript:void(0);" class="ref">(28)</a> and HPMCAS-LG and HPMCAS-MG, 1.29 g/cm<sup>3</sup>.<a onclick="showRef(event, &#39;ref29&#39;); return false;" href="JavaScript:void(0);" class="ref">(29)</a> The <i>T</i><sub>g</sub>’s predicted by the Gordon–Taylor equation were then compared to the experimental values measured by DSC.</div></div><div id="sec3.7" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e638">Thermogravimetric Analysis (TGA)</span><div class="NLM_p last">TGA was carried out on the ASDs using a Mettler TG50 measuring module coupled to a Mettler Toledo MT5 balance (Schwerzenbach, Switzerland). Approximately 8–10 mg samples were analyzed in open aluminum pans, using nitrogen as the purge gas. Samples were heated from 25 to 300 °C at a rate of 10 °C/min. Mettler Toledo STARe software (version 6.10) was used to analyze the thermograms.</div></div><div id="sec3.8" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e643">Dynamic Vapor Sorption (DVS)</span><div class="NLM_p last">DVS studies were carried out using an Advantage-1 automated gravimetric vapor sorption analyzer (Surface Measurement Systems Ltd., London, U.K.). The temperature was maintained at 25.0 ± 0.1 °C. Approximately 10 mg of ASD was added to the sample basket and placed in the instrument. The samples were equilibrated at 0% relative humidity (RH) until a constant mass was obtained (d<i>m</i>/d<i>t</i> ≤ 0.002 mg/min). The reference mass was recorded, and sorption–desorption analysis was then carried out between 0 and 90% RH, in steps of 10% RH. At each stage, the sample mass was equilibrated (d<i>m</i>/d<i>t</i> ≤ 0.002 mg/min for at least 10 min) before the RH was changed. An isotherm was calculated from the complete sorption and desorption profile. Following DVS analysis the samples were analyzed by PXRD in order to detect any crystallization.</div></div><div id="sec3.9" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e660">Accelerated Stability Study</span><div class="NLM_p last">A stability study of the ASDs was conducted under accelerated storage conditions of 40 °C and 75% RH. Samples of each powder were taken every 2–3 days for a period of 2 weeks. PXRD was used to determine whether crystallization had occurred in any of the samples.</div></div><div id="sec3.10" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e665">Dynamic Solubility Studies</span><div class="NLM_p last">10–20 mL of water, FaSSIF, or FaSSGF was added to 40 mL glass vials. These were placed into jacketed beakers connected to a Lauda M12 water bath (Lauda-Königshofen, Germany) and allowed to equilibrate to 37 °C. A quantity of pure drug or ASD, in excess of the expected saturated solubility (50–225 mg, depending on the sample), was added to the stirred vials. Samples were drawn from the vials at specific time points over a 2 h period. These aliquots were filtered with 0.45 μm PTFE membrane filters (VWR, USA). The filtered solutions were then diluted with a 2.45 g/L solution of phosphoric acid, previously adjusted to pH 3.0 with triethylamine. The concentration of CIP in each of the diluted samples was determined by UV spectrophotometry. The solubility studies were repeated at least in triplicate with each medium. The pH of the solutions was measured before the addition of the samples and at the end of the 2 h study using a Thermo Orion 420A+ pH meter (Thermo Scientific, Hampshire, U.K.). The solid material left in the vials at the end of the studies was filtered and analyzed by PXRD.</div></div><div id="sec3.11" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e671">UV Spectrophotometry</span><div class="NLM_p last">UV analysis was carried out using a Shimadzu UV-1700 PharmaSpec UV–vis spectrophotometer (Shimadzu Corp., Kyoto, Japan). Quartz cells with a 1 cm optical path length were used for all measurements. UV absorbance was measured at 278 nm. The instrument was first blanked using a 2.45 g/L solution of phosphoric acid, previously adjusted to pH 3.0 with triethylamine. This buffer was also used to produce a range of concentrations of pure CIP, in order to construct a calibration curve.</div></div><div id="sec3.12" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e676">Parallel Artificial Membrane Permeability Assay (PAMPA)</span><div class="NLM_p">Permeability studies were carried out using the lipid–PAMPA method described by Merck Millipore.<a onclick="showRef(event, &#39;ref30&#39;); return false;" href="JavaScript:void(0);" class="ref">(30)</a> A 96-well MultiScreen Filter Plate (Millipore Corporation, Billerica, MA, USA), with underdrain removed, was used as the donor plate, and a 96-well MultiScreen Transport Receiver Plate (Millipore Corporation, Billerica, MA, USA) as the acceptor plate. Solutions of CIP, CIP HCl, CIP/Eudragit L100, CIP/HPMCAS-LG, and CIP/HPMCAS-MG in PBS pH 7.4 and 6.4, at concentrations of 50–125 μg/mL, were prepared. 300 μL of PBS pH 7.4 was added to each well of the acceptor plate. 5 μL of a 1% (w/v) solution of lecithin in dodecane was added to the filter within each donor well to form an artificial membrane. The drug solutions (150 μL) were immediately added to each well of the donor plate in triplicate. The donor plate was then placed into the acceptor plate and incubated at room temperature for 16 h. Following incubation, the contents of each well in the acceptor plate was diluted 1:4 with HPLC mobile phase and filtered with 0.45 μm PTFE membrane filters (VWR, USA). The concentration of CIP in each sample was then measured using HPLC.</div><div class="NLM_p last">The effective permeability (<i>P</i><sub>e</sub>) of the samples was calculated using the following equation reported by Wohnsland and Faller:<a onclick="showRef(event, &#39;ref31&#39;); return false;" href="JavaScript:void(0);" class="ref">(31)</a><span class="NLM_disp-formula" id="eq3"><img src="./test1_files/mp-2017-00039m_m003.gif" alt=""><span class="labelSpan">(3)</span></span>where<span class="NLM_disp-formula" id="ueq1"><img src="./test1_files/mp-2017-00039m_m004.gif" alt=""></span><i>V</i><sub>D</sub> and <i>V</i><sub>A</sub> are the volumes of the donor and acceptor compartment, respectively, in cm<sup>3</sup>, <i>t</i> is the incubation time in seconds, and <i>A</i> is the active surface area of the membrane (equal to the membrane area multiplied by the porosity ratio. For Millipore MultiScreen Permeability Filter Plate membranes this is equal to 0.24 cm<sup>2</sup> × 100%, or 0.24 cm<sup>2</sup>).<a onclick="showRef(event, &#39;ref30&#39;); return false;" href="JavaScript:void(0);" class="ref">(30)</a> [drug]<sub>acceptor</sub> is the concentration of the drug in the acceptor compartment at the end of the assay. [drug]<sub>equilibrium</sub> is determined by measuring the concentration of a reference solution, containing the drug at the theoretical equilibrium concentration (the overall concentration of the donor and acceptor solutions combined).<a onclick="showRef(event, &#39;ref32&#39;); return false;" href="JavaScript:void(0);" class="ref">(32)</a> Given that the acceptor and donor compartments used in this study had a volume of 150 and 300 μL respectively, the equilibrium concentration of the drug should theoretically be one-third of that of the original solution added to the donor well.</div></div><div id="sec3.13" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e843">High Performance Liquid Chromatography (HPLC)</span><div class="NLM_p last">The content of CIP was measured with a Shimadzu 10Avp HPLC system (Kyoto, Japan). A Luna 5u C8 column, with a length of 250 mm, internal diameter of 4.6 mm, and 5 μm particle size, was used. The mobile phase consisted of 13 volumes of acetonitrile and 87 volumes of a 2.45 g/L solution of phosphoric acid, previously adjusted to pH 3.0 with triethylamine. An injection volume of 10 μL and flow rate of 1.5 mL/min for 15 min was used. The separation was carried out at room temperature. A Shimadzu SPD-10Avp UV–vis detector at 278 nm was used to detect the drug.</div></div><div id="sec3.14" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e848">Bacterial Studies</span><div class="NLM_p">Bacterial studies were carried out on the following bacterial strains: (1) <i>Staphylococcus aureus</i> ATCC 25923, (2) <i>Escherichia coli</i> ATCC 25922, (3) <i>Pseudomonas aeruginosa</i> ATCC 27853, and (4) <i>Klebsiella pneumoniae</i> DSM 16609. The bacteria were cultured on Columbia agar supplemented with sheep blood. The inoculum was prepared as described previously.<a onclick="showRef(event, &#39;ref33&#39;); return false;" href="JavaScript:void(0);" class="ref">(33)</a> The density of the microorganism suspension was adjusted to equal that of the 1.1 McFarland standard for <i>S. aureus</i>, and the 0.5 McFarland standard for <i>P. aeruginosa, E. coli</i>, and <i>K. pneumoniae</i>. The former suspension was further diluted 100-fold with BHI medium, while the latter were diluted 10-fold.</div><div class="NLM_p last">The minimum inhibitory concentrations (MICs) of CIP and the ASDs were determined using the broth microdilution method described by Umerska et al.<a onclick="showRef(event, &#39;ref33&#39;); return false;" href="JavaScript:void(0);" class="ref">(33)</a> Several 2-fold dilutions of the samples in BHI medium were prepared in order to obtain the desired concentration range. 50 μL of the bacterial suspension in BHI broth was then added to a well containing 50 μL of test sample or a control. The samples were incubated for 24 h at 37 °C. All MIC assays were performed in triplicate on separate days. The MIC was taken to be the lowest concentration that completely inhibited the growth of bacteria, as detected by the unaided eye. The Minimum bactericidal concentrations (MBCs) were determined by withdrawing 10 μL from each well, transferring it onto a plate containing Mueller Hinton agar, and incubating overnight at 37 °C. MIC and/or MBC values were considered as different if they varied by more than one dilution.<a onclick="showRef(event, &#39;ref33&#39;); return false;" href="JavaScript:void(0);" class="ref">(33)</a></div></div><div id="sec3.15" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e885">Statistical Analysis</span><div class="NLM_p last">Statistical analysis was carried out using Minitab 16 software. Data was analyzed using analysis of variance (ANOVA) with Tukey’s multiple comparison test, and two-sample Student <i>t</i> tests. A <i>p</i>-value of ≤0.05 was considered significant.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i20">Results and Discussion</h2><hr><div id="sec4.1" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e899">Production of Amorphous Solid Dispersions</span><div class="NLM_p">A number of binary solid dispersions of CIP with different polymers, in various concentrations, were produced by ball milling. Ball milling was previously found to be a suitable method for forming the amorphous CIP/succinic acid 2:1 salt, as it did not result in any degradation of the drug.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> The first polymer to be used was PVP, in a concentration range of 10–95% (w/w). PVP was chosen as it is a neutral, amorphous polymer, which is commonly used to produce ASDs of poorly soluble drugs.<a onclick="showRef(event, &#39;ref16&#39;); return false;" href="JavaScript:void(0);" class="ref">(16)</a> Interestingly, CIP did not become amorphous when milled with any concentration of PVP tested. As the ratio of polymer to drug increased, the intensity of the peaks seen in the PXRDs decreased (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.1</a>). However, this was most likely due to a dilution effect. Although CIP may theoretically interact with PVP via hydrogen bonds, these interactions were evidently too weak to yield a fully amorphous solid dispersion. Similarly, when CIP was milled with 40% (w/w) Soluplus or PEG 4000, both neutral polymers, a crystalline product was obtained (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">2</a>a).</div><div class="figure" id="fig2"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0002.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 2. (a) PXRD analysis following milling of CIP with various polymers at a 40% (w/w) concentration, for 4 h at room temperature. (b) PXRD analysis of CIP and CIP ASDs. The peak at 25.3 2θ degrees corresponds to the major slip plane in the crystal lattice of CIP, and therefore it is the most likely peak to be present following mechanical stress of the drug.<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a></p></div></div><div class="NLM_p">The next polymer chosen for milling with CIP was poly(vinyl alcohol) (PVA), whose hydroxyl group can act as both a hydrogen bond acceptor and donor. Following 4 h of milling at room temperature with 40% (w/w) PVA, small peaks were still seen by PXRD (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">2</a>a). Milling at room temperature can result in increased temperatures, and a subsequent increase in molecular mobility.<a onclick="showRef(event, &#39;ref34&#39;); return false;" href="JavaScript:void(0);" class="ref">(34)</a> This can induce nucleation and crystallization of amorphous material. The use of too low a concentration of polymer can also result in an unstable product.<a onclick="showRef(event, &#39;ref35&#39;); return false;" href="JavaScript:void(0);" class="ref">(35)</a> Therefore, a higher concentration of 60% (w/w) PVA, 6 h milling time, and milling temperature of 2–5 °C were implemented. This resulted in a product that was almost fully amorphous, however very small peaks could still be detected at approximately 20 and 25 2θ degrees due to the presence of residual crystalline CIP (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.2</a>).</div><div class="NLM_p">As polymers with neutral functional groups were ineffective at amorphizing CIP, it was hypothesized that perhaps a polymer with ionizable moieties is necessary for this. As discussed above, many salts of CIP have been produced using acidic counterions, such as succinic acid. The secondary amine of CIP’s piperazine ring is ionized in these salts, and forms hydrogen bonds with the negatively charged carboxylate groups of the acid.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> Therefore, the processing of CIP with acidic polymers may be a suitable means of producing a stable amorphous formulation. Eudragit L100, Eudragit L100-55, and Carbopol 981 all contain carboxylic acid groups and were the first acidic polymers to be used. As can be seen from <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">2</a>b, each of these polymers resulted in the formation of an X-ray amorphous solid dispersion when milled with CIP for 4 h at room temperature, at a concentration of 40% (w/w). While higher ratios of polymer were also successful, the use of lower quantities of the Eudragit polymers resulted in a partially crystalline product (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.3</a>). Carbopol on the other hand still produced an ASD when used at a concentration of 20% (w/w).</div><div class="NLM_p">HPMCAS also contains acidic groups. The LG grade contains 5–9% acetyl and 14–18% succinoyl groups, and the MG grade 7–11% and 10–14% of each group, respectively.<a onclick="showRef(event, &#39;ref26&#39;); return false;" href="JavaScript:void(0);" class="ref">(26)</a> However, when these were milled with CIP using the same conditions as for the other acidic polymers, the product was only partially amorphous (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">2</a>a). Higher concentrations of polymer and longer milling times still resulted in partially crystalline systems, as evidenced by PXRD peaks, although polymer concentration appears to have a greater effect on the crystallinity of these samples than milling time (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.4</a>). Milling was next conducted at 2–5 °C, with a 60% (w/w) concentration of HPMCAS, for 6 h. These conditions resulted in the formation of X-ray amorphous solid dispersions (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig2">2</a>b).</div><div class="NLM_p last">ASDs formed from the five acidic polymers discussed above (i.e., Eudragit L100, Eudragit L100-55, Carbopol 981, HPMCAS-LG, and HPMCAS-MG) were chosen for further examination. While a higher proportion of polymer should increase the physical stability of an ASD,<a onclick="showRef(event, &#39;ref36&#39;); return false;" href="JavaScript:void(0);" class="ref">(36)</a> it also necessitates the use of a larger preparation in order to deliver the required dose as an oral solid dosage form. This could result in problems with patient acceptability and compliance. Therefore, a polymer concentration of 40% (w/w) was chosen for the ASDs containing Eudragit L100, Eudragit L100-55, and Carbopol, and 60% (w/w) for those containing HPMCAS.</div></div><div id="sec4.2" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e979">Solid State Characterization of Amorphous Solid Dispersions</span><div class="NLM_p">The FTIR spectra of the ASDs, polymers, and crystalline CIP are shown in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig3">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig3">3</a>. The spectra of the physical mixtures (PMs) are also shown for comparison.</div><div class="figure" id="fig3"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0003.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 3. FTIR spectra of ASDs and PMs containing (a) Eudragit L100 and Eudragit L100-55 40% (w/w), (b) Carbopol 40% (w/w), and (c) HPMCAS-LG and HPMCAS-MG 60% (w/w).</p></div></div><div class="NLM_p">In the spectra of each of the polymers, a peak can be seen between 1709 and 1744 cm<sup>–1</sup> due to the C═O stretch of their carboxylic acid groups. A matching peak is present in the spectra of the PMs. The spectrum of crystalline CIP contains peaks at 1590 and 1375 cm<sup>–1</sup>, corresponding to the asymmetric and symmetric vibrations of the carboxylate ion, respectively.<a onclick="showRef(event, &#39;ref37&#39;); return false;" href="JavaScript:void(0);" class="ref">(37)</a> The peak at 1590 cm<sup>–1</sup> is absent from the spectra of the ASDs containing Eudragit and Carbopol, while those containing HPMCAS display a small peak, due to the presence of a residual amount of zwitterionic CIP. Interestingly, with all of the ASDs a strong peak is seen between 1723 and 1734 cm<sup>–1</sup>, due to the C═O stretch of COOH. In each case, this peak is far more intense than the corresponding peak in the spectra of the PMs. Therefore, these peaks can be assigned to the carboxylic acid of CIP, and it can be concluded that this group is uncharged in the ASDs. This is in contrast to the semicrystalline solid dispersions containing PVP and Soluplus, which also show the characteristic peaks of the ionized carboxylate group of CIP. These peaks are weaker and broader in the more disordered CIP/PVA solid dispersion, as the proportion of crystalline CIP is greatly reduced. In addition, like the ASDs, this sample has a peak at approximately 1720 cm<sup>–1</sup>, which confirms the presence of the protonated carboxylic acid group of CIP (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.5</a>).</div><div class="NLM_p">The strongest peak in the spectrum of crystalline CIP, at approximately 1618 cm<sup>–1</sup>, can be assigned to the C═O stretch of the ketone carbonyl.<a onclick="showRef(event, &#39;ref37&#39;); return false;" href="JavaScript:void(0);" class="ref">(37)</a> This peak is shifted to 1628 cm<sup>–1</sup> in the spectra of the ASDs, which may be due to changes in the hydrogen bonding of this group. This peak was also found to shift to 1627–1629 cm<sup>–1</sup> when zwitterionic CIP was heated to its melting point, which results in the formation of the un-ionized form of the drug.<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a> When the carboxylic acid of CIP is un-ionized, an intramolecular hydrogen bond is formed between this ketone and the neighboring carboxylic acid.<a onclick="showRef(event, &#39;ref1&#39;); return false;" href="JavaScript:void(0);" class="ref">(1)</a> This hydrogen bond is also found in CIP salts, in which the carboxylic acid of CIP is also protonated.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> In contrast, no such shift in the ketone carbonyl peak is seen in the spectra of the semicrystalline solid dispersions, as they contain zwitterionic CIP.</div><div class="NLM_p">In each of the ASD spectra a broad peak at 2400–2600 cm<sup>–1</sup> can be assigned to the NH<sub>2</sub><sup>+</sup> stretching vibrations of CIP.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> Therefore, the drug is in an ionization state in these ASDs that is similar to that in crystalline salts formed using various acids, i.e., with a neutral carboxylic acid and positively charged secondary amine. This group most likely interacts with negatively charged carboxylate groups in the polymers, as was seen with CIP succinate salts.<a onclick="showRef(event, &#39;ref2&#39;); return false;" href="JavaScript:void(0);" class="ref">(2)</a> The p<i>K</i><sub>a</sub> of the carboxylic acid of CIP has been reported as 6.16, while that of the piperazine amine is 8.62.<a onclick="showRef(event, &#39;ref38&#39;); return false;" href="JavaScript:void(0);" class="ref">(38)</a> Given that the p<i>K</i><sub>a</sub> values of the polymers vary from 5 to 6.0,<a onclick="showRef(event, &#39;ref24 ref25 ref26 ref39&#39;); return false;" href="JavaScript:void(0);" class="ref">(24-26, 39)</a> the p<i>K</i><sub>a</sub> difference between the secondary amine of the drug and carboxylic acid of the polymers falls within the limits of salt formation of ≥2–3 in each case.<a onclick="showRef(event, &#39;ref40&#39;); return false;" href="JavaScript:void(0);" class="ref">(40)</a> Therefore, these formulations could be considered as amorphous polymeric drug salts. Amorphous drug–polymer salts have also been produced by Weuts  et al.,<a onclick="showRef(event, &#39;ref41&#39;); return false;" href="JavaScript:void(0);" class="ref">(41)</a> Song  et al.,<a onclick="showRef(event, &#39;ref42&#39;); return false;" href="JavaScript:void(0);" class="ref">(42)</a> and Maniruzzaman et al.<a onclick="showRef(event, &#39;ref43&#39;); return false;" href="JavaScript:void(0);" class="ref">(43)</a> In each case an ionic interaction between the COOH groups of the polymers and amino groups of the drugs was detected.</div><div class="NLM_p">Conventional DSC, using a heating rate of 10 °C/min, resulted in DSC thermograms that proved difficult to interpret for these samples (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">4</a>a). In each case it was impossible to pinpoint a definite glass transition temperature (<i>T</i><sub>g</sub>). Due to their high water content, the samples were first heated from 25 to 100 °C to allow for evaporation of sorbed water.</div><div class="figure" id="fig4"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0004.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 4. (a) Conventional DSC thermograms of CIP and CIP ASDs. The thermograms of the ASDs are those obtained from the second heating cycle, following initial heating to 100 °C to allow for water evaporation. (b) Heat flow traces from temperature modulated DSC (StepScan). Solid lines: specific heat curves. Dotted lines: isokinetic baseline curves. The arrows point to the location of the <i>T</i><sub>g</sub>’s. The <i>T</i><sub>g</sub>’s obtained using the StepScan method as well as those calculated using the Gordon–Taylor (G-T) equation are also listed.</p></div></div><div class="NLM_p">Crystalline CIP has a melting point of approximately 272 °C, which is accompanied by degradation. The ASDs did not display a clear melting endotherm, which can be taken as confirmation of their amorphous nature.<a onclick="showRef(event, &#39;ref44&#39;); return false;" href="JavaScript:void(0);" class="ref">(44)</a> Like the pure drug, the ASDs undergo thermal degradation, as shown by TGA (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.6</a>). All of the ASDs initially underwent water evaporation, followed by substantial degradation above ∼230 °C, leading to a total mass loss of 14–19%.</div><div class="NLM_p">Temperature-modulated DSC (StepScan) was used to locate the <i>T</i><sub>g</sub>’s of the ASDs, and these are listed in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">4</a>b. No crystallization in the temperature range 80–170 °C was detected using the StepScan method, as can be seen from the isokinetic baseline traces (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">4</a>b). A single <i>T</i><sub>g</sub> was visible in the thermograms of all of the ASDs. This suggests that CIP is miscible with each of these polymers<a onclick="showRef(event, &#39;ref45&#39;); return false;" href="JavaScript:void(0);" class="ref">(45)</a> and that phase separation does not occur in the ASDs.<a onclick="showRef(event, &#39;ref15&#39;); return false;" href="JavaScript:void(0);" class="ref">(15)</a> Unfortunately, despite the use of the StepScan method, the <i>T</i><sub>g</sub> of the CIP/Carbopol ASD could not be detected. The <i>T</i><sub>g</sub>’s that were calculated using the Gordon–Taylor (G-T) equation are also shown in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig4">4</a>b. The G–T equation is based on the assumption that the components form an ideal mixture, with additive free volumes, but without any strong interactions between the constituents.<a onclick="showRef(event, &#39;ref22 ref23&#39;); return false;" href="JavaScript:void(0);" class="ref">(22, 23)</a> For all of the ASDs the <i>T</i><sub>g</sub> values obtained experimentally were higher than those predicted theoretically. This was also found to be the case for the amorphous polymeric salts produced by Weuts et al. and Song et al.<a onclick="showRef(event, &#39;ref41 ref42&#39;); return false;" href="JavaScript:void(0);" class="ref">(41, 42)</a> Particularly large positive deviations of approximately 48 and 45 °C were obtained for the ASDs containing Eudragit L100 and L100-55, respectively. The G–T equation is known to underestimate the <i>T</i><sub>g</sub> of salts due to their ionic bonds, and larger deviations are obtained with counterions that form stronger electrostatic interactions with the drug.<a onclick="showRef(event, &#39;ref46 ref47&#39;); return false;" href="JavaScript:void(0);" class="ref">(46, 47)</a> Therefore, the FTIR analysis and the higher than predicted <i>T</i><sub>g</sub>’s of these ASDs suggest that ionic interactions exist between CIP and the polymers.</div><div class="NLM_p last">In contrast to the Eudragit-containing ASDs, the experimental and calculated <i>T</i><sub>g</sub>’s of the CIP/HPMCAS-MG ASD were very similar, differing by only 1 °C. This suggests that the drug and polymer are fully miscible and do not interact specifically with one another.<a onclick="showRef(event, &#39;ref48&#39;); return false;" href="JavaScript:void(0);" class="ref">(48)</a> Alternatively, the strength of the interactions formed between the drug and polymer may be equal in strength to the homomolecular interactions in the pure components.<a onclick="showRef(event, &#39;ref49&#39;); return false;" href="JavaScript:void(0);" class="ref">(49)</a> This formulation would therefore be expected to be less stable than the ASDs containing Eudragit L100 or L100-55. A larger deviation of 7.5 °C was seen with CIP/HPMCAS-LG, suggesting that the drug interacts more substantially with this grade of HPMCAS, but less so than with the Eudragit polymers, possibly due to a larger content of succinoyl groups in this grade of HPMCAS. Similarly, stronger drug–polymer interactions may exist in the Eudragit-containing ASDs due to the higher proportion of carboxylic acid groups present in these polymers in comparison to HPMCAS (see polymer structures in <a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.7</a>). This may explain why it was more difficult to amorphize the CIP/HPMCAS mixtures, with larger polymer concentrations, longer milling times, and lower temperatures being required compared to the other ASDs.</div></div><div id="sec4.3" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e1218">Stability Studies</span><div class="NLM_p">DVS analysis showed that all of the ASDs are capable of sorbing a large amount of water. At 90% RH, a change in mass of between 16 and 20% was seen for all of the samples. CIP/Eudragit L100 sample sorbed the greatest amount of water, and CIP/HPMCAS-MG the least. The sorption–desorption isotherms obtained with all of the samples had a similar sigmoidal shape and hysteresis (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig5">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig5">5</a>). These results are to be expected, as amorphous drugs are more hygroscopic than their crystalline forms. Water can absorb into the internal structure of amorphous materials rather than just adsorb to the surface.<a onclick="showRef(event, &#39;ref50&#39;); return false;" href="JavaScript:void(0);" class="ref">(50)</a> The presence of hygroscopic polymers would also have contributed to the water uptake of the ASDs.</div><div class="figure" id="fig5"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0005.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 5. DVS analysis of CIP ASDs containing (a) Eudragit L100, Eudragit L100-55, and Carbopol 40% (w/w) and (b) HPMCAS-LG and HPMCAS-MG 60% (w/w).</p></div></div><div class="NLM_p">Water sorption can negatively affect drug stability by increasing the rate of crystallization. This is due to a lowering of the <i>T</i><sub>g</sub>, increase in molecular mobility, and plasticization by moisture.<a onclick="showRef(event, &#39;ref50&#39;); return false;" href="JavaScript:void(0);" class="ref">(50)</a> However, all of the ASDs studied here remained amorphous following DVS analysis, as shown by PXRD (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.8</a>). Electrostatic forces between the amino group of CIP and carboxylic acid of the polymers most likely stabilized the ASDs and prevented their crystallization during the study. Similar interactions were responsible for the improved stability of loperamide–poly(acrylic acid)  and lapatinib–hydroxypropylmethylcellulose phthalate ASDs during stability studies.<a onclick="showRef(event, &#39;ref41 ref42&#39;); return false;" href="JavaScript:void(0);" class="ref">(41, 42)</a> In addition, the long chains of polymers can delay crystallization by sterically hindering the diffusion of drug molecules, blocking sites of crystal growth, and increasing the kinetic barrier to nucleation.<a onclick="showRef(event, &#39;ref36 ref49&#39;); return false;" href="JavaScript:void(0);" class="ref">(36, 49)</a></div><div class="NLM_p">All of the ASDs, except for CIP/Eudragit L100, began to crystallize after 24 h in accelerated storage conditions of 40 °C/75% RH. However, by day 3 of the study, this sample also began to show small crystallization peaks (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig6">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig6">6</a>a). There was only a slight increase in the intensity of the bands seen in the PXRD of the HPMCAS samples between days 1 and 14, and no noticeable change in the Carbopol sample during the same time frame (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig6">Figures </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig6">6</a>b and <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig6">6</a>c). As CIP/Eudragit L100 did not show prominent peaks until day 3 of the study, it is therefore slightly more resistant to crystallization than the other ASDs. After 14 days, all of the samples were partially crystalline by PXRD, displaying a number of low intensity peaks. Therefore, although the ASDs were physically stable under the high humidity conditions of DVS, when this was combined with high temperature, a small degree of crystallization occurred. All of the ASDs, except for CIP/Carbopol, showed PXRD peaks corresponding to that of hydrated CIP, in particular the most characteristic peak of the 3.7 hydrate at approximately 6.5 2θ degrees.<a onclick="showRef(event, &#39;ref51&#39;); return false;" href="JavaScript:void(0);" class="ref">(51)</a> Peaks corresponding to the 3.1 hydrate (see next <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#sec4.4">section</a>) were also identified. In contrast to the other ASDs, the peaks of hydrated CIP were absent from the diffractograms of the CIP/Carbopol ASD, which instead showed broad peaks corresponding to anhydrous zwitterionic CIP.</div><div class="figure" id="fig6"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0006.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 6. PXRD analysis of ASDs stored at 40 °C/75% RH for 1, 3, and 14 days: (a) CIP/Eudragit L100 and CIP/Eudragit L100-55, (b) CIP/Carbopol, and (c) CIP/HPMCAS-LG and CIP/HPMCAS-MG. The arrows identify the most prominent peaks, corresponding to CIP, CIP 3.7 hydrate (3.7), and CIP 3.1 hydrate (3.1).</p></div></div></div><div id="sec4.4" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e1284">Dynamic Solubility Studies</span><div class="NLM_p">As previously mentioned, CIP is a zwitterionic compound, with a basic and an acidic group that can ionize depending on the pH of the solvent. Therefore, it is important to study the solubility of this drug in different media in order to estimate how it will behave in various sections of the gastrointestinal tract.<a onclick="showRef(event, &#39;ref52&#39;); return false;" href="JavaScript:void(0);" class="ref">(52)</a> Solubility studies were carried out in water, FaSSIF (fasted state simulated intestinal fluid, pH 6.5), and FaSSGF (fasted state simulated gastric fluid, pH 1.6). Due to excessive clumping and the viscous nature of the solutions formed when the CIP/Eudragit L100-55 and Carbopol samples were added to the media, it was not possible to accurately carry out solubility tests on these ASDs.</div><div class="NLM_p">CIP has low aqueous solubility, achieving a concentration of only 0.09 mg/mL in water after 2 h. The Eudragit and HPMCAS ASDs showed superior solubility, obtaining concentrations approximately 7 and 19 times that of the pure drug, respectively, in the same time frame. After a steep initial increase in concentration within the first 10 min or so, these levels were then sustained for the duration of the experiment (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">7</a>a). All three of these polymers are practically insoluble in water,<a onclick="showRef(event, &#39;ref26 ref27&#39;); return false;" href="JavaScript:void(0);" class="ref">(26, 27)</a> which may have limited their ability to improve the aqueous solubility of CIP. Although the LG grade of HPMCAS resulted in slightly higher drug concentrations in the initial portion of the study, after 2 h no statistically significant difference was seen when compared to the MG grade (<i>p</i> = 0.27).</div><div class="figure" id="fig7"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0007.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 7. Solubility studies in (a) water, (b) FaSSIF, and (c) FaSSGF at 37 °C. The averages of at least 3 experiments are plotted, ± the standard deviation. The average pH of the solutions at the end of the study is also shown.</p></div></div><div class="NLM_p">The solubility profiles of the ASDs are similar to the “spring” and “parachute” model described by Guzmán et al.<a onclick="showRef(event, &#39;ref18&#39;); return false;" href="JavaScript:void(0);" class="ref">(18)</a> Due to their disordered structure, ASDs enable the rapid dissolution of drugs and act as a “spring” for the formation of a supersaturated solution. Unfortunately, the high energy supersaturated state is usually short-lived, and amorphous drugs tend to quickly convert to a more stable and less soluble crystal form. This leads to precipitation of the API and reduced absorption in vivo. However, polymers which are present in the ASD can inhibit the nucleation and crystallization of the drug, decreasing the rate of precipitation.<a onclick="showRef(event, &#39;ref53&#39;); return false;" href="JavaScript:void(0);" class="ref">(53)</a> In this way they act as “parachutes”, helping to maintain supersaturation, and thus increase the rate and extent of drug absorption.<a onclick="showRef(event, &#39;ref18&#39;); return false;" href="JavaScript:void(0);" class="ref">(18)</a> The polymers present in the CIP ASDs appear to have played a similar role, enabling high concentrations of CIP to remain in solution for at least 2 h.</div><div class="NLM_p">PXRD analysis of the excess solid recovered at the end of the studies confirms that a low proportion of CIP crystallized from the ASDs in solution overall (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.9</a>). CIP/Eudragit L100 was quite resistant to crystallization in water, with just one small peak appearing in the PXRD of the excess solid recovered at the end of the study, at 6.5 2θ degrees. The HPMCAS ASDs showed a greater number of peaks, of higher intensity, but still remained somewhat disordered. As demonstrated in the stability study, these ASDs have a greater propensity to crystallize when exposed to water than those containing Eudragit L100. The excess solids recovered at the end of the solubility studies in FaSSIF were also partially crystalline. A more crystalline product was obtained with CIP/HPMCAS-LG, indicating that this ASD is less resistant to crystallization at basic pH. Unlike the ASDs, pure crystalline CIP formed a fully crystalline hydrate in all media; however the PXRD pattern of the residue from solubility studies in water differed from those conducted in FaSSIF and FaSSGF (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.9d</a>). In the latter two cases, the CIP 3.7 hydrate was identified,<a onclick="showRef(event, &#39;ref51&#39;); return false;" href="JavaScript:void(0);" class="ref">(51)</a> while TGA of the former hydrate found it to contain 14.3% water (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">Figure SI.10</a>). This corresponds to approximately 3.1 mol of water per mole of CIP. Interestingly, while the HPMCAS-LG ASD also formed the 3.7 hydrate in water, all the other ASD/media combinations resulted in the CIP 3.1 hydrate.</div><div class="NLM_p">In FaSSIF crystalline CIP reached a peak concentration of 0.9 mg/mL after 1 min. This quickly fell over the first 10 min, and then remained fairly constant at approximately 0.15 mg/mL for the remainder of the study. The sodium taurocholate and lecithin present in FaSSIF mimic bile salts and phospholipids, respectively, in intestinal fluid.<a onclick="showRef(event, &#39;ref54&#39;); return false;" href="JavaScript:void(0);" class="ref">(54)</a> The increased solubility of the pure drug in this medium compared to water may be due to the presence of these surfactants. The Eudragit L100 and HPMCAS ASDs behaved differently over the course of the study. The solubility of the former increased gradually over 2 h, giving the plot in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">7</a>b a convex shape. In contrast, the HPMCAS-LG and HPMCAS-MG ASDs reached a peak in CIP concentration after 5–10 min, and then slowly fell over the remainder of the study. The LG grade of HPMCAS reached a top concentration of 1.9 mg/mL, whereas the MG grade obtained a maximum of 1.5 mg/mL. Solid dispersions containing different grades of HPMCAS would be expected to show discrepancies in solubility at various pH values, due to differences in their succinoyl and acetyl content.<a onclick="showRef(event, &#39;ref55&#39;); return false;" href="JavaScript:void(0);" class="ref">(55)</a> However, although the former sample remained at a higher concentration for the majority of the study, after 2 h an equal concentration of 1.3 mg/mL was obtained with both HPMCAS ASDs. The decrease in the solubility of CIP/HPMCAS-LG over time may be due to the conversion of the drug to its hydrate, as detected by PXRD, as the aqueous solubility and dissolution rate of CIP hydrate are significantly lower than those of the anhydrous drug.<a onclick="showRef(event, &#39;ref56&#39;); return false;" href="JavaScript:void(0);" class="ref">(56)</a> Although HPMCAS-LG and HPMCAS-MG are soluble at a pH above 5.5 and 6.0 respectively,<a onclick="showRef(event, &#39;ref26&#39;); return false;" href="JavaScript:void(0);" class="ref">(26)</a> this did not result in a substantial increase in the solubility of these ASDs in FaSSIF.</div><div class="NLM_p">In FaSSGF the Eudragit L100 and HPMCAS-LG ASDs showed very similar behavior to each other, achieving maximum CIP concentrations of 3.2 mg/mL after 2 h. The HPMCAS-MG formulation was somewhat more soluble at low pH, reaching 4.1 mg/mL (<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">7</a>c). The solubility of the pure drug however was approximately 3–4 times higher than that of the ASDs. This may be due to the fact that the polymers are insoluble in aqueous acidic solutions.<a onclick="showRef(event, &#39;ref55&#39;); return false;" href="JavaScript:void(0);" class="ref">(55)</a> CIP on the other hand has high solubility at pH &lt; 5, as it has a net positive charge. In contrast, it has minimal solubility at neutral pH, where it bears no overall charge.<a onclick="showRef(event, &#39;ref4&#39;); return false;" href="JavaScript:void(0);" class="ref">(4)</a> Similar results were seen in solubility studies of malonic, tartaric, and oxalic acid salts of CIP, which were also found to be less soluble in acidic media than the pure drug.<a onclick="showRef(event, &#39;ref10&#39;); return false;" href="JavaScript:void(0);" class="ref">(10)</a> An amorphous solid was recovered at the end of this study for all of the ASDs, indicating that they are resistant to crystallization at low pH.</div><div class="NLM_p">The pH of the solutions at the end of the studies was measured and is listed in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig7">7</a>. Very small changes in pH, of ±0.2 on average, occurred over the course of the study, with the exception of pure CIP in FaSSGF. In this case the high quantity of weakly basic drug in solution increased the pH to 4.7. Therefore, the differences in solubility described above cannot be attributed to changes in pH, but rather to the physical form of the drug and the presence of polymers.</div><div class="NLM_p">A modification of the Henderson–Hasselbalch equation was used to construct the theoretical pH–solubility profile of pure CIP and the commercial hydrochloride salt, CIP HCl:<span class="NLM_disp-formula" id="eq4"><img src="./test1_files/mp-2017-00039m_m005.gif" alt=""><span class="labelSpan">(4)</span></span><i>S</i><sub>T</sub> is the total solubility of the drug in mol/L, and [B] is the concentration of the free base (approximately 0.000266 M for CIP and 0.0008 M for CIP HCl). As previously mentioned, the p<i>K</i><sub>a</sub> values of the carboxylic acid (p<i>K</i><sub>a</sub><sub>1</sub>) and piperazine amine (p<i>K</i><sub>a</sub><sub>2</sub>) of CIP are equal to 6.16 and 8.62, respectively.<a onclick="showRef(event, &#39;ref38&#39;); return false;" href="JavaScript:void(0);" class="ref">(38)</a> The CIP ASDs may be considered as basic salts, as they consist of an interaction between the positively charged amino group of the drug and negatively charged carboxylate groups of the polymers. According to Kramer and Flynn, the pH–solubility profile of a basic salt can be represented by two independent solubility profiles, one of which describes when the free base is the saturation species, and the other when the salt is the saturation species.<a onclick="showRef(event, &#39;ref57&#39;); return false;" href="JavaScript:void(0);" class="ref">(57)</a> The point at which the two curves intersect is referred to as the pH<sub>max</sub>, the pH of maximum solubility. In a saturated solution above pH<sub>max</sub>, the dissolved solute is in equilibrium with the free base, and at a pH below pH<sub>max</sub>, it is in equilibrium with the salt.<a onclick="showRef(event, &#39;ref6&#39;); return false;" href="JavaScript:void(0);" class="ref">(6)</a> The following equation was used to predict the pH–solubility profile of the ASDs:<a onclick="showRef(event, &#39;ref6&#39;); return false;" href="JavaScript:void(0);" class="ref">(6)</a><span class="NLM_disp-formula" id="eq5"><img src="./test1_files/mp-2017-00039m_m006.gif" alt=""><span class="labelSpan">(5)</span></span>[BH<sup>+</sup>]<sub>s</sub> is the concentration of the protonated amorphous salt. The subscript s highlights the fact that the salt is the saturation species at a pH below pH<sub>max</sub>.<a onclick="showRef(event, &#39;ref6&#39;); return false;" href="JavaScript:void(0);" class="ref">(6)</a></div><div class="NLM_p">As can be seen from <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig8">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig8">8</a>, the experimental data does not fit the theoretical pH–solubility curve of CIP exactly. The solubility of the drug from the ASDs in water and FaSSIF is higher than that predicted for CIP. These experimental data points align more closely with the profile of CIP HCl. Therefore, a more accurate pH<sub>max</sub> for these salts would be the intersection of the curve for CIP HCl and the CIP ASDs, which occurs at a pH of 5.1. The three main outliers in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig8">Figure </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#fig8">8</a> correspond to the particularly high solubility of the ASDs in FaSSIF. As previously mentioned, FaSSIF contains surfactants, which may enhance the solubility of these solids compared to water. This lack of fit also suggests that the solubility enhancement of these formulations is not due to their effect on pH. Instead this may be attributed to their amorphous nature and polymer content. The solubility of the pure drug in FaSSGF is also higher than that predicted, and aligns more closely with the CIP HCl curve. Due to the presence of HCl in FaSSGF, the drug is likely to be in an environment in this medium that is similar to that of CIP HCl in water. At a pH below pH<sub>max</sub>, i.e., in FaSSGF, the ASDs no longer follow the solubility curve of CIP, as the equilibrium species is now the salt. At acidic pH they may be more accurately described by <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#eq5">eq </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#eq5">5</a>.</div><div class="figure" id="fig8"><a title="Open Figure Viewer" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="thumbnail showFiguresEvent"><img alt="figure" src="./test1_files/mp-2017-00039m_0008.gif"><span class="overlay"></span></a><div class="caption hlFld-FigureCaption"><p class="first last">Figure 8. Theoretical pH–solubility profiles of CIP (black), CIP HCl (green), and CIP ASDs (blue). The symbols represent the average concentrations obtained from solubility studies after 2 h in water (filled symbols), FaSSIF (empty symbols), and FaSSGF (half-filled symbols). The plot above shows the distribution of species for CIP, Eudragit L100, and HPMCAS as a function of pH (black lines, CIP; red line, Eudragit L100; and blue line, HPMCAS).</p></div></div></div><div id="sec4.5" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e1613">PAMPA Permeability Study</span><div class="NLM_p">The results of the PAMPA study, under iso-pH and pH gradient conditions, are shown in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl1">Table </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl1">1</a>. The commercially available hydrochloride salt, CIP HCl, was included in the study for comparison. PAMPA is usually carried out using donor and acceptor solutions of the same pH (iso-pH conditions), however this does not accurately mimic what occurs in vivo. Fortuna et al. obtained the best correlation between apparent permeability from PAMPA studies and human intestinal absorption for a range of drugs, including the fluoroquinolone norfloxacin, with a pH of 6.5 and 7.4 in the donor and acceptor compartments, respectively.<a onclick="showRef(event, &#39;ref58&#39;); return false;" href="JavaScript:void(0);" class="ref">(58)</a> The pH of the blood and the cytosol of intestinal cells lining the duodenum is about 7.4, therefore this is a suitable pH to use for the acceptor compartment.<a onclick="showRef(event, &#39;ref59&#39;); return false;" href="JavaScript:void(0);" class="ref">(59)</a> CIP is believed to be absorbed from the upper section of the duodenum, which has a pH of 6.4.<a onclick="showRef(event, &#39;ref60 ref61&#39;); return false;" href="JavaScript:void(0);" class="ref">(60, 61)</a> A donor/acceptor pH of 6.4/7.4 was therefore chosen for this study in order to more closely represent the pH gradient present in vivo at the site of CIP absorption.<a onclick="showRef(event, &#39;ref59&#39;); return false;" href="JavaScript:void(0);" class="ref">(59)</a> In addition, as the permeability of ionizable drugs, such as CIP, depends on pH, it is useful to carry out PAMPA at two different pH values for such compounds, to prevent under- or overestimation of permeability.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption"><div class="title2">Table 1. PAMPA Permeability Values of CIP</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left"><col align="char" char="."><col align="char" char="."><col align="char" char="."><col align="char" char="."><col align="char" char="."></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">&nbsp;</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">iso-pH</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">pH gradient</th><th class="colsep0 rowsep0" align="center" char=".">&nbsp;</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sample</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>e</sub><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#t1fn1"><sup>a</sup></a> ×&nbsp;10<sup>6</sup> (cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">log <i>P</i><sub>e</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>e</sub> ×&nbsp;10<sup>6</sup> (cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">log <i>P</i><sub>e</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>p</i>-value<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#t1fn2"><sup>b</sup></a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">crystalline CIP</td><td class="colsep0 rowsep0" align="char" char=".">0.56&nbsp;±&nbsp;0.06</td><td class="colsep0 rowsep0" align="char" char=".">–6.25&nbsp;±&nbsp;0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.62&nbsp;±&nbsp;0.08</td><td class="colsep0 rowsep0" align="char" char=".">–6.21&nbsp;±&nbsp;0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP HCl</td><td class="colsep0 rowsep0" align="char" char=".">0.32&nbsp;±&nbsp;0.00</td><td class="colsep0 rowsep0" align="char" char=".">–6.50&nbsp;±&nbsp;0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.32&nbsp;±&nbsp;0.01</td><td class="colsep0 rowsep0" align="char" char=".">–6.49&nbsp;±&nbsp;0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/Eudragit L100</td><td class="colsep0 rowsep0" align="char" char=".">0.52&nbsp;±&nbsp;0.00</td><td class="colsep0 rowsep0" align="char" char=".">–6.28&nbsp;±&nbsp;0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.50&nbsp;±&nbsp;0.06</td><td class="colsep0 rowsep0" align="char" char=".">–6.31&nbsp;±&nbsp;0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/HPMCAS-LG</td><td class="colsep0 rowsep0" align="char" char=".">0.75&nbsp;±&nbsp;0.06</td><td class="colsep0 rowsep0" align="char" char=".">–6.13&nbsp;±&nbsp;0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.64&nbsp;±&nbsp;0.10</td><td class="colsep0 rowsep0" align="char" char=".">–6.20&nbsp;±&nbsp;0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/HPMCAS-MG</td><td class="colsep0 rowsep0" align="char" char=".">0.64&nbsp;±&nbsp;0.03</td><td class="colsep0 rowsep0" align="char" char=".">–6.19&nbsp;±&nbsp;0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.67&nbsp;±&nbsp;0.03</td><td class="colsep0 rowsep0" align="char" char=".">–6.18&nbsp;±&nbsp;0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot"><div class="footnote" id="t1fn1">a<p class="last"><i>P</i><sub>e</sub>: effective permeability. The average of three measurements is shown, ± the standard deviation.</p></div><div class="footnote" id="t1fn2">b<p class="last"><i>p</i>-value from <i>t</i> test comparing <i>P</i><sub>e</sub> from regular and pH-gradient PAMPA.</p></div></div></div><div class="NLM_p">According to Sugano, a permeability of less than 1 × 10<sup>–6</sup> cm/s (or log <i>P</i><sub>e</sub> &lt; −6) can be considered as low permeability.<a onclick="showRef(event, &#39;ref62&#39;); return false;" href="JavaScript:void(0);" class="ref">(62)</a> As can be seen from <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl1">Table </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl1">1</a>, all of the samples are poorly permeable, with a <i>P</i><sub>e</sub> &lt; 1 × 10<sup>–6</sup> cm/s. A similarly low <i>P</i><sub>e</sub> of 0.19 × 10<sup>–6</sup> cm/s for CIP was obtained by Tehler et al. in Caco-2 studies.<a onclick="showRef(event, &#39;ref63&#39;); return false;" href="JavaScript:void(0);" class="ref">(63)</a> Two-sample <i>t</i> tests were used to compare the results of the individual samples under both pH conditions, and in each case no statistically significant difference was found (see <i>p</i>-values in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl1">Table </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl1">1</a>). The p<i>I</i> of CIP is around 7.4–7.5.<a onclick="showRef(event, &#39;ref64&#39;); return false;" href="JavaScript:void(0);" class="ref">(64)</a> The passive absorption of this drug would therefore be expected to be highest at this pH. As the pH is decreased below the p<i>I</i>, the carboxylate group of CIP will become protonated, and the proportion of drug bearing an overall positive charge will increase. This should reduce its passive transport through a lipid membrane. However, at neutral pH the drug exists primarily as the zwitterion, with only about 2% expected to be present in the un-ionized form at the p<i>I</i>.<a onclick="showRef(event, &#39;ref64&#39;); return false;" href="JavaScript:void(0);" class="ref">(64)</a> While the membrane penetration and diffusion of un-ionized CIP are energetically favorable, the transmembrane translocation of zwitterionic CIP is unlikely to occur.<a onclick="showRef(event, &#39;ref65&#39;); return false;" href="JavaScript:void(0);" class="ref">(65)</a> Evidently, dropping from pH 7.4 to 6.4 does not have a large effect on the proportion of un-ionized CIP present, and thus no significant difference in <i>P</i><sub>e</sub> was seen when the donor solution pH was changed in the above study.</div><div class="NLM_p">ANOVA and Tukey’s multiple comparison test were carried out to compare the <i>P</i><sub>e</sub> of the different samples. CIP from ASDs containing HPMCAS-LG and HPMCAS-MG possessed the highest permeability, with a <i>P</i><sub>e</sub> of 0.75 × 10<sup>–6</sup> and 0.64 × 10<sup>–6</sup> cm/s, respectively, under iso-pH conditions, and 0.64 × 10<sup>–6</sup> and 0.67 × 10<sup>–6</sup> cm/s, respectively, with a pH gradient; however these samples were not statistically significantly different from each other under either pH condition. In addition, the CIP/HPMCAS-MG system did not differ significantly from the pure drug in either study, while CIP from the HPMCAS-LG sample was only significantly more permeable than CIP under iso-pH conditions. CIP as the HCl salt on the other hand had a significantly lower permeability than the other samples, with a <i>P</i><sub>e</sub> of 0.32 × 10<sup>–6</sup> cm/s under both pH conditions. The drug from the ASD containing Eudragit L100 had a slightly lower average <i>P</i><sub>e</sub> than the pure crystalline drug in both PAMPA experiments; however this difference was not statistically significant. The lower <i>P</i><sub>e</sub> obtained with the CIP/Eudragit L100 ASD compared to those containing HPMCAS may be due to the formation of drug–polymer complexes in solution. As shown previously by Friesen et al, upon addition to aqueous solutions, ASDs may rapidly disperse to form a number of species.<a onclick="showRef(event, &#39;ref66&#39;); return false;" href="JavaScript:void(0);" class="ref">(66)</a> These can potentially include large drug–polymer aggregates, which may form a slowly dissolving amorphous precipitate, and thus reduce the concentration of free drug in solution.<a onclick="showRef(event, &#39;ref66&#39;); return false;" href="JavaScript:void(0);" class="ref">(66)</a> This would be more likely to occur with CIP/Eudragit L100 due to the stronger drug–polymer interactions present in this ASD, as suggested by its particularly high <i>T</i><sub>g</sub>.</div><div class="NLM_p">A number of studies have found that other solubility enhancing formulations such as cyclodextrins, surfactants, and cosolvents decrease the permeability of drugs in both PAMPA and intestinal perfusion assays, leading to a trade-off between solubility and permeability.<a onclick="showRef(event, &#39;ref21 ref67&#39;); return false;" href="JavaScript:void(0);" class="ref">(21, 67)</a> According to Miller et al., preparations such as these increase the equilibrium solubility of drugs, which results in a decrease in their apparent cell membrane/intestinal lumen partition coefficient. As the permeability of a drug is directly related to this coefficient, the solubility advantage provided by these formulations is accompanied by a decrease in permeability.<a onclick="showRef(event, &#39;ref67&#39;); return false;" href="JavaScript:void(0);" class="ref">(67)</a> In contrast, ASDs increase the solubility of drugs via supersaturation, which does not affect the apparent membrane/lumen partition coefficient. Amorphous formulations can therefore significantly increase the concentration of drug in solution, while also maintaining a constant effective permeability, giving them a superior solubility–permeability balance.<a onclick="showRef(event, &#39;ref21 ref67&#39;); return false;" href="JavaScript:void(0);" class="ref">(21, 67)</a> The results of this study are therefore in line with those of other researchers, with all of the CIP ASDs enhancing the solubility of the drug in water and FaSSIF, without a subsequent decrease in permeability. The crystalline CIP HCl salt on the other hand significantly reduced the permeability of the drug, most likely due to greater ionization of CIP. Although the <i>P</i><sub>e</sub> of a drug is not affected by its concentration (as long as the drug is free to pass through the membrane), the increased solubility afforded by ASDs should increase the transmembrane flux of a drug, and thus may also improve its in vivo absorption.<a onclick="showRef(event, &#39;ref67&#39;); return false;" href="JavaScript:void(0);" class="ref">(67)</a></div><div class="NLM_p last">According to Tam et al., 18% of CIP is absorbed via the paracellular route at pH 6.5.<a onclick="showRef(event, &#39;ref68&#39;); return false;" href="JavaScript:void(0);" class="ref">(68)</a> As the PAMPA model does not take account of paracellular transport, it is possible that the results above underestimate the in vivo absorption of CIP. PAMPA is also unable to predict active transport, and will therefore underestimate the permeability of compounds which are absorbed via drug transporters.<a onclick="showRef(event, &#39;ref69&#39;); return false;" href="JavaScript:void(0);" class="ref">(69)</a> This could explain why the effective permeability of CIP reported here is lower than that obtained by others in rat in situ and Caco-2 cell studies.<a onclick="showRef(event, &#39;ref68 ref70&#39;); return false;" href="JavaScript:void(0);" class="ref">(68, 70)</a> While CIP is mainly absorbed by passive transport, it is also a substrate for active transporters in the intestine, such as organic anion transporting polypeptide 1A2 (OATP1A2).<a onclick="showRef(event, &#39;ref71&#39;); return false;" href="JavaScript:void(0);" class="ref">(71)</a> In addition, it is a substrate for the efflux protein breast cancer resistance protein (BCRP), which reduces the bioavailability of the drug.<a onclick="showRef(event, &#39;ref72&#39;); return false;" href="JavaScript:void(0);" class="ref">(72)</a> Despite this, Bermejo et al. showed that, for fluoroquinolones such as CIP, there was a good correlation between the results of PAMPA and that of Caco-2 and rat in situ permeability studies.<a onclick="showRef(event, &#39;ref38&#39;); return false;" href="JavaScript:void(0);" class="ref">(38)</a> As the main aim of the permeability assay performed in this study was to determine whether ASD formation affects the permeability of CIP, PAMPA was suitable for this comparative analysis. However, in order to obtain a more accurate quantitative estimate of the permeability of the drug and ASDs, more representative permeability studies would be required, such as rat in situ perfusion assays, which more closely mimic the environment in vivo.</div></div><div id="sec4.6" class="NLM_sec NLM_sec_level_2"><span class="title2" id="d8590e1959">Bacterial Studies</span><div class="NLM_p">The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of CIP and the ASDs in a number of bacterial species are shown in <a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl2">Table </a><a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl2">2</a>. The values that differ significantly from those of pure crystalline CIP are shown in bold. The MBC is expected to be larger than the MIC, as a larger quantity of API is required to kill bacteria rather than just inhibit their growth. MICs ≤ 1.0 μg/mL indicate that the microorganism is susceptible to CIP, whereas MICs ≥ 2.0 μg/mL indicate resistance to this antibiotic.<a onclick="showRef(event, &#39;ref73&#39;); return false;" href="JavaScript:void(0);" class="ref">(73)</a> All of the organisms used in this study can therefore be considered as sensitive to CIP, with MICs ≤ 1 μg/mL. The MIC and MBC values obtained with CIP are close to those obtained by other researchers in these species.<a onclick="showRef(event, &#39;ref74 ref75 ref76&#39;); return false;" href="JavaScript:void(0);" class="ref">(74-76)</a> <i>E. coli</i> was found to be the most susceptible strain to CIP, with a MIC of 0.008–0.032 μg/mL. This was followed by <i>K. pneumoniae</i> (MIC 0.032–0.125 μg/mL), <i>P. aeruginosa</i> (MIC 0.125–1.0 μg/mL), and <i>S. aureus</i> (MIC 0.25–1.0 μg/mL). The MBCs also followed the same order of susceptibility. A drug is generally considered bactericidal if it has a MBC to MIC ratio of ≤4.<a onclick="showRef(event, &#39;ref77&#39;); return false;" href="JavaScript:void(0);" class="ref">(77)</a> Therefore, all of the samples in this study were bactericidal, with ratios of 1–2.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption"><div class="title2">Table 2. Minimum Inhibitory Concentration and Minimum Bactericidal Concentration of Ciprofloxacin and ASDs in Various Bacteria<a class="ref" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tbl2-fn1"><sup>a</sup></a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left"><col align="char" char="."><col align="char" char="."><col align="char" char="."><col align="char" char="."></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sample</th><th class="colsep0 rowsep0" align="center" char=".">S. aureus</th><th class="colsep0 rowsep0" align="center" char="."><i>E. coli</i></th><th class="colsep0 rowsep0" align="center" char="."><i>P. aeruginosa</i></th><th class="colsep0 rowsep0" align="center" char="."><i>K. pneumoniae</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center">Minimum Inhibitory Concentration (μg/mL)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/Eudragit L100</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/HPMCAS-LG</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="."><b>0.008–0.016</b></td><td class="colsep0 rowsep0" align="char" char=".">0.25–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.063–0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/HPMCAS-MG</td><td class="colsep0 rowsep0" align="char" char="."><b>0.25–0.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.008–0.016</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.125–0.25</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.032–0.063</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center">Minimum Bactericidal Concentration (μg/mL)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP</td><td class="colsep0 rowsep0" align="char" char=".">1.0–2.0</td><td class="colsep0 rowsep0" align="char" char=".">0.032–0.064</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/Eudragit L100</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/HPMCAS-LG</td><td class="colsep0 rowsep0" align="char" char="."><b>0.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.016</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CIP/HPMCAS-MG</td><td class="colsep0 rowsep0" align="char" char="."><b>0.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.016</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.25–0.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.063–0.125</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot"><div class="footnote" id="tbl2-fn1">a<p class="last">The values shown in bold differ significantly from those of pure crystalline CIP.</p></div></div></div><div class="NLM_p last">The formulation of CIP as an ASD did not result in a decrease in antibacterial activity in any case. In fact, CIP/HPMCAS-MG had a significantly lower MIC and MBC in all bacterial species studied compared to the pure drug. The MIC of HPMCAS-LG was also significantly improved in <i>E. coli</i>, while its MBC decreased in both <i>E. coli</i> and <i>S. aureus</i>. As described above, these ASDs had the highest <i>P</i><sub>e</sub> in PAMPA permeability studies, whereas CIP/Eudragit L100 did not differ significantly from the pure drug. Therefore, the improved permeability of these samples may have aided the penetration of CIP into the bacterial cells, most likely via the passive diffusion route through the cell membranes.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i29">Conclusions</h2><hr><div class="NLM_p">Amorphous solid dispersions are one formulation option for poorly soluble drugs, however the polymers used in these preparations must be carefully chosen. This work has shown that an acidic polymer is necessary to produce CIP ASDs by ball milling, as it enables the formation of stabilizing ionic interactions between the two components. These bonds resulted in high <i>T</i><sub>g</sub> values, above those predicted by the Gordon–Taylor equation. While the CIP ASDs crystallized quickly under accelerated stability conditions of 40 °C/75% RH, they remained amorphous following exposure to humidity levels of up to 90% at 25 °C during DVS analysis. Therefore, although the stabilizing effects of the polymers were not sufficient to prevent crystallization of CIP when exposed to a combination of high heat and humidity, these ASDs could be expected to remain stable if stored at ambient temperatures.</div><div class="NLM_p last">The ASDs chosen for further examination showed superior solubility in water and FaSSIF compared to the pure drug, which can be attributed to their amorphous nature, rather than any effect on pH. The polymer content of the ASDs also enabled the maintenance of supersaturation for at least 2 h in most cases. In addition, no decrease in the passive permeability of CIP occurred with any of these ASDs, while a modest increase in effective permeability was seen with the ASD containing HPMCAS-LG. In contrast, the crystalline CIP HCl salt significantly decreased the permeability of the drug, highlighting the benefit of amorphous polymeric formulations in this regard. In line with the results of the permeability assay, the formulation of CIP as an ASD did not reduce its antibacterial potency in the bacterial species studied, and a decrease in MIC and MBC was also obtained with the ASDs containing HPMCAS. This indicates that ASD formation with HPMCAS increases the proportion of CIP capable of diffusing through bacterial cell membranes. Therefore, ASDs may be a viable alternative for formulating CIP with improved solubility, bioavailability, and antibacterial activity.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-1"> <ul class="anchors"><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i30"><a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039">Supporting Information</a></h2><hr><p class="last">The Supporting Information is available free of charge on the <a href="http://pubs.acs.org/" class="ext-link">ACS Publications website</a> at DOI: <a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00039" class="ext-link">10.1021/acs.molpharmaceut.7b00039</a>.</p><ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">PXRD, FTIR, and TGA analysis and chemical structure of polymers (<a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul><p></p></div><div id="supInfoBox" class="supInfoBoxOnFTP " style="display: block;">
                            






<div class="sup-info-attachements">
    
    <ul>
        
            <li class="decorationNone">
                <h3>
                    

                    <div class="suppl-file-img img-pdf"></div>
                        PDF
                </h3>
                <ul>
                    
                        <li>
                            <a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039/suppl_file/mp7b00039_si_001.pdf">
                                
                                mp7b00039_si_001.pdf
                                
                                (1.31
                                MB)
                            </a>
                        </li>
                    
                </ul>
            </li>
        
    </ul>
    <div class="supplementInfoMessage" data-pb-dropzone="supplementInfoMessage">
        
    </div>
</div>
                        </div><div id="figshare-widget" style="display: block;"><figshare-widget data-reactroot="" class="fs-collection-viewer fs-app-wrapper" classname="fs-collection-viewer fs-app-wrapper"><div class="figshare-loader"><section class="fs-file-viewer fs-inline-viewer"><header class="fs-header"><div class="fs-title-section"><h1>Amorphous Polymeric Drug Salts as Ionic Solid Dispersion
Forms of Ciprofloxacin</h1></div></header><article><div class="fs-viewer-container" style="width: 706px; height: 498.94px;"><div class="fs-figshare-viewer"><div class="fs-display fs-document-display" style="width: 706px; height: 498.94px;"><div class="figshare-loader"><div class="fs-canvas-document-container" style="width: 706px; height: 498.94px;"><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="1272" height="1798" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"><div style="left: 538.119px; top: 832.966px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(1.0053);">SI.</div><div style="left: 552.7341261842371px; top: 832.9664180608747px; font-size: 12.819995968554727px; font-family: sans-serif;">1</div><div style="left: 76.92px; top: 77.42px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.897667);">J. </div><div style="left: 89.74px; top: 77.42px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.963456);">Supporting Information</div><div style="left: 98.6712px; top: 120.209px; font-size: 23.5247px; font-family: sans-serif; transform: scaleX(0.868448);">Amorphous polymeric drug salts as ionic solid </div><div style="left: 161.041px; top: 174.245px; font-size: 23.5247px; font-family: sans-serif; transform: scaleX(0.868706);">dispersion forms of ciprofloxacin</div><div style="left: 125.401px; top: 240.51px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.885823);">Hanah Mesallati</div><div style="left: 209.8206006853457px; top: 238.44008362886757px; font-size: 8.525297319088894px; font-family: sans-serif;">†</div><div style="left: 214.115px; top: 245.94px; font-size: 8.5253px; font-family: sans-serif; transform: scaleX(0.590537);">, </div><div style="left: 218.346px; top: 240.51px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.893546);">Anita Umerska</div><div style="left: 296.31284015319494px; top: 238.44008362886757px; font-size: 8.525297319088894px; font-family: sans-serif;">$</div><div style="left: 300.60753880266077px; top: 240.51021876889732px; font-size: 12.819995968554727px; font-family: sans-serif;">,</div><div style="left: 305.928px; top: 240.51px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.908611);">Krzysztof</div><div style="left: 359.708px; top: 240.51px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.820744);">J.</div><div style="left: 371.118px; top: 240.51px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.877058);">Paluch</div><div style="left: 405.9879056641806px; top: 238.44008362886757px; font-size: 8.525297319088894px; font-family: sans-serif;">§</div><div style="left: 412.334px; top: 240.51px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.881048);">and Lidia Tajber</div><div style="left: 497.8645434388228px; top: 240.51021876889732px; font-size: 12.819995968554727px; font-family: sans-serif;">*</div><div style="left: 504.2745414231002px; top: 238.44008362886757px; font-size: 8.525297319088894px; font-family: sans-serif;">,</div><div style="left: 506.3257407780689px; top: 238.44008362886757px; font-size: 8.525297319088894px; font-family: sans-serif;">†</div><div style="left: 76.91997581132836px; top: 280.74607032509823px; font-size: 8.525297319088894px; font-family: sans-serif;">†</div><div style="left: 81.21467446079419px; top: 282.81620546512784px; font-size: 12.819995968554727px; font-family: sans-serif;">S</div><div style="left: 88.3298px; top: 282.816px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.853225);">ynthesis and Solid State Pharmaceutical Centre, S</div><div style="left: 344.388px; top: 282.816px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.861723);">chool of Pharmacy </div><div style="left: 444.384px; top: 282.816px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.851997);">and Pharmaceutical </div><div style="left: 76.92px; top: 312.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.893372);">Sciences, Trinity College Dublin, C</div><div style="left: 260.652px; top: 312.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.893977);">ollege Green, Dublin 2, Ireland.</div><div style="left: 76.91997581132836px; top: 352.5380477490047px; font-size: 8.525297319088894px; font-family: sans-serif;">$</div><div style="left: 81.2147px; top: 354.608px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.914179);">MINT, UNIV Angers, INSERM 1066, CNRS 6021, Universite Bretagne Loire, 4 rue Larrey, </div><div style="left: 76.92px; top: 384.116px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.858426);">Angers 49933 Cedex, France</div><div style="left: 76.91997581132836px; top: 422.2360924980472px; font-size: 8.525297319088894px; font-family: sans-serif;">§</div><div style="left: 81.2147px; top: 424.306px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.870214);">School of Pharmacy and Medical Sciences, Faculty of Li</div><div style="left: 373.938px; top: 424.306px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.870409);">fe Sciences, University of Bradford, </div><div style="left: 76.92px; top: 453.792px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.903471);">Bradford, West Yorkshire, BD7 1DP, United Kingdom</div><div style="left: 359.96412013706913px; top: 453.7922183657528px; font-size: 12.819995968554727px; font-family: sans-serif;">.</div><div style="left: 76.92px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.952426);">Figure </div><div style="left: 116.491px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(1.05472);">SI.</div><div style="left: 131.81092521669018px; top: 777.7122354364038px; font-size: 12.819995968554727px; font-family: sans-serif;">1</div><div style="left: 138.22092320096755px; top: 777.7122354364038px; font-size: 12.819995968554727px; font-family: sans-serif;">.</div><div style="left: 144.631px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(1.00038);">PXRD</div><div style="left: 181.937px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.879152);">analysis</div><div style="left: 226.615px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.835914);">of </div><div style="left: 240.46px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.897336);">partially crystalline CIP </div><div style="left: 366.118px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.868872);">solid dispersion</div><div style="left: 447.012px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.764917);">s </div><div style="left: 455.153px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.874458);">containing</div><div style="left: 512.543px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.933816);">vari</div><div style="left: 532.479px; top: 777.712px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.826109);">ous </div><div style="left: 76.92px; top: 807.262px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.866196);">(w/w) concentrations of PVP.</div></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="1272" height="1798" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"><div style="left: 538.119px; top: 832.966px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(1.0053);">SI.</div><div style="left: 552.7341261842371px; top: 832.9664180608747px; font-size: 12.819995968554727px; font-family: sans-serif;">2</div><div style="left: 76.92px; top: 374.694px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.978948);">Figure SI.</div><div style="left: 131.81092521669018px; top: 374.69429550493845px; font-size: 12.819995968554727px; font-family: sans-serif;">2</div><div style="left: 138.22092320096755px; top: 374.69429550493845px; font-size: 12.819995968554727px; font-family: sans-serif;">.</div><div style="left: 144.631px; top: 374.694px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.894017);">PXRD analysis of partially cryst</div><div style="left: 311.312px; top: 374.694px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.903369);">alline </div><div style="left: 342.978px; top: 374.694px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.868872);">solid dispersion</div><div style="left: 423.872px; top: 374.694px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.896705);">s formed by milling CIP</div><div style="left: 76.92px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.876412);">with 40</div><div style="left: 115.78593025599677px; top: 406.99748034670415px; font-size: 11.730296311227576px; font-family: sans-serif;">–</div><div style="left: 121.619px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.879624);">60% (w/w) PVA at </div><div style="left: 223.474px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.851922);">room temperature (</div><div style="left: 322.402px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.983784);">RT</div><div style="left: 338.74702680911105px; top: 404.3725861721426px; font-size: 12.819995968554727px; font-family: sans-serif;">)</div><div style="left: 346.247px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.840234);">or 2</div><div style="left: 366.5664180608748px; top: 406.99748034670415px; font-size: 11.730296311227576px; font-family: sans-serif;">–</div><div style="left: 372.4px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.803859);">5 </div><div style="left: 382.01451320298327px; top: 402.3019645232815px; font-size: 8.525297319088894px; font-family: sans-serif;">o</div><div style="left: 386.309px; top: 404.373px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.920364);">C.</div><div style="left: 76.92px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.952426);">Figure </div><div style="left: 116.491px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.978074);">SI.3</div><div style="left: 138.22092320096755px; top: 746.7519451723442px; font-size: 12.819995968554727px; font-family: sans-serif;">.</div><div style="left: 144.631px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(1.00038);">PXRD</div><div style="left: 181.937px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.896499);">analysi</div><div style="left: 218.41px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.874337);">s of partially crystalline </div><div style="left: 342.978px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.862461);">solid dispersions</div><div style="left: 432.077px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.896281);">formed by milling </div><div style="left: 528.504px; top: 746.752px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.968265);">CIP</div><div style="left: 76.92px; top: 776.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.873245);">with 20% (w/w) Eudragit</div><div style="left: 210.91px; top: 776.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.885334);">L100 and Eudragit</div><div style="left: 310.287px; top: 776.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.961628);">L100</div><div style="left: 337.27272727272725px; top: 776.3020358798628px; font-size: 12.819995968554727px; font-family: sans-serif;">-</div><div style="left: 341.567px; top: 776.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.829366);">55 for 4 hours at </div><div style="left: 429.513px; top: 776.302px; font-size: 12.82px; font-family: sans-serif; transform: scaleX(0.849822);">room temperature</div><div style="left: 521.0046361620641px; top: 776.3020358798628px; font-size: 12.819995968554727px; font-family: sans-serif;">.</div></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="636" height="899" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="636" height="899" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="636" height="899" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="636" height="899" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="636" height="899" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"></div></div><div class="fs-page-wrapper" style="width: 636px; height: 899px;"><canvas width="636" height="899" style="width: 636px; height: 899px;"></canvas><div class="fs-text-layer"></div></div></div></div></div></div></div></article><footer class="fs-file-viewer-controls"><a class="fs-figshare-button" href="https://figshare.com/articles/Amorphous_Polymeric_Drug_Salts_as_Ionic_Solid_Dispersion_Forms_of_Ciprofloxacin/5097667" title="open in figshare" target="_blank"><div class="fs-logo"><svg class="figshare-logo" width="36px" height="36px" viewBox="0 0 14 14"><style>
        .style0 {fill: #566471;}
        .style1 {fill: #A2CD3C;}
        .style2 {fill: #C54C59;}
        .style3 {fill: #5BC4BD;}
    </style><g class="group-1"><path d="M5.578 0.72C5.679 1 5.5 1.4 5.2 1.461C4.892 1.6 4.6 1.4 4.5 1.1 c-0.102-0.309 0.068-0.641 0.377-0.74C5.146 0.2 5.5 0.4 5.6 0.7" class="style3"></path><path d="M4.987 1.953C5.11 2.2 5 2.5 4.8 2.621C4.525 2.7 4.2 2.6 4.1 2.4 C3.978 2.2 4.1 1.9 4.3 1.737C4.562 1.6 4.9 1.7 5 2" class="style3"></path><path d="M4.686 3.109c0.134 0.2 0.1 0.443-0.092 0.577C4.408 3.8 4.2 3.8 4 3.6 C3.882 3.4 3.9 3.2 4.1 3.018C4.292 2.9 4.6 2.9 4.7 3.1" class="style3"></path><path d="M4.588 4.099c0.135 0.1 0.1 0.4 0 0.487c-0.135 0.136-0.354 0.136-0.488 0 C3.966 4.5 4 4.2 4.1 4.1S4.453 4 4.6 4.1" class="style3"></path><path d="M4.655 4.943c0.127 0.1 0.2 0.3 0.1 0.398C4.625 5.5 4.4 5.5 4.3 5.4 S4.165 5.1 4.3 5.007C4.35 4.9 4.5 4.9 4.7 4.9" class="style3"></path><path d="M4.83 5.631C4.945 5.7 5 5.8 4.9 5.946C4.874 6.1 4.7 6.1 4.6 6 c-0.115-0.059-0.161-0.2-0.103-0.315C4.574 5.6 4.7 5.6 4.8 5.6" class="style3"></path></g><g class="group-2"><path d="M3.708 1.467c0.19 0.3 0.1 0.631-0.131 0.821c-0.263 0.191-0.631 0.133-0.822-0.13 c-0.19-0.264-0.132-0.631 0.131-0.822C3.148 1.1 3.5 1.2 3.7 1.5" class="style0"></path><path d="M3.526 2.823c0.193 0.2 0.2 0.5 0 0.702c-0.195 0.193-0.509 0.193-0.703 0 C2.63 3.3 2.6 3 2.8 2.823C3.018 2.6 3.3 2.6 3.5 2.8" class="style0"></path><path d="M3.596 4.015c0.186 0.1 0.2 0.4 0.1 0.578S3.295 4.8 3.1 4.7 C2.926 4.5 2.9 4.3 3 4.107C3.152 3.9 3.4 3.9 3.6 4" class="style0"></path><path d="M3.81 4.986C3.979 5.1 4 5.3 4 5.451C3.873 5.6 3.7 5.7 3.5 5.6 C3.327 5.5 3.3 5.3 3.3 5.138C3.432 5 3.6 4.9 3.8 5" class="style0"></path><path d="M4.135 5.769c0.149 0 0.2 0.2 0.2 0.359C4.27 6.3 4.1 6.4 4 6.3 c-0.15-0.049-0.231-0.21-0.184-0.359C3.824 5.8 4 5.7 4.1 5.8" class="style0"></path><path d="M4.513 6.367c0.13 0 0.2 0.1 0.2 0.271c-0.021 0.126-0.14 0.213-0.267 0.2 c-0.129-0.021-0.217-0.14-0.196-0.269C4.267 6.4 4.4 6.3 4.5 6.4" class="style0"></path></g><g class="group-3"><path d="M2.158 2.755c0.264 0.2 0.3 0.6 0.1 0.821C2.098 3.8 1.7 3.9 1.5 3.7 c-0.262-0.19-0.321-0.559-0.131-0.82C1.527 2.6 1.9 2.6 2.2 2.8" class="style2"></path><path d="M2.405 4.101c0.244 0.1 0.3 0.4 0.2 0.668C2.498 5 2.2 5.1 2 5 C1.71 4.9 1.6 4.6 1.7 4.318C1.862 4.1 2.2 4 2.4 4.1" class="style2"></path><path d="M2.84 5.214c0.219 0.1 0.3 0.3 0.3 0.521S2.802 6.1 2.6 6 c-0.217-0.07-0.336-0.304-0.265-0.521C2.39 5.3 2.6 5.1 2.8 5.2" class="style2"></path><path d="M3.343 6.071C3.531 6.1 3.7 6.3 3.6 6.466S3.424 6.8 3.2 6.8 C3.048 6.7 2.9 6.5 2.9 6.357C2.979 6.2 3.2 6 3.3 6.1" class="style2"></path><path d="M3.895 6.714c0.157 0 0.3 0.1 0.3 0.285c0 0.157-0.128 0.285-0.285 0.3 C3.737 7.3 3.6 7.2 3.6 6.999C3.609 6.8 3.7 6.7 3.9 6.7" class="style2"></path><path d="M4.44 7.168c0.128-0.021 0.2 0.1 0.3 0.194C4.729 7.5 4.6 7.6 4.5 7.6 C4.386 7.7 4.3 7.6 4.2 7.436S4.312 7.2 4.4 7.2" class="style2"></path></g><g class="group-4"><path d="M1.084 4.458C1.393 4.6 1.6 4.9 1.5 5.2C1.361 5.5 1 5.7 0.7 5.6 c-0.31-0.1-0.479-0.432-0.378-0.741C0.443 4.5 0.8 4.4 1.1 4.5" class="style1"></path><path d="M1.735 5.662C2.006 5.7 2.2 6 2.1 6.231C2.104 6.5 1.9 6.7 1.6 6.6 S1.124 6.3 1.2 6.075C1.21 5.8 1.5 5.6 1.7 5.7" class="style1"></path><path d="M2.492 6.586c0.229 0 0.4 0.2 0.4 0.413c0 0.229-0.186 0.414-0.414 0.414S2.079 7.2 2.1 7 C2.078 6.8 2.3 6.6 2.5 6.6" class="style1"></path><path d="M3.234 7.247c0.189-0.03 0.4 0.1 0.4 0.286c0.03 0.188-0.099 0.364-0.287 0.4 C3.155 8 3 7.8 2.9 7.641C2.92 7.5 3 7.3 3.2 7.2" class="style1"></path><path d="M3.959 7.688C4.108 7.6 4.3 7.7 4.3 7.871C4.366 8 4.3 8.2 4.1 8.2 c-0.15 0.049-0.311-0.032-0.359-0.182C3.728 7.9 3.8 7.7 4 7.7" class="style1"></path><path d="M4.619 7.95c0.114-0.059 0.255-0.013 0.3 0.103S4.945 8.3 4.8 8.4 C4.715 8.4 4.6 8.4 4.5 8.266C4.456 8.1 4.5 8 4.6 8" class="style1"></path></g><g class="group-5"><path d="M0.588 6.411c0.325 0 0.6 0.3 0.6 0.588c0 0.325-0.264 0.589-0.589 0.589S0 7.3 0 7 C0 6.7 0.3 6.4 0.6 6.4" class="style3"></path><path d="M1.579 7.355C1.85 7.3 2.1 7.5 2.1 7.768C2.19 8 2 8.3 1.7 8.3 C1.464 8.4 1.2 8.2 1.2 7.924C1.124 7.7 1.3 7.4 1.6 7.4" class="style3"></path><path d="M2.584 7.999c0.218-0.071 0.5 0 0.5 0.266C3.176 8.5 3.1 8.7 2.8 8.8 C2.623 8.9 2.4 8.7 2.3 8.521C2.248 8.3 2.4 8.1 2.6 8" class="style3"></path><path d="M3.496 8.397c0.17-0.087 0.378-0.019 0.5 0.151c0.087 0.2 0 0.377-0.151 0.5 C3.64 9.1 3.4 9 3.3 8.861C3.259 8.7 3.3 8.5 3.5 8.4" class="style3"></path><path d="M4.32 8.594C4.447 8.5 4.6 8.5 4.7 8.657c0.092 0.1 0.1 0.306-0.063 0.4 C4.527 9.1 4.3 9.1 4.3 8.992C4.165 8.9 4.2 8.7 4.3 8.6" class="style3"></path><path d="M5.028 8.64c0.091-0.092 0.239-0.091 0.3 0c0.092 0.1 0.1 0.2 0 0.3 c-0.092 0.091-0.239 0.092-0.331 0S4.937 8.7 5 8.6" class="style3"></path></g><g class="group-6"><path d="M0.721 8.422C1.029 8.3 1.4 8.5 1.5 8.799c0.1 0.31-0.069 0.641-0.378 0.741S0.443 9.5 0.3 9.2 C0.242 8.9 0.4 8.5 0.7 8.4" class="style0"></path><path d="M1.954 9.013C2.198 8.9 2.5 9 2.6 9.23c0.124 0.2 0 0.543-0.218 0.7 c-0.244 0.125-0.544 0.027-0.668-0.217S1.71 9.1 2 9" class="style0"></path><path d="M3.109 9.313C3.295 9.2 3.6 9.2 3.7 9.406C3.822 9.6 3.8 9.8 3.6 10 c-0.184 0.135-0.443 0.095-0.577-0.091C2.884 9.7 2.9 9.4 3.1 9.3" class="style0"></path><path d="M4.1 9.412c0.135-0.135 0.354-0.135 0.5 0s0.135 0.4 0 0.487s-0.354 0.135-0.488 0 C3.966 9.8 4 9.5 4.1 9.4" class="style0"></path><path d="M5.405 9.679C5.313 9.8 5.1 9.8 5 9.742C4.88 9.7 4.9 9.5 4.9 9.3 c0.093-0.128 0.271-0.156 0.398-0.063C5.469 9.4 5.5 9.6 5.4 9.7" class="style0"></path><path d="M6.05 9.382c-0.059 0.115-0.2 0.161-0.315 0.103C5.618 9.4 5.6 9.3 5.6 9.2 C5.69 9.1 5.8 9 5.9 9.066C6.062 9.1 6.1 9.3 6 9.4" class="style0"></path></g><g class="group-7"><path d="M1.467 10.292c0.264-0.19 0.631-0.133 0.8 0.13s0.133 0.631-0.131 0.8 c-0.263 0.191-0.63 0.132-0.82-0.13C1.146 10.9 1.2 10.5 1.5 10.3" class="style2"></path><path d="M2.824 10.474c0.193-0.194 0.507-0.194 0.7 0c0.193 0.2 0.2 0.5 0 0.7 c-0.195 0.193-0.509 0.193-0.702 0C2.63 11 2.6 10.7 2.8 10.5" class="style2"></path><path d="M4.686 10.89c-0.135 0.185-0.394 0.226-0.579 0.092c-0.184-0.135-0.225-0.394-0.091-0.578 c0.135-0.185 0.393-0.227 0.578-0.092C4.778 10.4 4.8 10.7 4.7 10.9" class="style2"></path><path d="M5.603 10.502c-0.088 0.171-0.295 0.238-0.465 0.151c-0.169-0.087-0.236-0.293-0.15-0.464 c0.086-0.169 0.294-0.236 0.464-0.15C5.62 10.1 5.7 10.3 5.6 10.5" class="style2"></path><path d="M6.312 10.041c-0.049 0.149-0.209 0.231-0.359 0.184c-0.15-0.049-0.231-0.21-0.183-0.36 c0.049-0.149 0.21-0.23 0.358-0.183C6.278 9.7 6.4 9.9 6.3 10" class="style2"></path><path d="M6.833 9.559C6.812 9.7 6.7 9.8 6.6 9.754C6.436 9.7 6.3 9.6 6.4 9.5 c0.021-0.129 0.141-0.216 0.27-0.195C6.765 9.3 6.9 9.4 6.8 9.6" class="style2"></path></g><g class="group-8"><path d="M3.708 12.532c-0.192 0.263-0.56 0.32-0.822 0.13s-0.321-0.559-0.131-0.821 c0.191-0.264 0.56-0.321 0.822-0.131C3.84 11.9 3.9 12.3 3.7 12.5" class="style1"></path><path d="M4.102 11.594c0.125-0.243 0.424-0.341 0.668-0.217c0.245 0.1 0.3 0.4 0.2 0.7 s-0.423 0.341-0.668 0.217C4.074 12.1 4 11.8 4.1 11.6" class="style1"></path><path d="M6.001 11.415c-0.071 0.217-0.304 0.336-0.521 0.266c-0.218-0.071-0.336-0.305-0.266-0.522 c0.07-0.217 0.304-0.335 0.521-0.265S6.071 11.2 6 11.4" class="style1"></path><path d="M6.753 10.764c-0.03 0.188-0.207 0.316-0.395 0.286c-0.188-0.029-0.316-0.206-0.286-0.394 c0.029-0.188 0.206-0.316 0.395-0.287C6.654 10.4 6.8 10.6 6.8 10.8" class="style1"></path><path d="M7.285 10.105c0 0.157-0.127 0.284-0.285 0.284c-0.157 0-0.285-0.127-0.285-0.284 C6.715 9.9 6.8 9.8 7 9.82C7.158 9.8 7.3 9.9 7.3 10.1" class="style1"></path><path d="M7.631 9.486c0.021 0.127-0.065 0.247-0.194 0.268C7.309 9.8 7.2 9.7 7.2 9.6 c-0.02-0.128 0.066-0.248 0.194-0.269C7.491 9.3 7.6 9.4 7.6 9.5" class="style1"></path></g><g class="group-9"><path d="M5.578 13.278c-0.1 0.31-0.433 0.479-0.741 0.378c-0.31-0.101-0.479-0.432-0.377-0.741 c0.1-0.309 0.432-0.478 0.74-0.377C5.51 12.6 5.7 13 5.6 13.3" class="style3"></path><path d="M5.664 12.266c0.043-0.271 0.298-0.457 0.568-0.414c0.27 0 0.5 0.3 0.4 0.6 c-0.042 0.271-0.297 0.456-0.567 0.412C5.806 12.8 5.6 12.5 5.7 12.3" class="style3"></path><path d="M7.413 11.508c0 0.228-0.185 0.414-0.413 0.414s-0.413-0.187-0.413-0.414c0-0.229 0.185-0.414 0.413-0.414 S7.413 11.3 7.4 11.5" class="style3"></path><path d="M7.928 10.656c0.03 0.188-0.099 0.364-0.286 0.395c-0.188 0.03-0.364-0.1-0.394-0.287 c-0.03-0.188 0.099-0.364 0.285-0.394C7.722 10.3 7.9 10.5 7.9 10.7" class="style3"></path><path d="M8.231 9.864c0.048 0.15-0.034 0.312-0.184 0.36c-0.149 0.048-0.311-0.034-0.358-0.184 C7.64 9.9 7.7 9.7 7.9 9.682C8.021 9.6 8.2 9.7 8.2 9.9" class="style3"></path><path d="M8.369 9.169c0.059 0.1 0 0.257-0.104 0.315C8.151 9.5 8 9.5 8 9.4 S7.938 9.1 8.1 9.066C8.169 9 8.3 9.1 8.4 9.2" class="style3"></path></g><g class="group-10"><path d="M7.589 13.411C7.589 13.7 7.3 14 7 14s-0.588-0.264-0.588-0.589c0-0.324 0.263-0.589 0.588-0.589 S7.589 13.1 7.6 13.4" class="style0"></path><path d="M7.356 12.42c-0.043-0.271 0.142-0.524 0.413-0.568c0.27-0.043 0.5 0.1 0.6 0.4 c0.043 0.271-0.141 0.524-0.412 0.566C7.653 12.9 7.4 12.7 7.4 12.4" class="style0"></path><path d="M8.787 11.158c0.07 0.218-0.049 0.451-0.267 0.522C8.304 11.8 8.1 11.6 8 11.4 c-0.07-0.218 0.048-0.451 0.265-0.521C8.482 10.8 8.7 10.9 8.8 11.2" class="style0"></path><path d="M9.012 10.189c0.088 0.2 0 0.377-0.149 0.464c-0.17 0.087-0.377 0.02-0.465-0.15 c-0.085-0.17-0.019-0.377 0.151-0.463C8.719 10 8.9 10 9 10.2" class="style0"></path><path d="M9.056 9.345C9.149 9.5 9.1 9.7 9 9.742C8.866 9.8 8.7 9.8 8.6 9.7 C8.503 9.6 8.5 9.4 8.7 9.281C8.785 9.2 9 9.2 9.1 9.3" class="style0"></path><path d="M8.972 8.64c0.092 0.1 0.1 0.2 0 0.332c-0.091 0.092-0.239 0.092-0.331 0 c-0.092-0.091-0.092-0.24 0-0.332S8.88 8.5 9 8.6" class="style0"></path></g><g class="group-11"><path d="M9.542 12.915c0.1 0.31-0.07 0.641-0.379 0.741s-0.642-0.068-0.741-0.378 c-0.101-0.309 0.069-0.64 0.378-0.74C9.109 12.4 9.4 12.6 9.5 12.9" class="style2"></path><path d="M9.897 11.594c0.125 0.2 0 0.544-0.216 0.668c-0.244 0.124-0.544 0.027-0.668-0.217 C8.889 11.8 9 11.5 9.2 11.377C9.475 11.3 9.8 11.4 9.9 11.6" class="style2"></path><path d="M9.984 10.403c0.135 0.2 0.1 0.443-0.091 0.578c-0.186 0.134-0.444 0.093-0.578-0.092 c-0.135-0.185-0.093-0.444 0.091-0.578C9.591 10.2 9.9 10.2 10 10.4" class="style2"></path><path d="M9.9 9.412c0.134 0.1 0.1 0.4 0 0.487c-0.135 0.135-0.354 0.135-0.487 0 c-0.136-0.135-0.136-0.353 0-0.487C9.547 9.3 9.8 9.3 9.9 9.4" class="style2"></path><path d="M9.68 8.594c0.128 0.1 0.2 0.3 0.1 0.398C9.651 9.1 9.5 9.1 9.3 9.1 C9.218 9 9.2 8.8 9.3 8.657S9.553 8.5 9.7 8.6" class="style2"></path><path d="M9.383 7.95c0.115 0.1 0.2 0.2 0.1 0.314c-0.059 0.116-0.2 0.162-0.315 0.1 c-0.115-0.06-0.161-0.201-0.103-0.315C9.126 7.9 9.3 7.9 9.4 8" class="style2"></path></g><g class="group-12"><path d="M11.245 11.841c0.19 0.3 0.1 0.631-0.13 0.821c-0.264 0.191-0.631 0.133-0.822-0.13 s-0.134-0.631 0.13-0.822C10.686 11.5 11.1 11.6 11.2 11.8" class="style1"></path><path d="M11.177 10.474c0.194 0.2 0.2 0.5 0 0.702c-0.195 0.193-0.508 0.193-0.702 0 c-0.194-0.194-0.194-0.508 0-0.702C10.669 10.3 11 10.3 11.2 10.5" class="style1"></path><path d="M10.89 9.313c0.186 0.1 0.2 0.4 0.1 0.579c-0.134 0.186-0.392 0.226-0.577 0.1 c-0.186-0.134-0.227-0.393-0.092-0.577S10.706 9.2 10.9 9.3" class="style1"></path><path d="M10.504 8.397c0.17 0.1 0.2 0.3 0.1 0.464c-0.086 0.17-0.294 0.237-0.463 0.2 c-0.17-0.087-0.238-0.295-0.151-0.465C10.127 8.4 10.3 8.3 10.5 8.4" class="style1"></path><path d="M10.042 7.688c0.149 0 0.2 0.2 0.2 0.359c-0.047 0.149-0.208 0.23-0.358 0.2 C9.717 8.2 9.6 8 9.7 7.871C9.731 7.7 9.9 7.6 10 7.7" class="style1"></path><path d="M9.56 7.168c0.129 0 0.2 0.1 0.2 0.268C9.733 7.6 9.6 7.7 9.5 7.6 C9.358 7.6 9.3 7.5 9.3 7.362S9.433 7.1 9.6 7.2" class="style1"></path></g><g class="group-13"><path d="M12.533 10.292c0.263 0.2 0.3 0.6 0.1 0.822c-0.19 0.262-0.558 0.321-0.821 0.1 c-0.264-0.19-0.322-0.56-0.131-0.822C11.902 10.2 12.3 10.1 12.5 10.3" class="style3"></path><path d="M12.046 9.013c0.244 0.1 0.3 0.4 0.2 0.668c-0.125 0.244-0.424 0.342-0.668 0.2 c-0.244-0.124-0.342-0.423-0.217-0.667S11.802 8.9 12 9" class="style3"></path><path d="M11.416 7.999c0.216 0.1 0.3 0.3 0.3 0.521c-0.07 0.217-0.304 0.336-0.521 0.3 c-0.218-0.069-0.336-0.304-0.267-0.521C10.965 8 11.2 7.9 11.4 8" class="style3"></path><path d="M10.765 7.247c0.188 0 0.3 0.2 0.3 0.394c-0.029 0.188-0.206 0.316-0.395 0.3 c-0.188-0.03-0.315-0.206-0.286-0.394C10.399 7.3 10.6 7.2 10.8 7.2" class="style3"></path><path d="M10.105 6.714c0.158 0 0.3 0.1 0.3 0.285c0 0.157-0.127 0.285-0.285 0.3 C9.948 7.3 9.8 7.2 9.8 6.999C9.821 6.8 9.9 6.7 10.1 6.7" class="style3"></path><path d="M9.486 6.368c0.128-0.02 0.2 0.1 0.3 0.195c0.02 0.128-0.067 0.247-0.195 0.3 c-0.127 0.02-0.248-0.066-0.268-0.194C9.271 6.5 9.4 6.4 9.5 6.4" class="style3"></path></g><g class="group-14"><path d="M13.279 8.422c0.31 0.1 0.5 0.4 0.4 0.741c-0.101 0.309-0.432 0.478-0.741 0.4 c-0.309-0.101-0.478-0.432-0.378-0.741C12.64 8.5 13 8.3 13.3 8.4" class="style0"></path><path d="M12.422 7.355c0.271 0 0.5 0.3 0.4 0.568c-0.043 0.271-0.297 0.455-0.567 0.4 c-0.271-0.043-0.456-0.298-0.414-0.568C11.896 7.5 12.2 7.3 12.4 7.4" class="style0"></path><path d="M11.508 6.586c0.229 0 0.4 0.2 0.4 0.413c0 0.229-0.185 0.414-0.414 0.4 c-0.228 0-0.413-0.185-0.413-0.414C11.095 6.8 11.3 6.6 11.5 6.6" class="style0"></path><path d="M10.657 6.071c0.188-0.03 0.4 0.1 0.4 0.286c0.03 0.188-0.099 0.365-0.286 0.4 c-0.188 0.03-0.365-0.099-0.395-0.286S10.469 6.1 10.7 6.1" class="style0"></path><path d="M9.865 5.769c0.15-0.049 0.3 0 0.4 0.183c0.049 0.149-0.032 0.311-0.182 0.4 S9.731 6.3 9.7 6.128S9.717 5.8 9.9 5.8" class="style0"></path><path d="M9.17 5.631c0.115-0.059 0.256-0.013 0.3 0.102C9.545 5.8 9.5 6 9.4 6 C9.269 6.1 9.1 6.1 9.1 5.946C9.009 5.8 9.1 5.7 9.2 5.6" class="style0"></path></g><g class="group-15"><path d="M13.412 6.411C13.736 6.4 14 6.7 14 6.999c0 0.325-0.264 0.589-0.588 0.6 c-0.325 0-0.589-0.264-0.589-0.588C12.823 6.7 13.1 6.4 13.4 6.4" class="style2"></path><path d="M12.267 5.662c0.271-0.042 0.5 0.1 0.6 0.413c0.043 0.271-0.142 0.525-0.413 0.6 c-0.271 0.043-0.524-0.142-0.567-0.412C11.811 6 12 5.7 12.3 5.7" class="style2"></path><path d="M11.16 5.214c0.217-0.071 0.5 0 0.5 0.265c0.07 0.217-0.05 0.45-0.266 0.5 c-0.218 0.071-0.451-0.048-0.521-0.265S10.942 5.3 11.2 5.2" class="style2"></path><path d="M10.191 4.986c0.169-0.086 0.377-0.019 0.5 0.151c0.087 0.2 0 0.377-0.15 0.5 c-0.17 0.086-0.377 0.019-0.463-0.15C9.955 5.3 10 5.1 10.2 5" class="style2"></path><path d="M9.346 4.943c0.127-0.092 0.306-0.064 0.4 0.063C9.836 5.1 9.8 5.3 9.7 5.4 C9.553 5.5 9.4 5.5 9.3 5.342C9.189 5.2 9.2 5 9.3 4.9" class="style2"></path><path d="M8.641 5.027c0.092-0.092 0.24-0.092 0.3 0c0.092 0.1 0.1 0.239-0.001 0.3 c-0.091 0.092-0.239 0.091-0.33 0C8.549 5.3 8.5 5.1 8.6 5" class="style2"></path></g><g class="group-16"><path d="M12.916 4.458c0.309-0.1 0.6 0.1 0.7 0.378c0.101 0.31-0.068 0.642-0.378 0.7 c-0.309 0.102-0.64-0.068-0.741-0.377C12.438 4.9 12.6 4.6 12.9 4.5" class="style1"></path><path d="M11.595 4.101c0.244-0.124 0.543-0.026 0.7 0.218c0.124 0.2 0 0.542-0.218 0.7 c-0.243 0.125-0.543 0.027-0.667-0.217S11.351 4.2 11.6 4.1" class="style1"></path><path d="M10.404 4.015c0.186-0.134 0.443-0.094 0.6 0.093c0.135 0.2 0.1 0.442-0.092 0.6 c-0.184 0.134-0.442 0.093-0.577-0.092S10.219 4.1 10.4 4" class="style1"></path><path d="M9.413 4.1c0.134-0.135 0.353-0.136 0.5 0c0.134 0.1 0.1 0.4 0 0.5 c-0.135 0.135-0.353 0.135-0.487 0C9.277 4.5 9.3 4.2 9.4 4.1" class="style1"></path><path d="M9.056 4.654C8.964 4.8 8.8 4.8 8.7 4.718C8.53 4.6 8.5 4.4 8.6 4.3 c0.091-0.128 0.271-0.155 0.397-0.063C9.12 4.3 9.1 4.5 9.1 4.7" class="style1"></path><path d="M8.369 4.829c-0.06 0.115-0.2 0.162-0.315 0.103C7.938 4.9 7.9 4.7 8 4.6 c0.059-0.115 0.2-0.161 0.314-0.103C8.382 4.6 8.4 4.7 8.4 4.8" class="style1"></path></g><g class="group-17"><path d="M11.842 2.755c0.263-0.191 0.631-0.133 0.8 0.13c0.191 0.3 0.1 0.631-0.13 0.8 c-0.263 0.19-0.631 0.133-0.822-0.131C11.521 3.3 11.6 2.9 11.8 2.8" class="style3"></path><path d="M10.475 2.823c0.194-0.194 0.508-0.194 0.7 0s0.194 0.5 0 0.702c-0.194 0.193-0.508 0.193-0.702 0 C10.28 3.3 10.3 3 10.5 2.8" class="style3"></path><path d="M9.984 3.596C9.851 3.8 9.6 3.8 9.4 3.687C9.223 3.6 9.2 3.3 9.3 3.1 c0.134-0.186 0.393-0.227 0.578-0.092C10.078 3.2 10.1 3.4 10 3.6" class="style3"></path><path d="M9.013 3.809c-0.086 0.17-0.294 0.237-0.464 0.15C8.38 3.9 8.3 3.7 8.4 3.5 c0.086-0.17 0.293-0.236 0.462-0.15C9.031 3.4 9.1 3.6 9 3.8" class="style3"></path><path d="M8.231 4.134c-0.049 0.149-0.21 0.231-0.36 0.183C7.723 4.3 7.6 4.1 7.7 4 c0.048-0.149 0.209-0.231 0.358-0.182C8.197 3.8 8.3 4 8.2 4.1" class="style3"></path><path d="M7.632 4.512c-0.021 0.13-0.141 0.216-0.27 0.196C7.235 4.7 7.1 4.6 7.2 4.4 c0.021-0.129 0.141-0.217 0.269-0.196C7.563 4.3 7.7 4.4 7.6 4.5" class="style3"></path></g><g class="group-18"><path d="M11.245 2.158c-0.191 0.263-0.56 0.32-0.822 0.13c-0.264-0.19-0.321-0.559-0.13-0.821 c0.19-0.264 0.559-0.321 0.822-0.131C11.377 1.5 11.4 1.9 11.2 2.2" class="style0"></path><path d="M9.014 1.953c0.124-0.244 0.424-0.341 0.668-0.216c0.244 0.1 0.3 0.4 0.2 0.7 C9.774 2.6 9.5 2.7 9.2 2.621C8.986 2.5 8.9 2.2 9 2" class="style0"></path><path d="M8.787 2.84c-0.07 0.217-0.305 0.336-0.522 0.266C8.048 3 7.9 2.8 8 2.584s0.304-0.336 0.521-0.266 C8.738 2.4 8.9 2.6 8.8 2.8" class="style0"></path><path d="M7.928 3.343C7.898 3.5 7.7 3.7 7.5 3.629C7.347 3.6 7.2 3.4 7.2 3.2 c0.029-0.188 0.205-0.317 0.394-0.287C7.829 3 8 3.2 7.9 3.3" class="style0"></path><path d="M7.285 3.894c0 0.157-0.127 0.285-0.285 0.285c-0.157 0-0.285-0.128-0.285-0.285S6.843 3.6 7 3.6 C7.158 3.6 7.3 3.7 7.3 3.9" class="style0"></path><path d="M6.832 4.439c0.02 0.128-0.066 0.248-0.195 0.269c-0.129 0.02-0.248-0.066-0.268-0.194 C6.349 4.4 6.4 4.3 6.6 4.245C6.692 4.2 6.8 4.3 6.8 4.4" class="style0"></path></g><g class="group-19"><path d="M9.542 1.083C9.44 1.4 9.1 1.6 8.8 1.461S8.321 1 8.4 0.72c0.1-0.31 0.432-0.479 0.741-0.378 C9.472 0.4 9.6 0.8 9.5 1.1" class="style2"></path><path d="M7.356 1.578c0.043-0.271 0.297-0.455 0.567-0.412c0.271 0 0.5 0.3 0.4 0.6 C8.293 2 8 2.2 7.8 2.146S7.312 1.9 7.4 1.6" class="style2"></path><path d="M7.413 2.491C7.413 2.7 7.2 2.9 7 2.905S6.587 2.7 6.6 2.491S6.771 2.1 7 2.1 S7.413 2.3 7.4 2.5" class="style2"></path><path d="M6.753 3.235C6.782 3.4 6.7 3.6 6.5 3.629C6.278 3.7 6.1 3.5 6.1 3.3 c-0.03-0.188 0.099-0.364 0.286-0.395S6.723 3 6.8 3.2" class="style2"></path><path d="M6.312 3.957c0.049 0.15-0.033 0.312-0.184 0.359C5.979 4.4 5.8 4.3 5.8 4.1 s0.033-0.311 0.183-0.359C6.103 3.7 6.3 3.8 6.3 4" class="style2"></path><path d="M6.05 4.617c0.059 0.1 0 0.256-0.104 0.314C5.831 5 5.7 4.9 5.6 4.8 C5.572 4.7 5.6 4.6 5.7 4.515C5.85 4.5 6 4.5 6 4.6" class="style2"></path></g><g class="group-20"><path d="M7.589 0.588c0 0.325-0.264 0.588-0.589 0.588S6.412 0.9 6.4 0.588S6.675 0 7 0 S7.589 0.3 7.6 0.6" class="style1"></path><path d="M5.664 1.733C5.62 1.5 5.8 1.2 6.1 1.166s0.524 0.1 0.6 0.4 c0.042 0.271-0.143 0.525-0.413 0.568C5.96 2.2 5.7 2 5.7 1.7" class="style1"></path><path d="M6.001 2.584c0.07 0.217-0.05 0.45-0.267 0.521c-0.217 0.07-0.45-0.049-0.521-0.266 c-0.07-0.218 0.048-0.451 0.266-0.521C5.696 2.2 5.9 2.4 6 2.6" class="style1"></path><path d="M5.603 3.495C5.688 3.7 5.6 3.9 5.5 3.96c-0.17 0.085-0.378 0.019-0.464-0.152 c-0.086-0.169-0.019-0.376 0.15-0.462C5.308 3.3 5.5 3.3 5.6 3.5" class="style1"></path><path d="M5.405 4.319c0.092 0.1 0.1 0.306-0.062 0.398C5.215 4.8 5 4.8 4.9 4.7 S4.88 4.3 5 4.256C5.134 4.2 5.3 4.2 5.4 4.3" class="style1"></path><path d="M5.359 5.027c0.092 0.1 0.1 0.2 0 0.332s-0.24 0.091-0.331 0c-0.092-0.093-0.092-0.24-0.001-0.332 C5.119 4.9 5.3 4.9 5.4 5" class="style1"></path></g></svg></div><div class="fs-button-text"><!-- react-text: 155 -->fig<!-- /react-text --><strong>share</strong></div></a><span class="fs-file-logo-controls-separator"> </span><span class="fs-file-controls-misc-separator"> </span><div class="fs-misc-controls"><button class="fs-enlarge" title="display enlarged"></button><button class="fs-share" title="share"><span class="fs-button-text">Share</span></button><a class="fs-download" href="https://ndownloader.figshare.com/files/8643301"><span class="fs-button-text">Download</span></a></div></footer></section></div></figshare-widget></div><div class="NLM_notes" id="notes-2"> <span class="title" id="d8590e2184">Funding Information</span><p class="last">Funding for this research was provided by the Science Foundation Ireland under Grant No. 12/RC/2275 (Synthesis and Solid State Pharmaceutical Centre).</p></div><div class="NLM_notes" id="notes-3"><p class="first last">The authors declare no competing financial interest.</p></div><ul class="anchors"><li class="refQuivkViewLink"><a title="Open Reference QuickView" onclick="showRef(event); return false;" href="JavaScript:void(0);"><span>Reference QuickView</span></a></li><li><a title="Jump to a Section" onclick="showPulldown(this); return false;" href="JavaScript:void(0);" class="anchorIMG"></a><ul style="display: none;"><li><a onclick="hidePulldown(this);" title="Top of Page" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#top"><span>Top of Page</span></a></li><li><a onclick="hidePulldown(this);" title="Abstract" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#Abstract"><span>Abstract</span></a></li><li><a onclick="hidePulldown(this);" title="Introduction" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i1"><span>Introduction</span></a></li><li><a onclick="hidePulldown(this);" title="Materials and Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i2"><span>Materials and Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Methods" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i4"><span>Methods</span></a></li><li><a onclick="hidePulldown(this);" title="Results and Discussion" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i20"><span>Results and Discussion</span></a></li><li><a onclick="hidePulldown(this);" title="Conclusions" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i29"><span>Conclusions</span></a></li><li><a onclick="hidePulldown(this);" title="References" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#_i32"><span>References</span></a></li></ul></li></ul><h2 id="_i32">References</h2><hr><p>This article references 77 other publications.</p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref1&#39;);return false;" class="refNumLink">1. </a></strong><div class="NLM_citation" id="cit1"><span class="hlFld-ContribAuthor ">Mesallati<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Mugheirbi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N. A.</span>; <span class="hlFld-ContribAuthor ">Tajber<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span><span class="NLM_article-title">Two Faces of Ciprofloxacin: Investigation of Proton Transfer in Solid State Transformations</span> <span class="citation_source-journal">Cryst. Growth Des.</span>  <span class="NLM_year">2016</span>,  <span class="NLM_volume">16</span>,  <span class="NLM_fpage">6574</span>– <span class="NLM_lpage">85</span>, <span class="refDoi">DOI: 10.1021/acs.cgd.6b01283</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/acs.cgd.6b01283" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aqtrrJ" title="">CAS</a>]<div class="casRecord" id="cas_cit1R"><div class="casContent"><span class="casTitleNuber">1. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Two Faces of Ciprofloxacin: Investigation of Proton Transfer in Solid State Transformations</cas:atitle></div><div class="casAuthors">Mesallati, Hanah; Mugheirbi, Naila A.; Tajber, Lidia</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth &amp; Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">16</cas:volume>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6574-6585</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CGDEFU</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ciprofloxacin (CIP) can exist in two different forms: the zwitterion and the un-ionized form.  While the crystal structure of each has been described independently, the ability of CIP to transform from one form to the other in the solid state has not been described.  The crystal structures of un-ionized and zwitterionic CIP were therefore compared using computational methods, including their packing arrangement, hydrogen bonding, packing energy, intermol. potentials, and HOMO/lowest occupied MO energy gap.  The pure amorphous form of CIP has also never been prepd. or studied.  Ball milling, cryomilling, and spray drying were used in this study to prep. partially and fully amorphous CIP for the first time.  The phys. characteristics were examd. by powder X-ray diffraction, Fourier transform IR spectroscopy, and differential scanning calorimetry.  CIP proved to be very difficult to amorphize, and only spray drying in pure water resulted in a fully amorphous product.  It was discovered that while most processing methods resulted in the more stable zwitterionic form of the drug, spray drying in an ethanol/water mixt. produced the un-ionized form.  The zwitterion was found to convert to the un-ionized form upon heating to its m.p., whereas the reverse transformation occurred when un-ionized CIP was exposed to high humidity.  This study thus provides insight into the proton transfer which can occur in a zwitterionic drug in the solid state and the resultant changes to its crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmv8CYhqGU-rVg90H21EOLACvtfcHk0lj5Z3FWqrkpEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aqtrrJ&amp;md5=14c1ac29f7f1cdc6f4e2296359ed5302</span></div></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref2&#39;);return false;" class="refNumLink">2. </a></strong><div class="NLM_citation" id="cit2"><span class="hlFld-ContribAuthor ">Paluch<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. J.</span>; <span class="hlFld-ContribAuthor ">McCabe<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.</span>; <span class="hlFld-ContribAuthor ">Müller-Bunz<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Corrigan<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O. I.</span>; <span class="hlFld-ContribAuthor ">Healy<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. M.</span>; <span class="hlFld-ContribAuthor ">Tajber<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span><span class="NLM_article-title">Formation and Physicochemical Properties of Crystalline and Amorphous Salts with Different Stoichiometries Formed between Ciprofloxacin and Succinic Acid</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2013</span>,  <span class="NLM_volume">10</span>,  <span class="NLM_fpage">3640</span>– <span class="NLM_lpage">3654</span>, <span class="refDoi">DOI: 10.1021/mp400127r</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp400127r" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OnsrnE" title="">CAS</a>]<div class="casRecord" id="cas_cit2R"><div class="casContent"><span class="casTitleNuber">2. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Formation and Physicochemical Properties of Crystalline and Amorphous Salts with Different Stoichiometries Formed between Ciprofloxacin and Succinic Acid</cas:atitle></div><div class="casAuthors">Paluch, Krzysztof J.; McCabe, Thomas; Muller-Bunz, H.; Corrigan, Owen I.; Healy, Anne Marie; Tajber, Lidia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">10</cas:volume>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3640-3654</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multi-ionizable compds., such as dicarboxylic acids, offer the possibility of forming salts of drugs with multiple stoichiometries.  Attempts to crystallize ciprofloxacin, a poorly water-sol., amphoteric mol. with succinic acid (S) resulted in isolation of ciprofloxacin hemisuccinate (1:1) trihydrate (CHS-I) and ciprofloxacin succinate (2:1) tetrahydrate (CS-I).  Anhyd. ciprofloxacin hemisuccinate (CHS-II) and anhyd. ciprofloxacin succinate (CS-II) were also obtained.  It was also possible to obtain stoichiometrically equiv. amorphous salt forms, CHS-III and CS-III, by spray drying and milling, resp., of the drug and acid.  Anhyd. CHS and CS had m.ps. at ∼215 and ∼228 °C, while the glass transition temps. of CHS-III and CS-III were ∼101 and ∼79 °C, resp.  Dynamic soly. studies revealed the metastable nature of CS-I in aq. media, resulting in a transformation of CS-I to a mix of CHS-I and ciprofloxacin 1:3.7 hydrate, consistent with the phase diagram.  CS-III was obsd. to dissolve noncongruently leading to high and sustainable drug soln. concns. in water at 25 and 37 °C, with the ciprofloxacin concn. of 58.8 ± 1.18 mg/mL after 1 h of the expt. at 37 °C.  This work shows that cryst. salts with multiple stoichiometries and amorphous salts have diverse pharmaceutically relevant properties, including mol., solid state, and soly. characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE8gmYOWGCfLVg90H21EOLACvtfcHk0lj5Z3FWqrkpEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3sXht1OnsrnE&amp;md5=74109f50d3c55d4addd894bf115bbdd8</span></div></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref3&#39;);return false;" class="refNumLink">3. </a></strong><div class="NLM_citation" id="cit3"><span class="hlFld-ContribAuthor ">Zhang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C.-L.</span>; <span class="hlFld-ContribAuthor ">Zhao<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>F.</span>; <span class="hlFld-ContribAuthor ">Wang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span><span class="NLM_article-title">Thermodynamics of the Solubility of Ciprofloxacin in Methanol, Ethanol, 1-Propanol, Acetone, and Chloroform from 293.15 to 333.15K</span> <span class="citation_source-journal">J. Mol. Liq.</span>  <span class="NLM_year">2010</span>,  <span class="NLM_volume">156</span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">193</span>, <span class="refDoi">DOI: 10.1016/j.molliq.2010.06.004</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.molliq.2010.06.004" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFCgsLfO" title="">CAS</a>]<div class="casRecord" id="cas_cit3R"><div class="casContent"><span class="casTitleNuber">3. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Thermodynamics of the solubility of ciprofloxacin in methanol, ethanol, 1-propanol, acetone, and chloroform from 293.15 to 333.15 K</cas:atitle></div><div class="casAuthors">Zhang, Cong-Liang; Zhao, Fang; Wang, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Liquids</span>
        (<span class="NLM_cas:date">2010</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">156</cas:volume>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">191-193</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JMLIDT</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0167-7322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The solubilities of ciprofloxacin in methanol, ethanol, 1-propanol, acetone, and chloroform were detd. with temps. from 293.15 to 333.15 K by a static equil. method.  The exptl. data were correlated with the modified Apelblat equation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOJMHhEoluk7Vg90H21EOLACvtfcHk0lj5Z3FWqrkpEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3cXhtFCgsLfO&amp;md5=612205e7a8be57f34bc824cc6149eca5</span></div></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref4&#39;);return false;" class="refNumLink">4. </a></strong><div class="NLM_citation" id="cit4"><span class="hlFld-ContribAuthor ">Breda<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. A.</span>; <span class="hlFld-ContribAuthor ">Jimenez-Kairuz<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. F.</span>; <span class="hlFld-ContribAuthor ">Manzo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. H.</span>; <span class="hlFld-ContribAuthor ">Olivera<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. E.</span><span class="NLM_article-title">Solubility Behavior and Biopharmaceutical Classification of Novel High-Solubility Ciprofloxacin and Norfloxacin Pharmaceutical Derivatives</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2009</span>,  <span class="NLM_volume">371</span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">113</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2008.12.026</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2008.12.026" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=19150493" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWktb4%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit4R"><div class="casContent"><span class="casTitleNuber">4. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives</cas:atitle></div><div class="casAuthors">Breda, Susana A.; Jimenez-Kairuz, Alvaro F.; Manzo, Ruben H.; Olivera, Maria E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">371</cas:volume>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">106-113</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The hydrochlorides of the 1:3 aluminum:norfloxacin and aluminum:ciprofloxacin complexes were characterized according to the Biopharmaceutics Classification System (BCS) premises in comparison with their parent compds.  The pH-soly. profiles of the complexes were exptl. detd. at 25 and 37 °C in the range of pH 1-8 and compared to that of uncomplexed norfloxacin and ciprofloxacin.  Both complexes are clearly more sol. than the antibiotics themselves, even at the lowest soly. pH.  The increase in soly. was ascribed to the species controlling soly., which were analyzed in the solid phases at equil. at selected pHs.  Addnl., permeability was set as low, based on data reported in the scientific literature regarding oral bioavailability, intestinal and cell cultures permeabilities and also considering the influence of stoichiometric amts. of aluminum.  The complexes fulfill the BCS criterion to be classified as class 3 compds. (high soly./low permeability).  Instead, the active pharmaceutical ingredients (APIs) currently used in solid dosage forms, norfloxacin and ciprofloxacin hydrochloride, proved to be BCS class 4 (low soly./low permeability).  The soly. improvement turns the complexes as potential biowaiver candidates from the scientific point of view and may be a good way for developing more dose-efficient formulations.  An immediate release tablet showing very rapid dissoln. was obtained.  Its dissoln. profile was compared to that of the com. ciprofloxacin hydrochloride tablets allowing to dissoln. of the complete dose at a crit. pH such as 6.8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4G3q35YLjfbVg90H21EOLACvtfcHk0ljOvzdFppjSNg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1MXjslWktb4%253D&amp;md5=10644d3b02c0e74f332c3eb221264257</span></div></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref5&#39;);return false;" class="refNumLink">5. </a></strong><div class="NLM_citation" id="cit5"><span class="hlFld-ContribAuthor ">Zaki<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N. M.</span>; <span class="hlFld-ContribAuthor ">Artursson<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Bergström<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. A. S.</span><span class="NLM_article-title">A Modified Physiological BCS for Prediction of Intestinal Absorption in Drug Discovery</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2010</span>,  <span class="NLM_volume">7</span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi">DOI: 10.1021/mp100124f</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp100124f" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSjur3O" title="">CAS</a>]<div class="casRecord" id="cas_cit5R"><div class="casContent"><span class="casTitleNuber">5. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">A Modified Physiological BCS for Prediction of Intestinal Absorption in Drug Discovery</cas:atitle></div><div class="casAuthors">Zaki, Noha M.; Artursson, Per; Bergstrom, Christel A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">7</cas:volume>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1478-1487</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the influence of physiol. relevant media on the compd. position in a biopharmaceutical classification system (BCS) which resembled the intestinal absorption was investigated.  Both soly. and permeability limited compds. (n = 22) were included to analyze the importance of each of these on the final absorption.  Soly. was detd. in three different dissoln. media, phosphate buffer pH 6.5 (PhB 6.5), fasted state simulated intestinal fluid (FaSSIF), and fed state simulated intestinal fluid (FeSSIF) at 37 °C, and permeability values were detd. using the 2/4/A1 cell line.  The soly. data and membrane permeability values were used for sorting the compds. into a BCS modified to reflect the fasted and fed state.  Three of the seven compds. sorted as BCS II in PhB 6.5 (high permeability, low soly.) changed their position to BCS I when dissolved in FaSSIF and/or FeSSIF (high permeability, high soly.).  These were low dosed (20 mg or less) lipophilic mols. displaying solvation limited soly.  In contrast, compds. having solid-state limited soly. had a minor increase in soly. when dissolved in FaSSIF and/or FeSSIF.  Although further studies are needed to enable general cutoff values, our study indicates that low dosed BCS Class II compds. which have soly. normally restricted by poor solvation may behave as BCS Class I compds. in vivo.  The large series of compds. investigated herein reveals the importance of investigating soly. and dissoln. under physiol. relevant conditions in all stages of the drug discovery process to push suitable compds. forward, to select proper formulations, and to reduce the risk of food effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYVGdADahMLVg90H21EOLACvtfcHk0ljOvzdFppjSNg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSjur3O&amp;md5=8214b55d8024b5b4fad8b636e65a8dcc</span></div></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref6&#39;);return false;" class="refNumLink">6. </a></strong><div class="NLM_citation" id="cit6"><span class="hlFld-ContribAuthor ">Serajuddin<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. T. M.</span><span class="NLM_article-title">Salt Formation to Improve Drug Solubility</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span>  <span class="NLM_year">2007</span>,  <span class="NLM_volume">59</span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">616</span>, <span class="refDoi">DOI: 10.1016/j.addr.2007.05.010</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.addr.2007.05.010" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=17619064" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFGksrc%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit6R"><div class="casContent"><span class="casTitleNuber">6. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Salt formation to improve drug solubility</cas:atitle></div><div class="casAuthors">Serajuddin, Abu T. M.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">59</cas:volume>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ADDREP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Salt formation is the most common and effective method of increasing soly. and dissoln. rates of acidic and basic drugs.  In this article, physicochem. principles of salt soly. are presented, with special ref. to the influence of pH-soly. profiles of acidic and basic drugs on salt formation and dissoln.  Non-ideality of salt soly. due to self-assocn. in soln. is also discussed.  Whether certain acidic or basic drugs would form salts and, if salts are formed, how easily they would dissoc. back into their free acid or base forms depend on interrelationships of several factors, such as S0 (intrinsic soly.), pH, pKa, Ksp (soly. product) and pHmax (pH of max. soly.).  The interrelationships of these factors are elaborated and their influence on salt screening and the selection of optimal salt forms for development are discussed.  Factors influencing salt dissoln. under various pH conditions, and esp. in reactive media and in presence of excess common ions, are discussed, with practical ref. to the development of solid dosage forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZdRvmSUWvN7Vg90H21EOLACvtfcHk0ljOvzdFppjSNg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2sXpsFGksrc%253D&amp;md5=6e77d1385622af6973a6d763746ad0db</span></div></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref7&#39;);return false;" class="refNumLink">7. </a></strong><div class="NLM_citation" id="cit7"><span class="hlFld-ContribAuthor ">Parojčić<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Stojković<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Tajber<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span>; <span class="hlFld-ContribAuthor ">Grbić<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S.</span>; <span class="hlFld-ContribAuthor ">Paluch<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. J.</span>; <span class="hlFld-ContribAuthor ">Djurić<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Z.</span>; <span class="hlFld-ContribAuthor ">Corrigan<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O. I.</span><span class="NLM_article-title">Biopharmaceutical Characterization of Ciprofloxacin HCl-Ferrous Sulfate Interaction</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2011</span>,  <span class="NLM_volume">100</span>,  <span class="NLM_fpage">5174</span>– <span class="NLM_lpage">5184</span>, <span class="refDoi">DOI: 10.1002/jps.22707</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.22707" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=21789771" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1Gjtr4%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit7R"><div class="casContent"><span class="casTitleNuber">7. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Biopharmaceutical characterization of ciprofloxacin HCl-ferrous sulfate interaction</cas:atitle></div><div class="casAuthors">Parojcic, Jelena; Stojkovic, Aleksandra; Tajber, Lidia; Grbic, Sandra; Paluch, Krzysztof; Djuric, Zorica; Corrigan, Owen I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">100</cas:volume>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5174-5184</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ciprofloxacin-iron interaction, resulting in a lower bioavailability, is well documented in vivo; however, a mechanistic explanation supported by exptl. data of this interaction is missing.  In the present study, ciprofloxacin hydrochloride (HCl) and ferrous sulfate interaction was simulated in vitro by performing soly. and dissoln. studies in the reactive media contg. ferrous sulfate.  Characterization of the ppt. formed indicated its probable chem. structure as Fe(SO42-)2(Cl-)2(ciprofloxacin)2 × (H2O)n, where n is up to 12 mols. of water.  The soly. of this complex in water was estd. to be approx. 2 mg/mL, being about 20-fold lower than the soly. of ciprofloxacin HCl.  The soly. of the complex was used as input parameter for an in silico modeling by GastroPlus and the resulting predicted plasma time curves were in good agreement with the in vivo data.  These results strongly indicate that ciprofloxacin-iron interaction in vivo is caused by the formation of a low sol. complex.  This interaction was also simulated by in vitro dissoln., in which a mini scale app. provided more biorelevant results than the std. dissoln. app., probably because the drug concns. in the mini app. were higher and, thus, closer to the conditions encountered in vivo. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_1RP9SRrGNrVg90H21EOLACvtfcHk0li29UXD78v0OA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXpt1Gjtr4%253D&amp;md5=4efbfd5a69e3c3b1dee396e487f6bbe5</span></div></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref8&#39;);return false;" class="refNumLink">8. </a></strong><div class="NLM_citation" id="cit8"><span class="hlFld-ContribAuthor ">Florence<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. T.</span><span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">; </x></span><span class="hlFld-ContribAuthor ">Attwood<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span>  <span class="citation_source-book">Physicochemical Principles of Pharmacy</span>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_publisher-name">Pharmaceutical Press</span>: <span class="NLM_publisher-loc">Cornwall</span>,  <span class="NLM_year">2011</span>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit8R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref9&#39;);return false;" class="refNumLink">9. </a></strong><div class="NLM_citation" id="cit9"><span class="hlFld-ContribAuthor ">Yeon<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. .</span><span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">; </x></span><span class="hlFld-ContribAuthor ">Kim<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. H.</span><span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">; </x></span><span class="hlFld-ContribAuthor ">Choi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. E.</span><span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">; </x></span><span class="hlFld-ContribAuthor ">Kim<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D. H.</span><span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">; </x></span><span class="hlFld-ContribAuthor ">Lee<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. H.</span> <span class="NLM_article-title">Salts of a Quinolone-Carboxylic Acid</span>. U.S. Patent US5484785A,  <span class="NLM_year">1996</span>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit9R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref10&#39;);return false;" class="refNumLink">10. </a></strong><div class="NLM_citation" id="cit10"><span class="hlFld-ContribAuthor ">Reddy<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. S.</span>; <span class="hlFld-ContribAuthor ">Ganesh<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. V.</span>; <span class="hlFld-ContribAuthor ">Nagalapalli<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Dandela<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Solomon<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. A.</span>; <span class="hlFld-ContribAuthor ">Kumar<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. A.</span>; <span class="hlFld-ContribAuthor ">Goud<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N. R.</span>; <span class="hlFld-ContribAuthor ">Nangia<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span><span class="NLM_article-title">Fluoroquinolone Salts with Carboxylic Acids</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2011</span>,  <span class="NLM_volume">100</span>,  <span class="NLM_fpage">3160</span>– <span class="NLM_lpage">3176</span>, <span class="refDoi">DOI: 10.1002/jps.22537</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.22537" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=21394722" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCrtLc%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit10R"><div class="casContent"><span class="casTitleNuber">10. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Fluoroquinolone salts with carboxylic acids</cas:atitle></div><div class="casAuthors">Reddy, J. Satyanarayana; Ganesh, Saraswatula Viswanadha; Nagalapalli, Ravikumar; Dandela, Rambabu; Solomon, K. Anand; Kumar, K. Anil; Goud, N. Rajesh; Nangia, Ashwini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">100</cas:volume>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3160-3176</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The crystn. of fluoroquinolone antibiotics norfloxacin and ciprofloxacin with carboxylic acids gave six new salts that were characterized by IR spectroscopy, differential scanning calorimetry, X-ray powder diffraction, and single crystal X-ray diffraction.  Five of these salts are hydrates with different levels of water content.  The mol. compn., stoichiometry, and proton transfer state in these salts are confirmed from the crystal structure.  The effect of carboxylate counterion, such as oxalate, tartarate, benzoate, malonate, and citrate, and hydration state on the soly. and dissoln. profile of drug salts are reported in pure water (pH 6.4), 0.1 N HCl (pH 1.2), and phosphate buffer soln. (pH 6.8).  These salts are more sol. and exhibit faster dissoln. in pure water and phosphate buffer medium than the ref. drugs, but the order is reversed in acidic medium.  These salts are chem. stable to the dissoln. measurement conditions, whereas the ref. drug norfloxacin undergoes phase transformation to norfloxacin hydrate at the end of the expt. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 100:3160-3176, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd0AH9ODVis7Vg90H21EOLACvtfcHk0li29UXD78v0OA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCrtLc%253D&amp;md5=de96706141a7e1acb43a27df1ddc0d91</span></div></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref11&#39;);return false;" class="refNumLink">11. </a></strong><div class="NLM_citation" id="cit11"><span class="hlFld-ContribAuthor ">Florindo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C.</span>; <span class="hlFld-ContribAuthor ">Costa<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Matos<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C.</span>; <span class="hlFld-ContribAuthor ">Nunes<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. L.</span>; <span class="hlFld-ContribAuthor ">Matias<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. N.</span>; <span class="hlFld-ContribAuthor ">Duarte<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. M. M.</span>; <span class="hlFld-ContribAuthor ">Rebelo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L. P. N.</span>; <span class="hlFld-ContribAuthor ">Branco<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L. C.</span>; <span class="hlFld-ContribAuthor ">Marrucho<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I. M.</span><span class="NLM_article-title">Novel Organic Salts Based on Fluoroquinolone Drugs: Synthesis, Bioavailability and Toxicological Profiles</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2014</span>,  <span class="NLM_volume">469</span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">189</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2014.04.034</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2014.04.034" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=24746413" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1els78%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit11R"><div class="casContent"><span class="casTitleNuber">11. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Novel organic salts based on fluoroquinolone drugs: Synthesis, bioavailability and toxicological profiles</cas:atitle></div><div class="casAuthors">Florindo, Catarina; Costa, Alexandra; Matos, Carla; Nunes, Sara L.; Matias, Ana N.; Duarte, Catarina M. M.; Rebelo, Luis Paulo N.; Branco, Luis C.; Marrucho, Isabel M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">469</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-189</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to overcome the problems assocd. with low water soly., and consequently low bioavailability of active pharmaceutical ingredients (APIs), novel org. salts contg. fluoroquinolones (e.g. ciprofloxacin and norfloxacin) were prepd., using an optimized synthetic procedure based on direct protonation, with different biocompatible counter ions such as mesylate, gluconate and glycolate.  All the prepd. org. salts were characterized by spectroscopic techniques, mass spectrometry and thermal anal.  Soly. studies in water and simulated biol. fluids at 25 °C and 37 °C were also performed.  Addnl., octanol-water and phospholipid-water partition coeffs. were measured at 25 °C.  The cytotoxicity and anti-inflammatory efficacy using an human cell model of intestinal epithelia (Caco-2 cells) were also evaluated and compared to those of the parent APIs.  The adequate selection of the biocompatible anions allows the tuning of important phys., thermal and toxicol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa42-n-BFY1rVg90H21EOLACvtfcHk0li29UXD78v0OA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2cXos1els78%253D&amp;md5=379393648ccd92373b4f85c85e9015ca</span></div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref12&#39;);return false;" class="refNumLink">12. </a></strong><div class="NLM_citation" id="cit12"><span class="hlFld-ContribAuthor ">Romañuk<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. B.</span>; <span class="hlFld-ContribAuthor ">Manzo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. H.</span>; <span class="hlFld-ContribAuthor ">Linck<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y. G.</span>; <span class="hlFld-ContribAuthor ">Chattah<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. K.</span>; <span class="hlFld-ContribAuthor ">Monti<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G. A.</span>; <span class="hlFld-ContribAuthor ">Olivera<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. E.</span><span class="NLM_article-title">Characterization of the Solubility and Solid-State Properties of Saccharin Salts of Fluoroquinolones</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2009</span>,  <span class="NLM_volume">98</span>,  <span class="NLM_fpage">3788</span>– <span class="NLM_lpage">3801</span>, <span class="refDoi">DOI: 10.1002/jps.21688</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.21688" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=19226631" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhsrzL" title="">CAS</a>]<div class="casRecord" id="cas_cit12R"><div class="casContent"><span class="casTitleNuber">12. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones</cas:atitle></div><div class="casAuthors">Romanuk, Carolina B.; Manzo, Ruben H.; Linck, Yamila Garro; Chattah, Ana K.; Monti, Gustavo A.; Olivera, Maria E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">98</cas:volume>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3788-3801</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Saccharinates salts of the fluoroquinolone antibiotics norfloxacin, ciprofloxacin, ofloxacin, and enrofloxacin were obtained as pure cryst. anhyd. solids with sweet taste.  The products were characterized by one- (13C) and two-dimensional (1H-13C) dimensions solid state NMR and IR spectroscopy showing ionic interactions between the saccharine amide and the fluoroquinolone piperazine.  Several intermol. bindings were also identified.  Thermal behavior and powder x-ray diffraction provided complementary evidences of salt formation.  The series of products showed improved properties with respect to water soly.  A soly. model was developed.  These salts would be a good way forward to developing more suitable formulations of these APIs. © 2009 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 98:3788-3801, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPFxb4f0KK_7Vg90H21EOLACvtfcHk0li29UXD78v0OA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhsrzL&amp;md5=d95913b72b574cdc28c611a84c694b2f</span></div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref13&#39;);return false;" class="refNumLink">13. </a></strong><div class="NLM_citation" id="cit13"><span class="hlFld-ContribAuthor ">Willis<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. R.</span>; <span class="hlFld-ContribAuthor ">Banker<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G. S.</span><span class="NLM_article-title">Polymer–drug Interacted Systems in the Physicochemical Design of Pharmaceutical Dosage Forms I. Drug Salts with PVM/MA and with a PVM/MA Hemi-Ester</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">1968</span>,  <span class="NLM_volume">57</span>,  <span class="NLM_fpage">1598</span>– <span class="NLM_lpage">1603</span>, <span class="refDoi">DOI: 10.1002/jps.2600570927</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.2600570927" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=4386450" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaF1cXkvV2ksL4%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit13R"><div class="casContent"><span class="casTitleNuber">13. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Polymer-drug interacted systems in the physicochemical design of pharmaceutical dosage forms.  I.  Drug salts with methyl vinyl ether-maleic-anhydride copolymer hemi-ester of the coolymer</cas:atitle></div><div class="casAuthors">Willis, C. R., Jr.; Banker, Gilbert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1968</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">57</cas:volume>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1598-1603</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">Salts of poly(methyl vinyl ether/maleic anhydride) and methapyrilene base were prepd.  In vitro release patterns were detd. by an equil. dialysis procedure.  Dialytic release rates of the polymer-drug salt in soln. demonstrated no appreciable difference in drug availability with respect to the free drug or its hydrochloride salt.  In vitro dissoln. rates of the polymer-drug salt in solid form showed similar results.  Polymer-drug salts formed with the 1,12-dihydroxyoctadecane hemi-ester of poly(methyl vinyl ether/maleic anhydride) exhibited prolongation of the release of the drug from granular and tableted forms in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb1VgobKaAyLVg90H21EOLACvtfcHk0lhg5V1T_tKJKQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF1cXkvV2ksL4%253D&amp;md5=01030f474ad22561fa70acc41c2e8661</span></div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref14&#39;);return false;" class="refNumLink">14. </a></strong><div class="NLM_citation" id="cit14"><span class="hlFld-ContribAuthor ">Yu<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span><span class="NLM_article-title">Amorphous Pharmaceutical Solids: Preparation, Characterization and Stabilization</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span>  <span class="NLM_year">2001</span>,  <span class="NLM_volume">48</span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">42</span>, <span class="refDoi">DOI: 10.1016/S0169-409X(01)00098-9</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2FS0169-409X%2801%2900098-9" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=11325475" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFejsrg%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit14R"><div class="casContent"><span class="casTitleNuber">14. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Amorphous pharmaceutical solids: preparation, characterization and stabilization</cas:atitle></div><div class="casAuthors">Yu, L.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">48</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ADDREP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 114 refs.  The importance of amorphous pharmaceutical solids lies in their useful properties, common occurrence, and physicochem. instability relative to corresponding crystals.  Some pharmaceuticals and excipients have a tendency to exist as amorphous solids, while others require deliberate prevention of crystn. to enter and remain in the amorphous state.  Amorphous solids can be produced by common pharmaceutical processes, including melt quenching, freeze- and spray-drying, milling, wet granulation, and drying of solvated crystals.  The characterization of amorphous solids reveals their structures, thermodn. properties, and changes (crystn. and structural relaxation) in single- and multi-component systems.  Current research in the stabilization of amorphous solids focuses on: (i) the stabilization of labile substances (e.g., proteins and peptides) during processing and storage using additives, (ii) the prevention of crystn. of the excipients that must remain amorphous for their intended functions, and (iii) the selection of appropriate storage conditions under which amorphous solids are stable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOtZX-jDA4LVg90H21EOLACvtfcHk0lhg5V1T_tKJKQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD3MXivFejsrg%253D&amp;md5=071ebf084a8316914970d9af20fcb575</span></div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref15&#39;);return false;" class="refNumLink">15. </a></strong><div class="NLM_citation" id="cit15"><span class="hlFld-ContribAuthor ">Al-Obaidi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Buckton<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_article-title">Evaluation of Griseofulvin Binary and Ternary Solid Dispersions with HPMCAS</span> <span class="citation_source-journal">AAPS PharmSciTech</span>  <span class="NLM_year">2009</span>,  <span class="NLM_volume">10</span>,  <span class="NLM_fpage">1172</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi">DOI: 10.1208/s12249-009-9319-x</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1208%2Fs12249-009-9319-x" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=19842041" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVGqsbs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit15R"><div class="casContent"><span class="casTitleNuber">15. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS</cas:atitle></div><div class="casAuthors">Al-Obaidi, Hisham; Buckton, Graham</div><div class="citationInfo"><span class="NLM_cas:title">AAPS PharmSciTech</span>
        (<span class="NLM_cas:date">2009</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">10</cas:volume>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1172-1177</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">AAPHFZ</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1530-9932</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The stability and dissoln. properties of griseofulvin binary and ternary solid dispersions were evaluated.  Solid dispersions of griseofulvin and hydroxypropyl methylcellulose acetate succinate (HPMCAS) were prepd. using the spray drying method.  A third polymer, poly[N-(2-hydroxypropyl) methacrylate] (PHPMA), was incorporated to investigate its effect on the interaction of griseofulvin with HPMCAS.  In this case, HPMCAS can form H bonds with griseofulvin directly: the addn. of PHPMA to the solid dispersion may enhance the stability of the amorphous griseofulvin due to greater interaction with griseofulvin.  The X-ray powder diffraction results showed that griseofulvin (binary and ternary solid dispersions) remained amorphous for more than 19 mo stored at 85% RH compared with the spray-dried griseofulvin which crystd. totally within 24 h at ambient conditions.  The Fourier transform IR scan showed that griseofulvin carbonyl group formed hydrogen bonds with the hydroxyl group in the HPMCAS, which could explain the extended stability of the drug.  Further broadening in the peak could be seen when PHPMA was added to the solid dispersion, which indicates stronger interaction.  The glass transition temps. increased in the ternary solid dispersions regardless of HPMCAS grade.  The dissoln. rate of the drug in the solid dispersion (both binary and ternary) has significantly increased when compared with the dissoln. profile of the spray-dried griseofulvin.  These results reveal significant stability of the amorphous form due to the hydrogen bond formation with the polymer.  The addn. of the third polymer improved the stability but had a minor impact on dissoln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFDsdTSR3ZpbVg90H21EOLACvtfcHk0lhg5V1T_tKJKQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3cXovVGqsbs%253D&amp;md5=3a4cbe60156fe56b31f07ce606da3709</span></div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref16&#39;);return false;" class="refNumLink">16. </a></strong><div class="NLM_citation" id="cit16"><span class="hlFld-ContribAuthor ">Huang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span>; <span class="hlFld-ContribAuthor ">Dai<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>W.-G.</span><span class="NLM_article-title">Fundamental Aspects of Solid Dispersion Technology for Poorly Soluble Drugs</span> <span class="citation_source-journal">Acta Pharm. Sin. B</span>  <span class="NLM_year">2014</span>,  <span class="NLM_volume">4</span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">25</span>, <span class="refDoi">DOI: 10.1016/j.apsb.2013.11.001</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.apsb.2013.11.001" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=26579360" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlKrsw%253D%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit16R"><div class="casContent"><span class="casTitleNuber">16. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Fundamental aspects of solid dispersion technology for poorly soluble drugs</cas:atitle></div><div class="casAuthors">Huang Yanbin; Dai Wei-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2014</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">4</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-25</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">The solid dispersion has become an established solubilization technology for poorly water soluble drugs.  Since a solid dispersion is basically a drug-polymer two-component system, the drug-polymer interaction is the determining factor in its design and performance.  In this review, we summarize our current understanding of solid dispersions both in the solid state and in dissolution, emphasizing the fundamental aspects of this important technology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFlwaK-_ZudimnfW6udTcc2eZvQ6BCUkdDKLntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC28rgtlKrsw%253D%253D&amp;md5=eda2caf6431b56db6c537e8e03472230</span></div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref17&#39;);return false;" class="refNumLink">17. </a></strong><div class="NLM_citation" id="cit17"><span class="hlFld-ContribAuthor ">Shamblin<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. L.</span>; <span class="hlFld-ContribAuthor ">Zografi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_article-title">The Effects of Absorbed Water on the Properties of Amorphous Mixtures Containing Sucrose</span> <span class="citation_source-journal">Pharm. Res.</span>  <span class="NLM_year">1999</span>,  <span class="NLM_volume">16</span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1124</span>, <span class="refDoi">DOI: 10.1023/A:1018960405504</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1023%2FA%3A1018960405504" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10450941" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaK1MXltVyhsLw%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit17R"><div class="casContent"><span class="casTitleNuber">17. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">The effects of absorbed water on the properties of amorphous mixtures containing sucrose</cas:atitle></div><div class="casAuthors">Shamblin, Sheri L.; Zografi, George</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">16</cas:volume>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1119-1124</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PHREEB</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">To measure the water vapor absorption behavior of sucrose-poly(vinylpyrrolidone) (PVP) and sucrose-poly(vinylpyrrolidone co-vinyl acetate) (PVP/VA) mixts., prepd. as amorphous solid solns. and as phys. mixts., and the effect of absorbed water on the amorphous properties, i.e., crystn. and glass transition temp., Tg, of these systems.  Mixts. of sucrose and polymer were prepd. by co-lyophilization of aq. sucrose-polymer solns. and by phys. mixing amorphous sucrose and polymer.  Absorption isotherms for the individual components and their mixts. were detd. gravimetrically at 30° as a function of relative humidity.  Following the absorption expts., mixts. were analyzed for evidence of crystn. by x-ray powder diffraction.  For co-lyophilized mixts. showing no evidence of cryst. sucrose, Tg was detd. as a function of water content by DSC.  The absorption of water vapor was the same for co-lyophilized and phys. mixed samples under the same conditions and equal to the weighted sums of the individual isotherms where no sucrose crystn. was obsd.  The crystn. of sucrose in the mixts. was reduced relative to sucrose alone only when sucrose was molecularly dispersed (co-lyophilized) with the polymers.  In particular, when co-lyophilized with sucrose at a concn. of 50%, PVP was able to maintain sucrose in the amorphous state for up to three months, even when the Tg was reduced well below the storage temp. by the absorbed water.  The water vapor absorption isotherms for co-lyophilized and phys. mixed amorphous sucrose-PVP and sucrose-PVP/VA mixts. at 30° are similar despite interactions between sugar and polymer which are formed when the components are molecularly dispersed with one another.  In the presence of absorbed water the crystn. of sucrose was reduced only by the formation of a solid-soln., with PVP having a much more pronounced effect than PVP/VA.  The effectiveness of PVP in preventing sucrose crystn. when significant levels of absorbed water are present was attributed to the mol. interactions between sucrose, PVP and water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIdQqI3R9grVg90H21EOLACvtfcHk0lhpKQSVyWo1KQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK1MXltVyhsLw%253D&amp;md5=c2f611fb5b466db693a8067db4e3d2aa</span></div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref18&#39;);return false;" class="refNumLink">18. </a></strong><div class="NLM_citation" id="cit18"><span class="hlFld-ContribAuthor ">Guzmán<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. R.</span>; <span class="hlFld-ContribAuthor ">Tawa<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Zhang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Z.</span>; <span class="hlFld-ContribAuthor ">Ratanabanangkoon<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Shaw<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Gardner<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. R.</span>; <span class="hlFld-ContribAuthor ">Chen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Moreau<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.-P.</span>; <span class="hlFld-ContribAuthor ">Almarsson<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O.</span>; <span class="hlFld-ContribAuthor ">Remenar<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. F.</span><span class="NLM_article-title">Combined Use of Crystalline Salt Forms and Precipitation Inhibitors to Improve Oral Absorption of Celecoxib from Solid Oral Formulations</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2007</span>,  <span class="NLM_volume">96</span>,  <span class="NLM_fpage">2686</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi">DOI: 10.1002/jps.20906</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.20906" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=17518357" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKrtLbJ" title="">CAS</a>]<div class="casRecord" id="cas_cit18R"><div class="casContent"><span class="casTitleNuber">18. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations</cas:atitle></div><div class="casAuthors">Guzman, Hector R.; Tawa, Mark; Zhang, Zhong; Ratanabanangkoon, Pasut; Shaw, Paul; Gardner, Colin R.; Chen, Hongming; Moreau, Jean-Pierre; Almarsson, Orn; Remenar, Julius F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">96</cas:volume>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2686-2702</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Biopharmaceutical evaluation of cryst. celecoxib salts in novel solid formulations, which were designed to simultaneously facilitate dissoln. and inhibit pptn. in vitro, showed fast and complete absorption in beagle dogs at doses up to 7.5 mg/kg orally.  In contrast, 5 mg/kg celecoxib in the form of Celebrex showed approx. 40% abs. bioavailability in a cross-over expt.  An in vitro-in vivo correlation was obsd. in dog, and a threshold level of in vitro dissoln. needed to maximize in vivo performance was highlighted.  Oral bioavailability was limited in the absence of excipient combinations that delayed pptn. of celecoxib free acid as the salt neutralized in the GI fluid.  Formulations of crystal forms having high energy (a 'spring'), thus transiently increasing soly. in aq. soln. relative to the free acid, combined with excipients functioning as pptn. inhibitors ('parachutes') were shown to provide both enhanced dissoln. and high oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0iz3ETGEcoLVg90H21EOLACvtfcHk0lhpKQSVyWo1KQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKrtLbJ&amp;md5=2ba39604f6120b2db586e567953e92d3</span></div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref19&#39;);return false;" class="refNumLink">19. </a></strong><div class="NLM_citation" id="cit19"><span class="hlFld-ContribAuthor ">Cheow<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>W. S.</span>; <span class="hlFld-ContribAuthor ">Hadinoto<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span><span class="NLM_article-title">Self-Assembled Amorphous Drug-Polyelectrolyte Nanoparticle Complex with Enhanced Dissolution Rate and Saturation Solubility</span> <span class="citation_source-journal">J. Colloid Interface Sci.</span>  <span class="NLM_year">2012</span>,  <span class="NLM_volume">367</span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">526</span>, <span class="refDoi">DOI: 10.1016/j.jcis.2011.10.011</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.jcis.2011.10.011" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=22051687" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsF2ltbrF" title="">CAS</a>]<div class="casRecord" id="cas_cit19R"><div class="casContent"><span class="casTitleNuber">19. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility</cas:atitle></div><div class="casAuthors">Cheow, Wean Sin; Hadinoto, Kunn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Colloid and Interface Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">367</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">518-526</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JCISA5</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0021-9797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dissoln. rate and soly. of poorly sol. drugs can be enhanced by formulating them into stable amorphous nanoparticle complex (nanoplex).  For this purpose, a highly sustainable self-assembly drug-polyelectrolyte complexation process is developed, with ciprofloxacin and dextran sulfate as the drug and polyelectrolyte models, resp.  The nanoplex are prepd. by mixing two aq. salt solns. - one contg. the drug and the other contg. the oppositely charged polyelectrolyte.  The nanoplex suspension is transformed into stable dry-powder form by freeze-drying.  The effects of drug concn., drug-to-polyelectrolyte charge ratio, and salt concn. on the complexation efficiency, yield, drug loading, and nanoplex morphol. are examd.  The dissoln. rates and soly. of the nanoplex are characterized and compared to raw drug crystals.  Nearly spherical amorphous nanoplex having fairly uniform sizes in the range of 200-400 nm and 80% drug loading are successfully produced at ≥80% complexation efficiency and yield.  The complexation efficiency is governed by the drug concn. and its ratio to the salt concn.  The nanoplex powders exhibit approx. twice higher dissoln. rate and soly. than raw drug crystals and remain stable after one-month storage.  Overall, amorphous nanoplex represent a promising bioavailability-enhanced formulation of poorly sol. drugs owed to their superior characteristics and ease of prepn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyCZXds6Ga2rVg90H21EOLACvtfcHk0lhpKQSVyWo1KQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXhsF2ltbrF&amp;md5=d3c2b3d7cdb060e02583fb471db49b59</span></div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref20&#39;);return false;" class="refNumLink">20. </a></strong><div class="NLM_citation" id="cit20"><span class="hlFld-ContribAuthor ">Osman<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Kan<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P. L.</span>; <span class="hlFld-ContribAuthor ">Awad<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Mortada<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N.</span>; <span class="hlFld-ContribAuthor ">El-Shamy<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.-E.</span>; <span class="hlFld-ContribAuthor ">Alpar<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O.</span><span class="NLM_article-title">Spray Dried Inhalable Ciprofloxacin Powder with Improved Aerosolisation and Antimicrobial Activity</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2013</span>,  <span class="NLM_volume">449</span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">58</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2013.04.009</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2013.04.009" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=23587967" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslahtr8%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit20R"><div class="casContent"><span class="casTitleNuber">20. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity</cas:atitle></div><div class="casAuthors">Osman, Rihab; Kan, Pei Lee; Awad, Gehanne; Mortada, Nahed; EL-Shamy, Abd-Elhameed; Alpar, Oya</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">449</cas:volume>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">44-58</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, the spray drying technique was used to prep. ciprofloxacin microparticles (CFX-MPs) for pulmonary administration.  By virtue of its amphoteric properties, CFX was dissolved in either a slightly alk. or acidic soln. depending on the used polymer.  Dextran and chitosan were used to prep. the MPs and modify the release characteristics of the drug.  Particle surface modification was done with either DPPC or PEG.  The effects of the manufg. and formulation parameters on the drug-polymer interactions were investigated by thermal anal. and IR spectroscopy.  CFX-MPs showed improved aerosolization properties and the encapsulated drug possessed high antimicrobial activity against two of the common and resistant respiratory pathogens: Pseudomonas aeruginosa and Staphylococus aureus.  MPs were safe on the lung epithelial cells.  Modulation of particle characteristics and drug release was possible by altering not only the polymer but also the type of the acid from which the powders were spray dried.  MPs prepd. with glutamic and aspartic acids showed better characteristics than those prepd. with acetic and hydrochloric acids.  Dextran modified particles showed improved aerosolization properties and safety on lung epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV8vIJnkc44LVg90H21EOLACvtfcHk0lhpKQSVyWo1KQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3sXmslahtr8%253D&amp;md5=6d6582b975285d11f61c721f39501afa</span></div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref21&#39;);return false;" class="refNumLink">21. </a></strong><div class="NLM_citation" id="cit21"><span class="hlFld-ContribAuthor ">Beig<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Miller<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. M.</span>; <span class="hlFld-ContribAuthor ">Lindley<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span>; <span class="hlFld-ContribAuthor ">Carr<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. A.</span>; <span class="hlFld-ContribAuthor ">Zocharski<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Agbaria<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Dahan<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span><span class="NLM_article-title">Head-to-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2015</span>,  <span class="NLM_volume">104</span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2947</span>, <span class="refDoi">DOI: 10.1002/jps.24496</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.24496" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=25989509" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKqtrk%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit21R"><div class="casContent"><span class="casTitleNuber">21. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay</cas:atitle></div><div class="casAuthors">Beig, Avital; Miller, Jonathan M.; Lindley, David; Carr, Robert A.; Zocharski, Philip; Agbaria, Riad; Dahan, Arik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">104</cas:volume>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2941-2947</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley &amp; Sons, Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to conduct a head-to-head comparison of different soly.-enabling formulations, and their consequent soly.-permeability interplay.  The low-soly. anticancer drug etoposide was formulated in several strengths of four soly.-enabling formulations: hydroxypropyl-β-cyclodextrin, the cosolvent polyethylene glycol 400 (PEG-400), the surfactant sodium lauryl sulfate, and an amorphous solid dispersion formulation.  The ability of these formulations to increase the soly. of etoposide was investigated, followed by permeability studies using the parallel artificial membrane permeability assay (PAMPA) and examn. of the consequent soly.-permeability interplay.  All formulations significantly increased etoposide's apparent soly.  The cyclodextrin-, surfactant-, and cosolvent-based formulations resulted in a concomitant decreased permeability that could be modeled directly from the proportional increase in the apparent soly.  On the contrary, etoposide permeability remained const. when using the ASD formulation, irresp. of the increased apparent soly. provided by the formulation.  In conclusion, supersatn. resulting from the amorphous form overcomes the soly.-permeability tradeoff assocd. with other formulation techniques.  Accounting for the soly.-permeability interplay may allow to develop better soly.-enabling formulations, thereby maximizing the overall absorption of lipophilic orally administered drugs. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZBmj2nb78DrVg90H21EOLACvtfcHk0lgny9qUclfEnA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2MXosVKqtrk%253D&amp;md5=e4d22ef92cd3cd03038186f7634a64c9</span></div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref22&#39;);return false;" class="refNumLink">22. </a></strong><div class="NLM_citation" id="cit22"><span class="hlFld-ContribAuthor ">Gordon<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Taylor<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. S.</span><span class="NLM_article-title">Ideal Copolymers and the Second-Order Transitions of Synthetic Rubbers. I. Non-Crystalline Copolymers</span> <span class="citation_source-journal">J. Appl. Chem.</span>  <span class="NLM_year">1952</span>,  <span class="NLM_volume">2</span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">500</span>, <span class="refDoi">DOI: 10.1002/jctb.5010020901</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjctb.5010020901" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaG3sXjvF2ntA%253D%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit22R"><div class="casContent"><span class="casTitleNuber">22. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Ideal copolymers and the second-order transitions of synthetic rubbers. I. Noncrystalline copolymers</cas:atitle></div><div class="casAuthors">Gordon, Manfred; Taylor, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Chemistry</span>
        (<span class="NLM_cas:date">1952</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2</cas:volume>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">493-500</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JACHAU</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0021-8871</span>.
    </div><div class="casAbstract">Theoretical and practical evidence is put forward to show that copolymers can be treated like solns. of small mols. in the interpretation of packing phenomena, and that ideal vol.-additivity of the repeating units in copolymers is frequently realized.  On this basis equations are derived for predicting θ, the 2nd-order transition temp., of binary copolymers from the two 2nd-order transition temps. of the pure polymers and their coeffs. of expansion in the glassy and rubbery states.  Previous mechanistic theories of the 2nd-order transition temp. of such copolymers are thus superseded by a general reduction of the problem to the mechanism of thermal expansion.  Practical applications to the choice of monomers in producing synthetic rubbers are outlined, and attention is drawn to the importance of 2nd-order transitions in kinetic measurements on the reactions of polymers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlIpYY5C5UlLVg90H21EOLACvtfcHk0lgny9qUclfEnA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaG3sXjvF2ntA%253D%253D&amp;md5=0ae600b10f43764185fa03086cdd2026</span></div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref23&#39;);return false;" class="refNumLink">23. </a></strong><div class="NLM_citation" id="cit23"><span class="hlFld-ContribAuthor ">Lu<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Q.</span>; <span class="hlFld-ContribAuthor ">Zografi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_article-title">Phase Behavior of Binary and Ternary Amorphous Mixtures Containing Indomethacin, Citric Acid, and PVP</span> <span class="citation_source-journal">Pharm. Res.</span>  <span class="NLM_year">1998</span>,  <span class="NLM_volume">15</span>,  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1206</span>, <span class="refDoi">DOI: 10.1023/A:1011983606606</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1023%2FA%3A1011983606606" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=9706050" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaK1cXltFynsbk%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit23R"><div class="casContent"><span class="casTitleNuber">23. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP</cas:atitle></div><div class="casAuthors">Lu, Qun; Zografi, George</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">15</cas:volume>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1202-1206</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PHREEB</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">To better understand the nature of drug-excipient interactions we studied the phase behavior of amorphous binary and ternary mixts. of citric acid, indomethacin and PVP, as model systems.  We prepd. amorphous mixts. by co-melting or copptn. from solvents, and measured glass transition temps. by DSC.  Citric acid and indomethacin in the amorphous state are miscible up to 0.25 wt. fraction of citric acid, equiv. to about 2 mol of citric acid and 3 mol of indomethacin.  Phase sepn., as reflected by 2 Tg values, occurs without crystn. leading to a satd. citric acid-indomethacin amorphous phase and 1 essentially contg. only citric acid.  PVP-citric acid and PVP-indomethacin form non-ideal miscible systems at all compns.  A ternary system contg. 0.3 wt. fraction of PVP produces a completely miscible system at all citric acid-indomethacin compns.  The use of 0.2 wt. fraction of PVP, however, only produces miscibility up to a wt. fraction of 0.4 citric acid relative to indomethacin.  The 2 phases above this point appear to contain citric acid in PVP and citric acid in indomethacin, resp.  Two components of an amorphous solid mixt. contg. citric acid and indomethacin with limited solid state miscibility can be solubilized as an amorphous solid phase by the addn. of moderate levels of PVP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCXdWGVbXEmrVg90H21EOLACvtfcHk0lgny9qUclfEnA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK1cXltFynsbk%253D&amp;md5=3bf46ebd90aafe60cc07897c35c46c09</span></div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref24&#39;);return false;" class="refNumLink">24. </a></strong><div class="NLM_citation" id="cit24">Evonik Industries. EUDRAGIT® L 100. <a href="http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/l-100/Pages/default.aspx" class="extLink">http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/l-100/Pages/default.aspx</a> (accessed Feb 18, 2015).<div class="citationLinks"><div class="casRecord empty" id="cas_cit24R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref25&#39;);return false;" class="refNumLink">25. </a></strong><div class="NLM_citation" id="cit25">Evonik Industries. EUDRAGIT® L 100-55. <a href="http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/l-100-55/pages/default.aspx" class="extLink">http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/l-100-55/pages/default.aspx</a>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit25R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref26&#39;);return false;" class="refNumLink">26. </a></strong><div class="NLM_citation" id="cit26">Ashland. AquaSolve hydroxypropylmethylcelluloseacetatesuccinate. <a href="http://www.ashland.com/Ashland/Static/Documents/ASI/PC_12624_AquaSolve_AS_Handbook.pdf" class="extLink">http://www.ashland.com/Ashland/Static/Documents/ASI/PC_12624_AquaSolve_AS_Handbook.pdf</a> (accessed Feb 11, 2015).<div class="citationLinks"><div class="casRecord empty" id="cas_cit26R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref27&#39;);return false;" class="refNumLink">27. </a></strong><div class="NLM_citation" id="cit27">Evonik Industries. EUDRAGIT® L 100 and EUDRAGIT®S 100. <a href="http://eudragit.evonik.com/sites/lists/HN/ProductSpecifications/TI-EUDRAGIT-L-100-S-100-EN.pdf" class="extLink">http://eudragit.evonik.com/sites/lists/HN/ProductSpecifications/TI-EUDRAGIT-L-100-S-100-EN.pdf</a> (accessed Jan 11, 2016).<div class="citationLinks"><div class="casRecord empty" id="cas_cit27R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref28&#39;);return false;" class="refNumLink">28. </a></strong><div class="NLM_citation" id="cit28">Evonik Industries. EUDRAGIT® L 100-55. <a href="http://eudragit.evonik.com/sites/lists/HN/ProductSpecifications/TI-EUDRAGIT-L-100-55-EN.pdf" class="extLink">http://eudragit.evonik.com/sites/lists/HN/ProductSpecifications/TI-EUDRAGIT-L-100-55-EN.pdf</a> (accessed Jan 11, 2016).<div class="citationLinks"><div class="casRecord empty" id="cas_cit28R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref29&#39;);return false;" class="refNumLink">29. </a></strong><div class="NLM_citation" id="cit29"><span class="hlFld-ContribAuthor ">Xiang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.-X.</span>; <span class="hlFld-ContribAuthor ">Anderson<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B. D.</span><span class="NLM_article-title">Molecular Dynamics Simulation of Amorphous Hydroxypropyl-Methylcellulose Acetate Succinate (HPMCAS): Polymer Model Development, Water Distribution, and Plasticization</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2014</span>,  <span class="NLM_volume">11</span>,  <span class="NLM_fpage">2400</span>– <span class="NLM_lpage">2411</span>, <span class="refDoi">DOI: 10.1021/mp500135f</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp500135f" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wqtr8%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit29R"><div class="casContent"><span class="casTitleNuber">29. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Molecular Dynamics Simulation of Amorphous Hydroxypropyl-Methylcellulose Acetate Succinate (HPMCAS): Polymer Model Development, Water Distribution, and Plasticization</cas:atitle></div><div class="casAuthors">Xiang, Tian-Xiang; Anderson, Bradley D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">11</cas:volume>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2400-2411</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. models for HPMCAS polymer have been developed for mol. dynamics (MD) simulation that attempt to mimic the complex substitution patterns in HPMCAS obsd. exptl.  These mol. models were utilized to create amorphous HPMCAS solids by cooling of the polymeric melts at different water contents to explore the influence of water on mol. mobility, which plays a crit. role in stability and drug release from HPMCAS-based solid matrixes.  The densities found for the simulated amorphous HPMCAS were 1.295, 1.287, and 1.276 g/cm3 at 0.7, 5.7, and 13.2% wt./wt. water, indicating swelling of the polymer with increasing water content.  These densities compare favorably with the exptl. d. of 1.285 g/cm3 for com. HPMCAS-(AQOAT AS-MF) supporting the present HPMCAS models as a realistic representation of amorphous HPMCAS solids.  Water mols. were obsd. to be mostly isolated from each other at a low water content (0.7% wt./wt.), while clusters or strands of water were pervasive and broadly distributed in size at 13.2% wt./wt. water.  The av. no. of first-shell water mols. (nw) increased from 0.17 to 3.5, though the latter is still far below that (8.9) expected for the onset of a sep. water phase.  Increasing water content from 0.7 to 13.2% wt./wt. was found to reduce the Tg by ∼81 K, similar to exptl. observations.  Plasticization with increasing water content resulted in increasing polymer mobility and water diffusivity.  From 0.7 to 13.2% wt./wt. water, the apparent water diffusivity increased from 1.1 × 10-9 to 7.0 × 10-8 cm2/s, though non-Einsteinian behavior persisted at all water contents explored.  This and the water trajectories in the polymers suggest that water diffusion at 0.7% wt./wt. water follows a "hopping" mechanism.  At a higher water content (13.2% wt./wt.) water diffusion follows dual diffusive processes: (1) fast water motions within water clusters; and (2) slower diffusion through the more rigid polymer matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe2WDpFQ_BerVg90H21EOLACvtfcHk0lgny9qUclfEnA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wqtr8%253D&amp;md5=4be390d6e59ccccab0b54dd8ca6f714e</span></div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref30&#39;);return false;" class="refNumLink">30. </a></strong><div class="NLM_citation" id="cit30">Merck Millipore. Lipid-PAMPA with the MultiScreen® Filter Plates; Billerica, MA,  <span class="NLM_year">2004</span>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit30R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref31&#39;);return false;" class="refNumLink">31. </a></strong><div class="NLM_citation" id="cit31"><span class="hlFld-ContribAuthor ">Wohnsland<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>F.</span>; <span class="hlFld-ContribAuthor ">Faller<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B.</span><span class="NLM_article-title">High-Throughput Permeability pH Profile and High-Throughput Alkane/water Log P with Artificial Membranes</span> <span class="citation_source-journal">J. Med. Chem.</span>  <span class="NLM_year">2001</span>,  <span class="NLM_volume">44</span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">930</span>, <span class="refDoi">DOI: 10.1021/jm001020e</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/jm001020e" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit31R"><div class="casContent"><span class="casTitleNuber">31. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">High-Throughput Permeability pH Profile and High-Throughput Alkane/Water log P with Artificial Membranes</cas:atitle></div><div class="casAuthors">Wohnsland, Frank; Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">44</cas:volume>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-930</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JMCMAR</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study reports on a novel, high-throughput assay, designed to predict passive, transcellular permeability in early drug discovery.  The assay is carried out in 96-well microtiterplates and measures the ability of compds. to diffuse from a donor to an acceptor compartment which are sepd. by a 9-10 μm hexadecane liq. layer.  A set of 32 well-characterized, chem. diverse drugs was used to validate the method.  The permeability values derived from the flux factors between donor and acceptor compartments show a good correlation with gastrointestinal absorption in humans.  For comparison, correlations based on exptl. or calcd. octanol/water distribution coeffs. (log Do/w,6.8) were significantly lower.  In addn., this simple and robust assay allows detn. of pH permeability profiles, crit. information to predict gastrointestinal absorption of ionizable drugs and difficult to obtain from cell culture expts.  Correction for the unstirred water layer effect allows to differentiate between effective and intrinsic membrane permeability and opens up the dynamic range of the method.  In addn., alkane/water partition coeffs. can be derived from intrinsic membrane permeabilities, making this assay the first high-throughput method able to measure alkane/water log P in the microtiterplate format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoYADWFOUn7Vg90H21EOLACvtfcHk0ljiPIysTGK9pw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D&amp;md5=de19e881e03d62d48a8acfea729790b4</span></div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref32&#39;);return false;" class="refNumLink">32. </a></strong><div class="NLM_citation" id="cit32"><span class="hlFld-ContribAuthor ">Schmidt<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span><span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">; </x></span><span class="hlFld-ContribAuthor ">Lynch<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span> MultiScreen Filter Plates for PAMPA - Evaluation of the Reproducibility of Parallel Artificial Membrane Permeation Assays (PAMPA); Massachusetts,  <span class="NLM_year">2003</span>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit32R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref33&#39;);return false;" class="refNumLink">33. </a></strong><div class="NLM_citation" id="cit33"><span class="hlFld-ContribAuthor ">Umerska<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Cassisa<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>V.</span>; <span class="hlFld-ContribAuthor ">Matougui<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N.</span>; <span class="hlFld-ContribAuthor ">Joly-Guillou<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.-L.</span>; <span class="hlFld-ContribAuthor ">Eveillard<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Saulnier<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span><span class="NLM_article-title">Antibacterial Action of Lipid Nanocapsules Containing Fatty Acids or Monoglycerides as Co-Surfactants</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span>  <span class="NLM_year">2016</span>,  <span class="NLM_volume">108</span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi">DOI: 10.1016/j.ejpb.2016.09.001</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ejpb.2016.09.001" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=27597268" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2jur%252FF" title="">CAS</a>]<div class="casRecord" id="cas_cit33R"><div class="casContent"><span class="casTitleNuber">33. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants</cas:atitle></div><div class="casAuthors">Umerska, Anita; Cassisa, Viviane; Matougui, Nada; Joly-Guillou, Marie-Laure; Eveillard, Matthieu; Saulnier, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">108</cas:volume>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-110</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EJPBEL</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lipid nanocapsules (LNCs) are a new generation of biomimetic nanocarriers obtained via a phase inversion temp. method and have an oily core of medium-chain triglycerides that is surrounded by a shelf contg. a lipophilic surfactant (lecithin) and a hydrophilic surfactant macrogol 15-hydroxystearate.  The aim of the present study was to produce LNCs with antibacterial activity by replacing lecithin with other lipophilic surface active compds., namely medium-chain fatty acids and their 1-monoglycerides, which are known to have antimicrobial properties.  Fatty acids and monoglycerides were found to affect the properties of LNCs, such as particle size and zeta potential.  Incorporation of a co-surfactant decreased significantly particle size (p ≤ 0.0039).  Furthermore, incorporation of either lecithin or fatty acids with at least 10 carbon atoms yielded LNCs with the zeta potential significantly more neg. than that of LNCs composed solely of triglycerides and macrogol 15 hydroxystearate (p ≤ 0.0310).  Moreover, they were capable of decreasing the phase inversion temp.  The activity of the LCNs against Gram-pos. S. aureus, including a methicillin-resistant strain, increased with increases in the length of the hydrocarbon tail.  Monoglyceride-LNCs were found to be more active than the corresponding fatty acids.  The opposite behavior was obsd. for Gram-neg. bacteria, whereby only caproic acid- and caprylic acid-LNCs were found to be active against these organisms.  The monoglyceride-LNCs were bactericidal, and they killed in a time-dependent manner.  Fatty acid-LNCs killed in a concn.-dependent manner.  A haemolysis assay was performed to obtain preliminary information on the safety of the tested LNCs.  In the case of fatty acid-LNCs, the concns. at which bacterial growth was inhibited were similar to the haemolytic concns.  However, monoglyceride-LNCs showed antibacterial action at concns. much lower than those at which haemolysis was obsd.  In conclusion, monoglyceride-LNCs are promising candidates as carriers for the encapsulation of antibacterial agents, particularly against S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpZCWdoFa9_rVg90H21EOLACvtfcHk0ljiPIysTGK9pw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28XhsV2jur%252FF&amp;md5=698ffecb29df39c1840d076049e0ff21</span></div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref34&#39;);return false;" class="refNumLink">34. </a></strong><div class="NLM_citation" id="cit34"><span class="hlFld-ContribAuthor ">Descamps<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Willart<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. F.</span>; <span class="hlFld-ContribAuthor ">Dudognon<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>E.</span>; <span class="hlFld-ContribAuthor ">Caron<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>V.</span><span class="NLM_article-title">Transformation of Pharmaceutical Compounds upon Milling and Comilling: The Role of T(g)</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2007</span>,  <span class="NLM_volume">96</span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi">DOI: 10.1002/jps.20939</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.20939" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=17455353" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVGqtLg%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit34R"><div class="casContent"><span class="casTitleNuber">34. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Transformation of pharmaceutical compounds upon milling and comilling: the role of Tg</cas:atitle></div><div class="casAuthors">Descamps, M.; Willart, J. F.; Dudognon, E.; Caron, V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">96</cas:volume>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1398-1407</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Milling is a usual process used in the course of drug formulation, which however may change the phys. nature of the end product.  The diversity of the transformations of org. compds. upon milling has been widely demonstrated in the pharmaceutical literature.  However, no effort has still been devoted to study the correlation between the nature of the transformation and the milling conditions.  Results clarifying such transformations are shortly reviewed with special attention paid to the temp. of milling.  The importance of the position of the glass transition temp. compared with that of milling is demonstrated.  Decreasing the milling temp. leads to an increase of the amorphization tendency whereas milling above Tg can produce a crystal-to-crystal transformation between polymorphic varieties.  These observations contradict the usual suggestion that milling transforms the phys. state only by a heating effect which induces a local melting.  Equil. thermodn. does not seem appropriate for describing the process.  The driven alloys concept offers a more rational framework to interpret the effect of the milling temp.  Other results are also presented, which demonstrate the possibility for milling to form low temp. solid-state alloys that offer new promising ways to stabilize amorphous mol. solids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3FF8HFsI5_rVg90H21EOLACvtfcHk0ljiPIysTGK9pw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2sXltVGqtLg%253D&amp;md5=4400b04a54ae3fc25ad624410fea5f80</span></div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref35&#39;);return false;" class="refNumLink">35. </a></strong><div class="NLM_citation" id="cit35"><span class="hlFld-ContribAuthor ">Yang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Z.</span>; <span class="hlFld-ContribAuthor ">Nollenberger<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span>; <span class="hlFld-ContribAuthor ">Albers<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Qi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S.</span><span class="NLM_article-title">Molecular Implications of Drug-Polymer Solubility in Understanding the Destabilization of Solid Dispersions by Milling</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2014</span>,  <span class="NLM_volume">11</span>,  <span class="NLM_fpage">2453</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi">DOI: 10.1021/mp500205c</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp500205c" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1SrtL8%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit35R"><div class="casContent"><span class="casTitleNuber">35. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Molecular Implications of Drug-Polymer Solubility in Understanding the Destabilization of Solid Dispersions by Milling</cas:atitle></div><div class="casAuthors">Yang, Ziyi; Nollenberger, Kathrin; Albers, Jessica; Qi, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">11</cas:volume>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2453-2465</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The soly. of drugs in polymer matrixes has been recognized as one of the key factors governing the phys. stability of solid dispersions.  This study has explored the implications of drug soly. on the destabilization that occurs on milling, which is often used as an addnl. process for hot melt extruded (HME) solid dispersions.  The theor. drug soly. in the polymer was first predicted using various theor. and exptl. approaches.  The destabilization effects of high-energy mech. milling on the solid dispersions with drug loadings below and above the predicted soly. were then investigated using a range of thermal, microscopic, and spectroscopic techniques.  Four model drug-polymer combinations were studied.  The HME formulations with drug loading below the predicted solid soly. (undersatd. and true mol. dispersion) showed good stability against milling.  In contrast, milling destabilized supersatd. HME dispersions via increasing mol. mobility and creating phase-sepd., amorphous, drug-rich domains.  However, these addnl. amorphous drug-rich domains created by milling show good stability under ambient conditions, though crystn. can be accelerated by addnl. heating.  These results highlighted that the processing method used to prep. the solid dispersions may play a role in facilitating the stabilization of amorphous drug in supersatd. solid dispersions.  The degree of supersatn. of the drug in the polymer showed significant impact on the destabilization behavior of milling on solid dispersions.  An improved understanding of the destabilization behavior of solid dispersions upon milling can provide new insights into the processing related apparent soly. of drugs in polymers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjK-uVZpuMLVg90H21EOLACvtfcHk0lhAuL8LoFwZQA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2cXpt1SrtL8%253D&amp;md5=313433a387684852d821e9aab3c84eee</span></div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref36&#39;);return false;" class="refNumLink">36. </a></strong><div class="NLM_citation" id="cit36"><span class="hlFld-ContribAuthor ">Yang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Grey<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span>; <span class="hlFld-ContribAuthor ">Doney<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span><span class="NLM_article-title">An Improved Kinetics Approach to Describe the Physical Stability of Amorphous Solid Dispersions</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2010</span>,  <span class="NLM_volume">384</span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">31</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2009.09.035</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2009.09.035" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=19786081" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVyju7zN" title="">CAS</a>]<div class="casRecord" id="cas_cit36R"><div class="casContent"><span class="casTitleNuber">36. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">An improved kinetics approach to describe the physical stability of amorphous solid dispersions</cas:atitle></div><div class="casAuthors">Yang, Jiao; Grey, Kristin; Doney, John</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">384</cas:volume>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">24-31</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The recrystn. of amorphous solid dispersions may lead to a loss in the dissoln. rate, and consequently reduce bioavailability.  The purpose of this work is to understand factors governing the recrystn. of amorphous drug-polymer solid dispersions, and develop a kinetics model capable of accurately predicting their phys. stability.  Recrystn. kinetics was measured using differential scanning calorimetry for initially amorphous efavirenz-polyvinylpyrrolidone solid dispersions stored at controlled temp. and relative humidity.  The exptl. measurements were fitted by a new kinetic model to est. the recrystn. rate const. and microscopic geometry of crystal growth.  The new kinetics model was used to illustrate the governing factors of amorphous solid dispersions stability.  Temp. was found to affect efavirenz recrystn. in an Arrhenius manner, while recrystn. rate const. was shown to increase linearly with relative humidity.  Polymer content tremendously inhibited the recrystn. process by increasing the crystn. activation energy and decreasing the equil. crystallinity.  The new kinetic model was validated by the good agreement between model fits and expt. measurements.  A small increase in polyvinylpyrrolidone resulted in substantial stability enhancements of efavirenz amorphous solid dispersion.  The new established kinetics model provided more accurate predictions than the Avrami equation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5Z64tgwdE7Vg90H21EOLACvtfcHk0lhAuL8LoFwZQA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1MXhsVyju7zN&amp;md5=91e182f7eaa4a6854f08ea5a07777ec1</span></div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref37&#39;);return false;" class="refNumLink">37. </a></strong><div class="NLM_citation" id="cit37"><span class="hlFld-ContribAuthor ">Dorofeev<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>V. L.</span><span class="NLM_article-title">The Betainelike Structure and Infrared Spectra of Drugs of the Fluoroquinolone Group</span> <span class="citation_source-journal">Pharm. Chem. J.</span>  <span class="NLM_year">2004</span>,  <span class="NLM_volume">38</span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">702</span>, <span class="refDoi">DOI: 10.1007/s11094-005-0064-5</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1007%2Fs11094-005-0064-5" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvF2ls7Y%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit37R"><div class="casContent"><span class="casTitleNuber">37. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">The betainelike structure and infrared spectra of drugs of the fluoroquinolone group</cas:atitle></div><div class="casAuthors">Dorofeev, V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Chemistry Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">38</cas:volume>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">698-702</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PCJOAU</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0091-150X</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4KyFY-0-XA7Vg90H21EOLACvtfcHk0lhAuL8LoFwZQA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2MXjvF2ls7Y%253D&amp;md5=fd2185e4c2c520c251062d4b52c2486d</span></div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref38&#39;);return false;" class="refNumLink">38. </a></strong><div class="NLM_citation" id="cit38"><span class="hlFld-ContribAuthor ">Bermejo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Avdeef<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Ruiz<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Nalda<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Ruell<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. A.</span>; <span class="hlFld-ContribAuthor ">Tsinman<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O.</span>; <span class="hlFld-ContribAuthor ">González<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I.</span>; <span class="hlFld-ContribAuthor ">Fernández<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C.</span>; <span class="hlFld-ContribAuthor ">Sánchez<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Garrigues<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T. M.</span><span class="NLM_etal"></span><span class="NLM_article-title">PAMPA--a Drug Absorption in Vitro Model 7. Comparing Rat in Situ, Caco-2, and PAMPA Permeability of Fluoroquinolones</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span>  <span class="NLM_year">2004</span>,  <span class="NLM_volume">21</span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">441</span>, <span class="refDoi">DOI: 10.1016/j.ejps.2003.10.009</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ejps.2003.10.009" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=14998573" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslWntb8%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit38R"><div class="casContent"><span class="casTitleNuber">38. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAMPA-a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones</cas:atitle></div><div class="casAuthors">Bermejo, Marival; Avdeef, Alex; Ruiz, Ana; Nalda, Ricardo; Ruell, Jeffrey A.; Tsinman, Oksana; Gonzalez, Isabel; Fernandez, Carlos; Sanchez, Gloria; Garrigues, Teresa M.; Merino, Virginia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">21</cas:volume>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPSCED</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parallel artificial membrane permeability assay (PAMPA) was used to measure the effective permeability, Pe, as a function of pH from 4 to 10, of 17 fluoroquinolones, including three congeneric series with systematically varied alkyl chain length at the 4'N-position of the piperazine residue.  The permeability values spanned over three orders of magnitude.  The intrinsic permeability, Po, and the membrane permeability, Pm, were detd. from the pH dependence of the effective permeability.  The pKa values were detd. potentiometrically.  The PAMPA method employed stirring, adjusted such that the unstirred water layer (UWL) thickness matched the 30-100 μm range estd. to be in the human small intestine.  The intrinsic permeability coeffs. (10-6 cm/s), representing the permeability of the uncharged form of the drug, are for 4'N-R-norfloxacin: 0.7 (R=H), 49 (Me), 132 (n-Pr), 365 (n-Bu); 4'N-R-ciprofloxacin: 2.7 (H), 37 (Me), 137 (n-Pr), 302 (n-Bu); 4'N-R-3'-methylciprofloxacin: 3.8 (H), 20 (Me), 51 (Et), 160 (n-Pr), 418 (n-Bu).  Increasing the alkyl chain length in the congeneric series resulted in increased permeability, averaging about 0.34 log units per methylene group, except that of the first (H-to-Me), which was about 1.2 log units.  These results were compared to Caco-2 and rat in situ permeability measurements.  The in situ closed loop technique used for obtaining permeability values in rat showed a water layer thickness effect quite consistent with in vivo expectations.  The rat-PAMPA correlation (r2=0.87) was better than that of rat-Caco-2 (r2=0.63).  Caco-2-PAMPA correlation indicated r2=0.66.  The latter correlation improved significantly (r2=0.82) when the Caco-2 data were cor. for the UWL effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FSWu8uWj6bVg90H21EOLACvtfcHk0lhAuL8LoFwZQA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2cXhslWntb8%253D&amp;md5=ec6df386f69a99de284e53dfdccbd352</span></div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref39&#39;);return false;" class="refNumLink">39. </a></strong><div class="NLM_citation" id="cit39">Lubrizol. Pharmaceutical Bulletin 23: Bioadhesion; Wickliffe, Ohio,  <span class="NLM_year">2011</span>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit39R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref40&#39;);return false;" class="refNumLink">40. </a></strong><div class="NLM_citation" id="cit40"><span class="hlFld-ContribAuthor ">Huang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.-S.</span>; <span class="hlFld-ContribAuthor ">Britton<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span>; <span class="hlFld-ContribAuthor ">Margaret<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span>; <span class="hlFld-ContribAuthor ">Etter<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. C.</span>; <span class="hlFld-ContribAuthor ">Byrn<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. R.</span><span class="NLM_article-title">A Novel Class of Phenol–pyridine Co-Crystals for Second Harmonic Generation</span> <span class="citation_source-journal">J. Mater. Chem.</span>  <span class="NLM_year">1997</span>,  <span class="NLM_volume">7</span>,  <span class="NLM_fpage">713</span>– <span class="NLM_lpage">720</span>, <span class="refDoi">DOI: 10.1039/a604311j</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1039%2Fa604311j" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlKgu7g%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit40R"><div class="casContent"><span class="casTitleNuber">40. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">A novel class of phenol-pyridine co-crystals for second harmonic generation</cas:atitle></div><div class="casAuthors">Huang, Kin-Shan; Britton, Doyle; Etter, Margaret C.; Byrn, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">7</cas:volume>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">713-720</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JMACEP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0959-9428</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">To test the approach of combining both ionic and hydrogen-bonding interactions for the design of non-linear optical (NLO) materials, a no. of phenol-pyridine co-crystals have been synthesized and their NLO properties investigated.  The co-crystals are characterized by second harmonic generation measurements as well as the more conventional methods of m.p. measurements, IR and NMR spectroscopy.  To investigate whether the phenol co-crystals are org. salts, the 2-methoxy-4-nitrophenol - 4-(dimethylamino)pyridine (2:1) co-crystal 6 and the 2-methoxy-4-nitrophenol - 4-pyrrolidinylpyridine - water (1:1:1) co-crystal 8 are further characterized by X-ray single-crystal diffraction.  Crystal structure analyses reveal that both 6 and 8 are ionic co-crystals (or org. salts) composed of a phenoxide anion, a pyridinium cation and a neutral mol.  In the two co-crystals, the phenoxide, pyridinium and neutral mols. are held together by ionic attractions as well as hydrogen-bonding interactions.  Both 6 and 8 crystallize in non-centrosym. structures [Pna21 (orthorhombic), a=6.880(4), b=38.40(1), c=8.454(3) Å, Z=4, Dc=1.369 g cm-3 and R=0.051 for 6 and Cc (monoclinic), a=7.302(3), b=23.518(2), c=9.940(1) Å, β = 107.12(2)°, Z=4, Dc=1.365 g cm-3 and R=0.036 for 8].  In addn. to X-ray structure detn., it is possible to predict whether phenol-pyridine co-crystals are org. salts based on the ΔpKa [pKa(pyridine)-pKa(phenol)] and stoichiometric ratio of the co-crystals.  Preliminary results suggest that this type of co-crystal, particularly for the ionic co-crystals, may have a higher chance of forming non-centrosym. structures than the normal achiral org. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYaq4y7VPeg7Vg90H21EOLACvtfcHk0lhEheJwNEwZEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK2sXjtlKgu7g%253D&amp;md5=e2c548f626acfc289e1a8cd56fd0e267</span></div></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref41&#39;);return false;" class="refNumLink">41. </a></strong><div class="NLM_citation" id="cit41"><span class="hlFld-ContribAuthor ">Weuts<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I.</span>; <span class="hlFld-ContribAuthor ">Kempen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span>; <span class="hlFld-ContribAuthor ">Verreck<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Peeters<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Brewster<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Blaton<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N.</span>; <span class="hlFld-ContribAuthor ">Van den Mooter<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_article-title">Salt Formation in Solid Dispersions Consisting of Polyacrylic Acid as a Carrier and Three Basic Model Compounds Resulting in Very High Glass Transition Temperatures and Constant Dissolution Properties upon Storage</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span>  <span class="NLM_year">2005</span>,  <span class="NLM_volume">25</span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">393</span>, <span class="refDoi">DOI: 10.1016/j.ejps.2005.04.011</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ejps.2005.04.011" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=15894472" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCltb4%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit41R"><div class="casContent"><span class="casTitleNuber">41. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage</cas:atitle></div><div class="casAuthors">Weuts, Ilse; Kempen, Dieter; Verreck, Geert; Peeters, Jef; Brewster, Marcus; Blaton, Norbert; Van den Mooter, Guy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">25</cas:volume>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">387-393</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPSCED</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of the study was to investigate the suitability of polyacrylic acid (PAA) as a carrier in solid dispersions, with the aim to delay crystn. of basic drugs and improve their dissoln. behavior.  The physicochem. properties were investigated to link the phys. state of some model compds. to their dissoln. properties.  Loperamide and 2 structurally related substances were selected as model compds.  Solid dispersions were prepd. by spray drying.  The amt. of residual solvents and water was detd. with gas chromatog. (GCS: S: solvent) and thermogravimetric anal. (TGA).  The drug loading of the dispersions was detd. using high performance liq. chromatog. (HPLC).  ADSC (alternating or temp. modulated DSC), XRD and FT-IR-spectroscopy were used to evaluate the phys. state and in vitro dissoln. tests were performed to measure the dissoln. properties.  IR-measurements demonstrated the formation of a salt between the COOH-groups of the polymer and the amino-groups of the compds.  This phenomenon results in high Tg-values of the dispersions, suppression of crystn. of the fragment mols. during prepn. and an increase of the dissoln. rate.  Furthermore, the stability study conducted on the dispersions with loperamide showed that both, the amorphous state of the drug and the dissoln. behavior are stable under the applied storage conditions.  Hence, from the exptl. results it could be concluded that PAA is a suitable carrier in the formulation of stable solid dispersions for the basic compds. that were investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWSWJpEm3KMrVg90H21EOLACvtfcHk0lhEheJwNEwZEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCltb4%253D&amp;md5=741c0553f96502a0db6d56ab7ea0e7ca</span></div></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref42&#39;);return false;" class="refNumLink">42. </a></strong><div class="NLM_citation" id="cit42"><span class="hlFld-ContribAuthor ">Song<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span>; <span class="hlFld-ContribAuthor ">Yang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>X.</span>; <span class="hlFld-ContribAuthor ">Chen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>X.</span>; <span class="hlFld-ContribAuthor ">Nie<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Byrn<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S.</span>; <span class="hlFld-ContribAuthor ">Lubach<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. W.</span><span class="NLM_article-title">Investigation of Drug–Excipient Interactions in Lapatinib Amorphous Solid Dispersions Using Solid-State NMR Spectroscopy</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2015</span>,  <span class="NLM_volume">12</span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">866</span>, <span class="refDoi">DOI: 10.1021/mp500692a</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp500692a" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFCquw%253D%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit42R"><div class="casContent"><span class="casTitleNuber">42. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Investigation of Drug-Excipient Interactions in Lapatinib Amorphous Solid Dispersions Using Solid-State NMR Spectroscopy</cas:atitle></div><div class="casAuthors">Song, Yang; Yang, Xinghao; Chen, Xin; Nie, Haichen; Byrn, Stephen; Lubach, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">12</cas:volume>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">857-866</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study investigated the presence of specific drug-excipient interactions in amorphous solid dispersions of lapatinib (LB) and four commonly used pharmaceutical polymers, including Soluplus, polyvinylpyrrolidone vinyl acetate (PVPVA), hydroxypropylmethylcellulose acetate succinate (HPMCAS), and hydroxypropylmethylcellulose phthalate (HPMCP).  Based on predicted pKa differences, LB was hypothesized to exhibit a specific ionic interaction with HPMCP, and possibly with HPMCAS, while Soluplus and PVPVA were studied as controls without ionizable functionality.  Thermal studies showed a single glass transition (Tg) for each dispersion, in close agreement with predicted values for Soluplus, PVPVA, and HPMCAS systems.  However, the Tg values of LB-HPMCP solid dispersions were markedly higher than predicted values, indicating a strong intermol. interaction between LB and HPMCP.  15N solid-state NMR provided direct spectroscopic evidence for protonation of LB (i.e., salt formation) within the HPMCP solid dispersions. 1H T1 and 1H T1ρ relaxation studies of the dispersions supported the ionic interaction hypothesis, and indicated multiple phases in the cases of excess drug or polymer.  In addn., the dissoln. and stability behavior of each system was examd.  Both acidic polymers, HPMCAS and HPMCP, effectively inhibited the crystn. of LB on accelerated stability, likely owing to beneficial strong intermol. hydrogen and/or specific ionic bonds with the acidic polymers.  Soluplus and PVPVA showed poor phys. properties on stability and subsequently poor crystn. inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR3B0pEPL9_7Vg90H21EOLACvtfcHk0lhEheJwNEwZEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2MXnvFCquw%253D%253D&amp;md5=95b9f77649920f4cc2294883a5ed926b</span></div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref43&#39;);return false;" class="refNumLink">43. </a></strong><div class="NLM_citation" id="cit43"><span class="hlFld-ContribAuthor ">Maniruzzaman<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Morgan<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D. J.</span>; <span class="hlFld-ContribAuthor ">Mendham<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. P.</span>; <span class="hlFld-ContribAuthor ">Pang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Snowden<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. J.</span>; <span class="hlFld-ContribAuthor ">Douroumis<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span><span class="NLM_article-title">Drug-Polymer Intermolecular Interactions in Hot-Melt Extruded Solid Dispersions</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2013</span>,  <span class="NLM_volume">443</span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2012.11.048</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2012.11.048" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=23262428" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFagsLs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit43R"><div class="casContent"><span class="casTitleNuber">43. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions</cas:atitle></div><div class="casAuthors">Maniruzzaman, Mohammed; Morgan, David J.; Mendham, Andrew P.; Pang, Jiayun; Snowden, Martin J.; Douroumis, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">443</cas:volume>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">199-208</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of the study was to investigate and identify the interactions within solid dispersions of cationic drugs and anionic polymers processed by hot-melt extrusion (HME) technique.  Propranolol HCl (PRP) and diphenhydramine HCl (DPD) were used as model cationic active substances while pH sensitive anionic methacrylic acid based Me methacrylate copolymers Eudragit L100 (L100) and Et acrylate copolymer Eudragit L100-55 (Acryl EZE) (L100-55) were used as polymeric carriers.  The extrudates were further characterised using various physicochem. characterization techniques to det. the morphol., the drug state within the polymer matrixes and the type of drug-polymer interactions.  Mol. modeling predicted the existence of two possible H-bonding types while the X-ray photon spectroscopy (XPS) advanced surface anal. of the extrudates revealed intermol. ionic interactions between the API amino functional groups and the polymer carboxylic groups through the formation of hydrogen bonding.  The magnitude of the intermol. interactions varied according to the drug-polymer miscibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMFWT8x7E7i7Vg90H21EOLACvtfcHk0lhEheJwNEwZEA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3sXhtFagsLs%253D&amp;md5=9eed673b1d9dffa6c08916b798bc6170</span></div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref44&#39;);return false;" class="refNumLink">44. </a></strong><div class="NLM_citation" id="cit44"><span class="hlFld-ContribAuthor ">Borbas<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>E.</span>; <span class="hlFld-ContribAuthor ">Sinko<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B.</span>; <span class="hlFld-ContribAuthor ">Tsinman<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O.</span>; <span class="hlFld-ContribAuthor ">Tsinman<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span>; <span class="hlFld-ContribAuthor ">Kiserdei<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>E.</span>; <span class="hlFld-ContribAuthor ">Demuth<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B.</span>; <span class="hlFld-ContribAuthor ">Balogh<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Bodak<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B.</span>; <span class="hlFld-ContribAuthor ">Domokos<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Dargo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_etal"></span><span class="NLM_article-title">Investigation and Mathematical Description of the Real Driving Force of Passive Transport of Drug Molecules from Supersaturated Solutions</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2016</span>,  <span class="NLM_volume">13</span>,  <span class="NLM_fpage">3816</span>– <span class="NLM_lpage">26</span>, <span class="refDoi">DOI: 10.1021/acs.molpharmaceut.6b00613</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/acs.molpharmaceut.6b00613" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVynu7fJ" title="">CAS</a>]<div class="casRecord" id="cas_cit44R"><div class="casContent"><span class="casTitleNuber">44. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Investigation and Mathematical Description of the Real Driving Force of Passive Transport of Drug Molecules from Supersaturated Solutions</cas:atitle></div><div class="casAuthors">Borbas, Eniko; Sinko, Balint; Tsinman, Oksana; Tsinman, Konstantin; Kiserdei, Eva; Demuth, Balazs; Balogh, Attila; Bodak, Brigitta; Domokos, Andras; Dargo, Gergo; Balogh, Gyorgy T.; Nagy, Zsombor K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">13</cas:volume>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3816-3826</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the impact of formulation excipients and solubilizing additives on dissoln., supersatn., and membrane transport of an active pharmaceutical ingredient (API).  When a poorly water-sol. API is formulated to enhance its dissoln., additives, such as surfactants, polymers, and cyclodextrins, have an effect not only on dissoln. profile but also on the measured physicochem. properties (soly., pKa, permeability) of the drug while the excipient is present, therefore also affecting the driving force of membrane transport.  Meloxicam, a nonsteroidal anti-inflammatory drug, was chosen as a poorly water-sol. model drug and formulated in order to enhance its dissoln. using solvent-based electrospinning.  Three polyvinylpyrrolidone (PVP) derivs. (K30, K90, and VA 64), Soluplus, and (2-hydroxypropyl)-β-cyclodextrin were used to create five different amorphous solid dispersions of meloxicam.  Through exptl. design, the various formulation additives that could influence the characteristics of dissoln. and permeation through artificial membrane were obsd. by carrying out a simultaneous dissoln.-permeation study with a side-by-side diffusion cell, μFLUX.  Although the dissoln. profiles of the formulations were found to be very similar, in the case of Soluplus contg. formulation the flux was superior, showing that the driving force of membrane transport cannot be simplified to the concn. gradient.  Supersatn. gradient, the difference in degree of supersatn. (defined as the ratio of dissolved amt. of the drug to its thermodn. soly.) between the donor and acceptor side, was found to be the driving force of membrane transport.  It was math. derived from Fick's first law, and exptl. proved to be universal on several meloxicam contg. ASDs and DMSO stock soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN6ybeVh72bVg90H21EOLACvtfcHk0liu68XIVb8u3Q"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28XhsVynu7fJ&amp;md5=a3946e566df62cf1c2364c5ac91f7647</span></div></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref45&#39;);return false;" class="refNumLink">45. </a></strong><div class="NLM_citation" id="cit45"><span class="hlFld-ContribAuthor ">Brostow<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>W.</span>; <span class="hlFld-ContribAuthor ">Chiu<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Kalogeras<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I. M.</span>; <span class="hlFld-ContribAuthor ">Vassilikou-Dova<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span><span class="NLM_article-title">Prediction of Glass Transition Temperatures: Binary Blends and Copolymers</span> <span class="citation_source-journal">Mater. Lett.</span>  <span class="NLM_year">2008</span>,  <span class="NLM_volume">62</span>,  <span class="NLM_fpage">3152</span>– <span class="NLM_lpage">3155</span>, <span class="refDoi">DOI: 10.1016/j.matlet.2008.02.008</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.matlet.2008.02.008" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFagtrY%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit45R"><div class="casContent"><span class="casTitleNuber">45. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Prediction of glass transition temperatures: Binary blends and copolymers</cas:atitle></div><div class="casAuthors">Brostow, Witold; Chiu, Rachel; Kalogeras, Ioannis M.; Vassilikou-Dova, Aglaia</div><div class="citationInfo"><span class="NLM_cas:title">Materials Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">62</cas:volume>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">3152-3155</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MLETDJ</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0167-577X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glass transition temp. T g values characterize pure polymers, polymer blends, copolymers, as well as matrixes in polymer-based composites.  T gs as function of compn. reflect miscibility (or lack of it) and det. all properties.  We present a new equation for the dependence of T g on compn. in blends as well as in copolymers.  We compare results obtained from earlier equations (Fox, Gordon-Taylor, Kwei) and those from the new equation with exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwAMFwJlDNCbVg90H21EOLACvtfcHk0liu68XIVb8u3Q"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1cXlvFagtrY%253D&amp;md5=41b279c1f322983d86b52d978fbb973d</span></div></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref46&#39;);return false;" class="refNumLink">46. </a></strong><div class="NLM_citation" id="cit46"><span class="hlFld-ContribAuthor ">Jensen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. T.</span>; <span class="hlFld-ContribAuthor ">Löbmann<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span>; <span class="hlFld-ContribAuthor ">Rades<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.</span>; <span class="hlFld-ContribAuthor ">Grohganz<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span><span class="NLM_article-title">Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline</span> <span class="citation_source-journal">Pharmaceutics</span>  <span class="NLM_year">2014</span>,  <span class="NLM_volume">6</span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">435</span>, <span class="refDoi">DOI: 10.3390/pharmaceutics6030416</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.3390%2Fpharmaceutics6030416" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=25025400" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslensLbK" title="">CAS</a>]<div class="casRecord" id="cas_cit46R"><div class="casContent"><span class="casTitleNuber">46. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Improving Co-amorphous drug formulations by the addition of the highly water soluble amino acid, proline</cas:atitle></div><div class="casAuthors">Jensen, Katrine Tarp; Loebmann, Korbinian; Rades, Thomas; Grohganz, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">6</cas:volume>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">416-435</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PHARK5</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Co-amorphous drug amino acid mixts. were previously shown to be a promising approach to create phys. stable amorphous systems with the improved dissoln. properties of poorly water-sol. drugs.  The aim of this work was to expand the co-amorphous drug amino acid mixt. approach by combining the model drug, naproxen (NAP), with an amino acid to phys. stabilize the co-amorphous system (tryptophan, TRP, or arginine, ARG) and a second highly sol. amino acid (proline, PRO) for an addnl. improvement of the dissoln. rate.  Co-amorphous drug-amino acid blends were prepd. by ball milling and investigated for solid state characteristics, stability and the dissoln. rate enhancement of NAP.  All co-amorphous mixts. were stable at room temp. and 40 °C for a min. of 84 days.  PRO acted as a stabilizer for the co-amorphous system, including NAP-TRP, through enhancing the mol. interactions in the form of hydrogen bonds between all three components in the mixt.  A salt formation between the acidic drug, NAP, and the basic amino acid, ARG, was found in co-amorphous NAP-ARG.  In comparison to cryst. NAP, binary NAP-TRP and NAP-ARG, it could be shown that the highly sol. amino acid, PRO, improved the dissoln. rate of NAP from the ternary co-amorphous systems in combination with either TRP or ARG.  In conclusion, both the soly. of the amino acid and potential interactions between the mols. are crit. parameters to consider in the development of co-amorphous formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTwrv5_JyZtbVg90H21EOLACvtfcHk0liu68XIVb8u3Q"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2cXhslensLbK&amp;md5=73de9d362b74fe76fcd4484b9aeeb0e2</span></div></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref47&#39;);return false;" class="refNumLink">47. </a></strong><div class="NLM_citation" id="cit47"><span class="hlFld-ContribAuthor ">Tong<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Taylor<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L. S.</span>; <span class="hlFld-ContribAuthor ">Zografi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_article-title">Influence of Alkali Metal Counterions on the Glass Transition Temperature of Amorphous Indomethacin Salts</span> <span class="citation_source-journal">Pharm. Res.</span>  <span class="NLM_year">2002</span>,  <span class="NLM_volume">19</span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">654</span>, <span class="refDoi">DOI: 10.1023/A:1015310213887</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1023%2FA%3A1015310213887" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=12069168" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFCisb8%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit47R"><div class="casContent"><span class="casTitleNuber">47. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Influence of Alkali Metal Counterions on the Glass Transition Temperature of Amorphous Indomethacin Salts</cas:atitle></div><div class="casAuthors">Tong, Ping; Taylor, Lynne S.; Zografi, George</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">19</cas:volume>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-654</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PHREEB</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose. To test the hypothesis that the choice of counterion in salt formation would generally result in a change in the glass transition temp., Tg, in relation to the nature of the interaction between the ionized parent structure and its counterion.  Methods. Various alkali metal salts of indomethacin (IMC), lithium (Li+), sodium (Na+), potassium (K+), rubidium (Rb+), and cesium (Cs+) IMC were prepd. as amorphous solid powders by lyophilization.  The Tg was measured using differential scanning calorimetry or modulated-temp. differential scanning calorimetry.  The spectroscopic properties of these salts were analyzed using Fourier transform-Raman and Fourier transform-IR spectroscopy.  Results. A comparison of the Tg values of the five salts showed Tg values in the order of Li+ &gt; Na+ &gt; K+ &gt; Rb+ &gt; Cs+, which is consistent with an order of decreasing ionic radius, and hence an increased charge d. and an increased electrostatic interaction energy between the carboxylate ion and the alkali metal cation.  Spectroscopic data support this interpretation by showing that the different salts exhibit spectral differences only in the region of the carboxylate group.  Conclusions.  Changes in Tg due to salt formation for alkali metal salts of IMC mainly result from differences in ionic interaction between the oppositely charged ions that appear to be related to the size/charge ratio of the counterion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmjA4lz913tbVg90H21EOLACvtfcHk0ljV34x90uQZOQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD38XksFCisb8%253D&amp;md5=b34cdb98d9ff7fd2ba841290cff6f462</span></div></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref48&#39;);return false;" class="refNumLink">48. </a></strong><div class="NLM_citation" id="cit48"><span class="hlFld-ContribAuthor ">van Drooge<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D. J.</span>; <span class="hlFld-ContribAuthor ">Hinrichs<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>W. L. J.</span>; <span class="hlFld-ContribAuthor ">Visser<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. R.</span>; <span class="hlFld-ContribAuthor ">Frijlink<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. W.</span><span class="NLM_article-title">Characterization of the Molecular Distribution of Drugs in Glassy Solid Dispersions at the Nano-Meter Scale, Using Differential Scanning Calorimetry and Gravimetric Water Vapour Sorption Techniques</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2006</span>,  <span class="NLM_volume">310</span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">229</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2005.12.007</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2005.12.007" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=16427226" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslKht7Y%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit48R"><div class="casContent"><span class="casTitleNuber">48. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques</cas:atitle></div><div class="casAuthors">van Drooge, D. J.; Hinrichs, W. L. J.; Visser, M. R.; Frijlink, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">310</cas:volume>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">220-229</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mol. distribution in fully amorphous solid dispersions consisting of poly(vinylpyrrolidone) (PVP)-diazepam and inulin-diazepam was studied.  One glass transition temp. (Tg), as detd. by temp. modulated differential scanning calorimetry (TMDSC), was obsd. in PVP-diazepam solid dispersions prepd. by fusion for all drug loads tested (10-80 wt.%).  The Tg of these solid dispersions gradually changed with compn. and decreased from 177 °C for pure PVP to 46 °C for diazepam.  These observations indicate that diazepam was dispersed in PVP on a mol. level.  However, in PVP-diazepam solid dispersions prepd. by freeze drying, 2 Tg's were obsd. for drug loads above 35 wt.% indicating phase sepn.  One Tg indicated the presence of amorphous diazepam clusters, the other Tg was attributed to a PVP-rich phase in which diazepam was dispersed on a mol. level.  With both the value of the latter Tg and the ΔCp of the diazepam glass transition the concns. of mol. dispersed diazepam could be calcd. (27-35 wt.%).  Both methods gave similar results.  Water vapor sorption (DVS) expts. revealed that the PVP-matrix was hydrophobised by the incorporated diazepam.  TMDSC and DVS results were used to est. the size of diazepam clusters in freeze dried PVP-diazepam solid dispersions, which appeared to be in the nano-meter range.  The inulin-diazepam solid dispersions prepd. by spray freeze drying showed one Tg for drug loads up to 35 wt.% indicating homogeneous distribution on a mol. level.  However, this Tg was independent of the drug load, which is unexpected because diazepam has a lower Tg than inulin (46 and 155 °C, resp.).  For higher drug loads, a Tg of diazepam as well as a Tg of the inulin-rich phase was obsd., indicating the formation of amorphous diazepam clusters.  From the ΔCp of the diazepam glass transition the amt. of molecularly dispersed diazepam was calcd. (12-27 wt.%).  In contrast to the PVP-diazepam solid dispersions, DVS-expts. revealed that inulin was not hydrophobised by diazepam.  Consequently, the size of diazepam clusters could not be estd.  It was concluded that TMDSC enables characterization and quantification of the mol. distribution in amorphous solid dispersions.  When the hygroscopicity of the carrier is reduced by the drug, DVS in combination with TMDSC can be used to est. the size of amorphous drug clusters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi-yX48cKnTLVg90H21EOLACvtfcHk0ljV34x90uQZOQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28XhslKht7Y%253D&amp;md5=6e5953e30675d48cdc7de7d9d1e1e4c9</span></div></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref49&#39;);return false;" class="refNumLink">49. </a></strong><div class="NLM_citation" id="cit49"><span class="hlFld-ContribAuthor ">Konno<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Taylor<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L. S.</span><span class="NLM_article-title">Influence of Different Polymers on the Crystallization Tendency of Molecularly Dispersed Amorphous Felodipine</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2006</span>,  <span class="NLM_volume">95</span>,  <span class="NLM_fpage">2692</span>– <span class="NLM_lpage">2705</span>, <span class="refDoi">DOI: 10.1002/jps.20697</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.20697" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=16892209" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSis7%252FE" title="">CAS</a>]<div class="casRecord" id="cas_cit49R"><div class="casContent"><span class="casTitleNuber">49. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine</cas:atitle></div><div class="casAuthors">Konno, Hajime; Taylor, Lynne S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">95</cas:volume>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2692-2705</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ability of various polymers to inhibit the crystn. of amorphous felodipine was studied in amorphous mol. dispersions.  Spin-coated films of felodipine with poly(vinylpyrrolidone) (PVP), hydroxypropylmethylcellulose acetate succinate (HPMCAS), and hydroxypropylmethylcellulose (HPMC) were prepd. and used for measurement of the nucleation rate and to probe drug-polymer intermol. interactions.  Bulk solid dispersions were prepd. by a solvent evapn. method and characterized using thermal anal.  It was found that each polymer was able to significantly decrease the nucleation rate of amorphous felodipine even at low concns. (3-25% wt./wt.).  Each polymer was found to affect the nucleation rate to a similar extent at an equiv. wt. fraction.  For HPMC and HPMCAS, thermal anal. indicated that the glass transition temp. (Tg) of the solid dispersions were not significantly different from that of felodipine alone, whereas an increase in Tg was obsd. for the PVP contg. solid dispersions.  IR spectroscopic studies indicated that hydrogen bonding interactions were formed between felodipine and each of the polymers.  These interactions were stronger between felodipine and PVP than for the other polymers.  It was speculated that, at the concns. employed, the polymers reduce the nucleation rate through increasing the kinetic barrier to nucleation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof7KBWiqfKZrVg90H21EOLACvtfcHk0ljV34x90uQZOQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28XhtlSis7%252FE&amp;md5=d329afdaeae267e9fd9ad6a9502df2dd</span></div></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref50&#39;);return false;" class="refNumLink">50. </a></strong><div class="NLM_citation" id="cit50"><span class="hlFld-ContribAuthor ">Andronis<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>V.</span>; <span class="hlFld-ContribAuthor ">Yoshioka<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Zografi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span><span class="NLM_article-title">Effects of Sorbed Water on the Crystallization of Indomethacin from the Amorphous State</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">1997</span>,  <span class="NLM_volume">86</span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">351</span>, <span class="refDoi">DOI: 10.1021/js9602711</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1021%2Fjs9602711" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=9050804" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVGhtrs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit50R"><div class="casContent"><span class="casTitleNuber">50. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Effects of Sorbed Water on the Crystallization of Indomethacin from the Amorphous State</cas:atitle></div><div class="casAuthors">Andronis, Vlassios; Yoshioka, Minoru; Zografi, George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1997</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">86</cas:volume>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-351</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The water sorption isotherm and the crystn. rates for amorphous indomethacin were detd. at 30° as a function of relative humidity (RH), along with the effects of water content on the glass transition temp. (Tg).  Below 43% RH, only the stable γ crystal form appears, whereas at higher RH, only the metastable α crystal form appears.  The tendency for the α crystals to form at higher RH is consistent with the Ostwald step rule.  The crystn. rate of the α form continuously increased with increasing RH due to increasing mol. mobility.  The crystn. mechanism of the γ form changed from surface-initiated to bulk-initiated crystn. at 21% RH, and although crystn. rates of the γ form increased with increasing RH in both cases, they were higher when crystn. was surface-initiated.  The complex crystn. behavior of the γ form is explained by the higher water content and mol. mobility of the surface relative to the bulk and the general effect of water on α or γ crystal form selection as described by the Ostwald step rule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMWEIuEWbQRLVg90H21EOLACvtfcHk0ljV34x90uQZOQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK2sXhtVGhtrs%253D&amp;md5=c5bdb49f1308a0812dc207822279dd12</span></div></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref51&#39;);return false;" class="refNumLink">51. </a></strong><div class="NLM_citation" id="cit51"><span class="hlFld-ContribAuthor ">Mafra<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span>; <span class="hlFld-ContribAuthor ">Santos<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. M.</span>; <span class="hlFld-ContribAuthor ">Siegel<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Alves<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I.</span>; <span class="hlFld-ContribAuthor ">Paz<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>F. A. A.</span>; <span class="hlFld-ContribAuthor ">Dudenko<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span>; <span class="hlFld-ContribAuthor ">Spiess<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. W.</span><span class="NLM_article-title">Packing Interactions in Hydrated and Anhydrous Forms of the Antibiotic Ciprofloxacin: A Solid-State NMR, X-Ray Diffraction, and Computer Simulation Study</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span>  <span class="NLM_year">2012</span>,  <span class="NLM_volume">134</span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">4</span>, <span class="refDoi">DOI: 10.1021/ja208647n</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/ja208647n" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFejtb3N" title="">CAS</a>]<div class="casRecord" id="cas_cit51R"><div class="casContent"><span class="casTitleNuber">51. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Packing Interactions in Hydrated and Anhydrous Forms of the Antibiotic Ciprofloxacin: a Solid-State NMR, X-ray Diffraction, and Computer Simulation Study</cas:atitle></div><div class="casAuthors">Mafra, Luis; Santos, Sergio M.; Siegel, Renee; Alves, Ines; Almeida Paz, Filipe A.; Dudenko, Dmytro; Spiess, Hans W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">134</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-74</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JACSAT</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an exptl. NMR, x-ray diffraction (XRD), and computational study of the supramol. assemblies of two cryst. forms of Ciprofloxacin: one anhydrate and one hydrate forming water wormholes.  The resonance assignment of up to 51 and 54 distinct 13C and 1H resonances for the hydrate is reported.  The effect of crystal packing, identified by XRD, on the 1H and 13C chem. shifts including weak interionic H-bonds, is quantified; 1H chem. shift changes up to ∼-3.5 ppm for CH···π contacts and ∼+2 ppm (CH···O(-)); ∼+4.7 ppm ((+)NH···O(-)) for H-bonds.  Water intake induces chem. shift changes up to 2 and 5 ppm for 1H and 13C nuclei, resp.  Such chem. shifts are found to be sensitive detectors of hydration/dehydration in highly insol. hydrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOKaO1OLrVCrVg90H21EOLACvtfcHk0ljoUCUVWk8d9g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXhsFejtb3N&amp;md5=f5527fb69c0aaf17b41ff912547496a6</span></div></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref52&#39;);return false;" class="refNumLink">52. </a></strong><div class="NLM_citation" id="cit52"><span class="hlFld-ContribAuthor ">Chawla<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Bansal<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. K.</span><span class="NLM_article-title">A Comparative Assessment of Solubility Advantage from Glassy and Crystalline Forms of a Water-Insoluble Drug</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span>  <span class="NLM_year">2007</span>,  <span class="NLM_volume">32</span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">57</span>, <span class="refDoi">DOI: 10.1016/j.ejps.2007.05.111</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ejps.2007.05.111" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=17618092" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSgtbs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit52R"><div class="casContent"><span class="casTitleNuber">52. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug</cas:atitle></div><div class="casAuthors">Chawla, Garima; Bansal, Arvind K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">32</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-57</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPSCED</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objective of the present study was to generate and characterize the glassy state of Irbesartan (IBS), with a view to exploit the soly. advantage from disordered high energy system.  The major reason for limited soly. benefit from amorphous systems is their devitrification, on exposure to primarily aq. dissoln. medium.  IBS is a lipophilic mol. and exhibits poor aq. soly. and incomplete dissoln.  IBS was found to be a good glass former (with glass transition/melting temp. &gt;0.7), non-hygroscopic in nature and showed reasonable solid-state stability.  The present work places particular emphasis on studying the influence of various dissoln. environments on the devitrification of amorphous system.  It was noted that IBS forms a relatively stable' glassy system with a 2.5-fold increase in aq. soly. and a higher intrinsic dissoln. rate (IDR).  The dissoln. behavior showed pH dependency and about eight-fold soly. advantage was obtained from amorphous system at pH 3.  Both the cryst. and amorphous forms exhibited appreciably high soly. in HCl and HCl strength was found to significantly influence the soly. of cryst. form.  Amorphous IBS showed reduced devitrification in HCl, as against water, thus highlighting the effect of dissoln. environment on devitrification kinetics.  Statistical and math. analyses were performed to compare the soly. advantage obtained using amorphous IBS vis-a-vis the cryst. counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJx6pCTfuBYLVg90H21EOLACvtfcHk0ljoUCUVWk8d9g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2sXotlSgtbs%253D&amp;md5=e1d055c6d15e0aa2037a4b7f3df028a3</span></div></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref53&#39;);return false;" class="refNumLink">53. </a></strong><div class="NLM_citation" id="cit53"><span class="hlFld-ContribAuthor ">Warren<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D. B.</span>; <span class="hlFld-ContribAuthor ">Benameur<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Porter<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. J. H.</span>; <span class="hlFld-ContribAuthor ">Pouton<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. W.</span><span class="NLM_article-title">Using Polymeric Precipitation Inhibitors to Improve the Absorption of Poorly Water-Soluble Drugs: A Mechanistic Basis for Utility</span> <span class="citation_source-journal">J. Drug Target</span>  <span class="NLM_year">2010</span>,  <span class="NLM_volume">18</span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">731</span>, <span class="refDoi">DOI: 10.3109/1061186X.2010.525652</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.3109%2F1061186X.2010.525652" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=20973755" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOrsbnL" title="">CAS</a>]<div class="casRecord" id="cas_cit53R"><div class="casContent"><span class="casTitleNuber">53. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility</cas:atitle></div><div class="casAuthors">Warren, Dallas B.; Benameur, Hassan; Porter, Christopher J. H.; Pouton, Colin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2010</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">18</cas:volume>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">704-731</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JDTAEH</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The inclusion of certain polymers within solid dispersion or lipid-based formulations can maintain drug supersatn. after dispersion and/or digestion of the vehicle, leading to improvements in bioavailability and variability in exposure.  This review presents an overview of the fundamental principles that underpin drug pptn. mechanisms, describes the mechanisms by which pptn. may be inhibited, discusses the methods that can be used to identify polymeric pptn. inhibitors (PPIs), and summarizes current literature evidence of the most effective PPIs.  Preliminary data from the authors' lab. is also presented, which describes the pptn. inhibition behavior of 53 polymeric materials using supersatd. solns. of danazol as a model, poorly water-sol. drug.  These studies identify a group of PPIs with superior pptn. inhibition qualities, the majority of which are cellulose-based.  These new results in combination with previous published data indicate that PPIs represent an appealing new technol. with the potential to improve drug absorption for poorly water-sol. drugs.  The mol. determinants of polymer utility, however, remain relatively poorly understood, although the cellulose derivates appear, in general, to provide the most benefit.  More detailed studies are therefore required to define the parameters that most effectively predict and quantify the drug-polymer relationships that control pptn. inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoyEA9FPBC_rVg90H21EOLACvtfcHk0ljoUCUVWk8d9g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOrsbnL&amp;md5=6f5019c3ee6f30b2fbc4ea8a2b05ce6c</span></div></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref54&#39;);return false;" class="refNumLink">54. </a></strong><div class="NLM_citation" id="cit54">biorelevant.com. FaSSIF, FeSSIF &amp; FaSSGF contain bile salts and phospholipids; <a href="http://biorelevant.com/fassif-fessif-fassgf-powder/contains-bile-salts-phospholipids/" class="extLink">http://biorelevant.com/fassif-fessif-fassgf-powder/contains-bile-salts-phospholipids/</a> (accessed Feb 18, 2015).<div class="citationLinks"><div class="casRecord empty" id="cas_cit54R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref55&#39;);return false;" class="refNumLink">55. </a></strong><div class="NLM_citation" id="cit55"><span class="hlFld-ContribAuthor ">Tanno<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>F.</span>; <span class="hlFld-ContribAuthor ">Nishiyama<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span>; <span class="hlFld-ContribAuthor ">Kokubo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H.</span>; <span class="hlFld-ContribAuthor ">Obara<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S.</span><span class="NLM_article-title">Evaluation of Hypromellose Acetate Succinate (HPMCAS) as a Carrier in Solid Dispersions</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span>  <span class="NLM_year">2004</span>,  <span class="NLM_volume">30</span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi">DOI: 10.1081/DDC-120027506</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1081%2FDDC-120027506" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=15000425" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1SgsA%253D%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit55R"><div class="casContent"><span class="casTitleNuber">55. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Evaluation of Hypromellose Acetate Succinate (HPMCAS) as a Carrier in Solid Dispersions</cas:atitle></div><div class="casAuthors">Tanno, Fumie; Nishiyama, Yuichi; Kokubo, Hiroyasu; Obara, Sakae</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2004</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">30</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DDIPD8</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The utility of hypromellose acetate succinate (HPMCAS), a cellulosic enteric coating agent, as a carrier in a solid dispersion of nifedipine (NP) was evaluated in comparison with other polymers, including hypromellose (HPMC), hypromellose phthalate (HPMCP), methacrylic acid Et acrylate copolymer (MAEA), and povidone (PVP).  An x-ray diffraction study showed that the min. amt. of HPMCAS required to make the drug completely amorphous was the same as that of other cellulosic polymers, and less than that in dispersions using non-cellulosic polymers.  Hypromellose acetate succinate showed the highest drug dissoln. level from its solid dispersion in a dissoln. study using a buffer of pH 6.8.  This characteristic was unchanged after a storage test at high temp. and high humidity.  The inhibitory effect of HPMCAS on recrystn. of NP from a supersatd. soln. was the greatest among all the polymers examd.  Further, the drug release pattern could be modulated by altering the ratio of succinoyl and acetyl moieties in the polymer chain.  Our results indicate that HPMCAS is an attractive candidate for use as a carrier in solid dispersions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSl7yx22SJNrVg90H21EOLACvtfcHk0ljoUCUVWk8d9g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2cXpt1SgsA%253D%253D&amp;md5=255924033d118174c230d75884f6b48b</span></div></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref56&#39;);return false;" class="refNumLink">56. </a></strong><div class="NLM_citation" id="cit56"><span class="hlFld-ContribAuthor ">Li<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>X.</span>; <span class="hlFld-ContribAuthor ">Zhi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>F.</span>; <span class="hlFld-ContribAuthor ">Hu<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span><span class="NLM_article-title">Investigation of Excipient and Processing on Solid Phase Transformation and Dissolution of Ciprofloxacin</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2007</span>,  <span class="NLM_volume">328</span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">182</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2006.08.012</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2006.08.012" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=16978809" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqurbJ" title="">CAS</a>]<div class="casRecord" id="cas_cit56R"><div class="casContent"><span class="casTitleNuber">56. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin</cas:atitle></div><div class="casAuthors">Li, Xianwen; Zhi, Feng; Hu, Yiqiao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">328</cas:volume>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-182</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ciprofloxacin, a very slightly sol. antibiotics, is known to exist as both anhyd. and hydrous forms.  This study was carried out to investigate the solid phase transformation of ciprofloxacin during conventional formulation processing that impacts the performance of solid dosage forms.  In addn., alternative processing and formulation options were also evaluated to circumvent phase transformation.  Anhydrate and hydrate of ciprofloxacin were characterized using differential scanning calorimetry (DSC), thermogravimetric anal. (TGA), powder x-ray diffraction (PXRD) and powder dissoln.  As expected, the anhydrate exhibited significantly higher dissoln. rate than the hydrate.  However, it rapidly converted to the hydrate upon exposure to aq. medium.  Interestingly, premixing the anhydrate with HPMC in the presence of water or ethanol was found to inhibit the processing-induced phase transition.  Further studies demonstrated that wet granulation could be an option for prepg. tablets with high loading of ciprofloxacin anhydrate through proper selection of excipients and control of processing conditions.  Dissoln. study of ciprofloxacin in HPMC based extended release matrix tablets indicated different dissoln. rates between tablets contg. the anhydrate and hydrate, suggesting transformation to the hydrate was significantly inhibited by HPMC in the gel layer of the hydrated tablets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY4QjA1BQR3LVg90H21EOLACvtfcHk0ljfX7YBbzgPnw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqurbJ&amp;md5=17945aa6b2e5e62dcc210c660086ac52</span></div></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref57&#39;);return false;" class="refNumLink">57. </a></strong><div class="NLM_citation" id="cit57"><span class="hlFld-ContribAuthor ">Kramer<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. F.</span>; <span class="hlFld-ContribAuthor ">Flynn<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G. L.</span><span class="NLM_article-title">Solubility of Organic Hydrochlorides</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">1972</span>,  <span class="NLM_volume">61</span>,  <span class="NLM_fpage">1896</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi">DOI: 10.1002/jps.2600611203</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.2600611203" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=4638094" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaE3sXkslOhsg%253D%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit57R"><div class="casContent"><span class="casTitleNuber">57. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Solubility of organic hydrochlorides</cas:atitle></div><div class="casAuthors">Kramer, S. F.; Flynn, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1972</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">61</cas:volume>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1896-904</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">The solubilities of two polysubstituted 1,3-dioxolanes (I and II), each contg. a 4-(2-piperidyl) substituent, were examd. as a function of pH, temp., and solvent compn.  Math. equations describing the total soly. at any arbitrary pH in terms of the independent solubilities of the hydrochloride and free base species and the dissocn. const. of the salt were derived and fitted to the data with good result.  Alternatively, a method of estg. the true pK'a of a hydrochloride from the soly. profile at a given temp. is indicated.  The data show that the shape of the pH profile is more dependent on the soly. of the free base than on that of the hydrochloride.  The free base soly. dets. the pH range in which the soly. abruptly drops from that of the sol. salt to that of the relatively insol. free amine.  To shift the pH-soly. profile to higher pH values, as may be required in formulation, it is necessary to increase the soly. of the free base.  Methods and solvents are indicated whereby this can be accomplished without appreciably affecting the soly. of the hydrochloride form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwjdg4bONe3LVg90H21EOLACvtfcHk0ljfX7YBbzgPnw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaE3sXkslOhsg%253D%253D&amp;md5=1ba238d27b3468fdb659713b34efcfed</span></div></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref58&#39;);return false;" class="refNumLink">58. </a></strong><div class="NLM_citation" id="cit58"><span class="hlFld-ContribAuthor ">Fortuna<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Alves<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Soares-da-Silva<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Falcão<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span><span class="NLM_article-title">Optimization of a Parallel Artificial Membrane Permeability Assay for the Fast and Simultaneous Prediction of Human Intestinal Absorption and Plasma Protein Binding of Drug Candidates: Application to Dibenz[b,f]azepine-5-Carboxamide Derivatives</span> <span class="citation_source-journal">J. Pharm. Sci.</span>  <span class="NLM_year">2012</span>,  <span class="NLM_volume">101</span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">540</span>, <span class="refDoi">DOI: 10.1002/jps.22796</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2Fjps.22796" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=22052653" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSktbfL" title="">CAS</a>]<div class="casRecord" id="cas_cit58R"><div class="casContent"><span class="casTitleNuber">58. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: Application to dibenz[b,f]azepine-5-carboxamide derivatives</cas:atitle></div><div class="casAuthors">Fortuna, Ana; Alves, Gilberto; Soares-da-silva, Patricio; Falcao, Amilcar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">101</cas:volume>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">530-540</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JPMSAE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Parallel artificial membrane permeability assay (PAMPA) has been successfully applied by pharmaceutical industries as high-throughput technique capable of screening compds. for passive oral absorption.  Herein, the possible applicability of this assay to predict simultaneously biodistribution parameters such as plasma protein binding (PPB) and apparent vol. of distribution (VD) was investigated for the first time.  Apparent permeability (Papp) of 18 ref. drugs was detd. by nine PAMPA conditions and compared with the corresponding intestinal absorption fraction (Fa), PPB, and VD in humans.  In all the models, Papp was not correlated with VD; however, it was correlated with Fa and PPB.  In these cases, the best correlations (r ≥ 0.8953) were found when using a membrane of 2% of L-α-phosphatidylcholine, at pH 6.5/7.4 for donor/acceptor compartments.  Under these conditions, good correlation with traditional PAMPA (r = 0.9633) and Caco-2 models (r = 0.9246) were also achieved.  This method correctly predicted compds.' permeability and was robust enough to distinguish compds. with high Fa (Papp ≥ 1.1 × 10-6 cm/s) and PPB (Papp ≥ 1.0 × 10-5 cm/s), with no false positives or negatives recorded.  In addn., ultrafiltration method was used to det. the PPB of 10 tested derivs. of dibenz[b,f]azepine-5-carboxamide, which were also assessed through the new PAMPA model developed herein, and equal classifications were achieved. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5OKLSZBaXC7Vg90H21EOLACvtfcHk0ljfX7YBbzgPnw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSktbfL&amp;md5=11bde00f27392e8fb7ef0fd9b38eb00c</span></div></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref59&#39;);return false;" class="refNumLink">59. </a></strong><div class="NLM_citation" id="cit59"><span class="hlFld-ContribAuthor ">Avdeef<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>  <span class="citation_source-book">Absorption and Drug Development: Solubility, Permeability, and Charge State</span>; <span class="NLM_publisher-name">John Wiley &amp; Sons, Inc.</span>: <span class="NLM_publisher-loc">NJ</span>,  <span class="NLM_year">2003</span>.<div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1002%2F047145026X" title="">CrossRef</a>]<div class="casRecord empty" id="cas_cit59R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref60&#39;);return false;" class="refNumLink">60. </a></strong><div class="NLM_citation" id="cit60"><span class="hlFld-ContribAuthor ">Harder<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S.</span>; <span class="hlFld-ContribAuthor ">Fuhr<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>U.</span>; <span class="hlFld-ContribAuthor ">Beermann<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D.</span>; <span class="hlFld-ContribAuthor ">Staib<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. H.</span><span class="NLM_article-title">Ciprofloxacin Absorption in Different Regions of the Human Gastrointestinal Tract. Investigations with the Hf-Capsule</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span>  <span class="NLM_year">1990</span>,  <span class="NLM_volume">30</span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">39</span>, <span class="refDoi">DOI: 10.1111/j.1365-2125.1990.tb03740.x</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1111%2Fj.1365-2125.1990.tb03740.x" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=2390430" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaK3cXlsVCku7k%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit60R"><div class="casContent"><span class="casTitleNuber">60. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Ciprofloxacin absorption in different regions of the human gastrointestinal tract.  Investigations with the hf-capsule</cas:atitle></div><div class="casAuthors">Harder, S.; Fuhr, U.; Beermann, D.; Staib, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">30</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-9</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">BCPHBM</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">The absorption of ciprofloxacin from different regions of the human gastrointestinal tract was investigated in healthy males, using a remote-controlled drug delivery device (hf-capsule).  Significant differences in AUC were obsd. in the control study (oral administration of ciprofloxacin soln. without the hf-capsule = 100%) and after release of ciprofloxacin in the jejunum (geometric mean: 37%), the ileum (mean 23%), the ascending colon (mean: 7%) and the descending colon (mean: 5%), whereas tmax showed no difference for any of the absorption sites.  Ciprofloxacin release in the stomach resulted in the greatest AUC (mean: 140%).  Thus, it is concluded that the main absorption site of ciprofloxacin is the upper gastrointestinal tract, up to the jejunum.  Differences in presystemic metab. of known drug metabolites along the gut could be excluded, as the pattern of urinary recovery of desethylene-, sulfo-, and oxo-ciprofloxacin and the parent compd. was similar for all drug release sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRCFrs1wV6LVg90H21EOLACvtfcHk0ljfX7YBbzgPnw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK3cXlsVCku7k%253D&amp;md5=7563120b01104ed3235392be91a83c2a</span></div></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref61&#39;);return false;" class="refNumLink">61. </a></strong><div class="NLM_citation" id="cit61"><span class="hlFld-ContribAuthor ">Said<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. M.</span>; <span class="hlFld-ContribAuthor ">Blair<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. A.</span>; <span class="hlFld-ContribAuthor ">Lucas<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. L.</span>; <span class="hlFld-ContribAuthor ">Hilburn<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. E.</span><span class="NLM_article-title">Intestinal Surface Acid Microclimate in Vitro and in Vivo in the Rat</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span>  <span class="NLM_year">1986</span>,  <span class="NLM_volume">107</span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">424</span><div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=3701189" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaL28XktVChtL0%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit61R"><div class="casContent"><span class="casTitleNuber">61. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Intestinal surface acid microclimate in vitro and in vivo in the rat</cas:atitle></div><div class="casAuthors">Said, Hamid M.; Blair, John A.; Lucas, Michael L.; Hilburn, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Laboratory and Clinical Medicine</span>
        (<span class="NLM_cas:date">1986</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">107</cas:volume>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-4</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JLCMAK</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-2143</span>.
    </div><div class="casAbstract">The existence and distribution of the intestinal surface acid microclimate (ISAM), a layer of H+ adjacent to the luminal surface, along the rat small intestine and colon were studied, and its general characteristics were detd.  The results clearly demonstrate the existence of the ISAM in vitro and in vivo.  Glucose and Na+ in the incubation medium, as well as normal intracellular metab., are essential requirements for the formation and maintenance of the ISAM.  Thus, the ISAM is a normal physiol. phenomenon of the luminal surface of the intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQxtLHByGIrVg90H21EOLACvtfcHk0lgFmrUer8ejMQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaL28XktVChtL0%253D&amp;md5=0de2f4c73dec309a49e5798341a8faa0</span></div></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref62&#39;);return false;" class="refNumLink">62. </a></strong><div class="NLM_citation" id="cit62"><span class="hlFld-ContribAuthor ">Sugano<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span> <span class="NLM_article-title">Permeability of a Drug</span>. In  <span class="citation_source-book">Biopharmaceutics modeling and simulations: theory, practice, methods, and applications</span>; <span class="NLM_publisher-name">John Wiley &amp; Sons</span>: <span class="NLM_publisher-loc">NJ</span>,  <span class="NLM_year">2012</span>; p  <span class="NLM_fpage">170</span>.<div class="citationLinks"><div class="casRecord empty" id="cas_cit62R
                "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref63&#39;);return false;" class="refNumLink">63. </a></strong><div class="NLM_citation" id="cit63"><span class="hlFld-ContribAuthor ">Tehler<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>U.</span>; <span class="hlFld-ContribAuthor ">Fagerberg<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. H.</span>; <span class="hlFld-ContribAuthor ">Svensson<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Larhed<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Artursson<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>P.</span>; <span class="hlFld-ContribAuthor ">Bergström<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C. A. S.</span><span class="NLM_article-title">Optimizing Solubility and Permeability of a Biopharmaceutics Classification System (BCS) Class 4 Antibiotic Drug Using Lipophilic Fragments Disturbing the Crystal Lattice</span> <span class="citation_source-journal">J. Med. Chem.</span>  <span class="NLM_year">2013</span>,  <span class="NLM_volume">56</span>,  <span class="NLM_fpage">2690</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi">DOI: 10.1021/jm301721e</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/jm301721e" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVWqsbY%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit63R"><div class="casContent"><span class="casTitleNuber">63. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Optimizing solubility and permeability of a biopharmaceutics classification system (BCS) class 4 antibiotic drug using lipophilic fragments disturbing the crystal lattice</cas:atitle></div><div class="casAuthors">Tehler, Ulrika; Fagerberg, Jonas H.; Svensson, Richard; Larhed, Mats; Artursson, Per; Bergstroem, Christel A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">56</cas:volume>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2690-2694</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JMCMAR</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Esterification was used to simultaneously increase soly. and permeability of ciprofloxacin, a biopharmaceutics classification system (BCS) class 4 drug (low soly./low permeability) with solid-state limited soly.  Mol. flexibility was increased to disturb the crystal lattice, lower the m.p., and thereby improve the soly., whereas lipophilicity was increased to enhance the intestinal permeability.  These structural changes resulted in BCS class 1 analogs (high soly./high permeability) emphasizing that simple medicinal chem. may improve both these properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ4L9_TAPbC7Vg90H21EOLACvtfcHk0lgFmrUer8ejMQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3sXjtVWqsbY%253D&amp;md5=4c34c68d37c9b3dfa5b5b65f0c917673</span></div></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref64&#39;);return false;" class="refNumLink">64. </a></strong><div class="NLM_citation" id="cit64"><span class="hlFld-ContribAuthor ">Sun<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Sakai<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S.</span>; <span class="hlFld-ContribAuthor ">Tauchi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span>; <span class="hlFld-ContribAuthor ">Deguchi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>Y.</span>; <span class="hlFld-ContribAuthor ">Chen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J.</span>; <span class="hlFld-ContribAuthor ">Zhang<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Morimoto<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span><span class="NLM_article-title">Determination of Lipophilicity of Two Quinolone Antibacterials, Ciprofloxacin and Grepafloxacin, in the Protonation Equilibrium</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span>  <span class="NLM_year">2002</span>,  <span class="NLM_volume">54</span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">58</span>, <span class="refDoi">DOI: 10.1016/S0939-6411(02)00018-8</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2FS0939-6411%2802%2900018-8" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=12084502" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslKisbs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit64R"><div class="casContent"><span class="casTitleNuber">64. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium</cas:atitle></div><div class="casAuthors">Sun, Jin; Sakai, Shigeko; Tauchi, Yoshihiko; Deguchi, Yoshiharu; Chen, Jimin; Zhang, Ruhua; Morimoto, Kazuhiro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">54</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EJPBEL</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The objective of this study was to compare protonation equil. and lipophilicity of two quinolone antibacterials, grepafloxacin (GPFX) and ciprofloxacin (CPFX), in order to give an insight into effects on the physicochem. properties by slight structural motifs.  The protonation equil. was investigated by a spectrophotometry.  Macro- and micro-dissocn. consts. were simultaneously detd., based on nonlinear regression anal. using the MULTI program, and then microspecies distribution could be described accordingly.  Zwitterionic microspecies predominated at isoelec. point (pI) for both drugs, and the concn. ratio of neutral to zwitterionic forms was near 4-fold greater for GPFX than that for CPFX.  The apparent partition coeff. (DO/B,pH) vs. pH profiles had the shape of a parabolic curve in an n-octanol/buffer system, and reached the max. around pI for both, resp.  Moreover, two introduced Me groups in GPFX increased not only intrinsic lipophilicity but also neutral microspecies fraction relative to CPFX, and DO/B,pH of GPFX was consequently far higher than that of CPFX.  The results emphasized that there were significant differences in protonation equil. and lipophilicity between GPFX and CPFX, which conduced to explaining their different behavior in terms of antibacterial activities and pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZSbKfhWJvbVg90H21EOLACvtfcHk0lgFmrUer8ejMQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD38XkslKisbs%253D&amp;md5=57efcb116233e75ae696fa379c579c3b</span></div></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref65&#39;);return false;" class="refNumLink">65. </a></strong><div class="NLM_citation" id="cit65"><span class="hlFld-ContribAuthor ">Cramariuc<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O.</span>; <span class="hlFld-ContribAuthor ">Rog<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.</span>; <span class="hlFld-ContribAuthor ">Javanainen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Monticelli<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L.</span>; <span class="hlFld-ContribAuthor ">Polishchuk<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. V.</span>; <span class="hlFld-ContribAuthor ">Vattulainen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I.</span><span class="NLM_article-title">Mechanism for Translocation of Fluoroquinolones across Lipid Membranes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span>  <span class="NLM_year">2012</span>,  <span class="NLM_volume">1818</span>,  <span class="NLM_fpage">2563</span>– <span class="NLM_lpage">2571</span>, <span class="refDoi">DOI: 10.1016/j.bbamem.2012.05.027</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.bbamem.2012.05.027" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=22664062" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1emtrfE" title="">CAS</a>]<div class="casRecord" id="cas_cit65R"><div class="casContent"><span class="casTitleNuber">65. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Mechanism for translocation of fluoroquinolones across lipid membranes</cas:atitle></div><div class="casAuthors">Cramariuc, Oana; Rog, Tomasz; Javanainen, Matti; Monticelli, Luca; Polishchuk, Anna V.; Vattulainen, Ilpo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2012</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">1818</cas:volume>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2563-2571</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">BBBMBS</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Classical atom-scale mol. dynamics simulations, constrained free energy calcns., and quantum mech. (QM) calcns. are employed to study the diffusive translocation of ciprofloxacin (CPFX) across lipid membranes.  CPFX is considered here as a representative of the fluoroquinolone antibiotics class.  Neutral and zwitterionic CPFX coexist at physiol. pH, with the latter being predominant.  Simulations reveal that only the neutral form permeates the bilayer, and it does so through a novel mechanism that involves dissoln. of concerted stacks of zwitterionic ciprofloxacins.  Subsequent QM anal. of the obsd. mol. stacking shows the important role of partial charge neutralization in the stacks, highlighting how the zwitterionic form of the drug is neutralized for translocation.  The findings propose a translocation mechanism in which zwitterionic CPFX mols. approach the membrane in stacks, but they diffuse through the membrane as neutral CPFX monomers due to intermol. transfer of protons favored by partial solvation loss.  The mechanism is expected to be of importance in the permeation and translocation of a variety of ampholitic drugs with stacking tendencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxQUjezu5MSrVg90H21EOLACvtfcHk0lgFmrUer8ejMQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC38Xht1emtrfE&amp;md5=f1919dda602314111a4ef48a20558bcf</span></div></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref66&#39;);return false;" class="refNumLink">66. </a></strong><div class="NLM_citation" id="cit66"><span class="hlFld-ContribAuthor ">Friesen<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D. T.</span>; <span class="hlFld-ContribAuthor ">Shanker<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Crew<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Smithey<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>D. T.</span>; <span class="hlFld-ContribAuthor ">Curatolo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>W. J.</span>; <span class="hlFld-ContribAuthor ">Nightingale<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. A. S.</span><span class="NLM_article-title">Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2008</span>,  <span class="NLM_volume">5</span>,  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1019</span>, <span class="refDoi">DOI: 10.1021/mp8000793</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp8000793" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb3F" title="">CAS</a>]<div class="casRecord" id="cas_cit66R"><div class="casContent"><span class="casTitleNuber">66. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview</cas:atitle></div><div class="casAuthors">Friesen, Dwayne T.; Shanker, Ravi; Crew, Marshall; Smithey, Daniel T.; Curatolo, W. J.; Nightingale, J. A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">5</cas:volume>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1003-1019</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spray-dried dispersions (SDDs) of low-soly. drugs have been prepd. using the polymer hydroxypropyl methylcellulose acetate succinate (HPMCAS).  For a variety of drug structures, these SDDs provide supersatn. in in vitro dissoln. detns. and large bioavailability increases in vivo.  In bile-salt/lecithin in vitro solns., these SDDs provide amorphous drug/polymer colloids and an increased concn. of free drug and drug in micelles relative to cryst. or amorphous drug.  As dry powders, the SDDs are a single amorphous phase in which the drug remains amorphous and dispersed and does not crystallize over storage times relevant for practical drug products.  A melting temp. (Tm)/glass-transition temp. (Tg) (K/K) vs. log P map for 139 compds. formulated as SDDs provides a perspective on an appropriate formulation strategy for low-soly. drugs with various phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf-Shnc2vArbVg90H21EOLACvtfcHk0ljRtNcLutKQkg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb3F&amp;md5=fde03d051c36ecaeb377c4591e6d51fe</span></div></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref67&#39;);return false;" class="refNumLink">67. </a></strong><div class="NLM_citation" id="cit67"><span class="hlFld-ContribAuthor ">Miller<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. M.</span>; <span class="hlFld-ContribAuthor ">Beig<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Carr<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. A.</span>; <span class="hlFld-ContribAuthor ">Spence<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. K.</span>; <span class="hlFld-ContribAuthor ">Dahan<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span><span class="NLM_article-title">A Win-Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2012</span>,  <span class="NLM_volume">9</span>,  <span class="NLM_fpage">2009</span>– <span class="NLM_lpage">2016</span>, <span class="refDoi">DOI: 10.1021/mp300104s</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp300104s" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFOmtbk%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit67R"><div class="casContent"><span class="casTitleNuber">67. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">A Win-Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability</cas:atitle></div><div class="casAuthors">Miller, Jonathan M.; Beig, Avital; Carr, Robert A.; Spence, Julie K.; Dahan, Arik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">9</cas:volume>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2009-2016</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, we have revealed a trade-off between soly. increase and permeability decrease when soly.-enabling oral formulations are employed.  We have shown this trade-off phenomenon to be ubiquitous, and to exist whenever the aq. soly. is increased via solubilizing excipients, regardless if the mechanism involves decreased free fraction (cyclodextrins complexation, surfactant micellization) or simple cosolvent solubilization.  Discovering a way to increase drug soly. without concomitant decreased permeability represents a major advancement in oral delivery of lipophilic drugs and is the goal of this work.  For this purpose, we sought to elucidate the soly.-permeability interplay when increased apparent soly. is obtained via supersatn. from an amorphous solid dispersion (ASD) formulation.  A spray-dried ASD of the lipophilic drug progesterone was prepd. in the hydrophilic polymer hydroxypropyl methylcellulose acetate succinate (HPMC-AS), which enabled supersatn. up to 4× the cryst. drug's aq. soly. (8 μg/mL).  The apparent permeability of progesterone from the ASD in HPMC-AS was then measured as a function of increasing apparent soly. (supersatn.) in the PAMPA and rat intestinal perfusion models.  In contrast to previous cases in which apparent soly. increases via cyclodextrins, surfactants, and cosolvents resulted in decreased apparent permeability, supersatn. via ASD resulted in no decrease in apparent permeability with increasing apparent soly.  As a result, overall flux increased markedly with increasing apparent soly. via ASD as compared to the other formulation approaches.  This work demonstrates that supersatn. via ASDs has a subtle yet powerful advantage over other soly.-enabling formulation approaches.  That is, increased apparent soly. may be achieved without the expense of apparent intestinal membrane permeability.  Thus, supersatn. via ASDs presents a markedly increased opportunity to maximize overall oral drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbm0PKRlFqM7Vg90H21EOLACvtfcHk0ljRtNcLutKQkg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC38XnsFOmtbk%253D&amp;md5=938d8032d959b7f0993f5b9874e3a344</span></div></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref68&#39;);return false;" class="refNumLink">68. </a></strong><div class="NLM_citation" id="cit68"><span class="hlFld-ContribAuthor ">Tam<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. Y.</span>; <span class="hlFld-ContribAuthor ">Avdeef<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Tsinman<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O.</span>; <span class="hlFld-ContribAuthor ">Sun<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N.</span><span class="NLM_article-title">The Permeation of Amphoteric Drugs through Artificial Membranes--an in Combo Absorption Model Based on Paracellular and Transmembrane Permeability</span> <span class="citation_source-journal">J. Med. Chem.</span>  <span class="NLM_year">2010</span>,  <span class="NLM_volume">53</span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi">DOI: 10.1021/jm901421c</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/jm901421c" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2hurjO" title="">CAS</a>]<div class="casRecord" id="cas_cit68R"><div class="casContent"><span class="casTitleNuber">68. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">The Permeation of Amphoteric Drugs through Artificial Membranes - An in Combo Absorption Model Based on Paracellular and Transmembrane Permeability</cas:atitle></div><div class="casAuthors">Tam, Kin Y.; Avdeef, Alex; Tsinman, Oksana; Sun, Na</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">53</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JMCMAR</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The permeability characteristics of 33 amphoteric drugs (about 64% zwitterions at physiol. pH) were studied using the parallel artificial membrane permeability assay (PAMPA) at pH 6.5.  The PAMPA data were modified to include the paracellular permeability component found in cellular monolayers based on a newly generalized version of a popular model devised for Caco-2 cells.  These "in combo" PAMPA data were used to predict the human abs. bioavailability of the ampholytes.  The anal. produced a good fit, with only five outliers whose transport properties, could be rationalized by (a) nonpassive permeability processes, (b) metabolic instability, and (c) the possible sensitivity to microclimate pH effects in the case of acidic ampholytes.  With the exception of two compds., all of the ampholytes with bioavailability &lt;50% were predominantly transported by the paracellular route, surprisingly with several of the compds. having mol. wts. exceeding 350 Da.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAna98uyyUs7Vg90H21EOLACvtfcHk0ljRtNcLutKQkg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2hurjO&amp;md5=93344e87f7a783144a1f57bcafbfa6ca</span></div></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref69&#39;);return false;" class="refNumLink">69. </a></strong><div class="NLM_citation" id="cit69"><span class="hlFld-ContribAuthor ">Markovic<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B. D.</span>; <span class="hlFld-ContribAuthor ">Vladimirov<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>S. M.</span>; <span class="hlFld-ContribAuthor ">Cudina<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>O. A.</span>; <span class="hlFld-ContribAuthor ">Odovic<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. V.</span>; <span class="hlFld-ContribAuthor ">Karljikovic-Rajic<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. D.</span><span class="NLM_article-title">A PAMPA Assay as Fast Predictive Model of Passive Human Skin Permeability of New Synthesized Corticosteroid C-21 Esters</span> <span class="citation_source-journal">Molecules</span>  <span class="NLM_year">2012</span>,  <span class="NLM_volume">17</span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">491</span>, <span class="refDoi">DOI: 10.3390/molecules17010480</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.3390%2Fmolecules17010480" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=22222907" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFeit74%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit69R"><div class="casContent"><span class="casTitleNuber">69. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">A PAMPA assay as fast predictive model of passive human skin permeability of new synthesized corticosteroid C-21 esters</cas:atitle></div><div class="casAuthors">Markovic, Bojan D.; Vladimirov, Sote M.; Cudina, Olivera A.; Odovic, Jadranka V.; Karljikovic-Rajic, Katarina D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">17</cas:volume>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">480-491</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MOLEFW</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The permeation properties of twenty newly synthesized α-alkoxyalkanoyl and α-aryloxyalkanoyl C-21 esters of std. corticosteroids: fluocinolone acetonide, dexamethasone, triamcinolone acetonide and hydrocortisone were established using a PAMPA assay (70% silicone oil and 30% iso-Pr myristate).  The data were compared with parent corticosteroids with addn. of mometasone furoate and hydrocortisone acetate.  All newly synthesized corticosteroid C-21 esters have effective permeability coeffs. higher then -6, mostly followed with high values of retention factors and low permeation.  The examd. compds. were grouped through relationship between obtained retention factors and permeation parameters (groups I-III).  The classification confirmed group I (membrane retentions as well as permeation lower then 30%) for all corticosteroid stds. except mometasone furoate, a potent topical corticosteroid which, with high membrane retention (81%) and low permeation (7.7%) fits into group III.  The largest no. of new synthesized corticosteroids C-21 esters, among them all fluocinolone acetonide C-21 esters, have high membrane retentions (32.4%-86.5%) and low permeations (1.3%-27.1%), fitting in group III.  The classification was related to previously obtained anti-inflammatory activity data for the fluocinolone acetonide C-21 esters series.  According to the PAMPA results the new synthesized esters could be considered as potential new prodrugs with useful benefit/risk ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT41ScolhT-7Vg90H21EOLACvtfcHk0ljRtNcLutKQkg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC38XitFeit74%253D&amp;md5=89a9e4bb6b27038207c6828173ae6a96</span></div></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref70&#39;);return false;" class="refNumLink">70. </a></strong><div class="NLM_citation" id="cit70"><span class="hlFld-ContribAuthor ">Rodríguez-Ibáñez<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Sánchez-Castaño<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Montalar-Montero<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Garrigues<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T. M.</span>; <span class="hlFld-ContribAuthor ">Bermejo<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Merino<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>V.</span><span class="NLM_article-title">Mathematical Modelling of in Situ and in Vitro Efflux of Ciprofloxacin and Grepafloxacin</span> <span class="citation_source-journal">Int. J. Pharm.</span>  <span class="NLM_year">2006</span>,  <span class="NLM_volume">307</span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">41</span>, <span class="refDoi">DOI: 10.1016/j.ijpharm.2005.09.014</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2Fj.ijpharm.2005.09.014" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=16257153" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12isrzL" title="">CAS</a>]<div class="casRecord" id="cas_cit70R"><div class="casContent"><span class="casTitleNuber">70. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin</cas:atitle></div><div class="casAuthors">Rodriguez-Ibanez, M.; Sanchez-Castano, G.; Montalar-Montero, M.; Garrigues, T. M.; Bermejo, M.; Merino, V.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">307</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-41</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IJPHDE</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The efflux process due to p-glycoprotein-like mechanisms of ciprofloxacin (CIP) and grepafloxacin (GRX) was studied "in situ" in rats and "in vitro" in Caco-2 cells.  The results were modeled by a curve fitting procedure which allowed the characterization of the passive (P d) and carrier mediated parameters (Vm and Km) from the raw data without initial velocities estn.  CIP absorption in rat was characterized as a passive diffusion at the assayed concns.  Although the involvement of an efflux transporter cannot be ruled out, its relevance in the transport of the fluoroquinolone is negligible.  In GRX absorption, an efflux process is implicated and it is detected in both absorption models.  GRX permeability depends on the intestinal segment, reflecting the previously reported different expression level of the efflux transporters along the gut in rat.  A first attempt to correlate the "in vitro" and the "in situ" data was done.  The math. model was constructed using very simplistic assumptions and it will require further refinement but, nevertheless, the results are promising and demonstrate that a good modeling approach helps to identify the system crit. parameters and how the system behavior change when the parameters are modified as it happens when the authors move from the "in vitro" to the "in situ" level.  Predicted vs. exptl. permeability values show a good correlation, demonstrating that the relevance of the secretion process "in situ" in rat can be predicted from the "in vitro" cell results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorLrkcmgozLbVg90H21EOLACvtfcHk0lgu7webeUJzhQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2MXht12isrzL&amp;md5=e0892d9b6aa85111aeb45d3be950e084</span></div></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref71&#39;);return false;" class="refNumLink">71. </a></strong><div class="NLM_citation" id="cit71"><span class="hlFld-ContribAuthor ">Maeda<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.</span>; <span class="hlFld-ContribAuthor ">Takahashi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span>; <span class="hlFld-ContribAuthor ">Ohtsu<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>N.</span>; <span class="hlFld-ContribAuthor ">Oguma<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.</span>; <span class="hlFld-ContribAuthor ">Ohnishi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>T.</span>; <span class="hlFld-ContribAuthor ">Atsumi<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R.</span>; <span class="hlFld-ContribAuthor ">Tamai<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>I.</span><span class="NLM_article-title">Identification of Influx Transporter for the Quinolone Antibacterial Agent Levofloxacin</span> <span class="citation_source-journal">Mol. Pharmaceutics</span>  <span class="NLM_year">2007</span>,  <span class="NLM_volume">4</span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">94</span>, <span class="refDoi">DOI: 10.1021/mp060082j</span> <div class="citationLinks">[<a href="http://pubs.acs.org/doi/10.1021/mp060082j" title="">ACS Full Text <img src="./test1_files/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSlsLrL" title="">CAS</a>]<div class="casRecord" id="cas_cit71R"><div class="casContent"><span class="casTitleNuber">71. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Identification of influx transporter for the quinolone antibacterial agent levofloxacin</cas:atitle></div><div class="casAuthors">Maeda, Tomoji; Takahashi, Koichi; Ohtsu, Naoko; Oguma, Toshihiro; Ohnishi, Toshimasa; Atsumi, Ryo; Tamai, Ikumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">4</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-94</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPOHBP</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolone antibacterial agents exhibit high intestinal absorption, selective tissue distribution, and renal and biliary excretion.  Several ATP-binding cassette transporters are involved in efflux transport of these agents, but no influx transporters have yet been molecularly identified.  In the present study, we aimed to identify the influx transporter(s) of quinolone antibiotics using levofloxacin as a model compd.  Several candidate transporter genes were selected based on differential expression of mRNAs among Caco-2 cell subclones that exhibited differential uptake activities for levofloxacin.  Based on a functional anal. of each transporter gene for which a good correlation was found between expression level and levofloxacin transport activity in the Caco-2 subclones, org. anion transporting polypeptide 1A2 (OATP1A2 (OATP-A), SLCO1A2) was concluded to transport levofloxacin.  When OATP1A2 was expressed in Xenopus oocytes, levofloxacin transport was essentially pH-independent and was not stereoselective.  OATP1A2-mediated uptake of levofloxacin showed a Km value of 136 μM.  Apparent uptake of levofloxacin by Caco-2 cells showed high- and low-affinity components with Km values of 0.489 and 14.6 mM, resp.  Accordingly, plural transporters are functional for the transport of levofloxacin in Caco-2 cells, and OATP1A2 is likely to function as a high-affinity transporter.  The inhibitory effects and the expression of transport activity of other quinolone antibacterial agents suggested that OATP1A2 commonly transports all the agents tested.  In conclusion, this is the first identification of an influx transporter for fluoroquinolones, and the results suggest that active influx transport at least partially explains the high membrane permeability of the quinolone agents in various tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSgHRd9x8HWbVg90H21EOLACvtfcHk0lgu7webeUJzhQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28XhtFSlsLrL&amp;md5=9424a698d86edea3f318f0d5b9348aa5</span></div></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref72&#39;);return false;" class="refNumLink">72. </a></strong><div class="NLM_citation" id="cit72"><span class="hlFld-ContribAuthor ">Merino<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G.</span>; <span class="hlFld-ContribAuthor ">Alvarez<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. I.</span>; <span class="hlFld-ContribAuthor ">Pulido<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M. M.</span>; <span class="hlFld-ContribAuthor ">Molina<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. J.</span>; <span class="hlFld-ContribAuthor ">Schinkel<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. H.</span>; <span class="hlFld-ContribAuthor ">Prieto<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. G.</span><span class="NLM_article-title">Breast Cancer Resistance Protein (BCRP/ABCG2) Transports Fluoroquinolone Antibiotics and Affects Their Oral Availability, Pharmacokinetics, and Milk Secretion</span> <span class="citation_source-journal">Drug Metab. Dispos.</span>  <span class="NLM_year">2006</span>,  <span class="NLM_volume">34</span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">695</span>, <span class="refDoi">DOI: 10.1124/dmd.105.008219</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1124%2Fdmd.105.008219" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=16434544" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlKnsbs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit72R"><div class="casContent"><span class="casTitleNuber">72. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion</cas:atitle></div><div class="casAuthors">Merino, Gracia; Alvarez, Ana I.; Pulido, Mivis M.; Molina, Antonio J.; Schinkel, Alfred H.; Prieto, Julio G.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">34</cas:volume>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">690-695</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DMDSAI</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The breast cancer resistance protein (BCRP/ABCG2) is an ATP-binding cassette drug efflux transporter that extrudes xenotoxins from cells in intestine, liver, mammary gland, and other organs, affecting the pharmacol. and toxicol. behavior of many compds., including their secretion into the milk.  The purpose of this study was to det. whether three widely used fluoroquinolone antibiotics (ciprofloxacin, ofloxacin, and norfloxacin) are substrates of Bcrp1/BCRP and to investigate the possible role of this transporter in the in vivo pharmacokinetic profile of these compds. and their secretion into the milk.  Using polarized cell lines, we found that ciprofloxacin, ofloxacin, and norfloxacin are transported by mouse Bcrp1 and human BCRP.  In vivo pharmacokinetic studies showed that the ciprofloxacin plasma concn. was more than 2-fold increased in Bcrp1-/- compared with wild-type mice (1.77±0.73 vs. 0.85±0.39 μg/mL, p &lt; 0.01) after oral administration of ciprofloxacin (10 mg/kg).  The area under the plasma concn.-time curve in Bcrp1-/- mice was 1.5-fold higher than that in wild-type mice (48.63±5.66 vs. 33.10±4.68 min · μg/mL, p &lt; 0.05) after i.v. administration (10 mg/kg).  The milk concn. and milk/plasma ratio of ciprofloxacin were 2-fold higher in wild-type than in Bcrp1-/- lactating mice.  We conclude that Bcrp1 is one of the determinants for the bioavailability of fluoroquinolones and their secretion into the milk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbzLERLUkS3LVg90H21EOLACvtfcHk0lgu7webeUJzhQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28XjtlKnsbs%253D&amp;md5=ec414027a4a288788ac17e815c09114e</span></div></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref73&#39;);return false;" class="refNumLink">73. </a></strong><div class="NLM_citation" id="cit73"><span class="hlFld-ContribAuthor ">Barry<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. L.</span>; <span class="hlFld-ContribAuthor ">Fass<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. J.</span>; <span class="hlFld-ContribAuthor ">Anhalt<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. P.</span>; <span class="hlFld-ContribAuthor ">Neu<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. C.</span>; <span class="hlFld-ContribAuthor ">Thornsberry<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C.</span>; <span class="hlFld-ContribAuthor ">Tilton<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. C.</span>; <span class="hlFld-ContribAuthor ">Painter<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B. G.</span>; <span class="hlFld-ContribAuthor ">Washington<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>J. A.<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>2nd</span><span class="NLM_article-title">Ciprofloxacin Disk Susceptibility Tests: Interpretive Zone Size Standards for 5-Microgram Disks</span> <span class="citation_source-journal">J. Clin. Microbiol.</span>  <span class="NLM_year">1985</span>,  <span class="NLM_volume">21</span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">883</span><div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=3159749" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaL2MXktF2ksbs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit73R"><div class="casContent"><span class="casTitleNuber">73. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Ciprofloxacin disk susceptibility tests:  interpretive zone size standards for 5-μg disks</cas:atitle></div><div class="casAuthors">Barry, Arthur L.; Fass, Robert J.; Anhalt, John P.; Neu, Harold C.; Thornsberry, Clyde; Tilton, Richard C.; Painter, Barbara G.; Washington, John A., II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">1985</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">21</cas:volume>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">880-3</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">JCMIDW</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    </div><div class="casAbstract">Evaluations of 5-μg ciprofloxacin disk diffusion susceptibility tests were performed independently by 7 different investigators.  The results of the sep. tests were combined to increase the no. of resistant strains in the challenge set of microorganisms.  Based on data with 2652 isolates, the following interpretive breakpoints are tentatively proposed for use in ongoing clin. trials of ciprofloxacin: ≤15 mm, resistant [min. inhibitory concn. (MIC) &gt;2.0 μg/mL]; 16-20 mm, intermediate (1.0 &lt; MIC ≤2.0 μg/mL); and ≥21 mm, susceptible (MIC ≤1.0 μg/mL).  Disk tests with Streptococcus species and with Pseudomonas maltophilia were not reliable; other microorganisms were accurately categorized by the disk diffusion test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry8oQSopzTKLVg90H21EOLACvtfcHk0lgu7webeUJzhQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaL2MXktF2ksbs%253D&amp;md5=098e899ef981d5d7cd63a585e5bb4933</span></div></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref74&#39;);return false;" class="refNumLink">74. </a></strong><div class="NLM_citation" id="cit74"><span class="hlFld-ContribAuthor ">Barry<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A. L.</span>; <span class="hlFld-ContribAuthor ">Jones<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>R. N.</span>; <span class="hlFld-ContribAuthor ">Thornsberry<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>C.</span>; <span class="hlFld-ContribAuthor ">Ayers<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L. W.</span>; <span class="hlFld-ContribAuthor ">Gerlach<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>E. H.</span>; <span class="hlFld-ContribAuthor ">Sommers<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. M.</span><span class="NLM_article-title">Antibacterial Activities of Ciprofloxacin, Norfloxacin, Oxolinic Acid, Cinoxacin, and Nalidixic Acid</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span>  <span class="NLM_year">1984</span>,  <span class="NLM_volume">25</span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">637</span>, <span class="refDoi">DOI: 10.1128/AAC.25.5.633</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1128%2FAAC.25.5.633" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=6233935" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaL2cXksFWmu7w%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit74R"><div class="casContent"><span class="casTitleNuber">74. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid</cas:atitle></div><div class="casAuthors">Barry, A. L.; Jones, R. N.; Thornsberry, C.; Ayers, L. W.; Gerlach, E. H.; Sommers, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1984</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">25</cas:volume>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-7</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">AMACCQ</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">In vitro studies were performed comparing ciprofloxacin (Bay o 9867) and norfloxacin with 3 related org. acids.  Ciprofloxacin was 2-8 fold more active than norfloxacin against 658 bacterial isolates representing 30 species.  For all species tested, ciprofloxacin min. inhibitory concns. for 90% inhibition were ≤2.0 μg/mL.  Addnl. tests with 5994 isolates detected only 37 (0.6%) strains resistant to 2.0 μg of ciprofloxacin per mL and 106 (1.8%) resistant to 1.0 μg/mL.  Only 6 (0.1%) of the 5994 strains were resistant to 16 μg of norfloxacin per mL, and 129 (2.1%) were resistant to 4.0 μg/mL.  The majority of resistant strains were streptococci or Pseudomonas species.  Resistance among the Enterobacteriaceae was extremely rare (i.e., &gt;99.8% susceptible to both drugs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkqd6p_ZrRrVg90H21EOLACvtfcHk0liaWXZHZ31yQQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaL2cXksFWmu7w%253D&amp;md5=fd968ab7cdffe035983924fc01417289</span></div></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref75&#39;);return false;" class="refNumLink">75. </a></strong><div class="NLM_citation" id="cit75"><span class="hlFld-ContribAuthor ">Standiford<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>H. C.</span>; <span class="hlFld-ContribAuthor ">Drusano<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G. L.</span>; <span class="hlFld-ContribAuthor ">Forrest<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>A.</span>; <span class="hlFld-ContribAuthor ">Tatem<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>B.</span>; <span class="hlFld-ContribAuthor ">Plaisance<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K.</span><span class="NLM_article-title">Bactericidal Activity of Ciprofloxacin Compared with that of Cefotaxime in Normal Volunteers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span>  <span class="NLM_year">1987</span>,  <span class="NLM_volume">31</span>,  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi">DOI: 10.1128/AAC.31.8.1177</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1128%2FAAC.31.8.1177" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=3631942" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaL2sXlsVKrurw%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit75R"><div class="casContent"><span class="casTitleNuber">75. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers</cas:atitle></div><div class="casAuthors">Standiford, Harold C.; Drusano, George L.; Forrest, Alan; Tatem, Beverly; Plaisance, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1987</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">31</cas:volume>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1177-82</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">AMACCQ</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Ciprofloxacin (200 mg) was compared with cefotaxime (2 g) when each was administered i.v. over a 30-min period to volunteers in a crossover manner 1 wk apart.  To integrate the pharmacol. and microbiol. activity, inhibitory and bactericidal activities in serum were obtained for both antibiotics 1 and 6 h after administration against 10 strains of Escherichia coli, 10 strains of Klebsiella pneumoniae, 15 strains of Pseudomonas aeruginosa, and 10 strains each of methicillin-susceptible and -resistant Staphylococcus aureus.  Geometric mean bactericidal titers for E. coli 1 h after the infusion were 1:60 for ciprofloxacin and 1:252 for cefotaxime, and for K. pneumoniae they were 1:20 and 1:256, resp.  However, geometric mean titers were poor for both antibiotics against methicillin-susceptible S. aureus (&lt;1:2 for ciprofloxacin vs. 1:5 for cefotaxime) and methicillin-resistant S. aureus (&lt;1:2 for both antibiotics), as well as against P. aeruginosa (1:3 for ciprofloxacin vs. 1:2 for cefotaxime).  These data suggest that ciprofloxacin may be useful for the treatment of serious infectons caused by E. coli and K. pneumoniae.  However, caution is suggested when this dose of ciprofloxacin is used in situations in which septicemia is caused by P. aeruginosa or S. aureus and originates outside the urinary tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvVsvyXyHx5bVg90H21EOLACvtfcHk0liaWXZHZ31yQQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaL2sXlsVKrurw%253D&amp;md5=13e098aeef31b5403253076ea583f199</span></div></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref76&#39;);return false;" class="refNumLink">76. </a></strong><div class="NLM_citation" id="cit76"><span class="hlFld-ContribAuthor ">Well<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Naber<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>K. G.</span>; <span class="hlFld-ContribAuthor ">Kinzig-Schippers<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>M.</span>; <span class="hlFld-ContribAuthor ">Sörgel<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>F.</span><span class="NLM_article-title">Urinary Bactericidal Activity and Pharmacokinetics of Enoxacin versus Norfloxacin and Ciprofloxacin in Healthy Volunteers after a Single Oral Dose</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span>  <span class="NLM_year">1998</span>,  <span class="NLM_volume">10</span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">38</span>, <span class="refDoi">DOI: 10.1016/S0924-8579(98)00014-4</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1016%2FS0924-8579%2898%2900014-4" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=9624541" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1Ogtbs%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit76R"><div class="casContent"><span class="casTitleNuber">76. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose</cas:atitle></div><div class="casAuthors">Well, Michaela; Naber, Kurt G.; Kinzig-Schippers, M.; Sorgel, Fritz</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">1998</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">10</cas:volume>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IAAGEA</cas:coden>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In an open, randomized monocentric crossover study in six male and six female healthy volunteers, the urinary antibacterial activity and pharmacokinetics of enoxacin, norfloxacin and ciprofloxacin were assessed.  Urine was collected up to 6 days, and venous blood samples up to 12 h, after a single oral dose of 400 mg enoxacin, 400 mg norfloxacin and 500 mg ciprofloxacin.  Enoxacin (250 mg/l) demonstrated the highest peak concn. (median) in the urine (0-6 h), followed by ciprofloxacin (237 mg/l) and norfloxacin (157 mg/l) as detd. by the HPLC assay.  The total amt. (mean) excreted by the kidneys as parent drugs were as follows: enoxacin 54% of dose, ciprofloxacin 33% of dose, and norfloxacin 22% of dose.  The mean plasma concns. decreased from 1 to 4 h after administration for enoxacin from 1.9 to 1.4 mg/l, for ciprofloxacin from 2.0 to 0.8 mg/l and for norfloxacin from 1.3 to 0.5 mg/l.  The antibacterial activity in urine was detd. as urinary bactericidal titers (UBT), i.e. the highest 2-fold diln. of urine still bactericidal for the ref. organism (E. coli ATCC 25922) and for five uropathogens with minimal inhibitory (MIC) and bactericidal (MBC) concns. ranging from highly susceptible to resistant cultured from the urine of patients with complicated urinary tract infections (UTI).  For the E. coli ATCC 25922, the organism with the lowest MIC, median UBTs of ciprofloxacin were present for 4 days, decreasing from 1:512 to 1:2, that of enoxacin for 2 days, decreasing from 1:256 to 1:4, and that of norfloxacin for 2 days, decreasing from 1:128 to 1:2.  For the five uropathogens (with increasing MICs: K. pneumoniae, P. mirabilis, E. coli (resistant to nalidixic acid), P. aeruginosa and E. faecalis), the UBTs decreased in general, according to MICs, demonstrating the same relations of UBTs for ciprofloxacin (highest) vs. enoxacin (medium) vs. norfloxacin (lowest) with one exception (P. mirabilis) for which norfloxacin showed higher UBTs than enoxacin.  The minimal urinary bactericidal concns. (MUBC), as derived from urinary concns., and UBTs showed a fairly wide inter- and intraindividual range and were generally higher than the corresponding MBCs as detd. in Mueller Hinton broth.  In conclusion, according to antibacterial activity in urine detd. as UBTs, a single oral dose of ciprofloxacin (500 mg) generally resulted in the highest and longest-lasting UBTs followed by that of enoxacin (400 mg) and norfloxacin (400 mg).  A dose of 400 mg enoxacin can be expected to be at least equiv. if not superior to that of 400 mg enoxacin.  Only enoxacin and ciprofloxacin exhibited urinary bactericidal activity against all test organisms up to 12 h in all individuals.  Therefore, clin. comparison of enoxacin vs. ciprofloxacin in the treatment of complicated UTI could be worth testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorVqajeg-KOrVg90H21EOLACvtfcHk0liaWXZHZ31yQQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK1cXkt1Ogtbs%253D&amp;md5=90b21da5931dd9c39389c5fefc1f2deb</span></div></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="JavaScript:void(0);" onclick="showRef(event, &#39;ref77&#39;);return false;" class="refNumLink">77. </a></strong><div class="NLM_citation" id="cit77"><span class="hlFld-ContribAuthor ">Pankey<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>G. A.</span>; <span class="hlFld-ContribAuthor ">Sabath<span class="NLM_x"><x xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:space="preserve">, </x></span>L. D.</span><span class="NLM_article-title">Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram-Positive Bacterial Infections</span> <span class="citation_source-journal">Clin. Infect. Dis.</span>  <span class="NLM_year">2004</span>,  <span class="NLM_volume">38</span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">870</span>, <span class="refDoi">DOI: 10.1086/381972</span> <div class="citationLinks">[<a href="http://pubs.acs.org/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=10.1086%2F381972" title="">CrossRef</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=14999632" title="">PubMed</a>], [<a href="http://pubs.acs.org/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.molpharmaceut.7b00039&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlCksrc%253D" title="">CAS</a>]<div class="casRecord" id="cas_cit77R"><div class="casContent"><span class="casTitleNuber">77. </span><div class="casTitle"><cas:atitle xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections</cas:atitle></div><div class="casAuthors">Pankey, G. A.; Sabath, L. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <cas:volume xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">38</cas:volume>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-870</span>CODEN:
                <cas:coden xmlns:cas="http://www.cas.org/citations" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:acs="http://namespace.acs.org/2008/acs" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CIDIEL</cas:coden>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  The distinction between bactericidal and bacteriostatic agents appears to be clear according to the in vitro definition, but this only applies under strict lab. conditions and is inconsistent for a particular agent against all bacteria.  The distinction is more arbitrary when agents are categorized in clin. situations.  The supposed superiority of bactericidal agents over bacteriostatic agents is of little relevance when treating the vast majority of infections with gram-pos. bacteria, particularly in patients with uncomplicated infections and noncompromised immune systems.  Bacteriostatic agents (e.g., chloramphenicol, clindamycin, and linezolid) were effectively used for treatment of endocarditis, meningitis, and osteomyelitis-indications that are often considered to require bactericidal activity.  Although bacteriostatic/bactericidal data may provide valuable information on the potential action of antibacterial agents in vitro, it is necessary to combine this information with pharmacokinetic and pharmacodynamic data to provide more meaningful prediction of efficacy in vivo.  The ultimate guide to treatment of any infection must be clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_xAGW1Cri1rVg90H21EOLACvtfcHk0liaWXZHZ31yQQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2cXjtlCksrc%253D&amp;md5=4847394218daaf4fa66c1fce9e21f543</span></div></div></div></div></li></ol></div></div></div><script type="text/javascript">
                    window.figureViewer={doi:'10.1021/acs.molpharmaceut.7b00039',path:'/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627',figures:[{i:'f_tgr1',g:[{m:'mp-2017-00039m_0009.gif',l:'mp-2017-00039m_0009.jpeg'}]}
                    ,{i:'fig1',g:[{m:'mp-2017-00039m_0001.gif',l:'mp-2017-00039m_0001.jpeg'}]}
                    ,{i:'fig2',g:[{m:'mp-2017-00039m_0002.gif',l:'mp-2017-00039m_0002.jpeg'}]}
                    ,{i:'fig3',g:[{m:'mp-2017-00039m_0003.gif',l:'mp-2017-00039m_0003.jpeg'}]}
                    ,{i:'fig4',g:[{m:'mp-2017-00039m_0004.gif',l:'mp-2017-00039m_0004.jpeg'}]}
                    ,{i:'fig5',g:[{m:'mp-2017-00039m_0005.gif',l:'mp-2017-00039m_0005.jpeg'}]}
                    ,{i:'fig6',g:[{m:'mp-2017-00039m_0006.gif',l:'mp-2017-00039m_0006.jpeg'}]}
                    ,{i:'fig7',g:[{m:'mp-2017-00039m_0007.gif',l:'mp-2017-00039m_0007.jpeg'}]}
                    ,{i:'fig8',g:[{m:'mp-2017-00039m_0008.gif',l:'mp-2017-00039m_0008.jpeg'}]}
                    ]}</script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77']}</script><div class="imageMetaContainer"><input type="hidden" class="og-meta-image" name="og:image" value="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627/images/medium/mp-2017-00039m_0009.gif"><input type="hidden" class="og-meta-url" name="og:url" value="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039"><input type="hidden" class="og-meta-title" name="og:title" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><input type="hidden" class="og-meta-description" name="og:description" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><input type="hidden" class="twitter-meta-image" name="twitter:image" value="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627/images/medium/mp-2017-00039m_0009.gif"><input type="hidden" class="twitter-meta-title" name="twitter:title" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><input type="hidden" class="twitter-meta-description" name="twitter:description" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"></div>
                        </article>
                        
                    
            </div>
            <div class="tab tab-pane" id="relatedContent">
                






            </div>
            

        </div>
        












    
</div>
    </div>
<input id="viewLargeImageCaption" type="hidden" value="View Large Image">
<input class="orcid-show-icon" type="hidden" value="true"></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget citingRelatedContent none relatedcontent widget-none" id="f7276e41-a542-4df4-95ec-7d4523771d8a">
        
        
            
        

        <div class="wrapped " id="relatedcontent">
            
            <div class="widget-body body body-none "><div class="decorated-tabs tabs tabs-widget layout-tabs"><ul class="tab-nav citingRelatedNav"><li aria-selected="true" class="active"><a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#tabs-2">Related Content</a></li></ul><div class="tab-content"><div id="tabs-2" class="tab-pane active"><div id="relatedArticles"><ul class="additionalPubList recommendedPubList"><h3 class="relatedArticlesHead">Related Content:</h3><li><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b01151?src=recsys">Understanding the Impact of Water on the Miscibility and Microstructure of Amorphous Solid Dispersions: An AFM–LCR and TEM–EDX Study</a><div class="achsLabel">Molecular Pharmaceutics</div><span class="entryAuthor normal hlFld-ContribAuthor">Li</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Gilpin</span>, and <span class="entryAuthor normal hlFld-ContribAuthor">Taylor</span><div class="recoPubMetaData"><span><span class="bold">2017</span> <em>14</em> (5), pp 1691–1705</span></div><div class="recoPubAbstract"><span><span class="bold">Abstract:</span> Miscibility is critical for amorphous solid dispersions (ASDs). Phase-separated ASDs are more prone to crystallization, and thus can lose their solubility advantage leading to product failure. Additionally, dissolution performance can be diminished as a ...</span></div><div class="linkbar recoPublinkbar"><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b01151?src=recsys">Abstract</a> | <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.6b01151?src=recsys">Full Text HTML</a> | <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.6b01151?src=recsys">PDF w/ Links</a> | <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b01151?src=recsys">Hi-Res PDF</a></div></li><li><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00097?src=recsys">Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility</a><div class="achsLabel">Molecular Pharmaceutics</div><span class="entryAuthor normal hlFld-ContribAuthor">Shi</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Zhang</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Su</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Zhang</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Zhou</span>, and <span class="entryAuthor normal hlFld-ContribAuthor">Cai</span><div class="recoPubMetaData"><span><span class="bold">2017</span> <em>14</em> (7), pp 2262–2272</span></div><div class="recoPubAbstract"><span><span class="bold">Abstract:</span> This study aims to investigate the crystallization behavior and molecular dynamics of amorphous griseofulvin (GSF) in the presence of low-concentration poly(ethylene oxide) (PEO). We observe that the addition of 3% w/w PEO remarkably increases the crystal ...<sub></sub><sub></sub><sub></sub></span></div><div class="linkbar recoPublinkbar"><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00097?src=recsys">Abstract</a> | <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00097?src=recsys">Full Text HTML</a> | <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.7b00097?src=recsys">PDF w/ Links</a> | <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00097?src=recsys">Hi-Res PDF</a></div></li><li><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00178?src=recsys">Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives</a><div class="achsLabel">Molecular Pharmaceutics</div><span class="entryAuthor normal hlFld-ContribAuthor">Ueda</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Higashi</span>, and <span class="entryAuthor normal hlFld-ContribAuthor">Moribe</span><div class="recoPubMetaData"><span><span class="bold">2017</span> <em>14</em> (7), pp 2314–2322</span></div><div class="recoPubAbstract"><span><span class="bold">Abstract:</span> We investigated the phase separation behavior and maintenance mechanism of the supersaturated state of poorly water-soluble nifedipine (NIF) in hypromellose (HPMC) derivative solutions. Highly supersaturated NIF formed NIF-rich nanodroplets through phase ...<sup></sup></span></div><div class="linkbar recoPublinkbar"><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00178?src=recsys">Abstract</a> | <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00178?src=recsys">Full Text HTML</a> | <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.7b00178?src=recsys">PDF w/ Links</a> | <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00178?src=recsys">Hi-Res PDF</a></div></li><li><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00338?src=recsys">Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux <i>in Vitro</i> and Oral Bioavailability in Rats</a><div class="achsLabel">Molecular Pharmaceutics</div><span class="entryAuthor normal hlFld-ContribAuthor">Stewart</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Grass</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Brodeur</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Goodwin</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Morgen</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Friesen</span>, and <span class="entryAuthor normal hlFld-ContribAuthor">Vodak</span><div class="recoPubMetaData"><span><span class="bold">2017</span> <em>14</em> (7), pp 2437–2449</span></div><div class="recoPubAbstract"><span><span class="bold">Abstract:</span> Improving the oral absorption of compounds with low aqueous solubility is a common challenge that often requires an enabling technology. Frequently, oral absorption can be improved by formulating the compound as an amorphous solid dispersion (ASD). Upon ...</span></div><div class="linkbar recoPublinkbar"><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00338?src=recsys">Abstract</a> | <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00338?src=recsys">Full Text HTML</a> | <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.7b00338?src=recsys">PDF w/ Links</a> | <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00338?src=recsys">Hi-Res PDF</a></div></li><li><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00197?src=recsys">Chemical End Group Modified Diblock Copolymers Elucidate Anchor and Chain Mechanism of Membrane Stabilization</a><div class="achsLabel">Molecular Pharmaceutics</div><span class="entryAuthor normal hlFld-ContribAuthor">Houang</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Haman</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Kim</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Zhang</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Lowe</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Sham</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Lodge</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Hackel</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Bates</span>, and <span class="entryAuthor normal hlFld-ContribAuthor">Metzger</span><div class="recoPubMetaData"><span><span class="bold">2017</span> <em>14</em> (7), pp 2333–2339</span></div><div class="recoPubAbstract"><span><span class="bold">Abstract:</span> Block copolymers can be synthesized in an array of architectures and compositions to yield diverse chemical properties. The triblock copolymer Poloxamer 188 (P188), the family archetype, consisting of a hydrophobic poly(propylene oxide) core flanked by ...</span></div><div class="linkbar recoPublinkbar"><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00197?src=recsys">Abstract</a> | <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00197?src=recsys">Full Text HTML</a> | <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.7b00197?src=recsys">PDF w/ Links</a> | <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00197?src=recsys">Hi-Res PDF</a></div></li><li><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00226?src=recsys">Isotope-Edited Infrared Spectroscopy for Efficient Discrimination between Pharmaceutical Salts and Cocrystals</a><div class="achsLabel">Molecular Pharmaceutics</div><span class="entryAuthor normal hlFld-ContribAuthor">Iwata</span>, <span class="entryAuthor normal hlFld-ContribAuthor">Karashima</span>, and <span class="entryAuthor normal hlFld-ContribAuthor">Ikeda</span><div class="recoPubMetaData"><span><span class="bold">2017</span> <em>14</em> (7), pp 2350–2358</span></div><div class="recoPubAbstract"><span><span class="bold">Abstract:</span> Isotope-edited infrared spectroscopy using carboxylic acids selectively labeled with <sup>13</sup>C is proposed herein for the efficient discrimination of pharmaceutical salts and cocrystals, whereby proton-transfer probe vibrations are highlighted by isotope ...</span></div><div class="linkbar recoPublinkbar"><a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00226?src=recsys">Abstract</a> | <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00226?src=recsys">Full Text HTML</a> | <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.7b00226?src=recsys">PDF w/ Links</a> | <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00226?src=recsys">Hi-Res PDF</a></div></li></ul></div></div></div></div><div class="imageMetaContainer"><input type="hidden" class="og-meta-image" name="og:image" value="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627/images/medium/mp-2017-00039m_0009.gif"><input type="hidden" class="og-meta-url" name="og:url" value="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039"><input type="hidden" class="og-meta-title" name="og:title" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><input type="hidden" class="og-meta-description" name="og:description" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><input type="hidden" class="twitter-meta-image" name="twitter:image" value="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2017/mpohbp.2017.14.issue-7/acs.molpharmaceut.7b00039/20170627/images/medium/mp-2017-00039m_0009.gif"><input type="hidden" class="twitter-meta-title" name="twitter:title" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"><input type="hidden" class="twitter-meta-description" name="twitter:description" value="Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin"></div></div>
        </div>
    </div>
    
        </div>
    </div>
    <div class="width_7_24">
        <div data-pb-dropzone="right" class="pb-autoheight">



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-frame none article-rightCol widget-regular  widget-compact-all" id="067d2636-8e51-4c5b-ab96-1f9f356e2d63">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-regular  body-compact-all"><div data-pb-dropzone="contents">
    


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-bookmark-share alignCenter  widget-none" id="38e82894-a98f-40d3-9bce-ee8aa23396f5">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none "><!-- AddThis Button BEGIN -->
<div class="addthis_toolbox addthis_default_style addthis_32x32_style" addthis:url="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039">
        <a class="addthis_button_twitter at300b" title="Twitter" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#"><span class="at-icon-wrapper" style="background-color: rgb(29, 161, 242); line-height: 32px; height: 32px; width: 32px;"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 32 32" title="Twitter" alt="Twitter" class="at-icon at-icon-twitter" style="width: 32px; height: 32px;"><g><path d="M27.996 10.116c-.81.36-1.68.602-2.592.71a4.526 4.526 0 0 0 1.984-2.496 9.037 9.037 0 0 1-2.866 1.095 4.513 4.513 0 0 0-7.69 4.116 12.81 12.81 0 0 1-9.3-4.715 4.49 4.49 0 0 0-.612 2.27 4.51 4.51 0 0 0 2.008 3.755 4.495 4.495 0 0 1-2.044-.564v.057a4.515 4.515 0 0 0 3.62 4.425 4.52 4.52 0 0 1-2.04.077 4.517 4.517 0 0 0 4.217 3.134 9.055 9.055 0 0 1-5.604 1.93A9.18 9.18 0 0 1 6 23.85a12.773 12.773 0 0 0 6.918 2.027c8.3 0 12.84-6.876 12.84-12.84 0-.195-.005-.39-.014-.583a9.172 9.172 0 0 0 2.252-2.336" fill-rule="evenodd"></path></g></svg></span></a>
        <a class="addthis_button_facebook at300b" title="Facebook" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#"><span class="at-icon-wrapper" style="background-color: rgb(59, 89, 152); line-height: 32px; height: 32px; width: 32px;"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 32 32" title="Facebook" alt="Facebook" class="at-icon at-icon-facebook" style="width: 32px; height: 32px;"><g><path d="M22 5.16c-.406-.054-1.806-.16-3.43-.16-3.4 0-5.733 1.825-5.733 5.17v2.882H9v3.913h3.837V27h4.604V16.965h3.823l.587-3.913h-4.41v-2.5c0-1.123.347-1.903 2.198-1.903H22V5.16z" fill-rule="evenodd"></path></g></svg></span></a>
        <a class="addthis_button_google_plusone_share at300b" target="_blank" title="Google+" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#"><span class="at-icon-wrapper" style="background-color: rgb(220, 78, 65); line-height: 32px; height: 32px; width: 32px;"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 32 32" title="Google+" alt="Google+" class="at-icon at-icon-google_plusone_share" style="width: 32px; height: 32px;"><g><path d="M12 15v2.4h3.97c-.16 1.03-1.2 3.02-3.97 3.02-2.39 0-4.34-1.98-4.34-4.42s1.95-4.42 4.34-4.42c1.36 0 2.27.58 2.79 1.08l1.9-1.83C15.47 9.69 13.89 9 12 9c-3.87 0-7 3.13-7 7s3.13 7 7 7c4.04 0 6.72-2.84 6.72-6.84 0-.46-.05-.81-.11-1.16H12zm15 0h-2v-2h-2v2h-2v2h2v2h2v-2h2v-2z" fill-rule="evenodd"></path></g></svg></span></a>
        <a class="addthis_button_email at300b" target="_blank" title="Email" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#"><span class="at-icon-wrapper" style="background-color: rgb(132, 132, 132); line-height: 32px; height: 32px; width: 32px;"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 32 32" title="Email" alt="Email" class="at-icon at-icon-email" style="width: 32px; height: 32px;"><g><g fill-rule="evenodd"></g><path d="M27 22.757c0 1.24-.988 2.243-2.19 2.243H7.19C5.98 25 5 23.994 5 22.757V13.67c0-.556.39-.773.855-.496l8.78 5.238c.782.467 1.95.467 2.73 0l8.78-5.238c.472-.28.855-.063.855.495v9.087z"></path><path d="M27 9.243C27 8.006 26.02 7 24.81 7H7.19C5.988 7 5 8.004 5 9.243v.465c0 .554.385 1.232.857 1.514l9.61 5.733c.267.16.8.16 1.067 0l9.61-5.733c.473-.283.856-.96.856-1.514v-.465z"></path></g></svg></span></a>
    <a class="addthis_button_compact at300m" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#"><span class="at-icon-wrapper" style="background-color: rgb(255, 101, 80); line-height: 32px; height: 32px; width: 32px;"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 32 32" title="More" alt="More" class="at-icon at-icon-addthis" style="width: 32px; height: 32px;"><g><path d="M18 14V8h-4v6H8v4h6v6h4v-6h6v-4h-6z" fill-rule="evenodd"></path></g></svg></span></a>
<div class="atclear"></div></div>
<script type="text/javascript">
    var script = document.createElement('script');
    script.type='text/javascript';
    script.src='//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-553ffb6a26ba3f77';
    script.async = true;
    $('head').append(script)
</script>
<!-- AddThis Button END --></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget publicationFormatLinks none  widget-none  widget-compact-all" id="e665b162-cd85-4a56-ab94-9d58c9e3b43a">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="publicationFormatCont">
    
    
    
            <label class="sideConetntHeader">Article Options</label>
        

    <ul class="publicationFormatList icons">

        
            <li class="icon-item icon-item-24px active-view-pdf">
                <a href="http://pubs.acs.org/doi/ipdf/10.1021/acs.molpharmaceut.7b00039" title="ACS ActiveView PDF" target="_blank">
                    ACS ActiveView PDF
                    <div class="icon-24px"></div>
                </a>
                <div class="details">Hi-Res Print, Annotate, Reference QuickView</div>
            </li>
        

        
            <li class="icon-item icon-item-24px subordinate pdf-high-res">
                
                <a href="http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00039" title="High-Res PDF: 3655 KB" target="_blank">
                    PDF <span class="details">(3655 KB)</span>

                    <div class="icon-24px"></div>
                </a>
            </li>
        

        
            <li class="icon-item icon-item-24px subordinate pdf-low-res">
                
                <a href="http://pubs.acs.org/doi/pdfplus/10.1021/acs.molpharmaceut.7b00039" title="Low-Res PDF: 820 KB" target="_blank">
                    PDF w/ Links <span class="details">(820 KB)</span>

                    <div class="icon-24px"></div>
                </a>
            </li>
        

        
            <li class="icon-item icon-item-24px subordinate full-text-html active">
                <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039" title="Full Text HTML">
                    Full Text HTML
                    <div class="icon-24px"></div>
                </a>
            </li>
        
    </ul>

    <ul class="publicationFormatrightList">
        <li class="">
            <a href="http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00039" title="View the Abstract">
                Abstract
            </a>
        </li>
        
            <li class="">
                <a href="http://pubs.acs.org/doi/suppl/10.1021/acs.molpharmaceut.7b00039">
                    Supporting Info
                </a>
            </li>
        

        
            <li>
                
                        <a class="showFiguresLink" href="JavaScript:void(0);" onclick="showFigures(event); return false">
                            Figures
                        </a>
                    

            </li>
        

        
            
                    <li>
                        
                        <a onclick="showRef(event); return false;" href="JavaScript:void(0);" class="showRefLink">
                            References
                        </a>
                    </li>
                
        
        

    </ul>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumArticleToolsWidget none  widget-none  widget-compact-all" id="9f81f65c-f41b-4b98-a9f0-28dc0dbb08ed">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="articleTools">
    
            



















    

<div class="toolbar-section toolbar-tools-sharing">
    <label class="toolbar-section-header">Tools &amp; Sharing</label>
    <ul class="icons">
        
                
                    <li class="icon-item icon-item-24px add-favorites">
                        <a href="http://pubs.acs.org/personalize/addFavoritePublication?doi=10.1021%2Facs.molpharmaceut.7b00039" title="Add to Favorites">
                            Add to Favorites
                            <div class="icon-24px"></div>
                        </a>
                    </li>
                
                
                    <li class="icon-item icon-item-24px download-citation">
                        <a href="http://pubs.acs.org/action/showCitFormats?href=http%3A%2F%2Fpubs.acs.org%2Fdoi%2Ffull%2F10.1021%2Facs.molpharmaceut.7b00039&amp;doi=10.1021%2Facs.molpharmaceut.7b00039" title="Download Citation">
                            Download Citation
                            <div class="icon-24px"></div>
                        </a>
                    </li>
                
            
        
            <li class="icon-item icon-item-24px email-colleague citation-alerts">
                <a href="http://pubs.acs.org/action/showMailPage?href=%2Fdoi%2Ffull%2F10.1021%2Facs.molpharmaceut.7b00039&amp;title=Amorphous+Polymeric+Drug+Salts+as+Ionic+Solid+Dispersion+Forms+of+Ciprofloxacin&amp;doi=10.1021%2Facs.molpharmaceut.7b00039" title="Email a Colleague">
                    
                    
                    Email a Colleague
                    <div class="icon-24px"></div>
                </a>
            </li>
        

        
            
                <li class="icon-item icon-item-24px order-reprints">
                    <a id="orderReprints" title="Order Commercial Reprints" href="http://services.acs.org/pubshelp/passthru.cgi?action=kb&amp;item=1190" target="_blank">
                        Order Reprints
                        <div class="icon-24px"></div>
                    </a>
                </li>
            
            
                
                    <li class="icon-item icon-item-24px rights-permissions">
                        <a id="rightsAndPermissions" title="Rights &amp; Permissions" href="http://pubs.acs.org/servlet/linkout?type=rightslink&amp;url=startPage%3D2209%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHanah%2BMesallati%252C%2BAnita%2BUmerska%252C%2BKrzysztof%2BJ.%2BPaluch%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D14%26issueNum%3D7%26contentID%3Dacs.molpharmaceut.7b00039%26title%3DAmorphous%2BPolymeric%2BDrug%2BSalts%2Bas%2BIonic%2BSolid%2BDispersion%2BForms%2Bof%2BCiprofloxacin%26issn%3D1543-8384%26publisherName%3Dacs%26publication%3Dmpohbp%26rpt%3Dn%26endPage%3D2223%26publicationDate%3DJuly%2B2017" target="_blank">
                            Rights &amp; Permissions
                            <div class="icon-24px"></div>
                        </a>
                    </li>
                
            
            
                <li class="icon-item icon-item-24px citation-alerts">
                    <a href="http://pubs.acs.org/action/addCitationAlert?doi=10.1021%2Facs.molpharmaceut.7b00039" title="Citation Alerts">
                        Citation Alerts
                        <div class="icon-24px"></div>
                    </a>
                </li>
            
        
    </ul>
</div>
        
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none toolbar widget-none  widget-compact-all" id="c81a0122-0045-4ad2-9ed7-5743378e5b2e">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="chemworx-sidebar chemworx-entry icon-item-24px">
  <a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" onclick="ACSPubs.platinum.addCitation([&#39;10.1021/acs.molpharmaceut.7b00039&#39;]);return false;">
    <span class="icon-24px"></span>
    Add to ACS ChemWorx</a>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumSciFinderWidget none  widget-none  widget-compact-all" id="3adc9478-c3fb-4127-b9b7-650d0b059113">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div id="casSection" class="toolbar-section toolbar-sci-finder">
            <div class="toolbar-section-header">
                
                        <img class="sciFinderLogo" src="./test1_files/new-scifinder.png" alt="SciFinder Subscribers">
                    
                <a href="https://scifinder.cas.org/" target="_blank">
                    <button type="submit">Sign in</button>
                </a>
            </div>
            <ul class="cas-links">
                
                    
                    <li class="first">
                        <a href="http://pubs.acs.org/action/clickThrough?id=202424&amp;url=https%3A%2F%2Fscifinder.cas.org%2Fscifinder%2Fview%2Flink_v1%2Freference.jsf%3Fl%3DBmxxGlm8wGpgyAXosaE5H7Vg90H21EOLACvtfcHk0liO2MHfEYfB2g&amp;loc=%2FControllerServlet&amp;pubId=40026041&amp;placeholderId=3130&amp;productId=0" title="Retrieve Detailed Record of this Article" target="scifinder">Retrieve Detailed Record of this Article</a>
                    </li>
                
                    
                    <li class="">
                        <a href="http://pubs.acs.org/action/clickThrough?id=202432&amp;url=https%3A%2F%2Fscifinder.cas.org%2Fscifinder%2Fview%2Flink_v1%2FsubstancesFromReference.jsf%3Fl%3D4t9nkuNz3tw0bBf2vQptEltoDFflTVYFQkCTEVQ_hd2IqWT69oQQGIlopjZB5xMttQwD9OmoEd2VBNs_ZAsJKQzP5DSE-pIQ&amp;loc=%2FControllerServlet&amp;pubId=40026041&amp;placeholderId=3130&amp;productId=0" title="Retrieve Substances Indexed for this Article" target="scifinder">Retrieve Substances Indexed for this Article</a>
                    </li>
                
                    
                    <li class="last">
                        <a href="http://pubs.acs.org/action/clickThrough?id=202448&amp;url=https%3A%2F%2Fscifinder.cas.org%2Fscifinder%2Fview%2Flink_v1%2Fcited.jsf%3Fl%3DAkUi5EvKt81oKPlj93mNSTgnAicRmhHFtrnDmCxc-CThi25Vg2O3MgrUf8uL9NLu&amp;loc=%2FControllerServlet&amp;pubId=40026041&amp;placeholderId=3130&amp;productId=0" title="Retrieve All References Cited for this Article" target="scifinder">Retrieve All References Cited for this Article</a>
                    </li>
                
            </ul>
            
                <form id="sci-finder-search--modes" class="sci-finder-form" action="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#">
                    <h5>Explore by:</h5>
                    
                        <label for="sci-finder-article-author">
                            <input onclick="toggleSFinterface(this);" id="sci-finder-article-author" type="radio" name="sci-finder-explore" value="article-authors" checked="checked">
                            Author of this
                            
                                    Article
                                
                        </label>
                    
                    <label for="sci-finder-any-author">
                        <input onclick="toggleSFinterface(this);" id="sci-finder-any-author" type="radio" name="sci-finder-explore" value="any-author">
                        Any Author
                    </label>
                    <label for="sci-finder-research-topic">
                        <input onclick="toggleSFinterface(this);" id="sci-finder-research-topic" type="radio" name="sci-finder-explore" value="research-topic">
                        Research Topic
                    </label>
                    <hr>
                </form>

                
                    <form action="http://pubs.acs.org/action/sciFinderSearch" id="sci-finder-search--article-authors" name="sfArtAuthorsLayer" class="sci-finder-form" method="post" target="scifinder"><label for="science-finder-article-author" class="science-finder-article-author">
                            <select id="science-finder-article-author" name="authorName">

                                
                                    <option>Mesallati, Hanah</option>
                                
                                    <option>Umerska, Anita</option>
                                
                                    <option>Paluch, Krzysztof J.</option>
                                
                                    <option>Tajber, Lidia</option>
                                
                            </select>

                        </label>
                        <button type="submit">Search</button>
                        <input type="hidden" name="searchAuthorsFromContent" value="Search"></form>
                

                <form action="http://pubs.acs.org/action/sciFinderSearch" id="science-finder-search--article-authors" name="science-finder-search--article-authors" class="sci-finder-form hidden" method="post" target="scifinder" onsubmit="return validateSciFinderContent();"><label for="sci-finder-author-last-name">
                        <span class="sci-finder-name">Last *</span>
                        <input id="sci-finder-author-last-name" type="text" name="lastName" value="" size="15">
                        
                    </label>
                    <label for="sci-finder-author-first-name">
                        <span class="sci-finder-name">First</span>
                        <input id="sci-finder-author-first-name" type="text" name="firstName" value="" size="15">
                    </label>
                    <label for="sci-finder-author-middle-name">
                        <span class="sci-finder-name">Middle</span>
                        <input id="sci-finder-author-middle-name" type="text" name="middleName" value="" size="15">
                    </label>
                    <button type="submit">Search</button>
                    <input type="hidden" name="searchAnyAuthor" value="Search"></form>

                <form action="http://pubs.acs.org/action/sciFinderSearch" id="sci-finder-search--topics" name="sfTopicLayer" class="sci-finder-form hidden" method="post" target="scifinder" onsubmit="return validateSciFinderContent();"><label for="sci-finder-topic">
                        <span>Topic *</span>
                        <input id="sci-finder-topic" type="text" name="topic" value="" size="15">
                        
                    </label>
                    <label for="sci-finder-patents-only">
                        <input id="sci-finder-patents-only" type="checkbox" name="patentsOnly" value="" size="15">
                        <span>Patents only search</span>
                    </label>
                    <button type="submit">Search</button>
                    <input type="hidden" name="searchTopic" value="Search"></form>
            
        </div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
            
            
            
                
                
                
            
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-frame none  widget-none  widget-border-toggle widget-compact-all" id="cd9ede2c-2a1d-4310-867b-8e5effc7cf54">
        
        

        <div class="wrapped ">
            <h1 class="widget-header header-none  header-border-toggle header-compact-all">Metrics</h1>
            <div class="widget-body body body-none  body-border-toggle body-compact-all"><div data-pb-dropzone="contents">
    


    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-frame none metrics-main widget-none  widget-compact-all" id="657f3034-5703-45e5-a18e-4d77374a21b8">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div data-pb-dropzone="contents">
    


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumContentItemDownloadCount none  widget-none" id="d57ee61e-12de-460c-97b7-4f67e39377de">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none ">Article Views: 186 Times</div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget literatumContentItemHistory none  widget-none" id="764a4ee4-9265-43f8-8a38-36480fcd64fa">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none "><div>Received 13 January 2017</div>



    
    
    
    <div>Date accepted 1 June 2017</div>





    
    <div>Published online 1 June 2017</div>




    
        
        
        
        <div>Published in print 3 July 2017</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none" id="fa60c5ef-3bfe-4d88-b9ac-c2e4d3748e79">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none "><span class="tooltip">
Learn more about these metrics
<span>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.<br><br>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on <a href="https://help.altmetric.com/support/solutions/articles/6000060969-how-is-the-altmetric-attention-score-calculated" target="_blank"> the Altmetric Attention Score and how the score is calculated</a>.
</span>
</span>
<style>
span.tooltip {
    outline: none;
    text-decoration: none;
    border-bottom: dotted 1px blue;
    position: relative;
}

span.tooltip strong {
    line-height: 30px;
}

span.tooltip > span {
    width: 300px;
    padding: 10px 20px;
    margin-top: -150px;
    margin-left: -300px;
    opacity: 0;
    visibility: hidden;
    z-index: 10;
    position: absolute;
    font-family: Arial;
    font-size: 12px;
    font-style: normal;
    border-radius: 3px;
    box-shadow: 2px 2px 2px #999;
    -webkit-transition-property: opacity, margin-top, visibility, margin-left;
    -webkit-transition-duration: 0.4s, 0.3s, 0.4s, 0.3s;
    -webkit-transition-timing-function: ease-in-out, ease-in-out, ease-in-out, ease-in-out;
    transition-property: opacity, margin-top, visibility, margin-left;
    transition-duration: 0.4s, 0.3s, 0.4s, 0.3s;
    transition-timing-function: 
        ease-in-out, ease-in-out, ease-in-out, ease-in-out;
}

/*span.tooltip > span:hover,*/
span.tooltip:hover > span {
    opacity: 1;
    text-decoration: none;
    visibility: visible;
    overflow: visible;
    margin-top: -200px;
    display: inline;
    margin-left: -400px;
}

span.tooltip span b {
    width: 15px;
    height: 15px;
    margin-left: 260px;
    margin-top: 153px;
    display: block;
    position: absolute;
    -webkit-transform: rotate(135deg);
    -moz-transform: rotate(135deg);
    -o-transform: rotate(135deg);
    transform: rotate(135deg);
    -webkit-box-shadow: inset -1px 1px 0 #fff;
    -moz-box-shadow: inset 0 1px 0 #fff;
    -o-box-shadow: inset 0 1px 0 #fff;
    box-shadow: inset 0 1px 0 #fff;
    display: none\0/;
    *display: none;
}    

span.tooltip > span {
color: #000000; 
background: #FBF5E6;
background: -webkit-linear-gradient(top, #FBF5E6, #FFFFFF);
background: linear-gradient(top, #FBF5E6, #FFFFFF);	   
border: 2px solid #CFB57C;	    
}    
 
span.tooltip span b {
background: #FFFFFF;
border-top: 2px solid #CFB57C;
border-right: 2px solid #CFB57C;
}
</style>
<script>
    $('.tooltip').hover(function(event){
      ga('send', 'event', 'Altmetrics', 'Journal of the American Chemical Society', 'Learn more about these metrics');  
    });
</script></div>
        </div>
    </div>
    
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none  widget-compact-all" id="522bb550-8662-4c2c-b995-1005294d410f">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="altmetric-toggle">
    <div id="toggler" class="toggle">+</div>
    <img id="metric-small" class="metric-small" src="./test1_files/altmetrics-logo.png">
    <span class="altmetric-toggle-text">More Article Metrics</span>
</div>
<div class="altmetric-wrap">
	<div data-badge-details="right" data-badge-type="medium-donut" data-doi="10.1021/acs.molpharmaceut.7b00039" data-condensed="true" data-link-target="_blank" target="_blank" class="altmetric-embed" data-uuid="d9eee0b9-273c-2299-b3e7-9dc5ad867e27"><div style="overflow:hidden;">
    <div class="altmetric-condensed-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=pubs.acs.org&amp;citation_id=20852845" style="display:inline-block;">
                <img alt="Article has an altmetric score of 2" src="./test1_files/saved_resource" width="120px" height="120px" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=pubs.acs.org&amp;citation_id=20852845">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container" id="_altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right" id="_altmetric_popover_inner">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=pubs.acs.org&amp;citation_id=20852845&amp;tab=twitter">
          Twitter (2)
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              Mendeley (5)
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
</div>

<script type="text/javascript" src="./test1_files/embed.js"></script>
<script type="text/javascript">
$(function(){
	$('.altmetric-toggle').click(function(){
		var button = $('.altmetric-toggle');
		var buttonText = $('.altmetric-toggle-text');
		if ($(buttonText).text() == 'More Article Metrics') {
			$(button).addClass('open');
			$(buttonText).text('Hide More Article Metrics');
			$('#toggler').addClass('toggle-rotate');
			$('.metrics-main').slideUp();
			$('.altmetric-wrap').slideDown();
		}
		else {
			$(button).removeClass('open');
			$(buttonText).text('More Article Metrics');
			$('#toggler').removeClass('toggle-rotate');
			$('.metrics-main').slideDown();
			$('.altmetric-wrap').slideUp();
		}
	});
});
</script>
<style>
.altmetric-toggle{
    height:20px;
}
#toggler {
  position: relative;
  font-size: 24px;
  font-weight: bold;
  margin-right: 5px;
  margin-left: -10px;
  transition: transform 100ms ease-in-out;
  float: left;
  line-height: 20px;
  color:#666666;
}

.toggle-rotate {
  transform: rotate(45deg);
}
.metric-small{
    float:left;
    margin-left:15px;
    margin-top: -1px;
    margin-bottom: 4px;
}
.altmetric-toggle-text{
    float:left;
  color:#006ea9;
  font-size:15px;
  height:20px;
  line-height:24px;
  margin-left:5px;
}
</style></div>
        </div>
    </div>
    
</div></div>
        </div>
    </div>
    





    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget layout-frame none  widget-none  widget-compact-all" id="e256cbbb-9f21-4c9a-af7c-47ed5b7cfa9e">
        
        
            
        

        <div class="wrapped " id="combolist2">
            
            <div class="widget-body body body-none  body-compact-all"><div data-pb-dropzone="contents">
    


    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-rss-feed-reader none cen_latest_news hide widget-none  widget-compact-all" id="2ed58af7-de11-400f-9f95-6c88201821cb">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><!--content loaded via ajax-->
<div class="general-rss-feed-reader general-rss-feed-readerjs" id="2ed58af7-de11-400f-9f95-6c88201821cb">
    <div class="rss-body"><!--?xml version="1.0" encoding="UTF-8"?--><div xmlns:rss="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:achsxje="java:com.atypon.achs.util.xml.AchsXslJavaExtension" class="widget-rss-reader"><a href="http://cen.acs.org/news/ln.html" title="true" class="title">Chemical &amp; Engineering News: Latest News</a><hr class="titleHR"><ul class="listOfPublications"><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Accounting-public-heath-gains-pollution.html" title="Accounting for public heath gains from pollution control">Accounting for public heath gains from pollution control</a><div class="content">All health benefits from regulation need to be in cost-benefit analyses, researchers say</div></li><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Janitorial-system-red-blood-cells.html" title="Janitorial system in red blood cells discovered">Janitorial system in red blood cells discovered</a><div class="content">Enzyme helps trash most of the proteins inside cells that are transforming into red  ... </div></li><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Self-driving-vesicles-penetrate-blood.html" title="Self-driving vesicles penetrate blood-brain barrier ">Self-driving vesicles penetrate blood-brain barrier </a><div class="content">Potential drug carriers follow glucose gradients in mice</div></li><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Dr-Reddys-struggles-meet-FDA.html" title="Dr. Reddy’s struggles to meet FDA concerns">Dr. Reddy’s struggles to meet FDA concerns</a><div class="content">Indian drugmaker doesn’t expect to make facilities compliant before year-end</div></li><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Polyladderenes-unzip-form-semiconducting-polymers.html" title="Polyladderenes unzip to form semiconducting polymers">Polyladderenes unzip to form semiconducting polymers</a><div class="content">Molecules could report mechanical stress in materials</div></li><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Dow-investors-tussle-over-Dow.html" title="Dow, investors tussle over Dow Corning’s future">Dow, investors tussle over Dow Corning’s future</a><div class="content">Activist investors want a better breakup plan for the DowDuPont split</div></li><li class=""><br><a href="http://cen.acs.org/articles/95/i32/Semiconductor-industry-begin-using-MOFs.html" title="Semiconductor industry to begin using MOFs">Semiconductor industry to begin using MOFs</a><div class="content">Start-up technology will enhance gas purity and safety</div></li></ul></div></div>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
            
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-rss-feed-reader none axial_rss hide widget-none  widget-compact-all" id="1f3786df-bb08-4b49-b274-4f0a589a4347">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><!--content loaded via ajax-->
<div class="general-rss-feed-reader general-rss-feed-readerjs" id="1f3786df-bb08-4b49-b274-4f0a589a4347">
    <div class="rss-body"><!--?xml version="1.0" encoding="UTF-8"?--><div xmlns:rss="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:achsxje="java:com.atypon.achs.util.xml.AchsXslJavaExtension" class="widget-rss-reader"><a href="http://axial.acs.org/" title="true" class="title">ACS Axial: Your Bond With Chemistry Research</a><hr class="titleHR"><ul class="listOfPublications"><li class=""><br><a href="http://axial.acs.org/2017/08/04/cane-toad-microbiome/" title="Cane Toad Microbiome Transforms its Toxins">Cane Toad Microbiome Transforms its Toxins</a><div class="content"><p>Australia’s invasive cane toads are a scourge to native species, poisoning predators with toxic  ... </p></div></li><li class=""><br><a href="http://axial.acs.org/2017/08/04/2017-jafc-article-year-award/" title="Congratulations to the JAFC 2017 Article of the Year Award Lectureship Winners">Congratulations to the JAFC 2017 Article of the Year Award Lectureship Winners</a><div class="content"><p>The Journal of Agricultural and Food Chemistry (JAFC) and the ACS Divisions of Agrochemicals  ... </p></div></li><li class=""><br><a href="http://axial.acs.org/2017/08/04/chemical-communications/" title="Eavesdropping on Plant–Insect–Microbe Chemical Communications in Agricultural Ecology">Eavesdropping on Plant–Insect–Microbe Chemical Communications in Agricultural Ecology</a><div class="content"><p>The following is an excerpt from an editorial&nbsp;that originally appeared in the Journal of  ... </p></div></li><li class=""><br><a href="http://axial.acs.org/2017/08/04/evaluating-cellular-drug-uptake/" title="ACS Editors’ Choice: A New Approach to Evaluating Cellular Drug Uptake — and More!">ACS Editors’ Choice: A New Approach to Evaluating Cellular Drug Uptake — and More!</a><div class="content"><p>This week:&nbsp;A new approach to evaluating cellular drug uptake — and more! Each and  ... </p></div></li><li class=""><br><a href="http://axial.acs.org/2017/08/03/mother-of-pearl-bone-growth/" title="Understanding How Mother-of-Pearl Promotes Bone Growth">Understanding How Mother-of-Pearl Promotes Bone Growth</a><div class="content"><p>The Mayans used seashells as dental implants, and researchers have shown that small chunks  ... </p></div></li><li class=""><br><a href="http://axial.acs.org/2017/08/03/nsf-graduate-research-fellowship/" title="Learn More About the NSF Graduate Research Fellowship Program">Learn More About the NSF Graduate Research Fellowship Program</a><div class="content"><p>Are you a senior undergraduate or graduate student pursuing a research-based master’s and doctoral  ... </p></div></li><li class=""><br><a href="http://axial.acs.org/2017/08/03/best-est-letters-2016/" title="Read the Best Environmental Science &amp; Technology Letters Papers of 2016">Read the Best Environmental Science &amp; Technology Letters Papers of 2016</a><div class="content"><p>Learn about Environmental Science &amp; Technology Letters Editor-in-Chief David Sedlak’s GUINNESS WORLD RECORDS™ official  ... </p></div></li></ul></div></div>
</div></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none  widget-compact-all" id="02a27881-ff24-4337-8d5f-d2c1994112d2">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><style type="text/css">
	.combo-bi-container {
		min-height: 640px;
	    width: 100%;
	    overflow: hidden;
	}

	.combo-bi-container-slider {
		width: 645px;
    	height: auto;
    	position:relative;
    	transition: all .8s ease-in-out;
		transition-delay: .1s;
	}

	.show-right {
		right: 322px;
	}

	.show-left {

	}

	 #axiallist, #cen_list {
	 	/*position: absolute;*/
	 	display: none;
	 	display: inline-block;
	 	position: relative;
	 }

	  #axiallist {
	  	float: right;
	  }

	  #cen_list {
	  	float: left;
	  }

	    .journal-active {
	    	display: block;
			opacity: 1;
			
			transition-delay: .2s;
			-webkit-transition: .2s;
			-o-transition: .2s;
			-moz-transition: .2s;
			-webkit-transition: opacity 1.5s ease-in;
			-moz-transition: opacity 1.5s ease-in;
			-o-transition: opacity  1.5ease-in;
			 transition: opacity 1.5s ease-in;
		}

		.journal-in-active {
	    	display:none;
			opacity: 0;
			
			transition-delay: .1s;
			-webkit-transition: .1s;
			-o-transition: .1s;
			-moz-transition: .1s;
			-webkit-transition: opacity 2s ease-out;
			-moz-transition: opacity 2s ease-out;
			-o-transition: opacity 2s ease-out;
			 transition: opacity 2s ease-out;
		}

		.cl-nodata-fadeout {
			opacity: 0;
			transition-delay: .1s;
			-webkit-transition: .1s;
			-o-transition: .1s;
			-moz-transition: .1s;
			-webkit-transition: opacity 2s ease-out;
			-moz-transition: opacity 2s ease-out;
			-o-transition: opacity 2s ease-out;
			 transition: opacity 2s ease-out;
		}

		.j-hidden {
			display: none;
			opacity: 0;
		}

	.combo-rss-wrapper {
		width: 320px;
    	min-height: 624px;
    	border: 1px solid lightgrey;
	}

	.combo-rss-header {
		height: 100px;
	 	width: 96%;;
	}
		.shadow {
			  -webkit-box-shadow: 0 6px 4px -4px lightgrey;
			  -moz-box-shadow: 0 6px 4px -4px lightgrey;
			  box-shadow: 0 6px 4px -4px lightgrey;
		}

		.cen-color {
			background-color: #EC272D;
		}

		.axial-color { 
			background-color:#00a2e0;
		}

		.title_image {
			width:210px;
			height: 76px;
			margin: 0 auto;
			display: table;
			position: relative;
		}


		.ax-header-img, .cen-header-img {
			height: 50px;
			margin: 0 auto;
    		padding-top: 10px;
			display: block;
		}

		.cen-header-img {
			z-index: 200;
		}

		.ax-header-img {
			z-index: 100;
			position: relative;
		    top: 10px;
		    left:0; 
		}


			.switch-wrap {
				display: block;
				height: 20px;
			}

			.switch {
				display: inline-block;
				font-family: Helvetica;
				text-decoration: none;
				color: white;
				font-weight: 100;
				font-size: 12px;
				letter-spacing: 1px;

			}

			#latest-news {
				float: right;
				margin-right: 20px;
			}

			#current-issue {
				float: left;
				margin-left: 10px;
			}

			#latest-news a:hover, #current-issue a:hover {
				text-decoration: none !important;
				color: white !important;
			}
		
		.indicator-line {
			height: 4px;
			width: 50%;
			transition: all 1s ease-in;
			transition-delay: .2s;
			background: #D1D1D1; /*#ffc900   cen blue: #425469*/ 
		}

		.change-line {
			transform: translateX(152px);
		}

	.combo-rss-body {
		width: 320px;
		height: 600px;
		overflow: hidden;
    	display: block;
	}

	#rss-combolist-wrap {
		width: 648px;
		height: 585px;
		position: relative;
		transition: all 1s ease-in;
		transition-delay: .3s;
	}	
		.ax-wrap {
			width: 300px;
		}

		.mov-right {
			right: 320px;
		}
		.mov-left {
			/*left: 0px;*/
		}
		

	#cencurrent, #cenlatest {
		width: 320px;
		height: auto;
		display: inline-block;
		position: relative;
		float: left;
	}

	#latest {
		width: 320px;
		height: auto;
		display: inline-block;
		float: right;
		position: relative;
	}		
		
			
		.axlist,.cencurrent, .cenlatest { /*ul*/
		    padding: 0 10px 0 10px !important;
		    width: 100%;
		}

		/*.cencurrent {
			padding-top: 10px !important;
		}
*/
		.axlist li:last-child{
			border-bottom: none;
		}

		 #axlist {
		 	width: 100%;
		 	/*min-height: 586px;*/
		 }

		.combo-list-item {
			list-style: none;
			border: none;
		    min-height: 64px;
		    margin: 0 !important;
		    width: 87%;
		}

			.cl-border {
				border-bottom: 1px solid lightgrey !important;
			}

		.cl-img-area {
			float: left;
			display: inline-block;
			width: 72px;
			overflow: hidden;
			margin-bottom: 6px;
			height: 100px;
		}

		.cl-img-area-coverart {
			float: left;
			display: inline-block;
			width: 94px;
			/*overflow: hidden;*/
			margin-bottom: 6px;
		}

		.cl-section {
			width:40px;
		    background:white;
		    position: relative;
		    top: -2px;
		    left: 0;
		    z-index: 100;
		    color: #645555;
		    font-size: 9px;
		    font-family: Helvetica;
		}

		.cl-section-cover {
			width: 40px;
		    background: white;
		    position: relative;
		    top: 16px;
		    left: 100px;
		    z-index: 100;
		    color: #645555;
		    font-size: 9px;
		    font-family: Helvetica;
		}

		.cl-borderline {
			width: 150px;
			display: inline-block;
			float: right;
			margin-right: 0px;
		}

		.cl-borderline-first {
			width: 100px;
		    display: inline-block;
		    float: right;
		    position: relative;
		    top: 18px;
		}

		.cl-borderline-last {
			width: 160px;
			display: inline-block;
			float: right;
			margin-right: 0px;
		}

		.cl-item-right {
		    width: 200px;
		    height: 100px;
		    float: right;
		    display: inline-block;
		    margin-right: -2px;
		    font-weight: 400;
		}

		.cl-item-right-cover {
		    width: 180px;
		    height: 100px;
		    float: right;
		    display: inline-block;
		    margin-right: -2px;
		    font-weight: 400;
		    margin-top: 10px;
		}

		.ax-extend {
			margin-left: 8px;
			width: 280px;
		}

			.cl-a-image {
			   /*height: 100px;*/
               width: 72px;
			   display: block;
			}

			.cl-a-image-cover {
				height: 124px;
			    display: block;
			    position: relative;
			    top: -5px;
			}

			.story-title {
				text-decoration: none !important;
			}
			.story-title h2 {
				font-size: 12px;
				line-height: 13px;
			    font-family: Helvetica;
			    text-decoration: none;
			    padding: 0;
			    margin: 0;
			    margin-bottom: 4px;
			}
				

			.lnews-color {
				color: #556185;
			}

			.story-title-ax-color {
				color: #00a2e0;
			}

			.story-title-cen-color {
				color: #645555 !important;
			}

			.combo-list-inner-wrap {
				display: inline-block;
				height: auto;
				padding-top: 10px;
				width: 100%;
			}

			.small-logo {
				float: right;
				display: block;
			}
			
			.cl-desc {
				font-family: Arial;
    			font-size: 12px
			}

			.last {
				border-bottom: none !important; 
			}

		.cl-footer {
			height: 40px;
			background: white;
			display: block;
			text-align: center;
			/*margin-top: 20px;*/
			padding-top: 2px;
			position: relative;
    		top: -20px;
		}

		.ax-footer {
			background: white;
		    position: absolute;
		    bottom: 4px;
		    left: 50%;
		    margin-left: -50px;
		}


		#cen-more-from, #ax-more-from{
			font-family: Helvetica;
			padding-top: 14px;
			/*font-family: Arial;*/
		    font-size: 11px;
		    text-decoration: none;
		    color: grey;
		    display: block;
		    /*position: relative;
    		top: -4px;*/
		}
		

</style>
	
<div class="combo-bi-container">
		<div class="combo-bi-container-slider">
			<div id="cen_list" class="combo-rss-wrapper">
				<div class="combo-rss-header shadow cen-color">
					<div class="title_image"><img src="./test1_files/CEN-Logo.png" class="cen-header-img"></div> 
					<div class="switch-wrap"><a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="switch" id="current-issue">CURRENT ISSUE</a><a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="switch" id="latest-news">LATEST NEWS</a></div> <!--switch-->
					<div class="indicator-line"></div>
				</div>
				<div class="combo-rss-body">
					<div id="rss-combolist-wrap" class="mov-left">
					<div id="cencurrent"><ul class="cencurrent"><li class="combo-list-item"><span class="cl-section-cover">COVER STORY</span><hr class="cl-borderline-first"><div class="combo-list-inner-wrap"><div class="cl-img-area-coverart"><a href="http://pubs.acs.org/doi/full/10.1021/cen-09531-cover?ref=PubsWidget" target="_blank"><img src="./test1_files/showCoverImage" id="climage-1" class="cl-a-image-cover"></a></div><div class="cl-item-right-cover"><a class="story-title" target="_blank" href="http://pubs.acs.org/doi/full/10.1021/cen-09531-cover?ref=PubsWidget" title="Protein-folding mysteries"><h2 class="story-title-cen-color">Protein-folding mysteries</h2></a><p class="cl-desc">When he wasn’t playing the viola or sailing around the Chesapeake Bay during the early 1950s, National...</p></div></div></li><li class="combo-list-item"><span class="cl-section">SCIENCE CONCENTRATES</span><hr class="cl-borderline"><div class="combo-list-inner-wrap"><div class="cl-img-area"><a href="http://pubs.acs.org/doi/full/10.1021/cen-09531-notw1?ref=PubsWidget" target="_blank"><img src="./test1_files/09531-notw1-nccover3.gif" id="climage-4" class="cl-a-image"></a></div><div class="cl-item-right"><a class="story-title" target="_blank" href="http://pubs.acs.org/doi/full/10.1021/cen-09531-notw1?ref=PubsWidget" title="Chemistry weaves a molecular fabric"><h2 class="story-title-cen-color">Chemistry weaves a molecular fabric</h2></a><p class="cl-desc">Researchers in Europe have threaded their chemical needles to create a fabric woven, not from fibers,...</p></div></div></li><li class="combo-list-item"><span class="cl-section">BUSINESS CONCENTRATES</span><hr class="cl-borderline"><div class="combo-list-inner-wrap"><div class="cl-img-area"><a href="http://pubs.acs.org/doi/full/10.1021/cen-09531-notw10?ref=PubsWidget" target="_blank"><img src="./test1_files/default.jpg" id="climage-18" class="cl-a-image"></a></div><div class="cl-item-right"><a class="story-title" target="_blank" href="http://pubs.acs.org/doi/full/10.1021/cen-09531-notw10?ref=PubsWidget" title="Eurofins pushes into drug contract services"><h2 class="story-title-cen-color">Eurofins pushes into drug contract services</h2></a><p class="cl-desc">The testing services giant Eurofins Scientific has agreed to acquire Advinus, an India-based contract...</p></div></div></li><li class="combo-list-item last"><span class="cl-section">POLICY CONCENTRATES</span><hr class="cl-borderline"><div class="combo-list-inner-wrap"><div class="cl-img-area"><a href="http://pubs.acs.org/doi/full/10.1021/cen-09531-notw14?ref=PubsWidget" target="_blank"><img src="./test1_files/09531-notw20-supplements.gif" id="climage-35" class="cl-a-image"></a></div><div class="cl-item-right"><a class="story-title" target="_blank" href="http://pubs.acs.org/doi/full/10.1021/cen-09531-notw14?ref=PubsWidget" title="Unintended dietary supplement exposure on the rise"><h2 class="story-title-cen-color">Unintended dietary supplement exposure on the rise</h2></a><p class="cl-desc">More than 70% of Americans take some form of dietary supplement. Yet these increasingly popular products...</p></div></div></li></ul></div>
					<div id="cenlatest"><ul class="cenlatest"><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title lnews-color" href="http://cen.acs.org/articles/95/i32/Accounting-public-heath-gains-pollution.html?utm_source=PubsWidget&amp;utm_medium=Pubs&amp;utm_campaign=CEN" title="Accounting for public heath gains from pollution control"><h2 class="story-title-cen-color">Accounting for public heath gains from pollution control</h2></a><p class="cl-desc">All health benefits from regulation need to be in cost-benefit analyses, researchers say</p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title lnews-color" href="http://cen.acs.org/articles/95/i32/Janitorial-system-red-blood-cells.html?utm_source=PubsWidget&amp;utm_medium=Pubs&amp;utm_campaign=CEN" title="Janitorial system in red blood cells discovered"><h2 class="story-title-cen-color">Janitorial system in red blood cells discovered</h2></a><p class="cl-desc">Enzyme helps trash most of the proteins inside cells that are transforming into red  ... </p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title lnews-color" href="http://cen.acs.org/articles/95/i32/Self-driving-vesicles-penetrate-blood.html?utm_source=PubsWidget&amp;utm_medium=Pubs&amp;utm_campaign=CEN" title="Self-driving vesicles penetrate blood-brain barrier "><h2 class="story-title-cen-color">Self-driving vesicles penetrate blood-brain barrier </h2></a><p class="cl-desc">Potential drug carriers follow glucose gradients in mice</p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title lnews-color" href="http://cen.acs.org/articles/95/i32/Dr-Reddys-struggles-meet-FDA.html?utm_source=PubsWidget&amp;utm_medium=Pubs&amp;utm_campaign=CEN" title="Dr. Reddy’s struggles to meet FDA concerns"><h2 class="story-title-cen-color">Dr. Reddy’s struggles to meet FDA concerns</h2></a><p class="cl-desc">Indian drugmaker doesn’t expect to make facilities compliant before year-end</p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title lnews-color" href="http://cen.acs.org/articles/95/i32/Polyladderenes-unzip-form-semiconducting-polymers.html?utm_source=PubsWidget&amp;utm_medium=Pubs&amp;utm_campaign=CEN" title="Polyladderenes unzip to form semiconducting polymers"><h2 class="story-title-cen-color">Polyladderenes unzip to form semiconducting polymers</h2></a><p class="cl-desc">Molecules could report mechanical stress in materials</p></div></li><li class="combo-list-item  cl-border last"><div class="combo-list-inner-wrap"><a class="story-title lnews-color" href="http://cen.acs.org/articles/95/i32/Dow-investors-tussle-over-Dow.html?utm_source=PubsWidget&amp;utm_medium=Pubs&amp;utm_campaign=CEN" title="Dow, investors tussle over Dow Corning’s future"><h2 class="story-title-cen-color">Dow, investors tussle over Dow Corning’s future</h2></a><p class="cl-desc">Activist investors want a better breakup plan for the DowDuPont split</p></div></li></ul></div> 
					
					</div>
					<!-- <div class="cl-footer">
						<a id="cen-more-from" href="#">MORE FROM ACS AXIAL</a> 
					</div> -->
				</div>
			</div>

			<div id="axiallist" class="combo-rss-wrapper j-hidden"><!--  style="display:none;" --> 
				<div class="combo-rss-header shadow axial-color cen-color">
					<div class="title_image"><img src="./test1_files/Axial-Logo.png" class="ax-header-img"></div> 
				</div>   
				<div class="combo-rss-body">
					<div id="rss-combolist-wrap ax-wrap">
					<div id="axlist"><ul class="axlist"><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title" href="http://axial.acs.org/2017/08/04/cane-toad-microbiome/?utm_source=Widget&amp;utm_medium=Pubs&amp;utm_campaign=Axial" title="Cane Toad Microbiome Transforms its Toxins"><h2 class="story-title-ax-color">Cane Toad Microbiome Transforms its Toxins</h2></a><p class="cl-desc">Australia’s invasive cane toads are a scourge to native species, poisoning predators with toxic  ... </p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title" href="http://axial.acs.org/2017/08/04/2017-jafc-article-year-award/?utm_source=Widget&amp;utm_medium=Pubs&amp;utm_campaign=Axial" title="Congratulations to the JAFC 2017 Article of the Year Award Lectureship Winners"><h2 class="story-title-ax-color">Congratulations to the JAFC 2017 Article of the Year Award Lectureship Winners</h2></a><p class="cl-desc">The Journal of Agricultural and Food Chemistry (JAFC) and the ACS Divisions of Agrochemicals  ... </p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title" href="http://axial.acs.org/2017/08/04/chemical-communications/?utm_source=Widget&amp;utm_medium=Pubs&amp;utm_campaign=Axial" title="Eavesdropping on Plant–Insect–Microbe Chemical Communications in Agricultural Ecology"><h2 class="story-title-ax-color">Eavesdropping on Plant–Insect–Microbe Chemical Communications in Agricultural Ecology</h2></a><p class="cl-desc">The following is an excerpt from an editorial&nbsp;that originally appeared in the Journal of  ... </p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title" href="http://axial.acs.org/2017/08/04/evaluating-cellular-drug-uptake/?utm_source=Widget&amp;utm_medium=Pubs&amp;utm_campaign=Axial" title="ACS Editors’ Choice: A New Approach to Evaluating Cellular Drug Uptake — and More!"><h2 class="story-title-ax-color">ACS Editors’ Choice: A New Approach to Evaluating Cellular Drug Uptake — and More!</h2></a><p class="cl-desc">This week:&nbsp;A new approach to evaluating cellular drug uptake — and more! Each and  ... </p></div></li><li class="combo-list-item  cl-border"><div class="combo-list-inner-wrap"><a class="story-title" href="http://axial.acs.org/2017/08/03/mother-of-pearl-bone-growth/?utm_source=Widget&amp;utm_medium=Pubs&amp;utm_campaign=Axial" title="Understanding How Mother-of-Pearl Promotes Bone Growth"><h2 class="story-title-ax-color">Understanding How Mother-of-Pearl Promotes Bone Growth</h2></a><p class="cl-desc">The Mayans used seashells as dental implants, and researchers have shown that small chunks  ... </p></div></li><li class="combo-list-item  cl-border last"><div class="combo-list-inner-wrap"><a class="story-title" href="http://axial.acs.org/2017/08/03/nsf-graduate-research-fellowship/?utm_source=Widget&amp;utm_medium=Pubs&amp;utm_campaign=Axial" title="Learn More About the NSF Graduate Research Fellowship Program"><h2 class="story-title-ax-color">Learn More About the NSF Graduate Research Fellowship Program</h2></a><p class="cl-desc">Are you a senior undergraduate or graduate student pursuing a research-based master’s and doctoral  ... </p></div></li></ul></div>
					
					</div>
					<!-- <div class="ax-footer">
						<a id="ax-more-from" href="#">MORE FROM C&amp;EN</a>
					</div> -->
				</div>
			</div>
		</div>
	</div>

<script>

$(document).ready(function() { 
			

	var comboListBuilder = {

		//cenCurrentIssueArray:[], 
		axialListArray:[],
		cenNewsArray:[],
		journalChoice: "",
		
		init: function(){

			$("#current-issue, #latest-news").on("click", function(event){
				event.preventDefault();
				//console.log(event.target.id);
				comboListBuilder.switchItnow(event.target.id);
				
			});

			$("#cen-more-from, #ax-more-from").bind("click", function(event){
					event.preventDefault();
					$("#axiallist, #cen_list").removeClass("j-hidden");
					var value = 0;
				 	var $slider = $(".combo-bi-container-slider");

					if (event.target.id === "ax-more-from") {
						//switch to cen	
						if ($slider.hasClass("show-right") ) {
							value = 322;
						} else {
							value = 0;
						}	
										
						$slider.css("transform", "translateX(" +  value + "px)");

						$("#axiallist").removeClass("journal-active");
						$('#cen_list').addClass("journal-active");
						$("#axiallist").addClass("journal-in-active");
						$("#cen_list").removeClass("journal-in-active");


					} else if (event.target.id === "cen-more-from") {
						// switch to axial
						if ($slider.hasClass("show-right") ) {
							value = 0;
						} else {
							value = -322;
						}
						
						$slider.css("transform", "translateX(" +  value + "px)");
						
						$("#cen_list").removeClass("journal-active");
						$('#axiallist').addClass("journal-active");
						$("#cen_list").addClass("journal-in-active");
						$('#axiallist').removeClass("journal-in-active");
					}		 
				
			});
			
			// Set classes initially - This will need to change 
			// Currently adding classes for the different sliding panels only for the c&en 

			if (this.journalChoice === "axial") {
				
				//$(".indicator-line").addClass("change-line");
				//$('#rss-combolist-wrap').addClass("mov-right");
				
			} else if (this.journalChoice === "cenge") {
				$('.combo-rss-header').addClass("cen-color");
				$(".indicator-line").removeClass("change-line");
				$('#rss-combolist-wrap').addClass("mov-left");

			}

			$("[id^=climage-]").error(function () {
				  $(this).unbind("error").attr("src", "/pb-assets/images/default.jpg"); ///pb-assets/images/default.jpg
			});

	   
		},	

		getLists: function() {
			var self = this;

			var title, image, description, cl_section, tag,  clborderline;
		   	console.log("Getting the Lists...");
		   	// var fullTextPath = "/doi/full/";  //http://pubs.acs.org/doi/full/
   			// var coverart = "http://pubs.acs.org/action/showCoverImage?journalCode=cgeabj";

   					    //Get contents of Latest news 
	    	$('.cen_latest_news').find('.listOfPublications li a').each(function() {
	    	    if ($(this).next().html() === undefined || $(this).attr('href') === undefined || $(this).html() === undefined) {
	    	         return true;
	    	     } else {
	    		  var description = $(this).next().html();
	    		  var link = $(this).attr('href') + "?utm_source=PubsWidget&utm_medium=Pubs&utm_campaign=CEN";
	    		 // console.log("C&EN URL: " + link );
	    		 // description = description.replace(/<\/?[^>]+(>|$)/g, ""); //there is a p tag in the axial feed that does not exist in the c&en feed.

	         	    var tag = "<div class='combo-list-inner-wrap'><a class='story-title lnews-color' href='" + link + "' class='jounral1_items'" + ' title="'+ $(this).html() + '"><h2 class="story-title-cen-color">' +  $(this).html() + "</h2></a><p class='cl-desc'>"+ description +"</p></div>";
		    		    comboListBuilder.cenNewsArray.push(tag);
		    		    // console.log(tag); 
	    	     }
	     	});

	 		//Get contents for Axial
	    	$('.axial_rss').find('.listOfPublications li a').each(function() {
	    	     if ($(this).next().html() === undefined || $(this).attr('href') === undefined || $(this).html() === undefined) {
	    	         return true;
	    	     } else {
	    	         console.log(this);
	    	          var description = $(this).next().html();
	    		  description = description.replace(/<\/?[^>]+(>|$)/g, ""); //there is a p tag in the axial feed that does not exist in the c&en feed.
	    		var link = $(this).attr('href') + '?utm_source=Widget&utm_medium=Pubs&utm_campaign=Axial';
	    		//console.log(link);
	         	var tag = "<div class='combo-list-inner-wrap'><a class='story-title' href='" + link + "' class='jounral1_items'" + ' title="'+ $(this).html() + '"><h2 class="story-title-ax-color">' +  $(this).html() + "</h2></a><p class='cl-desc'>"+ description +"</p></div>";
		    		    comboListBuilder.axialListArray.push(tag);
		    		    // console.log(tag); 
		    		  
	    	     }
	    		 
	     	});


			//Get contents of CEN Current issue
			var feed = "/iapps/rss/cgeabj.xml";
		    //console.log("Running Ajax");
		    $.ajax(feed, {
		        accepts:{
		            xml:"application/rss+xml"
		        },
		        dataType:"xml",
		        success: handleCenData,
		        error: function(){
		        	$('.combo-bi-container').hide();
		        }
		    });

		    function handleCenData (data) {

		        if (!data) {
		        		console.log("Something is wrong with the data ?? ");
		        } else { 
		        	var cenAjaxHolder = [];
		            var coverStory = {}, science = {}, business = {}, policy ={};
		            var csIndex, sciIndex, bizIndex, poliIndex;
		            var fullTextPath = "/doi/full/";  //http://pubs.acs.org/doi/full/
   					var coverart = "/action/showCoverImage?journalCode=cgeabj";

		            $(data).find("item").each(function (index) {
		                var el = $(this);
		              	var title = el.find("title").text();
		              	var link = el.find("link").text();
		              	link = link.split("http://dx.doi.org/");
		    			link = fullTextPath + link[1] + "?ref=PubsWidget";

		              	var description = el.find("description").text();
		              	
		              	//image
		              	var regexp = /<img[^>]+src="(http:\/\/[^">]+)"/g; 
		              	var image = description.match(regexp);

		              	description =  description.replace(/<\/?[^>]+(>|$)/g, "");
		    			description = description.replace(/^(.{100}[^\s]*).*/, "$1");
		    			description += "...";

						if (image != null) {
							image = image[0];
							image = image.split("src=");
							image = image[1].replace(/^"(.*)"$/, '$1');
						}

		              	if (title == "COVER STORY") {
		              		csIndex =  index;
		              		coverStory.section = title; 
		              	}

			              	if (index == (csIndex+ 1)) {
			              		coverStory.title = title;
			              		coverStory.description = description;
			              		coverStory.link = link;
			              		coverStory.image = coverart;
			              		coverStory.clborderline = "cl-borderline-first";
			              		coverStory.index  = index;
		   
			              	}

		              	if (title == "SCIENCE CONCENTRATES") {
		              		sciIndex = index;
		              		science.section = title;
		              	}

			              	if (index == (sciIndex+ 1) ) {
			              		science.title = title;
			              		science.description = description;
			              		science.link = link;
			              		if (image) { //This should not be on production - the images are too blurry
			              			image = image.toLowerCase();
			              			image = image.replace("medium", "small");
			              			science.image = image.replace("jpeg", "gif");
			              			//console.log(science.image);
			              		}
			              		science.clborderline= "cl-borderline";
			              		science.index  = index;
			              	}

		              	if (title == "CONCENTRATES") {
		              		return true;
		              	}	

		              	if (title == "BUSINESS CONCENTRATES") {
		              		bizIndex = index;
		              		business.section = title;
		              	}	

			              	if (index == (bizIndex+ 1) ) {
			              		business.title = title;
			              		business.description = description;
			              		business.link = link;
			              		if (image) {
			              			image = image.toLowerCase();
			              			image = image.replace("medium", "small");
			              			business.image = image.replace("jpeg", "gif");
			              			//console.log(business.image);
			              		}
			              		business.clborderline= "cl-borderline";
			              		business.index  = index;
			              	}

		              	if (title == "POLICY CONCENTRATES") {
		              		poliIndex = index;
		              		policy.section = title;
		              	}

			              	if (index == (poliIndex+ 1) ) {
			              		policy.title = title;
			              		policy.description = description;
			              		policy.link = link;
			              		if (image) {
			              			image = image.toLowerCase();
			              			image = image.replace("medium", "small");
			              			policy.image = image.replace("jpeg", "gif");
			              			//console.log(policy.image);
			              		}
			              		
			              		policy.clborderline = "cl-borderline";
			              		policy.index  = index;
			              	}

		            });

					//create ui elements from the data
					createUI_Element_Cover(coverStory);
					createUI_Element(science);
					createUI_Element(business);
					createUI_Element(policy);
					//self.cenCurrentIssueArray
					//Build this list 
					if (cenAjaxHolder) {
						comboListBuilder.buildList(cenAjaxHolder, "cencurrent");
					}

					//Handle bad images
					$("[id^=climage-]").error(function () {
				  		$(this).unbind("error").attr("src", "/pb-assets/images/default.jpg"); ///pb-assets/images/default.jpg
					});
					
				}

				//cl-section is the name
				function createUI_Element_Cover(dataObject) {

					//console.log("Creating UI Elem: cover story " );
					var tag = "<span class='cl-section-cover'>" + dataObject.section + "</span><hr class='" + dataObject.clborderline + "'/><div class='combo-list-inner-wrap'><div class='cl-img-area-coverart'><a href='"+ dataObject.link +"' target='_blank'><img src='"+ dataObject.image +"'  id='climage-" + dataObject.index +"'  class='cl-a-image-cover' /></a></div><div class='cl-item-right-cover'><a class='story-title' target='_blank' href='" + dataObject.link +  "'title='"+ dataObject.title + "'><h2 class='story-title-cen-color'>" +  dataObject.title + "</h2></a><p class='cl-desc'>"+ dataObject.description +"</p></div></div>"; 
		    		    cenAjaxHolder.push(tag); 
				}

				function createUI_Element(dataObject) {
					//console.log("Creating UI Elem: sections  " );
					var tag = "<span class='cl-section'>" +dataObject.section + "</span><hr class='" + dataObject.clborderline + "'/><div class='combo-list-inner-wrap'><div class='cl-img-area'><a href='"+ dataObject.link +"' target='_blank'><img src='"+ dataObject.image +"'  id='climage-" + dataObject.index +"'  class='cl-a-image' /></a></div><div class='cl-item-right'><a class='story-title' target='_blank' href='" + dataObject.link +  "'title='"+ dataObject.title + "'><h2 class='story-title-cen-color'>" +  dataObject.title + "</h2></a><p class='cl-desc'>"+ dataObject.description +"</p></div></div>"; 
		    		    cenAjaxHolder.push(tag);
				}
		   
		   }


	    	    	
	  	   if ( comboListBuilder.axialListArray.length != 0 && comboListBuilder.cenNewsArray.length != 0) {
	  	   		
	  	   		//self.numberOfArticles(self.cenCurrentIssueArray, 10);
	  	   		self.numberOfArticles(self.axialListArray, 6);
	  	   		self.numberOfArticles(self.cenNewsArray, 6);

	  	   		this.journalChoice  = comboListBuilder.randomChoice();
	 			//self.buildList(self.cenCurrentIssueArray, "cencurrent");  
	 			self.buildList(self.cenNewsArray, "cenlatest"); 
	 			self.buildList(self.axialListArray, "axlist"); 

	 			self.init();
	 		
	  	    } else {
	  	    	// Hide if no data
	  	    	$('.combo-bi-container').addClass("journal-in-active");
	  	    }
	   		
	   },

	   switchItnow: function(elem){
	   		var $inter_wrapper = $("#rss-combolist-wrap");
	   		var value = 320;
	    	if (elem === "current-issue") {
	    		
	    		 $(".indicator-line").removeClass("change-line");

	    		if ($inter_wrapper.hasClass("mov-right")) {
	    			$inter_wrapper.css("transform", "translateX(" +  value + "px)");
	    		}

	    		if ($inter_wrapper.hasClass("mov-left")) {
	    			value = 0;
	    			$inter_wrapper.css("transform", "translateX(" +  value + "px)");
	    		}
	    	} 

	    	else if (elem === "latest-news") {
	    		$(".indicator-line").addClass("change-line");
	

				if ($inter_wrapper.hasClass("mov-right")) {
					value = 0;
					$inter_wrapper.css("transform", "translateX(" +  value + "px)");
				}

	    		if ($inter_wrapper.hasClass("mov-left")) {
	    			value = -320;
	    			$inter_wrapper.css("transform", "translateX(" +  value + "px)");
	    		} 
	    		
	    	}

	    },

	    randomChoice: function() {
		      var min = Math.ceil(1);
			  var max = Math.floor(10);
			  var value =  Math.floor(Math.random() * (max - min)) + min;
			  if (value > 7) {
			  		value = "axial";
					
					$("#axiallist").removeClass("j-hidden"); //journal-active
					$(".combo-bi-container-slider").addClass("show-right");

					$("#rss-combolist-wrap").addClass("mov-left");
					$(".indicator-line").removeClass("change-line");


			  } else {
			  		value = "cenge";
			  		//$("#cen_list").show();
			  		//$("#cen_list").removeClass("journal-in-active"); //journal-in-active
			  		$("#cen_list").removeClass("j-hidden"); //journal-active
			  }
			  //console.log("Value " + value);
			  return value;
		},

		

		buildList: function (journ, jname) {
	        console.log("Building the List ...");
			var $thelist = $('<ul class="' + jname + '"></ul>');
			var holder ='';
	        
	      	for (var i = 0; i < journ.length; i++) {
			     var li = '<li class="combo-list-item">' + journ[i] + '</li>';
			     if (i == journ.length - 1) {
			     	li = '<li class="combo-list-item last">' + journ[i] + '</li>';
			     	// console.log(displayArray[i]);
			     }

			     if (jname != "cencurrent") {
			     	if (i == journ.length - 1) {
			     		li = '<li class="combo-list-item  cl-border last">' + journ[i] + '</li>';
			     	} else {
			     	 	li = '<li class="combo-list-item  cl-border">' + journ[i] + '</li>';
			     	}
			     }
			     
			    $thelist.append(li);
			 };
	
			 	$("#"+ jname +"").append($thelist);
			
			 //console.log($thelist);
	    },

	    numberOfArticles: function(arrayToTrim, numberOfArticles) {
	    	if (arrayToTrim.length != 0) {
	    		//console.log("arrayToTrim.length " + arrayToTrim.length)

				var limit = numberOfArticles;

				if (limit === arrayToTrim.length) {
					return false;
				} else {
					limit = arrayToTrim.length - limit;
					//console.log("limit " + limit)
					// 
					for (var i = 0; i < limit; i++) {
						arrayToTrim.pop();
						//console.log(i);
					}
				}
	    	}
	    }

	};

	//Script Starts here
        $(window).load(function(){
			setTimeout(function(){
				if ($('.axial_rss').length != 0  &&  $('.cen_latest_news').length != 0) {
					comboListBuilder.getLists();
				}
			}, 100);
		});

});

		
</script></div>
        </div>
    </div>
    
</div></div>
        </div>
    </div>
    
</div></div>
        </div>
    </div>
    
        </div>
    </div>
</div></div>
        </div>
    </div>
    
</div></div>
        </div>
    </div>
    
    </div>
</div><!--end pagefulltext--></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget pageFooter none  widget-none  widget-compact-all" id="65b3a46e-5016-4d9a-9cc0-1224e4bbf46a">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><footer class="page-footer">
    <div data-pb-dropzone="main">
    


    
    
    
    
    
    
        
    
        
            
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
        
    
        
            
            
                
            
            
                
                
                
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none  widget-none  widget-compact-all" id="711aa7bf-5b37-481e-81f0-992b43dca726">
        
        

        <div class="wrapped ">
            
            <div class="widget-body body body-none  body-compact-all"><div class="acs-footer-wrap follow-bar">
    <div class="acs-footer">
        <div id="pageFooterFollowBar">
            <ul>
                <li class="follow-acs"><a href="http://pubs.acs.org/page/follow.html" title="Follow ACS"></a></li>
                <li class="follow-e-alerts"><a href="http://pubs.acs.org/page/follow.html" title="e-Alerts" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;E-Alerts Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html#e-alerts&#39;}, 100); return false;"></a></li>
                <li class="follow-facebook"><a href="http://pubs.acs.org/page/follow.html?widget=follow-pane-facebook" title="Facebook" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;Facebook Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html?widget=follow-pane-facebook&#39;}, 100); return false;"></a></li>
                <li class="follow-twitter"><a href="http://pubs.acs.org/page/follow.html?widget=follow-pane-twitter" title="Twitter" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;Twitter Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html?widget=follow-pane-twitter&#39;}, 100); return false;"></a></li>
                <li class="follow-rss"><a href="http://pubs.acs.org/page/follow.html?widget=follow-pane-rss" title="RSS Feeds" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;RSS Feeds Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html?widget=follow-pane-rss&#39;}, 100); return false;"></a></li>
                <li class="follow-podcasts"><a href="http://pubs.acs.org/page/follow.html?widget=follow-pane-podcasts" title="Podcasts" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;Podcasts Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html?widget=follow-pane-podcasts&#39;}, 100); return false;"></a></li>
                <li class="follow-youtube"><a href="http://pubs.acs.org/page/follow.html?widget=follow-pane-youtube" title="YouTube" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;YouTube Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html?widget=follow-pane-youtube&#39;}, 100); return false;"></a></li>
                <li class="follow-tools"><a href="http://pubs.acs.org/page/follow.html?widget=follow-pane-mobile" title="Mobile" onclick="ga(&#39;send&#39;,&#39;event&#39;, &#39;Footer&#39;, &#39;Follow Bar&#39;, &#39;Mobile Tab&#39;); setTimeout(function(){this.location = &#39;http://pubs.acs.org/page/follow.html?widget=follow-pane-mobile&#39;}, 100); return false;"></a></li>
            </ul>
        </div>
    </div>
</div>


<div class="acs-footer-wrap footer-links">
    <div class="acs-footer">
        <div id="pageFooterLinks">
            <div id="pageFooterAddress">
                <img src="./test1_files/pubslogo-small(1).png">
                <p>1155 Sixteenth Street N.W.<br>Washington, DC 20036</p>
                <p><span class="beian">京ICP备13047075</span></p>
                <p><a href="http://www.acs.org/content/acs/en/copyright.html" title="ACS Copyright Information">Copyright © 2017<br>American Chemical Society</a></p>
            </div>
            
            <ul class="products">
                <li><h3>Products</h3></li>
                <li><a href="http://pubs.acs.org/action/showPublications?display=journals">Journals A–Z</a></li>
                <li><a href="http://pubs.acs.org/page/books/index.html">eBooks</a></li>
                <li><a href="http://pubs.acs.org/cen">C&amp;EN</a></li>
                <li><a href="http://pubs.acs.org/cen-archives">C&amp;EN Archives</a></li>
                <li><a href="http://pubs.acs.org/page/4librarians/products/archives/index.html">ACS Legacy Archives</a></li>
                <li><a href="http://pubs.acs.org/r/acsmobile">ACS Mobile</a></li>
                <li><a href="http://pubs.acs.org/page/audio-video/index.html">Video</a></li>
            </ul>
            <ul class="user-resources">
                <li><h3>User Resources</h3></li>
                <li><a href="http://pubs.acs.org/page/about-us.html">About Us</a></li>
                <li><a href="http://pubs.acs.org/page/membership/index.html">ACS Members</a></li>
                <li><a href="http://pubs.acs.org/page/4librarians/index.html">Librarians</a></li>
                <li><a href="http://pubs.acs.org/page/4authors/index.html">Authors &amp; Reviewers</a></li>
                <!-- <li><a href="/page/4authors/index.html">Students</a></li> -->
                <li><a href="http://pubs.acs.org/page/demo/index.html">Website Demos</a></li>
                <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
                <li><a href="http://pubs.acs.org/?mobileUi=1">Mobile Site</a></li>
            </ul>
            <ul class="support">
                <li><h3>Support</h3></li>
                <li><a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="help">Get Help</a></li>
                <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">For Advertisers</a></li>
                <li><a href="http://pubs.acs.org/page/4librarians/contact-us/index.html">Institutional Sales</a></li>
                <li class="help" href="#"><a href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" class="help help-chat">Live Chat</a></li>
            </ul>
        </div>
    </div>
</div>

<div class="acs-footer-wrap partners">
    <div class="acs-footer">
        <ul>
            <li><h3>Partners</h3></li>
            <li><a href="http://www.atypon.com/" title="Atypon"><img src="./test1_files/atypon-logo.png" alt="Atypon"></a></li>
            <li><a href="http://www.chorusaccess.org/" title="CHORUS"><img src="./test1_files/chorus-logo.png" alt="CHORUS"></a></li>
            <li><a href="http://publicationethics.org/" title="COPE"><img src="./test1_files/cope-logo.png" alt="COPE"></a></li>
            <li><a href="http://www.projectcounter.org/" title="COUNTER"><img src="./test1_files/counter-logo.png" alt="COUNTER"></a></li>
            <li><a href="http://www.crossref.org/" title="CrossRef"><img src="./test1_files/crossref-logo.png" alt="CrossRef"></a></li>
            <li><a href="http://www.crossref.org/crosscheck/index.html" title="CrossCheck Depositor"><img src="./test1_files/crosscheck-logo.png" alt="CrossCheck Depositor"></a></li>
            <li><a href="http://www.orcid.org/" title="Orcid"><img src="./test1_files/orcid-logo.png" alt="Orcid"></a></li>
            <li><a href="http://www.portico.org/" title="Portico"><img src="./test1_files/portico-logo.png" alt="Portico"></a></li>
        </ul>
    </div>
</div>

<script src="./test1_files/chat-pubs.js"></script>
<script>
ACSPubs.login.listenerActive = false;
ACSPubs.login.listen = function (callback){
        var done = false;
        if(ACSPubs.login.listenerActive == false){
            ACSPubs.login.listenerActive= true;
            var interval = setInterval(function(){
                if(document.cookie.match(/(?:^|;) ?ERIGHTS=([^;$]+)(?:;|$)/)){
                    done = true;
                    listenerActive = false;
                    clearInterval(interval);
                    return callback();
                }
            }, 1000);
        }    
    };</script></div>
        </div>
    </div>
    



    
    
    
    
    
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
        
    
    
        
    
        
    
        
    
        
    
        
    
        
            
            
            
        
    
        
    
        
    
        
    
    
    

    
    <div class="widget general-html none hide widget-none" id="fe197482-aec7-44dd-8734-ca0859abfaa5">
        
        
            
        

        <div class="wrapped " id="link-to-top">
            
            <div class="widget-body body body-none "><script type="text/javascript">
function backToTop() {
    var offset1 = $('body').scrollTop();
	var offset2 = $('html').scrollTop();
	var offset = offset1 + offset2; /* because one of these will be zero, depending on browser */
    var winWidth = $(window).width();
    var winHeight = $(window).height();
    var viewportBottom = offset + winHeight;
    var linkTrigger = winHeight * 2;
    var linkToTop = '<a id="linkToTop" style="display:none;" title="Return to top" href="#" onclick="$(\'body,html\').animate({scrollTop: $(\'body,html\').offset().top});return false;">&nbsp;<\/a>';

    // insert link to top when scrolled past 2x the viewport height
    // only show it if the user's window is big enough (<1110px)
    if ($('#linkToTop').length && $('#linkToTop').is(':visible')) {
        if (winWidth < 1110) {
            $('#linkToTop').remove();
		}
        else if (viewportBottom < linkTrigger) {
            $('#linkToTop').fadeOut();
		}
	}
   	else if (winWidth > 1110 && viewportBottom > linkTrigger) {
		if ($('#linkToTop').length==0) {
			$('body').append(linkToTop);
		}
		$('#linkToTop').fadeIn();
    }
};
$(function() {
	setInterval("backToTop()", 1000);
});

// a general show/hide toggle function
function toggleView(link, animate) {
    var target = $(link).parents('div:eq(0)').find('.toggled');
    var linkText = $(link).html();

	if ($(target).is(':visible')) {
		$(link).html(linkText.replace("Hide","View"));
	}
	else {
		$(link).html(linkText.replace("View","Hide"));
	}
	
    if (!animate) {
        $(target).toggle();
	}
	else {
		$(target).fadeToggle();
	}
}
</script>

<script type="text/javascript">

    var _elqQ = _elqQ || [];
    _elqQ.push(['elqSetSiteId', '1913652004']);
    _elqQ.push(['elqTrackPageView']);
    (function () {
    function async_load() {
    var s = document.createElement('script'); s.type = 'text/javascript';
    s.async = true; s.src = '//img.en25.com/i/elqCfg.min.js';
    var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore (s, x);
    }
    if (window.addEventListener) window.addEventListener('DOMContentLoaded',
    async_load, false);
    else if (window.attachEvent) window.attachEvent('onload', async_load);
    })();
    
</script></div>
        </div>
    </div>
    
    </div>
</footer></div>
        </div>
    </div>
    
        </div>
    </div>


<ul class="ui-autocomplete ui-front ui-menu ui-widget ui-widget-content ui-corner-all quickSearchAutocomplete" id="ui-id-1" tabindex="0" style="display: none;"></ul><ul class="ui-autocomplete ui-front ui-menu ui-widget ui-widget-content ui-corner-all quickSearchAutocomplete" id="ui-id-2" tabindex="0" style="display: none;"></ul><script type="text/javascript" src="./test1_files/acs.molpharmaceut.7b00039"></script><div id="_atssh" style="visibility: hidden; height: 1px; width: 1px; position: absolute; top: -9999px; z-index: 100000;"><iframe id="_atssh342" title="AddThis utility frame" style="height: 1px; width: 1px; position: absolute; top: 0px; z-index: 100000; border: 0px; left: 0px;" src="./test1_files/sh.886bb8b2fb82aeab6a228151.html"></iframe></div><style id="service-icons-0"></style><div id="SnapABug_W" style="position: fixed; display: none; top: 0%; left: 0px; width: 100%; height: 100%; z-index: 2147483644; margin: 0px; padding: 0px; border-collapse: collapse; border-spacing: 0px; border: none; list-style: none; text-align: left; font-size: 100%; font-weight: normal; outline: none; background-image: url(&quot;http://chtatic.appspot.com/wbg/blank.gif&quot;); background-repeat: repeat;"><div id="SnapABug_O" style="position:absolute;width:100%;height:100%;top:0px;left:0px;text-align:left;z-index:auto;-moz-opacity:0.5;opacity:.50;filter:alpha(opacity=50);background-color:white;"></div></div><div id="SnapABug_WP" style="position: fixed; display: none; z-index: 2147483645; overflow: hidden; margin: 0px; padding: 0px; border-collapse: collapse; border-spacing: 0px; border: none; list-style: none; outline: none;"><div id="SnapABug_P" style="position:absolute;left:0px;top:0px;margin:0;padding:0;border:none;text-align:left;z-index:1;overflow:hidden;background-color:transparent;"></div><div id="SnapABug_IP" style="position:absolute;left:0px;top:0px;z-index:0;"></div><div id="SnapABug_DB" style="position:absolute;left:0px;top:0px;margin:0;border:0;padding:0;z-index:1;cursor:move;background-image:url(&#39;http://chtatic.appspot.com/wbg/blank.gif&#39;);background-repeat:repeat;"></div></div><div id="SnapABug_Applet" style="position: fixed; display: none; top: 0%; left: 0px; width: 100%; height: 2px; text-align: left; z-index: 2147483646;"></div><iframe id="google_osd_static_frame_5672471509039" name="google_osd_static_frame" style="display: none; width: 0px; height: 0px;" src="./test1_files/saved_resource(1).html"></iframe><figshare-overlay class=""><div data-reactroot=""></div></figshare-overlay><div id="fb-root" class=" fb_reset"><div style="position: absolute; top: -10000px; height: 0px; width: 0px;"><div></div></div><div style="position: absolute; top: -10000px; height: 0px; width: 0px;"><div><iframe name="fb_xdm_frame_http" frameborder="0" allowtransparency="true" allowfullscreen="true" scrolling="no" id="fb_xdm_frame_http" aria-hidden="true" title="Facebook Cross Domain Communication Frame" tabindex="-1" src="./test1_files/XBwzv5Yrm_1.html" style="border: none;"></iframe><iframe name="fb_xdm_frame_https" frameborder="0" allowtransparency="true" allowfullscreen="true" scrolling="no" id="fb_xdm_frame_https" aria-hidden="true" title="Facebook Cross Domain Communication Frame" tabindex="-1" src="./test1_files/XBwzv5Yrm_1(1).html" style="border: none;"></iframe></div></div></div><a id="linkToTop" title="Return to top" href="http://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.7b00039#" onclick="$(&#39;body,html&#39;).animate({scrollTop: $(&#39;body,html&#39;).offset().top});return false;" style="display: block;">&nbsp;</a></body></html>